{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e1_kg_minimal/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-04T00:35:42.221558"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "The Colgate‑Palmolive filing (shown in both Chunk 1 and Chunk 2) reports that equity‑compensation plans approved by security holders have **37,028 thousand securities remaining available for future issuance** (≈ 37 million). Procter & Gamble’s filing (Chunk 3) shows that its equity‑compensation plans approved by security holders involve a **total of 133,185,995 securities** across stock options, restricted stock units and performance stock units, which is roughly **3.6 times larger** than the amount remaining available at Colgate‑Palmolive.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 37,028 thousand (i.e., 37,028,000) for Colgate-Palmolive and 133,185,995 for Procter & Gamble are correctly reported, with appropriate rounding noted (≈37 million). The comparison stating that PG's available securities are roughly 3.6 times larger is accurate: 133,185,995 ÷ 37,028,000 ≈ 3.60. (2) The answer is complete, addressing both companies' equity compensation plan availability and directly comparing them as required by the multi-part question. (3) Entity accuracy is correct—Colgate-Palmolive (CL) and Procter & Gamble (PG) are properly identified, and the relevant securities (stock options, RSUs, PSUs) are correctly attributed to PG’s filing. (4) The reasoning is sound: the model correctly synthesizes data from separate filings (implied by reference to chunks), performs a valid quantitative comparison, and draws the correct conclusion about relative scale. (5) The semantic meaning fully aligns with the original answer, even enhancing it with a precise multiplicative comparison. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 330,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s foreign‑exchange forward contracts are designated as net‑investment hedges.  A 10 % weakening of the U.S. dollar would have reduced the cumulative translation adjustment (CTA) recorded in AOCI by about **$946 million for 2023 and $660 million for 2024** – a relatively modest exposure measured in the low‑hundreds‑of‑millions.\n\nDisney, by contrast, uses forward and option contracts as cash‑flow hedges of its **forecasted foreign‑currency transactions**.  As of 28 Sept 2024 the net notional amount of those hedges was **$9.9 billion** (up from $8.3 billion a year earlier), and the company’s policy is to hedge such transactions for periods **generally not to exceed four years**.\n\nThus, Disney’s hedge program provides far larger notional coverage (billions versus Google’s sub‑billion CTA impact) and is structured to mitigate currency risk over a multi‑year horizon, whereas Google’s sensitivity reflects a smaller, short‑term translation‑risk effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key numbers are correct: Google's $660 million AOCI impact as of December 31, 2024, from a 10% USD weakening is accurately reported. The LLM adds $946 million for 2023, which is not in the original answer but does not contradict it—this extra detail may come from additional data and does not reduce accuracy. Disney's $9.9 billion notional exposure as of September 28, 2024, and the four-year risk mitigation horizon are correctly stated. (2) The comparison of notional exposure (billions for Disney vs. sub-billion for Google) is valid and well-reasoned. (3) Entity and metric accuracy is strong: both companies are correctly identified, with proper distinction between Google’s net investment hedges (affecting AOCI/CTA) and Disney’s cash flow hedges of forecasted transactions. The reasoning correctly synthesizes multi-hop information: different hedge objectives (translation risk vs. earnings stability), instruments used, and time horizons. (4) The answer is contextually complete and relevant, directly addressing notional exposure and risk mitigation horizon as asked. The only minor deviation is the inclusion of the 2023 figure for Google, which, while not in the original answer, does not introduce error. Overall, the semantic meaning and factual content match the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Hedges]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 393,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble’s 2022 filing (Chunk 1) lists the securities remaining available for future issuance under equity‑compensation plans only as footnote references – “(1)” for each plan and “(2)” for the total – with no numeric total shown. By contrast, Colgate‑Palmolive’s filing (Chunks 2‑3) explicitly reports 37,028 thousand (≈37 million) securities remaining available under the same “Equity compensation plans approved by security holders” category. Consequently, Colgate‑Palmolive’s disclosed figure is about 37 million, whereas Procter & Gamble’s figure is not provided in the excerpt, so a direct numeric comparison cannot be made.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Procter & Gamble's figure is not provided in the excerpt, when in fact the ground truth confirms that P&G reports 133,185,995 available securities. This is a major factual error. Colgate-Palmolive’s number (37,028,000 or 37,028 thousand) is correctly identified. (2) Quantitative accuracy is partially correct for Colgate-Palmolive (37,028 thousand = 37,028,000), but fails on P&G’s side—where the correct number is available in the source data but claimed as 'not provided.' The comparison fails due to omission of P&G’s actual figure. (3) The reasoning is flawed: the LLM claims a direct comparison cannot be made due to missing data, but the ground truth shows both figures are available and comparable. This breaks the multi-hop synthesis requirement—comparing two companies’ equity plan availability. (4) Contextual relevance is moderate because the response addresses the right category and companies, and interprets Colgate’s data correctly, but fails the core task of comparing both disclosed figures. The conclusion that a comparison cannot be made contradicts the ground truth, which clearly enables one. Thus, despite correct identification of Colgate’s number and category, the failure to report P&G’s actual figure severely undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 367,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie has opened a direct infringement suit in the Delaware federal court (filed Nov 2023) accusing Sandoz, Inc. and related entities of infringing AbbVie’s upadacitinib (Rinvoq) patents and is seeking declaratory and injunctive relief. Amgen’s case, filed in the New Jersey district court, likewise targets Sandoz – this time over a denosumab biosimilar – and Amgen is pursuing a judgment and permanent injunction (plus monetary damages) while moving to dismiss Sandoz’s counterclaims that the asserted patents are invalid or unenforceable. Thus, both companies are using patent‑enforcement actions to block Sandoz’s generic launches, with AbbVie suing for infringement of upadacitinib and Amgen defending its denosumab patents by seeking injunctions and rejecting Sandoz’s invalidity counterclaims.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AbbVie's offensive litigation posture against Sandoz over upadacitinib and Amgen's defensive posture in the denosumab case, where Sandoz has filed counterclaims of patent invalidity. The core factual elements—companies (AbbVie, Amgen, Sandoz), drugs (upadacitinib/Rinvoq, denosumab biosimilar), legal actions (infringement suits, counterclaims), and remedies sought (injunctive relief, dismissal of counterclaims)—are all correct. (2) Quantitatively, the LLM adds specific details not in the original answer—such as the November 2023 filing date and the courts (Delaware and New Jersey)—which are plausible and consistent with public records, though not present in the ground truth. Since the original answer does not include dates or court names, their inclusion is a value-add rather than an error, and they do not contradict the ground truth. No calculations are involved, so numerical accuracy is not applicable. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies are engaged in patent litigation with Sandoz but in different legal roles—AbbVie as plaintiff initiating enforcement, Amgen as defendant responding to counterclaims while seeking to uphold its patents. The contrast in legal dynamics is accurately conveyed. (4) The LLM slightly enhances the original answer with jurisdictional and procedural details, but the semantic meaning and factual core remain equivalent. The only reason for not scoring a 10 is that the original answer emphasizes the *contrasting legal dynamics* more explicitly, while the LLM focuses more on parallel enforcement actions, slightly underemphasizing the offensive vs. defensive distinction. However, this is a nuance in framing, not a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP -[Discloses]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 494,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s charter locks the voting power of its high‑vote shares in place: each Class B share carries 15 votes and the Class B series as a whole always controls roughly 33 ⅓ % of the company’s total votes, a level that “cannot be diluted by additional issuances of any other class of common stock.”  When a Class B share is converted share‑for‑share into Class A, the voting power of the Class B pool is preserved and the voting weight of the new Class A share simply reflects the relative numbers of Class A and Class B shares outstanding.  \n\nAlphabet’s (GOOGL) structure works the opposite way.  Class B shares have 10 votes, Class A shares have one vote and Class C shares have none, and any Class B holder may convert to Class A at any time (which would cut the per‑share voting power from 10 to 1).  Rather than a statutory non‑dilution clause, Alphabet has concentrated voting power by buying back low‑vote shares – it repurchased **$62.2 billion** of Class A and Class C stock in 2023, shrinking the pool of one‑vote and no‑vote shares and thereby increasing the relative influence of the remaining Class B shares.  \n\nSo, CMCSA protects its Class B voting strength through a non‑dilutable 33 ⅓ % aggregate share, while GOOGL relies on optional conversion plus massive repurchases of lower‑voting Class A and C shares to concentrate voting power in its high‑vote Class B stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have 15 votes and are capped at 33 1/3% aggregate voting power with anti-dilution protection; GOOGL's Class B shares have 10 votes and convert to 1-vote Class A shares upon conversion; GOOGL repurchased $62.2 billion in Class A and C shares in 2023. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount is correctly cited, and the 33 1/3% voting cap is accurately represented. (3) Multi-hop reasoning is sound: the answer correctly contrasts CMCSA’s structural anti-dilution mechanism (constitutional cap) with GOOGL’s dynamic concentration via share repurchases and conversion rules. It synthesizes information across both companies’ stock structures and the impact of GOOGL’s 2023 repurchases. (4) The explanation is clearer than the original in some respects, explicitly framing the contrast between 'non-dilutable percentage' (CMCSA) vs. 'concentration via buybacks' (GOOGL). Wording differs but meaning is preserved and enhanced. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 324,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 Form 10‑K discloses, in the Equity Compensation Plan information (Item 12), that **97,567,370 shares are remaining available for future issuance** under the plan (Chunk 2, referenced in the governance discussion of Chunk 1).  \n\nTesla’s 2023 Form 10‑K shows that **outstanding warrants represent 11 shares** in the diluted‑EPS computation (Chunk 3).  \n\nThus, the shares Nike has set aside for future issuance are roughly **97.6 million – i.e., about 8.9 million times – more** than the 11 shares represented by Tesla’s outstanding warrants.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error: it states that Tesla's outstanding warrants represent '11 shares', whereas the ground truth correctly reports 11 million shares. This is a massive discrepancy—off by a factor of one million—rendering the quantitative comparison completely invalid. The Nike figure (97,567,370 shares) is correct. (2) The calculation comparing 97.6 million to 11 shares, resulting in '8.9 million times more', is mathematically absurd due to the erroneous Tesla number. The correct comparison would be approximately 8.9 times more (97.6M vs 11M), not 8.9 million times. (3) While the model correctly identifies the relevant data points from the correct filings and attempts multi-hop reasoning by comparing shares from two different companies' 2023 10-Ks, the reasoning collapses due to the Tesla number error. (4) Contextual relevance is high—the model understands the question structure, cites correct documents and sections, and attempts a direct comparison. However, the quantitative inaccuracy is so severe that the conclusion is entirely misleading, warranting a very low correctness score despite partial structural accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 328,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "- **Tesla (2023 10‑K)** – In the diluted‑EPS reconciliation, Tesla reports that the warrants outstanding would add **11 shares** (the “Warrants” line in the “Add:” section of the weighted‑average‑shares table on page 63).  \n\n- **Nike (2023 10‑K)** – Nike’s equity‑compensation‑plan table shows that there are **97,567,370 shares** still available for future issuance under its equity compensation plans (the “Number of securities remaining available for future issuance” column on page 101, which is referenced in the corporate‑governance and executive‑compensation sections on page 96).  \n\n**Comparison:** Nike’s pool of shares that can still be issued under its compensation plans (≈ 97.6 million) is vastly larger than the 11 shares Tesla reports could be issued upon exercise of its outstanding warrants.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the Tesla share count: it reports '11 shares' instead of '11 million shares', which is a severe quantitative inaccuracy. The original answer and ground truth clearly state 11 million shares, a figure confirmed in Tesla's 2023 10-K. The Nike number (97,567,370 shares) is correctly reported. (2) The calculation and comparison are therefore fundamentally flawed: stating that 11 shares (Tesla) are vastly smaller than ~97.6 million (Nike) is technically true but misleading and incorrect in magnitude due to the Tesla number being off by six orders of magnitude. This undermines the entire comparison. (3) The multi-hop reasoning structure is sound—correctly identifying the relevant disclosures in both companies' 10-Ks and synthesizing them for comparison—but the reasoning collapses due to the erroneous Tesla figure. The sources cited (page numbers, table descriptions) appear plausible and contextually appropriate, indicating correct document navigation. (4) The contextual relevance is high because the answer addresses the right documents, metrics, and comparison framework. However, the quantitative accuracy is extremely low due to the '11 shares' error, which renders the conclusion invalid despite correct sourcing. The qualitative accuracy is partially correct due to proper identification of disclosure locations and intent, but the factual error in magnitude severely limits usefulness. Correctness score is low because financial data must be numerically precise, especially in multi-hop comparisons involving scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 438,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s 2024 Form 10‑K (Note 11) makes clear that its Class B common stock carries **ten votes per share**, whereas Class A carries one vote and Class C carries none.  Because Class B shares can be held and converted at the option of the stockholder, the holders of those shares (largely founders and insiders) retain a disproportionate ability to elect directors and approve major corporate actions, concentrating control in a small group even if their economic ownership is modest.  \n\nNetflix’s 2024 Form 10‑K (Voting Rights section) states that **each share of common stock is entitled to one vote**, giving every shareholder an equal vote on all matters.  This “one‑share‑one‑vote” model spreads voting power proportionally to economic ownership, producing a more democratic governance structure without a controlling class.  \n\nThus, GOOGL’s 10‑to‑1 voting differential centralizes decision‑making authority in its Class B holders, while NFLX’s uniform voting rights distribute influence evenly among all shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights are accurately reported: GOOGL's Class B has 10 votes per share, Class A has 1, and Class C has none; NFLX has 1 vote per share. These numbers exactly match the original answer. (2) The answer is complete, addressing both companies' voting structures and their implications on corporate governance. It correctly contrasts GOOGL's differential voting model with NFLX's uniform model. (3) Entity accuracy is perfect: GOOGL (Alphabet) and NFLX (Netflix) are correctly identified, and the references to their 2024 10-K filings are consistent with the knowledge source. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the structural difference in share classes to their governance implications—centralized control vs. egalitarian/democratic voting. The conclusion about disproportionate control in GOOGL versus proportional influence in NFLX is logically derived and semantically equivalent to the ground truth. Minor enhancements like citing specific sections of the 10-K (e.g., Note 11, Voting Rights section) add precision without introducing error. Wording differs slightly but conveys identical meaning. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 362,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s stake in Qatargas Operating Company Limited gave it a 30.0 % interest in the QG3 project, which means that 30 percent of Chevron’s average daily net crude‑oil production in 2021 came from QG3 (as shown in the tables in both Chunk 2 and Chunk 3). The CVX filing (Chunk 1) does not add further detail to this percentage.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claim. The ground truth states that Chevron's net crude oil production from the QG3 project was 13 thousand barrels per day (MBD) in 2021, but it does not state that this 13 MBD represents 30% of Chevron's total average daily net crude oil production. Instead, the 30% refers to Chevron's ownership stake in Qatargas, meaning that the 13 MBD is Chevron's 30% share of the QG3 project's output—not that 30% of Chevron's total production came from QG3. The LLM incorrectly interprets the 30% ownership stake as the percentage contribution to Chevron's total crude production, which is unsupported by the data. This is a critical error in both quantitative accuracy and reasoning. The answer fabricates a percentage (30% of total production) that is not present in the original answer or logically derivable from the provided information. While the entity names (Chevron, Qatargas, QG3), year (2021), and ownership percentage (30%) are correctly identified, the synthesis and conclusion are invalid. The contextual relevance is moderate because it discusses the right entities and project, but the core answer misrepresents the relationship between the stake and production share.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 345,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "ASU 2022‑04 requires every buyer that uses a supplier‑finance program to disclose, each year, the program’s key terms, where the amounts appear on the balance sheet and a **roll‑forward of the outstanding balances**. The roll‑forward provision became effective on January 1 2024, and both 3M and Honeywell have adopted it.\n\n* **3M** – In Note 16 the filing now shows the year‑end confirmed‑invoice balances (≈ $0.3 billion at both 12/31/2024 and 12/31/2023) and the activity during 2024 (about $1.5 billion of invoices confirmed and $1.5 billion paid, plus adjustments). These figures constitute the roll‑forward required by ASU 2022‑04, giving investors a clear view of how the obligation changes over time.\n\n* **Honeywell** – The company’s notes state that it adopted the ASU on 1 Jan 2023 and began providing the roll‑forward disclosure on 1 Jan 2024. Although the guidance does not change recognition or measurement, the required roll‑forward now shows the amount outstanding at each period‑end, thereby increasing the transparency of Honeywell’s supplier‑finance liabilities.\n\nThus, the adoption of ASU 2022‑04 enhances transparency for both firms by obligating them to present a period‑to‑period roll‑forward of supplier‑finance obligations starting in 2024, allowing stakeholders to track the size and movement of those liabilities more clearly.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core impact of ASU 2022-04 on transparency for both 3M and Honeywell, particularly regarding the new roll-forward disclosure requirements effective in 2024. It correctly identifies that both companies adopted the roll-forward provisions starting in 2024 and that this enhances transparency. The qualitative reasoning is sound: it explains the purpose of the roll-forward, its location in financial notes, and its benefit to stakeholders. However, there is a key quantitative discrepancy: the LLM states that 3M's year-end confirmed-invoice balances were approximately $0.3 billion at both 2023 and 2024 year-ends. This conflicts with the ground truth, which reports $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024—but does not mention a $0.3 billion ending balance. The $0.3 billion figure appears to be incorrect or at least unsupported by the ground truth, suggesting a potential misreading of data. While the $1.5 billion confirmed and $1.5 billion paid figures are accurately cited, the inclusion of the $0.3 billion ending balance introduces a factual inconsistency. Additionally, the LLM claims Honeywell adopted the ASU on January 1, 2023, but the ground truth states adoption began in 2024, aligning with the phased implementation—this is a minor error in timing. Despite these issues, the answer correctly synthesizes multi-hop information (ASU requirement → application to both firms → specific disclosures → impact on transparency), and the overall message about improved comparability and visibility is consistent with the original. Wording differences are acceptable under semantic equivalence, but the numerical and date inaccuracies prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 473,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "LMT treats its U.S. Government work as a FAR‑governed cost‑plus arrangement – the contract price is set at estimated or actual costs plus a reasonable profit, variable consideration is constrained to avoid reversal, and revenue is recognized over time as work‑in‑process is transferred to the government under clauses that give the customer ownership and a termination‑for‑convenience right. RTX, however, is financially exposed because most of its U.S. Government contracts are fixed‑price (firm‑fixed‑price or fixed‑price‑incentive); under those contracts RTX receives a set price and must absorb any cost overruns (or lose upside on cost underruns), and it also bears the risk of terminations, funding delays or OTA‑type contracts. Both companies operate under the FAR (as noted in the regulatory discussion), but LMT’s revenue‑recognition method is designed to mitigate reversal risk, whereas RTX’s reliance on fixed‑price structures creates a higher profit‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: LMT uses a cost-plus-fixed-fee model under FAR, which provides cost reimbursement plus a reasonable profit, and revenue is recognized over time with controls to avoid reversal of variable consideration. RTX faces financial exposure due to its reliance on firm fixed-price (FFP) and fixed-price-incentive contracts, where it absorbs cost overruns. Both are subject to FAR and U.S. Government contract risks, but differ in risk profile. (2) There are no numeric values in the question or answer requiring verification; thus, quantitative accuracy is 10 as no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes LMT's revenue recognition approach with its risk mitigation effect and contrasts it with RTX's higher-risk fixed-price exposure. The mention of termination-for-convenience rights, funding delays, and OTA-type contracts adds context beyond the original answer but remains factually relevant and does not introduce error. (4) Semantic equivalence is strong—while the LLM uses more detailed accounting language (e.g., 'variable consideration is constrained', 'work-in-process transferred'), the meaning aligns with the ground truth’s emphasis on predictability for LMT and higher profit risk for RTX. The only reason for not scoring a 10 is that the original answer explicitly notes that LMT’s standalone selling price equals contract price due to FAR mandates, a nuance slightly downplayed in the LLM version, though implied. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 467,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s (BMY’s) composition‑of‑matter patent for Eliquis and its associated SPCs are still in force in Europe – the company is actively litigating to keep the patents alive and to block generic launches, and no expiration date is disclosed, implying that the patent protection will extend beyond the current court actions. In contrast, Merck’s (MRK’s) key U.S. patent on the sitagliptin compound expired in January 2023, but a later‑expiring patent covering the specific sitagliptin salt form keeps U.S. market exclusivity for Januvia until May 2026 (and for Janumet XR until July 2026).  \n\nBecause BMY’s European patents remain valid, its market‑exclusivity strategy is centered on defending those patents to delay generic entry, whereas MRK, having already lost exclusivity in the EU (September 2022‑April 2023), now relies on the later‑expiring U.S. patent and settlement agreements to preserve U.S. exclusivity through 2026. This reflects the KG pattern: BMY depends on its patent‑risk factor to provide regulatory market exclusivity, which in turn limits MRK’s exclusivity prospects in Europe while MRK focuses on extending exclusivity in the United States.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core contrast between BMY's ongoing European patent litigation and MRK's U.S. exclusivity extension through secondary patents, which aligns with the ground truth. However, it contains inaccuracies: it states that BMY's patents are 'still in force' and 'no expiration date is disclosed,' which oversimplifies the situation. The ground truth specifies that generic competition has already entered in Finland and Portugal, and BMY has faced negative rulings in the UK, indicating that exclusivity is already eroding—this nuance is missing. Additionally, the LLM incorrectly implies BMY’s strategy is fully successful, while the original answer highlights mixed outcomes (positive in Norway, Sweden, Switzerland; negative in UK; ongoing appeals). (2) Quantitatively, the LLM correctly states MRK’s key U.S. patent expired in January 2023 and that exclusivity extends to May 2026 for Januvia/Janumet and July 2026 for Janumet XR—this matches the ground truth exactly. However, it omits the specific EU expiration timeline for MRK (September 2022–April 2023), which was mentioned in the original answer and is relevant context. (3) The multi-hop reasoning is partially sound: it correctly contrasts BMY’s European defense with MRK’s U.S. extension strategy. But it misrepresents the effectiveness of BMY’s strategy by not acknowledging actual generic entry, and incorrectly suggests MRK lost exclusivity in the EU due to patent expiry when the original answer focuses on U.S. strategy post-expiry. The claim that 'MRK’s exclusivity prospects in Europe' are limited due to BMY’s actions is factually unsupported and reverses the logic—there is no indication BMY’s actions affect MRK’s European exclusivity. (4) Despite these issues, the answer is contextually relevant and captures the essential strategic difference: BMY is fighting to maintain European exclusivity amid fragmentation, while MRK has secured extended U.S. exclusivity via secondary patents. The core financial and strategic implications are partially conveyed, warranting a score of 7 for correctness, with deductions for factual omissions and one-sided portrayal of BMY’s litigation success.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 587,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of **$35 million** to secure stays of adverse verdicts that are on appeal.  By contrast, since October 2004 the company has **paid roughly $1 billion** in judgments and settlements (plus about $241 million in interest) for tobacco‑related litigation.  Thus the appeal‑bond amount is only a few percent of the total payments made on those judgments and settlements.  (The filing also notes other litigation – e.g., CAD 1.1 billion trust deposits in Canadian class actions – but those figures are separate from the appeal‑bond and payment totals.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported with correct formatting variations (e.g., $1 billion = approximately $1 billion). (2) The answer addresses both parts of the multi-part question: the total appeal bonds posted and the comparison to total payments since October 2004. (3) Entities are correctly identified—PM USA, the time frame (since October 2004), and the types of payments (judgments, settlements, interest) are all accurate. (4) The reasoning is sound: the LLM correctly synthesizes that the $35 million in bonds is a small fraction (a few percent) of the $1 billion in payments, which is a valid qualitative comparison. The mention of Canadian litigation is appropriately noted as separate, showing careful distinction between related but distinct financial outflows. The answer is semantically equivalent to the original, with no factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Posts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 306,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s 2022 Greater China segment – which the filing states “includes China mainland, Hong Kong and Taiwan” – generated **$74,200 million** in net sales (Chunk 1 + Chunk 2). NVIDIA’s 2022 revenue that is directly attributed to Taiwan was **$8,544 million** (Chunk 3). Thus, the Apple segment that contains Taiwan produced roughly **$65.7 billion more** – about **8‑9 times** the amount of revenue NVIDIA earned from Taiwan alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: Apple's Greater China segment revenue of $74,200 million and NVIDIA's Taiwan revenue of $8,544 million match the original answer exactly. The difference calculation ($74,200M - $8,544M = $65,656M ≈ $65.7 billion) is accurate, and the ratio (approximately 8.7 times) is reasonably rounded to '8–9 times,' which is acceptable for qualitative comparison. (2) The answer addresses all parts of the question: it identifies Apple’s revenue contribution that includes Taiwan (within Greater China) and contrasts it with NVIDIA’s direct Taiwan revenue. (3) Entities are correctly identified—Apple, NVIDIA, 2022, Greater China segment, and Taiwan-specific revenue—with proper context from the filings. (4) The reasoning is sound: the model correctly notes that Apple’s figure includes Taiwan but does not isolate it, while NVIDIA’s is direct. It avoids falsely claiming Apple’s Taiwan-specific revenue, which cannot be determined. The only minor shortcoming is that it could have explicitly stated, like the original answer, that Apple’s exact Taiwan revenue is not separately disclosed—instead, it implies this by referencing the broader segment. However, this does not detract significantly from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect factual and logical alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 403,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s Taiwan revenue rose from **$3,025 million in FY 2020** to **$8,544 million in FY 2022** – an increase of **$5,519 million**, or roughly **182 %** growth (more than double).  \n\nApple’s “Greater China” segment (which, per the filing, **includes Taiwan**) grew from **$40,308 million in FY 2020** to **$74,200 million in FY 2022** – an increase of **$33,892 million**, or about **84 %** growth.  \n\nThus, NVDA’s Taiwan revenue grew faster on a percentage basis, while Apple’s Greater China revenue (including Taiwan) grew far more in absolute dollars.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: NVDA's revenue from Taiwan is correctly stated as $3,025 million in FY 2020 and $8,544 million in FY 2022; AAPL's Greater China revenue is correctly given as $40,308 million in 2020 and $74,200 million in 2022. (2) Calculations are precise: the 182% increase for NVDA (actual: ~182.5%, rounded appropriately) and 84% for AAPL (actual: ~84.1%, also reasonably rounded) are correct and consistent with the source data. The absolute dollar increases ($5,519M and $33,892M) are accurate. (3) Multi-hop reasoning is sound: the model correctly identifies that NVDA's revenue is specific to Taiwan, while AAPL's is for the broader Greater China region (which includes Taiwan), and makes a valid comparison on both percentage and absolute growth. (4) The conclusion — that NVDA had higher percentage growth while AAPL had larger absolute growth — is logically derived and adds contextual insight beyond the original answer, without introducing error. All entities, fiscal years, and metrics are correctly identified. The answer is factually complete, semantically equivalent, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 338,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says that the OECD Pillar‑Two rules, which impose a 15 % global minimum tax, will begin to apply to it in fiscal 2025 but it “does not currently estimate a material impact” to its consolidated statements.  Its effective tax rate of roughly 18‑19 % (well above the 15 % floor) and the fact that its foreign earnings are already taxed at lower‑rate jurisdictions such as Ireland mean its projected Pillar‑Two liability is expected to be minimal.  \n\nBroadcom (AVGO), however, notes that many countries are adopting the same global minimum tax and that this “may materially increase our effective tax rate and cash‑tax costs” – for example, Singapore’s adoption will affect its FY 2026 results.  Consequently, Broadcom’s exposure to the minimum‑tax regime is viewed as potentially material, whereas Microsoft’s exposure is judged to be non‑material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft expects no material impact from Pillar Two starting in FY2025, while Broadcom anticipates a material increase in tax rate and cash taxes due to adoption in jurisdictions like Singapore starting FY2026. (2) Quantitative accuracy is excellent: the LLM correctly notes Microsoft’s effective tax rate of 18–19%, which is above the 15% minimum, and correctly identifies the relevant fiscal years (2025 for Microsoft, 2026 for Broadcom). No calculations are required, and all numbers match or are reasonably inferred from the original. (3) Multi-hop reasoning is sound: the model correctly contrasts Microsoft’s limited exposure (due to already high foreign tax rates, e.g., Ireland) with Broadcom’s vulnerability due to reliance on tax incentives in low-rate jurisdictions. The explanation for divergence is logically consistent with the original. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The only minor shortcoming is that the LLM adds a detail not in the original (mention of Ireland as a lower-rate jurisdiction), which, while plausible, is not confirmed in the ground truth. This does not make the answer incorrect but introduces a small assumption. Otherwise, completeness, entity accuracy (Microsoft, Broadcom/AVGO, OECD Pillar Two, Singapore adoption), and contextual relevance are perfect. The answer fully addresses the comparative exposure question with accurate, synthesized reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 424,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "Netflix’s proxy statement makes clear that every share of its common stock is entitled to **one vote per share** on all matters presented to stockholders. Alphabet’s filing, by contrast, specifies that **each Class B share carries ten votes per share** (while its Class A shares have one vote). Because voting power is tied to the number of votes attached to each share, a holder of a Class B share can influence corporate decisions with ten‑times the weight of a Netflix shareholder’s single‑vote share; thus, Class B owners enjoy a disproportionately larger ability to affect board elections, mergers and other shareholder votes, whereas Netflix shareholders’ influence is proportional only to the number of shares they own.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that NFLX common stock carries one vote per share and that GOOGL Class B shares carry ten votes per share, matching the original answer. (2) All quantitative details are correct: the 1:10 vote ratio is accurately represented, and no calculations are required beyond this comparison. (3) The multi-hop reasoning is sound—LLM synthesizes voting rights structures from two different companies (NFLX and GOOGL) and correctly contrasts their impact on shareholder influence. It identifies that disproportionate voting power exists in GOOGL’s structure due to the 10-vote Class B shares, while NFLX maintains proportional influence. (4) The answer is fully relevant, directly addressing how the structural difference impacts shareholder control, including specific examples like board elections and mergers. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 282,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported $2,091 million of sales to Taiwan in 2021 (Chunk 1). Apple’s “Greater China” segment – which the filing explains includes mainland China, Hong Kong and Taiwan (Chunk 2) – generated $74,200 million of net sales in 2022 (Chunk 3). Therefore, AMD’s Taiwan revenue is roughly $72 billion lower, or about 2.8 % (≈1/35) of Apple’s 2022 Greater China revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. It states AMD's 2021 revenue from Taiwan was $2,091 million, but the ground truth is $1,187 million—a major discrepancy. Apple's revenue is correctly reported as $74,200 million from Greater China in 2022. (2) Calculations are based on incorrect inputs: the difference is stated as roughly $72 billion lower, but with corrected numbers, the difference should be about $73.013 billion ($74,200M - $1,187M). The percentage (2.8% or ~1/35) is approximately correct if using the LLM's AMD number, but would be closer to 1.6% using the true value, so this is also inaccurate. (3) The multi-hop reasoning structure is sound—LLM correctly identifies that Apple’s Greater China includes Taiwan and compares the two figures across companies and years. It attempts proper synthesis and makes a logical comparison. (4) Despite correct framing and context (hence high contextual relevance), the severe quantitative inaccuracy in AMD’s revenue number undermines the factual correctness. The model likely pulled an incorrect figure from a wrong chunk or misread the data. This leads to a low quantitative accuracy score and a moderate qualitative score due to correct reasoning. Overall, partial credit is given for correct Apple number and structural logic, but major deductions for wrong AMD revenue and derived metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 386,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of 12/31/2021, whereas Starbucks reported 99.7 million shares of common stock still available for future equity‑based compensation awards as of 10/2/2022. Thus, Starbucks’ remaining equity‑grant capacity is roughly double the amount Tesla has left under its 2019 Plan. Both firms rely on incentive stock options as a key element of their compensation programs—Tesla’s plan expressly permits incentive stock options for employees, and Starbucks’ multiple equity incentive plans also include incentive stock options alongside other awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers 49.0 million shares for Tesla as of December 31, 2021, and 99.7 million shares for Starbucks as of October 2, 2022, are accurately reported with correct dates. The comparison stating Starbucks' remaining capacity is roughly double Tesla's is a reasonable qualitative interpretation and does not overstate the data. (2) Completeness: The answer addresses both parts of the question—comparing available shares under Tesla’s 2019 Equity Incentive Plan and Starbucks’ remaining equity grant capacity, and discussing the role of incentive stock options in both companies’ compensation strategies. (3) Entity accuracy: Both companies are correctly identified, with accurate plan names and time periods. The use of 'incentive stock options' is correctly attributed to both firms, with appropriate context about Tesla’s 2019 Plan and Starbucks’ multiple plans. (4) Reasoning: The multi-hop synthesis across two companies, different plans, and dates is sound. The conclusion about relative grant capacity and strategic use of incentive stock options is logically derived and factually supported. (5) Semantic equivalence: The LLM conveys the same information as the original answer using slightly different phrasing (e.g., 'expressly permits' vs 'explicitly including'), but the meaning is preserved. No factual discrepancies or omissions exist.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 400,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD determines the fair value of its Level 2 assets with a market‑based valuation model that pulls observable inputs—including interest‑rate curves, bond yields and broker‑dealer quotes for similar securities—to estimate price (the 10‑K notes describe this model‑driven approach and Gilead’s similar use of third‑party pricing services). By contrast, BA values its available‑for‑sale debt investments with a pure market approach that simply applies the quoted market price or broker‑dealer quote of an identical or comparable instrument, without an additional modeling step. Thus, GD’s fair‑value measurement is model‑driven and uses broker‑dealer quotes as one of several inputs, whereas BA’s measurement is more directly price‑driven, relying on the broker‑dealer quote itself as the fair value.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—however, since there are no numbers in the ground truth either, the absence of numerical errors earns a score of 10 by default. Contextual relevance is high because the response directly addresses the comparison between GD and BA regarding fair value determination of Level 2 assets. However, the qualitative accuracy is low due to a critical misrepresentation of the companies' methodologies. The original answer states that both GD and BA use valuation models incorporating broker/dealer quotes and third-party pricing services with industry-standard models, indicating a 'parallel approach.' In contrast, the LLM incorrectly frames GD as using a 'model-driven' approach and BA as using a 'pure market approach' without modeling, implying a divergence in methodology. This contradicts the ground truth that both companies use similar, model-informed processes relying on observable inputs like broker/dealer quotes. The LLM introduces a distinction (model-driven vs. price-driven) that is not supported by the original data, suggesting a failure in multi-hop reasoning and synthesis. While the entities (GD, BA, Level 2 assets, available-for-sale debt investments) are correctly identified, the core reasoning about their valuation approaches is factually incorrect, leading to a correctness score of 4—partially correct due to accurate entity identification and context, but significantly flawed in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 411,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Because the Federal Reserve has set the counter‑cyclical capital buffer at **0 %**, the CCyB adds no capital to either firm’s Basel III buffer.  \n\n- **Morgan Stanley** – Under the Standardized Approach its buffer equals the **Stress Capital Buffer + G‑SIB surcharge + CCyB (0 %)**; under the Advanced Approach it equals the **2.5 % Capital‑Conservation Buffer + G‑SIB surcharge + CCyB (0 %)** (the SCB is effectively the only stress‑related component). Thus the total buffer is just the SCB (or the 2.5 % CCB) plus any G‑SIB surcharge, with the CCyB contribution equal to zero.  \n\n- **American Express** – Its regulatory buffers explicitly include the **Stress Capital Buffer** (and the capital‑conservation buffer for its banking subsidiary) together with any G‑SIB surcharge, and the **CCyB is also 0 %**. Consequently, the total buffer for American Express is the SCB (plus the capital‑conservation buffer) with no additional CCyB requirement.  \n\nIn short, the zero‑percent CCyB leaves both companies’ total capital‑buffer requirements unchanged except for the stress‑capital and other required buffers.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key misrepresentation in the description of Morgan Stanley's capital buffer framework. The original answer specifies that under the Advanced Approach, Morgan Stanley's total capital buffer includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB surcharge, and the Stress Capital Buffer (SCB)—with the SCB being incorporated into the Advanced Approach calculation. However, the LLM incorrectly presents two separate approaches (Standardized and Advanced) and implies that under the Standardized Approach, the buffer is SCB + G-SIB + CCyB (0%), while under the Advanced Approach it is CCB + G-SIB + CCyB (0%). This mischaracterizes the regulatory framework: the SCB is not a standalone buffer under the Standardized Approach, and the CCB is a permanent component of Basel III, not an alternative depending on the approach. The SCB is integrated into the Advanced Approach for large banks like Morgan Stanley, and the CCB applies regardless. The LLM also incorrectly suggests that the SCB and CCB are mutually exclusive depending on the approach, which is not accurate. The zero percent CCyB is correctly noted, and its impact—no additional capital requirement for either firm—is accurately conveyed. The treatment of American Express is largely correct: it is subject to the SCB and the CCyB is zero, so no additional buffer is required. The core facts (SCB applies to both, CCyB = 0%, G-SIB surcharge applies) are correct, but the structural explanation of how buffers apply to Morgan Stanley lacks precision in regulatory mechanics. Quantitative accuracy is high: all percentages (2.5%, 0%) are correct, and no incorrect calculations are made. Contextual relevance is strong—the answer directly addresses the question and synthesizes across both firms and regulatory frameworks. However, the flawed reasoning on Morgan Stanley’s buffer composition reduces qualitative accuracy. Thus, the correctness score is 7 due to a significant but not fundamental error in regulatory interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 546,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "The $4 billion increase to AMT’s 2021 Credit Facility raised the revolving‑loan limit to $5.5 billion and, together with the multicurrency facility and the 2021 Term Loan, supplied the roughly $5.1 billion of liquidity that funded the Telxius and CoreSite acquisitions; the ample committed capacity also let AMT cancel a $10.5 billion JPMorgan bridge‑loan commitment that had been intended for the CoreSite deal. In contrast, Simon Property Group does not rely on large credit‑facility borrowings for growth; as of 31 December 2021 it financed its portfolio mainly through equity‑based joint‑venture arrangements and modest construction‑loan advances of about $88.4 million, using partnership structures to share risk rather than drawing on sizable revolving credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AMT's $4.0 billion increased commitment under its 2021 Credit Facility and links it to financing acquisitions like CoreSite, which matches the original answer. It adds contextual detail (e.g., total revolving loan increased to $5.5B, use of liquidity for Telxius and CoreSite, cancellation of $10.5B bridge loan) that is consistent with a deeper understanding of AMT’s financing strategy. (2) Quantitatively, the $4.0 billion increase is correctly stated, and the $88.4 million financing to joint ventures by SPG is accurately reported. The additional figures (e.g., $5.5B total revolver, $5.1B liquidity, $10.5B bridge loan) are not in the original answer but are factually plausible and do not contradict the ground truth; they enhance detail without introducing errors. (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s reliance on large credit facilities with SPG’s use of joint ventures and limited construction loans, capturing the strategic difference in financing approaches. (4) The entity names (AMT, SPG), time frame (as of December 31, 2021), and financial instruments (credit facilities, joint ventures, construction loans) are all correctly identified. The only minor point preventing a perfect 10 is that the original answer emphasizes SPG’s use of joint ventures for 'diversifying risk' and 'real estate development,' which the LLM mentions only implicitly. However, the core contrast in strategy is clearly and accurately conveyed. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 452,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 stores in Taiwan – its count rose from 523 on Oct 3 2021 to 544 on Oct 2 2022, roughly a 4 % increase. Nike’s Greater China segment – which, as Apple’s segment note confirms, includes Taiwan – generated $7.5 billion of revenue in 2022. Thus, the modest net‑increase of 21 Starbucks locations in Taiwan is tiny compared with the multi‑billion‑dollar revenue contribution that Nike derives from the broader Greater China region that also encompasses Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately states that Starbucks added 21 net new stores in Taiwan from FY2021 to FY2022, increasing from 523 to 544 stores, which is approximately a 4% growth—this aligns with the ground truth. The LLM correctly reports Nike's Greater China revenue as $7.5 billion in FY2022 (ground truth: $7,547 million), a negligible rounding difference that does not affect accuracy. (2) All numbers are correct: 523 → 544 is indeed a +21 increase; the percentage (~4%) is accurate (21/523 ≈ 4.01%). Nike’s $7.5 billion is a valid rounding of $7,547 million. The fiscal years (2021 to 2022) match the original answer’s timeframe. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across Starbucks (store count in Taiwan) and Nike (revenue from Greater China), acknowledges that Taiwan is included in Nike’s Greater China reporting (citing Apple’s segment note as external confirmation, though not required, adds credibility), and draws a logical comparison between physical expansion (Starbucks) and financial performance (Nike). (4) The answer is semantically equivalent to the ground truth, with added precision (exact store counts, percentage). The only minor limitation is the slightly stronger comparative language ('tiny compared with') which introduces a subjective framing not present in the neutral tone of the original, but this does not undermine factual correctness. Thus, the answer earns a 9/10 for correctness—excellent, with no factual errors but slight interpretive emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 433,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s OPB plan invests the bulk of its assets in a balanced index fund that is composed of roughly 60 % equities (the remaining 40 % being debt securities) 【Chunk 1†L9-L11】【Chunk 2†L9-L11】.  \n\nIn contrast, 3M’s pension plan held equities with a fair‑value total of **$785 million** as of December 31, 2023 【Chunk 3†L13-L15】.  \n\nThus, Boeing’s indirect equity exposure is expressed as a 60 % share of its plan assets, whereas 3M’s equity holdings are quantified at $785 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 60% equity allocation in Boeing's OPB plan through the balanced index fund is accurately reported, and the $785 million fair value of equities in 3M's pension plan as of December 31, 2023, is correctly stated with proper formatting. (2) The answer is complete, addressing both parts of the multi-hop question: Boeing’s indirect equity exposure percentage and 3M’s total equity fair value. (3) Entity accuracy is perfect—Boeing (BA), 3M (MMM), 'OPB plan', 'pension plan', and the correct date (December 31, 2023) are all correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes information across sources, distinguishing between percentage-based indirect exposure (Boeing via a fund) and absolute fair value (3M), and presents a clear, logical comparison. (5) Semantic equivalence is maintained—though phrased more elaborately, the core facts and their implications match the original answer exactly. No errors in calculation, logic, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 303,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "AMT’s 2021 USD Delayed‑Draw Term Loans were entered into as a component of a multi‑billion‑dollar financing package – the $10.5 billion of committed credit that also included its multicurrency and revolving credit facilities and was used to fund the CoreSite acquisition and other corporate liquidity needs.  By contrast, SPG’s financing for its real‑estate joint‑venture portfolio consists of direct, interest‑bearing construction loans and other advances totalling only $88.4 million, a far smaller dollar amount and a simpler loan‑to‑partner structure rather than a large, multi‑year term‑loan facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $10.5 billion for AMT's financing and $88.4 million for SPG's joint venture financing as of December 31, 2021. The formatting variations (e.g., $10.5 billion vs. $10.5B) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: AMT (American Tower Corporation) and SPG (Simon Property Group), the 2021 timing, and the specific financing instruments—Delayed Draw Term Loans for AMT and interest-bearing construction loans/advances for SPG. (3) The multi-hop reasoning is sound: it synthesizes AMT’s use of term loans for a large-scale acquisition (CoreSite) with SPG’s smaller-scale, joint-venture-oriented financing, correctly contrasting scale, structure, and purpose. (4) The only minor shortcoming is that the LLM slightly downplays the 'delayed-draw' feature of AMT’s term loan—focusing more on the broader credit facility—though it does mention the delayed-draw term loans as a component. It also omits explicit mention that AMT avoided bridge loans, a nuance in the original. However, these omissions do not detract significantly from the overall correctness. The comparison in dollar amounts and financing structure is accurate and well-reasoned, making the answer contextually excellent and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 380,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s 10‑K makes clear that crude oil is the core raw material for its business. Through a 15 % equity stake in the Caspian Pipeline Consortium, CVX is directly linked to the pipeline that, in 2024, moved an average of 1.4 million barrels of crude per day – of which about 1.2 million barrels per day came from Chevron‑operated fields in Kazakhstan (Tengizchevroil and Karachaganak). Thus CVX’s ownership gives it exposure to the same Kazakh crude volumes that underpin XOM’s raw‑material supply, tying the two companies together via the CPC‑transported oil flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that XOM relies on crude oil as a core raw material and that CVX holds a 15% stake in the Caspian Pipeline Consortium (CPC), which aligns with the ground truth. It accurately states that CPC transported an average of 1.4 million barrels per day, with about 1.2 million barrels per day originating from Chevron-operated fields in Kazakhstan (Tengizchevroil and Karachaganak), matching the original answer’s data. These figures are quantitatively precise and consistent with the ground truth, earning full marks for quantitative accuracy. (2) The only minor deviation is the mention of '2024' as the year for the transportation volume, which is not present in the original answer; the ground truth does not specify a year, so this addition, while plausible, introduces an unverified temporal detail. However, since the volume figures are correct and the year does not contradict known data, this is a minor issue. (3) The multi-hop reasoning is sound: the model correctly links CVX’s ownership in CPC to its operations in Kazakhstan, connects the crude transported via CPC to Chevron’s involvement, and ties this to XOM’s dependence on crude oil as a raw material. The conclusion that both companies are linked through CPC-transported oil flow is logically derived and semantically equivalent to the original answer’s implication about supply chain interdependence. (4) The answer is fully contextually relevant, addressing all components of the question—XOM’s reliance on crude, CVX’s CPC ownership, volume transported, and the connection via Chevron’s Kazakh operations. The synthesis across entities (XOM, CVX, CPC, Tengiz, Karachaganak) is accurate and complete. The qualitative score is slightly reduced only due to the unsupported year reference, but overall, the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Transports]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 509,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE warns that the amount it has set aside in its nuclear‑decommissioning funds may be insufficient – the eventual decommissioning cost “could exceed the amount available in NEE’s … decommissioning funds,” creating a direct short‑fall risk. By contrast, Duke Energy’s risk is tied to the market‑linked assets that back its nuclear‑decommissioning trusts; a decline in those assets “may increase the funding requirements” because the trusts “are subject to market fluctuations and will yield uncertain returns.” Both companies therefore face the same underlying environmental, health and financial hazards of nuclear power, but NEE’s exposure is a possible deficit in its dedicated fund, while Duke’s exposure is volatility‑driven uncertainty that could also lead to a funding gap.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or the original answer, so no quantitative inaccuracies are possible; the LLM correctly avoids introducing any false numbers. (2) The answer fully addresses the comparative risk exposure of NEE and Duke Energy regarding nuclear decommissioning funding, capturing the core distinction: NEE faces a direct shortfall risk if costs exceed fund balances, while Duke Energy’s risk stems from market volatility affecting its Nuclear Decommissioning Trust Funds (NDTFs). (3) Entities are correctly identified—NEE and Duke Energy (without erroneous conflation or misnaming), and the financial mechanisms (decommissioning funds, market fluctuations, funding requirements) are accurately described. (4) The multi-hop reasoning is sound: the LLM synthesizes the nature of financial risk for both companies, contrasts their risk profiles (shortfall vs. volatility), and correctly notes their shared exposure to nuclear decommissioning hazards. The conclusion that both could face funding gaps, though via different mechanisms, aligns perfectly with the original answer. Wording differs but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 365,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Both companies treat Level 3 fair‑value measurements as those that depend on inputs that cannot be observed in the market, consistent with the accounting policy that classifies valuations by the observability of their inputs (Chunk 2 and the hierarchy described in Chunk 3). Lowe’s (LOW) explicitly applies an option‑pricing income model to its Level 3 contingent‑consideration investment, using significant unobservable inputs such as total equity value, volatility and expected term (Chunk 1). General Motors (GM) likewise places any instrument whose “significant inputs are unobservable” in Level 3 and, when quoted prices are unavailable, determines fair value with pricing‑service quotes, pricing models or discounted‑cash‑flow techniques that incorporate those unobservable assumptions (Chunk 3). Thus, LOW’s Level 3 measurement is described as a single, clearly‑identified pricing model with unobservable inputs, while GM’s Level 3 approach is broader, using various model‑based valuations that also rely on unobservable inputs, but both conform to the same policy that Level 3 valuations are driven by non‑observable market data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: LOW uses an income-based option-pricing model with unobservable inputs (volatility, expected term) for Level 3 contingent consideration related to its Canadian retail business sale; GM applies unobservable inputs in Level 3 valuations, particularly for GM Financial receivables using models like static pool and economic forecasts. The accounting policy based on input observability is correctly described. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies, identifies their respective use of pricing models and unobservable inputs, and aligns both with the fair value hierarchy based on input observability. The only minor difference is that the LLM answer does not explicitly name 'static pool modeling' or 'unemployment/GDP forecasts' for GM, but it does refer broadly to 'pricing models or discounted-cash-flow techniques that incorporate unobservable assumptions,' which captures the essence. (4) Contextual relevance is perfect—the response directly addresses the comparison between LOW and GM in light of the accounting policy. Wording differs slightly but meaning is preserved. One point deducted from qualitative accuracy for slightly less specificity on GM’s modeling techniques, though not enough to impact overall correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Applies]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 429,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s 2021 Multicurrency Credit Facility (together with its related credit and term‑loan facilities) gave the company a $10.5 billion pool of committed financing – a revolving, high‑capacity source that was used to fund the Telxius and CoreSite acquisitions, repay existing debt and provide general corporate liquidity, and that even served as a backup bridge‑loan commitment that was never drawn.  By contrast, Simon Property Group’s financing of its joint‑venture portfolio is limited to $88.4 million of construction loans and other advances to 84 JV properties, a modest, partnership‑focused deployment that spreads risk across many assets rather than relying on a large corporate‑level credit line.  Thus AMT’s strategy is a massive, flexible liquidity platform for strategic growth, while SPG’s approach is a targeted, risk‑sharing use of relatively small capital within joint‑venture structures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $10.5 billion financing for AMT and the $88.4 million in SPG joint venture financing are accurately reported, with correct context on usage (e.g., Telxius and CoreSite acquisitions for AMT, construction loans to 84 JV properties for SPG). Format variations (e.g., $10.5 billion vs $10.5B) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the financing amounts and the comparative capital deployment strategies and risk diversification approaches. It correctly contrasts AMT’s large-scale, corporate-level revolving credit facility used for strategic acquisitions and liquidity with SPG’s smaller, targeted, partnership-focused construction loans that spread risk across joint ventures. (3) Entity accuracy is strong: American Tower (AMT) and Simon Property Group (SPG) are correctly identified, along with relevant financial instruments (Multicurrency Credit Facility, construction loans), years (2021), and transactions (CoreSite, Telxius). (4) The multi-hop reasoning is sound—synthesizing data across two companies, their financing structures, and strategic implications—while drawing a valid conclusion about differing capital strategies: AMT’s centralized, high-capacity liquidity platform vs SPG’s decentralized, risk-sharing model. The LLM adds contextual depth (e.g., undrawn bridge loan, number of JVs) that enhances accuracy without introducing error. All elements align with the ground truth, making this a factually precise, semantically equivalent, and well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 445,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 Form 10‑K shows that sales to customers in Taiwan were **$1.841 billion**, or about **8 % of its total $22.68 billion** revenue. Qualcomm’s filing does not give a Taiwan‑specific revenue figure, but it states that the company’s **ability to receive consistent chipset supply from its foundry partners—most of which are located in Taiwan—is a critical operational dependency**; a conflict that disrupts those Taiwanese fabs would have a **material adverse impact on Qualcomm’s business**. Thus, AMD’s exposure is a defined, modest share of revenue, whereas Qualcomm’s exposure is a broader, supply‑chain reliance that could jeopardize its entire product output if geopolitical tensions in Taiwan materialize.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.841 billion in sales to Taiwan (equivalent to $1,841 million) and the 8% of total revenue ($22.68 billion) are accurately reported. The percentage is correctly calculated (1.841 / 22.68 ≈ 8.11%, rounded to 8%). (2) Entity accuracy is strong: AMD and QCOM (Qualcomm) are correctly identified, with correct fiscal year 2023 context. (3) Reasoning is sound: the model correctly distinguishes AMD’s revenue exposure from Qualcomm’s supply chain dependency, synthesizing information from both companies’ filings. It accurately reflects that Qualcomm does not disclose Taiwan-specific revenue but emphasizes operational reliance on Taiwanese foundries. (4) The answer captures the core contrast in exposure types—revenue vs. manufacturing—and correctly highlights the material adverse impact a geopolitical disruption would have on Qualcomm. The only minor shortcoming is that the original answer notes AMD’s exposure is 'declining compared to previous years,' a nuance not mentioned in the LLM response, slightly reducing completeness. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and the response is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 361,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Both Starbucks (SBUX) and McDonald’s (MCD) say the 15 % global minimum tax under OECD Pillar 2 will not be material to their consolidated financial statements. Starbucks notes that, although some jurisdictions have already enacted Pillar 2 and others are expected to follow, the tax will not become effective for the company until fiscal 2025 and therefore is not expected to have a material impact. McDonald’s, by contrast, points out that many countries have already enacted Pillar 2 with the earliest effective date for taxable years beginning after December 31 2023, yet it likewise does not expect a material effect on its consolidated results. Both assessments reflect the same industry‑wide view—highlighted in the GE filing—that jurisdictions are adopting Pillar 2 on staggered timelines and companies are monitoring the rollout, but the ultimate impact for both firms is judged to be minimal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SBUX expects no material impact with Pillar 2 effective in fiscal 2025; MCD notes many jurisdictions enacted Pillar 2 effective for taxable years after December 31, 2023, but also expects no material impact. Both are monitoring developments due to phased implementation. (2) Quantitative accuracy is perfect: dates (fiscal 2025, December 31, 2023), percentages (15%), and company tickers (SBUX, MCD) are correct. No calculations required. (3) Multi-hop reasoning is sound—correctly synthesizes information across SBUX and MCD filings and contextualizes within broader OECD Pillar 2 rollout. The mention of GE filing as a source of industry-wide context is extraneous but does not detract from correctness. (4) Semantic equivalence is strong; wording differs slightly but meaning matches. Minor deduction in qualitative accuracy only because the reference to GE is not in the original answer and slightly overreaches, though it doesn't contradict. Otherwise, completeness, entity accuracy, and logic are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 316,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑governance framework makes every line‑of‑business and corporate unit responsible for identifying, assessing and escalating risk, with the CRO and Firmwide Risk Executives overseeing a firmwide, ownership‑driven risk‑assessment process that directly feeds into its stress‑testing program. As a result, JPM’s stress‑testing methodology is embedded in and driven by this enterprise‑wide risk‑assessment and escalation structure rather than being framed primarily as a capital‑adequacy exercise. Goldman Sachs, on the other hand, explicitly links stress testing to its capital‑adequacy and capital‑planning processes, using firmwide, sensitivity and scenario analyses to evaluate whether its capital buffers meet regulatory and internal capital‑adequacy standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers were introduced or misrepresented, scoring 10. (2) The LLM correctly identifies both companies—JPMorgan Chase and Goldman Sachs—and accurately describes their respective risk governance and stress testing approaches. JPMorgan Chase’s firmwide ownership model, with oversight by the CRO and Firmwide Risk Executives, is correctly linked to a governance-driven stress testing process. Goldman Sachs’ explicit connection between stress testing and capital adequacy is also accurately portrayed, including its use of scenario and sensitivity analyses. (3) The multi-hop reasoning is sound: the model synthesizes differences in governance frameworks and traces their implications for stress testing methodology and purpose. The contrast between JPMorgan’s embedded, ownership-driven approach and Goldman Sachs’ capital-adequacy focus is logically drawn and aligns with the ground truth. (4) The only minor shortcoming is slight omission of the mention of 'nonfinancial risks' in Goldman Sachs’ testing, which appears in the original answer. However, the reference to 'firmwide, sensitivity and scenario analyses' implies broad coverage. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the comparative framework and purpose of stress testing. Correctness is excellent, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Requires]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 424,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM’s long‑lived asset base in Kazakhstan was about **$8.5 billion** at year‑end 2021 (the table in Chunk 1 lists $8,463 million).  Chevron (CVX) — which derives a material portion of its upstream earnings from Tengizchevroil (as noted in Chunk 2) — holds a **50 % equity interest** in the joint‑venture and has also made a **$4.5 billion loan** to TCO to fund field development (Chunk 3).  Thus CVX’s direct financial commitment to the Kazakh operation (the loan) is roughly half the size of XOM’s $8.5 billion asset exposure, and the 50 % equity stake adds further, though undisclosed, value beyond the loan.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies XOM's long-lived assets in Kazakhstan as $8,463 million (rounded to $8.5 billion), CVX's 50% equity interest in Tengizchevroil (TCO), and the $4.5 billion loan (stated as $4,500 million in ground truth). All numeric values are accurate with acceptable formatting variations. 2) Quantitatively, the numbers match the ground truth exactly when adjusted for unit presentation ($8,463 million = $8.5 billion; $4,500 million = $4.5 billion). There are no calculation errors. 3) However, the reasoning contains a key flaw: the LLM states that CVX's loan is 'roughly half the size' of XOM's asset exposure, which is factually correct ($4.5B vs $8.5B), but fails to acknowledge the original answer's central point — that CVX's *combined* financial exposure (equity stake + $4.5B loan) may *exceed* XOM's $8.5B asset base. Instead, the LLM treats the loan as smaller and the equity as 'undisclosed' without considering their potential combined magnitude. This misrepresents the comparative financial exposure, which is the core of the multi-hop reasoning. 4) The entities (XOM, CVX, TCO, Kazakhstan), years (2021), and financial terms are all correct. The answer is contextually relevant and well-structured, but the qualitative reasoning falls short in synthesizing the full implication of CVX's dual financial stake. Hence, correctness is reduced to 7 due to incomplete and slightly misleading comparative analysis despite strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 404,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Both companies flag Taiwan‑related geopolitics as a supply‑chain risk. QCOM says its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan.” Likewise, NVDA warns that “geopolitical tensions, such as those involving Taiwan and China… where we have suppliers, contract manufacturers, and assembly partners who are critical to our supply continuity, could have a material adverse impact on us.” Thus, any escalation in Taiwan‑China tensions could disrupt the Taiwan‑based foundry partners that feed both QCOM’s chipsets and NVDA’s component supply, threatening production, deliveries and financial performance for both firms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies both QCOM and NVDA as relying on foundry partners in Taiwan and highlights the risk of geopolitical tensions involving China and Taiwan disrupting their supply chains. The key risks—QCOM's dependence on consistent chipset supply and NVDA's reliance on suppliers, contract manufacturers, and assembly partners in the region—are accurately represented. (2) There are no numerical values, dates, or financial metrics in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ risk disclosures, identifying the common dependency on Taiwan-based manufacturing and the shared vulnerability to geopolitical instability. (4) The wording differs slightly but preserves full meaning, using direct quotes and paraphrasing effectively without introducing errors. All aspects of the question are addressed with high precision and contextual fidelity, justifying top scores across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 343,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company cautions that the substantial environmental‑compliance spending it expects – for new controls, CCR‑facility closures, unit retirements and other regulatory actions – will largely be passed through regulated rates, and “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas. Additionally, many commercial and industrial customers may be affected by existing and future environmental requirements, which for some may have the potential to reduce their demand for electricity or natural gas.” In contrast, Duke Energy’s risk factors focus on the volatility of industrial demand that stems from broader economic conditions: “declines in demand for electricity or natural gas … will reduce overall sales and lessen cash flows, especially as industrial customers reduce production and, therefore, consumption of electricity and the use of natural gas.” Thus, Southern’s potential demand shift is driven by regulatory‑induced cost pass‑through that could suppress industrial usage, whereas Duke’s exposure is tied to macro‑economic swings that cause industrial customers to cut consumption, both posing a risk of lower sales but originating from different underlying forces.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly addresses both parts of the multi-hop question: it explains how Southern Company's environmental compliance costs—though recovered through regulated rates—may reduce industrial demand due to cost pass-through effects and customer-level regulatory burdens. It also accurately contrasts this with Duke Energy’s risk exposure, which centers on industrial demand volatility driven by macroeconomic conditions affecting production levels. (3) The reasoning is sound and synthesizes information across both companies’ risk factors as required. The distinction between regulatory-driven demand reduction (Southern) and economically driven demand shifts (Duke) is clearly and correctly articulated. (4) All entities—Southern Company, Duke Energy, industrial customers, electricity and natural gas demand—are correctly identified and contextualized. The LLM uses direct quotes and paraphrasing that align with the original sources, maintaining factual integrity while enhancing clarity. No omissions or inaccuracies are present. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_on]-> REGULATORY_REQUIREMENT -[Impacted_By]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 376,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s 2024 filing shows that it has $9.9 billion of net foreign‑exchange cash‑flow hedge notional – primarily option contracts that are used to offset the foreign‑currency assets and liabilities arising from its global operations. McDonald’s, on the other hand, discloses its foreign‑currency net‑asset exposures only qualitatively, noting that they are diversified across a broad basket of currencies and listing its largest exposures without providing a dollar amount. Thus, Nike’s hedge position is a concrete, quantified amount of risk it is covering, whereas McDonald’s exposure is described in aggregate terms, making a direct numeric comparison impossible, though both firms rely on hedging (Nike via options, McDonald’s via managing net‑asset positions) to mitigate cross‑border financial risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $9.9 billion notional amount for NKE is accurately reported, matching the original answer. There are no calculations required, so numerical accuracy is perfect. (2) The LLM correctly identifies that MCD does not disclose a dollar amount for its foreign currency net asset exposures, only qualitative descriptions, which makes a direct numeric comparison impossible—this is consistent with the ground truth. (3) On reasoning: the LLM correctly synthesizes that NKE uses derivative hedges (specifically options) to manage transactional risk, while MCD manages risk through balance sheet net asset positioning. However, the LLM slightly mischaracterizes MCD’s approach by implying it still 'relies on hedging' when the original answer emphasizes MCD focuses on balancing assets and liabilities directly rather than using derivatives. This nuance is important—MCD’s strategy is structural (net asset management), not derivative-based hedging like NKE. (4) Despite this minor conflation in terminology, the core contrast in risk management strategies is conveyed. The answer is contextually relevant, addresses the comparison question, and correctly concludes that a direct numeric comparison is not possible. Thus, the correctness score is 8 due to a minor inaccuracy in portraying MCD’s strategy as 'hedging' when it is more accurately described as natural hedging via balance sheet structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 408,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "The Coca‑Cola Company’s link to Ukraine is indirect – it depends on its independent bottler Coca‑Cola HBC, which lists Ukraine as one of many bottling territories (Coca‑Cola HBC is one of the five largest bottlers that together account for about 41 % of Coca‑Cola’s worldwide case volume, but Ukraine’s share of that volume is not disclosed, so the exposure is a relatively small slice of a diversified network).  \n\nProcter & Gamble, on the other hand, has a direct foothold in Ukraine: it operates two manufacturing facilities there, and Ukraine‑related assets – though less than 1 % of total net assets – are essential to its supply‑chain and production stability. Consequently, P&G’s reliance on Ukraine is more direct and potentially more vulnerable to disruption, whereas Coca‑Cola’s exposure is indirect and diluted across a broader bottling portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 41% contribution of the top five bottlers to Coca-Cola's global unit case volume and the less than 1% of net assets attributed to Ukraine for P&G are accurately reported. No calculation errors are present. (2) The LLM correctly identifies the entities: The Coca-Cola Company, Coca-Cola HBC, and Procter & Gamble, with accurate descriptions of their operational relationships to Ukraine. (3) The reasoning is sound: it correctly distinguishes between Coca-Cola’s indirect exposure via a bottler and P&G’s direct ownership of two manufacturing facilities, noting that while P&G’s asset footprint is small, its operational reliance introduces direct supply chain vulnerability. (4) The only minor shortcoming is that the original answer explicitly mentions that P&G faces risks in raw material sourcing and distribution, which the LLM implies but does not state directly. Additionally, the LLM notes that Ukraine’s share within Coca-Cola HBC’s volume is undisclosed (a valid point), which slightly extends beyond the original answer but does not introduce inaccuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning by synthesizing corporate structure, asset exposure, and supply chain implications across two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 386,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "As of December 31 2023, MET reported a Level‑3 fair‑value balance of **$4.551 billion** for its Structured Securities, a category that the notes explain includes commercial mortgage‑backed securities (CMBS) (see MET 10‑K, p. 274 & p. 92). BAC’s 10‑K shows an **amortized‑cost balance of $10.922 billion** for Commercial mortgage‑backed securities (see BAC 10‑K, p. 115). Together the two firms have **$15.473 billion** of CMBS exposure, and MET’s CMBS fair‑value amount is roughly **$6.4 billion (about 42 %) lower** than BAC’s amortized‑cost amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and match the ground truth: MET's CMBS fair value is $4,551 million ($4.551 billion), BAC's amortized cost is $10,922 million ($10.922 billion), and their combined exposure is $15,473 million ($15.473 billion). The LLM correctly reports these figures with acceptable format variation (billion vs million). The comparison stating MET’s amount is ~$6.4 billion (~42%) lower than BAC’s is accurate: $10,922M - $4,551M = $6,371M ≈ $6.4 billion, and ($6,371 / $10,922) ≈ 58.3% of BAC’s value, meaning MET’s is 41.7% lower ≈ 42%. (2) Calculations are precise and correctly derived. (3) Multi-hop reasoning is sound: the LLM synthesizes data from two companies (MET and BAC), two different accounting treatments (fair value vs amortized cost), and correctly compares them while citing appropriate document locations. (4) The only minor shortcoming is that the LLM does not explicitly explain the accounting difference (fair value vs amortized cost) as a reason for the gap in reported values, which the original answer includes for context. However, it does correctly label the metrics, so the distinction is implied. All parts of the question are addressed: combined exposure, individual exposures, and comparison. Thus, the answer is factually complete and highly accurate, warranting a 9/10 due to slight omission in qualitative context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 384,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats to nuclear facilities are identified as a risk for both Duke Energy’s nuclear plants and Southern Company’s nuclear units. For Duke Energy, a cyber incident could trigger additional security‑and‑compliance spending that, combined with market‑driven declines in the value of its nuclear‑decommissioning trust fund (NDTF), would raise the cash needed to fund de‑commissioning obligations and could strain the cash‑flows on which the holding company relies to meet debt‑service and dividend payments. For Southern Company, the same cyber‑intrusion risk could lead to higher NRC licensing and compliance costs—costs that may exceed the amounts held in its de‑commissioning trusts—forcing the company to set aside extra capital and adjust its operational strategy to strengthen cybersecurity and ensure sufficient reserves for nuclear‑related compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face cyber intrusion risks impacting their nuclear operations; Duke Energy's decommissioning trusts are exposed to market fluctuations, which could necessitate additional capital injections; Southern Company faces increased compliance and licensing costs due to cybersecurity requirements. The answer correctly identifies Duke Energy’s subsidiaries and Southern Company’s Southern Nuclear as operators, though it doesn’t name them explicitly—this is a minor omission but not factually incorrect. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound: the LLM correctly links cyber risks to financial and operational consequences—market performance affecting trust funds (Duke) and regulatory compliance costs (Southern Company)—and synthesizes across both companies’ exposures. The logic that underfunded trusts may require additional capital is correctly inferred. (4) The answer is fully contextually relevant, addressing both financial obligations (decommissioning trusts, cash flow strain) and operational strategies (cybersecurity enhancements, reserve planning). The only reason for not scoring a 10 in correctness and qualitative accuracy is the slightly less precise naming of Duke’s subsidiaries (e.g., Duke Energy Carolinas) compared to the original, though the overall meaning and accuracy remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 431,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s (HD) restricted‑stock‑unit awards accrue dividend equivalents on the unvested units, and those equivalents are settled in the form of **additional shares of common stock when the units vest** (the same applies to its deferred‑share awards). Thus, the dividend‑equivalent mechanism directly increases the number of shares issued at vesting.\n\nLowe’s (LOW) ASR settlements in fiscal 2021 generated **additional shares at the time of settlement**, not from vesting. According to the ASR table, the company delivered 0.2 additional shares in Q1 2021, 4.0 in Q2 2021, 1.7 in Q3 2021 and 1.6 in Q4 2021—a total of roughly 7.5 extra shares for the year. So, HD’s extra shares arise from dividend‑equivalent payouts on RSUs, whereas LOW’s extra shares come from contractual ASR deliveries, with LOW’s 2021 additional‑share total explicitly quantified in the settlement data.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the mechanism at HD: dividend equivalents on unvested RSUs are paid in additional shares upon vesting, increasing total shares issued. This aligns with the ground truth. For LOW, it correctly frames additional shares as arising from ASR agreements, a capital return strategy, and not from employee compensation. The qualitative comparison between HD and LOW is sound and captures the essential contrast in origin (compensation vs. capital structure). 2) However, there are key quantitative inaccuracies: the LLM states LOW delivered 0.2M, 4.0M, 1.7M, and 1.6M shares in Q1–Q4 FY2021, totaling ~7.5M. But the ground truth specifies ASR settlements in Q1 (0.2M), Q4 (1.6M), and Q2 (4M)—not Q3. There is no mention of a Q3 1.7M delivery in the original. This introduces a false data point and inflates the total. The correct total is 5.8M (0.2 + 4.0 + 1.6), not 7.5M. The LLM also misorders the quarters and adds a non-existent Q3 transaction. 3) The multi-hop reasoning is strong: it correctly synthesizes HD’s RSU dividend policy from its 10-K and contrasts it with LOW’s ASR activity, distinguishing the nature and timing of share issuance. However, the incorrect ASR data undermines the precision of the comparison. 4) Contextual relevance is high—the answer directly addresses both parts of the question and draws a meaningful contrast. Due to the significant error in LOW’s ASR share numbers and the introduction of a false quarter, the quantitative accuracy is reduced to 6, pulling the overall correctness to 7 despite strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> FIN_INST -[Increases]-> FIN_INST <-[Delivers]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 434,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T’s auditors performed independent sensitivity analyses on the key assumptions used in its $67,854 million goodwill‑impairment test—such as projected terminal growth rates, long‑term EBITDA margins and the weighted‑average cost of capital—to see how changes would affect the fair‑value of the reporting units. Netflix’s auditors used the same type of sensitivity analyses on the historical and forecasted viewing‑hour assumptions that drive the amortization of its content, evaluating how different viewing‑pattern scenarios would change the amount of amortization recorded. Because both companies are audited by the same firm, the auditor applied a parallel approach—using sensitivity analysis to test the material, judgment‑heavy assumptions underlying AT&T’s goodwill valuation and Netflix’s content‑amortization methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on key assumptions like terminal growth rates and weighted average cost of capital is correctly described. Netflix's application of sensitivity analyses to viewing-hour assumptions affecting content amortization is also factually sound. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) is correctly stated, and no calculations are required beyond accurate representation of figures. (3) Multi-hop reasoning is strong: the answer successfully synthesizes information across two companies (AT&T and Netflix), their respective accounting estimates (goodwill impairment and content amortization), and the role of the common auditor in applying sensitivity analyses. The LLM adds slightly more detail (e.g., long-term EBITDA margins, viewing-hour scenarios) not in the original but consistent with plausible audit procedures—this enhances clarity without introducing error. (4) Semantic equivalence is maintained: the core message—that the same auditor applied sensitivity analyses to material, judgment-heavy assumptions in both companies—is preserved and well-articulated. The only minor shortcoming is that the original emphasizes the auditor evaluating 'reasonableness and robustness' of management’s assumptions, a nuance slightly underemphasized in the LLM response, but the substance is intact. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 449,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that regulations such as Europe’s PSD2 give fintechs the ability to route transactions and offer account‑information or payment‑initiation services outside its network, allowing them to build platforms that could “disintermediate” Mastercard and even commoditise the transaction data Mastercard shares with partners. In its 10‑K, Mastercard therefore frames fintech‑developed payment platforms as a competitive product that threatens demand for its integrated offerings.  \n\nVisa, by contrast, describes a “network‑of‑networks” strategy that treats fintechs, digital‑wallets, alternative‑payment providers and RTP networks as strategic partners—working with them to launch new flows, value‑added services and tailored solutions even as regulatory initiatives (e.g., Interchange Fee Regulation, RTP mandates) intensify competition. Thus, while Mastercard sees fintech‑driven platforms as a disintermediation risk, Visa embraces fintechs as collaborators to leverage regulatory‑driven market changes and protect its competitive position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) It correctly identifies Mastercard's concern about disintermediation due to fintechs leveraging regulatory frameworks like PSD2 in the EEA to route transactions outside its network, potentially commoditizing the data it shares—this aligns exactly with the original answer. It also accurately contrasts this with Visa’s 'network-of-networks' strategy, portraying Visa as proactively partnering with fintechs, digital wallets, and alternative payment providers to maintain centrality in the ecosystem. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, references to regulations (PSD2, Interchange Fee Regulation, RTP mandates) are correctly named and contextually accurate, warranting a perfect score. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Mastercard and Visa), their strategic stances toward fintechs, and the impact of regulatory changes in the digital payments space. The only minor shortcoming is that the LLM answer does not explicitly mention Visa’s use of local financial institutions (a detail in the original), nor does it fully elaborate on how Visa sees fintechs as both partners and competitors—though the tension is implied. (4) Contextual relevance is excellent: every part of the question is addressed—Mastercard's concern, Visa's partnership approach, and the role of regulation in shaping competitive dynamics. Overall, the answer is factually correct, well-reasoned, and only slightly less comprehensive than the ground truth, justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Develops]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 487,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "Both companies are subject to the OECD’s Pillar 2 framework, which sets a 15 % global minimum tax on multinational profits. McDonald’s notes that many jurisdictions have already enacted Pillar 2 with the earliest effective date for taxable years beginning after December 31 2023, but the company does not expect the rule to have a material impact on its consolidated financial statements. Starbucks, while acknowledging that some countries have adopted Pillar 2 for years after December 31 2023, says the tax will not become effective for the company until fiscal 2025 and likewise is not expected to be material. Thus, the key difference is timing: McDonald’s earliest exposure is in 2024, whereas Starbucks’ exposure is delayed until fiscal 2025, though both anticipate an immaterial impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: both MCD and SBUX do not expect a material impact from the 15% global minimum tax under Pillar 2; MCD's earliest exposure is for taxable years beginning after December 31, 2023 (i.e., 2024), while SBUX's implementation is delayed until fiscal 2025. The 15% rate and OECD's Pillar 2 framework are correctly cited. (2) Quantitative elements—dates (December 31, 2023, fiscal 2025), percentages (15%), and the absence of material financial impact—are accurately reported with no calculation errors. Format variations (e.g., 'fiscal 2025' vs 'taxable years beginning after December 31, 2023') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their respective implementation timelines, and the common OECD framework, then draws a valid comparison on timing differences. (4) The answer is contextually complete, addressing all parts of the question: the OECD framework, effective dates, and differential impact on MCD vs SBUX. Wording differs slightly but preserves full semantic equivalence. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 342,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "Both BlackRock Institutional Trust Company (BTC) and American Express (AXP) report that they are comfortably above the minimum U.S. banking capital standards.  \n\n- BTC, a wholly‑owned BlackRock subsidiary chartered as a national bank, is subject to OCC‑administered capital rules. Its 2024 calculations show that it “exceeded the applicable capital‑adequacy requirements,” meaning its Common‑Equity Tier 1, Tier 1 leverage and total risk‑based capital ratios are all above the required minima.  \n\n- AXP, supervised by the Federal Reserve (and its bank subsidiary by the OCC), likewise states that as of December 31 2024 it “met all capital requirements… and maintained regulatory capital ratios in excess of those required to qualify as well‑capitalized,” i.e., its CET1, Tier 1, total capital and leverage ratios are above the Federal Reserve thresholds.  \n\nThus, each entity’s capital‑adequacy position exceeds the regulatory minimums, and both are in a strong, well‑capitalized condition, though the filings do not disclose the exact numeric ratios for a more granular comparison.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual information is accurate: both BTC and AXP are confirmed to exceed applicable capital adequacy requirements as of December 31, 2024, with correct references to CET1, Tier 1 leverage, and risk-based capital ratios. (2) There are no numeric values missing or incorrect—while exact percentages are not disclosed in either answer, the LLM correctly notes that filings do not provide granular ratios, which aligns with the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes regulatory frameworks across two entities—BTC regulated by the OCC, AXP supervised by the Federal Reserve with its subsidiary under OCC oversight—and compares their capital adequacy positions under U.S. banking rules. (4) The LLM captures all key elements: both firms exceed minimum requirements, maintain 'well-capitalized' status, and are subject to relevant U.S. regulatory standards. Wording differs slightly but meaning is preserved, including proper use of regulatory terminology and accurate entity identification (BTC, AXP, OCC, Federal Reserve). No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 336,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s joint‑venture financing was limited to $88.4 million of interest‑bearing construction loans, which are shown on its balance sheet as deferred costs and other assets. By contrast, AMT tapped its 2021 Multicurrency Credit Facility for roughly $7.8 billion of borrowings during 2021 – about $5.1 billion of which was used to fund the CoreSite (and Telxius) acquisitions. The contrast shows that SPG relies on modest, project‑level loans to support development partnerships, whereas AMT leans on a large revolving credit facility to finance sizable acquisitions, indicating a far more leverage‑intensive growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $88.4 million in construction loans by SPG is correctly stated. AMT's $7.8 billion in borrowings under the 2021 Multicurrency Credit Facility is accurate, matching the original answer. The breakdown of $5.1 billion used for CoreSite and Telxius acquisitions is not in the ground truth, but this detail may be derived from additional context and does not contradict known facts; however, the original answer emphasizes €2.4 billion ($2.9 billion) of that amount was in euros, which the LLM omits. This is a minor omission but affects completeness of the currency composition. (2) The LLM correctly identifies both companies (SPG and AMT), the relevant financial instruments (construction loans vs. multicurrency credit facility), and the year (2021). (3) The multi-hop reasoning is sound: it contrasts SPG’s project-level joint venture financing with AMT’s large-scale acquisition financing, correctly inferring different strategic approaches—modest development support vs. leverage-intensive growth. (4) The semantic meaning aligns with the original: SPG uses internal, limited financing for development; AMT uses large credit facilities for major acquisitions. The only shortfall is the lack of explicit mention of the euro-denominated portion of AMT’s borrowing, which slightly reduces quantitative completeness. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Supplies]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 417,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "CSCO’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts the fixed‑rate senior note it covers into a floating‑rate exposure; the swap’s gain or loss directly offsets the change in fair value of that $0.5 billion notional, so CSCO’s interest‑rate sensitivity is limited to a relatively small, hedged amount. In contrast, AVGO has $56.3 billion of fixed‑rate senior notes outstanding, and a 50‑basis‑point shift in market rates would move the fair value of those notes by about $1.7 billion, indicating a far larger exposure and much greater sensitivity to interest‑rate fluctuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate senior notes by converting fixed to floating rates (based on SOFR, though SOFR is not explicitly named in the LLM answer, the mechanism is correctly described as a fair-value hedge that offsets fair value changes). AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value impact from a 50 bps rate change are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts ($0.5 billion, $56.3 billion, $1.7 billion) and the 50-basis-point rate shift are correctly stated and consistent with the original. No calculations are required beyond the implied sensitivity, which is correctly represented. (3) Multi-hop reasoning is sound: the model correctly contrasts CSCO’s hedging strategy (reducing interest rate sensitivity via swap) with AVGO’s large unhedged fixed-rate debt exposure, drawing a valid comparative conclusion about relative sensitivity to interest rate fluctuations. (4) The answer is fully relevant, directly addressing the comparison of interest rate sensitivity between the two firms. Minor omission: the LLM does not explicitly name SOFR as the floating rate benchmark, but this detail is not central to the core comparison of sensitivity. Overall, the answer demonstrates precise factual recall, correct synthesis across entities and financial instruments, and clear, logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 420,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike manages its transactional currency risk by entering into forward and **option contracts that are designated as cash‑flow hedges**. Because they are cash‑flow hedges, the fair‑value changes on those contracts are **deferred in other‑comprehensive income (AOCI) and only re‑recognized in earnings when the hedged cash‑flows occur** – the same accounting treatment Disney reports for its $99 million of net deferred gains in AOCI. Tesla, by contrast, holds sizable foreign‑currency‑denominated monetary assets and liabilities but **does not typically hedge them**, so foreign‑exchange gains and losses on those assets flow directly through “other income (expense), net” (e.g., the $523 million swing in 2024) and are **not deferred in OCI**, resulting in immediate earnings volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative contrast between NKE and TSLA in foreign currency hedging strategy: NKE uses option contracts designated as cash flow hedges with gains/losses deferred in AOCI, while TSLA does not typically hedge, leading to immediate recognition of FX gains/losses in earnings. However, there are significant quantitative inaccuracies. The LLM incorrectly attributes the $99 million in net deferred gains to Disney instead of NKE, which is a critical error in entity attribution. The ground truth states that NKE has $99 million in net deferred gains expected to mature in the next twelve months, not Disney. Additionally, the LLM introduces a $523 million swing in 'other income (expense), net' for TSLA in 2024, which is not present in the original answer and lacks support from the provided ground truth. The notional amount of $9.9 billion in foreign exchange hedges for NKE is omitted entirely. While the reasoning structure is sound—correctly explaining the accounting treatment for cash flow hedges versus unhedged exposures—the incorrect numbers and misattribution of data to Disney undermine factual reliability. The contextual relevance is high as the response directly addresses the comparison of hedging strategies and their impact on OCI. However, the quantitative inaccuracies, especially the false attribution of figures to Disney, reduce the correctness score significantly despite otherwise accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 403,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit agreement – dated October 30, 2019 – names **Citibank, N.A.** as the **administrative agent** (and also as a joint lead arranger and book‑manager), and the agreement was first amended on **August 25, 2022** (Amendment No. 1).  \n\nCaterpillar’s five‑year facility – dated September 1, 2022 – likewise designates **Citibank, N.A.** as the **Agent** (the sole agent role is disclosed; no arranger‑book‑manager function is noted), and that facility received its first amendment on **August 31, 2023** (Amendment No. 1).  \n\nThus, while both companies rely on Citibank, N.A. as the primary agent for their credit facilities, Boeing’s agreement is older, gives Citibank additional arranger/book‑manager duties, and was amended in 2022, whereas Caterpillar’s newer 5‑year facility was amended a year later in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All dates are correct — Boeing's agreement dated October 30, 2019, amended August 25, 2022; Caterpillar's agreement dated September 1, 2022, amended August 31, 2023. These match the original answer exactly. (2) Completeness: The response addresses both parts of the question — Citibank's role (administrative agent for Boeing, Agent for Caterpillar) and amendment timelines (2022 vs 2023). It adds value by specifying Boeing’s additional roles (joint lead arranger, book-manager), which are consistent with the ground truth’s mention of a 'dual role'. (3) Entity accuracy: Both companies (Boeing, Caterpillar), the financial institutions (Citibank, N.A.), and the agreements (Five-Year Credit Agreement, 5-Year Facility) are correctly identified with accurate titles and dates. (4) Reasoning: The multi-hop synthesis across two companies and their respective credit agreements is sound. The comparison of Citibank’s roles and the staggered amendment timelines is logically presented and factually accurate. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with enhanced clarity and precision in describing roles and amendment dates. Minor wording differences (e.g., 'Agent' vs 'administrative agent') are acceptable as they reflect standard terminology variations in legal documents. No factual discrepancies or omissions exist.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 405,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s 2024 proxy notes that each share of its **common stock carries one vote per share**. Meta’s filing shows that the company has a separate Class B common‑stock series, and the voting‑rights policy disclosed for Class B common stock (the series held by Meta) provides **ten votes per share**. Accordingly, a Meta Class B share has nine more votes – or roughly ten‑times the voting power – than a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and fully aligned with the ground truth. (1) It accurately states that Netflix's common stock provides one vote per share and Meta's Class B common stock provides ten votes per share, matching the original answer exactly in substance. (2) The quantitative comparison is correct: 10 votes vs. 1 vote per share, and the statement that a Meta Class B share has nine more votes and roughly ten times the voting power is mathematically accurate. (3) The multi-hop reasoning—synthesizing voting rights from two different companies' capital structures—is sound and correctly executed. (4) The entities (Netflix, Meta, Class B common stock) and the context (voting rights per share as disclosed in filings) are correctly identified and compared. Minor wording differences (e.g., 'ten-times the voting power' vs. 'significant disparity') do not affect semantic equivalence; the core information is preserved and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 276,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY disclosed that Cardinal Health supplied 23 % of its drug distribution in 2023 (Chunk 1). Cardinal Health is also a 50 % owner of Red Oak Sourcing, LLC—a generic‑pharmaceutical sourcing venture that CVS co‑owns and fully consolidates in its financial statements (Chunks 2 & 3). Thus, BMY’s reliance on Cardinal Health ties a sizable slice of its supply chain to the same partner that jointly controls the Red Oak entity whose economics are reflected in CVS’s consolidated results, creating a direct link between BMY’s distribution network and CVS’s generic‑sourcing arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: BMY's 23% reliance on Cardinal Health for distribution in 2023, Cardinal's 50% ownership in Red Oak Sourcing, and CVS's consolidation of Red Oak due to being the primary beneficiary. All entities, percentages, and relationships are accurately represented. (2) Quantitative accuracy is perfect: the 23% distribution share and 50% ownership stakes are correctly cited. While the original answer includes the $183 million annual payment from Cardinal to CVS, this figure is absent in the LLM response—this is a minor omission but does not distort any calculation or core financial relationship. (3) The multi-hop reasoning is sound: the LLM successfully connects BMY → Cardinal Health → Red Oak Sourcing → CVS financial consolidation, highlighting the structural interdependency. It correctly infers that BMY’s supply chain is linked to CVS’s financials through shared ownership and consolidation, though it stops short of explaining the indirect economic influence (e.g., how payments affect cost of goods sold or pricing). (4) The answer is contextually fully relevant and semantically equivalent to the ground truth in intent and substance, with only slight reduction in depth regarding financial implications. Thus, high scores across all categories with a 9 on correctness due to the omitted $183M detail that adds explanatory depth in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> COMP <-[Consolidates]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 391,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement and Income Solutions (RIS) business – which the company notes contains “life and annuity‑based insurance and investment products” – is directly exposed to the hypothetical interest‑rate scenarios it models.  In a declining‑rate environment the minimum crediting‑rate guarantees on those long‑duration life and annuity contracts compress gross margins, while a rising‑rate environment can partially offset that compression by allowing cash‑flows to be reinvested at higher yields, so the profitability of MetLife’s Life‑Insurance line is tied to the RIS interest‑rate exposure.  \n\nAIG’s experience is different: its Life‑Insurance reserves are adjusted each year for actuarial‑assumption changes that reflect the same interest‑rate dynamics (e.g., lower projected investment earnings).  Those updates produced a $106 million net‑favorable impact in 2021 (partly offset by lower earnings) and a $101 million net‑unfavorable impact in 2020, showing that AIG’s Life‑Insurance results swing with reserve‑level changes driven by rate‑sensitive assumptions rather than margin compression alone.  \n\nThus, MetLife’s RIS exposure mainly pressures margins on its Life‑Insurance products, whereas AIG’s Life‑Insurance line experiences direct reserve adjustments that can be either positive or negative under similar interest‑rate shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MetLife's margin compression due to minimum crediting rate guarantees and reinvestment risks in its Retirement and Income Solutions (RIS) segment affecting life insurance products is accurately described. The explanation of rising rates enabling reinvestment at higher yields is consistent with the original. For AIG, the $106 million favorable impact in 2021 from actuarial assumption updates (specifically policy fee modeling) is correctly cited, as is the context of lower projected investment earnings creating margin pressure. The LLM adds a new but plausible detail—the $101 million unfavorable impact in 2020—which is not in the original answer but does not contradict it and may reflect broader context from AIG filings; this does not reduce accuracy but slightly exceeds the provided ground truth. (2) Quantitative accuracy is perfect: the $106 million figure for AIG in 2021 is correct in amount and year, and no incorrect calculations are made. (3) Multi-hop reasoning is sound: the model correctly synthesizes how interest rate dynamics affect MetLife’s margins through product guarantees and asset-liability management (ALM), and contrasts this with AIG’s experience of direct reserve adjustments due to actuarial updates—highlighting a structural difference in how each company reflects interest rate impacts. (4) The answer is contextually relevant, directly addressing both parts of the question: MetLife’s exposure and its effect on life insurance, and a comparative analysis with AIG. The only minor gap is that the original mentions MetLife uses ALM strategies and AIG adjusts assumptions/reserves—this is implied in the LLM answer but could be slightly more explicit. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with excellent use of precise terminology and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Includes]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 526,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s battery supply from Panasonic is governed by a long‑running series of contracts.  The filings list a 2011 Supply Agreement (with a 2013 amendment), a 2014 General Terms and Conditions, a 2015 Letter Agreement, successive Gigafactory‑related amendments (2016, 2020 Amended and Restated General Terms), a Production Pricing Agreement, an Investment Letter Agreement (Oct 1 2014), and a set of pricing agreements that target specific cell families – the 2019 and 2021 Japan‑cell pricing agreements (linked to the 2011 supply deal) and the 2020 Gigafactory 2170‑cell pricing agreement.  In addition, Tesla and Panasonic entered into several lease‑related agreements for the Gigafactory facilities.\n\nGeneral Motors, by contrast, discloses in its 2023 Form 10‑K only a high‑level dependency on Panasonic for its battery supply – it notes that GM’s batteries are sourced from Panasonic but does not enumerate individual supply contracts.  Thus, Tesla’s relationship with Panasonic is detailed through multiple, dated supply, pricing and lease agreements, whereas GM’s disclosed relationship is described simply as a reliance on Panasonic for battery sourcing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. It correctly identifies Tesla's key agreements with Panasonic, including the 2011 Supply Agreement (with 2013 amendment), 2019 and 2021 pricing agreements for Japan-sourced cells, and the 2020 Gigafactory 2170-cell pricing agreement. It also references additional supporting agreements (e.g., Investment Letter Agreement, lease agreements, General Terms), which are consistent with the depth of the partnership described in the original answer. The comparison to General Motors is factually sound: GM’s 2023 10-K does state reliance on Panasonic for battery supply but does not specify individual contracts, unlike Tesla’s detailed disclosures. The only minor deviation is that the LLM answer mentions a '2014 General Terms and Conditions' and '2015 Letter Agreement', which are not explicitly listed in the ground truth; however, these may be part of the 'ongoing amendments and investment letters' referenced in the original answer, so they do not constitute clear factual errors. Quantitative accuracy is high—dates and agreement types are correct, and no calculations are required. The reasoning is strong, demonstrating multi-hop synthesis between Tesla’s detailed contractual disclosures and GM’s more general dependency statement. The answer is contextually fully relevant and conveys the same core conclusion: Tesla has a more explicitly defined and contractually secured battery sourcing strategy with Panasonic than GM. Thus, the answer earns a 9 for correctness, with slight deduction only for the inclusion of additional agreements not confirmed in the ground truth, though they are plausible and do not contradict it.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 462,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ’s risk‑management program explicitly uses exchange‑traded commodity futures and options to hedge the price of key inputs such as cocoa, sugar, wheat and energy (Chunk 1).  Because exchange‑traded commodity futures and listed options are classified as **Level 1 financial assets**—valued at quoted market prices on commodity exchanges (Chunk 2)—MDLZ records these instruments at fair value on its balance sheet and manages the associated market‑ and credit‑risk through counterparty limits and hedge‑effectiveness testing.\n\nCostco, on the other hand, states that at the end of 2022 (and 2021) it **did not hold any Level 1 (or Level 3) financial assets or liabilities** measured at fair value on a recurring basis (Chunk 3).  Consequently, Costco’s risk‑management approach does not involve exchange‑traded commodity futures, and it has no fair‑value exposure or hedge accounting related to Level 1 assets.\n\nIn short, MDLZ actively employs Level 1 commodity‑future contracts as a core hedging tool, whereas COST’s disclosures show it holds none of these instruments, indicating a more limited or different use of financial derivatives in its risk‑management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: MDLZ uses commodity futures (cocoa, sugar, wheat, energy) classified as Level 1 financial assets due to quoted market prices; COST disclosed holding no Level 1 or Level 3 financial assets as of end of 2022 (aligns with August 28, 2022 date in ground truth). (2) No numerical inaccuracies: the dates (end of 2022, 2021) are consistent with the original answer’s timeframe; no calculations are required, but the absence of Level 1 assets for COST is correctly stated. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across MDLZ’s use of exchange-traded futures (implying Level 1 classification) and COST’s explicit disclosure of no Level 1 holdings, drawing a valid contrast in risk management strategies. (4) The answer addresses all parts of the question: compares MDLZ’s active use of Level 1 instruments with COST’s non-use, explains the fair value hierarchy context, and links both to their respective risk management approaches. Wording differs slightly (e.g., 'wheat' added as input, not in original but plausible and not contradictory), but meaning and factual content are preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 360,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s senior executives entered Rule 10b5‑1(c) trading plans in late August 2024 – Deirdre O’Brien’s plan covers the shares that will vest between April 1 2025 and October 1 2026 (with no specific share count disclosed) and Jeff Williams’ plan permits the sale of **up to 100,000** shares that vest from April 1 2025 to October 1 2025, with the plans expiring on December 31 2026 and December 15 2025 respectively. Broadcom’s board member Diane M. Bryant adopted a similar Rule 10b5‑1(c) plan on September 23 2024 that allows the **potential sale of up to 15,000** shares and expires on September 12 2025, with no vesting schedule noted. Thus, Apple’s plans involve a far larger possible share volume and a later‑ending sales window (through 2025‑2026) than Broadcom’s more modest 15,000‑share plan that ends in September 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key executives and directors involved—Deirdre O'Brien and Jeff Williams at Apple, and Diane M. Bryant at Broadcom—and accurately reports the adoption of Rule 10b5-1(c) plans in August 2024 (Apple) and September 2024 (Broadcom). The share volumes are correctly stated: up to 100,000 shares for Williams and up to 15,000 for Bryant. However, there is a discrepancy in the expiration dates: the LLM states O'Brien's plan expires December 31, 2026, and Williams' on December 15, 2025, while the ground truth specifies expiration dates in 2025 and 2026 without exact dates. Since the ground truth does not provide exact expiration dates, the LLM's specific dates (Dec 15/31) are likely fabricated or over-specified, which reduces quantitative accuracy. (2) The vesting period for O'Brien (April 1, 2025 – October 1, 2026) is correctly reported, as is Williams’ vesting through October 1, 2025. The LLM correctly notes that no vesting schedule is disclosed for Bryant. The comparison of volume (Apple’s plans involving significantly more shares) and timing (longer horizon for Apple) is accurate and well-reasoned. (3) Multi-hop reasoning is sound: the model synthesizes data across two companies, compares volume and timing, and draws a valid conclusion about scale and duration differences. (4) The answer is contextually excellent, directly addressing the question about volume and timing. The only issue is the introduction of unverified exact expiration dates not present in the ground truth, which prevents a 9–10 correctness score. Overall, core facts and comparisons are correct, but minor over-precision in dates slightly undermines quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> ACCOUNTING_POLICY <-[Affects_Stock]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 467,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s Five‑Year Credit Agreement dated May 11 2023 (Chunk 1) and Honeywell’s Amended and Restated Five‑Year Credit Agreement dated March 20 2023 (Chunk 3) name JPMorgan Chase Bank, N.A. as a syndication agent. The KG triplet (Three‑Month Credit Agreement → JPMorgan Chase Bank, N.A. → Honeywell) confirms that the same bank is linked to each company’s credit facility, showing that 3M and Honeywell share a common banking partner to arrange and distribute their syndicated five‑year credit lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. Dates and entity names match the original answer. (2) Quantitative accuracy is perfect—dates (May 11, 2023; March 20, 2023) and roles (syndication agent) are correctly reported. There are no numerical calculations, but the factual data points are precise. (3) The multi-hop reasoning is sound: the model correctly infers a shared banking relationship by identifying JPMorgan’s role across both companies’ credit agreements. The mention of the KG triplet adds traceability, though it contains a minor error: 'Three-Month Credit Agreement' appears to be a typo or hallucination (should be 'Five-Year'). This does not affect the core conclusion but slightly weakens the qualitative accuracy. (4) The answer conveys the same semantic meaning as the original—both companies share JPMorgan as a key coordinator in syndicated lending, indicating a strategic commonality in credit facility management. Wording differs slightly but meaning is preserved. Contextual relevance is excellent, directly addressing the shared banking relationship as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 376,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU‑ and U.S. sanctions that bar the trade of goods used to make tobacco products in Belarus (see Chunk 3) tighten the overall commercial climate in that market and impose extra compliance and logistical hurdles for any company that operates there. Coca‑Cola HBC – which the filing lists as having bottling and distribution operations in Belarus (Chunk 1/2) – could therefore see its ability to import concentrates, produce, or distribute Coca‑Cola beverages in Belarus curtailed or delayed. Because The Coca‑Cola Company depends on Coca‑Cola HBC for a sizable share of its sales – Coca‑Cola HBC accounts for roughly 17 % of the Company’s worldwide unit‑case volume and is one of the five bottlers that together represent 41 % of total volume – any disruption to HBC’s Belarus operations would shave a modest amount off the Company’s overall case volume, even though the Belarus market is only a small part of HBC’s overall footprint.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies that EU and U.S. sanctions on the tobacco sector in Belarus could impact Coca-Cola HBC's operations due to broader commercial and logistical challenges, and that this could affect The Coca-Cola Company’s overall unit case volume. The reasoning about supply chain disruptions and compliance hurdles is sound and contextually appropriate. However, there is a critical error in the quantitative claim that Coca-Cola HBC accounts for 'roughly 17%' of The Coca-Cola Company’s worldwide unit-case volume. The ground truth states that Coca-Cola HBC represented 41% of KO’s total volume in 2021, not 17%. The 17% figure appears to be a misinterpretation—possibly confusing HBC’s individual share with the combined share of multiple bottlers. (2) The 41% figure is explicitly stated in the original answer and is a key data point; the LLM’s substitution with 17% significantly undermines factual accuracy. No other numbers (e.g., 83% of volume from non-U.S. markets) are mentioned in the LLM response, leading to partial completeness. (3) The multi-hop reasoning is generally logical: sanctions → Belarus operational challenges → impact on HBC → impact on KO’s volume. The model correctly links HBC’s presence in Belarus to KO’s supply chain dependency. However, it fails to fully synthesize that HBC alone accounts for 41% of KO’s volume, weakening the implication of disruption. (4) Contextual relevance is high—the answer addresses both parts of the question and uses appropriate logic. Qualitative accuracy is fair due to correct entity identification and reasoning structure, but quantitative accuracy is low due to the incorrect percentage, which distorts the magnitude of risk to KO’s volume.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 468,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 notice to cut the debit‑card interchange‑fee cap by roughly 28 %‑30 % (Chunk 2) would directly lower the maximum fee Capital One can collect on any debit purchase that runs on Mastercard’s four‑party network. Capital One’s debit‑card earnings are already constrained by Regulation II, which caps fees for cards issued on four‑party networks such as Mastercard (Chunk 1), and the company explicitly warns that any loss of interchange income “could have a material adverse effect” on its results. Because Mastercard (the network that sets the fee ceiling) is itself the subject of extensive antitrust and MDL litigation against Visa and Mastercard (Chunk 3), the regulatory pressure is being reinforced by ongoing legal challenges that have already forced fee reductions and large settlement payments. Taken together, the 28‑30 % cap reduction is likely to shave roughly a quarter‑to‑a‑third of Capital One’s debit‑interchange fee revenue, creating a material downward impact on its overall interchange‑fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 28%-30% reduction in debit interchange fee caps is accurately cited, and the reference to Regulation II and its impact on four-party networks like Mastercard is factually sound. The LLM correctly interprets the magnitude of the impact as 'a quarter-to-a-third' of Capital One’s debit-interchange fee revenue, which is semantically equivalent to a 28%-30% reduction. (2) The entities are correctly identified: Capital One (COF), Mastercard, Visa, the Federal Reserve, and the ongoing multidistrict litigation (MDL) are all accurately referenced. The mention of 'antitrust and MDL litigation' aligns with the ground truth’s reference to merchant legal challenges. (3) The multi-hop reasoning is strong: the LLM synthesizes the regulatory cap reduction, Capital One’s reliance on Mastercard’s network, the constraints of Regulation II, and the compounding effect of legal challenges against Visa and Mastercard. It correctly infers that these combined pressures could materially impact Capital One’s interchange income. (4) The only minor shortcoming is that the LLM does not explicitly state that Mastercard may be forced to reduce fees due to regulatory oversight—this is implied but not directly articulated. However, the core conclusion about material adverse impact is clearly conveyed and supported. Wording differs slightly (e.g., 'material adverse effect' is quoted from Capital One’s disclosures), but semantic equivalence is maintained. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 452,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy’s balance sheet contains variable‑rate debt and interest‑rate swaps that are currently tied to LIBOR, so the company is actively reviewing the optional expedients in ASU 2020‑04 and, although the guidance is elective, it has **not yet adopted the standard as of December 31 2021**. Because its LIBOR‑linked contracts may need amendment or termination after the 2023 phase‑out, Duke is preparing to apply the expedients for any contract modifications through the December 31 2022 window, but it expects the overall impact to be immaterial.  \n\nSouthern Company, by contrast, only notes that it will **continue to evaluate ASU 2020‑04 and the transition to an alternative rate** and does not cite specific LIBOR‑indexed exposures or a concrete adoption deadline; like Duke, it also judges that the regulation is unlikely to have a material effect.  \n\nThus, Duke’s direct exposure to LIBOR‑indexed financial contracts pushes it toward a near‑term, contract‑focused assessment of adoption, whereas Southern Company takes a broader, ongoing review with no defined timeline, even though both conclude the impact will be immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy has LIBOR-indexed contracts (variable-rate debt and swaps), is evaluating ASU 2020-04 optional expedients, and had until December 31, 2022, to apply them, with immaterial expected impact. Southern Company is also assessing the standard and alternative rates, with no material impact expected, but lacks a defined timeline. The date 'December 31, 2021' mentioned for Duke's non-adoption is consistent with a reasonable reporting timeline and does not contradict the ground truth, which focuses on the 2022 deadline for application. (2) Quantitative accuracy is perfect: all dates (2021, 2022, 2023) are correctly used, and the phase-out timeline and evaluation window are accurately represented. (3) Multi-hop reasoning is sound—LLM correctly infers that Duke’s direct exposure leads to a time-bound, contract-focused approach, while Southern’s broader evaluation lacks urgency, synthesizing across both companies’ disclosures. (4) The only minor limitation is that the original answer notes Duke had *until* December 31, 2022, to apply the expedients, while the LLM emphasizes non-adoption as of 2021, which is true but slightly less precise on the full window. However, this does not constitute an error. Semantic equivalence is maintained, and the conclusion about differing timelines due to exposure level is well-supported. All entities (Duke Energy, Southern Company, ASU 2020-04, LIBOR) and financial concepts (hedge accounting, contract modifications) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 442,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "KO values its stock‑option awards with a Black‑Scholes‑Merton option‑pricing model that uses weighted‑average assumptions – such as the stock’s volatility, the risk‑free rate, dividend yield and expected term – to estimate the fair value of each grant, and then expenses that fair value on a straight‑line basis over the typical four‑year vesting period. In contrast, CL calculates the net periodic benefit cost of its pension plans using weighted‑average assumptions that include a 5.66 % discount rate, a 6.25 % expected long‑term return on plan assets, a 3.50 % compensation‑increase rate (plus ESOP growth, medical‑cost‑trend and interest‑crediting rates), which flow through to the pension expense and the disclosed total pension cost (e.g., $325 million in 2023). Thus, while both companies rely on weighted‑average inputs, KO’s inputs determine equity‑based compensation expense, whereas CL’s inputs determine pension‑cost measurement and the related liability/asset and expense recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: KO uses the Black-Scholes-Merton model with weighted-average assumptions (volatility, risk-free rate, dividend yield, expected term) for stock option valuation, and expenses the fair value over the vesting period. CL uses weighted-average assumptions for pension cost calculations, including the exact 2023 values: 5.66% discount rate, 6.25% expected return on assets, and 3.50% compensation increase. The mention of $325 million in total pension cost for CL in 2023 is consistent with the knowledge graph context, even if not in the original answer—it does not contradict and adds relevant detail. (2) Quantitative accuracy is perfect: all percentages and financial figures match or are reasonably inferred from the ground truth. (3) Multi-hop reasoning is sound: the model correctly distinguishes between KO’s use of assumptions in equity valuation (a financial economics model) versus CL’s use in actuarial pension accounting (a liability estimation process), highlighting the different financial reporting implications. (4) The only minor shortcoming is that the original answer emphasizes the conceptual contrast in application (pricing model vs. actuarial estimates), while the LLM adds slight elaboration (e.g., dividend yield, ESOP, medical trends) not in the original. However, these additions are contextually appropriate and do not introduce errors. Semantic equivalence is preserved, and the core comparison is fully accurate. Thus, the answer earns a 9/10 for correctness—excellent, with negligible deviation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 445,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower’s $525 million Series 2015‑2 Notes are **secured** – the indenture gives the lenders a security interest in “substantially all … personal property and fixtures of the GTP entities, including GTP Acquisition Partners’ equity interests in its subsidiaries.” In other words, AMT pledged the equity stakes of its wholly‑owned subsidiary as collateral rather than selling them.  \n\nSimon Property Group, by contrast, has been **monetizing** its equity holdings. It disposed of equity interests during 2021 and recorded a **$18.8 million gain** from those sales.  \n\nThus, AMT leverages subsidiary equity as a pledge to back debt, preserving ownership, while SPG converts equity into cash and earnings through outright disposals, generating a realized gain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AMT's $525.0 million Series 2015-2 Notes are secured by a security interest in the personal property of the GTP Entities, including equity interests in subsidiaries via GTP Acquisition Partners; SPG recorded an $18.8 million gain from disposals of equity interests in 2021. The numbers match exactly, with acceptable formatting ($525 million = $525.0 million; $18.8 million is identical). (2) The answer is complete, addressing both companies' strategies—AMT’s use of equity as collateral versus SPG’s monetization through sales—and directly compares them as required. (3) Entities are correctly identified: American Tower (AMT), Simon Property Group (SPG), GTP Acquisition Partners, and the relevant financial instruments and transactions. The year 2021 for SPG’s gain is correctly cited. (4) The reasoning is sound and reflects proper multi-hop synthesis: it distinguishes between secured financing (AMT) and direct capital realization (SPG), accurately characterizing the strategic difference. The conclusion that AMT retains ownership while SPG realizes gains through disposal aligns perfectly with the original answer. No factual, numerical, or conceptual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Depends_On]-> FIN_INST <-[Disposes]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 361,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ 2021 10‑K confirms that its Nigerian deep‑water assets are operated under Nigeria’s production‑sharing‑contract (PSC) regime, which typically provides a 30‑year term – a 10‑year exploration phase followed by a 20‑year production phase, with extensions permitted under the Petroleum Industry Act. By contrast, ExxonMobil’s 10‑K discloses that PSC‑based assets account for roughly 12 % of its total proved reserves and that those reserves are reported on the basis of the economic interest defined in the PSCs; the PSCs it uses also follow a similar 30‑year structure (exploration and production phases with possible extensions). Thus, ConocoPhillips’ exposure is a specific operational risk tied to Nigeria’s PSC terms, while ExxonMobil’s reliance on PSCs is reflected in a measurable share of its reserve portfolio and governed by comparable long‑term contractual terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers and timeframes are correct: the 30-year PSC term (10-year exploration, 20-year production), the 12% of ExxonMobil's proved reserves under PSCs in 2021, and the reference to the Petroleum Industry Act allowing extensions—all align with the original answer. (2) The LLM correctly identifies both companies (ConocoPhillips and ExxonMobil), the correct context (Nigeria PSCs), and the relevant year (2021), satisfying entity accuracy. (3) The reasoning is sound: it synthesizes operational exposure (ConocoPhillips in Nigeria) with reserve reporting implications (ExxonMobil’s 12% PSC-linked reserves), noting that both face similar contractual term structures. The only minor shortcoming is that the LLM does not explicitly mention the inverse relationship between reserve volumes and price changes in PSCs due to fiscal terms—a key nuance in ExxonMobil’s reserve reporting methodology highlighted in the ground truth. It also omits ConocoPhillips’ partial relinquishment requirements. These omissions prevent a perfect 10 but do not undermine the core correctness. (4) Despite these small gaps, the answer is contextually relevant, factually accurate, and semantically equivalent in intent and substance, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 369,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM’s strategy treats generative AI as a cloud‑first capability: the company has woven generative AI into its hybrid‑cloud and quantum offerings and is counting on its R&D spend and a broad developer ecosystem to quickly commercialize and scale AI‑driven services (Chunk 1). Qualcomm, by contrast, is investing in putting generative‑AI models directly on its high‑performance, low‑power chip platforms for mobiles, automotive, IoT and other edge devices, using its QCT semiconductor business and a dedicated cloud‑computing processing initiative to complement the on‑device workloads (Chunks 2 & 3). Thus, IBM leans on cloud‑centric innovation to sell AI solutions at scale, while Qualcomm focuses on edge‑based AI that runs efficiently in power‑constrained environments, with cloud computing acting as a supporting layer for both.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core strategic differences between IBM and QCOM (Qualcomm) in commercializing generative AI in high-performance, low-power environments. It accurately identifies IBM's cloud-first, hybrid-cloud and R&D-driven approach focused on enterprise solutions and ecosystem development, and contrasts it with Qualcomm's edge-based strategy leveraging its semiconductor platforms (QCT) for mobile, automotive, and IoT devices. The answer also correctly notes Qualcomm's use of cloud computing as a supporting layer for edge workloads. However, the LLM answer omits a key quantitative projection from the original answer: that Qualcomm projects 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. This is a significant omission in terms of completeness, as it was a specific data point directly tied to QCOM's commercialization strategy and market outlook. No numbers are incorrect (quantitative accuracy is perfect), and all entities (IBM, QCOM/Qualcomm, edge vs cloud, low-power computing) are correctly identified and contrasted. The reasoning is sound and synthesizes multi-hop information appropriately—linking chip design, edge AI, cloud support, and commercialization models. The omission of the smartphone adoption projection prevents a higher score, but the rest of the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 385,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Both companies face the same underlying financial risk – the need to fund nuclear‑plant de‑commissioning from trust assets whose value is set by the capital markets – but the magnitude and mitigation of that risk differ. Duke Energy’s nuclear de‑commissioning trusts (the NDTF) are described as “subject to market fluctuations” and a decline in market value could “increase the funding requirements” and materially hurt its results of operations, cash flows and overall financial position, meaning Duke could be called on for significant additional cash. NextEra Energy, by contrast, also relies on market‑linked trust assets but “maintains decommissioning funds and external insurance coverage” and actively manages market volatility through derivative instruments; it acknowledges that decommissioning costs could exceed the funds, yet its insurance and broader risk‑management framework cushions the exposure. Thus, Duke’s exposure is more immediate and potentially larger because it hinges directly on trust‑asset performance, whereas NextEra’s exposure is buffered by insurance and financial‑risk‑management tools, even though both are ultimately dependent on market performance to meet trust‑funded obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Duke Energy and NextEra Energy rely on trust-funded obligations for nuclear decommissioning, with market performance affecting their funding adequacy. The LLM correctly identifies that Duke Energy’s trusts are subject to market fluctuations that could increase funding requirements, potentially impacting financial results. It also accurately notes that NextEra Energy (including FPL) maintains decommissioning funds and insurance coverage, and acknowledges the risk that costs could exceed funds. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across both companies, compares their risk exposure, and correctly infers that while both face market-linked risks, NextEra has additional mitigation tools (insurance, derivatives) that Duke Energy’s description does not emphasize. This nuanced comparison goes beyond repetition of facts and reflects valid inference from the source data. (4) The only reason for not scoring a perfect 10 is that the original answer does not explicitly mention NextEra’s use of 'derivative instruments' or 'external insurance coverage' as risk-mitigation tools—these details, while plausible and consistent with industry practices, are not confirmed in the provided ground truth. Thus, the LLM adds slight interpretive detail not present in the source, marginally reducing qualitative accuracy. However, the core comparison and factual content remain semantically equivalent and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 460,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT applies ASU 2020‑04 as an ongoing hedge‑accounting framework – it designates foreign‑currency forwards, options and cross‑currency contracts (and fixed‑to‑floating interest‑rate swaps) as cash‑flow or fair‑value hedges, formally documents each relationship, tests effectiveness on an ongoing basis and manages contracts with a policy horizon of up to roughly five years (about 60 months). UPS, by contrast, adopted the update in March 2020 to address reference‑rate reform and used it to transition its affected debt instruments and contracts to the SOFR rate, completing that transition by 31 December 2023 and electing not to use the practical expedients, with further monitoring through the standard’s December 2024 sunset. Both companies noted that adoption of ASU 2020‑04 did not have a material impact on their consolidated financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies affecting completeness. (1) Quantitatively, all key dates and timeframes are accurate: CAT's use of hedging for up to five years (60 months) and application of ASU 2020-04 relief through December 31, 2024, are correctly stated; UPS's transition to SOFR by December 31, 2023, is also accurate. The mention of the December 2024 sunset aligns with CAT’s extended relief period. (2) The LLM correctly notes that both companies found the adoption of ASU 2020-04 immaterial to financial statements, which matches the original answer. (3) However, the LLM incorrectly states that UPS 'adopted the update in March 2020'—the ground truth does not specify when UPS adopted ASU 2020-04, only that it completed its SOFR transition by 2023 and did not use the practical expedients. This introduces a potentially inaccurate timeline. Additionally, while the LLM mentions UPS continued monitoring 'through the standard’s December 2024 sunset,' the original answer specifies UPS continued assessing impacts through 2024, which is close but slightly less precise in framing. (4) The LLM includes extra detail (e.g., cross-currency contracts, interest-rate swaps) not in the original answer, which is acceptable if accurate, but these are not confirmed in the ground truth and slightly overextend the response. Despite these minor issues, the core multi-hop comparison—CAT using expedients with extended relief vs. UPS transitioning directly without expedients—is correctly synthesized. The reasoning is sound, entities are accurate, and the response is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 454,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast discloses that it holds **no voting rights** in Atairos – it only has limited consent rights and therefore cannot direct the VIE’s activities, accounting for its roughly **$5.1 billion** investment on an equity‑method basis. In contrast, Alphabet’s capital structure concentrates **voting power in its Class B common stock (10 votes per share)**, while Class A carries one vote and Class C carries none; the company has repurchased about **$62 billion of Class A and Class C shares in 2024** (and $59‑62 billion in each of the prior two years). Those large repurchases shrink the pool of non‑voting or low‑voting shares, thereby increasing the relative control of the Class B shareholders – a stark opposite to Comcast’s passive, non‑controlling stake in Atairos.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in one numeric value. (1) Quantitatively: The LLM states Comcast's investment as $5.1 billion, while the ground truth mentions a $1.4 billion unfunded capital commitment as of December 31, 2024. These figures represent different financial concepts — the $5.1 billion likely reflects cumulative equity-method investment, whereas $1.4 billion is the remaining unfunded commitment. Since the ground truth does not provide the total investment amount, the $5.1 billion may be correct based on broader data; however, it introduces a number not in the original answer, creating a slight mismatch. All other numbers are correct: Alphabet’s $62 billion in 2024 share repurchases for Class A and C shares matches the ground truth exactly. (2) Completeness: The LLM addresses all parts of the multi-hop question — Comcast’s lack of voting rights and control implications, Alphabet’s dual-class structure, the differential voting rights across share classes, and the impact of repurchasing non-voting/low-voting shares. (3) Entity accuracy: Companies (Comcast, Atairos, Alphabet), share classes (A, B, C), and years (2024) are correctly identified. (4) Reasoning: The LLM correctly synthesizes that repurchasing Class A and C shares increases the relative control of Class B shareholders, contrasting this active control preservation with Comcast’s passive, non-controlling stake — a sound and insightful comparison. (5) Semantic equivalence: Despite slightly different phrasing and the inclusion of an additional financial figure ($5.1B), the LLM captures the essential meaning and implications accurately. The reasoning and qualitative analysis are excellent, making the answer contextually relevant and logically robust. The correctness score is 9 due to the unverified $5.1B figure, but all other aspects are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 526,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "ASU 2022‑06 pushes the sunset of the reference‑rate‑reform guidance (ASU 2020‑04) out to December 31 2024, so the optional expedients can be used through that date. UPS had already moved its LIBOR‑linked debt to SOFR by December 31 2023, and the extension simply gives it a year to keep reviewing any residual contracts rather than forcing a later transition. FedEx, which as of May 31 2024 was still monitoring its contracts, can continue to rely on the ASU 2022‑06 relief and defer any required transition until the new December 31 2024 deadline. This reflects the chain UPS → ASU 2020‑04 → ASU 2022‑06 ← FedEx.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extended the sunset date of ASU 2020-04 to December 31, 2024; UPS transitioned to SOFR by December 31, 2023; FedEx was still monitoring contracts as of May 31, 2024. These dates and events match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (December 31, 2023, May 31, 2024, December 31, 2024) are correctly stated with no calculation errors. (3) The multi-hop reasoning is sound—correctly linking ASU 2022-06 to both companies’ timelines and explaining how the extension benefited each differently. It captures that UPS had already transitioned but could continue assessing residual impacts, while FedEx retained flexibility to delay decisions. (4) Minor deduction in qualitative accuracy because the LLM omits that UPS did not elect to apply Topic 848 expedients, a nuance present in the original. Also, the phrase 'chain UPS → ASU 2020-04 → ASU 2022-06 ← FedEx' is informal and slightly unclear, though not incorrect. Otherwise, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 327,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s 2023 10‑K shows that 29 percent of its beverage revenue comes from the Africa‑Middle East‑South Asia (AMESA) region, a sizable international concentration (see the AMESA row in the PepsiCo tables). Target’s filing, by contrast, lists beverages only as a component of its U.S.‑focused merchandise categories and provides no regional breakdown—its beverage sales are confined to domestic operations. Thus PepsiCo’s beverage business is markedly more exposed to AMESA markets, whereas Target’s exposure is essentially limited to the United States.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PepsiCo generated 29% of its beverage revenue from the Africa-Middle East-South Asia (AMESA) region in 2023, matching the ground truth in both percentage and year. It accurately contrasts this with Target’s lack of international beverage sales disclosure, noting that Target’s beverage sales are part of its U.S.-focused merchandise operations. No numbers are incorrect, and the 29% figure is properly attributed to PepsiCo’s AMESA region in 2023. (2) Quantitative accuracy is perfect: the 29% figure is correct, and there are no calculations required beyond accurate reporting of this percentage. Format is consistent and clear. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different 10-K filings—PepsiCo’s regional revenue breakdown and Target’s domestic-only operational description—to compare geographic exposure. It infers, correctly, that Target has no international beverage sales based on the absence of such reporting, which aligns with the ground truth interpretation. The only minor shortcoming is a slight lack of explicit emphasis on Target’s complete absence of international operations (vs. just beverage sales), though this is implied. (4) The answer is contextually fully relevant, directly addressing the comparison of geographic concentration in beverage sales between the two companies. Wording differs slightly from the original answer but maintains semantic equivalence and factual accuracy. The conclusion that PepsiCo has significant AMESA exposure while Target’s is U.S.-only is correctly drawn.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 443,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Both firms have a **zero counter‑cyclical capital buffer**, so the CCB adds no extra capital to either requirement. For Schwab (SCHW), the minimum capital ratios—including its 2.5 % stress buffer and 2.5 % conservation buffer—are 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total risk‑based capital. For Goldman Sachs (GS), the TLAC‑to‑RWAs requirement consists of an 18 % base minimum plus a 2.5 % buffer and a 1.5 % G‑SIB surcharge (the CCB is zero), yielding roughly a **22 % of RWAs** requirement. Thus, the absence of the CCB does not raise the minimum for either firm, but SCHW’s overall minimum capital requirement is substantially lower than GS’s TLAC‑to‑RWAs requirement because of the different base minima and additional surcharges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: SCHW's CET1 (7.0%), Tier 1 (8.5%), and Total Risk-Based Capital (10.5%) ratios are accurately reported, as are GS's 18% TLAC base, 2.5% buffer, and 1.5% G-SIB surcharge. The CCB is correctly noted as zero for both. The final implied TLAC requirement of ~22% (18% + 2.5% + 1.5%) is a correct calculation. (2) Quantitative accuracy is perfect—no errors in percentages or calculations. (3) The reasoning is sound: the answer correctly identifies that the absence of the CCB (set to zero) does not increase requirements for either firm, and it appropriately contrasts SCHW’s regulatory capital framework with GS’s TLAC regime, highlighting the impact of systemic importance. The only minor shortcoming is that the LLM mentions a '2.5% conservation buffer' for SCHW, which is not mentioned in the ground truth (the ground truth only specifies a 2.5% stress capital buffer). While conservation buffers are standard under Basel rules, this detail was not in the original answer and introduces a slight over-assumption. (4) The answer is fully contextually relevant, directly addressing the comparative impact of the absent CCB on both firms’ capital requirements. Overall, the answer demonstrates strong multi-hop reasoning across regulatory frameworks and entities (SCHW vs. GS), with only a minor addition of a buffer type not specified in the ground truth. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 418,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement from Georgia Power is a cost‑sharing payment under the Vogtle Joint‑Ownership Agreements that compensates Dalton for its share of construction costs on Plant Vogtle Units 3‑4. The filing notes that Dalton, like MEAG Power, “serves its requirements from self‑owned generation facilities, some of which are jointly‑owned with Georgia Power,” so the reimbursement directly reflects Dalton’s stake in a self‑owned (and partially joint‑owned) generation asset. By contrast, NextEra Energy Resources (NEER) does not depend on such ownership‑based reimbursements; instead, about 94 % of its net generating capacity is already committed under long‑term bilateral contracts that generate revenue from the output of its plants, providing a stable, contract‑driven income stream rather than a cost‑recovery model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, reflecting its partial ownership in a jointly held generation facility. The 94% long-term contract coverage for NEE (specifically through NextEra Energy Resources) is correctly cited. (2) Quantitative accuracy is perfect: the $5.3 million amount and 94% figure are both correctly reported with no calculation errors. Format variations (e.g., spacing in $5.3 million) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes Dalton’s cost-reimbursement model (indicative of ownership for self-supply) with NEE’s revenue-focused, contract-driven model. It draws a valid contrast between cost recovery via ownership (Dalton) and revenue generation via output sales (NEE). (4) The only minor shortcoming is that the LLM slightly reframes NEE’s model around 'NextEra Energy Resources (NEER)' without clarifying that NEER is a subsidiary of NEE—though this is contextually accurate, the original answer more clearly attributes the 94% to NEE broadly. However, this does not constitute a factual error. Wording differs but semantic meaning and factual content are equivalent. The answer fully addresses both parts of the question and maintains high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> COMP -[Has_Stake_In]-> PRODUCT <-[Generates_Revenue_From]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 388,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX manages its customer‑financing risk primarily through a large pool of bank‑backed credit facilities. At year‑end 2021 the company had $7 billion of revolving credit agreements (a $5 billion facility through 2025 and a $2 billion facility through 2022) and access to a $5 billion commercial‑paper program, none of which were drawn, giving RTX a flexible liquidity source that can be used for operating, investing or financing needs.  \n\nIn contrast, Boeing (BA) embeds financing directly in long‑term lease contracts with its airline customers. Its “customer‑financing” arrangements are 1‑ to 12‑year leases that may include extension, termination or purchase options, and under ASC‑based lease accounting the lease assets and liabilities are recorded at the present value of payments (operating leases in “Other assets” and finance leases in PP&E). Thus BA’s approach relies on structured lease terms rather than a blanket credit line.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, all key numbers are correct: RTX's $7 billion in credit facilities (broken into $5B through 2025 and $2B through 2022) and access to a $5B commercial paper program are accurately reported. The original answer does not specify the split or maturity dates of the credit facilities, but this additional detail in the LLM answer is factually consistent and enhances precision without contradiction. (2) The description of BA’s lease structures—1 to 12 years with extension, termination, or purchase options—is fully aligned with the ground truth. The mention of ASC-based lease accounting and classification of operating vs. finance leases (with assets/liabilities recorded at present value) adds technical depth and is correct. (3) Multi-hop reasoning is sound: the LLM correctly contrasts RTX’s liquidity-backed, flexible credit approach with BA’s structured, long-term lease model, capturing the fundamental difference in financing strategies. (4) The LLM answer includes slightly more detail (e.g., commercial paper program, accounting treatment) than the original, but all additions are factually accurate and contextually relevant. The only reason for not scoring a 10 is that the original emphasizes RTX’s avoidance of short-term borrowings, which the LLM implies but does not explicitly state. However, this does not constitute a factual error. Overall, the answer is semantically equivalent, factually precise, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Contains]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 435,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s 10‑K shows that the company discloses weighted‑average assumptions **only as inputs to its Black‑Scholes‑Merton option‑pricing model** – they are used to calculate the fair value of stock‑option awards (the exercise price is set at the average of the high and low market prices on the grant date).  \n\nPhilip Morris, by contrast, discloses weighted‑average assumptions **in the actuarial calculations for its net pension and post‑retirement health‑care costs**.  \n\nThus, Coca‑Cola applies weighted‑average assumptions to equity‑compensation valuation, while Philip Morris applies them to defined‑benefit pension and health‑care cost estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Coca-Cola uses weighted-average assumptions in the Black-Scholes-Merton model for valuing stock options, while Philip Morris applies them to actuarial calculations for pension and postretirement healthcare costs—this matches the original answer's key distinction. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either answer that conflict; the LLM omits the specific years (2023, 2022, 2021) mentioned in the original answer but this is a minor omission that does not affect the correctness of the conceptual comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and financial reporting domains (equity compensation vs. employee benefits), demonstrating appropriate cross-document inference. (4) Semantic equivalence is maintained—wording differs slightly but meaning is preserved. The only reason for not scoring a 10 is the omission of the specific years for which Coca-Cola applied the assumptions, which is a minor completeness issue. All other aspects—entity accuracy, reasoning, and relevance—are fully correct and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 355,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia, Janumet and Janumet XR are expected to retain U.S. market (and thus regulatory) exclusivity only until May 2026 for Januvia/Janumet and July 2026 for Janumet XR, whereas Gilead’s U.S. regulatory exclusivity does not run out until 2032. Because regulatory exclusivity blocks the FDA from using the innovator’s data to approve generics, Merck will face generic competition roughly six years earlier than Gilead, likely accelerating sales declines for the Januvia family, while Gilead’s later 2032 expiry gives it a longer protected window to preserve its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and accurately states that Gilead's U.S. regulatory exclusivity expires in 2032. These dates match the ground truth exactly. (2) All numeric values (dates) are correct and properly formatted; no calculations are required beyond the comparison of time spans, which is accurately conveyed (roughly six years earlier). (3) The reasoning is sound: the LLM correctly explains that regulatory exclusivity delays generic competition by preventing FDA reliance on innovator data, and it logically infers that Merck will face earlier generic entry and sales declines, while Gilead benefits from a longer protected period. The multi-hop synthesis across two companies and their respective timelines is accurate. (4) The only minor shortcoming is that the LLM does not explicitly mention the impact on 'market positions' in as much detail as the original (e.g., 'substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry'), though it does reference 'accelerating sales declines' and 'longer protected window', capturing the core implication. Thus, the answer is semantically equivalent with only slight omission of contextual depth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 397,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel’s 10‑K shows that the developed‑technology assets that support its cybersecurity (including cloud‑security) products generate an amortization charge of $1.283 billion for the year ended Dec 25 2021 (up from $1.211 billion in 2020).  By contrast, Cisco’s 10‑K states that its Cloud Security offerings are accounted for as a single distinct performance obligation with revenue recognized ratably over the contract term – i.e., the revenue is spread out over time rather than taken all at once.  Thus Intel records a large, period‑based amortization expense, while Cisco spreads the related cloud‑security revenue across the life of each contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's amortization expense for developed technology as $1.283 billion for the year ended December 25, 2021, matching the ground truth of $1,283 million in 2021. The format variation ($1.283 billion vs $1,283 million) is acceptable and numerically equivalent. It also accurately notes the increase from $1.211 billion in 2020, which, while not in the original answer, is factually correct and adds context without introducing error. Cisco’s revenue recognition method for cloud security offerings is correctly described as ratable (i.e., recognized ratably over the contract term), aligning with the ground truth. (2) All numeric values are accurate and properly contextualized. No calculations were required, but the comparison of timing patterns (amortization vs. revenue recognition) is correctly framed. (3) The multi-hop reasoning is sound: the model synthesizes Intel’s cost-side amortization pattern from its 10-K with Cisco’s revenue-side accounting policy, drawing a valid contrast between Intel’s period-based expense recognition and Cisco’s time-based revenue spreading. The answer captures the core conceptual contrast in financial reporting models. (4) The only minor shortcoming is the absence of the specific detail about the 9-year weighted average useful life for Intel’s developed technology, which is included in the ground truth and adds precision to the amortization pattern. While this detail strengthens the original answer, its omission does not invalidate the correctness of the LLM’s response, which still conveys the essential comparison. Overall, the answer is factually accurate, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 466,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MET’s 2023 filing shows that, after adopting ASU 2022‑02, the company no longer applies the old TDR concession test and now discloses “financial‑difficulty modifications” (FDMs) – the same set of actions that COF describes (principal forgiveness, interest‑rate reductions, other‑than‑insignificant payment delays, term extensions or any combination thereof). The adoption “reduced the complexity” of evaluating such changes and, aside from expanded note‑11 disclosures, “did not have a material impact on the Company’s consolidated financial statements.” In contrast, JPMorgan’s legacy‑TDR reporting (for periods prior to 1 Jan 2023) treated comparable borrower‑difficulty concessions as TDRs, reporting large credit‑loss amounts – $362 million in 2022 and $866 million in 2021 – and focused on the concession assessment rather than quantifying the loan‑term effects. Thus, MET’s post‑ASU disclosures are narrative, non‑material and classify the unchanged modification types as FDMs, whereas JPM’s legacy TDR approach highlighted substantial TDR balances without the granular impact metrics now required under the new guidance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct conceptual shift from TDRs to FDMs under ASU 2022-02 and correctly notes that MET's adoption did not have a material impact on financial statements. It accurately describes the types of modifications (rate reductions, term extensions, etc.) and references expanded disclosures. However, there are significant quantitative inaccuracies: the LLM states JPM reported $362 million in TDRs in 2022 (correct) but adds $866 million in 2021, which is not in the ground truth and irrelevant to the question's focus on 2022–2023 comparison. More critically, the ground truth states that in 2023 under FDM reporting, JPM reported $136 million in FDMs with specific impacts: weighted-average loan life extended by 20 years and interest rate reduced from 7.21% to 4.44%. The LLM completely omits these key financial impact metrics, which are central to the question about 'financial impact of modifications'. Additionally, the LLM incorrectly implies JPM used FDM reporting post-2023, but attributes only narrative-level changes without data, contradicting the ground truth’s specific numerical disclosures. The mention of 'COF' (Capital One) is extraneous and not part of the original question or answer, suggesting a hallucination or misattribution. While the reasoning around the principles-based shift is sound and contextually relevant, the failure to report critical quantitative impacts and inclusion of unsupported figures (2021 TDRs) and entities (COF) reduces correctness. The answer is partially complete but lacks essential multi-hop synthesis of JPM’s 2023 FDM data versus its 2022 TDR reporting as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 447,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream portfolio is anchored in South America, where it held roughly 455 billion cubic feet of natural‑gas reserves in the “Other Americas 1” category at year‑end 2021. In contrast, ExxonMobil’s downstream business is described as a large, highly integrated operation with a well‑established presence across the entire Americas region—covering refining, marketing, logistics and trading—so its footprint spans both North and South America. Apple’s 10‑K likewise groups North and South America together as a single “Americas” segment, underscoring that XOM’s downstream activities cover the broader geographic area that includes CVX’s South‑American upstream resources.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It states that CVX held '455 billion cubic feet' of natural gas reserves in South America in 'year-end 2021', whereas the ground truth reports 329 billion cubic feet as of December 31, 2022. This is a major discrepancy in both volume and reporting year. Additionally, the mention of 'Other Americas 1' category is not present in the original answer and introduces unverified segmentation. (2) The reference to 'Apple’s 10-K' is factually incorrect and nonsensical in context—Apple is unrelated to the energy operations of CVX or XOM, and this severely undermines the credibility of the response. This appears to be a hallucination. (3) While the qualitative comparison between CVX’s upstream focus and XOM’s downstream footprint across the Americas is conceptually sound and reflects correct multi-hop reasoning in intent, the flawed data and erroneous source citation weaken the synthesis. The geographic point that XOM’s downstream operations span the broader Americas, including South America, is correctly understood and relevant. (4) The contextual relevance is high because the structure and intent of the answer align with the question—comparing upstream vs. downstream positioning across regions. However, correctness is low due to incorrect numbers, wrong year, and the introduction of a non-sequitur entity (Apple). Quantitative accuracy is poor (3/10) due to wrong figures and dates. Qualitative accuracy is moderate (5/10) as the reasoning framework is logical but based on incorrect data. Contextual relevance is strong (8/10) because the answer attempts the right comparison and geographic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 469,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper exposure is $25 million (see the Duke Energy 10‑K table, where Ohio reports $25 million of commercial paper – Chunk 2), which is a modest slice of its $52 million short‑term debt in Ohio and a tiny fraction of its overall $625 million commercial‑paper program. By contrast, Tesla reports $470 million of commercial paper on its balance sheet (Tesla 10‑K, cash‑and‑short‑term‑investments schedule – Chunk 3), a substantial component of its $29.1 billion total cash and short‑term‑investment pool. Thus, Tesla’s short‑term liquidity strategy relies on commercial paper at a scale roughly 19 times larger than Duke Energy Ohio’s exposure, reflecting a far more aggressive use of this instrument; both activities occur in a market where Ohio hosts significant corporate operations, as illustrated by Home Depot’s 70 stores in the state (Chunk 1).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Duke Energy Ohio's $25 million commercial paper exposure and Tesla's $470 million commercial paper holdings, matching the ground truth numerically. However, it introduces additional figures not in the original answer or question—such as Duke Energy Ohio’s $52 million short-term debt and $625 million commercial paper program, and Tesla’s $29.1 billion cash and short-term investments—which, while possibly accurate, are not part of the verified ground truth and distract from the core comparison. The claim that Tesla’s holdings are '19 times larger' (470/25 ≈ 18.8) is mathematically correct but framed misleadingly: the original answer emphasizes functional difference (liability vs. asset), not scale of use. (2) Quantitative accuracy is mostly preserved: $25M and $470M are correct; the 19x calculation is accurate but not contextually appropriate since the original answer does not make a quantitative size comparison but a qualitative strategic one. (3) The reasoning is flawed in interpretation: the LLM frames Tesla’s commercial paper holdings as part of an 'aggressive use of this instrument,' which misrepresents the nature of commercial paper as an investment (i.e., Tesla is buying, not issuing). The original answer correctly identifies Tesla holds commercial paper as an investment (short-term asset), while Duke Energy issues it (short-term liability). The LLM confuses strategy: Tesla is not using commercial paper aggressively; it is investing in it conservatively. The mention of Home Depot’s 70 stores in Ohio is irrelevant and unsupported as contextual justification. (4) Correctness is scored 5 due to correct numbers but significant misinterpretation of financial roles and strategy. Qualitative accuracy is low because the model fails to distinguish between issuing and holding commercial paper—a critical financial distinction. Contextual relevance is moderate because the core entities and figures are addressed, but extraneous and irrelevant details reduce focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 547,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "META’s filing makes clear that its Class A shares are the low‑vote equity – they carry the ordinary one‑vote‑per‑share right and are eclipsed by the super‑voting Class B shares that let Mark Zuckerberg control the company even though he owns far less than a majority of the total equity.  By contrast, Alphabet’s filing shows that its Class B shares are the high‑vote equity, each entitled to ten votes per share, giving Class B holders a ten‑to‑one voting advantage over the one‑vote‑per‑share Class A holders.  Thus, while both firms use dual‑class structures to concentrate control, META’s Class A is the weaker voting class, whereas GOOGL’s Class B is the powerful voting class with a defined 10‑vote multiplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth in all key aspects. (1) It correctly identifies that META's Class A common stock has limited voting power (1 vote per share) compared to its Class B shares, which carry superior voting rights and enable Mark Zuckerberg to retain control—this aligns with the original answer's description of concentrated control and the 35% threshold for change-in-control transactions, even though the latter detail is omitted. (2) The LLM accurately states that GOOGL's Class B shares have 10 votes per share versus 1 for Class A, which matches the ground truth exactly. (3) The comparison between the two companies' dual-class structures is logically sound: both use dual-class systems to concentrate voting power, with META’s Class A being the weaker class and GOOGL’s Class B being the powerful one—this synthesis across entities is correct. (4) The LLM omits the CMCSA example from the original answer, which provides additional context about industry patterns in dual-class structures, but this does not detract from answering the core question about META and GOOGL. All entities (META, GOOGL, Class A/B shares), voting rights (1 vs 10 votes), and structural implications are correctly identified. No calculation errors. Minor deduction in qualitative accuracy due to omission of the 35% threshold detail from META’s filing, but the core reasoning remains intact. Contextual relevance is perfect—directly addresses shareholder influence under dual-class structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 421,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s proxy table shows that its B‑class shares are **non‑voting but carry “Dividend rights”** (Chunk 1 & 2).  By singling out the B class, Mastercard separates the entitlement to dividends from voting power, so non‑voting shareholders receive a dividend but their right to it is disclosed as a distinct, potentially board‑controlled policy rather than being automatically identical to the voting A‑class shares.  \n\nCharles Schwab, by contrast, explicitly states that the “participation rights, including dividend and liquidation rights, are identical between the voting and non‑voting stock classes” (Chunk 3).  Consequently, both Schwab’s voting and non‑voting shares receive the same per‑share dividend, fully aligning shareholder returns across the two classes.  \n\nThus, Mastercard’s structure creates a separate dividend stream for non‑voting holders that may not be perfectly aligned with voting‑shareholder returns, whereas Schwab’s identical‑rights approach ensures complete alignment of dividend returns between voting and non‑voting equity holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's B-class shares are non-voting but have dividend rights, and that Charles Schwab explicitly states identical dividend and liquidation rights across share classes. The core facts about both companies' dividend structures are correct. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable in a traditional sense—but all referenced attributes (e.g., 'dividend rights', 'identical participation rights') are accurately reported from the source chunks, with no factual errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their dividend structures to assess alignment of shareholder returns. The conclusion that Schwab ensures complete alignment while Mastercard maintains dividend rights but with potential board discretion is logically derived and consistent with the ground truth. (4) The only minor deviation from the original answer is the LLM's suggestion that Mastercard’s dividend rights for B-class shares may be 'potentially board-controlled' and 'not perfectly aligned', which introduces a slight interpretive nuance not explicitly stated in the ground truth. However, this does not contradict known facts and is a reasonable inference given the explicit distinction in share class treatment. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 430,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that the OECD Pillar‑Two rules, which impose a 15 % global minimum tax, will begin to apply to it in FY 2025 but “we do not currently estimate a material impact to our consolidated financial statements.” Its effective tax rate of 18 %‑19 % (well above the 15 % floor) and the observation in the BA filing that firms without material operations in sub‑15 % jurisdictions “are not expected to materially increase our global tax costs” reinforce that Microsoft’s mix of U.S. and foreign income is unlikely to be pushed up by the new rule.  \n\nOracle, by contrast, warns that the same Pillar‑Two framework “could materially increase the level of income tax on our international profits” and that its future income‑tax provision and effective tax rate “could materially increase” under the new 15 % minimum and related digital‑technology taxes. Thus, while Microsoft expects little or no change to its effective tax rate, Oracle anticipates a material rise in its international tax costs because of greater exposure to jurisdictions that would be affected by the global minimum tax.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft expects no material impact due to its effective tax rate (18%-19%) being above the 15% Pillar Two threshold and lack of significant operations in low-tax jurisdictions. Oracle explicitly states potential material increases in international tax costs and effective tax rate under Pillar Two. These points match the original answer's core claims. (2) Quantitative accuracy is excellent: the 15% minimum tax rate, Microsoft’s 18%-19% effective tax rate, and FY2025 applicability are all correctly reported. No calculations are required, but comparisons (e.g., Microsoft’s rate > 15% floor) are logically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes Microsoft’s and Oracle’s differing exposures based on geographic footprint and tax strategy, drawing a clear contrast in expected impacts despite the same regulatory framework. (4) Minor deduction in qualitative accuracy due to the mention of 'BA filing'—a likely typo or mislabeling (possibly meant '10-K' or another source)—which slightly undermines sourcing clarity, though it doesn’t affect factual correctness. Otherwise, the answer is complete, relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 361,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM’s Level 3 fair‑value measurements are used for marketable debt securities and other instruments where quoted prices are not available; the company relies on a pricing service and industry‑standard pricing models (including discounted‑cash‑flow models) and treats the unobservable inputs as market assumptions derived from the best‑available evidence. In contrast, Lowe’s only Level 3 item is a performance‑based contingent‑consideration investment, which is measured with an income‑approach option‑pricing model that depends on specific unobservable inputs such as total equity value, volatility, expected term, operating‑performance assumptions and a risk‑adjusted discount rate. Thus, both firms follow the three‑level hierarchy and use pricing models, but GM applies broader market‑based unobservable inputs to securities, whereas Lowe applies a tailored option‑pricing methodology with distinct, investment‑specific unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM uses Level 3 for marketable debt securities and finance receivables (implied in 'other instruments') with pricing and discounted cash flow models, relying on unobservable inputs such as macroeconomic assumptions. LOW’s sole Level 3 application is contingent consideration from its Canadian retail business sale, which the LLM correctly identifies as a performance-based contingent-consideration investment. The unobservable inputs listed—total equity value, volatility, expected term, operating-performance assumptions, and risk-adjusted discount rate—are consistent with the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; all references are qualitative and correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in scope (GM’s broad use across financial instruments vs. LOW’s narrow use for a specific contingent consideration) and methodology (market-based macroeconomic inputs vs. investment-specific option-pricing model). The mention of 'fiscal 2022' is missing in the LLM answer, which is a minor omission but does not affect the core accuracy. (4) The answer is contextually relevant, directly addressing the differences in unobservable inputs and methodologies. Wording differs slightly (e.g., 'option-pricing model' is more specific than 'income approach'), but this adds precision and is semantically equivalent. One point deducted from qualitative accuracy for not explicitly mentioning the Canadian retail business sale context, which is part of the full picture but not critical to the methodological comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Applies]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 483,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s Class B stock holds a fixed one‑third of the company’s voting power (33.3 % of total votes) with each share carrying 15 votes and being convertible share‑for‑share into Class A; with about 9.44 million Class B shares outstanding versus roughly 3.97 billion Class A shares, any conversion would move a sizable block of high‑vote power into the lower‑vote pool, but the non‑dilutable clause protecting the 33.3 % voting share limits the overall impact on control. Alphabet, by contrast, has aggressively repurchased $62.2 billion of its Class A and Class C shares in 2023 (with $36.3 billion still authorized for further buy‑backs), dramatically shrinking the pool of low‑vote shares, so converting its high‑vote Class B shares (10 votes per share and convertible at any time) would have a proportionally larger effect on voting influence than a similar conversion at CMCSA. Thus, CMCSA’s protected voting structure tempers the effect of Class B‑to‑Class A conversions, whereas Alphabet’s share‑repurchase program amplifies the voting consequences of any such conversion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and captures the core dynamics between CMCSA's voting structure and Alphabet's repurchase strategy. It correctly states that CMCSA’s Class B shares have 15 votes per share and hold 33 1/3% (represented as 33.3%) of voting power, which is non-dilutable—a key point from the ground truth. It accurately cites Alphabet’s $62.2 billion in share repurchases in 2023 and $36.3 billion remaining authorization. However, the LLM introduces specific share counts—9.44 million Class B and 3.97 billion Class A shares at CMCSA—that are not present in the original answer or typically public in such precise form; these numbers, while plausible, are not verifiable from the provided ground truth and represent an overprecision not supported by the source.\n\n2) Quantitative accuracy is high: $62.2 billion and $36.3 billion match exactly. The 33.3% voting power is a valid approximation of 33 1/3%. The 15 votes per Class B share at CMCSA is correct. However, the introduction of exact share counts (9.44M, 3.97B) is unsupported in the ground truth and risks inaccuracy, though they do not contradict it directly. No calculation errors are present.\n\n3) The multi-hop reasoning is sound: the LLM correctly contrasts CMCSA’s protected voting structure with Alphabet’s repurchase-driven concentration effect. It draws a valid comparative insight—Alphabet’s shrinking share base amplifies the voting impact of any potential Class B conversion, whereas CMCSA’s non-dilutable clause limits such impact. This synthesis across companies and mechanisms (voting rights, convertibility, repurchases) is logically coherent and adds analytical depth beyond the original answer.\n\n4) The answer is contextually excellent—directly addressing the influence of voting power on conversion dynamics and integrating Alphabet’s repurchases meaningfully. The qualitative reasoning is strong, though it slightly overreaches by introducing unverified share counts. The conclusion about differential conversion effects is insightful and aligns with the ground truth’s implication about concentrated influence. Minor deduction for unsupported specifics, but overall a high-quality, semantically aligned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 595,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "- MDLZ’s 2022 10‑K shows **48,932,017** securities remaining available for future issuance under its equity‑compensation plans (Chunk 1).  \n- CL’s 2022 10‑K reports **37,028 thousand** securities (i.e., **37,028,000**) remaining under its equity‑compensation plans (both Chunk 2 and Chunk 3 confirm this figure).  \n\nThe difference is **48,932,017 − 37,028,000 = 11,904,017** more securities available for future issuance for MDLZ than for CL.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: MDLZ's 48,932,017 and CL's 37,028,000 (converted correctly from '37,028 thousand') securities are correctly extracted from the 2022 10-K filings. (2) The calculation of the difference (48,932,017 − 37,028,000 = 11,904,017) is precise and correctly attributed. (3) The multi-hop reasoning—comparing data across two different companies' filings—is sound, with proper synthesis of information from both sources. (4) The answer addresses all parts of the question: it identifies the correct entities (MDLZ and CL), correct metric (securities available for future issuance under equity compensation plans), correct year (2022), and performs the correct quantitative comparison. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in numbers, entities, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 267,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "Illinois – where Home Depot operates 76 stores – is a state that now faces a suite of regulatory challenges.  Under the Illinois Clean Energy Law, Exelon’s ComEd must file a new transmission‑rate case (or a four‑year multi‑year plan) by early 2023, accelerate amortization of excess deferred income taxes, adjust its energy‑efficiency savings goals and accommodate expanded renewable‑energy charges; the law also opens the utility to possible legal challenges that could reshape its transmission‑rate structure and revenue requirement.  By contrast, Tesla’s risk in Illinois (and other states) stems from state‑level statutes that restrict its direct‑to‑consumer sales model, limiting dealer‑license availability and exposing the company to litigation and regulatory push‑back that could curtail market access.  Both firms therefore confront state‑level regulatory risk, but ComEd’s exposure is financial‑rate‑structure‑centric, while Tesla’s is operational‑sales‑access‑centric.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core regulatory impacts on ComEd and Tesla, but introduces an irrelevant fact—Home Depot operating 76 stores in Illinois—which is not mentioned in the original question or ground truth and distracts from the focus. This does not affect factual correctness directly but reduces precision. The mention of ComEd filing a transmission-rate case or multi-year plan by 'early 2023' is plausible but not specified in the ground truth, which only notes the requirement for a four-year multi-year plan without a date—this introduces a potentially inaccurate timeline. The ground truth specifies a 39.5-year amortization period for excess deferred income taxes, which the LLM omits entirely, representing a missing quantitative detail. The 11.50% ROE with a 50-basis-point incentive adder for ComEd is completely omitted, a significant financial metric affecting rate of return—this is a notable omission in quantitative and qualitative accuracy. (2) No calculations are present in either answer, but key numbers such as the 39.5-year amortization and 11.50% ROE are missing or incorrect in the LLM response. The LLM does not provide any numerical values related to ComEd’s rate of return, reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound: the LLM correctly contrasts ComEd’s regulatory exposure (rate structure, cost recovery) with Tesla’s (sales model, dealer restrictions), capturing the essential difference in nature of regulatory risk—financial vs. operational. It correctly identifies that both face state-level challenges but of different types. However, it fails to fully synthesize the financial implications as detailed in the ground truth (e.g., impact on capital structure vs. go-to-market strategy). (4) The contextual relevance is high—despite the irrelevant Home Depot mention, the rest of the answer stays focused on the comparison between ComEd and Tesla’s regulatory risks. The qualitative reasoning is strong, but the missing specifics on ComEd’s ROE and amortization period prevent a higher score. Overall, the answer is partially correct with key omissions in quantitative details and one irrelevant addition, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Faces]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 600,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Medicare Part D redesign forces manufacturers to provide mandatory discounts and price caps beginning Jan 1 2025, so Amgen’s ENBREL – which is already flagged as a regulatory exposure under the IRA – will incur new manufacturer‑discount obligations and inflation‑penalty rebates that began accruing in 2022‑23, driving higher gross‑to‑net rebate accruals and reducing its Medicare profitability. Bristol‑Myers, which records GTN liabilities based on payer‑channel mix, contract‑price assumptions and other judgments, must now embed those required discounts and lower contract prices into its GTN calculations, resulting in larger U.S. Medicare Part D rebate accruals for its affected products.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of the IRA-driven Medicare Part D redesign on both AMGN and BMY's gross-to-net (GTN) rebate accruals. It correctly identifies the key elements: the 2025 start date for mandatory manufacturer discounts and price caps under the IRA, the increased GTN accruals for both companies, and the fact that BMY uses payer channel mix and contract price assumptions in its GTN accounting. It also correctly notes that ENBREL is a regulatory exposure for AMGN. However, it omits two important forward-looking elements from the ground truth: (1) the specific 2026 set price for ENBREL that is significantly lower than current pricing, and (2) the potential inclusion of Otezla in the 2027 Medicare price setting, both of which compound AMGN's exposure. Additionally, while it mentions inflation-penalty rebates accruing in 2022–23, this detail is not in the original answer and may conflate timelines—the original focuses on 2025+ impacts. The answer also fails to mention the catastrophic phase cost shift, a key mechanism increasing BMY's liability. Despite these omissions, the reasoning is sound, entities are accurate, and the overall directionality and qualitative impact are correctly conveyed. The answer is semantically aligned but lacks full completeness on multi-hop elements involving future pricing events and detailed IRA mechanics. Quantitative accuracy is high—dates like Jan 1, 2025 are correct—but no numerical values (e.g., rebate percentages, price levels) are present in either answer, so scoring is based on event timing and sequence accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 439,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG accounts for its structured securities—including the ABS‑CLO pool—on an amortized‑cost basis; yields are periodically re‑estimated using actual cash‑flow experience and a credit‑loss allowance, and any unrealized gains or losses on securities classified as available‑for‑sale are recorded in a separate component of AOCI (with yield adjustments flowing through net‑investment income). MetLife, by contrast, places ABS & CLO in its fixed‑maturity securities that are designated available‑for‑sale and measured at estimated fair value (using Level 3 inputs), so both realized and unrealized gains or losses are recognized directly in earnings. The result is that AIG’s ABS‑CLO valuation appears on the balance sheet at amortized cost with equity‑impact (AOCI) and limited earnings volatility, whereas MetLife’s fair‑value approach produces a balance‑sheet fair‑value amount and immediate earnings volatility for those assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite using correct terminology. It incorrectly states that AIG accounts for structured securities on an 'amortized-cost basis' with unrealized gains/losses recorded in AOCI — this contradicts the ground truth, which specifies AIG uses the effective yield method with yield adjustments flowing through net investment income, not fair value or AOCI. AIG does not classify these assets as available-for-sale, so recording unrealized gains/losses in AOCI is incorrect. (2) For MetLife (MET), the LLM correctly identifies that ABS & CLO are classified as available-for-sale and measured at fair value using Level 3 inputs, aligning with the original answer. However, it incorrectly states that 'both realized and unrealized gains or losses are recognized directly in earnings' — this is false: AFS unrealized gains/losses go to OCI, not earnings; only realized gains/losses hit earnings. This is a critical error in accounting treatment. (3) The multi-hop reasoning is partially sound — the model attempts to compare valuation methods and their impact on financial statements — but fails in accurately representing the core accounting models for both companies. It conflates amortized cost with effective yield adjustments and mischaracterizes AFS accounting. (4) While no numeric values are present (so quantitative accuracy is not penalized), the qualitative inaccuracies in accounting treatment significantly undermine the correctness. The contextual relevance is high because the structure and intent of the response match the question’s focus on valuation and reporting differences, but the technical flaws reduce the correctness score to 5 due to major errors in both entities’ accounting models.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 481,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s consolidated reserve portfolio shows that only 8 percent of its 2021 reserves are tied to production‑sharing contracts (PSC‑related reserves were 8 % in 2021, down from 10 % in the prior two years). ExxonMobil, by contrast, has an active presence in Nigeria (its open‑tax‑year table lists Nigeria from 2006 through 2021), and—as the 10‑K notes—Nigeria’s deep‑water offshore exploration and production are “typically governed by production‑sharing contracts (PSCs).” Thus, while Chevron’s PSC exposure is modest at about 8 percent of its total reserves, ExxonMobil’s Nigerian operations are wholly subject to PSCs, implying a far higher (effectively 100 % of its Nigerian exposure) reliance on PSCs than Chevron’s 8 % reserve share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Chevron's PSC-related reserves are accurately reported as 8% in 2021, consistent with the original answer. The mention of a decline from 10% in prior years is an additional detail not contradicted by the ground truth and may reflect real trends. ExxonMobil's operational presence in Nigeria from 2006 to 2021 is contextually appropriate and supports the claim of long-term exposure. (2) The key financial and percentage data are precise and match the ground truth. (3) The reasoning is sound: the LLM correctly synthesizes that Chevron’s PSC exposure is measured directly as 8% of reserves, while ExxonMobil’s Nigerian operations are structurally governed by PSCs, leading to a higher operational reliance. The conclusion that XOM’s Nigerian exposure is 'effectively 100%' under PSCs is a reasonable interpretation of the regulatory environment described, even if not explicitly quantified in the ground truth. (4) The answer fully addresses the comparative aspect of the question—how CVX’s reserve percentage compares with XOM’s operational exposure in a PSC-dependent region. The only minor limitation is that the original answer emphasizes the 30-year PSC structure (10-year exploration + 20-year production), which the LLM omits, slightly reducing qualitative completeness. However, this does not undermine the core correctness. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong multi-hop reasoning across companies and contractual frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 440,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets a **fixed pool of 49.0 million shares** that are reserved and available for grant, establishing a hard ceiling on the amount of equity that can be issued (Tesla 10‑K, Note 13). In contrast, Home Depot’s stock‑appreciation‑rights awards are **accounted for with estimated forfeitures**, meaning the number of shares that actually vest is adjusted downward as employees leave or forfeit their awards (HD 10‑K, Stock‑Based Compensation). Consequently, Tesla’s plan provides a static, predetermined amount of equity, whereas Home Depot’s forfeiture‑adjusted SAR methodology gives it greater long‑term flexibility because the ultimate share count can vary with actual vesting outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Tesla's 49.0 million fixed share reservation under the 2019 Plan and HD's forfeiture-adjusted vesting methodology are accurately represented. The numbers (49.0 million shares) are exact and properly cited. (2) Quantitative accuracy is perfect—no calculations were required beyond correct reporting of the share number, which matches the original. (3) The multi-hop reasoning is sound: the model correctly contrasts Tesla’s static, capped equity pool with HD’s dynamic, forfeiture-adjusted SAR approach, synthesizing information across both companies' 10-K disclosures. It correctly infers that HD's method allows variable share issuance based on actual retention, offering greater flexibility. (4) The only minor shortcoming is a slight lack of explicit mention that HD recognizes compensation expense on a straight-line basis as restrictions lapse—a detail in the ground truth that adds nuance to the accounting methodology. However, the core insight about flexibility due to forfeiture adjustments is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparison on long-term equity compensation flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 365,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s Kazakhstan exposure is tied to its 50 % equity stake in Tengizchevroil (TCO) and, explicitly, a loan of **$4.5 billion** that it provided to fund the FGP/WPMP development (Chunk 1).  The equity investment’s carrying amount is only about $100 million above the underlying net‑asset value, and the higher upstream earnings from TCO in 2021 are noted as a contributor to Chevron’s income (Chunk 2).  By contrast, ExxonMobil reports **$8,463 million** of long‑lived assets in Kazakhstan as of 2021 (Chunk 3).  Therefore, Chevron’s direct loan exposure of $4.5 billion – even when adding the modest equity‑related amount – is roughly half, or about $4 billion less, than ExxonMobil’s reported Kazakhstan long‑lived asset base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's 50% equity stake in Tengizchevroil (TCO) and the $4.5 billion ($4,500 million) loan for the FGP/WPMP development, matching the ground truth. It accurately reports ExxonMobil's long-lived asset value in Kazakhstan as $8,463 million in 2021. All numeric values are correct and properly formatted (e.g., $4.5 billion = $4,500 million). (2) The quantitative comparison is accurate: $4.5 billion is indeed roughly half of $8,463 million, and the difference is approximately $3.963 billion, which the LLM reasonably rounds to 'about $4 billion less'—this is acceptable given the context of high-level comparison. (3) The multi-hop reasoning is sound: the model synthesizes Chevron’s equity and loan exposure with ExxonMobil’s asset value from different sources, correctly contrasting their capital deployment strategies. It adds contextual insight about the modest equity carrying amount, which is consistent with the ground truth’s implication of differing investment structures. (4) The only minor shortcoming is that the LLM slightly overemphasizes the 'direct loan exposure' as the primary component of Chevron’s involvement, without fully articulating that the equity stake is a core, long-term investment—though it does mention it. The original answer better frames the strategic contrast in capital deployment. However, all key facts and calculations are correct, and the reasoning is logically coherent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 410,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable‑energy PPAs are treated as a strategic financing tool – the company negotiates the contracts as part of its VIE and tax‑equity arrangements and cites them as a key driver of the facilities’ economic performance, but the filing does not link those PPAs to a specific, near‑term cash‑flow boost from tax credits.  \n\nSouthern Power’s wind PPAs, on the other hand, are accounted for as operating‑lease arrangements and are explicitly tied to the production tax credits (PTCs) earned on the first ten years of wind output.  With roughly $0.8 billion of unused federal PTCs expected to be fully utilized by 2024, those credits have already had, and will continue to have, a material positive effect on Southern Power’s cash flow and net income.  \n\nThus, while Duke’s PPAs are primarily a contract‑negotiation and VIE‑management activity, Southern Power’s PPA structure directly leverages PTCs, delivering a clearer and larger cash‑flow benefit through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Southern Power's PPAs are operating leases tied to PTCs, Duke Energy's PPAs are part of VIE/tax-equity structures influencing economic performance but not directly linked to near-term PTC cash flows. The $0.8 billion in unutilized PTCs at end of 2021 and full utilization by 2024 are correctly stated. (2) Quantitative accuracy is perfect: the dollar amount ($0.8 billion), time frame (first 10 years of production), and deadline for utilization (2024) match the original. Format variation (e.g., $0.8 billion vs $800 million) is acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the model correctly contrasts Duke’s VIE-focused PPA strategy with Southern Power’s PTC-driven lease income model, synthesizing across entities and financial mechanisms. (4) The only minor shortcoming is a slight underemphasis on Southern Power’s tax equity partnership returns, which are mentioned in the original but not explicitly in the LLM response—this is a small omission, not an error. Otherwise, the semantic meaning, comparison, and cash flow implications are fully preserved. Wording differs slightly but meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed: PPA structures, cash flow implications, and PTC utilization through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 386,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s extra shares come from the settlement of its variable‑notional ASR agreements with third‑party financial institutions – after paying the maximum notional amount, the company receives additional shares (and a cash payment equal to the pre‑payment‑minus‑final‑notional difference). By contrast, HD issues additional shares to non‑employee directors as dividend equivalents attached to deferred‑share awards; these equivalents accrue and are paid out as extra shares when the underlying shares are delivered after a director’s service ends. Thus, LOW’s additional shares arise from a repurchase transaction with a financial institution, whereas HD’s additional shares are a compensation‑related issuance to directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LOW receives additional shares from variable-notional ASR agreements with financial institutions, where the final share delivery depends on repurchase efficiency; HD issues additional shares via dividend equivalents on deferred share awards to non-employee directors, paid upon termination. (2) There are no numeric values (e.g., dollar amounts, share counts) in either answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) The multi-hop reasoning is sound: the model correctly distinguishes between LOW’s transactional, repurchase-driven share receipt and HD’s compensation-driven share issuance, synthesizing across two different companies and mechanisms. (4) The only minor shortcoming is a slight overstatement in the LLM answer: it mentions LOW receives 'a cash payment equal to the pre-payment-minus-final-notional difference,' which is not in the original answer and may misrepresent the ASR settlement (typically, the company receives extra shares if the average price is below the cap, not a cash payment). This does not undermine the core correctness but slightly affects qualitative precision. Otherwise, the answer is semantically equivalent, contextually relevant, and accurately framed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 379,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported $125 million of equity‑method income from United Launch Alliance in 2024 — its direct share of ULA’s earnings. Lockheed Martin, which owns 50 % of ULA, rolls its share of ULA’s launch earnings into the Space segment’s operating profit and backs that activity with $665 million of receivables from other governments and commercial customers (the commercial portion that includes satellite‑launch work). Thus, while Boeing’s exposure to ULA’s commercial launch market shows up as a $125 million equity income line, Lockheed’s commercial launch revenue is part of a much larger commercial‑customer base (≈$665 million), reflecting a broader scale of commercial launch activity tied to ULA’s dual government‑and‑commercial role.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Boeing's $125 million equity income from ULA in 2024 and Lockheed Martin's $665 million in receivables from commercial and other customers as of December 31, 2024. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $125 million). (2) Quantitatively, all numbers are accurate: $125 million (Boeing’s equity income) and $665 million (Lockheed Martin’s receivables including commercial satellite launch work) are correctly cited. The 50% ownership of ULA by both Boeing and Lockheed Martin is implied in the context and consistent with known structure, though not explicitly stated in the original answer — this is a minor omission but not factually incorrect. (3) The multi-hop reasoning is sound: the answer correctly links Boeing’s equity income to ULA’s earnings, connects ULA’s commercial launches to Lockheed Martin’s Space segment revenue, and references the $665 million receivables as backing commercial activity. However, the LLM slightly mischaracterizes the $665 million as including 'other governments and commercial customers', while the original specifies 'commercial customers' — this introduces a small inaccuracy in scope, though the core point about commercial satellite launch linkage remains valid. (4) The answer is contextually relevant, fully addressing the correlation between Boeing’s equity income and Lockheed’s commercial launch revenue via ULA’s dual role. The synthesis across entities (Boeing, Lockheed Martin, ULA) and financial metrics (equity income, receivables, commercial revenue) is strong. A score of 9 is justified due to high factual accuracy and reasoning quality, with only a minor imprecision in describing the receivables breakdown.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 480,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly makes clear that a product’s market‑exclusivity is set by the life of its patents **and** by the statutory data‑protection periods that differ by region – generally five years of data‑package protection in the United States (twelve years for new biologics), about ten years in Europe and eight years in Japan – with additional extensions such as six‑months of pediatric exclusivity and seven‑years of orphan exclusivity where applicable.  When those patent or data‑protection windows close, Lilly expects a “severe and rapid decline” in revenue because generics or biosimilars can enter the market.\n\nMerck’s filing, by contrast, stresses that its business is “dependent on its patent rights” and that any invalidation, circumvention, compulsory‑licensing or regulatory change could strip its products of market‑exclusivity in the United States and other major markets.  Merck does not enumerate the specific exclusivity terms, but it flags the same consequence – a swift loss of sales – as a general patent‑related risk across the U.S., Europe and Japan.\n\nThus, while both companies face loss of exclusivity when patent protection erodes, Lilly’s risk is quantified by defined data‑protection periods that vary by market, whereas Merck’s exposure is described more broadly as the uncertainty of patent enforceability and potential compulsory licensing, without specifying exact exclusivity durations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies that LLY's market exclusivity is determined by both patent rights and regulatory data protection, with specific durations: 12 years for biologics in the U.S. (correct), 10 years in Europe (correct), and 8 years in Japan (correct). It also accurately notes additional exclusivity mechanisms like 7-year orphan drug exclusivity and 6-month pediatric exclusivity. The statement that LLY expects a 'severe and rapid decline' in revenue post-exclusivity matches the original answer. For MRK, it correctly states dependence on patent rights and risks from invalidation or compulsory licensing, with similar revenue loss consequences. (2) Quantitatively, all numbers are correct: 12-year U.S. biologic exclusivity, 10-year EU, 8-year Japan, 7-year orphan, 6-month pediatric. The only minor inaccuracy is mentioning 'five years of data-package protection' for non-biologics in the U.S., which is not in the original answer and slightly overgeneralizes; the ground truth does not specify 5 years, so this is a small factual addition not supported by the evidence. (3) Multi-hop reasoning is sound: the model correctly synthesizes across LLY and MRK, comparing LLY’s reliance on defined regulatory exclusivity periods versus MRK’s emphasis on patent enforceability and litigation risk. (4) The answer is contextually excellent, directly addressing the comparison of patent-related risks and exclusivity durations across major markets. The slight overstatement about 5-year U.S. data protection prevents a perfect 10, but overall the response is factually strong, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> REGULATORY_REQUIREMENT -[Determined_By]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 466,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company’s nuclear plants face a cyber‑intrusion risk that could trigger “increased nuclear licensing or compliance costs that are difficult to predict,” including possible fines, additional security upgrades and other operating‑ or capital‑expenditure outlays that may exceed insurance coverage. By contrast, Duke Energy’s nuclear exposure is a funding‑shortfall risk: the value of its nuclear‑decommissioning trust‑fund assets is subject to market fluctuations, and a decline could require “significant additional funding” that would strain cash flows and its overall financial position. Thus, Southern’s risk is an uncertain, potentially large compliance‑cost burden from cyber threats, whereas Duke’s risk is a market‑driven trust‑fund shortfall that could force extra cash contributions for decommissioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: Southern Company faces uncertain compliance costs due to cyber intrusion risks at its nuclear facilities, and Duke Energy faces decommissioning trust fund risks due to market fluctuations. The LLM correctly identifies the nature of each risk—Southern's potential for increased licensing/compliance costs and Duke's exposure to funding shortfalls from trust asset declines. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., percentages of KWH generation) are repeated in the LLM answer, it does not misstate any figures, and the omission of the 26%/28% KWH generation data from Alabama Power and Georgia Power is a minor completeness gap rather than an error. These percentages were present in the ground truth but not included in the LLM response, which slightly reduces completeness but does not affect the correctness of the comparison. (3) Multi-hop reasoning is sound: the model correctly synthesizes distinct risk types (cyber-related compliance vs. market-dependent decommissioning funding) across two companies with nuclear operations, drawing a valid contrast. (4) Semantic equivalence is strong—wording differs but meaning aligns closely. The LLM enhances clarity by specifying possible outcomes like fines or security upgrades, which are reasonable elaborations consistent with the source. Contextual relevance is excellent, directly addressing the comparative financial impacts as asked. The only reason for not scoring 10 is the omission of the specific 2021 KWH generation percentages tied to Southern’s subsidiaries, which adds contextual depth in the original. However, since the question focuses on financial impact comparison rather than operational generation mix, this omission does not undermine the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 509,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 deferred‑stock‑unit awards to non‑employee directors vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of shareholders (with possible acceleration), and the units simply “earn dividend equivalents” – the filing does not describe a separate share‑for‑share payout of those equivalents. In contrast, Home Depot’s deferred‑share awards vest only upon a director’s termination of board service, and any dividend equivalents that accrue are paid out as additional shares of stock when the underlying deferred shares are delivered after termination. Thus, Lowe’s uses a time‑based vesting schedule with dividend equivalents earned but not expressly paid in shares, whereas Home Depot’s awards vest at termination and pay dividend equivalents in the form of extra shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lowe's vesting schedule for deferred stock units granted to non-employee directors in 2023 as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, matching the original answer. It also correctly contrasts this with Home Depot’s policy, where vesting occurs upon termination of service. (2) There are no numeric values requiring calculation, but all dates and time-based conditions are accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Lowe’s and Home Depot), two compensation structures, and compares both vesting schedules and payout mechanisms. The only minor shortcoming is that the LLM answer states the filing 'does not describe a separate share-for-share payout' for Lowe’s, while the ground truth clarifies that awards granted prior to 2022 have immediate vesting — a detail not fully addressed in the LLM response. However, since the question focuses on 2023 grants, this omission is not critical. (4) The LLM clearly distinguishes between the two companies’ approaches to dividend equivalents — Lowe’s awards earn them without explicit payout in shares, while Home Depot pays them in additional shares upon termination — which matches the ground truth’s emphasis on differing payout structures. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 418,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen’s 10‑K makes clear that its biologics depend on a 12‑year data‑exclusivity “umbrella”; if the FDA decides that this umbrella does not apply to reference biologics, biosimilars could launch earlier, stripping Amgen of the market‑exclusivity period that underpins most of its revenue. In contrast, Merck’s filing shows it layers compound patents (with up to five‑year term restoration) and six‑month pediatric‑exclusivity extensions on top of the statutory data‑protection period, creating multiple IP layers that can extend market exclusivity beyond the basic regulatory term. Because market exclusivity is generally a function of both patents and regulatory exclusivity (as noted in the BMY discussion), the loss of the 12‑year exclusivity would erode Amgen’s competitive position far more than Merck’s, whose broader patent‑and‑pediatric‑exclusivity strategy can sustain protection even if the data‑exclusivity period is shortened.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 12-year biologic data exclusivity for AMGN, the risk of earlier biosimilar competition, and MRK's use of compound patents and pediatric exclusivity (six-month extension) are all accurately represented. The mention of 'up to five-year term restoration' for patents slightly extends beyond the original answer, which does not specify patent term restoration length, but this is a plausible detail from Hatch-Waxman and not factually incorrect. (2) Quantitative elements—12-year exclusivity, six-month pediatric extension—are correctly stated and match the ground truth. No calculations are required, and all numbers are consistent. (3) Multi-hop reasoning is sound: the model correctly contrasts AMGN’s reliance on regulatory exclusivity with MRK’s layered IP strategy, synthesizing implications for competitive positioning. It correctly infers that AMGN would be more vulnerable than MRK if the 12-year exclusivity were lost. (4) The answer is contextually relevant and fully addresses the comparative impact on competitive positioning. The only minor deviation is the reference to 'BMY discussion' and 'term restoration,' which are not in the original answer, but they do not introduce inaccuracy. Overall, the semantic meaning and factual content match the ground truth very closely, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 394,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC‑to‑RWA requirement does list a counter‑cyclical capital buffer, but the Federal Reserve has set that buffer at **zero percent**, so the firm’s TLAC is driven by the **18 % minimum TLAC‑to‑RWA threshold** (plus a 2.5 % buffer and a 1.5 % G‑SIB surcharge). Charles Schwab likewise has a **zero‑percent counter‑cyclical buffer**, but it must also maintain a **separate 2.5 % stress capital buffer** (CSC) above its regulatory minimums, meaning the buffer is applied as an additional capital charge rather than as part of a TLAC ratio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor overstatement regarding Goldman Sachs' TLAC components. (1) Quantitatively, all key percentages are accurate: GS's 18% minimum TLAC-to-RWA threshold, the 0% countercyclical buffer, and SCHW's 2.5% stress capital buffer are correctly reported. The mention of a '2.5% buffer and a 1.5% G-SIB surcharge' for GS is factually plausible but not explicitly confirmed in the original answer or required by the question—this additional detail is not in the ground truth and could imply a breakdown not directly supported by the provided data, slightly reducing quantitative precision. (2) The core entities—Goldman Sachs (GS), Charles Schwab (SCHW), TLAC, countercyclical capital buffer, stress capital buffer—are correctly identified and contextually applied. (3) The reasoning correctly synthesizes that both firms operate under a 0% countercyclical buffer but differ in how they apply additional buffers: GS within a TLAC framework, SCHW via a separate stress capital buffer. This captures the multi-hop comparison intent—linking regulatory treatment across two firms and two capital buffer types. (4) The answer is highly contextually relevant, directly addressing the comparative treatment of the countercyclical buffer under TLAC-like requirements. However, the original answer does not mention a G-SIB surcharge or a 2.5% additional buffer for GS, so introducing these elements—while consistent with broader regulatory knowledge—adds unsupported detail, preventing a perfect score. Overall, the semantic meaning and key facts match the ground truth, warranting a high but not full correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 459,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM’s 2023 Form 10‑K shows that it has **$7.728 billion of long‑lived assets in Kazakhstan**.  By contrast, CVX’s filing indicates that its presence in the same region is through a **minority ownership in TCO’s operations – essentially a 15 % interest in the Caspian Pipeline Consortium that transports TCO’s production** – rather than a large dollar‑valued asset base.  In other words, XOM’s exposure is quantified in billions of dollars, while CVX’s exposure is a modest percentage stake in the TCO‑related infrastructure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies XOM's $7,728 million ($7.728 billion) in long-lived assets in Kazakhstan from its 2023 10-K, which matches the ground truth and satisfies the quantitative aspect for XOM. However, the answer contains significant inaccuracies regarding CVX's stake in TCO. The LLM claims CVX has a '15% interest in the Caspian Pipeline Consortium' (CPC), which is factually incorrect based on the ground truth: CVX holds a direct stake in TCO (not just the CPC), and TCO operates major oil fields like Tengiz and Korolev under a concession agreement. The ground truth emphasizes CVX’s strategic positioning through TCO’s operations and ongoing projects (FGP and Karachaganak Expansion), none of which are mentioned. Instead, the LLM incorrectly frames CVX’s exposure as limited to pipeline infrastructure with a 'minority ownership,' which misrepresents the nature and significance of CVX’s involvement. This undermines both quantitative and qualitative accuracy. While the comparison between XOM’s direct asset ownership and CVX’s indirect exposure is conceptually relevant, the failure to accurately describe CVX’s actual stake—its operational role via TCO and project timelines—results in incomplete and misleading synthesis. The reasoning is partially sound but based on incorrect entity relationships. Contextual relevance is high as the answer attempts the right comparison, but factual errors in key entities and stakes reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 404,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company says it will keep evaluating ASU 2020‑04 and that the ultimate financial outcome of moving from LIBOR to an alternative rate “cannot be determined at this time” (Chunk 1). In contrast, NextEra Energy’s filing notes that it is already applying the same ASU 2020‑04 guidance to its interest‑rate contracts under the reference‑rate‑reform framework (Chunk 3)—a stance similar to 3M’s disclosure that applying the guidance would not have a material impact on its results (Chunk 2). Thus, while both companies are subject to the ASU 2020‑04 accounting policy that supports the FASB’s reference‑rate‑reform regulatory requirement, Southern Company remains uncertain about the impact, whereas NextEra Energy (and 3M) have implemented the standard without indicating material uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies Southern Company's (SO) uncertainty about the financial impact of transitioning from LIBOR, quoting the key phrase 'cannot be determined at this time,' and contrasts this with NextEra Energy's (NEE) active application of ASU 2020-04 to its interest rate contracts. The inclusion of 3M as an additional example (from Chunk 2) is contextually relevant and supports the broader point about companies applying the guidance without material impact, though 3M was not part of the original comparison question. This addition does not detract from correctness but slightly extends beyond the scope. All entities (Southern Company, NextEra Energy, ASU 2020-04, reference rate reform) are accurately identified and correctly contextualized. There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The reasoning is sound: the LLM correctly synthesizes disclosures across multiple companies and draws a valid contrast between SO’s ongoing evaluation and NEE’s implementation. The semantic meaning fully matches the original answer, with only minor expansion (mention of 3M) that does not introduce error. Thus, the answer earns a 9 in correctness and qualitative accuracy due to excellent fidelity with a slight over-extension, and perfect scores in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 393,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "Alphabet’s (GOOGL) certificate of incorporation builds explicit safeguards for minority shareholders: any amendment that would adversely affect a class of stock must be approved by the class that would be harmed and, before a stock‑holder vote, must receive the board’s unanimous consent. Although Class A, B and C shares have different voting powers, the rights to liquidation and dividends are identical and Delaware law bars unequal per‑share dividends, so the class‑specific consent requirement protects minority holders (Chunk 1).  \n\nMeta’s dual‑class structure, by contrast, gives the founder‑controlled Class B shares (10 votes per share) the ability to control all matters that require stock‑holder approval even though Zuckerberg owns far less than a majority of the total shares, and its anti‑takeover provisions require a separate majority of Class B voting to approve mergers, amendments or board changes (Chunk 3). Thus, while GOOGL’s governance framework includes mandatory class‑approval and board‑unanimity safeguards that shield minority shareholders, Meta’s framework concentrates decisive voting power in the controlling class and limits the influence of Class A shareholders, offering far weaker protection for minority interests. (The contrast is underscored by the fact that, in other companies, Class A common stockholders retain full voting rights on all matters, whereas Meta’s Class A holders are effectively out‑voted by the controlling Class B bloc – see Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that GOOGL's Certificate of Incorporation requires unanimous board approval before proposing amendments that adversely affect a class of stock, and that such amendments must also be approved by the affected class—key structural protections for minority shareholders. It accurately contrasts this with META's governance, where Class B stockholders (with superior voting rights) control key decisions, and highlights the entrenchment effect. (2) There are no numeric values (e.g., percentages, dollar amounts, vote ratios) in the original or LLM answer that conflict; the LLM correctly references superior voting power (10 votes per share for Class B) which is consistent with public knowledge and implied in the context, though not explicitly stated in the ground truth. The absence of the specific 'two-thirds majority' threshold in META’s anti-takeover provision when Class B voting power drops below 35% is a minor omission, but the core dynamic—entrenched control limiting minority influence—is correctly conveyed. (3) The multi-hop reasoning is sound: the LLM synthesizes governance mechanisms across two companies, compares voting rights, dividend/liquidation parity, and decision-making power, and draws a valid conclusion about relative minority shareholder protection. (4) The answer is contextually precise, directly addressing the comparative governance frameworks and their implications. The slight deduction in qualitative accuracy is due to the omission of the two-thirds vote threshold detail in META’s charter, which is part of the formal anti-takeover mechanism. However, the overall conclusion remains factually robust and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 484,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "The OECD’s Pillar‑Two rules – a 15 % global minimum tax that EU members are set to enact in 2024 and that is expected to roll out worldwide by 2025 – are being flagged as a source of higher tax liabilities for multinationals (BlackRock notes that such reforms “could increase its tax liabilities”). PepsiCo explicitly warns that, as the new rules become effective in the many countries where it operates, its tax provision could rise and its overall effective tax rate is likely to climb because a sizable share of its earnings comes from outside the United States. By contrast, Altria’s 2023 pre‑tax earnings were $10.9 bn almost entirely U.S.‑based, with a $2.8 bn tax provision (≈ 25 % effective rate) driven by federal and state taxes; its foreign earnings are negligible, so the 15 % minimum tax on overseas profits would have little impact on Altria’s effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo is exposed to the OECD's global minimum tax due to its international operations, which could increase its effective tax rate—consistent with the original answer. Altria’s minimal foreign exposure and predominantly domestic earnings are accurately highlighted as reasons for limited impact, matching the ground truth’s emphasis on its $2.346 billion in federal taxes and negligible foreign liabilities. (2) Quantitatively, the LLM reports Altria’s pre-tax earnings as $10.9 billion and tax provision as $2.8 billion, resulting in an ~25% effective tax rate—this is plausible and consistent with Altria’s typical tax burden, though the original answer did not include these specific figures. The $2.8B tax provision is close to the ground truth’s $2.346B federal tax payment, but the LLM may be including state or total taxes; this minor discrepancy is acceptable given format flexibility and lack of exact contradiction. No specific PepsiCo numbers were in the original, so the LLM’s qualitative warning from PepsiCo’s 10-K suffices. (3) The multi-hop reasoning is sound: the model correctly synthesizes the OECD framework’s implications based on company-specific tax profiles, drawing a clear contrast between a multinational (PepsiCo) and a domestic-focused firm (Altria). (4) Semantic equivalence is strong—while the LLM adds slightly more detail (e.g., EU rollout timeline, BlackRock reference), the core conclusion and factual basis match. One minor point: the original emphasizes U.S. tax legislation context, which the LLM omits, but this does not undermine the central reasoning. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 483,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "The U.S. orphan‑drug program grants a designated use seven years of market exclusivity that runs alongside any patents and can be stacked with data‑ and pediatric exclusivity, so a product can stay protected even after its compound patent expires (Chunk 1). Eli Lilly explicitly uses this orphan‑drug exclusivity to extend market protection beyond the patent term (Chunk 2; KG LLY → Orphan Drug Exclusivity → Market Exclusivity). Because AbbVie’s revenue depends on patent‑driven exclusivity, the creation of such regulatory market exclusivity for a competitor shortens the window in which AbbVie’s own products are shielded from generics and therefore raises its risk of generic competition once its patents lapse (Chunk 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the U.S. orphan drug designation granting seven years of market exclusivity that can extend beyond compound patent expiration, which aligns with the ground truth and Eli Lilly's use of the mechanism (Chunk 1 and 2). The quantitative claim about 'seven years' is correct, and no other numbers are misstated, warranting a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses how orphan drug exclusivity affects market protection and ties it to both Eli Lilly and AbbVie. However, the qualitative accuracy is lower because the reasoning contains a logical flaw: it incorrectly suggests that Eli Lilly’s use of orphan exclusivity shortens AbbVie’s exclusivity window and increases its risk of generic competition. This misrepresents the causal relationship. In reality, Eli Lilly’s use of the mechanism does not directly impact AbbVie’s timeline; rather, the ground truth emphasizes that AbbVie itself is vulnerable if *its own* orphan exclusivity is weakened. The correct multi-hop reasoning should center on AbbVie’s dependence on such exclusivity and the risks if it is lost, not on competitor actions reducing AbbVie’s protection. Thus, while key facts are correct and well-contextualized, the synthesis and logic are partially flawed, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 381,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "In 2021 Coca‑Cola FEMSA’s bottling and distribution footprint in Argentina (the Buenos Aires region and surrounding areas) meant that a slice of The Coca‑Cola Company’s $14.471 billion of net sales to equity‑method investees was tied to the Argentine market, giving KO an indirect, equity‑investee‑based exposure to Argentina. PepsiCo, on the other hand, flags Argentina explicitly as a market where volatile economic, political and social conditions directly affect its business, indicating a direct exposure to Argentine volatility (no dollar amount is quantified). Thus KO’s Argentine exposure is embedded in its large equity‑investee sales figure, whereas PEP’s exposure is a direct, stand‑alone risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $14.471 billion figure for KO's net sales to equity-method investees in 2021 is correctly reported (matches $14,471 million in original answer), and the geographic scope (Buenos Aires region and surrounding areas) accurately reflects Coca-Cola FEMSA's operational footprint in Argentina. (2) The answer correctly identifies that KO’s exposure is indirect through equity investee sales, while PEP has direct exposure due to operating in Argentina, facing economic volatility. Although the original answer specifies 'currency controls and inflationary pressures' and the LLM answer generalizes as 'volatile economic, political and social conditions,' this is a minor wording difference without material inaccuracy—PEP does report such broad risks in its filings. (3) Multi-hop reasoning is sound: the model correctly links Coca-Cola FEMSA’s Argentina operations → KO’s equity investee sales → indirect exposure, and contrasts it with PEP’s direct operational presence and associated risk disclosures. (4) The only minor shortcoming is the lack of explicit mention of 'pandemic recovery' as a factor influencing KO’s equity investee sales, which slightly reduces completeness. However, this does not undermine the core comparative insight about exposure type (indirect vs. direct). Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 409,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s market‑exclusivity plan for emraclidine is built on the patent rights it inherited when it bought Cerevel Therapeutics.  The acquisition gave AbbVie an exclusive global license to Pfizer’s patents covering the compound, obligates the company to pay up to $1.6 billion in milestones and tiered royalties, and has already resulted in a $4.5 billion intangible‑asset impairment charge that reflects the risk of losing that protection (Chunk 1).  As the filing explains, patents – together with any regulatory exclusivity periods – are the primary source of market exclusivity for branded drugs (Chunk 2).  Merck’s experience with Januvia shows the opposite side of that equation: the key U.S. patent expired in January 2023, and although later‑expiring salt‑form patents and regulatory exclusivity extensions push U.S. exclusivity out to May/July 2026, the company has already lost EU exclusivity and is forecasting steep sales declines (Chunk 3).  In short, AbbVie is proactively securing fresh patent coverage through acquisition to create future exclusivity, whereas Merck is relying on the tail‑end of existing patents and limited regulatory extensions, which ultimately still lead to a loss of exclusivity and revenue erosion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key facts: AbbVie's $4.5 billion impairment charge, the exclusive global license from Pfizer via Cerevel acquisition, and Merck's core patent expiration for Januvia in January 2023 with extended exclusivity to May/July 2026 due to salt-form patents. However, it introduces a $1.6 billion milestone payment obligation not present in the original answer, which lacks support in the ground truth and may be a hallucination or misattribution. (2) Quantitatively, the $4.5 billion impairment and Januvia patent expiration in January 2023 are accurate. The May/July 2026 U.S. exclusivity dates for Januvia/Janumet and Janumet XR are correctly cited. The $1.6 billion milestone figure is unverified and not in the original, reducing quantitative accuracy slightly. (3) The multi-hop reasoning is generally sound—comparing AbbVie’s proactive patent licensing strategy through acquisition versus Merck’s reliance on secondary patents and regulatory extensions. However, the LLM incorrectly frames Merck as having already lost EU exclusivity and forecasting steep declines, which, while plausible, is not stated in the original answer and adds unsupported detail. The core contrast—AbbVie’s strategy failing despite patent licensing (evidenced by impairment) vs. Merck successfully extending exclusivity—is underdeveloped in the LLM response. (4) The answer is contextually relevant and well-structured, addressing both companies and the exclusivity strategies. However, the addition of unverified financial terms and the omission of Merck’s successful legal settlements as a reason for extension (a key point in the original) reduce qualitative and quantitative accuracy. The conclusion captures the strategic contrast but with less precision than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1653,
        "completion_tokens": 489,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 percent stake in the Caspian Pipeline Consortium gives it a direct claim on the pipeline’s average 1.4 million barrels‑per‑day of transport capacity (about 1.2 million b/d from Kazakhstan and 0.2 million b/d from Russia), and the recent CPC debottlenecking project expands that capacity to support new output such as the Future Growth Project. By contrast, ConocoPhillips’ upstream business is fundamentally dependent on the volume of crude oil it can produce—its performance hinges on crude‑oil production itself rather than on a specific export‑pipeline asset. Thus, Chevron leverages a pipeline investment to secure export capacity, whereas ConocoPhillips relies directly on crude‑oil output for its upstream operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in quantitative detail. (1) Correctness: The LLM correctly identifies Chevron's 15% stake in the CPC, its role in enabling crude oil exports from Kazakhstan, the relevance of the debottlenecking project completed in January 2023 (implied by 'recent'), and the connection to the Future Growth Project (FGP) ramp-up. It also accurately contrasts this with ConocoPhillips' direct reliance on crude oil production for upstream operations. (2) Quantitative Accuracy: The LLM states the CPC has an average transport capacity of 1.4 million b/d (1.2 from Kazakhstan, 0.2 from Russia), which is factually plausible and consistent with public data, though the original answer focuses only on the 1.2 million b/d from Kazakhstan that is directly relevant to Chevron’s export access. This addition is not incorrect but slightly over-specified. The key figure of 1.2 million b/d from Kazakhstan matches the ground truth exactly. No calculation errors are present. (3) Reasoning: The multi-hop synthesis is sound—linking Chevron’s equity stake in CPC → export capacity → support for FGP, and contrasting with ConocoPhillips’ operational dependence on production volume rather than infrastructure—demonstrates strong logical and comparative reasoning. (4) Contextual Relevance: The response directly addresses both parts of the question and maintains focus on the strategic difference in how the two companies engage with crude oil: Chevron via export infrastructure investment, ConocoPhillips via production-centric operations. Minor point: The original specifies the debottlenecking was completed in January 2023; the LLM says 'recent,' which is acceptable but less precise. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Transports]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 499,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle embeds generative‑AI straight into its MySQL HeatWave offering, turning the service into a single managed cloud database that runs AI‑driven analytics, machine‑learning and generative‑AI workloads on OCI and Exadata infrastructure. Qualcomm, by contrast, is betting that generative‑AI will live primarily on edge devices—its QCT chips and connectivity platforms will run large language‑model inference locally for privacy, low‑latency and energy efficiency, while the cloud (via Qualcomm’s cloud‑computing processing initiative and QSI investments) supplies the training, model‑update and orchestration back‑end. Thus Oracle’s AI is cloud‑centric, whereas Qualcomm’s AI is edge‑centric, but both strategies hinge on robust cloud‑computing infrastructure to complement the generative‑AI capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual content is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service on OCI and Exadata, combining transactions, analytics, ML, and generative AI. Qualcomm focuses on on-device generative AI via its QCT chips for edge computing, emphasizing privacy, low latency, and energy efficiency, with cloud support for training and orchestration through its QSI segment. (2) Quantitative accuracy is perfect—no numeric claims were made in the LLM answer that contradict or misrepresent the ground truth (e.g., the 46% and 19% smartphone projections for 2027 and 2024 are not mentioned in the LLM answer, but their absence does not reduce correctness since the LLM did not attempt to include them; thus, no inaccuracy). (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s cloud-centric AI strategy with Qualcomm’s edge-centric vision while acknowledging both rely on cloud infrastructure—Oracle for hosting the full stack, Qualcomm for backend training and updates. (4) Semantic equivalence is strong: though the LLM uses different phrasing (e.g., 'cloud-centric' vs 'edge-centric'), it captures the core strategic distinction and complementary role of cloud computing. The only minor shortcoming is the omission of specific forward-looking market penetration figures (19% in 2024, 46% in 2027), which were present in the original answer and would have strengthened completeness. However, since the LLM answer does not claim or require those numbers to make its point, the omission does not constitute a factual error, just a slight reduction in richness. Hence, a score of 9/10 on correctness and qualitative accuracy is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 493,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s cash‑flow protection comes from the large pool of legally binding firm‑commitment contracts it has entered into – $37.2 billion of purchase obligations (including $15.9 billion due within one year) for inventory and utility purchases that lock in quantities, prices and timing and therefore give the retailer a predictable out‑flow schedule (Chunk 1). Colgate‑Palmolive, on the other hand, relies on derivative‑based hedges – option contracts that are used to offset foreign‑currency risk on purchases, assets and liabilities, providing a right‑but‑not‑obligation mechanism that smooths cash‑flow volatility (Chunk 3); the Disney filing illustrates that such option contracts are commonly employed to hedge firm‑commitments and other forecasted transactions (Chunk 2). Thus, Walmart mitigates cash‑flow risk through contractual certainty, whereas Colgate‑Palmolive does so through flexible option‑contract hedges that offset exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its qualitative assessment: Walmart uses firm commitments (not derivatives) for inventory and utilities, while Colgate-Palmolive uses option contracts to hedge foreign exchange risk, aligning with their respective risk management strategies. The core comparison on cash flow risk mitigation through contractual certainty vs. financial hedges is accurate and well-reasoned.\n\n2) Quantitative inaccuracy: The LLM states Walmart has $37.2 billion in total purchase obligations, with $15.9 billion due within one year. However, the ground truth only confirms $15.9 billion in firm commitments due within one year. The $37.2 billion figure is not present in the original answer and appears to be an overstatement or misattribution (possibly conflating total long-term obligations with short-term ones). This is a significant error, though the $15.9 billion figure — the key number — is correct.\n\n3) Multi-hop reasoning is sound: The model correctly synthesizes that Walmart relies on operational contracts (firm commitments) while Colgate uses financial instruments (options), and it draws a valid contrast in risk management philosophy. The reference to Disney’s filing as an example of option use is extraneous but not incorrect; however, it slightly distracts from the direct comparison between Walmart and Colgate-Palmolive.\n\n4) Despite the inflated total obligation figure, the answer captures the essential distinction in financial exposure management. The reasoning, entity identification (Walmart, Colgate-Palmolive), and use of correct financial terms (firm commitments, option contracts, cash flow volatility) are strong. The answer remains contextually relevant and semantically aligned with the ground truth, except for the unsupported $37.2 billion number. Hence, a score of 8 is justified: core facts and logic are correct, but with a notable quantitative error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Utilizes]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 515,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its exposure to a credit‑event by buying and selling credit‑default swaps, which give it protection against the loss of principal if a reference obligor defaults (bankruptcy, insolvency, failure‑to‑pay, etc.) and by using other risk‑mitigation limits. Capital One, on the other hand, does not hedge the risk but values its net derivative‑asset liabilities with a discounted‑cash‑flow model that treats the “default” rate as a key unobservable input (a range of 53 %‑163 % with a weighted‑average assumption of about 4 %). Thus, both firms are highly sensitive to the same default‑risk factor: Morgan Stanley’s CDS contracts offset the impact of a credit event, while Capital One’s fair‑value of its derivative liabilities moves directly with the default‑rate assumptions used in its valuation.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Morgan Stanley's use of CDS to hedge credit event risk and Capital One's reliance on default rate assumptions in valuing derivative assets. The core reasoning about both firms' sensitivity to default outcomes is sound and matches the ground truth. However, there is a critical error in the presentation of the default rate range: the LLM states 'a range of 53 %‑163 %' which incorrectly implies 53% to 163%, whereas the original answer specifies a weighted average default rate assumption of 4% with a range of 53–163 basis points (i.e., 0.53%–1.63%). This is a significant quantitative misrepresentation, as 53% default rates are implausible in a financial context. (2) The 4% weighted average is correctly stated, but the range is off by a factor of 100 due to the missing clarification that it's in basis points. This undermines quantitative accuracy despite correct qualitative intent. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both institutions are exposed to credit event outcomes—Morgan Stanley through direct CDS triggers and Capital One through valuation sensitivity—even though their mechanisms differ. The connection via systemic credit risk is accurately drawn. (4) Contextual relevance is perfect—the answer directly addresses the relationship between the two firms' credit risk exposure. Qualitative accuracy is high due to correct entity identification, proper explanation of CDS mechanics, and logical flow. The correctness score is reduced to 8 due to the material but not fundamental numerical error in the default rate range, which affects interpretation of Capital One’s assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Protected_Against]-> RISK_FACTOR -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 461,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s Georgia footprint is part of a much larger system – the company reports 35,700 miles of natural‑gas distribution‑and‑transmission pipelines and 28,800 miles of service lines (across all its service areas, which include Georgia) 【Chunk 1】.  By contrast, Southern Company Gas owns a 50 % stake in SNG, the “largest natural‑gas pipeline investment” that comprises a 7,000‑mile interstate pipeline delivering gas from Texas, Louisiana, Mississippi and Alabama into markets that include Georgia 【Chunk 2】.  \n\nBecause of its size, Duke’s network provides extensive local‑distribution capacity that directly delivers gas to Georgia customers, underpinning day‑to‑day reliability.  Southern’s SNG investment, while smaller in mileage, adds critical interstate supply diversity and capacity to the region, bolstering overall reliability of the Georgia gas market from a supply‑side perspective.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core comparison between Duke Energy and Southern Company Gas in Georgia but contains key quantitative inaccuracies. It states Duke Energy has 35,700 miles of pipelines and 28,800 miles of service lines 'across all its service areas, which include Georgia,' implying these are not Georgia-specific figures. However, the ground truth specifies that Duke operates 28,000 miles of pipelines *in Georgia*—a critical distinction. The LLM inflates the number and misattributes system-wide data to Georgia, leading to a significant factual error. The 7,000-mile figure for SNG is correct and properly attributed to Southern Company Gas’s 50% stake. 2) Quantitative accuracy is compromised: the 35,700 and 28,800 mile figures do not appear in the ground truth and are not tied specifically to Georgia, making them misleading. The ground truth does not mention service lines, so their inclusion adds unverified detail. The SNG mileage and ownership percentage are accurate. 3) Qualitatively, the reasoning is sound: the LLM correctly distinguishes Duke’s local distribution role from SNG’s supply-side transmission function and links them to different aspects of reliability (local delivery vs. supply diversity). It synthesizes the multi-hop concept that SNG supports regional utilities including Duke, though this integration is implied rather than explicitly stated. 4) Contextual relevance is high—the answer directly addresses capital scale (mileage) and contribution to infrastructure reliability in Georgia, aligning with the question’s focus. However, it omits the Southern Power investment coverage ratio (97% through 2028), a key financial indicator of revenue stability from the ground truth, weakening completeness. Overall, the answer is partially correct with strong reasoning but undermined by incorrect numerical attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 501,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "The 2024 corporate‑tax‑rate reductions enacted by Louisiana and Arkansas together lowered Union Pacific’s deferred tax expense by **$34 million**, as disclosed in its 2024 Form 10‑K. Because UNP operates in both states (e.g., a classification yard in Livonia, LA and facilities in North Little Rock and Marion, AR) and the same Louisiana legislation is referenced in GE’s filing, the tax‑rate cuts affect UNP’s future tax liabilities in each jurisdiction; however, the filing does not break out the $34 million benefit by state, so the impact of Louisiana’s law and Arkansas’s law cannot be distinguished beyond the combined reduction.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $34 million reduction in deferred tax expense due to Louisiana and Arkansas's 2024 tax rate reductions, matching the ground truth in total amount and context. However, it diverges significantly by stating that the $34 million is a combined figure and that the impact cannot be broken out by state. In contrast, the original answer explicitly attributes $34 million to Louisiana’s legislation and describes Arkansas as having a 'comparable adjustment,' implying a similar magnitude of impact, not a shared or undifferentiated total. This misrepresents the distribution of the impact and fails to reflect the parallel, distinct effects described in the ground truth. (2) Quantitatively, the $34 million figure is accurate and correctly attributed to 2024 state tax changes affecting Union Pacific; no calculation errors are present. The date (2024) and entity (Union Pacific) are correct. (3) The multi-hop reasoning is partially sound—LLM correctly links state-level tax legislation to deferred tax expense and recognizes Union Pacific's operations in both states. However, it incorrectly infers from the lack of state-level breakout in the filing that the $34 million is a combined total, whereas the ground truth treats Louisiana’s $34 million as a standalone figure with Arkansas being separately comparable. This reflects a failure in accurate synthesis across the knowledge graph data. (4) Contextual relevance is high—the answer addresses the core issue of tax legislation impact on deferred tax expense and names the correct states and company. However, due to the mischaracterization of the financial impact allocation, the qualitative accuracy is reduced, pulling the overall correctness score into the mid-range.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 482,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "META’s filing shows that it has two share classes – about 2.19 billion Class A shares and 343.8 million Class B shares (Chunk 1).  Although the 10‑K does not spell out the vote‑per‑share, the voting‑rights description in the other filing (Chunk 2) makes clear that Class B common stock “has no right to vote on any matters, except for certain defined matters, including any consolidation, merger, combination or similar transaction…,” and that when such a merger‑type event occurs the Class B holders vote as a single class with votes multiplied by the applicable conversion rate.  By contrast, Alphabet’s 10‑K (Chunk 3) states that each Class A share is entitled to one vote on **all** shareholder matters, while its Class B shares carry ten votes per share and its Class C shares have no voting rights.  \n\nBecause META’s Class B shares can only exercise voting power in narrow circumstances such as mergers, corporate control in those scenarios is concentrated in the hands of the relatively few Class B holders, while they have essentially no influence on routine governance.  GOOGL’s Class A shareholders, however, retain a continuous one‑vote‑per‑share voice on every matter, producing a more broadly distributed governance structure.  Thus, the limited, merger‑specific voting rights of META’s Class B stock create a governance model that centralizes decision‑making for major transactions, whereas GOOGL’s Class A stock supports ordinary, shareholder‑wide participation in corporate governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: META's Class B shares have no voting rights except in specified merger scenarios, where they vote with conversion-rate weighting; GOOGL's Class A shares have one vote per share, Class B have ten, and Class C have none. These details match the original answer's emphasis on differential voting rights and governance implications. (2) Quantitative accuracy is perfect: the share counts (2.19 billion Class A, 343.8 million Class B) are correctly cited from the filings and do not require calculation. No numerical errors exist. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across META and GOOGL filings to contrast governance models: META’s Class B voting is event-triggered and limited, leading to concentrated control in major transactions, while GOOGL’s Class A shareholders have continuous, albeit minority, voting influence. The conclusion about centralized vs. distributed governance is logically derived. (4) Semantic equivalence is strong: while the LLM adds specific share counts not in the original answer, this enhances completeness without distorting meaning. The only minor shortcoming is a slightly less explicit emphasis on how META's structure specifically concentrates power among Class A holders (rather than Class B), but the overall governance contrast is accurately conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 428,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. commercial payers are increasingly using step‑therapy, prior‑authorization, high‑deductible and copay‑accumulator designs to limit access to high‑cost drugs such as Amgen’s Repatha, forcing the company to cut list prices, deepen rebates and accept restricted formulary placement—actions that directly reduce net sales and patient affordability. Pfizer’s 10‑K flags the same “access restrictions” and the difficulty of obtaining timely, favorable formulary placement for its cardiovascular portfolio, meaning it will face comparable payer‑driven discount and rebate pressures. Following the model described by Gilead, Pfizer is likely to tighten its gross‑to‑net estimation process and recognize revenue net of higher estimated rebates, chargebacks and other payer deductions, adopting a more conservative revenue‑recognition strategy to reflect the impact of U.S. payer restrictions on pricing and sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: U.S. payer restrictions (e.g., prior authorization, formulary exclusions, cost-sharing) impacting Repatha are accurately described, as are Pfizer's challenges with formulary placement and pricing. The reference to Gilead’s gross-to-net revenue recognition strategy is correctly applied by analogy to Pfizer. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in that regard. Thus, quantitative accuracy is 10, as no numbers are misstated or miscalculated. (3) The multi-hop reasoning is sound: the model correctly links payer dynamics affecting Amgen’s Repatha → broader industry trend → Pfizer’s exposure → implications for revenue recognition strategy, using Gilead as a benchmark. The synthesis across companies (Amgen, Pfizer, Gilead) and concepts (formulary access, rebates, gross-to-net deductions) is logically coherent and factually grounded. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'step-therapy', 'copay-accumulator designs', 'tighten its gross-to-net estimation process'), these are valid and more detailed elaborations of the same concepts in the original answer. The only minor gap is that the LLM does not explicitly mention 'patient affordability trends' as a modeled factor in gross-to-net deductions, though it references 'patient affordability' in context—hence a slight deduction in qualitative accuracy. Overall, the response is contextually precise, factually correct, and demonstrates strong cross-company, cross-concept synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Pays]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 460,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s exposure to the upcoming Tengiz‑Korolev “Future Growth Project” (FGP) is confined to its 15 % working interest in the Caspian Pipeline Consortium (CPC), the conduit that carries virtually all of TCO’s Kazakhstan crude.  CPC moves about 1.2 million barrels per day (bpd) of Kazakh oil, so Chevron’s share is roughly 180,000 bpd; when the FGP comes on‑line in the first half of 2025 and reaches full output within three months, that incremental volume will be reflected only in Chevron’s proportional 15 % slice of the pipeline throughput.  By contrast, ConocoPhillips (COP) discloses in its 10‑K that crude oil is a primary raw material for its business, meaning COP’s risk is tied to the overall crude‑oil market and to the total volume of oil it consumes—not to a single stake—so its exposure to TCO’s ramp‑up is far broader and less bounded than Chevron’s limited, stake‑based exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several key inaccuracies that affect factual correctness, particularly in quantitative and entity-related details. (1) QUANTITATIVE ACCURACY: The claim that Chevron holds a 15% working interest in the Caspian Pipeline Consortium (CPC) is correct per the ground truth, but the LLM incorrectly frames Chevron's exposure as being *only* through CPC, whereas the original answer states Chevron has a 15% ownership in *TCO* (Tengizchevroil), which is the operator of the FGP project—this is a critical multi-hop error. The 180,000 bpd calculation (15% of 1.2 million bpd) is mathematically correct but misleading because it implies Chevron’s exposure is solely via pipeline throughput, not equity production. Additionally, the LLM omits that Chevron’s 15% TCO stake gives it direct exposure to production volumes, not just pipeline fees. (2) COMPLETENESS: The answer fails to mention Chevron’s 15% ownership in TCO—the core of its exposure—thus missing a key link in the multi-hop reasoning. It incorrectly shifts focus entirely to CPC. (3) ENTITY ACCURACY: The LLM confuses the nature of Chevron’s stake: it is a 15% interest in TCO (the producing entity), not just CPC (the transporter). This misrepresents the mechanism of exposure. (4) REASONING: The logic is partially sound in comparing Chevron’s limited, proportional exposure to COP’s broader crude oil dependence, but the foundation is flawed because it misattributes the source of Chevron’s exposure. The comparison to COP is reasonable—COP’s 10-K does cite crude oil as a primary raw material, so its exposure is market-wide—but the contrast is weakened by the incorrect characterization of Chevron’s position. (5) SEMANTIC EQUIVALENCE: While the general idea of 'limited vs. broad exposure' is preserved, the factual basis differs significantly. The LLM invents a narrative centered on CPC working interest as the sole exposure, while the ground truth emphasizes dual 15% stakes in both TCO and CPC, with TCO being primary. Overall, the answer gets the timeline (H1 2025 start, 3-month ramp-up) and COP’s crude dependency right, but fails on a key entity and exposure mechanism, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 586,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs says its commercial‑real‑estate book contains loans and lending commitments that are “directly or indirectly secured by hotels” – i.e., its hotel exposure is a credit‑risk position embedded in its broader loan portfolio (Chunk 1). MetLife, on the other hand, invests in real‑estate funds that include hotel assets; those fund interests are part of its $13.3 billion real‑estate investment portfolio (about 2.9 % of its cash‑and‑invested assets) and are disclosed as equity‑style holdings (Chunks 2 and 3). So Goldman’s exposure is a loan‑based, hotel‑secured credit exposure, whereas MetLife’s exposure is an equity investment in hotel‑focused real‑estate funds that sits within a multi‑billion‑dollar real‑estate portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Goldman Sachs' exposure is credit-based through loans secured by hotels, while MetLife's exposure is through equity investments in real estate funds focused on hotels. The $13.3 billion real estate investment figure for MetLife as of December 31, 2024, is correctly cited (implied from context, though date not explicitly repeated in LLM answer). The 2.9% of cash-and-invested assets is an accurate derivation from MetLife’s total portfolio size, and while not in the original answer, it is a valid inference and does not contradict the ground truth. (2) Quantitative accuracy is perfect: $13.3 billion is correctly reported, and no other numbers are misstated. (3) Multi-hop reasoning is sound—LLM correctly distinguishes between lending (credit exposure) and investment (equity exposure), synthesizing across both companies’ strategies. (4) The only minor shortcoming is that the LLM does not explicitly mention that Goldman Sachs’ loans are often connected to real estate funds, a nuance present in the original answer that adds depth to the strategic comparison. However, this omission does not distort the core contrast. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses the comparison, strategy, and nature of exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 387,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA’s private‑equity and real‑asset exposure is held through limited‑partnership vehicles that, like most private‑equity structures, are illiquid and have long‑term horizons, but the filing does not spell out specific redemption windows or unfunded commitments. UPS’s pension plan, however, invests in limited‑partnership interests in real‑estate funds that cannot be redeemed until the partnership’s 10‑ to 15‑year term ends, and the plan carries roughly $3.3 billion of unfunded commitments that must be funded over the next three to six years—an explicit, sizable liquidity obligation on assets valued at about $9.9 billion and measured only at NAV. Thus, while both firms face illiquidity from LP holdings, UPS’s risk is more clearly quantified by the 10‑15‑year lock‑up and the large unfunded obligation, whereas BA’s liquidity risk is less specifically disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that both BA and UPS have liquidity risks tied to limited partnership (LP) investments with 10–15 year terms, and accurately states UPS’s $3.3 billion in unfunded commitments as of December 31, 2023 (implied from context). The quantitative details—$3.3 billion unfunded, 10–15 year lock-up, NAV-based valuation—are factually correct and match the ground truth. However, the LLM incorrectly implies that BA’s filing does not disclose specific redemption windows or unfunded commitments, whereas the ground truth confirms BA also has LP investments with 10–15 year durations, indicating similar structural illiquidity. This omission or mischaracterization weakens the comparison. 2) Quantitatively, all numbers are accurate: $3.3 billion unfunded for UPS, 10–15 year terms, and NAV-based valuation are all correct. No calculation errors. 3) The multi-hop reasoning is partially sound—correctly linking LP structure to illiquidity and comparing across firms—but understates the symmetry in risk profiles by suggesting BA’s risk is less disclosed rather than equally structured but perhaps less explicitly detailed. The core insight that both face long-term illiquidity due to LP terms is valid, but the conclusion that UPS’s risk is 'more clearly quantified' introduces a nuance not in the ground truth, which treats both as similarly structured. 4) Despite minor overemphasis on disclosure differences, the LLM answer remains contextually relevant, directly addressing the comparison of liquidity risks, time horizons, and unfunded obligations. The answer is factually grounded and well-structured, but loses points for not fully affirming the parallel nature of the liquidity constraints as stated in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 475,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "META’s dual‑class system concentrates control in the hands of its controlling shareholder – Mr. Zuckerberg – because the relatively few Class B shares retain special voting rights until they fall below 35 % of the combined voting power, allowing him to dictate outcomes even though he owns far less than a majority of the total Class A and Class B shares. In contrast, Comcast (CMCSA) splits voting power roughly two‑thirds to Class A holders (≈66 % of the vote) and one‑third to Class B (≈33 % of the vote), with each of the 9.4 million Class B shares carrying 15 votes and owned entirely by Mr. Roberts; voting is generally as a single class, so while the Roberts family has strong influence, ordinary shareholders retain a majority of the vote. Thus, META’s structure creates a higher concentration of control and a less attractive position for Class A investors, whereas CMCSA’s structure distributes voting power more evenly, albeit with a weighted minority that still provides significant family influence.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences in voting power distribution between META and CMCSA. It correctly identifies that META's Class B shares (held primarily by Mark Zuckerberg) have superior voting rights and that control remains concentrated until Class B falls below 35% of combined voting power—this aligns with the ground truth. The description of CMCSA’s structure is mostly accurate: Class B shares have 15 votes each and are owned entirely by Brian L. Roberts (referred to as 'Roberts family'—a reasonable generalization). However, there is a key quantitative inaccuracy: the LLM states that Class A holders have 'roughly two-thirds' (≈66%) of the vote and Class B '≈33%', implying Class A has majority voting power. But the ground truth specifies that Class A has exactly 66 2/3% of *combined* voting power, while Class B—though fewer in number—have 15 votes per share and are non-dilutable. The LLM incorrectly implies that Class A shareholders collectively hold a majority influence, when in fact the Class B shares (due to 15x voting power and non-dilutable status) are structured to preserve long-term control by Roberts, even with fewer shares. This misrepresents the degree of control concentration at CMCSA. The LLM also introduces a specific number—'9.4 million Class B shares'—that is not present in the original answer and cannot be verified from the provided ground truth, constituting an unsupported detail. Despite this, the overall reasoning and comparison are sound: META has stronger anti-takeover provisions and greater control concentration than CMCSA, and the dual-class structures in both companies limit shareholder influence to varying degrees. The answer addresses all parts of the question, synthesizes across both companies, and draws a valid comparative conclusion, albeit with minor factual overprecision and one incorrect implication about shareholder balance at CMCSA. Wording differences are acceptable under semantic equivalence, but the numerical and structural misstatement about CMCSA’s voting split prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 559,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan holds about **$1.8 billion of government securities** – roughly **15 % of its $11.7 billion U.S. plan assets** (see the 2023 table).  These securities are part of a **well‑diversified mix of equities, corporate bonds, real‑estate and high‑quality debt**, and the plan’s policy targets a **7.4 % long‑term rate of return** while using derivatives (futures, forwards) to hedge interest‑rate and currency risk.  \n\nCostco’s short‑term portfolio, by contrast, is **concentrated in U.S. government and agency obligations, money‑market funds and repo collateral**, with the **primary objective of preserving principal and only secondarily generating modest yields**; its exposure to interest‑rate changes is described as immaterial.  \n\nThus, PEP treats government securities as one component of a higher‑return, risk‑balanced, long‑term strategy, whereas Cost‑co relies on government and agency securities as the core of a low‑risk, short‑term, principal‑preservation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.8 billion allocation to government securities by PEP is correctly reported (ground truth: $1.812 billion — acceptable rounding). The 7.4% long-term return target is exact. While the LLM introduces additional context not in the original (e.g., total U.S. plan assets of $11.7B and 15%), these are plausible inferences consistent with the data and do not contradict the ground truth. (2) COST's short-term holdings are accurately described as focused on capital preservation with low volatility, and the emphasis on government and agency securities is correct. The claim that interest rate exposure is 'immaterial' aligns with the original's focus on short-duration, fixed-rate instruments limiting rate risk. (3) The multi-hop reasoning is sound: the model correctly contrasts PEP’s long-term, diversified, actively managed strategy (including derivatives for risk mitigation) with COST’s short-term, low-risk, principal-preservation focus. (4) The qualitative synthesis of risk management and return objectives is excellent — correctly identifying PEP's government securities as one component of a broader return-seeking portfolio versus COST's use as a core, low-risk holding. The only minor gap is that the original specifies 'effective maturities of three months to five years' for COST, which the LLM omits, but the concept is captured through 'short-term' and 'low volatility'. No factual errors; wording differences are semantically equivalent. Thus, the answer earns a 9 for correctness — excellent but not perfect due to slight expansion beyond provided data and omission of maturity range detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Contains]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 463,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s 2020 fair‑value table shows that it actually held **$9 million of mortgage‑ and asset‑backed securities** within its fixed‑income portfolio.  That amount represents only about **0.3 % of its total fixed‑income holdings** (≈$9 m of $3.4 bn of U.S. Treasury, corporate and pooled‑fund bonds) and roughly 0.06 % of its overall assets.  \n\nNextEra Energy’s pension‑plan policy, by contrast, targets **32 % of the plan’s assets to be allocated to fixed‑income investments** (which, per the filing, include mortgage‑backed securities).  \n\nThus, while both companies classify mortgage‑backed securities as part of fixed‑income assets (as noted in the MMM filing), Southern Company’s **actual exposure to mortgage‑backed securities is a tiny fraction of its fixed‑income mix**, whereas NextEra Energy’s **target is a much larger, 32 % allocation to fixed‑income overall**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Southern Company's $9 million allocation to mortgage-backed securities and NextEra Energy's 32% target allocation to fixed income, which includes mortgage-backed securities. Both companies' classification of these securities under fixed income is accurately noted. However, there is a significant error in the denominator used to calculate Southern Company's percentage: the LLM states $9 million is 'about 0.3%' of $3.4 billion in fixed income holdings, but the ground truth specifies $6,154 million (i.e., $6.154 billion) in Level 2 fixed income investments, not $3.4 billion. Using $6.154 billion, $9 million is approximately 0.15%, not 0.3%. The $3.4 billion figure does not appear in the ground truth and appears to be an incorrect subset or misstatement.\n\n2) Quantitative inaccuracies include: (a) incorrect total fixed income portfolio size for Southern Company ($3.4 billion vs. $6,154 million), leading to (b) an erroneous percentage (0.3% vs. <0.15%). The $9 million and 32% figures are correct. The 0.06% of overall assets is not in the ground truth and cannot be verified, but it's presented as additional context, not central to the comparison.\n\n3) The multi-hop reasoning is generally sound—comparing actual allocation (Southern) vs. target framework (NextEra)—and both entities are correctly identified. The synthesis across companies and concepts (actual vs. target, classification consistency) is appropriate and logical.\n\n4) The answer is contextually relevant and addresses the core comparison. However, the incorrect portfolio total and resulting percentage undermine the quantitative accuracy. While the qualitative direction (Southern has very low exposure vs. NextEra’s large target) is correct, the magnitude is misrepresented. Hence, correctness is reduced to 6 due to the material calculation error, despite correct entity identification and reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 519,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic have codified their Gigafactory partnership through a cascade of binding contracts – a 2011 Supply Agreement, a 2014 Production Pricing Agreement and General Terms and Conditions (supplemented by an Investment Letter Agreement), and later amendments that lock in cell‑type‑specific pricing (the 2019 Japan‑cell Pricing Agreement, the 2020 Gigafactory‑2170‑cell Pricing Agreement and the 2021 Japan‑cell Pricing Agreement) together with lease‑related documents that tie the parties to a joint‑venture‑style supply and investment structure. In contrast, GM’s 2023 Form 10‑K merely discloses that it depends on batteries supplied by Panasonic, without detailing comparable joint‑venture terms, cell‑specific pricing contracts or facility‑lease arrangements, indicating a far shallower level of supplier integration and contractual depth than Tesla’s multi‑layered arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core contractual framework between Tesla and Panasonic, including multiple pricing agreements and supply arrangements. However, it introduces a 2011 Supply Agreement and a 2014 Production Pricing Agreement with an Investment Letter Agreement, which are not present in the ground truth. The ground truth specifies the Amended and Restated General Terms and Conditions (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells) — the LLM correctly names the 2020 and 2021 agreements but adds earlier ones not in the original. (2) The dates mentioned (2019, 2020, 2021) are mostly accurate, though the 2019 agreement is not in the ground truth (which starts with 2020). The LLM also references a '2014' agreement not in the original, which is a factual error. (3) The multi-hop reasoning is strong: the LLM correctly contrasts Tesla’s detailed, structured agreements with GM’s lack of disclosed contractual depth, citing GM’s 2023 Form 10-K as evidence of weaker supplier integration — this aligns with the ground truth’s conclusion. (4) Despite the addition of unverified earlier agreements, the LLM captures the essence of Tesla’s deep contractual integration and GM’s relative lack thereof. The core comparison is logically sound and contextually appropriate, warranting high scores in qualitative accuracy and relevance. The quantitative accuracy is slightly penalized due to incorrect dates and unverified agreements, but the key 2020 and 2021 agreements are correctly cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 436,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s exposure in Nigeria is driven by an unresolved tax audit – the most recent Nigerian audit year is 2007 – and the company carries $5.3 billion of unrecognized tax benefits, roughly 82 % of which would alter its effective tax rate if they were to be recognized; the timing and amount of any adjustment remain unknown. Exxon’s risk, by contrast, is linked to Nigeria’s production‑sharing contracts, which are generally 30‑year agreements (a 10‑year exploration phase followed by a 20‑year production phase, with mandatory partial relinquishment and possible extensions under the 2021 Petroleum Industry Act); PSC‑related assets account for about 12 % of Exxon’s proved reserves, so the exposure is confined to that share of its portfolio and is defined by the contract’s statutory terms rather than an uncertain tax liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: Chevron's $5.3 billion in unrecognized tax benefits aligns with the $5,288 million reported (rounded appropriately), the 2007 audit year is correctly cited, and Exxon's 12% of proved reserves under PSCs is accurately reflected. The 82% figure regarding impact on effective tax rate is additional but plausible context not contradicted by the original. (2) The structure of Nigeria's PSCs—10-year exploration, 20-year production, 30-year total with possible extensions under the 2021 Petroleum Industry Act—is correctly described, including relinquishment provisions. (3) Entity accuracy is strong: Chevron and Exxon are correctly attributed to their respective risks (tax audits vs. PSCs), and the years (2021) and metrics (proved reserves, unrecognized tax benefits) are properly associated. (4) Multi-hop reasoning is sound: the model correctly synthesizes Chevron’s tax exposure with audit delays and financial impact, and contrasts it with Exxon’s operational exposure via PSCs, linking contract duration, price sensitivity, and reserve exposure. The only minor gap is the omission of the explicit inverse relationship between production volumes and price changes mentioned in the original, which slightly weakens the qualitative completeness. However, the core contrast—Chevron’s regulatory/tax uncertainty vs. Exxon’s contractual/price-linked exposure—is clearly and correctly conveyed. Wording differs but semantic equivalence is maintained. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 443,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reported **$470 million** of commercial paper on its balance sheet (see the “Commercial paper” line in its cash‑and‑short‑term‑investments table). By contrast, Duke Energy’s Ohio subsidiary disclosed only **$25 million** of commercial paper (part of its $52 million short‑term financing mix). Thus, Tesla’s commercial‑paper borrowing is roughly 19 times larger than that of a company with a sizable Ohio operation such as Duke Energy Ohio (even though Ohio hosts many other firms – e.g., 84 units for Lowe’s).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Tesla's commercial paper as $470 million and Duke Energy Ohio's as $25 million, matching the ground truth exactly. These figures are accurately cited and formatted consistently (e.g., $470 million = $470 million). The calculation that Tesla’s commercial paper is roughly 19 times larger (470 / 25 = 18.8, rounded to 19) is quantitatively accurate. (2) All numbers are correct: Tesla — $470 million as of December 31, 2023 (implied by context), Duke Energy Ohio — $25 million. The mention of Duke Energy Ohio’s $52 million short-term financing mix adds contextual detail not in the original but does not contradict it and may reflect additional filing data; it does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies Tesla and a major Ohio-operating company (Duke Energy Ohio), retrieves their respective commercial paper amounts, and synthesizes a valid comparison. The reference to Lowe’s Ohio units is extraneous but not factually incorrect, and doesn’t undermine the core comparison. (4) The answer conveys the same essential information as the ground truth — differing only in slight emphasis (e.g., framing Tesla’s amount as 'borrowing' rather than 'holdings', which could imply a liability vs. asset interpretation). However, in context, 'commercial paper' on a balance sheet can refer to either issuances (liabilities) or investments (assets); the ground truth frames Tesla’s as holdings (investments), while the LLM frames it as 'borrowing', which may be a mischaracterization. This is a minor but notable qualitative issue, hence the 9/10 on qualitative accuracy. Otherwise, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 474,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan flags transition risk – the financial fallout from a shift to a low‑carbon economy – as a core climate‑risk factor and places it under its Climate Risk Management function, which is charged with setting policies, standards and procedures and with ensuring that the firm complies with all applicable climate‑related laws and regulations. Because transition‑risk drivers (policy changes, new technologies, shifting consumer preferences) can trigger new regulatory requirements, JPMorgan’s exposure to transition risk directly creates a compliance‑risk exposure.  \n\nMorgan Stanley’s filing, by contrast, notes that the impacts of transition risk have already led to heightened legal and regulatory scrutiny of its climate‑related disclosures, exposing the firm to compliance‑ and litigation‑risk as regulators enforce new reporting and carbon‑tax rules. Thus, JPMorgan’s compliance risk is a forward‑looking consequence of its internal transition‑risk framework, whereas Morgan Stanley’s compliance risk reflects the reactive fallout of actual regulatory scrutiny tied to its climate disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's integration of transition risk into its Climate Risk Management function, the forward-looking compliance risk due to regulatory changes, and Morgan Stanley's experience with actual regulatory scrutiny tied to climate disclosures are all accurately represented. There are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and terms (e.g., transition risk, compliance risk, litigation risk) are used correctly. (2) The LLM correctly synthesizes information across both firms’ disclosures, capturing the multi-hop requirement: it contrasts JPMorgan’s proactive, framework-driven approach with Morgan Stanley’s reactive exposure to enforcement. (3) The reasoning is sound: the conclusion that JPMorgan faces forward-looking compliance risk while Morgan Stanley faces reactive fallout from actual scrutiny is a valid interpretation of the original answer’s distinction between proactive integration and regulatory enforcement emphasis. (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of Morgan Stanley’s experience as 'actual regulatory scrutiny'—while implied, the original answer says 'heightened legal and regulatory scrutiny' without confirming enforcement actions occurred. However, this is a reasonable inference. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 438,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements that give an oil‑prospecting license (OPL) for up to 10 years, require partial relinquishment at the end of that exploration phase and then provide a 20‑year oil‑mining lease (OML) that can be extended under the Petroleum Industry Act. Because ConocoPhillips’ deep‑water assets in Nigeria are disclosed in its 2021 10‑K, the company must plan its development and joint‑venture activities around that 10‑year exploration window, the 20‑year production period and the relinquishment/extension rules, which shape its investment horizon and risk profile. Chevron (CVX) also depends on the same PSC regime, and consequently reports the Nigerian assets as “PSC‑related” reserves—accounting for about 8 % of its total reserves in 2021 (down from 10 % in 2020‑19) and included in its African reserve balances—so the 30‑year contract terms directly affect how Chevron measures and presents those reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the 30-year PSC structure, 10-year exploration phase, 20-year production period, and Chevron's 8% of reserves in 2021 (noted as down from 10% in 2019–2020) match the context. The slight rephrasing of '8–10%' in the original to 'about 8%' in 2021 is reasonable given the downward trend and is supported by the data. (2) The entity accuracy is strong: ConocoPhillips and Chevron (CVX) are correctly identified, and the reference to the 2021 10-K filing is consistent with available disclosures. The mention of the Petroleum Industry Act and partial relinquishment is accurate. (3) Multi-hop reasoning is sound: the model correctly links Nigeria’s PSC framework to ConocoPhillips’ operational planning and investment horizons, and to Chevron’s reserve accounting practices, including geographic classification and disclosure trends. (4) The answer is contextually complete and relevant, addressing both companies and both aspects of the question—operations and accounting. The only minor shortcoming is a slight simplification of Chevron’s reserve range (8–10% in original vs. 8% cited), but this is mitigated by the temporal clarification. Overall, the answer demonstrates strong factual grounding, correct synthesis across regulatory, operational, and financial domains, and semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 400,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s large exposure to U.S.‑government contracts – about 37 % of 2023 revenue – means that any contract modifications the government may impose (e.g., curtailments, terminations or funding reductions) must be accounted for under ASU 2022‑06, using the standard’s optional expedients and the extended‑to‑Dec 31 2024 sunset date to mitigate the operational and financial impact of those changes (including any reference‑rate adjustments that may be required). FedEx, by contrast, applies the same ASU 2022‑06 chiefly to manage reference‑rate‑reform impacts on its LIBOR‑linked contracts and hedging relationships; it also benefits from the optional relief and deferral but has reported no material effect on its financial condition. Thus both companies rely on ASU 2022‑06 for contract‑modification accounting, but Boeing’s use is driven by broader government‑contract risk, whereas FedEx’s use is focused on easing the accounting burden of reference‑rate reform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 37% exposure of Boeing's revenue to U.S. government contracts is accurately stated, and the December 31, 2024 sunset date for ASU 2022-06 is correctly cited (consistent with the extended relief through 2024 in the original). No calculations were required, but the factual numeric content matches. (2) The answer addresses both parts of the multi-hop question: Boeing’s application of ASU 2022-06 in the context of government contract modifications and FedEx’s use regarding reference rate reform. It correctly notes that both companies applied the standard with no material financial impact, though the drivers differ. (3) Entity accuracy is strong: Boeing and FedEx are correctly identified, ASU 2022-06 is properly referenced, and the context of LIBOR transition and government contracts is accurate. (4) The reasoning is sound and synthesizes the multi-hop elements well—distinguishing Boeing’s broader government contract risk from FedEx’s focused use on reference rate reform, while correctly noting both benefit from the optional expedients and extended sunset. The only minor shortcoming is that the original explicitly states Boeing did not experience material impacts from contract modifications, while the LLM implies it through context but doesn’t state it as clearly. Still, the core facts, synthesis, and semantics are equivalent. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 424,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that, at the end of 2021, it held roughly 2.9 million offshore acres in Angola (out of a total 3.0 million acres).  Chevron, on the other hand, does not hold acreage there but owns a financial stake in the Angola LNG joint‑venture; that stake generated upstream‑related earnings that were reflected in Chevron’s $5.657 billion equity‑affiliate income for 2021 and is shown in its share of production volumes from Angola LNG.  In short, ExxonMobil’s presence is measured in 2.9 million offshore acres, while Chevron’s involvement is measured by a revenue‑producing equity stake in Angola LNG rather than land acreage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's 2.9 million offshore acres in Angola at year-end 2021 is accurately reported. The mention of Chevron's $5.657 billion equity-affiliate income in 2021 is an additional detail not in the original answer but is factually consistent with Chevron’s 2021 10-K and supports the claim about upstream earnings contributions from Angola LNG. While the original answer does not specify the $5.657B figure, it does confirm that Angola LNG contributed to upstream-related earnings via equity affiliates, so this addition enhances rather than distorts accuracy. (2) The entity identification is correct: ExxonMobil (acreage holder), Chevron (equity stakeholder in Angola LNG), and Angola LNG (joint venture) are all properly identified with correct roles. The time frame (2021) is consistent. (3) Multi-hop reasoning is sound: the model correctly contrasts ExxonMobil’s physical asset (offshore acreage) with Chevron’s financial stake in a joint venture, synthesizing information across different types of holdings and reporting metrics. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., total acreage of 3.0 million, specific equity income figure), which improves clarity without introducing error. The only minor limitation is that the original does not mention the 3.0 million total acres or the exact $5.657B figure, so while those are accurate, their inclusion could be seen as extrapolation—though not incorrect. Overall, the answer fully addresses the comparison asked in the question with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 454,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture said it spent **$6.6 billion** on 46 strategic acquisitions in fiscal 2024 to scale its industry‑solutions capabilities. Microsoft’s 2024 filing shows that its **Enterprise and partner services** segment – which the filing notes includes industry solutions – generated **$7.594 billion** in revenue. Thus, Accenture’s investment is roughly $1 billion (about 12‑13 %) lower than the revenue Microsoft earned from the comparable enterprise‑and‑partner services segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's $7.594 billion in 'Enterprise and partner services' revenue (which includes industry solutions) are correctly reported. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect: the $6.6B vs $7.594B comparison is exact, and the LLM correctly calculates the difference as approximately $1 billion. The percentage difference (~12-13%) is a reasonable approximation (actual: (7.594 - 6.6)/7.594 ≈ 13.1%), so this minor rounding is acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two different companies and financial contexts (investment vs revenue) and draws a logical comparison. (4) The answer adds analytical value by quantifying the gap between Accenture’s investment and Microsoft’s revenue, which enhances the original answer. The only reason for not scoring 10 is that the original answer emphasizes differing strategic approaches (investment vs revenue generation), which the LLM mentions implicitly but could have articulated more explicitly. However, the core information, numbers, and logic are fully correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Includes]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 358,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio’s FERC‑approved dividend policy obliges the company to keep its adjusted equity at least 30 % of total capital, and it does so by limiting dividend payouts and accounting for the merger‑related push‑down effects on its balance sheet. Southern Company can apply the same discipline to its $1.5 billion (50 % of the $3 billion) cost‑share of the SNG pipeline—securing FERC approval only if its equity ratio remains comfortably above a regulator‑set floor, using the $146 million of annual equity‑method earnings from the SNG investment and restricting dividends as needed to preserve that cushion. In short, Duke’s experience shows that maintaining a minimum equity buffer under FERC oversight is essential, and Southern should embed a similar equity‑threshold covenant in its financing plan for the pipeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy Ohio's 30% equity threshold under FERC-approved policies and Southern Company's 50% cost share in the $3 billion SNG pipeline project, which requires FERC approval. It appropriately draws a parallel between the two cases for financial planning. However, the LLM introduces a specific figure—$146 million of annual equity-method earnings from the SNG investment—that is not present in the original answer or supported by the provided ground truth. This number appears to be fabricated or inferred without basis, which undermines quantitative accuracy. (2) The calculation of Southern Company’s $1.5 billion cost share (50% of $3 billion) is correct and aligns with the ground truth. But the $146 million earnings figure has no verification in the original data and introduces a false precision that affects the reliability of the financial reasoning. (3) The multi-hop reasoning is largely sound: the model connects Duke Energy’s regulatory experience with equity thresholds to Southern Company’s need for compliance in a similar FERC-regulated context. It correctly infers that equity management strategies (like dividend restrictions) could be applied analogously. However, the addition of unverified financial data weakens the logical chain. (4) Despite the invented number, the core insight—that Southern should consider embedding equity-threshold covenants in its financing plan based on Duke’s precedent—is semantically aligned with the original answer. The reasoning is contextually relevant and captures the regulatory and financial planning implications accurately, just tainted by one unsupported quantitative claim. Hence, correctness is reduced to 7 due to partial factual inaccuracy, though the overall structure and intent are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 491,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS discloses that its corporate bonds are measured at fair value using Level 2 inputs and, when broker quotes are not available, the company applies matrix pricing (or yield‑curve models) as an observable input – a practice that is also described in the generic policy for corporate‑debt pricing (Chunk 1 + Chunk 2). MMM, however, does not list matrix pricing as a separate fair‑value level; instead it values corporate debt instruments either by using yields on comparable issuers or by a discounted‑cash‑flow approach that relies on observable yields and then adds adjustments for credit and liquidity risk (Chunk 3). Thus, UPS isolates matrix pricing within its Level‑2 fair‑value hierarchy, whereas MMM incorporates similar observable‑input pricing into a broader yield‑or‑DCF methodology with risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UPS uses matrix pricing under Level 2 inputs when broker quotes are unavailable, and MMM uses comparable yields or discounted cash flow models with adjustments for credit and liquidity risk. The LLM correctly identifies that UPS explicitly categorizes matrix pricing within Level 2 of the fair value hierarchy, while MMM integrates similar techniques into broader methodologies without isolating matrix pricing as a distinct category. (2) There are no numeric values, dates, or financial figures in dispute; both the original and LLM answers reference 2022 disclosures implicitly through context, and no specific numbers (e.g., dollar amounts) are involved, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information about two companies (UPS and MMM), their valuation methodologies, and differences in how they apply matrix pricing or equivalent techniques, particularly regarding risk adjustments. The only minor shortcoming is that the LLM does not explicitly state that both companies use matrix pricing (or equivalent) *as a fallback when broker quotes are unavailable*—though this is implied by referencing the same condition. (4) The answer captures the nuanced difference: MMM adjusts for non-observable risks like credit and liquidity, while UPS does not mention such adjustments. Wording differs slightly but maintains semantic equivalence. Thus, the answer is contextually relevant, factually correct, and well-reasoned, meriting a 9/10 due to slight omission in explicitly framing matrix pricing as a fallback method for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 462,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The $2.8 billion that Verizon received from Vertical Bridge in December 2024 was not treated as a pure sale‑proceeds financing; Verizon recorded $2.0 billion of the cash as prepaid rent and the remaining $830 million as a financing obligation, reflecting a lease‑back of a portion of the tower capacity (a 10‑year lease with eight five‑year renewal options) while the towers remain on Verizon’s balance sheet and continue to be depreciated. By contrast, AT&T’s 2013 Crown Castle transaction brought $4.827 billion in cash that was booked entirely as a financing liability (interest‑bearing at about 3.9 %) because AT&T concluded it had not transferred control of the assets; Crown Castle obtained exclusive rights to lease and operate the towers (with purchase options at lease end) but AT&T retained ownership of the towers and sub‑leased space for an original 20‑year term, thereby preserving its operational control. Both deals hinge on the counterparties obtaining exclusive‑rights to the towers, but the Vertical Bridge deal splits the upfront cash into prepaid rent plus debt and features a shorter lease‑back, whereas the Crown Castle deal is recorded as a single financing obligation with a longer sublease horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 is correctly split into $2.0 billion in prepaid rent and $830 million in financing obligation; the 2013 AT&T (T) transaction with Crown Castle is accurately cited at $4.827 billion, recorded entirely as a financing obligation with ~3.9% interest. These numbers match the original answer exactly, with acceptable formatting (e.g., $2.8 billion vs $2.8 billion). (2) The qualitative analysis is strong: both transactions correctly reflect retained ownership and operational control, continued depreciation of tower assets, and the distinction in accounting treatment—VZ’s dual classification vs T’s single financing obligation. The LLM adds useful context not in the original but factually consistent: lease-back terms (10-year with renewal options for VZ; 20-year sublease for T), exclusive rights to counterparties, and purchase options at lease end. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (VZ and T), two years (2024 and 2013), two counterparties (Vertical Bridge and Crown Castle), and compares financing structures and control retention—fully addressing the comparative nature of the question. (4) Minor deduction in qualitative accuracy due to slight expansion beyond the original (e.g., mention of purchase options and renewal terms), which, while plausible and consistent, are not confirmed in the ground truth. However, these do not contradict the original and are typical in such transactions. Overall, the answer is factually correct, comprehensive, and contextually precise—warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Obtains]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 472,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "MRK’s 2024 filing warns that the IRS’s review of its TCJA “transition‑tax” positions could create a **significant, but as‑yet‑unquantified** tax liability – the company already recorded $51 million of interest and penalties in 2024 and carries $437 million of accrued interest/penalties, underscoring the potential size of any additional liability. In contrast, MDT’s exposure to the same TCJA‑created BEAT is **explicitly quantified**: the BEAT line in its 2024 tax reconciliation adds only **$0.3 million** (a 0.3‑point rise in its effective tax rate). Thus, MRK’s possible TCJA‑related liability is far larger and more uncertain than MDT’s modest, disclosed BEAT impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers compared to the ground truth. The ground truth states that MRK has $2.3 billion in unrecognized tax benefits at risk, while the LLM claims only $437 million in accrued interest/penalties and $51 million in interest and penalties for 2024 — these figures are not equivalent and misrepresent the scale and nature of the liability. The LLM incorrectly frames the $437 million as the total potential liability when it is only accrued interest/penalties, not the principal tax exposure. Additionally, the LLM states MDT’s BEAT impact is $0.3 million, but the ground truth reports a 0.3% increase in effective tax rate, not a $0.3 million dollar amount — this is a critical error conflating percentage points with absolute dollars. (2) Quantitative accuracy is low: the $0.3 million figure appears fabricated or misextracted; no such dollar value is implied in the original answer, which only cites a 0.3 percentage point increase in tax rate. The $51M and $437M figures for MRK do not align with the $2.3B unrecognized tax benefits highlighted in the ground truth, suggesting confusion between penalties and principal liability. (3) The reasoning partially follows the correct multi-hop structure — linking TCJA to BEAT, comparing MRK’s uncertain liability to MDT’s measurable impact — but fails in synthesis because it mischaracterizes the magnitude and type of financial exposure for both companies. It correctly identifies that MRK’s liability is uncertain and potentially large and that MDT’s BEAT impact is small, but the basis for comparison is flawed due to incorrect metrics. (4) Contextual relevance is high because the answer addresses the TCJA, BEAT, IRS examination, and comparative tax impacts, and attempts a direct comparison. However, due to major quantitative errors and misrepresentation of financial exposures, the correctness score is limited to 4 — partially correct on structure and directionality, but significantly flawed in factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 550,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements that contain a 10‑year exploration phase (with OPLs that can be converted to OMLs) followed by a 20‑year production phase, require partial relinquishment at the end of the exploration period and can be extended under the Petroleum Industry Act. ConocoPhillips’ 2021 10‑K shows that its deep‑water offshore activities in Nigeria are structured around exactly those PSC terms – its OPLs are limited to ten years, it must convert to an OML for the production period and comply with the relinquishment and extension rules, which defines the size and duration of its operational footprint in the country. The same regulatory regime governs how Chevron reports its African reserves: its 10‑K disclosures list African reserves of roughly 98 million barrels (Jan 1 2019) rising to 106 million barrels (Dec 31 2021), figures that are disclosed under the “exploration and production activities” framework set by Nigeria’s 30‑year PSCs. Thus, Nigeria’s PSC framework shapes both ConocoPhillips’ operational tenure in the country and the basis for Chevron’s reserve disclosures across Africa.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Chevron's African reserves are accurately cited as 106 million barrels as of December 31, 2021, matching the ground truth (from hop3_evidence). The mention of 98 million barrels as of January 1, 2019, is an additional but plausible data point not contradicted by the original answer and consistent with trend. Dates, contract durations (10-year exploration, 20-year production), and structural elements (OPL to OML conversion, relinquishment, extension under Petroleum Industry Act) are factually sound. (2) The answer correctly identifies both companies (ConocoPhillips and Chevron), the relevant regulatory framework (Nigeria’s 30-year PSCs), and ties them to operational and disclosure impacts. (3) Multi-hop reasoning is strong: it links Nigeria’s PSC structure (hop2_evidence) to ConocoPhillips’ operational footprint (hop1_evidence) and Chevron’s reserve disclosures (hop3_evidence), demonstrating synthesis across entities and documents. (4) The only minor shortcoming is the introduction of the Petroleum Industry Act and OPL/OML terminology not present in the ground truth, which, while factually accurate in context, slightly extends beyond the provided evidence. However, this does not detract from correctness and may reflect real-world knowledge. Wording differs but semantic equivalence is preserved. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 417,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s charter creates a separate Series C preferred stock (see the designation in Chunk 1) whose holders enjoy only limited voting rights (Chunk 2): they can vote only on narrowly defined matters—most notably any consolidation, merger or similar transaction that would give them different consideration than the company’s Class A common shareholders—and their approval is required as a distinct voting class. Netflix, on the other hand, gives every common share one vote on all matters (Chunk 3), so any restructuring is decided by a uniform, one‑share‑one‑vote shareholder vote with no special‑class veto. As a result, AT&T’s restructuring proposals must clear an additional, class‑specific consent hurdle, whereas Netflix’s can be approved through a straightforward majority of all shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: AT&T's Series C Preferred Stockholders have limited voting rights, specifically in merger or consolidation events where they receive different consideration, and their separate class approval is required. Netflix follows a one-share-one-vote model for common stockholders, allowing broad governance participation. The LLM correctly contrasts the two structures, emphasizing that AT&T requires class-specific consent for certain restructurings, while Netflix does not. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes governance structures from two different companies and draws a valid comparison regarding how each affects restructuring decisions. The mention of 'different consideration than Class A common shareholders' adds precision beyond the original answer, which is consistent with the truth. (4) The only reason for not scoring a 10 is minor: the LLM slightly narrows the trigger for voting rights to 'different consideration' without explicitly mentioning broader restructuring scenarios like amendments to charter provisions affecting equity treatment, which the original answer implies. However, this detail is often contextually equivalent in practice. Overall, the answer is semantically equivalent, highly relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 417,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Enbrel’s core U.S. patents listed by Amgen run out on 11 Nov 2028 (fusion‑protein composition), 24 Apr 2029 (DNA‑encoding and manufacturing methods) and 19 Oct 2037 (formulation and preparation methods).  Because Pfizer markets Enbrel only outside the United States and Canada (Pfizer 10‑K, Specialty‑Care Inflammation & Immunology), those dates define the longest period of patent‑based protection Pfizer can count on for its overseas sales.  \n\nAbbVie, however, routinely pursues the full suite of patent‑term‑restoration and biologics‑exclusivity tools described in its 10‑K (up to a five‑year restoration under Hatch‑Waxman and the 12‑year BPCIA exclusivity with possible pediatric extensions).  That broader approach can push the effective exclusivity horizon beyond the nominal 2028‑2037 expiries, delaying biosimilar entry and giving Pfizer a longer window to extract revenue.  \n\nAccordingly, Pfizer’s long‑term Enbrel strategy hinges on maximizing sales through the 2037 expiry while preparing for eventual competition once any AbbVie‑driven extensions lapse.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer includes mostly correct patent expiration dates (2028, 2029, 2037), aligning with the ground truth, though it adds specific dates (e.g., Nov 11, Apr 24, Oct 19) not present in the original answer. These specific dates may be accurate but are not confirmed in the ground truth, introducing unverified precision. 2) The answer incorrectly states that Pfizer markets Enbrel only outside the U.S. and Canada, which contradicts the known fact that Pfizer co-developed and co-marketed Enbrel in the U.S. with Amgen (and later transferred rights), and the original answer does not support this geographic limitation. This is a significant entity and factual error affecting reasoning. 3) The LLM misattributes the patent ownership and strategy: the original answer discusses Pfizer's strategy regarding Enbrel patents, but the LLM implies Amgen holds the patents (correct) yet frames Pfizer’s revenue strategy around patents it doesn’t control, creating confusion. The multi-hop reasoning fails because it doesn’t acknowledge that Pfizer’s rights to Enbrel are limited post-2013 (U.S.) and that AbbVie’s strategy is for its own products (e.g., Humira), not Enbrel. 4) The comparison to AbbVie’s Hatch-Waxman and BPCIA strategies is conceptually sound and contextually relevant, but the implication that AbbVie’s actions could delay biosimilar entry for Enbrel is incorrect—AbbVie does not own Enbrel and thus cannot extend its exclusivity. This undermines the core reasoning. 5) The conclusion that Pfizer’s strategy hinges on maximizing sales through 2037 is partially reasonable but based on flawed premises. The original answer suggests Pfizer may need to adopt AbbVie-like tactics, while the LLM incorrectly implies such tactics are already being applied or are externally enabled by AbbVie. 6) Despite these issues, the answer captures the staggered patent expirations and the general idea of lifecycle management, showing partial understanding. Quantitative accuracy is high (dates align within year), but qualitative accuracy suffers from incorrect entity relationships and flawed synthesis. Contextual relevance is strong as it addresses patent timelines and revenue strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 584,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore complex is listed as producing **about 1.9 million units of ethylene (million metric tons per year)** (see XOM 10‑K, Asia‑Pacific table). Chevron’s indirect exposure comes from its ownership stake in the Map Ta Phut Olefins joint‑venture in Thailand, which the CVX filing shows has an **ethylene manufacturing capacity of roughly 175 thousand barrels per day** (see CVX 10‑K capacity table, and the Dow filing confirming Map Ta Phut makes ethylene). Thus, ExxonMobil’s Singapore plant delivers ethylene in annual‑million‑ton terms, while Chevron’s stake backs a daily‑barrel‑per‑day capacity that is smaller when expressed in comparable annual volume.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies ExxonMobil's Singapore ethylene capacity as 1.9 million metric tons per year, matching the ground truth. However, it introduces a significant error by stating that the Map Ta Phut Olefins joint venture has an ethylene capacity of 'roughly 175 thousand barrels per day'—this figure is not present in the ground truth and appears to be a misinterpretation or fabrication. The original answer explicitly states that while Chevron holds a 32.77% stake, the exact ethylene capacity attributable to Chevron is not specified. (2) The number 175,000 barrels per day is not supported by the evidence provided in the ground truth, and no conversion or calculation is offered to translate barrels per day into annual metric tons, undermining the comparison. Even if the barrel figure were accurate, the LLM fails to convert it into comparable units (e.g., million metric tons per year) to make a valid comparison. (3) The reasoning is partially sound in structure—attempting to compare ExxonMobil’s direct capacity with Chevron’s indirect exposure—but fails in execution due to reliance on an unsupported number and lack of proper unit conversion. The multi-hop synthesis is flawed because it assumes capacity data that the evidence does not provide. (4) The contextual relevance is high because the answer addresses the core comparison and cites relevant documents (CVX and XOM 10-Ks), but the quantitative inaccuracy severely undermines correctness. The qualitative accuracy is moderate due to correct entity identification and logical intent, but incorrect data input leads to invalid conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 447,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company booked a pre‑tax charge of about $96 million (≈ $72 million after tax) for the disallowance of certain capital investments at Nicor Gas – a utility that serves roughly 2.3 million customers and operates about 34.7 thousand miles of gas pipe in Illinois. In the same state, NextEra Energy’s assets are far smaller in physical scope, consisting of roughly 90 miles of transmission lines and five substations (listed under its “Other” jurisdiction), so the $96 million hit represents a sizable monetary impact compared with NextEra’s modest infrastructure footprint in Illinois.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states Southern Company's $96 million pre-tax charge and Nicor Gas's 2.3 million customers and 34.7 thousand miles of pipeline in Illinois, it grossly misrepresents NextEra Energy's infrastructure in Illinois. The LLM claims NextEra operates only '90 miles of transmission lines' in Illinois, but the ground truth states that NextEra operates 90 thousand miles of transmission lines across five states—Illinois, Indiana, Kentucky, New Hampshire, and New York—combined, not just in Illinois. The LLM incorrectly interprets this as 90 miles and confines it solely to Illinois, which is a major quantitative and qualitative error. (2) The number '90 miles' is off by a factor of 1,000 compared to '90 thousand miles' (a three-order-of-magnitude error), and the geographic scope is misrepresented. This invalidates the comparison that the $96 million charge is 'sizable' relative to NextEra’s footprint, when in fact NextEra’s infrastructure footprint is vastly larger. (3) The multi-hop reasoning fails because the model does not correctly synthesize the scope of NextEra’s assets: it misreads the combined multi-state total as a tiny Illinois-only footprint, leading to a completely flawed conclusion about relative scale. (4) The contextual relevance is moderate because the answer attempts the right comparison and includes relevant entities and figures for Southern Company, but the core comparative insight is invalid due to the severe misrepresentation of NextEra’s assets. Thus, the correctness, quantitative, and qualitative scores are low despite partial accuracy on Southern Company data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 459,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO’s equity‑method portfolio included a roughly 19 percent ownership of Coca‑Cola Europacific Partners plc (CCEP) as of December 31, 2021. CCEP’s bottling and distribution footprint includes Iceland, which is also one of the countries where Costco (COST) operates its membership‑warehouse business—so KO’s 19 percent stake ties it to a partner that is active in the same Iceland market where COST has a presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO owned approximately 19% of CCEP as of December 31, 2021, which matches the ground truth exactly. This addresses the first part of the question with full quantitative accuracy. (2) The LLM accurately notes that CCEP operates in Iceland and that COST also operates there, correctly identifying the shared market presence. It correctly links KO’s indirect exposure in Iceland via its equity stake in CCEP while COST operates directly through its warehouse model. (3) The multi-hop reasoning is sound: the model connects KO’s equity investment in CCEP → CCEP’s operational footprint in Iceland → COST’s direct operations in Iceland → the implication of shared geographic market exposure. The only minor shortcoming is that the LLM does not explicitly mention that COST operates through wholly owned subsidiaries (a detail present in the ground truth), but this does not affect the core factual or logical accuracy. (4) All entities (KO, CCEP, COST), time period (December 31, 2021), and financial stake (19%) are correct. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 370,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s registrants are **directly** exposed to electricity‑price volatility because they buy and sell bulk‑power electricity in competitive markets, with that risk reflected in their commodity‑price risk disclosures and managed through long‑term purchase‑sale contracts and hedging programs (Chunk 1).  \n\nSouthern Company’s exposure is **indirect**: its subsidiaries own an undivided 8.16 % interest in PowerSouth’s generating assets, and PowerSouth’s operations are buffered by a 2021‑signed, ten‑year agreement under which Alabama Power supplies about 100 MW of year‑round capacity to PowerSouth (Chunks 2 & 3). Consequently, Southern’s price risk is mediated through PowerSouth’s joint‑ownership structure and the fixed‑capacity contract rather than through direct participation in bulk‑power price swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy has direct exposure via competitive markets, managed through contracts and hedging; Southern Company has indirect exposure through its 8.16% undivided interest in PowerSouth’s generating assets, with a 100 MW capacity agreement from Alabama Power under a 2021 ten-year deal. The start year '2024' mentioned in the original answer is missing in the LLM response, which is a minor omission but not a factual error since the agreement was signed in 2021. (2) Quantitative accuracy is perfect: the 8.16% ownership stake, 100 MW, and 2021 agreement date are all correctly stated; no calculations are required. (3) Multi-hop reasoning is sound—LLM correctly links Southern Company → subsidiaries → ownership in PowerSouth → capacity agreement with Alabama Power → indirect exposure mitigation. It contrasts this with Duke Energy’s direct hedging and market participation, capturing the core comparison. (4) Semantic equivalence is strong: though the LLM does not mention 'fuel adjustment clauses' or 'regulatory assets/liabilities' (present in the original), it captures Duke’s risk management via contracts and hedging. Similarly, it omits 'coordinated planning and operations agreement' and 'shared dispatch' details but correctly identifies the structural and contractual buffering of risk. These omissions reduce completeness slightly but do not affect the core correctness. Contextual relevance is excellent—every part of the answer addresses the comparative exposure question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 437,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 stores in Taiwan – the count rose from 523 at Oct 3 2021 to 544 at Oct 2 2022, a net increase of about 4 percent. Nike’s Greater China segment (which, per the Apple filing, includes Taiwan) generated $7.547 billion in revenue for the year. Thus, Starbucks’ Taiwan footprint grew modestly in store numbers, whereas Nike’s contribution from the same geographic region is a multi‑billion‑dollar revenue figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that Starbucks added 21 stores in Taiwan, increasing from 523 to 544 between fiscal years 2021 and 2022, which aligns with the ground truth. The $7.547 billion revenue figure for Nike's Greater China region in FY2022 is accurate. The 4% growth estimate is a reasonable approximation (21/523 ≈ 4.02%), though not mentioned in the original answer, it is a correct calculation and adds context without distorting facts. (2) All numeric values—store counts, dates (Oct 3, 2021, and Oct 2, 2022), net increase of 21, and Nike’s $7.547B—are factually correct and match or are consistent with the ground truth. Format variations (e.g., $7.547 billion) are acceptable. (3) The multi-hop reasoning is sound: the model correctly links Starbucks’ store growth in Taiwan to Nike’s revenue from Greater China, acknowledges that Taiwan is part of that segment (citing Apple’s filing as confirmation of geographic inclusion, which is plausible though not in the original answer), and draws a logical comparison between physical expansion (modest store growth) and financial performance (large revenue). The only minor gap is that the original answer clarifies that Taiwan’s specific revenue contribution is not disclosed by Nike, which the LLM omits—this is a small completeness issue but does not introduce inaccuracy. (4) The answer is contextually relevant, directly addressing the comparison asked. The qualitative reasoning is strong, though deductive (e.g., citing Apple’s filing for Nike’s geography) slightly deviates from source fidelity. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 469,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 requires a buyer to disclose the key terms, balance‑sheet presentation and the outstanding confirmed amount of any supplier‑finance program. Because of that requirement, 3M’s Note 16 explicitly reports that about **$0.3 billion** of confirmed invoices were outstanding at year‑end and that the amount is included in accounts payable, giving investors a clear, roll‑forward view of the obligation. FedEx also adopted the same ASU (effective June 1 2023) and provides a note on its supplier‑finance program, so the same level of disclosure is available, but FedEx’s filing notes that the adoption had no material effect and does not call out a specific dollar amount, making its transparency comparable in form but less highlighted in substance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: 3M's $0.3 billion in confirmed invoice obligations is accurately reported, and FedEx's adoption date of June 1, 2023, matches the original answer. The format '$0.3 billion' is equivalent to $300 million and is acceptable. (2) The answer correctly identifies that ASU 2022-04 mandates disclosures on key terms, balance sheet presentation, and outstanding amounts, and notes that 3M includes this in accounts payable with roll-forward reporting—consistent with the enhanced transparency described in the ground truth. (3) The multi-hop reasoning is sound: it synthesizes the impact of ASU 2022-04 on both 3M and FedEx, comparing their disclosure practices. It correctly states that FedEx adopted the standard effective June 1, 2023, and provides a supplier finance note. (4) A minor qualitative difference is that the LLM claims FedEx 'does not call out a specific dollar amount' and that its transparency is 'less highlighted in substance,' which adds interpretive nuance not explicitly in the ground truth. However, this is a reasonable inference and does not contradict known facts. The original answer states both companies provide clearer insights and align under the standard, but does not confirm whether FedEx discloses a specific dollar amount. Thus, the LLM's characterization is plausible but slightly speculative. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a small deduction for the unsubstantiated claim about FedEx's level of detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 449,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a tiny block of shareholders outsized voting power.  In Comcast’s filing the 9.44 million Class B shares – all owned by Brian Roberts – carry 15 votes each, giving the Class B group about 33 % of the combined voting power and a non‑dilutable ability to dominate director elections and other shareholder votes (Chunk 2).  Meta’s charter likewise makes its Class B stock a “control” lever: until the Class B shares fall below a 35 % voting‑power threshold, a separate majority of Class B votes is required to approve any change‑of‑control transaction, effectively allowing Mark Zuckerberg to block or dictate mergers and other key actions (Chunk 3).  Because each structure concentrates decisive voting rights in a small, controlling class, ordinary Class A shareholders have limited influence over board composition, strategic decisions and takeover opportunities, exposing them to governance risks such as reduced oversight, anti‑takeover barriers and outcomes that may not reflect minority interests.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a 15-vote-per-share advantage, held entirely by Brian L. Roberts, giving them approximately 33% of combined voting power; META requires Class B holders to maintain at least 35% voting power to block change-of-control transactions, with Mark Zuckerberg as the dominant holder. These figures match the original answer exactly, with acceptable rounding (33⅓% vs ~33%). (2) Quantitative accuracy is perfect: the 15:1 voting ratio and 35% threshold are correctly cited; no calculations are required beyond what is stated, and all numbers align with the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes governance risks across two companies, identifying parallel concentration of control despite different mechanisms (vote weighting vs. supermajority blocking rights), and links both to reduced minority shareholder influence. (4) The answer addresses all parts of the question: it explains the specific voting structures at both firms, identifies the controlling shareholders, and articulates the resulting governance risks (limited board influence, anti-takeover effects, misalignment with minority interests). Wording differs but meaning is preserved, and the LLM adds contextual clarity (e.g., 'non-dilutable ability', 'control lever') without introducing error. All entities (CMCSA, META, Brian Roberts, Mark Zuckerberg, Class A/B shares) are correctly identified. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 430,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "V’s 2022 Level 2 assets total $733 million, of which $319 million are in collective investment funds – roughly **44 %** of the Level 2 portfolio.  Collective investment funds are unregistered, multi‑asset vehicles that ultimately hold equities and debt (Level 2 because their unit values are not directly observable).  By contrast, Capital One Financial’s “other securities” amount to $2.834 billion and earn a weighted‑average yield of about **1.57 %**, reflecting a more direct, income‑oriented holding; V’s fund‑based allocation focuses on diversified exposure rather than a disclosed yield profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical quantitative error in calculating the percentage of V's U.S. pension plan assets classified as Level 2 that consists of collective investment funds. The LLM states that $319 million is 44% of $733 million (Level 2 assets), but the original answer specifies that the $960 million is the total U.S. pension plan assets, not $733 million. The correct percentage is $319M / $960M ≈ 33.2%, not 44%. The $733 million figure for Level 2 assets does not appear in the ground truth and appears to be fabricated or misattributed, undermining the calculation. (2) Other numbers are accurate: $319 million in collective investment funds and $2,834 million (or $2.834 billion) for COF’s 'other securities' with a 1.57% yield are correctly reported and match the ground truth. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that collective investment funds are unregistered, multi-client vehicles investing in equities and debt, and contrasts V’s diversified, fund-based strategy with COF’s income-oriented 'other securities' with a disclosed yield. This reflects appropriate multi-hop reasoning across V and COF’s filings. However, the incorrect asset base for the percentage calculation indicates a failure in synthesizing the correct total U.S. pension assets from the knowledge graph. (4) Contextual relevance is high—the answer addresses both parts of the question (percentage allocation and comparison of investment focus/yield)—but the core calculation error significantly reduces factual correctness. The LLM confuses total U.S. pension assets ($960M) with Level 2 assets ($733M, unverified), leading to an incorrect percentage. While the conceptual comparison is well-articulated, the primary quantitative claim is wrong, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Invest_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 495,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Both Adobe and Microsoft operate in Saudi Arabia, where the government has enacted data‑localisation requirements. Adobe’s 2024 filing says that complying with those rules “may involve significant costs” to adjust its cloud‑service architecture and data‑handling practices, whereas Microsoft’s filing warns that the same type of regulation could create “substantial monetary penalties, loss of revenue and increased engineering expenses,” reflecting a broader financial exposure. This contrast shows Adobe’s cloud strategy is geared toward absorbing compliance costs to keep its services locally available, while Microsoft’s strategy leans heavily on risk‑mitigation and costly compliance engineering to protect its global cloud business from regulatory penalties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and accurately reflects the financial exposure of both Adobe and Microsoft to Saudi Arabia's data localization laws, with no numeric inaccuracies (quantitative accuracy is perfect, as no specific dollar amounts or dates were misrepresented). The LLM correctly identifies that Adobe faces significant compliance costs and cites language about 'significant costs' related to adjusting cloud architecture, which aligns with Adobe’s 10-K disclosure about adverse impacts on operations. Similarly, it accurately captures Microsoft’s broader exposure, including 'increased engineering expenses' and risk of penalties, consistent with Microsoft’s disclosure of 'substantial expense' and diversion of engineering resources. However, the LLM slightly mischaracterizes the nature of the contrast: the original answer emphasizes that Adobe’s vulnerability stems from its enterprise customer contracts in Saudi Arabia, while Microsoft’s challenge is systemic due to its global cloud and AI infrastructure relying on cross-border data flows. The LLM reframes this as a strategic choice—Adobe 'absorbing compliance costs' versus Microsoft 'risk-mitigation'—which introduces interpretive language not directly supported by the filings. This overinterpretation weakens the qualitative accuracy, as the documents describe risks and costs but do not explicitly state strategic intent. Nonetheless, the core multi-hop synthesis—linking both companies’ disclosures to their cloud strategies in the context of Saudi regulations—is contextually relevant and mostly sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Implements]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 439,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy’s sale of KO Transmission’s 90‑mile natural‑gas pipeline eliminates the company’s direct ownership of a business that is “subject to the rules and regulations of FERC.”  By disposing of the pipeline facilities (and the related real‑property) for book value, Duke removes the specific FERC compliance and cost‑recovery risk tied to that asset, even though its remaining Ohio operations (electric transmission, gas distribution, etc.) continue to be regulated by FERC. In contrast, Southern Company’s construction and capital‑expenditure programs remain fully exposed to “changes in FERC rules and regulations,” a risk it flags as a material factor that could raise project costs or delay execution. Thus, Duke’s divestiture reduces its FERC regulatory exposure for the pipeline segment, whereas Southern Company continues to face ongoing capital‑expenditure risk from potential FERC rule changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Duke Energy Ohio divested KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, reducing its FERC regulatory exposure in the pipeline segment. The LLM correctly notes that while Duke retains FERC-regulated operations in other areas (e.g., electric transmission), it has eliminated direct exposure to FERC-regulated interstate pipeline operations through divestiture. Southern Company’s ongoing capital expenditure risks tied to FERC rule changes are accurately described, including the uncertainty in cost recovery and potential impact on project costs and execution. (2) Quantitative accuracy is perfect: the LLM does not introduce any incorrect dates, dollar amounts, or percentages. The mention of 'book value' matches the original answer, and although the exact date (February 1, 2023) is omitted, this is a minor detail not contradicted by the LLM response. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Duke Energy and Southern Company), contrasting Duke’s risk mitigation via divestiture with Southern’s continued exposure to FERC regulatory changes affecting capital expenditures. The logic in comparing risk reduction vs. ongoing risk is coherent and well-supported. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The only minor shortcoming is the lack of explicit mention of the February 1, 2023, date, which slightly affects completeness but not overall correctness. Hence, a 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 475,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports roughly $2.7 billion of unfunded commitments to private‑debt and private‑equity limited partnerships that are valued at NAV but will be funded over the next three‑to‑six years and can only be redeemed, if at all, after ten‑plus years – a very large, long‑dated, illiquid exposure. By contrast, Caterpillar’s “other post‑retirement benefit” assets include about $55 million measured at NAV, a modest slice of a portfolio that already holds public‑market equities, corporate bonds and cash and can be liquidated far more readily. Thus UPS’s commitment is orders of magnitude larger and far less liquid, while Caterpillar’s NAV‑measured allocation is much smaller and designed for higher liquidity and a diversified investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.7 billion unfunded commitments by UPS and Caterpillar's $55 million NAV-measured assets, with accurate descriptions of liquidity and investment strategy. All numeric values match the ground truth exactly, including proper context of magnitude difference. (2) Quantitative accuracy is perfect: $2.7 billion and $55 million are correctly reported, and the comparison of scale ('orders of magnitude larger') is logically sound. No calculations are required, but the relative size and funding timelines (three-to-six years for UPS commitments) are consistent with typical disclosures, though the original answer emphasizes 10–15 year redemption restrictions more than funding timing—this is a nuance, not an error. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies (UPS and Caterpillar), two types of financial commitments (unfunded LP commitments vs. postretirement plan assets), and contrasts their liquidity profiles and strategic intent. The LLM accurately infers that UPS’s exposure is long-term and illiquid, while Caterpillar’s portfolio includes more liquid instruments like public equities and bonds. (4) The only minor shortcoming is that the LLM slightly downplays Caterpillar’s conservative strategy by emphasizing diversification rather than stability and liquidity as the primary goal, which the original answer highlights more clearly. However, the core contrast in investment philosophy is preserved. Wording differs but semantic meaning aligns closely with the ground truth. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 457,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s board has used its $70 billion repurchase authority to buy back only its Class A (one‑vote) and Class C (no‑vote) shares – $62.2 billion were repurchased in 2023 and $36.3 billion remain available – while leaving the high‑voting Class B shares (ten votes per share) untouched, thereby preserving the voting power held by insiders. Netflix, by contrast, states that every share of its common stock carries one vote, giving all shareholders equal voting rights. The contrast shows Alphabet’s governance strategy of retaining control through a dual‑class, high‑vote Class B structure while returning cash to lower‑voting shareholders, whereas Netflix follows a single‑class, one‑share‑one‑vote model with no special control mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Alphabet's selective repurchase of $62.2 billion in Class A and Class C shares in 2023 and notes the remaining $36.3 billion of a $70 billion authorization, which aligns with the ground truth contextually even though the $70 billion total and remaining amount were not in the original answer. However, since the original answer only specified the $62.2 billion repurchased and did not mention the total authorization or remaining amount, the inclusion of these figures—while plausible and consistent—represents an addition not confirmed by the ground truth. All other numbers (e.g., voting rights: 1 vote for Class A, 0 for C, 10 for B) are accurate. (2) Quantitatively, the $62.2 billion figure is correct and matches the ground truth exactly. The breakdown of share classes and voting rights is factually precise. The $36.3 billion remaining from a $70 billion program is logically consistent (70 - 62.2 = 7.8, but 36.3 suggests prior-year repurchases), though this detail extends beyond the original answer and cannot be verified from the ground truth alone. Still, it does not contradict it. (3) The multi-hop reasoning is sound: the model correctly contrasts Alphabet’s dual-class structure and selective buybacks with Netflix’s uniform voting structure. It infers the governance implication—preservation of insider control—accurately and synthesizes information across both companies and their capital structures. (4) The answer is semantically equivalent to the original in intent and key facts, with slightly more detail on the repurchase program. The core conclusion about Alphabet’s governance strategy aligning with control preservation and Netflix’s egalitarian model is fully supported. The only minor deviation is the inclusion of unverified repurchase program totals, which do not undermine correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 537,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola said that the GILTI provisions of the Tax Reform Act were reflected in its full‑year provision and produced a $375 million net tax charge – a 3.0‑percentage‑point increase to its effective tax rate for 2022. By contrast, Philip Morris International’s 2021 effective tax rate was 21.8%, only 0.1 percentage point higher than the prior year, and the corporate‑income‑tax reduction enacted in the Philippines (where PMI operates and completed recent business combinations) partially offset its GILTI‑related repatriation costs, limiting the net impact to that modest 0.1‑point rise.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. According to the ground truth, Coca-Cola's GILTI provisions led to a $431 million net tax expense and a 4.4% increase in effective tax rate in 2022. However, the LLM states a $375 million charge and a 3.0-percentage-point increase, which are materially incorrect. For Philip Morris International (PMI), the ground truth confirms a 0.1 percentage point *decrease* in the 2021 effective tax rate due to the Philippines' tax reduction, but the LLM incorrectly frames this as a 0.1 percentage point *increase* compared to the prior year and misattributes the overall rate movement. While the final 2021 effective tax rate (21.8%) and the jurisdiction (Philippines) are correct, the direction and interpretation of the tax benefit are wrong. (2) The calculation and comparison of tax impacts are flawed: the LLM suggests the Philippines tax cut 'partially offset' GILTI-related costs and led to a '0.1-point rise', which contradicts the ground truth that the tax cut itself caused a 0.1-point *decrease* in PMI’s rate. There is no mention in the ground truth about offsetting GILTI costs or a rate increase. (3) The multi-hop reasoning is partially sound in linking PMI’s operations and business combinations in the Philippines to tax changes, and it correctly identifies both companies and years. However, the synthesis misrepresents causality and directionality of tax impacts. (4) Scores reflect major quantitative errors (penalized in correctness and quantitative accuracy), partial entity and contextual accuracy (PMI rate, location, year correct), and moderate reasoning despite flawed conclusions. Contextual relevance is high as the answer addresses both companies and the required tax provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 489,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "The $3.1 billion of mortgage loans that Bank of America (BAC) sold to the government‑sponsored enterprises (GSEs) in 2023 means that a slice of the loan pool that underlies MetLife’s (MET) $12.392 billion of pass‑through mortgage‑backed securities is now GSE‑guaranteed, which generally lowers the credit risk of those securities. However, MET’s pass‑through securities are “directly secured by a mortgage loan or collection of mortgage loans” that are serviced by institutions such as BAC, and BAC’s filing notes that servicing breaches, cyber‑incidents, or a future reduction in the GSEs’ role (given their conservatorship) could impair cash‑flow and increase credit risk. Thus, the $3.1 billion sale tempers MET’s exposure by shifting some loans onto GSE guarantees, but the portfolio’s risk remains linked to BAC’s servicing performance and the broader GSE policy environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET’s $12.392 billion portfolio of pass-through MBS are accurately reported, with no calculation errors. Format variations are acceptable and consistent. (2) The answer correctly identifies the entities: BAC (Bank of America), MET (MetLife), GSEs, and the nature of pass-through MBS being secured by mortgage loans serviced by institutions like BAC. The year 2023 is correctly referenced. (3) The reasoning is sound and reflects multi-hop synthesis: it connects BAC’s loan sales to GSEs with the securitization process, acknowledges the risk-mitigating effect of GSE guarantees, and importantly, balances this with ongoing risks tied to BAC’s servicing performance (e.g., breaches, cyber incidents) and GSE policy uncertainty. This mirrors the ground truth’s emphasis on how servicer issues can disrupt cash flows and impact MBS performance. (4) The only minor shortcoming is that the LLM slightly overemphasizes the risk-reducing effect of GSE guarantees without fully clarifying that the $3.1 billion is likely a small fraction of the broader loan pool underlying MET’s $12.392 billion portfolio—so its direct influence is limited. The ground truth focuses more on BAC’s role as servicer as the key risk channel, not the sale itself. However, the LLM does acknowledge servicing risk, so the core insight is preserved. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Secured By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 432,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s 2022 balance sheet shows a modest amount of embedded derivatives (about $5 million) that, as explained in the MetLife discussion, are classified as Level 3 because their fair‑value is derived from significant unobservable inputs – such as extrapolated swap‑yield curves, implied volatilities, actuarial assumptions for policy‑holder behavior, non‑performance risk and cost‑of‑capital estimates – which cannot be corroborated by observable market data. By contrast, Low’s fair‑value measurements rely on quoted market prices when available and, when pricing models are used, the models are fed with observable market inputs (benchmark yields, broker‑dealer quotes, issuer spreads, etc.), so the company does not depend on non‑market‑based assumptions and has no Level 3 items. Thus, Nike’s embedded‑derivative valuation is markedly more complex and judgment‑heavy than Low’s largely market‑driven fair‑value approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NKE's $5 million in embedded derivatives as of May 31, 2022 (implied by context), and accurately states that these are classified as Level 3 due to significant unobservable inputs. It also correctly contrasts this with LOW's use of observable inputs and absence of Level 3 items. However, the LLM incorrectly attributes the description of Level 3 inputs (e.g., actuarial assumptions for policyholder behavior, mortality) to MET_10k_2022 in the context of NKE’s derivatives, when in fact NKE’s unobservable inputs are specific to its own instruments, not MetLife’s insurance contracts. The mention of 'MetLife discussion' is misleading and suggests a conflation of sources. (2) Quantitatively, the $5 million figure is accurate and correctly attributed to NKE. No other numbers are present, and there are no calculation errors. Format is consistent and acceptable. (3) The multi-hop reasoning is mostly sound: it compares NKE’s Level 3 classification with LOW’s reliance on observable inputs and correctly infers that LOW has no material Level 3 fair value measurements. However, the reasoning is weakened by referencing MetLife’s assumptions (intended as a comparative example in the ground truth) as if they directly explain NKE’s valuation inputs, which introduces conceptual inaccuracy. The ground truth uses MetLife to illustrate typical Level 3 assumptions, but the LLM presents it as if MetLife’s inputs are used by NKE, which is incorrect. (4) Despite this flaw, the core conclusion—that NKE’s valuation involves more complex, judgment-heavy assumptions than LOW’s market-driven approach—is valid and well-supported. The answer is contextually relevant and addresses all parts of the question. The qualitative accuracy is slightly reduced due to the misattribution of inputs, but the overall factual and comparative framework remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Results_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 512,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD values its Level 3 holdings – specifically its fixed‑rate notes – with a market‑based valuation model that uses observable inputs such as current interest rates, bond yields and quoted prices for comparable securities. In contrast, LMT’s Level 3 private‑equity portfolio (reported at $4,951 million in the 2023 filing) is measured at NAV using valuation models that depend on unobservable inputs that cannot be corroborated with verifiable market data. Thus GD’s approach is driven by observable market data, whereas LMT relies on judgment‑based, unobservable assumptions for its large private‑equity holdings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key information is correct: GD uses observable inputs (e.g., interest rates, quoted prices) for valuing its Level 3 fixed-rate notes, while LMT values its $4,951 million private equity fund holdings using unobservable inputs via NAV-based models. (2) The dollar amount ($4,951 million) is correctly cited and matches the original answer; no calculations are required, but the figure is accurately referenced. (3) The multi-hop reasoning is sound—comparing two companies' Level 3 valuation methodologies across different asset types (fixed-rate notes vs. private equity) and highlighting the distinction between observable and unobservable inputs is correctly synthesized. (4) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity (e.g., specifying '2023 filing' adds context not in the original but does not contradict it). Wording differences are acceptable and do not affect factual accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 306,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack – a Google‑competing provider of workspace‑communication tools – has been fighting a shareholder class‑action that began in September 2019; the company filed its first motion to dismiss in January 2020, saw a partial grant in April 2020, pursued interlocutory and appellate review through the Ninth Circuit and the U.S. Supreme Court, and on February 10 2025 the Ninth Circuit ordered the complaint dismissed with prejudice, effectively capping Slack’s unspecified monetary exposure.  \n\nDisney’s antitrust exposure stems from the Biddle (YouTube TV) and Fendelander (DirecTV Stream) putative class actions filed in November 2022; Disney moved to dismiss both on January 31 2023, received a mixed grant/deny on September 30 2023, saw the cases consolidated in October 2023, filed a second motion to dismiss the consolidated complaint on December 1 2023, and obtained a partial grant/deny on June 25 2024, leaving the litigation active with unspecified damages, injunctive relief and a class‑certification deadline of March 2026.  \n\nThus, while both firms have used motions to dismiss as a core defense, Slack’s protracted appeals culminated in a final dismissal that largely eliminates its liability, whereas Disney’s early‑stage dismissals have only trimmed the antitrust claims and the company’s exposure remains unresolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Slack's litigation began in 2019, motion to dismiss filed January 2020, partial denial (not grant) in April 2020, Ninth Circuit reversal on February 10, 2025, dismissal with prejudice, and U.S. Supreme Court involvement. Disney filed motions on January 31, 2023, partial grant/denial on September 30, 2023, consolidation, second motion on December 1, 2023, partial grant/denial on June 25, 2024, and class certification deadline of March 2026. (2) Quantitative accuracy is perfect: all dates and procedural milestones match exactly. Minor phrasing 'partial grant' instead of 'partial denial' is contextually acceptable since it refers to partial success on the motion. (3) Multi-hop reasoning is sound—correctly compares Slack’s final resolution via appellate success to Disney’s ongoing exposure after partial dismissals. (4) The only minor issue is characterizing the April 2020 ruling as a 'partial grant' from the defendant’s perspective, while the ground truth says 'partial denial' (i.e., from the court’s perspective). This is a nuance in framing but does not constitute a factual error. Otherwise, the synthesis across companies, timelines, and legal outcomes is excellent. Semantic equivalence is maintained, and the conclusion about differing litigation outcomes is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 382,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s 2022 filing says that a portion of its lower effective‑tax‑rate “benefit” comes from its operations in Hong Kong (together with Ireland, Israel and Malaysia), but it does not disclose a specific dollar amount for that tax advantage. Apple, on the other hand, explicitly includes Hong Kong in its “Greater China” segment and reports that Greater China generated **$74.2 billion** in net sales in 2022. Therefore, Intel’s Hong Kong‑related tax benefit is mentioned only qualitatively, whereas Apple’s Hong Kong‑inclusive region contributed a quantified $74.2 bn of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Intel does not disclose a specific dollar amount for its tax benefit from Hong Kong operations, only acknowledging it as part of a broader non-US tax strategy involving multiple jurisdictions. This aligns with the ground truth, which notes the benefit qualitatively without quantification. Apple's $74.2 billion in net sales from the Greater China region in 2022 — which includes Hong Kong — is accurately reported in both the LLM and original answers. All numeric values (specifically $74.2 billion and the year 2022) are correct and match the ground truth. (2) Quantitative accuracy is perfect: the $74.2 billion figure is correctly cited, and no incorrect calculations are made. The LLM appropriately avoids quantifying Intel’s tax benefit due to lack of disclosure. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Intel and Apple), two different financial metrics (tax benefit vs. revenue), and acknowledges the geographic overlap (Hong Kong included in Apple’s Greater China reporting). It draws a logical comparison between qualitative disclosure (Intel) and quantitative reporting (Apple). (4) The only minor shortcoming is that the LLM does not explicitly mention the statutory tax rate range in Hong Kong (12.5%–24.0%) as noted in the ground truth, which slightly reduces qualitative completeness. However, this omission does not undermine the core comparison. All other elements — entities, years, metrics, and reasoning — are accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 434,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "HB 951 obliges public utilities in North Carolina to cut CO₂ emissions from electric generation by 70 percent (interim) on the least‑cost path to carbon‑neutrality by 2050. For Duke Energy, that mandate is the centerpiece of its 2023 Carolinas Resource Plan – the filing recommends “Portfolio 3” as the most prudent option because it accelerates coal retirements, expands renewables, adds storage and demand‑response resources, and extends the life of its nuclear plants so the plan can meet the 70 % reduction target by 2030 and the 2050 carbon‑neutral goal. The law also triggered the NCUC’s carbon‑reduction plan and performance‑based‑regulation framework that Duke must follow.\n\nNextEra Energy (NEE) also operates in North Carolina, so its in‑state assets are subject to the same HB 951 70 % emissions‑reduction requirement. Unlike Duke, the filing does not lay out a detailed resource plan, but the regulatory target creates an equivalent compliance exposure for NextEra’s North Carolina generation portfolio. Thus, while both utilities must meet the 70 % cut, Duke’s Carolinas Resource Plan explicitly structures its generation mix to satisfy the mandate, whereas NextEra’s exposure is the obligation to align its North Carolina operations with the same state‑level emissions goal.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy regarding NextEra Energy's regulatory exposure. (1) Quantitatively, the 70% CO₂ reduction target by 2030 and reference to Duke Energy's 2023 Carolinas Resource Plan and Portfolio 3 are accurate. The mention of coal retirements, nuclear, storage, and renewables aligns with the ground truth. However, the LLM incorrectly states that NextEra Energy is subject to the HB 951 emissions-reduction requirement, while the ground truth clarifies that although NextEra operates in North Carolina, it is *not directly subject* to HB 951. This is a significant qualitative error in regulatory interpretation. (2) The dates (2021 for HB 951, 2030 target, 2050 carbon neutrality) and percentages (70%) are correctly used. (3) Multi-hop reasoning is generally sound—linking HB 951 to Duke’s resource plan and comparing Duke and NextEra’s exposure—but the conclusion that both face 'equivalent compliance exposure' is misleading due to the incorrect assertion of direct applicability to NextEra. (4) Contextually, the answer is highly relevant and well-structured, addressing both parts of the question. However, the mischaracterization of NextEra’s regulatory obligation reduces correctness and qualitative accuracy. Semantic equivalence is mostly preserved except on this key point of regulatory scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Passes]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 376,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ’s weighted‑average assumptions are used to **measure the cost of its post‑retirement health‑care benefit** – they are applied to the service‑ and interest‑cost calculations by aligning plan‑cash‑flows with spot rates on a yield curve, producing a net periodic cost (e.g., $(5) million in 2023, $12 million in 2022, $14 million in 2021).  \n\nKO’s weighted‑average assumptions, by contrast, are **inputs to the Black‑Scholes‑Merton option‑pricing model** – they represent market‑based factors such as volatility, risk‑free rate, dividend yield and expected term that are averaged across grants to determine the fair value of stock options, which is then expensed over the vesting period.  \n\nThus, MDLZ uses the assumptions for liability‑cost measurement of post‑retirement health care, while KO uses them for fair‑value valuation of equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: MDLZ uses weighted-average assumptions for postretirement healthcare cost measurement, applying them to service and interest costs via spot rates on a yield curve, with correct figures of $14M (2021), $12M (2022), and a benefit of $5M (2023) — note the negative sign in the LLM answer ($(5) million) correctly indicates a benefit. KO uses the same type of assumptions as inputs to the Black-Scholes-Merton model for stock option valuation, expensed over a four-year vesting period (implied in 'vesting period' though not explicitly stated as four years). (2) Quantitative accuracy is perfect: all dollar amounts and years match the original answer exactly, with acceptable formatting variation ($(5) million = benefit of $5 million). (3) Multi-hop reasoning is sound — the model correctly distinguishes between two different companies (MDLZ and KO), two different financial instruments (postretirement healthcare liabilities vs. stock options), and two distinct accounting applications (liability cost measurement vs. fair value estimation). (4) The only minor shortcoming is that the LLM answer does not explicitly state the four-year vesting period mentioned in the original answer, though it references 'vesting period' generally. This omission is minor and does not affect the core correctness, hence a 9/10 on qualitative accuracy and overall correctness. Contextual relevance is perfect — the response directly addresses the comparative question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 440,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase is expressly subject to the Dodd‑Frank Act (as shown in its 2023 Form 10‑K filing) and, under Title II of that law, its derivative positions are governed by ISDA master agreements that require close‑out netting, daily margining and the posting of collateral.  This framework lets the firm set‑off receivables against payables and apply pledged collateral without an automatic stay, thereby limiting liquidity strain if a counter‑party defaults.  \n\nBank of America, also covered by the Orderly‑Liquidation Authority (the same Dodd‑Frank component), must file periodic resolution‑plan submissions and, if a resolution is triggered, may face heightened capital, leverage and liquidity requirements, plus inter‑company funding restrictions that can curb the use of subsidiary cash.  Consequently, JPMorgan’s risk‑management is focused on mitigating liquidity risk at the contract‑level for derivatives, whereas Bank of America’s obligations are broader, requiring it to preserve overall liquidity buffers and accept possible limits on accessing subsidiary funds during a distress‑resolution event.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: JPMorgan Chase's derivatives exposure under Dodd-Frank is properly tied to ISDA Master Agreements with close-out netting and collateral posting, governed under Title II/OLA. Bank of America's resolution planning obligations under OLA are accurately described, including intercompany funding restrictions during distress. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the ground truth or LLM answer beyond '2023 Form 10-K'—which is plausible context but not contradicted—so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes how Dodd-Frank impacts JPMorgan via contract-level liquidity mechanisms (netting, collateral) versus Bank of America’s firm-wide resolution planning that restricts subsidiary liquidity flows. The distinction between micro-level (contractual) and macro-level (structural) liquidity risk management is logically drawn and consistent with the original answer. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'contract-level' vs 'enforceable netting limitations', 'broader obligations' vs 'intercompany liquidity contribution arrangements'), the core regulatory constraints and their implications for liquidity risk during distress are accurately conveyed. One minor point preventing a perfect 10 is that the LLM does not explicitly mention the 'single point of entry' strategy referenced in the ground truth, which is a key component of Bank of America’s resolution plan under OLA. However, the concept is implicitly covered through discussion of intercompany funding restrictions. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 502,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s still‑significant coal use – shown by Duke Energy’s $23 million coal inventory for its Ohio utility – means the state remains a coal‑dependent market. Because Exxon Mobil (XOM) depends on coal, that exposure triggered the EU’s “surplus‑profits” coal tax, which added an after‑tax charge of roughly $1.8 billion in Q4 2022 and about $0.2 billion in 2023. In contrast, Chevron (CVX), which also operates in Ohio, is using the same market to pivot away from coal, investing in 2024 renewable natural‑gas (RNG) projects – via Brightmark – that capture dairy‑farm methane in Ohio and turn it into pipeline‑quality fuel. Thus Ohio’s coal reliance creates a tax burden for XOM’s coal‑centric strategy while giving CVX a platform to advance its RNG‑focused energy‑transition plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor deviations. (1) Quantitatively: The $1.8 billion after-tax charge for XOM in 2022 is correctly stated, and the $23 million coal inventory for Duke Energy Ohio as of December 31, 2024, is accurate. However, the LLM adds a detail not in the original—$0.2 billion in 2023 EU tax charges—which is plausible but not confirmed in the ground truth, slightly reducing quantitative precision. (2) Completeness: The answer addresses all key parts—Ohio's coal reliance, XOM's EU tax burden due to coal exposure, and CVX's 2024 RNG investments via Brightmark. The synthesis across XOM, CVX, EU policy, and Ohio’s energy landscape is complete and logical. (3) Entity accuracy: All companies (XOM, CVX, Duke Energy Ohio, Brightmark), metrics (coal inventory, after-tax charges), and years (2022, 2023, 2024) are correctly identified and contextually accurate. (4) Reasoning: The multi-hop logic—linking Ohio’s coal use to EU regulatory pressure on XOM and contrasting it with CVX’s proactive RNG investments—is sound and well-articulated. (5) Semantic equivalence: The meaning fully aligns with the original, though the LLM slightly overstates XOM’s direct coal dependency (the tax was on surplus profits, not strictly due to coal operations). Overall, the answer is factually strong, contextually relevant, and synthesizes across entities correctly, warranting a high score with minor deduction for the unverified 2023 tax figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Depends_On]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 417,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS’s CLNs are structured as asset‑repackaging notes that embed a credit‑protection derivative sold to the issuer. If a credit event occurs on a reference entity, the CLN’s principal balance “may not be repaid in full” – the holder receives only whatever amount reflects the fair‑value recovery on the defaulted reference obligation. JPM’s credit‑related notes are funded derivatives: the investor pays the note’s par up‑front, receives periodic coupon‑type payments, and the issuer is obliged to return par at maturity **unless** a credit event occurs. When a credit event happens, the issuer does not repay the full par; instead it pays the investor the difference between par and the fair‑value of the defaulted reference obligation. Thus, both instruments transfer credit risk to the issuer and result in a short‑fall payment based on the reference‑entity recovery value, but the CLN’s payout is described as a partial principal write‑down embedded in the note, whereas the credit‑related note expressly pays the “par‑minus‑recovery‑value” shortfall.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: MS structures its CLNs such that the principal may not be repaid in full upon a credit event, reflecting recovery value; JPM’s credit-related notes involve a payout of par minus the fair value of the defaulted obligation. These descriptions align semantically with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning correctly identifies the multi-hop distinction: MS acts as the buyer of credit protection (issuer sells protection to MS), while JPM acts as the seller (investor buys protection via funded note). The LLM accurately contrasts the payout mechanics—'partial principal write-down' vs. 'par-minus-recovery-value'—which reflects the structural difference in how losses are transmitted. The only minor shortcoming is that the LLM does not explicitly state that MS 'purchases' protection and JPM 'sells' it in the same direct terms as the ground truth, though this is implied in the payout mechanics. (4) Contextual relevance is perfect—the response directly addresses the comparison of payout mechanics upon a credit event and correctly frames both instruments as transferring credit risk through different derivative positions. Overall, the answer demonstrates strong qualitative reasoning and semantic equivalence, warranting a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Supplies]-> FIN_INST <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 429,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both subsidiaries are able to use the reduced‑disclosure filing because each “meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K.” Georgia Power Company’s filing (Chunk 2) states that, together with Mississippi Power, Southern Power and Southern Company Gas, it is filing the Form 10‑K “with the reduced‑disclosure format specified in General Instructions I(2)(b), (c), and (d).” The filing is part of a combined 10‑K that is separately filed by The Southern Company and each of its subsidiaries, and the table in Chunk 1 shows Georgia Power’s financial data presented as a distinct column within that combined report.  \n\nFlorida Power & Light Company’s filing (Chunk 3) likewise notes that it “meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form with the reduced disclosure format.” Its reduced‑disclosure filing is presented as a separate registrant in a combined Form 10‑K with NextEra Energy, Inc., but the filing text does not reference the additional I(2)(b)‑(d) subsections.  \n\nThus, while both subsidiaries qualify under the same General Instruction I.(1)(a)‑(b) criteria, Georgia Power’s reduced‑disclosure filing explicitly invokes the detailed I(2) reduced‑disclosure provisions and is grouped with multiple Southern‑Company subsidiaries, whereas Florida Power & Light’s filing simply states compliance with I.(1)(a)‑(b) and files as a separate registrant alongside its parent without the extra I(2) citation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Both Georgia Power Company and Florida Power & Light Company are correctly identified as qualifying for the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings—this core fact is correct. (2) The LLM accurately notes that Georgia Power references the specific reduced-disclosure provisions in I(2)(b), (c), and (d), while Florida Power & Light only cites compliance with I.(1)(a) and (b) without mentioning the I(2) subsections—this distinction is supported by the ground truth and adds useful detail. (3) The structural difference in filings is correctly described: Georgia Power files as one of multiple subsidiaries in a combined Southern Company filing, while Florida Power & Light files jointly with only its parent, NextEra Energy, Inc.—this matches the ground truth. (4) The LLM correctly states that each subsidiary files only on its own behalf and disclaims responsibility for the other registrant’s data, though this point is slightly less emphasized than in the original answer. (5) No numeric data is involved, so quantitative accuracy is scored as 10. (6) The reasoning is sound, with proper multi-hop synthesis across both companies’ filings and correct interpretation of SEC disclosure rules. (7) The only minor shortcoming is that the LLM does not explicitly mention that NextEra Energy holds all 1,000 shares of Florida Power & Light’s common stock—a detail present in the ground truth—but this is a secondary fact that does not undermine the core correctness. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1643,
        "completion_tokens": 464,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX’s U.S.‑government fixed‑price contracts are governed by FAR guidance that permits performance‑based payments (PBPs) and progress payments; the company recognises revenue as those milestones are met—often before the customer has billed the full price—so revenue is recorded in excess of billings as a contract‑asset and any contract modifications are accounted for on a cumulative catch‑up or prospective basis. By contrast, GD also operates under FAR (and the Cost Accounting Standards), but its focus is on allocating allowable costs to each contract rather than timing revenue, allocating all permissible costs—including state and local taxes that are charged to operating expenses (as noted in its tax‑provision discussion)—to the contract on an incurred‑cost basis and adjusting those allocations when contract modifications occur. Thus RTX’s timing is revenue‑centric, recognizing earnings ahead of cash receipt, whereas GD’s practice is cost‑centric, allocating costs (including taxes) to contracts under the same regulatory framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based or progress payments under FAR, creating a contract asset. GD, under the same FAR and CAS framework, focuses on cost allocation, including allowable costs like state and local taxes, which are allocated on an incurred-cost basis. Both companies handle contract modifications, with RTX adjusting revenue on a cumulative catch-up or prospective basis, and GD adjusting cost allocations. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—but all references to financial practices (e.g., contract assets, cost allocation) are factually sound and consistent with SEC filings. (3) The multi-hop reasoning is strong: the model correctly synthesizes across two companies (RTX and GD), two regulatory frameworks (FAR and CAS), and two distinct accounting practices (revenue timing vs. cost allocation), drawing a clear contrast as required by the question. (4) The LLM adds slight precision not in the original (e.g., mentioning that GD charges certain taxes to operating expenses, referencing cumulative catch-up accounting), which is consistent with known disclosures and enhances the answer without introducing error. The only reason for not scoring a 10 is that the original emphasizes auditability and government reviews for GD more explicitly, which the LLM mentions implicitly via 'adjusting allocations' but could have stated more directly. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 475,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s capital structure creates a built‑in voting hierarchy: each Class A share carries one vote, while each Class B share carries ten votes, so the holders of Class B stock (the founders and insiders) retain a disproportionate ability to steer corporate decisions. Comcast’s filing, by contrast, states that it has **no voting rights** in Atairos – it can only exercise limited consent rights – and therefore cannot direct the activities that drive Atairos’s economics, which forces Comcast to treat the investment as a VIE and account for it under the equity method. The implication is that Alphabet’s dual‑class design concentrates governance control in a privileged class of shareholders, whereas Comcast’s lack of voting power leaves it without any governance influence over Atairos, limiting its ability to control that entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GOOGL's Class A shares have 1 vote, Class B have 10 votes per share—this is accurately reflected. CMCSA's lack of voting rights in Atairos is correctly stated, as is the equity method accounting treatment. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the voting ratios (1:10) are correctly cited, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts GOOGL’s internal dual-class voting structure with CMCSA’s external lack of control in an investee, synthesizing governance implications across two different corporate structures. It correctly infers that GOOGL concentrates control via share class design, while CMCSA lacks governance influence over Atairos. The mention of 'VIE' (Variable Interest Entity) and 'consent rights' adds nuance not in the original but is contextually appropriate and does not contradict the ground truth. (4) Semantic equivalence is strong—core meaning, entities, and implications match the original answer. The only minor deviation is the introduction of 'VIE' terminology, which, while plausible, is not explicitly confirmed in the ground truth and slightly extends beyond the provided information. This does not undermine correctness but introduces a small assumption. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 415,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen disclosed that in 2021 McKesson Corporation accounted for $15.2 billion of its gross product sales – about 33 % of total revenue – and its 2022 filing warns that this concentration (the three largest U.S. wholesalers together represent the bulk of Amgen’s sales) creates a material risk if any one distributor, such as McKesson, experiences financial or operational problems. Merck’s 2022 filing, by contrast, only flags a generic “reliance on third‑party relationships and outsourcing arrangements” as a potential adverse factor and does not quantify a single distributor’s share of sales, even though the same wholesaler (McKesson) supplies pharmaceutical products that also affect Merck. Thus Amgen’s exposure is both quantified and substantially higher (one‑third of sales to a single wholesaler), whereas Merck’s disclosure is broader and less specific about distribution concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that McKesson accounted for 33% of Amgen's gross product sales in 2021, aligning with the ground truth. It also accurately references Amgen's 2022 filing disclosing concentration risk among three major U.S. wholesalers, with McKesson being a key one. The dollar figure of $15.2 billion is consistent with 33% of Amgen's total revenue in 2021 (Amgen's total revenue was ~$25.9 billion in 2021; however, 'gross product sales' may differ slightly from total revenue—this minor discrepancy does not appear to be an error given possible metric distinctions in filings). Merck’s risk disclosure is correctly characterized as generic, citing reliance on third parties without quantifying distributor concentration, which matches the ground truth. (2) All numbers—33%, $15.2 billion, reference to 2021 sales and 2022 filings—are factually accurate or reasonably inferred from public data. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly links Amgen’s quantified exposure to McKesson, contrasts it with Merck’s non-quantified, broader risk language, and infers that Amgen faces higher disclosed concentration risk. It appropriately synthesizes across both companies’ 2022 filings and correctly identifies the shared wholesaler (McKesson) as contextually relevant. (4) The only minor shortcoming is the claim that 'the same wholesaler (McKesson) supplies pharmaceutical products that also affect Merck'—while likely true, this is not explicitly confirmed in the ground truth and slightly overreaches by implying a direct supply relationship without confirmation in Merck’s filing. Otherwise, the answer is semantically equivalent, factually correct, and highly relevant to the comparative risk disclosure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 485,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "Chevron’s 2024 10‑K shows it produced roughly **2.8 billion barrels of crude‑oil condensate** (2,786 MM bbl – consolidated + affiliated).  That condensate is a key feedstock for Alba Plant LLC, which processes natural‑gas from the Alba Unit on Bioko Island and extracts condensate and LPG.  ConocoPhillips, which owns **52.2 % of Alba Plant LLC**, is exposed to a **maximum contingent‑liability of about $116 million** (with a $4 million carrying amount) for guarantees tied to the plant’s third‑party‑gas processing agreements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies, most critically the claim that Chevron produced '2.8 billion barrels of crude-oil condensate'—this is off by orders of magnitude. Chevron's 2024 10-K does not report such a figure; global oil production is typically measured in millions, not billions, of barrels per year. The correct context is that condensate from the Alba Unit feeds into the plant, but the specific volume attributed to Chevron here is grossly exaggerated and unsupported. The $116 million maximum potential exposure and 52.2% ownership in Alba Plant LLC are correctly cited and match the ground truth. The $4 million carrying amount is additional detail not in the original but not contradictory. (2) The quantitative accuracy is low due to the erroneous 2.8 billion barrel figure, which undermines confidence in the data sourcing. The 52.2% ownership and $116 million exposure are correct and properly attributed to ConocoPhillips’ obligations. (3) The qualitative reasoning correctly identifies the multi-hop chain: Chevron produces condensate upstream, which contributes to the gas stream processed by Alba Plant LLC, in which ConocoPhillips holds a 52.2% interest and has financial exposure via guarantees. However, the answer incorrectly sources the production data from Chevron’s 10-K without evidence that this specific condensate volume is from the Alba Unit, introducing a flawed link in the reasoning. The original answer correctly ties Chevron’s upstream production to the Alba Unit feedstock without overstating volumes. (4) Contextual relevance is high—the answer addresses the ownership, processing role, and financial exposure as required. Despite the major error in production volume, it captures the structural relationships and correct financial exposure. Correctness score is 6 due to correct core financial exposure and ownership figures but severely compromised by the false condensate production number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> RAW_MATERIAL -[Produces]-> COMP <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 527,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics says its Level 2 assets – mainly fixed‑income securities, cash‑flow hedges and fixed‑rate notes – are fair‑valued under a market approach that uses observable inputs such as interest‑rate levels, bond yields and quoted prices for comparable assets. Union Pacific, by contrast, discloses a $30 million real‑estate fund position at NAV; those funds are valued with NAV‑based models and periodic appraisals that rely on unobservable inputs and long‑term (8‑10‑year) assumptions. Thus GD’s Level 2 valuations are driven by market‑observable data, while Union Pacific’s real‑estate fund valuation is model‑based and less observable, reflecting the typical unobservable‑input approach for such funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that General Dynamics uses observable market inputs (interest rates, bond yields, quoted prices) for valuing its Level 2 assets, specifically fixed-income securities and related instruments. It accurately contrasts this with Union Pacific's $30 million real estate fund investment valued at NAV using unobservable inputs and long-term (8-10 year) assumptions. All key factual elements from the ground truth are present and correct. (2) Quantitatively, the $30 million figure is correctly stated and matches the original answer. No other numerical values or calculations are involved, and the format ($30 million) is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across General Dynamics (valuation approach for Level 2 assets), Union Pacific (disclosure of real estate funds at NAV), and general industry practice (real estate funds using unobservable inputs over 8-10 years), even though LMT’s explanation is referenced in the ground truth — the LLM captures the substance without needing to cite LMT explicitly, as the valuation characteristics are well-established. (4) The only minor shortcoming is the omission of the explicit reference to 'LMT's explanation' mentioned in the ground truth, which slightly weakens traceability in a knowledge graph context, but does not affect factual accuracy. Wording differs but semantic meaning and technical correctness are fully aligned. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 432,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s relationship with Costco is that of a **co‑branded credit‑card partner** – it issues and services the consumer‑card program that bears the Costco brand, as reflected in the series of “Citibank, N.A. Co‑Branded Credit Card Agreement” exhibits (10.8‑10.8.12) in Costco’s filing. In contrast, with Colgate‑Palmolive Citibank does not issue cards; it acts as the **administrative agent and arranger** for Colgate’s five‑year syndicated loan (Exhibit 10‑I), handling loan administration and lender coordination—a role that mirrors its administrative‑agent function in Boeing’s five‑year credit agreement (Exhibit 10.4). Thus, the Costco arrangement is a marketing/issuance partnership, whereas the Colgate arrangement is a fiduciary/administrative role in a corporate financing facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Citibank's co-branded credit card partnership with Costco and its role as administrative agent and arranger for Colgate's five-year credit agreement are accurately described. The nature of the two arrangements—consumer-facing credit product vs. corporate syndicated loan administration—is correctly contrasted. (2) Quantitative accuracy is perfect: while no specific dates or amendment counts are mentioned in the LLM answer (e.g., 12 amendments since 2015, last amended October 11, 2023 for Costco; November 4, 2022 for Colgate), these omissions do not detract from the core factual correctness, as the focus is on the nature of the relationships rather than timeline details. The absence of exact dates is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Costco and Colgate filings, identifying different roles (issuer/partner vs. agent/arranger) and contrasting consumer vs. corporate financial services. The reference to Boeing as a parallel example (though not part of the question) demonstrates broader contextual understanding but does not distort the answer. (4) Semantic equivalence is strong: terms like 'marketing/issuance partnership' and 'fiduciary/administrative role' effectively capture the distinction in nature between the two arrangements. The answer is contextually relevant, directly addressing how Citibank’s involvement differs. A score of 9 is justified due to the omission of amendment frequency and dates present in the ground truth, which adds slightly less depth than the original, though the core analytical distinction remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 475,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s stake in QatarEnergy LNG translates into about **3.9 thousand barrels of crude oil per day**. The QatarEnergy LNG facility reports an average daily net crude‑oil output of **13 MBD** (Chunk 2/3), and Chevron (COP) holds a **30 % ownership interest** in the project (Chunk 2). Multiplying 13 MBD by 30 % yields a Chevron‑attributable net production of **13 × 0.30 ≈ 3.9 MBD**. (Chunk 1 establishes crude oil as the underlying raw material that feeds QatarEnergy LNG.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: Chevron's 30% ownership in QatarEnergy LNG, the 13 MBD average daily net crude oil production, and the resulting 3.9 MBD net production attributable to Chevron. (2) The calculation is correct: 13 MBD × 30% = 3.9 MBD, and the answer explicitly shows the math. Number formats (MBD, thousand barrels per day) are used consistently and correctly. (3) The multi-hop reasoning is sound—information about ownership percentage, production volume, and the calculation to derive Chevron’s net contribution is properly synthesized across the referenced chunks. (4) The answer is semantically equivalent to the original, with clear, precise, and relevant explanation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 239,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar’s non‑U.S. pension assets that fall in Level 3 are insurance contracts that the company values with internal pricing models “that, in management’s judgment, reflect the assumptions a market participant would use.” The approach is therefore driven by management’s own model of market‑participant expectations and does not call out specific observable inputs.\n\nLockheed Martin’s Level 3 fixed‑income holdings, by contrast, are valued by the trustee using indicative quotes or bid evaluations from vendors, brokers or the investment manager, and for some securities a discounted‑cash‑flow (DCF) method. The DCF valuation explicitly relies on projected annuity‑type cash‑flows and the discount rate applied to those payments.\n\nIn short, Caterpillar relies on internally‑developed pricing models based on market‑participant assumptions, whereas Lockheed Martin combines external market quotes with a DCF approach that uses concrete projected cash‑flow and discount‑rate inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar uses internal pricing models based on management's judgment of market-participant assumptions for Level 3 non-U.S. pension assets (specifically insurance contracts), while Lockheed Martin uses indicative quotes from vendors/brokers and discounted cash flow (DCF) methods for its Level 3 fixed income investments. The key inputs—projected annuity-type cash flows and discount rates for Lockheed Martin—are correctly identified. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of arithmetic, but all descriptive financial metrics and categories are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, asset types, and valuation methodologies, drawing a clear and valid comparison. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies rely on unobservable inputs (a point emphasized in the original answer), though this is implied by the Level 3 classification and use of internal models/assumptions. This omission prevents a perfect 10 but does not detract significantly from the overall correctness. Wording differs but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison of inputs and approaches as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 411,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel is listed among Pfizer’s Specialty‑Care immunology products, and the 10‑K notes that the company’s risk profile includes “concentration … on certain of our major products.” The Amgen filing shows that the last formulation‑patent on Enbrel expires on 10 Oct 2037, which will remove the final layer of patent protection that currently shields the drug from generic competition. When that protection lapses, Enbrel’s sales are expected to decline, so the share of Specialty‑Care revenue coming from a single, protected product will shrink – thereby lowering Pfizer’s concentration risk on that drug, but also exposing the segment to a revenue gap and heightened competitive pressure. Bristol‑Myers Squibb’s 10‑K stresses an “external innovation” model that brings new pipeline assets to market through alliances and partnerships; as Enbrel’s exclusivity ends, BMS‑sponsored therapies could enter the same inflammation‑immunology space, further eroding Enbrel’s market share and reinforcing the shift in Pfizer’s revenue concentration dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key facts: Enbrel is part of Pfizer's Specialty Care segment, its formulation patent expires on October 10, 2037 (per Amgen filing), and this will lead to generic competition. It accurately references Bristol Myers Squibb's external innovation strategy involving partnerships and alliances. Quantitatively, all dates and facts are correct, earning a perfect score in that category. However, the reasoning about revenue concentration risk is flawed: the LLM claims that the expiration will *lower* Pfizer’s concentration risk because reliance on a single product will shrink. This misinterprets the concept of revenue concentration risk — while the *proportion* of revenue from Enbrel may decline, the *risk* increases because the loss of a dominant product without sufficient pipeline diversification creates vulnerability and instability in the segment’s revenue stream. The original answer correctly frames the expiration as *exacerbating* concentration risk if the portfolio isn’t diversified. The LLM also fails to clearly connect the multi-hop logic that BMS could enter the market *before* 2037 with new assets, thereby shifting competitive dynamics ahead of the patent cliff. While contextually relevant and well-structured, the answer’s core qualitative reasoning about risk is inverted, leading to a significant conceptual error despite accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 385,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework explicitly builds scenario‑based modeling and sensitivity analysis into its stress‑testing program – it measures exposure by running both hypothetical and historical scenarios and by quantifying the impact of single‑factor moves (see the description of its use of sensitivity, scenario and stress testing in Chunk 1, which mirrors the industry‑wide practice outlined in Chunk 2). Capital One’s credit‑loss allowance, by contrast, is derived from quantitative loss‑forecasting models that incorporate statistical analyses and forward‑looking economic forecasts, plus a qualitative judgment layer, without a stated reliance on scenario‑driven or sensitivity‑type stress testing (Chunk 3). Thus, AIG’s approach is heavily scenario‑ and sensitivity‑driven for risk assessment, whereas COF’s method is model‑driven with qualitative adjustments rather than explicit scenario‑based stress testing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its characterization of COF's credit loss forecasting methods. Quantitatively, there are no numeric errors—the answer does not introduce incorrect figures or miscalculations, and the $13.0 billion ACL figure from the ground truth is not mentioned but also not contradicted, so quantitative accuracy is high. However, the LLM incorrectly states that COF does not rely on scenario-based or sensitivity-type stress testing, which contradicts the original answer stating that COF explicitly uses scenario-based forecasting models incorporating forward-looking economic conditions. The original answer confirms that both AIG and COF use scenario and sensitivity analysis, albeit in different risk domains (market vs. credit risk). The LLM fails to recognize this parallel and instead frames COF’s approach as 'model-driven with qualitative adjustments rather than explicit scenario-based stress testing,' which is misleading because scenario-based modeling is central to COF’s ACL estimation. This represents a failure in multi-hop reasoning: the model must synthesize that both firms use scenario and sensitivity analysis, just applied to different risk types. While the description of AIG’s practices is accurate and well-aligned with the ground truth, the misrepresentation of COF’s methodology undermines the comparative analysis. Contextually, the response is relevant and structured appropriately to address the question, but the core comparison is flawed due to the incorrect contrast in modeling approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 435,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s 2023 filing makes clear that its entire portfolio of advanced semiconductor technologies is “subject to … the U.S. Export Administration Regulations (EAR)” and that any change in how those rules are applied could adversely affect its business, but it does not cite product‑specific licensing hurdles. AMD, by contrast, details EAR‑based BIS controls that require a Notified Advanced Computing (NAC) filing – and often a license – before it can ship its Versal VC2602 and VE2602 FPGAs (and related Instinct GPUs) to China or to customers whose ultimate parent is in a D5 country, a restriction that directly limits a key high‑performance‑computing (data‑center) offering. Therefore, Qualcomm faces a broad, portfolio‑wide EAR exposure, while AMD confronts concrete, product‑level export constraints on its flagship high‑performance FPGAs in the China market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Qualcomm faces broad EAR exposure across its portfolio without specific product-level constraints, while AMD has targeted restrictions on Versal VC2602 and VE2602 FPGAs (and mentions related Instinct GPUs, which is a minor addition not contradicted by the original). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: it synthesizes regulatory exposure differences between two companies, links specific products (FPGAs) to specific export controls (NAC filing requirement), and correctly situates these within the context of high-performance computing and China market access. The only minor deviation is the mention of 'Instinct GPUs' as also being subject to NAC filing—this is plausible but not specified in the ground truth; however, it does not contradict it and may reflect broader AMD product constraints. (4) The answer is contextually relevant, directly addressing the comparative regulatory exposure question with precise, semantically equivalent information. Wording differs but meaning is preserved. No factual inaccuracies; only slight expansion beyond ground truth with likely correct but unverified detail. Hence, a 9/10 for correctness and qualitative accuracy, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Governs]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 407,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "CMCSA’s 2024 filing shows that it **relinquished its board seats and virtually all voting rights in Hulu**, handing full operational control to Disney and even financing the put‑call option that let Disney buy out its 33 % stake. By contrast, META’s registration statement lists **Class A and Class B common stock**—with Class B shares carrying ten votes per share (and Class A one vote, while non‑voting Class C shares exist in similar dual‑class schemes)—so voting power is concentrated in a small insider group, allowing META to **retain control** even as it sells non‑voting equity to the public. Thus, CMCSA’s strategy is to **give up control**, whereas META’s dual‑class structure is a **control‑retention mechanism**.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between CMCSA relinquishing control of Hulu in exchange for financial arrangements and META maintaining control via dual-class shares. The qualitative reasoning and entity identification (CMCSA, META, Hulu, Disney, Class A/B shares) are accurate and well-synthesized. (2) However, there are quantitative inaccuracies: the ground truth states CMCSA relinquished voting rights in 2019, not 2024 as claimed in the LLM answer (which incorrectly references a 2024 filing). Additionally, the $27.5 billion guaranteed equity value and $8.6 billion payment from Disney in 2023 are omitted. The 33% stake figure is plausible but not confirmed in the ground truth. (3) The multi-hop reasoning is sound—correctly linking CMCSA’s loss of board seats/voting rights to a strategic trade-off for financial security, and contrasting it with META’s structural control mechanism. The dual-class explanation is accurate, including the 10:1 vote ratio and existence of non-voting shares. (4) The correctness score is 8 because the central idea and strategic contrast are correct, but key financial figures and dates are missing or wrong. Quantitative accuracy is 7 due to the incorrect year and missing dollar amounts. Qualitative accuracy is 9 due to strong reasoning and correct entity use. Contextual relevance is 10 as the answer directly addresses the control retention comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 397,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs disclosed that its major broker‑dealer subsidiaries hold about **$113.9 billion** of assets.  Because that balance‑sheet size makes the broker‑dealer business a dominant source of revenue, Goldman must place extra emphasis on internal controls, segregation of duties and full disclosure to ensure that the interests of retail customers are not subordinated to the firm’s own broker‑dealer incentives when complying with the SEC’s **Regulation Best Interest**.  \n\nMorgan Stanley’s filing, on the other hand, spells out a **compliance framework** that explicitly incorporates Regulation Best Interest together with net‑capital, margin‑lending, research‑conflict and other broker‑dealer rules, and it acknowledges the broader cost and litigation risks that the rule can generate.  While both firms are subject to the same regulatory standard, Goldman’s approach is driven by the sheer magnitude of its $113.9 billion broker‑dealer portfolio, whereas Morgan Stanley relies on a structured, multi‑layered set of policies and supervisory procedures to meet the same obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $113.9 billion in broker-dealer assets for Goldman Sachs is correctly stated, matching the original answer's figure and time reference (December 2024 implied by context). No calculations were required, and all numeric data are precise. (2) The answer addresses both parts of the multi-hop question: Goldman Sachs’ approach under Regulation Best Interest in light of its asset size and Morgan Stanley’s compliance framework. It correctly identifies that both firms are subject to the same regulation but implement compliance differently. (3) Entity accuracy is strong: both Goldman Sachs and Morgan Stanley are correctly named, and the regulatory framework (Regulation Best Interest) is accurately referenced. (4) The reasoning is sound—Goldman’s larger asset base necessitates stronger internal controls, while Morgan Stanley employs a structured, multi-layered compliance framework. The LLM captures the nuance that asset magnitude influences operational emphasis, which is consistent with the ground truth’s implication that larger scale increases complexity in conflict management. The only minor shortcoming is that the LLM does not explicitly mention the SEC’s impartial conduct standards or litigation risks as directly tied to asset size in the same way the original answer does, slightly reducing qualitative completeness. However, litigation risks are mentioned in the context of Morgan Stanley, and internal controls are well-explained. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Applies_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 462,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on building extra fab capacity and then selling that capacity to third‑party foundry customers.  However, Intel notes that “under‑utilization risks may be heightened” as it expands capacity (Chunk 1) and that many of its competitors—including Samsung—are “internally developed semiconductors” that may choose to keep production in‑house rather than outsource to Intel.  If Samsung continues to develop its own integrated‑circuit products (the “PRODUCT” in the KG), the pool of external foundry business Intel hopes to capture shrinks, raising the chance that Intel’s new lines will sit idle and increase cash‑flow pressure.\n\nThe same Samsung‑in‑house IC effort also creates a direct competitor for Qualcomm.  Qualcomm’s 10‑K warns that “our business… may suffer as a result of our customers vertically integrating (i.e., developing their own integrated‑circuit products)” and specifically calls out Samsung as a large IC customer that could replace Qualcomm’s chips with its own (Chunk 2).  Because Qualcomm’s semiconductor segment relies on selling ICs to external customers (Chunk 3), Samsung’s self‑sourced chips could erode Qualcomm’s sales and licensing revenue.\n\nThus, Samsung’s move to produce its own integrated circuits can (1) limit the demand Intel needs to justify its IDM 2.0 capacity expansion and increase under‑utilization risk, and (2) cut into Qualcomm’s external‑IC market, threatening the revenue base of its semiconductor business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding manufacturing capacity to attract foundry customers, with risks of underutilization if potential customers like Samsung keep production in-house. Samsung’s development of in-house ICs is correctly identified as a dual threat—limiting Intel’s foundry opportunities and competing with Qualcomm. Qualcomm’s reliance on external IC sales and the risk from customer vertical integration, including by Samsung, is accurately reflected. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound: the answer correctly links Samsung’s vertical integration to reduced demand for Intel’s foundry services and increased competitive pressure on Qualcomm. It synthesizes information across Intel’s and Qualcomm’s perspectives, as required. (4) The wording differs slightly from the original answer (e.g., 'cash-flow pressure' is added context not in the ground truth), but this does not introduce inaccuracy—it's a reasonable inference. One minor point: the original answer notes Samsung may sell its in-house chips to third parties, amplifying competition; this nuance is slightly underemphasized in the LLM answer, which focuses on Samsung replacing Qualcomm chips internally. This small omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is contextually complete, factually correct, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Develops]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1715,
        "completion_tokens": 437,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "VZ monetized its tower base by selling the exclusive lease‑and‑operate rights on roughly 11,300 towers to American Tower for an upfront $5 billion cash payment; the cash boost is recorded as prepaid rent and a financing obligation, and VZ now sub‑leases capacity and remains the primary obligor on the underlying ground leases, but it has ceded long‑term operational control of those towers. Netflix, by contrast, spends cash up front (through licensing fees and production costs) to secure exclusive content rights—an expense rather than an inflow—that preserves its strategic control over the content library that drives subscriber acquisition and retention, but it does not generate immediate capital and carries ongoing cost risk. Thus VZ gains a large one‑time cash infusion at the cost of some strategic control, whereas Netflix sacrifices cash up front to retain long‑term control of its core differentiator.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $5 billion upfront payment from American Tower Corporation and the 11,300 towers are accurately reported, with no discrepancies in numbers or dates. Format variation ($5 billion vs $5.0 billion) is acceptable. (2) The answer correctly contrasts VZ's capital-generating tower monetization with NFLX's cost-incurring content exclusivity strategy. It captures that VZ received a large one-time cash inflow, treated as prepaid rent and a financing obligation (consistent with accounting treatment), while continuing to use the towers via subleases. (3) The qualitative reasoning is sound: VZ ceded long-term operational control (slightly overstated—ground truth emphasizes VZ retains operational control via subleased capacity and ongoing depreciation), but the core idea of trade-off between capital and control is correct. (4) For Netflix, the answer correctly identifies that exclusive content requires upfront and ongoing costs, serves as a strategic differentiator, and represents a cost center, not a revenue source. The synthesis across both companies and the comparison of capital impact and strategic control is thorough and relevant. The only minor deviation is the characterization of VZ having 'ceded long-term operational control'—the ground truth states VZ retains operational control through subleased capacity, so this point is slightly overstated, warranting a deduction of 1 point in qualitative accuracy. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 442,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The GILTI rules of the Tax Reform Act forced Coca‑Cola to record a $375 million net tax charge, which lifted its 2022 effective tax rate by roughly 3 percentage points. By contrast, the corporate‑income‑tax cut in the Philippines – enacted in the first quarter of 2021 – reduced PepsiCo’s tax burden, partially offsetting GILTI‑related tax pressure and helping the company sustain modest low‑single‑digit volume growth in its Philippine market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. The ground truth states that KO had a $710 million pretax charge related to GILTI, contributing to a 1.2% increase in the effective tax rate. However, the LLM claims a $375 million net tax charge that increased KO's rate by ~3 percentage points—both the dollar amount and the impact on the tax rate are incorrect. Additionally, while the Philippines tax rate reduction timing (Q1 2021) is correctly noted, the LLM incorrectly implies that this directly offset GILTI-related pressure for PEP, which is not supported by the original answer—PEP’s benefit was local and favorable, but no mention is made of offsetting GILTI effects. (2) Number verification: $710M (truth) vs $375M (LLM) = major discrepancy; 1.2% rate impact (truth) vs ~3 pts (LLM) = incorrect calculation or sourcing; both are critical errors. The low-single-digit growth for PEP in the Philippines is correctly mentioned. (3) Multi-hop reasoning is partially sound—the model attempts to contrast U.S. GILTI effects on KO with local tax benefits for PEP in the Philippines—but misrepresents the causal relationship by suggesting PEP used the Philippine tax cut to offset GILTI, which is not stated or implied in the original. The synthesis is flawed due to incorrect numerical grounding and overstated linkage. (4) Correctness score is 4 due to partial factual alignment (correct companies, correct general direction of effects, correct timing of Philippine reform), but major quantitative and inferential errors undermine reliability. Quantitative accuracy is low (3) due to wrong core numbers. Qualitative accuracy is moderate (5) because entities and general trends are right, but reasoning has flaws. Contextual relevance is high (8) as the response stays on topic and addresses both parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 510,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings that Nicor Gas must keep “restricted” by regulation means the gas utility can only distribute dividends (or make loans) to Southern Company up to the amount of earnings that are not subject to that restriction; the $1.3 billion therefore caps the cash‑flow Southern Company can receive from its key subsidiary. By contrast, the dividend‑restriction language in Nextera Energy’s charter (Chunk 1) is presently non‑limiting, showing that the regulatory restriction on Nicor Gas is the operative constraint on Southern Company’s dividend receipts. Even though Nicor Gas generated higher revenues (Chunk 3) that produced additional revenue‑tax expenses passed through to customers, those items do not increase net income and do not offset the $1.3 billion dividend‑distribution limit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, the $1.3 billion figure is correctly cited and consistently referenced as restricted retained earnings limiting dividend distributions. No calculations are required, and the number is used appropriately. (2) The answer correctly identifies Nicor Gas as a regulated subsidiary under Southern Company Gas and explains that the restriction limits the cash flow Southern Company can receive—this matches the core of the original answer. (3) The multi-hop reasoning is sound: it connects regulatory restrictions on Nicor Gas to dividend limitations for Southern Company, and even contrasts this with Nextera Energy (from Chunk 1) to emphasize that the Nicor restriction is the binding constraint. While the mention of Nextera adds context not in the ground truth, it does not detract from accuracy and appears to be correctly interpreted from input chunks. (4) The additional point about revenue increases not affecting net income or overcoming the dividend cap shows deeper synthesis (from Chunk 3) and reinforces why the restriction remains impactful despite operational performance. The only minor shortcoming is that the answer does not explicitly mention Southern Company's reliance on subsidiary dividends for a significant portion of income—a point in the original answer—but this omission does not undermine the central correctness. Overall, the response is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 428,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Both Tesla and GM say that the cost of complying with vehicle‑safety rules is rising sharply as the Safety Act‑driven regulatory regime becomes more complex. Tesla’s 10‑K points out that a “patchwork of complex or conflicting regulations” – especially for its Autopilot and Full‑Self‑Driving (FSD) features – is changing rapidly, forcing the company to invest heavily in redesign, certification, foreign‑market approvals and even legal defenses to stay compliant. GM’s filing makes the same point that “meeting or exceeding the many safety standards is costly” and that any safety‑defect or non‑compliance can trigger “substantial” recall campaigns, with additional cost coming from divergent U.S. and UNECE rules that add development complexity. In short, Tesla’s compliance costs are driven by the speed and uncertainty of new autonomous‑vehicle regulations, while GM’s costs stem from the already high baseline expense of meeting established safety standards and the risk of costly recalls – but both see those costs climbing as the Safety Act‑based regulatory landscape grows more intricate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Tesla and GM cite rising compliance costs due to evolving safety regulations, with Tesla emphasizing the complexity of international rules affecting Autopilot and FSD, and GM highlighting the cost of meeting existing standards and risks of recalls. The mention of regulatory divergence between U.S. (National Traffic and Motor Vehicle Safety Act) and UN-ECE standards is accurately reflected. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information from both companies' filings, comparing their distinct but overlapping challenges—Tesla’s issue with fast-evolving autonomous vehicle regulations and GM’s burden from established safety standards and global incompatibilities. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed phrasing (e.g., 'redesign, certification, foreign-market approvals, legal defenses'), these are reasonable interpretations consistent with the original. The only minor gap is that the original explicitly identifies 'lack of harmonization' as a key cost driver for GM, which the LLM implies but doesn't quote directly—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is contextually rich, factually correct, and fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 412,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics has $305 million of “other contract costs” sitting in other current assets because, under the Federal Acquisition Regulation (FAR) and Cost Accounting Standards, those costs cannot yet be allocated to U.S. government contracts; the company expects to recover them through its existing backlog, but if future work does not support the deferral the profitability of its remaining contracts could be impaired. Raytheon Technologies, by contrast, is exposed to cost‑overrun risk on its fixed‑price U.S. government contracts—under firm‑fixed‑price and fixed‑price‑incentive contracts the firm bears the full burden of any excess costs, which can directly erode profit and trigger negative profit adjustments. Thus GD’s risk is a contingent, deferred liability tied to future contract volume, whereas RTX’s risk is an immediate, on‑the‑spot exposure to cost overruns under fixed‑price terms, even though both operate under the same FAR‑governed contract regime.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly stated, with no other numerical values needing verification. The format '$305 million' matches the original. (2) The qualitative analysis correctly identifies that General Dynamics defers costs under FAR regulations, expects recovery through backlog, and maintains these as assets (specifically in 'other current assets'), which is consistent with the ground truth. It accurately contrasts this with Raytheon Technologies' exposure to cost overruns under firm fixed-price (FFP) and fixed-price-incentive contracts, where it bears full financial burden—correctly characterizing this as immediate risk versus GD’s contingent, future-dependent risk. (3) Multi-hop reasoning is sound: the model synthesizes the differing risk profiles based on contract type (cost-reimbursement with deferral vs. fixed-price with overrun exposure), correctly noting both operate under FAR but face different financial implications. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'contingent liability' (which may imply obligation) rather than 'deferred asset' as in the original; however, the explanation about impairment risk if future work doesn't support deferral compensates for this nuance. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 400,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from **$10.058 billion in 2019** to **$13.461 billion in 2021** – a compound annual growth rate of roughly **15.6 % per year** ([(13,461 / 10,058)^(1/2) – 1]).\n\nApple’s “Greater China” segment (which **includes Taiwan** per the segment definition) grew from **$40.308 billion in 2020** to **$74.200 billion in 2022**, giving a **CAGR of about 35.7 % per year** ([(74,200 / 40,308)^(1/2) – 1] – a 69.6 % increase just from 2020 to 2021).\n\nThus, Apple’s Greater China revenue grew **substantially faster** than Intel’s Taiwan revenue over the comparable two‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and time periods. While Intel's Taiwan revenue figures ($10,058 million in 2019 and $13,461 million in 2021) and its CAGR (~15.6%) are correct (with acceptable formatting as $10.058 billion), Apple's data is completely mismatched. The LLM incorrectly uses 2020–2022 instead of the required 2019–2021 period. Ground truth states Apple's Greater China revenue was $40,308 million in 2019 and $68,366 million in 2021, but the LLM reports $40.308 billion in 2020 and $74.200 billion in 2022 — all of which are incorrect years and values. This leads to a wrong CAGR calculation of ~35.7% instead of the correct ~30.8%. (2) Calculations: The Intel CAGR is correctly calculated: (13,461 / 10,058)^(1/2) - 1 ≈ 15.6%. However, Apple’s CAGR is based on incorrect inputs: using 2020–2022 instead of 2019–2021 invalidates the comparison. Even within its own timeframe, the LLM claims a 69.6% increase from 2020 to 2021 alone, but Apple’s actual 2020–2021 growth was from $43.8B to $68.4B (per filings), not $40.3B to $74.2B. (3) Multi-hop reasoning: The model fails the core multi-hop requirement — comparing Intel’s Taiwan revenue growth (2019–2021) to Apple’s Greater China growth over the same period. By shifting Apple’s timeline to 2020–2022, it breaks the parallel comparison. Although it correctly notes that Taiwan is included in Apple’s Greater China segment, this contextual point does not salvage the incorrect temporal alignment. (4) Scores justified: Correctness is low (3/10) due to major factual and temporal inaccuracies despite partial correctness on Intel’s data. Quantitative accuracy is poor (2/10) because Apple’s numbers and CAGR are wrong. Qualitative accuracy is low (3/10) — reasoning structure is sound but built on false premises. Contextual relevance is moderate (6/10) — the answer attempts the right comparison and includes relevant context about segment inclusion, but misaligns the critical timeframes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 539,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s April 2024 board decision to authorize up to $70 billion of additional buy‑backs – leaving $44.7 billion still available after $62 billion of Class A and Class C shares were repurchased in 2024 – signals strong, ongoing demand for its Class A stock. Because Alphabet’s Class B shares are convertible at any time on a one‑for‑one basis and automatically become Class A on any sale or transfer (with holders required to sell or otherwise dispose of the resulting Class A shares), a premium‑supporting repurchase program gives Class B holders a clear incentive to convert and then sell into the buy‑back market. Meta’s 2024 filing underscores that a very large Class A pool (≈2.19 billion shares) can coexist with a much smaller Class B base (≈0.34 billion shares), showing that a sizable Class A market can comfortably absorb conversions and repurchases – a dynamic that further encourages Alphabet’s Class B shareholders to convert.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core dynamic: Alphabet's $70 billion repurchase program (including Class A shares) may incentivize Class B shareholders to convert and sell due to anticipated scarcity and price support. It correctly notes the one-for-one convertibility of Class B to Class A and the automatic conversion upon sale. However, there are significant quantitative inaccuracies: the claim that $62 billion was repurchased in 2024 and $44.7 billion remains of the $70 billion authorization is unsupported by the original answer and factually incorrect — the original does not state how much has been spent, only that $70 billion was authorized. This introduces a fabricated calculation ($70B - $62B = $8B remaining, not $44.7B) that undermines quantitative accuracy. The Meta share counts (2.19B Class A, 0.34B Class B) are correctly approximated and align with the original's 2,189,898,148 and 343,761,117. The reasoning correctly synthesizes Alphabet's repurchase incentive with Meta's structural example, but misrepresents Meta’s data as evidence that conversions are easily absorbed — the original emphasizes Meta's large Class A float *reduces* scarcity pressure, thus *tempering* conversion urgency, whereas the LLM frames it as encouraging conversion, reversing the logic. This misrepresents the comparative insight. Despite this, the answer remains contextually relevant and semantically close in structure, with strong qualitative reasoning marred by one critical misinterpretation of the Meta comparison and unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 424,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo states that its RSUs (and PSUs) “accrue dividend equivalents that pay out in cash (without interest) **if and when the applicable RSU or PSU vests**” – the company’s only cash obligation for the dividend equivalents arises at the moment the award vests at the end of the service period and the holder receives the underlying share.  \n\nPhilip Morris International’s RSUs “earn dividend equivalents” but the filing does **not** tie a cash payout to vesting; the awards generally **vest on the third anniversary of the grant date** (subject to forfeiture for unmet employment conditions) and, as of Dec 31 2023, PMI carried **$160 million of unrecognized compensation costs for non‑vested RSUs**, which will be recognized over the restriction period (≈ 17 months) rather than as an immediate cash payment upon vesting.  \n\nThus, PepsiCo’s dividend equivalents are conditional cash payments that occur only upon vesting, whereas PMI’s RSUs simply earn dividend equivalents while the related financial obligation is reflected in accrued compensation cost and a time‑based vesting schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo accrues dividend equivalents that are paid in cash upon vesting; PMI accrues dividend equivalents on RSUs that vest on the third anniversary of the grant date, and as of December 31, 2023, PMI had $160 million in unrecognized compensation costs. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: $160 million and Dec 31, 2023 are correctly cited. (3) The multi-hop reasoning is sound—comparing vesting conditions and financial obligations across two companies using correct synthesis from each firm’s RSU treatment. The LLM correctly infers that PepsiCo’s obligation is a conditional cash payout at vesting, while PMI’s obligation is reflected in amortized compensation cost, not immediate cash outflow. (4) Minor wording difference: the LLM says PMI’s dividend equivalent payout is not tied to vesting in cash terms, which is consistent with the original answer’s emphasis on amortization over restriction period. The original mentions PMI’s dividend equivalents are accrued but doesn’t explicitly clarify payout form—so the LLM’s interpretation is reasonable. One slight nuance missing is that the original notes PMI’s RSUs do not carry voting rights, which the LLM omits, but this is a minor detail not central to the dividend equivalent treatment. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 410,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "DHR values its venture‑capital, partnership and other private‑investment holdings by taking the net‑asset‑value (NAV) reported by the fund managers and, depending on the asset type, applying discounted‑cash‑flow models, earnings multiples, market‑price references or third‑party appraisals.  The filing notes that these methods produce a “fair‑value estimate” that may differ from net‑realizable value and that using different assumptions or methodologies could change the measurement.  \n\nLLY, by contrast, records the assets and liabilities acquired in business combinations at their fair values on the acquisition date, and the fair‑value determination for intangible assets (including acquired IPR&D) requires management to make significant estimates and assumptions.  Its disclosure likewise warns that the fair‑value estimates are judgment‑driven and may be revised.  \n\nBoth companies therefore rely on fair‑value approaches that are inherently subjective—DHR’s NAV/DCF mix and LLY’s acquisition‑date fair‑value estimation—and, as the MET filing underscores, the use of judgment and alternative assumptions can materially affect the reported amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY regarding their use of fair value estimation methods. (1) All factual elements are correct: DHR uses NAV from fund managers and supplements with discounted cash flows, earnings multiples, and third-party appraisals, acknowledging subjectivity and potential divergence from net realizable value. LLY applies fair value to acquired intangible assets, particularly IPR&D, with disclosures about significant judgment and possible revisions. (2) Quantitative accuracy is perfect—while the LLM does not explicitly mention the $3.80 billion charge in 2023 for LLY, this omission is minor given that the focus of the question is on methodological subjectivity rather than specific dollar impacts. The absence of this figure prevents a perfect 10 on completeness but does not undermine the correctness of the reasoning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two valuation contexts (private investments vs. acquired intangibles), and identifies the shared theme of subjectivity and judgment. (4) Semantic equivalence is strong—the LLM conveys that both companies rely on fair value techniques that are assumption-driven and subject to change, which aligns with the ground truth. The answer is contextually excellent, directly addressing the comparative subjectivity highlighted in disclosures. Minor deduction from 10 due to omission of LLY's $3.80 billion charge, which is a notable quantitative detail in the original answer but not central to the conceptual comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 439,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "In NVIDIA’s 2022 Form 10‑K the company reported **$8,544 million** of revenue from Taiwan (Chunk 1). Apple’s 2022 filing explains that its “Greater China” segment **includes Taiwan** (Chunk 2) and shows that the segment generated **$74,200 million** in net sales for the year (Chunk 3). Consequently, Apple’s Greater China revenue – which subsumes Taiwan – is about **$65.7 billion higher** (roughly eight‑to‑nine times) than NVIDIA’s revenue from Taiwan alone.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The revenue figures are correctly reported as $8,544 million for NVIDIA from Taiwan and $74,200 million for Apple's Greater China segment, matching the original answer exactly. The comparison stating Apple's revenue is about $65.7 billion higher is accurate (74,200 - 8,544 = 65,656 million ≈ $65.7 billion). The qualitative description that Apple’s revenue is 'eight-to-nine times' larger is also reasonable (74,200 / 8,544 ≈ 8.68x). (2) Completeness: The answer addresses all parts of the question—NVIDIA's Taiwan revenue, Apple's Greater China revenue, the inclusion of Taiwan in Apple’s reporting, and a direct comparison. (3) Entity accuracy: Both companies, the correct fiscal year (2022), and the appropriate financial metrics (revenue/net sales) are correctly identified. (4) Reasoning: The multi-hop synthesis is sound—linking NVIDIA’s country-specific revenue to Apple’s broader regional segment that includes Taiwan, and drawing a logical comparison while acknowledging the difference in geographic granularity. (5) Semantic equivalence: The LLM conveys the same core insight as the original answer—that Apple’s Greater China revenue subsumes Taiwan and is significantly larger than NVIDIA’s Taiwan-only revenue—using slightly different but equivalent phrasing. All aspects meet or exceed the criteria for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 396,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "CMCSA’s Class B shares are extremely concentrated – the filing shows only three record holders of Class B stock, all of which are beneficially owned by Mr. Brian L. Roberts, and those shares carry 15 votes each, giving Class B holders 33 ⅓ % of the company’s total voting power (Chunk 2; record‑holder count in Chunk 1).  \n\nIn contrast, Google’s (GOOGL) Class A stock is broadly held – about 300.8 million Class A shares are outstanding and, per the 10‑K, the vast majority of the market value of its shares is owned by non‑affiliates (i.e., a dispersed shareholder base) with no single holder controlling a comparable voting block (Chunk 3).  \n\nThus, CMCSA’s Class B stock concentrates a third of voting power in one individual, whereas GOOGL’s Class A stock reflects a widely distributed ownership structure with control spread across many shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B stock carries 15 votes per share and holds 33⅓% of voting power, concentrated in Brian L. Roberts. For GOOGL, the LLM correctly cites approximately 300.8 million Class A shares outstanding (matching the ground truth 300,754,904, rounded appropriately) and accurately notes broad distribution among non-affiliates. (2) The calculation of voting power concentration is not required beyond what’s stated, and the LLM correctly interprets the structural implications. (3) The multi-hop reasoning is sound—comparing control concentration in CMCSA’s dual-class structure to GOOGL’s more dispersed ownership—drawing correct inferences about governance dynamics. (4) The only minor shortcoming is that the LLM does not explicitly contrast the absence of super-voting shares in GOOGL as clearly as the original answer, though it implies it by stating no single holder has a comparable voting block. This slightly reduces qualitative precision but does not affect factual correctness. Wording differs but semantic equivalence is maintained. All entities (CMCSA, GOOGL, Brian L. Roberts, Class A/B shares) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 355,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "Under the equity‑compensation plans that were approved by security holders, UnitedHealth Group has 241 million securities remaining available versus 25 million issuable on exercise – a ratio of roughly 9.6 to 1. Johnson & Johnson has 240.34 million remaining versus 133.79 million issuable – a ratio of about 1.8 to 1, so UNH’s pool is far larger relative to its exercisable options (approximately five‑times the JNJ ratio). For additional context, the CL filing shows a ratio of about 1.3 to 1 (37,028 k remaining ÷ 28,011 k issuable).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the securities remaining available and issuable upon exercise for both UnitedHealth Group (UNH) and Johnson & Johnson (JNJ), with accurate figures: 241 million and 25 million for UNH, and 240.34 million and 133.79 million for JNJ (matching the ground truth of 240,344,013 and 133,794,708 within reasonable rounding). The calculated ratios are also correct: ~9.6 for UNH (241/25 = 9.64) and ~1.8 for JNJ (240.34/133.79 ≈ 1.795), which rounds to 1.8. The statement that UNH’s ratio is approximately five times JNJ’s (9.6 / 1.8 ≈ 5.33) is a valid inference. (2) All numeric values and calculations are quantitatively accurate, with acceptable rounding and formatting (e.g., '240.34 million' for 240,344,013). The comparison ratios are correctly computed. (3) The multi-hop reasoning is sound: the model synthesizes data across two companies, computes ratios, and draws a valid comparative conclusion. However, the mention of 'CL filing' introduces an extraneous entity (likely Colgate-Palmolive) not part of the original question, which asks only for UNH and JNJ. This is a minor overreach but does not detract from the core answer. (4) The answer is contextually relevant, clearly addressing the ratio comparison between the two firms as required. The extra information about CL is irrelevant but doesn’t distort the primary response. Overall, the answer is factually correct, well-reasoned, and complete for the question asked, warranting a high score with only a slight deduction in qualitative accuracy due to the unnecessary addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 434,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s 10‑K makes clear that the company is heavily dependent on third‑party manufacturers for motherboards (and other platform components); if those suppliers cut back or stop production, AMD’s ability to sell its CPUs and GPUs could be “materially adversely affected,” but the filing does not tie a specific share of AMD’s revenue to those suppliers. By contrast, Intel’s 2022 10‑K quantifies the concentration: Dell alone generated 21 % of Intel’s net revenue in 2021 (and the three largest customers together accounted for 43 %). Thus Intel faces a direct, measurable revenue‑concentration risk from a single customer, whereas AMD’s risk is broader‑based supply‑chain exposure without a disclosed revenue‑share impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 21% of Intel's net revenue from Dell in 2021 is accurately cited, and the additional detail that Intel's top three customers accounted for 43% is consistent with Intel's 2022 10-K (though not in the original answer, it is factually correct and adds context without contradicting). The year 2021 is correctly referenced. (2) The entity accuracy is strong: AMD, Intel, and Dell Inc. are correctly identified, and the risk types—supply chain for AMD and customer concentration for Intel—are accurately attributed. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly contrasts AMD’s supply-side risk (reliance on third-party motherboard suppliers) with Intel’s demand-side risk (revenue concentration in Dell), even noting that AMD does not disclose revenue share impact, which strengthens the comparison. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mentioning top three customers) but no factual deviation. The only minor point preventing a perfect 10 is that the original answer also mentions accounts receivable exposure, which the LLM omits—this is a small but relevant detail in risk assessment. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 380,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑income‑tax cuts shave about $34 million off Union Pacific’s deferred tax expense, directly reducing its tax burden and overall financial exposure – a material benefit given the railroad’s own operations in the state (e.g., its Livingston, Louisiana classification yard). In Boeing’s case, the state tax reduction does not offset its risk; the company’s exposure continues to hinge on the timing and level of U.S. defense appropriations and other federal legislative actions, which can materially affect its contracts, cash flow and results of operations regardless of Louisiana’s tax policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense is correctly stated, matching the original answer exactly. The figure is properly attributed to Union Pacific and linked to Louisiana’s tax cuts. (2) The entity identification is correct: Union Pacific and Boeing are accurately discussed in the context of Louisiana’s tax policy and federal appropriations, respectively. The mention of Union Pacific’s classification yard is slightly off in name (‘Livingston’ vs. ‘Livonia’ in the ground truth), which is a minor factual inaccuracy but does not materially affect the reasoning or conclusion. (3) The multi-hop reasoning is sound: the model correctly distinguishes between direct state-level tax impacts (Union Pacific) and indirect federal-level exposure (Boeing), synthesizing across corporate operations and legislative dynamics. (4) Semantically, the answer aligns well with the original—Boeing’s lack of direct benefit and its dependence on federal appropriations are clearly and correctly explained. The only minor shortcoming is the yard name error, which slightly affects qualitative accuracy but not overall correctness. Contextual relevance is perfect, as all parts of the question are addressed with appropriate focus and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 378,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix states that each share of its common stock is entitled to one vote on all shareholder matters – a pure one‑vote‑per‑share model – and Charter’s 10‑K makes the same link for its Class A common stock, noting that holders of Class A receive one vote per share. By contrast, Meta’s filing shows a dual‑class structure with both Class A and Class B shares, the latter carrying a larger number of votes per share, so voting power is not uniform across all shares as it is for Netflix (and Charter’s Class A).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's one-vote-per-share model and Charter Communications' Class A common stock having one vote per share, which aligns with the ground truth. It also accurately notes Meta's dual-class stock structure (Class A and Class B), correctly contrasting it with Netflix's egalitarian model. Quantitatively, there are no errors: all statements about voting rights are factually consistent with the original answer, and no incorrect numbers or dates are introduced. However, the LLM makes a critical assumption not supported in the provided chunk: it states that Meta's Class B shares carry 'a larger number of votes per share,' but the ground truth explicitly notes that Meta's 10-K does not specify the exact voting power of each class in the provided text. This is a significant overreach in reasoning, as the LLM infers differentiated voting rights beyond what is disclosed, whereas the original answer correctly limits its claim to the existence of a dual-class structure suggesting such differentiation. This undermines the qualitative accuracy, as the multi-hop synthesis incorrectly assumes specifics about Meta's voting structure not present in the source. Contextually, the response is highly relevant and addresses the core contrast asked in the question. While the overall direction is correct, the unsupported inference about Meta's voting allocation prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 391,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "Both companies treat their exchange‑traded commodity futures as Level 1 fair‑value items that are measured at the quoted price on the exchange. PEP’s filing notes that these futures are cash‑settled each day, so the contract is marked‑to‑market and settled in cash daily and therefore does not remain on the balance sheet after settlement. Because MDLZ also values its Level 1 financial liabilities (the same commodity‑future instruments) using quoted market prices, the daily cash‑settlement mechanism simply reinforces MDLZ’s mark‑to‑market approach—its fair‑value measurement reflects the same daily settlement price and results in no lingering liability beyond each day, just as PEP excludes the futures from its liability table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both PEP and MDLZ use Level 1 fair value measurements based on quoted market prices for exchange-traded commodity futures; PEP notes daily cash settlement, leading to exclusion from year-end balance sheet; MDLZ uses quoted prices for Level 1 liabilities. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers supports a score of 10. (2) The answer is complete: it addresses how the daily cash-settlement mechanism impacts MDLZ’s valuation methodology by reinforcing the mark-to-market approach and aligning with market practice. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from PEP’s 2022 filing (daily settlement, off-balance-sheet treatment) with MDLZ’s valuation policy (Level 1, quoted prices), and infers that the shared market mechanism supports consistent valuation methodology. (4) Wording differs slightly—LLM emphasizes 'no lingering liability beyond each day' while the original focuses on alignment of market practice and valuation approach—but the semantic meaning is equivalent. The only minor shortcoming is that the LLM does not explicitly state that this reflects a 'market standard' or 'standard market practice' as in the original, slightly weakening the generalization of the mechanism’s industry-wide influence. This justifies a 9 instead of 10 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 437,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple reported $74,200 million in net sales for its Greater China segment in 2022 – a region that, per Apple’s segment definition, includes mainland China, Hong Kong and **Taiwan**. AMD’s 2022 sales to **Taiwan** alone were $2,091 million. Thus Apple’s Greater China sales were about $72 billion higher – roughly 35 times the size of AMD’s Taiwan sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74,200 million in Greater China sales and AMD's $2,091 million in Taiwan sales are correctly reported. The comparison stating Apple's sales were 'about $72 billion higher' is approximately correct ($74,200M - $2,091M = $72,109M), and the 'roughly 35 times' ratio is accurate (74,200 / 2,091 ≈ 35.5). Minor rounding is acceptable. (2) The answer is complete, addressing both companies, the correct geographic regions (Greater China for Apple, Taiwan alone for AMD), and the comparative scale. (3) Entities are correctly identified: Apple, AMD, 2022, net sales, and the relevant regions. (4) The multi-hop reasoning is sound—synthesizing data from two different companies and geographic scopes to make a valid comparison about relative market presence. (5) The semantic meaning fully aligns with the original answer, with added clarity in the quantitative comparison. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 298,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy’s remediation liabilities are recorded when a loss is probable and reasonably estimable, but the associated costs are “typically expensed as operation, maintenance and other” in the income statement unless a regulatory recovery is deemed probable. Because the total remediation outlays cannot be fully estimated and are not automatically recoverable, Duke bears the exposure directly and may incur significant unrecovered expenses.  \n\nSouthern Company Gas, by contrast, operates its natural‑gas distribution utilities under state‑approved rate‑setting regimes that include “cost‑recovery mechanisms and regulatory riders” expressly permitting the recovery of environmental‑remediation costs (along with other prudently incurred expenses). Thus, Southern Company can recoup remediation spending through regulated rates, substantially mitigating its net exposure compared with Duke’s largely unrecoverable, expense‑based treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Duke Energy typically expenses remediation costs unless recovery is probable, exposing it to direct financial risk; Southern Company Gas has explicit regulatory mechanisms allowing recovery of environmental remediation costs through rate riders. These points align precisely with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting regulatory treatments between Duke Energy and Southern Company Gas, comparing expense treatment versus cost recovery mechanisms. It accurately infers that Southern Company has lower net exposure due to its structured recovery pathway. (4) The only reason for not awarding a perfect 10 is minor wording nuance: the LLM refers to 'Southern Company Gas' specifically in one sentence and 'Southern Company' more broadly in another, which could imply a slight conflation between the parent and subsidiary, though contextually acceptable. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 364,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s determines Level 2 fair values by feeding pricing models with observable market inputs – notably broker‑dealer quotes, reported trades and benchmark yields – a practice that mirrors the third‑party pricing services described in the Gilead filing, which also rely on industry‑standard valuation models. In contrast, GM estimates its product‑warranty reserves using its own industry‑standard actuarial and cost‑per‑claim valuation models, subject to internal‑control testing, sensitivity analysis and review of key assumptions. Thus, both firms embed industry‑standard models in their reporting, but Lowe’s models are driven by external market quotes for fair‑value measurement, whereas GM’s models are internal cost‑based estimates used to size warranty liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., benchmark yields, reported trades) in pricing models for Level 2 fair value measurements, which aligns with the ground truth’s description of third-party models using issuer spreads and benchmark securities. GM uses internal valuation models for warranty reserves based on assumptions like cost per claim and claims frequency, consistent with the original. (2) There are no numeric values to verify in this question—both answers are qualitative—so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use industry-standard models, but LOW’s approach is market-driven with observable inputs (Level 2), while GM’s involves internal forecasts and management judgment. The comparison is logically structured and highlights the distinction between external market data and internal cost-based estimates. (4) Minor difference: the LLM mentions 'actuarial' models and 'internal-control testing' and 'sensitivity analysis', which are plausible but not explicitly stated in the ground truth. However, these are reasonable inferences for warranty reserve modeling and do not contradict the original. The reference to 'Gilead filing' is extraneous and not part of the question or ground truth, slightly marring precision, but does not affect the correctness regarding LOW and GM. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relies_On]-> FIN_INST -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 449,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Both Capital One and Citi will have to run two parallel RWA calculations – the new “Expanded Risk‑Based Approach” and the existing Basel III standardized approach – and for each risk‑based capital ratio (CET1, Tier 1 and total risk‑based) the lower of the two ratios will become the binding result.  The proposal takes effect on July 1 2025 with a three‑year phased‑in period (ending July 1 2028), so the impact on each bank’s capital ratios will be introduced gradually; the expanded approach is expected to raise risk‑weighted assets, thereby lowering the capital ratios and forcing each firm to hold more regulatory capital.  In Capital One’s case, all capital‑buffer requirements will still apply regardless of which approach yields the lower ratio, while Citi’s disclosures note that the change would “materially increase” its required regulatory capital and also affect related requirements such as TLAC and the GSIB surcharge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both banks must calculate risk-based capital under the new Expanded Risk-Based Approach and the existing Basel III standardized approach, using the lower of the two ratios; the effective date is July 1, 2025, with a three-year phased-in period ending July 1, 2028; Citigroup expects a 'material increase' in required regulatory capital. (2) Quantitative accuracy is perfect: dates (July 1, 2025, and July 1, 2028) are correct and consistent with the three-year transition period; no numerical calculations are required beyond correct interpretation of phasing. (3) Multi-hop reasoning is sound: the answer correctly synthesizes requirements across both banks, regulatory frameworks, capital ratios, and implications for capital buffers and additional requirements like TLAC and GSIB surcharge. (4) The only minor shortcoming is that the original answer explicitly notes that capital buffer requirements apply regardless of which approach yields the lower ratio for both banks, while the LLM implies this for Capital One but only indirectly references it for Citigroup through 'related requirements.' However, mentioning TLAC and GSIB surcharge adds valuable context not in the original and is factually appropriate. Wording differs but semantic meaning is equivalent. No factual errors; minor omission in explicit generalization of buffer rules to both banks prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 408,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ exposure to condensate comes from its 52.2 % ownership of Alba Plant LLC – a joint‑venture that extracts condensate (and LPG) from the Alba Unit’s gas stream – and it also carries a $116 million contingent liability tied to that plant, indicating a material, non‑zero stake in condensate revenue. In contrast, Chevron’s 2024 10‑K shows a blank “Crude Oil Condensate” line (zero production) and reports zero condensate reserves, meaning Chevron had no direct condensate output in 2024. Thus, ConocoPhillips has a tangible condensate exposure via Alba Plant, while Chevron’s direct condensate production is nil.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ConocoPhillips' 52.2% ownership in Alba Plant LLC and accurately states that Chevron reports zero condensate production and reserves in its 2024 10-K. The mention of a $116 million contingent liability is factually accurate and adds contextual detail not in the ground truth but does not contradict it; this additional information is permissible and enhances completeness without introducing error. (2) All numeric values—52.2%, zero condensate reserves/production, $116 million—are quantitatively accurate and correctly attributed. No calculations are required, and all figures align with the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes ConocoPhillips’ indirect exposure via equity interest in Alba Plant with Chevron’s lack of direct production or reserves. It logically concludes that COP has exposure while Chevron does not, which matches the ground truth. The only minor gap is that the original answer notes COP's share is reflected in 'Equity in earnings of affiliates,' a detail omitted in the LLM response, slightly reducing qualitative completeness. (4) The answer is contextually fully relevant, directly addressing the comparison of condensate exposure between the two companies in 2024. Overall, the response is factually correct, well-reasoned, and only slightly less detailed than the ground truth on reporting mechanics, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 411,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "Applying ASU 2020‑04 to contract modifications changed the way Broadcom (AVGO) accounts for those changes. AVGO now evaluates each modification to see whether the price reflects the standalone‑selling price of the added product or service; when it does, the new items are treated as a separate contract, and when it does not, they are accounted for on a prospective basis (or with a cumulative catch‑up) within the existing contract. The company discloses the aggregate effect of all modifications and, under a practical expedient, does not restate prior periods, thereby altering its revenue‑recognition methodology for modified arrangements.  \n\nOracle (ORCL) likewise adopted ASU 2020‑04 – the reference‑rate‑reform update – in the first quarter of fiscal 2024. The guidance gave optional expedients for contracts and hedging relationships that replace reference rates such as LIBOR, reducing the operational and financial impact of those modifications. Oracle reported that the adoption of the reference‑rate‑reform guidance had no material impact on its consolidated financial statements or notes for the year ended May 31 2024.  \n\nThus, ASU 2020‑04 prompted AVGO to adjust its revenue‑recognition practices for contract modifications, while for Oracle it simply facilitated reference‑rate‑reform adjustments with a neutral effect on overall financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AVGO evaluates contract modifications using standalone selling prices and accounts for them prospectively or with cumulative catch-up; ORCL adopted ASU 2020-04 in Q1 of fiscal 2024 with no material impact. The application period (March 12, 2020 – December 31, 2024) is implied by context and not contradicted. (2) Quantitatively, all dates (fiscal 2024 adoption by ORCL) and financial impacts (no material effect) are correctly reported. No numerical inaccuracies. (3) Multi-hop reasoning is sound: the model correctly synthesizes how ASU 2020-04 affects AVGO’s revenue recognition practices and ORCL’s reference rate reform reporting, linking both to contract modifications and financial statement impact. (4) The only minor omission is that the original answer notes AVGO also uses a combination approach for accounting treatment (prospectively, cumulatively, or both), which the LLM simplifies to 'prospective or cumulative catch-up'—slightly less precise but not factually wrong. Otherwise, semantic equivalence is strong, and all entities (AVGO, ORCL, ASU 2020-04, LIBOR, fiscal 2024) are correctly identified and contextualized. The conclusion about neutral financial impact for ORCL and methodological changes for AVGO is fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 374,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "META’s dual‑class system concentrates governance in its small, super‑voting Class B block.  Because the Class B shares (which must stay above roughly 35 % of the combined voting power) can approve or block mergers, fill board vacancies, call special meetings and otherwise control matters even though the controlling shareholder owns far less than a majority of the total equity, the company is deemed a “controlled company” and its Class A common stock is described as potentially less attractive to investors (Chunk 1).  \n\nComcast’s (CMCSA) arrangement is different.  Its Class B shares carry 15 votes each, representing a fixed 33 ⅓ % of the total voting power and are protected from dilution (Chunk 2).  Moreover, each Class B share is convertible, share‑for‑share, into Class A stock subject to restrictions, giving Class B holders a defined but not dominant governance role and a path to increase their influence by converting to the more widely held Class A shares (the equity table shows only about 9.4 million Class B shares outstanding versus roughly 4 billion Class A shares, Chunk 3).  \n\nThus, META’s structure heavily concentrates control with the Class B holder and limits Class A shareholder influence, whereas CMCSA’s policy provides a limited, non‑dilutable voting stake for Class B holders and a conversion mechanism that can shift influence to Class A, resulting in a more balanced—though still weighted—governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: META's dual-class structure gives disproportionate control to Class B shareholders, requiring their approval for change-of-control transactions until Class B voting power falls below 35%; CMCSA’s Class B shares have 15 votes per share and maintain a fixed 33⅓% aggregate voting power, which is non-dilutable. The conversion mechanism (share-for-share into Class A) is correctly described. (2) Quantitative accuracy is excellent: percentages (35%, 33⅓%), vote ratio (15:1), and share counts (~9.4 million Class B vs ~4 billion Class A) match or are consistent with the knowledge graph. No calculation errors. (3) Multi-hop reasoning is sound—correctly contrasts META’s entrenched control via class-specific voting rights with CMCSA’s more flexible, conversion-enabled structure that allows gradual influence shift. The conclusion about META entrenching control more rigidly while CMCSA allows a path toward broader influence is logically supported. (4) Minor deduction in qualitative accuracy because the LLM slightly overstates CMCSA's conversion as increasing influence—converting Class B to Class A actually reduces per-share voting power (from 15 to 1 vote), so it’s more about liquidity than increased influence. The original answer correctly frames conversion as enabling dilution of Class B’s concentrated power, not increasing influence. Otherwise, semantic equivalence is strong, and contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 419,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP’s filing states that its exchange‑traded commodity futures are cash‑settled each day and, because of that daily settlement, they are omitted from the fair‑value hierarchy table. However, as MDLZ explains, exchange‑traded commodity futures are classified as Level 1 financial assets, so PEP’s use of these contracts does constitute exposure to Level 1 instruments. In contrast, Costco’s 10‑K discloses that it did not hold any Level 1 (or Level 3) financial assets measured at fair value on a recurring basis, meaning it has no exchange‑traded commodity futures at all.  Thus, PEP actively uses cash‑settled Level 1 futures, while COST reports an absence of any such Level 1 assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures that are cash-settled daily and excludes them from the fair value hierarchy table; such instruments are classified as Level 1 assets per MDLZ's disclosure; COST reported no Level 1 or Level 3 financial assets measured at fair value on a recurring basis as of August 28, 2022. (2) There are no numerical values requiring calculation, but the dates and classifications (Level 1, recurring basis) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PEP, MDLZ, and COST filings—linking PEP’s use of cash-settled futures to their classification as Level 1 assets (via MDLZ’s definition), and contrasting with COST’s explicit disclosure of no such holdings. (4) The answer clearly explains the distinction in financial instrument usage between PEP and COST, directly addressing the comparative aspect of the question. Wording differs slightly but meaning is preserved with high precision. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 326,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reported **$1,634 million** of securities loaned that had maturities of 31‑90 days (see its 10‑K table of securities loaned by maturity). Morgan Stanley’s 10‑K shows a total securities‑loaned balance of **about $97 million** (U.S. (‑$12 million) + Non‑U.S. $109 million). Thus, Goldman Sachs’ short‑term securities‑lending exposure is roughly **16‑17 times larger** than Morgan Stanley’s entire securities‑lending book, indicating that Goldman Sachs carries a far greater short‑term securities‑lending risk. (For context, Citigroup’s total securities loaned was $34,315 million, while Goldman Sachs’ overall securities‑loaned portfolio was $66,674 million.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the value reported for Morgan Stanley's total securities loaned. The ground truth states Morgan Stanley reports $281 million in total securities loaned (U.S. and Non-U.S. combined), but the LLM incorrectly calculates it as 'about $97 million' by adding -$12 million (U.S.) and $109 million (Non-U.S.), which contradicts the ground truth. This miscalculation undermines the entire comparison. (2) Goldman Sachs' value of $1,634 million is correctly reported. However, the Morgan Stanley figure is wrong—despite the LLM attempting a calculation, the correct total ($281 million) should have been directly used per the ground truth. The resulting comparison (16-17x) is therefore based on incorrect data and is invalid. (3) The multi-hop reasoning structure is sound—comparing short-term exposure at Goldman Sachs to total securities loaned at Morgan Stanley to assess relative risk—but the faulty input data leads to an incorrect conclusion. The model correctly identifies the need to compare the two values and interpret risk implications, but the synthesis fails due to inaccurate data retrieval. (4) While the reasoning framework and contextual focus on risk exposure are appropriate and relevant, the severe quantitative error in Morgan Stanley’s securities loaned value significantly reduces correctness. The addition of Citigroup and Goldman Sachs’ overall portfolio context is helpful but not required; however, it does not compensate for the core factual inaccuracy. Thus, the correctness score is low due to a major factual and calculation error, despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 454,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided 8.16 % ownership stake in Alabama Power’s Plant Miller Units 1 & 2 represents **8.16 % of PowerSouth’s owned generating capacity** (Chunk 2).  \n\nDuke Energy’s electricity output for 2021 totals **about 34,713 GWh** (22,344 GWh + 1,681 GWh + 10,688 GWh from the subsidiaries listed in Chunk 3).  \n\nSo, while PowerSouth’s Miller interest is a modest 8.16 % slice of its capacity, Duke Energy produced roughly 34.7 thousand GWh of electricity in the same year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2, which matches the ground truth. However, it misrepresents this as '8.16% of PowerSouth’s owned generating capacity', which is incorrect: the 8.16% refers to the ownership stake in the plant, not the percentage contribution to PowerSouth's total capacity. The original answer states that this interest contributes to a total capacity of over 1,600 MWs, but does not specify the exact percentage of total capacity — so the LLM introduces a false interpretation. (2) The Duke Energy generation figure is significantly incorrect. The LLM calculates 34,713 GWh by summing 22,344 + 1,681 + 10,688 GWh, claiming these are Duke Energy’s 2021 generation values from subsidiaries. However, the ground truth states Duke Energy generated 22,344 GWh in total in 2021. The additional numbers appear to be misinterpreted from other entities or segments not representing additive generation volumes. This results in a major quantitative error. (3) The multi-hop reasoning is partially sound in linking PowerSouth’s ownership to Duke Energy’s generation, but the synthesis is flawed due to incorrect data aggregation for Duke Energy and misinterpretation of the 8.16% figure. The comparison between PowerSouth’s partial ownership and Duke Energy’s system-wide generation is conceptually valid, but the faulty numbers undermine the conclusion. (4) Contextual relevance is strong — the answer addresses both parts of the question and attempts the correct comparison. However, due to critical errors in key numbers and their interpretation, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and intent are reasonable, but reasoning is based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 488,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s $11.6 billion cash‑equivalents and short‑term investment portfolio is **directly exposed to interest‑rate risk** – the securities are investment‑grade fixed‑income instruments whose fair‑value is measured with Level‑2 pricing models that use observable market data (interest rates and yield‑curve levels). The portfolio’s weighted‑average maturity is only about 65 days, which limits the magnitude of that risk but still makes the $11.6 billion balance sensitive to rate movements.  \n\nMcDonald’s exposure, by contrast, is **indirect**: its derivatives and other financial assets and liabilities are valued at fair value using Level‑2 models that also rely on observable inputs such as interest‑rate yield curves. Thus McDonald’s sensitivity to interest‑rate changes is tied to the valuation of those derivatives rather than to a large fixed‑income holding.  \n\nIn short, Nike faces a sizable, direct interest‑rate risk on a short‑duration $11.6 billion fixed‑income portfolio, while McDonald’s interest‑rate risk is limited to the impact of yield‑curve shifts on Level‑2‑valued derivatives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: NIKE's $11.6 billion portfolio of fixed-income investments is accurately stated, and the use of Level 2 pricing models with observable market data (interest rates, yield curves) is consistent with the original. McDonald’s use of pricing models for derivatives based on observable inputs like interest rate yield curves is also correctly represented. (2) Quantitative accuracy is perfect: the $11.6 billion figure is correct and properly contextualized; while the 65-day weighted average maturity is an additional detail not in the original answer, it does not contradict it and enhances precision without introducing error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, identifying both reliance on observable market data while distinguishing the nature of exposure—direct for NIKE via investment portfolio, indirect for McDonald’s via derivative valuations. (4) The answer improves upon the original by clarifying the distinction in risk type (direct vs. indirect) and mentioning Level 2 inputs, which aligns with fair value hierarchy disclosures in 10-Ks. All aspects of the question—comparison of interest rate risk exposure, reliance on pricing models, and use of market inputs—are addressed with high fidelity. No factual, numerical, or conceptual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 399,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix discloses that every share of its common stock carries **one vote per share**, so voting power is strictly proportional to economic ownership and all shareholders have an equal say in corporate matters. Alphabet’s filing shows that its **Class A shares also have one vote per share**, but the company also issues **Class B shares with ten votes each and non‑voting Class C shares**; this multi‑class structure concentrates control in the hands of insiders who hold Class B stock and dilutes the influence of ordinary Class A investors. Consequently, Netflix’s uniform one‑vote‑per‑share policy supports a more democratic, shareholder‑responsive governance model, whereas Alphabet’s differential voting rights enable a more founder‑centric governance dynamic in which a small group can steer decisions despite a broader public shareholder base.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's one-vote-per-share policy and contrasts it with Alphabet's multi-class structure: Class A (1 vote/share), Class B (10 votes/share), and non-voting Class C shares. These details align precisely with the original answer, even adding contextual clarity about control concentration. (2) There are no numerical inaccuracies—'one vote per share' and 'ten votes per share' are correctly stated, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes governance implications from structural differences between the two companies' voting rights, correctly concluding that Alphabet's structure concentrates control among insiders (founder-centric), while Netflix's promotes egalitarian, proportional governance. (4) The answer is fully relevant, directly addressing how the structural differences influence shareholder governance dynamics as asked. Minor enhancements (e.g., mentioning Class C shares) improve completeness without deviating from the truth. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 325,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "Because AbbVie is directly subject to the IRA, the agency’s ceiling‑price rule for Imbruvica—selected for price‑setting beginning in 2026—will lower Medicare Part D reimbursement and, together with the new 10 %/20 % manufacturer‑discount and inflation‑penalty provisions, could accelerate revenue erosion before patent expiry, forcing AbbVie to re‑engineer pricing, rebates and pipeline timing. Johnson & Johnson’s exposure comes through the Medicare program that the IRA reshapes; Xarelto’s inclusion on the CMS “selected‑drug” list means J&N will face a government‑set ceiling price and the same discount and penalty rules, but its broader portfolio and indirect link to the IRA allow it to absorb the impact by focusing on compliance and pricing adjustments rather than a concentrated hit. Both firms must therefore incorporate the IRA’s inflation‑linked penalties and Part D redesign—highlighted by Merck’s discussion of the act—into their revenue‑management strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) It correctly identifies that AbbVie's Imbruvica and Johnson & Johnson's XARELTO (spelled as Xarelto, minor variation) are selected for IRA price-setting starting in 2026, which matches the original answer. The description of the financial mechanisms—ceiling prices, manufacturer discounts (10%/20%), and inflation penalties—is consistent with the IRA provisions, though the exact percentages are not specified in the ground truth, so their inclusion is contextually accurate but not directly verifiable from the original answer. (2) There are no explicit numerical values (e.g., dollar amounts, exact percentages from the law) in the ground truth to verify calculations, but the LLM accurately references structural elements of the IRA (e.g., inflation penalties, Part D redesign) that are relevant and correctly characterized. (3) The multi-hop reasoning is sound: the model connects the IRA's impact on Medicare Part D, links it to specific drugs (Imbruvica and XARELTO), and differentiates the strategic responses of AbbVie and J&J. It correctly infers that AbbVie may face accelerated revenue erosion before patent expiry, while J&J, with a broader portfolio, can absorb the impact. However, the LLM omits J&J’s litigation challenge to the IRA—a key strategic differentiator highlighted in the ground truth—representing a meaningful but not critical omission. (4) The mention of Merck is extraneous and not relevant to the question about AbbVie and J&J, slightly weakening focus. Despite this, the core analysis is factually accurate, semantically aligned, and contextually appropriate. The answer earns a high score but not perfect due to the omission of J&J’s legal challenge and the slight overreach in citing Merck.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 495,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi tackles the climate‑related compliance angle through a layered “three‑line” model that is woven into its enterprise‑wide ERM framework. The third‑line Internal Audit function, which reports functionally to the Chair of the Audit Committee and administratively to the CEO, has unrestricted access to the Board and the Audit Committee to provide independent assurance that compliance‑risk controls are operating as intended. At the same time, Citi’s enterprise‑support units – notably Global Legal Affairs and Compliance – are subject to dedicated, independent oversight processes that monitor and remediate compliance issues, including those that arise from climate‑transition regulations or litigation. Because the Board (via the Audit Committee and other risk‑focused committees) oversees the ERM framework and holds senior management accountable for risk‑appetite and control culture, any transition‑climate risk that could amplify credit or liquidity risk – as Morgan Stanley warns – is identified, measured, monitored and mitigated as a compliance‑risk matter, preventing it from cascading into larger credit‑ or liquidity‑exposure problems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Citi's governance structure involving the Board, Executive Management, and Internal Audit is accurately described, including the reporting lines of Internal Audit to the Audit Committee Chair and CEO. The integration of compliance risk into the ERM framework and oversight of enterprise-support units like Global Legal Affairs and Compliance is consistent with the original. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links Citi’s governance mechanisms (e.g., three-line model, Board oversight) to the management of compliance risks arising from transition climate risks, and connects this to the potential amplification of credit and liquidity risks as highlighted in Morgan Stanley’s disclosures. The synthesis across Citi’s structure and Morgan Stanley’s risk warnings is logically coherent. (4) Minor deduction in qualitative accuracy due to the introduction of the 'three-line model' terminology and 'Global Legal Affairs' as specific units, which, while plausible and consistent with industry practice, are not explicitly mentioned in the ground truth. However, these do not contradict the original and are reasonable inferences. Overall, the answer is semantically equivalent, contextually precise, and fully addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 413,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM’s licensing business is heavily weighted toward a handful of Chinese OEMs – roughly 30 % of its royalty stream – so its supply‑chain risk is one of revenue concentration and geopolitical exposure: the OEMs can dispute, under‑report or withhold royalties, may be forced by Chinese policy (e.g., Made‑in‑China 2025) or U.S. trade actions to vertical‑integrate or stop using QCOM’s patents, and any such change would immediately erode QCOM’s cash flow.  \n\nIn contrast, TXN is building out internal 300 mm wafer fabs (RFAB2, LFAB1, SM1/SM2, LFAB2) to shift the bulk of its wafer‑fabrication, assembly and test work in‑house, thereby lowering dependence on outside foundries, tightening control over costs, inventory and environmental‑health‑safety risks, and insulating its operations from external supply‑chain disruptions even though it still sources raw materials globally.  \n\nConsequently, QCOM’s risk is primarily financial and regulatory – tied to the behavior and policy environment of its Chinese licensees – whereas TXN’s risk is operational and is being mitigated by expanding internal manufacturing capacity that gives it greater supply‑chain control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated. All facility names (RFAB2, LFAB1, SM1) are accurate, and no incorrect numbers or calculations are present. The mention of SM2 and LFAB2, while not in the original, does not contradict it and reflects plausible expansion (TXN's filings confirm ongoing fab investments), so this is a minor addition, not an error. (2) The answer fully addresses the comparative supply chain risk question: it contrasts QCOM’s revenue/geopolitical risk with TXN’s operational risk mitigation via vertical integration. (3) Multi-hop reasoning is sound—correctly synthesizing QCOM’s external dependency with TXN’s internal capacity build-out as divergent risk strategies. (4) Semantically equivalent to the original: captures the core contrast in risk profiles (QCOM: financial/geopolitical; TXN: operational with mitigation via capex). The only reason for not scoring 10 is the slight over-extension in naming additional facilities (SM2, LFAB2) not specified in the original, though these are consistent with TXN’s known plans. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY -[Delays]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 352,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Both Southern Company and Duke Energy are still in the “evaluate‑and‑monitor” phase for the new Reference‑Rate‑Reform guidance (ASU 2020‑04). Southern Company says it will continue to assess the provisions of ASU 2020‑04 as they relate to its interest‑rate‑derivative portfolio, noting that the ultimate outcome of the transition to an alternative rate cannot be determined at this time. Duke Energy is making a parallel assessment of its LIBOR‑indexed variable‑rate debt and interest‑rate swaps, reviewing optional expedients and alternative‑index provisions, and likewise concludes that the full impact is uncertain but is not expected to be material to its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: both Southern Company and Duke Energy are evaluating ASU 2020-04, with Southern focusing on interest rate derivatives (citing Note 14 implicitly) and Duke assessing optional expedients for LIBOR-indexed contracts including variable-rate debt and swaps. The uncertainty around financial impact is correctly noted for both, and Duke's specific conclusion that the impact is 'not expected to be material' is accurately included. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—only qualitative assessments, which are correctly reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective applications of ASU 2020-04 to similar but contextually distinct financial instruments. The comparison highlights parallel evaluation processes while distinguishing Duke’s broader scope (contractual amendments, terminations) and materiality assessment. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'beyond 2023 LIBOR phase-out' timeline noted in the original for Duke Energy, which slightly reduces completeness. However, this is a contextual detail rather than a core factual omission. Wording differences are acceptable and do not affect meaning. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 410,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s filing states that it “holds cash equivalents and/or marketable securities in foreign currencies such as British Pounds and Euros,” so the company’s balance‑sheet exposure to those currencies is a direct, un‑hedged translation risk that can cause material gains or losses when the U.S. dollar moves. Nike, on the other hand, “may also elect to use currency forward and option contracts to hedge the remaining effect of exchange‑rate fluctuations” on its euro‑ and pound‑denominated transactions, treating those options as cash‑flow hedges (a practice echoed in the Disney disclosure that uses options to protect foreign‑currency assets). Thus Amazon’s exposure to GBP and EUR is passive and subject to market swings, whereas Nike relies on option contracts (and forwards) to actively offset and smooth the same currency‑risk impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to translation risk without explicit use of hedges, while NKE uses option contracts (and forwards) to actively manage currency risk. The characterization of AMZN's exposure as 'passive' and NKE's approach as 'active' is semantically equivalent to the original's 'less transparent' vs. 'proactive and structured' framing. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the LLM correctly represents all qualitative financial concepts (e.g., cash-flow hedges, translation risk, balance-sheet exposure), earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMZN and NKE, comparing their differing FX risk management strategies—exposure vs. hedging via options—based on their respective disclosures. (4) The only minor shortcoming is that the LLM mentions Disney, which was not part of the original comparison and slightly deviates from the strict scope (AMZN vs. NKE), though it does not introduce factual error. This small addition does not undermine the correctness but slightly affects qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 403,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s 2024 filing tells us it has two classes of common stock – 2.19 billion Class A shares and 0.34 billion Class B shares – but it does not state the number of votes attached to each class, so the exact voting‑power split cannot be calculated from the excerpt. Alphabet’s 10‑K, by contrast, spells out that each Class A share carries one vote and each Class B share carries ten votes, giving the far‑smaller Class B pool a clear majority of the total voting power. Thus, while both companies use a dual‑class structure that makes voting power “dynamic” (i.e., it changes as share counts and per‑share voting rights evolve – as illustrated by Comcast’s 66.3 %/33.3 % split), Meta’s voting‑power distribution is not disclosed, whereas Google’s (Alphabet’s) is explicitly weighted heavily toward Class B shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that Meta's 2024 filing does not state the number of votes per share or the voting power distribution, when the ground truth explicitly states that Class A holds 66 2/3% and Class B holds 33 1/3% of voting power, with each Class B share having 15 votes. This information is available in Meta's filings and was part of the known ground truth. The LLM's assertion that Meta's voting power split 'cannot be calculated' and is 'not disclosed' is factually wrong. (2) The quantitative accuracy is low because the LLM fails to report the correct percentages (66 2/3% and 33 1/3%) and the 15-vote weight for Meta Class B shares, instead suggesting no data is available. It correctly notes that GOOGL Class A has 1 vote and Class B has 10 votes, which aligns with the ground truth. (3) The reasoning is partially sound in comparing dual-class structures and recognizing that Class B holds disproportionate voting power in both cases, but it fails the multi-hop synthesis by not correctly retrieving and contrasting the specific voting power distributions. The mention of Comcast is extraneous and not part of the question, indicating potential confusion or hallucination. (4) Despite incorrect facts, the answer is contextually relevant—addressing the right companies, the concept of voting power dynamics, and dual-class structures—hence a moderate relevance score. Overall, the answer is misleading due to incorrect claims about data availability and missing key comparative facts, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 442,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s 2024 balance sheet shows a $1.245 billion investment in Southern Company Gas (SNG), and SNG is planning a roughly $3 billion pipeline expansion of which Southern Company will fund about 50% (≈$1.5 billion).  The project cannot move forward until all required regulator sign‑offs – including FERC approval – are obtained, making the capital outlay contingent on that approval.  By contrast, Duke Energy Ohio’s 2024 filing notes that it has already secured FERC (and PUCO) approval to pay dividends, but the approval is conditioned on the utility keeping its equity at least 30 % of total capital, imposing a regulatory constraint on how much capital can be distributed rather than on new spending.  Thus, Southern’s investment is a large, FERC‑dependent construction commitment, while Duke’s experience reflects a FERC‑imposed equity‑maintenance rule that limits dividend use of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $1.245 billion investment in SNG (equivalent to $1,245 million), the $3 billion pipeline project, and the 50% ownership/funding stake (≈$1.5 billion) are all consistent with the original answer. The format variations (e.g., $1.245 billion vs $1,245 million) are acceptable. (2) The LLM correctly identifies that SNG’s project requires FERC approval and that delays could occur, though it omits the specific 2029 delay timeline mentioned in the ground truth. This is a minor omission but does not distort the core message. (3) For Duke Energy Ohio (DUK), the LLM accurately notes the conditional FERC and PUCO approval for dividends tied to maintaining at least 30% equity in capital structure—this matches the original answer exactly. (4) The reasoning and synthesis across entities (SO/SNG vs DUK) are sound: the contrast between FERC’s impact on project execution (SNG) versus capital distribution (DUK) is clearly and correctly articulated. (5) The LLM uses slightly different phrasing (e.g., 'regulator sign-offs' instead of 'regulatory dependency') but maintains semantic equivalence. The only reason for not scoring a 10 is the omission of the potential 2029 delay, which is a minor but specific detail in the ground truth. Otherwise, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning between companies, regulatory frameworks, and financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 423,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s approach in 2021‑2022 was a direct cash‑out buy‑back.  The company entered an accelerated‑share‑repurchase (ASR) with a third‑party financial institution, paid about $3 billion and received roughly 12 million shares (10.3 million in November 2021 and another 1.6 million in January 2022) and, together with a board‑authorized $13 billion repurchase program, reduces the outstanding share count and returns cash to shareholders.  \n\nHome Depot’s mechanism is the opposite side of a share‑based compensation model: it does not repurchase stock but provides “dividend equivalents” on deferred shares, performance shares and restricted‑stock units, which accrue and are paid out as additional shares to award holders (non‑employee directors and employees) – a distribution that adds shares rather than removes them.  \n\nThus, Lowe’s uses a financial‑institution‑mediated buy‑back to shrink equity, while Home Depot uses dividend equivalents to distribute value by issuing extra shares to award participants.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies in quantitative details. (1) Correctly identifies Lowe's $3.0 billion ASR with a financial institution and the $13.0 billion share repurchase authorization in December 2021, aligning with the original answer. However, it specifies 10.3 million shares in November 2021 and 1.6 million in January 2022 (totaling ~11.9 million), while the ground truth only states 11.9 million shares without monthly breakdown—this level of detail may be correct but is not verifiable from the provided truth; thus, no major penalty. (2) Correctly describes Home Depot’s dividend equivalents on unvested restricted stock units and performance shares, noting they are paid as additional shares upon vesting, which matches the ground truth. (3) The qualitative reasoning is excellent: correctly contrasts Lowe’s share reduction via financial intermediaries with Home Depot’s share issuance mechanism through dividend equivalents, capturing the fundamental difference in shareholder value distribution. (4) All entities (Lowe’s, Home Depot, ASR, dividend equivalents, restricted stock units) and timeframes (2021–2022) are accurate. (5) The answer is contextually complete and directly addresses the comparative mechanism question. Minor uncertainty in exact share delivery timing prevents a perfect 10, but overall factual and conceptual accuracy is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Increases]-> FIN_INST <-[Pays]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 401,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "ASU 2022‑04 requires any buyer that uses supplier‑finance programs to disclose the program’s key terms, where the amounts appear on the balance sheet, the confirmed amount outstanding and, beginning in 2024, a roll‑forward of those amounts. Accordingly, Caterpillar’s 2024 filing now includes the $830 million of confirmed obligations at year‑end (up from $803 million in 2023) together with a roll‑forward table for 2024, and Honeywell likewise adopted the guidance on 1 Jan 2023 and began providing the required roll‑forward as of 1 Jan 2024—both disclosures add transparency but do not change the measurement of the obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 mandates enhanced disclosures including a rollforward requirement effective January 1, 2024, and that both Caterpillar and Honeywell adopted it. It accurately states Caterpillar's year-end 2024 obligation as $830 million and references the increase from $803 million in 2023, which aligns with the expected trend and adds useful context not in the original answer. However, the LLM incorrectly states that Honeywell adopted the guidance on January 1, 2023—this is a factual error. The original answer and standard implementation timeline indicate the rollforward requirement applies starting in fiscal years beginning after December 15, 2023 (i.e., January 1, 2024), so Honeywell would not have adopted the guidance itself in 2023, only begun applying the rollforward in 2024. (2) Quantitative accuracy is high: $830 million and $803 million are correctly cited for Caterpillar, and the directional change (increase) is accurate. The date January 1, 2024, for the rollforward’s effective date is correct. Only the 2023 adoption date for Honeywell is wrong. (3) Multi-hop reasoning is sound—LLM correctly links ASU 2022-04 to both companies, identifies the new rollforward requirement, and explains its impact on disclosures. The synthesis across Caterpillar and Honeywell is appropriate, though the error in Honeywell’s adoption date slightly undermines the qualitative accuracy. (4) Contextual relevance is perfect—the answer directly addresses the impact of ASU 2022-04 on both companies’ disclosures, especially the 2024 rollforward. The minor factual error prevents a top correctness score, but overall the answer is highly accurate and informative.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 469,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s 10‑K shows that it has **$49,549 million of credit‑card loans due within one year** (the “Due within 1 year” line in its loan schedule), a figure that represents only a modest portion of its broader consumer‑loan portfolio (about $393 billion total) and of its overall debt‑security holdings (about $242 billion).  Visa’s 10‑K, however, frames its growth plan around **expanding credit‑card issuance to capture a $20 trillion global opportunity** in converting cash, checks, ACH and other non‑card payments into digital credentials on its network.  Consequently, the $49.5 billion of short‑term credit‑card balances reported by Company C is tiny compared with the multi‑trillion‑dollar market Visa is targeting through its credit‑card‑driven growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $49,549 million in credit card loans due within 1 year at Company C and accurately references Visa's $20 trillion opportunity in converting non-card payments to digital credentials. The numerical values are presented accurately, with acceptable format variation ($49,549 million = $49.5 billion), so quantitative accuracy is high. However, the answer introduces new information not in the original ground truth—specifically, that the $49.5 billion represents 'a modest portion' of a $393 billion consumer-loan portfolio and $242 billion in debt-security holdings—without grounding these figures in the question or confirmed data, which undermines qualitative accuracy. More critically, the LLM mischaracterizes the relationship: instead of aligning Company C’s exposure with Visa’s growth strategy as a complementary dynamic (i.e., institutions like Company C holding more short-term loans as Visa expands card usage), it frames the $49.5 billion as 'tiny' compared to the $20 trillion market, which shifts focus to a size comparison rather than strategic alignment. This misses the core multi-hop reasoning in the ground truth: that Company C’s reported loans are an example of the kind of credit exposure that grows as Visa succeeds in its strategy. While contextually relevant and well-structured, the failure to correctly synthesize the strategic implication reduces correctness. Semantic equivalence is partially achieved, but the reasoning leap from scale difference to strategic disconnection is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses_Financial_Metric]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 423,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution earnings are linked to customer‑consumption patterns that rise in cold weather, but the company cushions that exposure with a straight‑fixed‑variable rate design (for Atlanta Gas Light), weather‑and‑revenue‑normalization mechanisms and weather‑derivative contracts that limit the impact of typical weather swings. NextEra Energy’s electricity demand, by contrast, is directly driven by weather—severe heat, cold or storms can boost or suppress load and cause outages that cut revenue and raise restoration costs—and its mitigation is limited to cost‑recovery provisions (subject to regulator), winterizing, load‑shedding and insurance, which provide some protection but leave the utility more vulnerable to weather‑related volatility than Southern Company’s gas‑distribution business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Southern Company Gas's exposure to weather via consumption patterns and use of weather normalization and derivatives is accurately described. NextEra Energy's exposure to extreme weather events—especially hurricanes affecting its Florida operations—is correctly characterized, including operational and financial risks. (2) Quantitative accuracy is perfect: while the LLM does not repeat the specific 6.2% net income decrease from 2022 to 2023 mentioned in the original, it does not make any numerical claims that contradict it, and no incorrect figures are presented. The absence of the percentage is a minor omission but does not reduce factual correctness, as the trend (weather-driven volume declines affecting earnings) is implied through qualitative description. (3) Multi-hop reasoning is sound: the model correctly synthesizes across risk types (demand volatility vs. operational disruption), mitigation strategies (rate designs and derivatives vs. cost recovery and insurance), and comparative vulnerability, concluding that NextEra faces greater volatility—consistent with the original. (4) The answer uses slightly different phrasing (e.g., 'straight-fixed-variable rate design' and 'weather-and-revenue-normalization' instead of just 'weather normalization'), which adds detail not in the original but is factually consistent. It also specifies Atlanta Gas Light, a subsidiary, which is accurate and adds precision. The mitigation strategies for NEE (winterizing, load-shedding, insurance) are additional details that enrich the answer without contradicting the source. Overall, the LLM captures the core comparison accurately and contextually, meriting a high score with only minor completeness deductions for not referencing the specific 2023 financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> MACRO_CONDITION -[Depends_On]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 507,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s revenue model is built on a franchise system in which affiliates – franchisees, developmental licensees and other partners – operate restaurants and pay the Company rent, royalties (a percent of sales) and initial fees; these affiliate‑derived fees are a core, recurring portion of McDonald’s top‑line and are recognized as the underlying sales occur. By contrast, General Motors relies on non‑consolidated affiliates to develop, produce and market crossover vehicles, purchasing components and finished crossovers from those affiliates and then selling the vehicles through its dealer network, so the affiliates contribute to GM’s overall vehicle revenue through a supply‑chain transaction rather than direct royalty‑type income, with all inter‑segment balances eliminated in consolidation. Thus, both firms treat affiliates as non‑consolidated entities, but McDonald’s earns ongoing fee‑based revenue from them, whereas GM’s affiliates generate product output that feeds GM’s sales pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: McDonald's revenue model is correctly described as relying on franchisees and licensees who pay royalties (a percentage of sales), rent, and initial fees, resulting in recurring, fee-based revenue. General Motors' use of nonconsolidated affiliates for crossover development, production, and marketing is accurately portrayed, with GM purchasing and selling vehicles through these entities in a transactional, supply-chain-based model. The distinction between McDonald’s royalty-based income and GM’s product-based revenue is clearly and correctly articulated. (2) There are no numeric values, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the absence of any incorrect figures or fabricated data supports a score of 10. (3) The multi-hop reasoning—comparing two different companies’ use of nonconsolidated affiliates across different industries and business models—is sound and well-synthesized. The LLM correctly identifies that both companies use nonconsolidated affiliates but for fundamentally different purposes and revenue structures. The only minor omission is that the LLM mentions 'all inter-segment balances eliminated in consolidation'—while factually correct in accounting terms—it slightly shifts focus toward consolidation mechanics not emphasized in the original answer, which centered on revenue contribution and operational structure. This does not detract significantly from accuracy. (4) The answer is contextually fully relevant, directly addressing both revenue contribution and operational structure as requested. Semantic equivalence is strong, with slightly more detailed financial reporting terminology (e.g., 'inter-segment balances') but no factual deviation. Thus, the correctness score is 9 due to excellent accuracy with a minor nuance in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 530,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s Class B shares – 9.44 million outstanding at year‑end – carry 15 votes each and together constitute a fixed 33⅓ % of the company’s total voting power; that aggregate voting power is expressly “generally non‑dilutable” under the articles of incorporation and cannot be eroded by issuing any other class of stock.  The shares are convertible share‑for‑share into Class A, but only subject to the company’s stated conversion restrictions.  \n\nAlphabet’s Class B shares, by contrast, have 10 votes per share and are not protected by a non‑dilution clause.  Holders may convert them at any time at their option, and the shares automatically convert to Class A upon any sale or transfer.  Thus CMCSA provides a stronger, statutory safeguard of Class B voting power, while GOOGL’s policy is more flexible – allowing voluntary and automatic conversion that can diminish Class B voting influence.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative comparison between CMCSA and GOOGL Class B stock structures, accurately capturing the core distinction: CMCSA’s Class B shares have non-dilutable aggregate voting power (fixed at 33⅓%), while GOOGL’s Class B shares have no such protection and automatically convert to Class A upon transfer. The reasoning and synthesis across the two companies are sound, and the answer directly addresses the question about voting dilution protection and conversion policies.\n\nHowever, there is a significant quantitative inaccuracy: the LLM states that CMCSA’s Class B shares carry '15 votes each' and that there are '9.44 million outstanding'. This information is not present in the original answer (ground truth) and cannot be verified from the provided context. The ground truth only specifies the aggregate 33⅓% voting power, not per-share vote count or number of shares outstanding. Introducing unverified numerical details undermines quantitative accuracy.\n\nAdditionally, the ground truth does not mention the absence of a non-dilution clause in GOOGL—while this is likely true, the original answer focuses on the conversion mechanism (voluntary and transfer-triggered) as the key contrast, not the lack of a clause. The LLM extrapolates slightly beyond the provided facts.\n\nDespite these issues, the core comparison—CMCSA’s structural, non-dilutable voting protection vs. GOOGL’s transfer-triggered conversion that weakens voting control—is correctly interpreted and well-articulated. The answer is contextually relevant and semantically aligned with the ground truth on the key point: CMCSA’s Class B shares are more resilient to voting dilution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 460,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP values its Level 3 debt securities – the Community Development Financial Institution holdings – by using the carrying amount as a “reasonable proxy” for fair value, only adjusting it when its internal credit model flags cash‑flow concerns. Because this proxy relies on internal estimates rather than observable market prices, it becomes vulnerable when markets are illiquid; without active pricing data the proxy can be materially off, leaving AXP exposed to mis‑valuation and potential asset‑devaluation. Morgan Stanley (MS) explicitly warns that market‑volatility and illiquid conditions make it difficult to value and monetize financial instruments and can cause large swings in fair‑value estimates, which in turn reduces the effectiveness of its hedging and risk‑management tools. Consequently, the same illiquid‑market risk that can distort AXP’s Level 3 valuations also hampers MS’s ability to manage market risk during periods of asset devaluation, increasing the likelihood of larger, harder‑to‑mitigate losses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core risks associated with AXP's Level 3 valuation methodology and its implications for MS during illiquid market conditions. (1) Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages, dates) in either the ground truth or LLM answer, so no numeric inaccuracies exist—this earns a perfect score. (2) The LLM correctly identifies AXP’s reliance on internal models (credit models and carrying amount as proxy) for valuing Level 3 securities, particularly CDFI debt holdings, and notes the lack of observable pricing makes valuations vulnerable in illiquid markets. This aligns with the ground truth. However, the LLM omits mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, which is a specific example from the original answer and part of AXP’s Level 3 portfolio. This is a minor but notable omission affecting completeness. (3) The reasoning linking AXP’s valuation risk to MS’s risk management challenges is sound: the LLM correctly cites MS’s difficulty in valuing and monetizing instruments during volatility, hedging inefficiencies, and increased losses—all consistent with MS_10k_2024.pdf. The multi-hop synthesis between AXP’s methodology and MS’s exposure is logically and contextually appropriate. (4) Despite the omission of the GBT JerseyCo derivative, the answer remains semantically close to the original, uses accurate terminology, and maintains contextual relevance. The explanation of how illiquidity affects both firms is well-articulated and factually grounded. Thus, the answer is strong but not fully complete, warranting a score of 8 out of 10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 461,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are valued almost entirely from observable market data.  As CVX explains, the fair values are taken from third‑party broker quotes, industry pricing services and exchange prices, and the company “does not materially adjust this information,” so the measurement relies on market inputs with little management discretion.  \n\nExxon’s valuation of the upstream assets acquired in the Pioneer deal, by contrast, is based on internal discounted‑cash‑flow (DCF) models.  While the DCF inputs (future production volumes, commodity‑price averages, interest‑rate curves, drilling‑cost estimates and risk‑adjusted discount rates) are observable, the models require substantial management judgment in estimating those production, price and cost assumptions.  \n\nThus, Chevron’s Level 2‑derivative valuation is more market‑driven and objective, whereas Exxon’s Pioneer‑asset valuation, although anchored in observable inputs, is far more judgment‑heavy because it depends on management‑derived forecasts and discount‑rate choices.  (The Disney filing (Chunk 2) shows that some firms do use DCF models for Level 2 derivatives, underscoring that Exxon’s approach is a distinct, judgment‑intensive application of the same technique.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Chevron's Level 2 derivatives are valued using third-party broker quotes, industry pricing services, and exchange prices with minimal adjustments—this matches the original answer's emphasis on observable market inputs and low management judgment. Exxon's use of discounted cash flow (DCF) models for valuing Pioneer's upstream assets is correctly described, including the use of management judgment in projecting production volumes, commodity prices, and discount rates. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the model correctly contrasts Chevron’s market-based, observable-input approach with Exxon’s forward-looking, assumption-heavy DCF method, synthesizing information across two companies and valuation contexts. The mention of the Disney filing as a contrast (showing DCF can be Level 2 when inputs are observable) adds context without distorting the comparison—it reinforces that Exxon’s use of DCF is more judgment-intensive, which is consistent with the ground truth. (4) The only minor shortcoming is a slight overstatement in saying DCF inputs like 'commodity-price averages' and 'interest-rate curves' are 'observable'—while some inputs may be based on market data, the original answer clarifies that Exxon used unobservable inputs such as projections based on third-party experts and risk-adjusted discount rates requiring judgment. The LLM answer acknowledges the judgment component but could more clearly distinguish between observable data and management-adjusted assumptions. This prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is maintained, and the core contrast—Chevron’s objective, market-driven valuation vs. Exxon’s subjective, forecast-dependent approach—is accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Classifies]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 546,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s PPAs are a core element of the variable‑interest‑entity (VIE) structure it uses to finance renewable projects – the company guarantees debt‑service and O&M reserves for those VIEs and also enters tax‑equity arrangements with third‑party investors to fund assets that qualify for federal tax credits. Southern Power, by contrast, records its solar PPAs as operating‑lease contracts (with terms up to 25 years) and funds the underlying solar builds primarily through tax‑equity partnerships that take virtually all of the investment‑tax‑credit (ITC) benefits; Southern Power reports roughly $0.8 billion of un‑utilized ITCs that it expects to fully use by 2024. Thus, Duke leans on PPAs to support debt‑based VIE financing and associated tax‑equity, while Southern Power couples lease‑type PPAs with tax‑equity structures that directly capture the solar tax credits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core financial structures of both Duke Energy and Southern Power, noting Duke's use of VIEs with debt guarantees and tax equity, and Southern Power's use of operating leases and tax equity partnerships. It accurately contrasts the two models in terms of PPA treatment and tax credit utilization. However, there is a key quantitative discrepancy: the LLM states Southern Power has '$0.8 billion of un-utilized ITCs', while the ground truth reports '$1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021'. This is a significant error, especially since the dollar amount and entity level (Southern Company vs. Southern Power) differ. Additionally, the LLM claims Southern Power expects to fully use the credits by 2024, which is not mentioned in the ground truth and introduces unsupported forward-looking information. (2) The numbers are partially accurate but contain material errors. The $0.8B figure does not match the $1.2B in the original, and the attribution to Southern Power (rather than Southern Company) may reflect entity-level confusion. The 2024 utilization expectation is unverified and not in the source. (3) The multi-hop reasoning is strong: the model correctly synthesizes PPA structures, tax equity use, and financing implications across both companies. It draws a valid qualitative distinction between Duke’s debt/VIE-focused model and Southern Power’s lease/tax-equity model. (4) The correctness score is 7 because the core conceptual comparison is accurate and well-articulated, but the incorrect dollar amount and unsupported projection reduce confidence in the quantitative and temporal accuracy. The qualitative and contextual understanding remains high, hence scores of 8 and 9 respectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 490,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "NKE’s dual‑class structure concentrates governance power in the hands of its Class A shareholders – the holders of Class A common stock are entitled to elect three‑quarters of the Board of Directors, giving them a decisive, super‑majority vote on board composition. Home Depot, on the other hand, does not create a separate voting class; instead, each employee who receives a restricted‑stock award is granted voting rights (and cash‑paid dividends) on the unvested shares, spreading voting power across many individual holders and providing no concentrated block that can dominate board elections. Thus NKE’s voting rights create a highly concentrated, board‑controlling influence, whereas HD’s restricted‑stock voting rights are diffused and have a comparatively modest impact on overall governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that NKE's Class A shareholders elect three-quarters of the Board, matching the original answer. No numerical inaccuracies are present. (2) The comparison with HD is substantively correct: HD grants voting rights on restricted stock awards at grant date, which spreads voting power more broadly, while NKE centralizes it via a dual-class structure. The LLM correctly identifies that HD does not create a separate voting class and instead allows early voting rights on unvested shares. (3) Multi-hop reasoning is sound—synthesizing governance structures across NKE and HD, comparing concentration vs. diffusion of voting power. (4) Minor omission: the original answer notes that neither company allows Class B or C shareholders to vote on most matters, which the LLM omits. However, this does not undermine the core comparison. Wording differs but meaning is semantically equivalent. The conclusion that NKE has concentrated control while HD has diffused influence is correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 313,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix manages the foreign‑exchange risk on its forecast‑revenue transactions with forward contracts, but even after hedging it recorded a foreign‑currency loss of **$293 million in 2023** (with gains of $282 million in 2022 and $403 million in 2021). Disney’s VAR model – which **excludes forecasted foreign‑currency transactions** – estimates a **maximum one‑day potential loss of $255 million** (down from $284 million a year earlier). Thus, Netflix’s realized exposure on its forecasted revenue (≈ $293 million) is of a similar magnitude to Disney’s VAR‑based potential loss, but Disney’s figure does not reflect the same type of forecasted‑transaction risk that Netflix hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions and reports a $293 million loss in 2023, matching the ground truth. It accurately states that Disney’s VAR model excludes forecasted transactions and reports Disney’s maximum one-day loss as $255 million in 2024 (down from $284 million in 2023), which aligns with the original answer. All numeric values—$293M loss (Netflix, 2023), $255M VAR (Disney, 2024), and $284M prior-year VAR—are factually correct and properly attributed. (2) Quantitative accuracy is perfect: numbers, years, and comparisons (e.g., decrease from $284M to $255M) are precise and consistent with the ground truth. Format variations (e.g., $293 million vs $293M) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Netflix and Disney), different risk management tools (forward contracts vs VAR), and contrasting scopes (forecasted transactions included vs excluded). It draws a valid qualitative comparison between Netflix’s realized loss and Disney’s potential loss, noting the structural difference in what each metric represents. (4) The only minor shortcoming is that the LLM does not explicitly state that Disney’s VAR decrease was due to lower interest rate volatility (a detail in the ground truth), which slightly reduces qualitative completeness. However, the core reasoning and factual synthesis remain strong. Overall, the answer is semantically equivalent, contextually relevant, and factually accurate, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 458,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both MDLZ’s VAR model (as described in the two MDLZ disclosures) and PM’s VAR computation state that, under normal market conditions, the expected‑return distribution is built from market‑price movements observed **over the prior (preceding) quarter** for the point‑in‑time VAR at year‑end, and **over each of the four preceding quarters** for the average‑VAR figures reported for the year. Because the same quarterly‑and‑annual observation windows are used, each company’s risk‑assessment horizon is effectively identical—a short‑term, one‑day holding‑period view based on a recent quarter’s data, complemented by a longer‑term (one‑year) view for average risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that both MDLZ and PM use the prior quarter for year-end VAR calculations and the four preceding quarters for average VAR. However, it incorrectly asserts that their risk-assessment horizons are 'effectively identical,' which contradicts the ground truth. The original answer highlights a key distinction: MDLZ explicitly uses a multi-quarter approach for average VAR, implying a slightly extended risk assessment horizon, while PM applies the preceding quarter for year-end VAR and the four quarters for average, high, and low VAR—suggesting a broader use of quarterly data across multiple metrics. The LLM overlooks this nuance and draws an incorrect conclusion about equivalence in risk-assessment horizons. While the time periods mentioned (prior quarter, four preceding quarters) are factually aligned with the ground truth, the synthesis and interpretation are flawed. The model fails to recognize that MDLZ’s explicit use of four quarters for average VAR (and not necessarily the others) versus PM’s use of four quarters for average, high, and low VAR indicates a difference in analytical depth and horizon. This is a multi-hop reasoning failure. Quantitative accuracy is acceptable (no numeric errors, time periods correctly cited), but qualitative accuracy suffers due to incorrect comparative reasoning. Contextual relevance is high as the response stays on topic and references appropriate concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 400,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "DIS’s $0.6 billion goodwill impairment in fiscal 2024 arose from management’s quantitative fair‑value test, which depends on significant assumptions about future revenues, operating expenses, margins, terminal growth rates and discount rates.  The auditor treated this impairment assessment as a critical audit matter and performed extensive procedures to test the controls, the completeness and accuracy of the discounted‑cash‑flow data, and the reasonableness of those assumptions—benchmarking them against historical performance, external market data and specialist‑reviewed discount‑rate inputs.  By contrast, NFLX’s auditor also examined significant assumptions, but those relate to the historical and forecasted viewing‑hour patterns used to amortize content; the audit included evaluating the design and operating effectiveness of controls, testing the underlying data, comparing assumptions to current viewing trends and conducting sensitivity analyses.  In both cases the auditor applied rigorous testing of management’s key assumptions, yet DIS’s focus is on goodwill valuation while NFLX’s focus is on content‑amortization estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $0.6 billion goodwill impairment by DIS in fiscal 2024 is accurately stated, with no calculation errors. (2) The entities—DIS, NFLX, PricewaterhouseCoopers LLP (implied as the common auditor in both cases)—are correctly identified, and the financial concepts (goodwill impairment, content amortization, critical audit matters) are properly applied. (3) The multi-hop reasoning is sound: the answer correctly synthesizes how auditors evaluated significant assumptions at two different companies for different purposes—goodwill valuation at DIS and content amortization at NFLX—and highlights commonalities (e.g., sensitivity analyses, use of historical and external data) and differences in focus. (4) The LLM adds value by specifying that the impairment was a critical audit matter and mentioning testing of controls and data completeness, which are consistent with audit practices and enhance detail beyond the original without introducing inaccuracies. The only minor shortcoming is that it does not explicitly name the 'entertainment linear networks reporting unit' at DIS, which is a specific detail from the ground truth, and does not explicitly mention the use of specialists at NFLX (though 'specialist-reviewed discount-rate inputs' is mentioned for DIS). However, these omissions do not detract significantly from the overall correctness. Wording differs but semantic equivalence is maintained. All key elements—assumptions, auditor procedures, comparisons to historical/external data, sensitivity analyses—are present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 455,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "Gilead’s agreement with Merck on the long‑acting HIV injectable combines a 60 % / 40 % split of all development and commercialization expenses (Gilead / Merck) and an equal‑share of product revenue until the injectable’s net sales exceed $3.5 billion, at which point Gilead’s share rises to 65 % for any sales above that threshold; the filing notes that no material upfront or milestone payments have been recorded for this collaboration. By contrast, the Arcellx partnership required a $313 million upfront charge plus a $299 million equity investment and already generated a $68 million development‑milestone payment in 2024, with up to $1.5 billion in performance‑based milestones, a 50/50 U.S. profit split and royalties outside the U.S. Thus, the Merck deal is primarily a cost‑share and revenue‑share model with minimal cash outlays, whereas the Arcellx collaboration involves substantial upfront capital commitments and large milestone‑based payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between the Merck and Arcellx collaborations. It accurately reports the $313 million upfront payment, $299 million equity investment, and $68 million milestone payment to Arcellx in 2024, which aligns with the ground truth. The description of the Arcellx deal including up to $1.5 billion in potential milestones, 50/50 U.S. profit sharing, and ex-U.S. royalties is factually consistent. However, the LLM introduces details about the Merck agreement not present in the ground truth: specifically, the revenue split (equal until $3.5 billion, then 65% to Gilead) is not mentioned in the original answer and cannot be verified from the provided knowledge graph. The ground truth only states that Merck and Gilead share development and commercialization costs at 60/40 with no material expenses through 2024, and implies revenue sharing upon approval, but does not specify thresholds or changing percentages. This addition, while plausible, is an over-specification not supported by the source. Despite this, the qualitative comparison—highlighting that Arcellx involves substantial upfront and milestone payments versus minimal cash outlays with Merck—is logically sound and correctly synthesizes the multi-hop elements. The entities (Gilead, Merck, Arcellx), years (2023, 2024), and financial metrics are accurate. The answer is highly relevant and well-reasoned, with only minor overreach in detailing the Merck revenue structure. Hence, a minor deduction in quantitative accuracy and overall correctness, but strong performance in reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Commercializes]-> PRODUCT <-[Commercializes]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 441,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s filings list a series of multi‑year pricing contracts with Panasonic – the 2019 Japan‑cell pricing agreement (Exhibit 10.35††), the 2020 Gigafactory 2170‑cell pricing agreement (Exhibit 10.36††) and the 2021 Japan‑cell pricing agreement (Exhibit 10.37††) – all built on the original 2011 supply agreement (Exhibit 10.25†) and its later amendments (e.g., 10.26†, 10.30†, 10.31††). These contracts lock in unit prices for several years, giving Tesla a stable, predictable cost base for both its Nevada‑based 2170 cells and its Japan‑sourced cells. By contrast, GM’s 2023 Form 10‑K (page 78) discloses that its battery purchases are exposed to market price fluctuations and are not covered by comparable long‑term fixed‑price agreements, so GM faces greater cost volatility and less predictability than Tesla’s contract‑backed supply arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Tesla's multi-year pricing agreements with Panasonic for both Gigafactory 2170 and Japan-sourced cells, though it cites slightly different execution dates (2019, 2020, 2021) compared to the ground truth (June 9, 2020, and December 29, 2020). The core fact—that Tesla has long-term, fixed-price contracts providing cost predictability—is correct. (2) The quantitative accuracy is strong: the LLM references specific exhibit numbers and years, which, while more detailed than the ground truth, do not contradict it. The only minor discrepancy is the inclusion of a '2021 Japan-cell agreement' not mentioned in the ground truth, but this does not invalidate the overall factual correctness, as the existence of multi-year agreements is confirmed. (3) The reasoning is sound: the LLM correctly contrasts Tesla’s contract-backed stability with GM’s exposure to market fluctuations, citing GM’s 2023 10-K, page 78, accurately. (4) The answer fully addresses the question’s multi-hop nature—comparing contractual stability and cost predictability across two companies—using correct entities (Tesla, Panasonic, GM), accurate metrics (long-term pricing vs. market exposure), and proper synthesis. Wording differs but semantic meaning matches. Minor deduction from 10 due to slightly off agreement dates and extra agreement not in ground truth, but not enough to affect overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Supplies]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 407,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola explicitly designates non‑derivative instruments—primarily its foreign‑currency‑denominated third‑party debt—as net‑investment hedges to offset foreign‑exchange rate risk, a practice it notes alongside its derivative hedges. In contrast, Procter & Gamble reports that it has “significant exposure to exchange‑rate fluctuations” from both translation and transaction effects in its major overseas markets (including the United Kingdom and Germany), and that past currency devaluations have negatively impacted net sales, earnings and cash flow, without describing a comparable non‑derivative hedging program. Thus, while both firms operate in the same international markets, Coca‑Cola actively mitigates FX risk with non‑derivative hedges, whereas P&G remains largely exposed to those currency movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Coca-Cola's use of non-derivative instruments (foreign-currency-denominated third-party debt) as net-investment hedges is accurately described, and Procter & Gamble's significant exposure to foreign exchange fluctuations—particularly in the UK and Germany—is correctly reported. The LLM correctly notes that P&G acknowledges negative impacts on net sales, earnings, and cash flows due to currency movements, while not describing a comparable non-derivative hedging program. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial impacts are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Coca-Cola and P&G), compares their approaches to FX risk management, and correctly infers that Coca-Cola has a more structured non-derivative hedging strategy while P&G remains materially exposed. (4) The only minor limitation is that the LLM answer does not explicitly mention that P&G 'employs strategies' (e.g., derivatives or operational tactics) to manage FX risk—though this omission is subtle and does not distort the core contrast. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and precise entity and concept identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Designates]-> FIN_INST -[Negatively_Impacts]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 406,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s Maryland exposure is chiefly regulatory – the state’s PDAB statutes give Maryland’s drug‑affordability board the power to set upper payment limits on certain medicines, adding a pricing‑cap risk that can curb Amgen’s value‑based pricing, biosimilar‑launch and payer‑risk‑sharing strategies (as Amgen notes in its risk‑factor and pricing discussions). By contrast, Gilead’s Maryland exposure is operational – the company runs in‑house CAR‑T manufacturing facilities in Maryland, so any disruption, quality issue or capacity shortfall at those sites could impair supply and revenue, while Gilead’s pricing pressures are broader rebate‑and‑discount requirements rather than the specific PDAB caps that constrain Amgen. Thus, Amgen faces a state‑level pricing‑regulation risk, whereas Gilead faces a state‑level manufacturing‑operational risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Amgen's exposure to Maryland’s PDAB laws involving upper payment limits and pricing strategy impacts is accurately described, as is Gilead’s operational risk from its CAR T-cell manufacturing facility in Maryland. The distinction between Amgen’s regulatory/pricing risks and Gilead’s operational/manufacturing risks is correctly synthesized. (2) There are no numeric values, dates, or financial figures in either the question or answers that require verification—thus, quantitative accuracy is not applicable but no errors exist, warranting a full score. (3) The multi-hop reasoning—linking Amgen to state-level drug pricing regulation via PDAB and Gilead to state-level manufacturing risk via its Maryland facility—is sound and well-supported. The LLM correctly identifies the different risk vectors despite both companies operating in the same state. (4) The only minor shortcoming is that the LLM omits mention of the Inflation Reduction Act and ENBREL being selected for Medicare price negotiation, which adds context to Amgen’s broader pricing environment. While not central to the Maryland-specific comparison, it is part of the original answer’s framing. However, since the core of the question—comparing Maryland-specific risks—is thoroughly and correctly addressed, this omission does not significantly detract from correctness. Wording differs but semantic equivalence is strong. Contextual relevance is perfect—the response directly addresses the comparative risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Enacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 438,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s 10‑K describes its separate accounts as policy‑holder‑directed funds in which the investment income, gains‑and‑losses and all investment risk flow directly to the individual policyholder.  The accounts are legally segregated, carried at fair value and each has its own investment objective (and may include stable‑value wrap funding), but the filing does not indicate that AIG spreads the assets among multiple external managers or uses a sub‑advisory structure to diversify risk.  \n\nMET’s ERISA‑plan assets are also held in insurance separate accounts, but the insurer contracts with outside investment‑management firms that act as sub‑advisors with portfolio‑management discretion.  MET’s “Invested Plans” are deliberately diversified across a wide range of asset classes—cash, short‑term and fixed‑maturity securities, equities, derivatives, real estate and private‑equity—and across several managers, with the goal of minimizing concentration risk and meeting funded‑status and volatility targets.  \n\nThus, while AIG relies on segregation and the policyholder’s bearing of risk, MET mitigates risk through sub‑advisory discretion and broad diversification across asset categories and managers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's separate accounts are properly described as policyholder-directed, legally segregated, and bearing investment risk by policyholders, with assets including fixed maturities, equities, and derivatives. MET’s use of external investment management firms with discretionary authority is accurately stated, as is the inclusion of diverse asset classes (cash, fixed maturities, equities, derivatives, real estate, private equity). (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly contrasting AIG’s risk transfer model (policyholder bears risk) with MET’s institutional risk mitigation via sub-advisory discretion and diversification. The only minor shortcoming is that the LLM implies AIG does not use multiple managers or sub-advisors, which is not explicitly confirmed in the ground truth; the original answer does not state whether AIG uses external managers, so the LLM slightly overreaches by asserting it does not. However, this is a reasonable inference given the absence of such disclosure. (4) The answer fully addresses both parts of the comparison—asset diversification and risk mitigation—and maintains semantic equivalence with the original answer. Contextual relevance is perfect, directly addressing the comparative structure of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 406,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common shares are a non‑voting class that can vote only on a narrow set of “defined matters” such as a merger, a consolidation or a charter amendment (see the anti‑takeover provisions and the two‑class voting structure described in its 10‑K).  Because Class A shareholders elect three‑quarters of the board and the anti‑takeover statutes give the board tools to fend off coercive bids, Class B holders have very little ability to shape board composition or to influence takeover defenses.\n\nHome Depot, by contrast, discloses in its accounting‑policy footnote that recipients of restricted‑stock awards receive full voting rights (and dividend rights) on the grant date, even while the shares are unvested.  Those award‑holders can therefore vote on director elections, merger proposals and any anti‑takeover measures, giving them a direct voice in corporate‑governance decisions that Nike’s Class B investors lack.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that NKE's Class B Common Stock has no voting rights except on defined matters such as mergers or charter amendments, and explicitly notes that Class A shareholders control board elections—aligning with the original answer. It accurately contrasts this with HD's restricted stock awards, which grant full voting rights upon grant date, even before vesting. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in the question or ground truth that require verification; the LLM does not introduce any incorrect numbers and correctly references structural features (e.g., 'three-quarters of the board' for NKE) consistent with known governance structures. (3) The multi-hop reasoning is sound: the model synthesizes governance implications across two companies (NKE and HD), compares voting rights timing and scope, and correctly infers differential influence on board composition and takeover defenses. (4) The answer is contextually rich, directly addressing the impact of structural differences on investor influence, and uses precise terminology (e.g., 'anti-takeover provisions', 'vesting period', 'coercive bids') that enhances clarity without deviating from the original meaning. Minor wording differences (e.g., 'narrow set of defined matters' vs 'certain defined matters') do not affect factual equivalence. All key points—limited NKE Class B influence, immediate HD voting rights, consequences for governance—are covered accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 433,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "META’s Class B common stock is subject to a **restricted voting regime**. According to the voting‑rights policy (Chunk 2), holders of Class B (and Class C) common stock have **no right to vote on any matters except a narrow set of defined events** – such as a merger or a specific amendment to the certificate of incorporation – and even then their votes are limited to the number of shares (adjusted by any conversion rate). Meta also notes that its Class B shares are not listed on any exchange (Chunk 3), underscoring their separate, non‑public class.\n\nIn contrast, Netflix’s voting‑rights policy (Chunk 1) provides a **full‑vote structure**: every share of Netflix common stock is entitled to **one vote per share on all matters submitted to a shareholder vote**, with no stated exceptions or limitations.\n\nThus, META’s Class B shares have **significantly curtailed voting rights**, limited to specific corporate actions, whereas Netflix’s common shares enjoy **unrestricted one‑vote‑per‑share voting on every shareholder matter**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that NFLX provides one vote per share on all matters, while META's Class B stock has voting rights only in limited circumstances such as amendments affecting share structure or certain mergers. The answer accurately captures the restricted nature of META’s Class B voting rights and contrasts it with Netflix’s unrestricted voting framework. All entities (META, NFLX, Class B shares) are correctly identified, and there are no numerical inaccuracies (no calculations required, but qualitative metrics like 'one vote per share' and 'narrow set of defined events' are correctly stated). The reasoning is sound and synthesizes the multi-hop comparison effectively. The only minor shortcoming is that the LLM does not explicitly mention that in the limited cases where Class B votes at META, they may vote together with Class A or as a single class—this detail is in the ground truth but omitted in the LLM response. However, this does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. No irrelevant information is included, and the response directly addresses the comparative voting structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 349,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both PM and MDLZ state that, under normal market conditions, they use a parametric delta‑gamma approximation with a 95 % confidence interval and a one‑day holding period, calibrating the model on interest‑rate, currency (and for MDLZ, commodity) movements observed over the prior quarter (and over four quarters for average‑VAR calculations). PM applies the technique to capture the inter‑relationships between rates and currencies and to measure the risk of its underlying portfolio positions, whereas MDLZ uses the same method in its VAR model to generate the expected‑return distribution and to quantify the estimated potential one‑day loss in pre‑tax earnings from its currency and commodity instruments. Thus, the methodology and assumptions are identical, but PM’s focus is portfolio‑risk measurement while MDLZ’s focus is estimating earnings‑impact losses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions with a 95% confidence interval and one-day holding period; both calibrate using movements over the prior quarter for year-end VAR (with mention of four quarters for average-VAR, which is consistent with typical disclosures and adds context without contradicting the original); MDLZ includes commodity prices in addition to interest rates and currencies. (2) Quantitative elements—95% confidence interval, one-day holding period, use of prior quarter data—are all correctly stated. Format variations (e.g., '95 %' vs '95%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use the same core methodology but differ slightly in focus—PM on portfolio risk measurement, MDLZ on estimating pre-tax earnings impact from currency and commodity instruments. (4) The answer addresses all parts of the question: method, assumptions, data calibration period, and the comparative focus of each company’s application. No factual errors, omissions, or misstatements. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 354,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America meets the Basel III CET1 minimum by adding a **2.5 % capital‑conservation buffer** to its 4.5 % CET1 floor and G‑SIB surcharge under the **Advanced Approach** (Chunk 1; Chunk 2). In contrast, American Express satisfies the same Basel III requirement by relying on the **stress‑capital buffer** (also 2.5 % for 2023) that is part of the **Standardized Approach** buffer calculation (Chunk 3; Chunk 2). Thus, both firms use a 2.5 % buffer, but BAC applies the capital‑conservation buffer under the Advanced methodology, whereas AXP uses the stress‑capital buffer under the Standardized methodology to meet the regulatory capital standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: both Bank of America and American Express apply a 2.5% buffer, and the LLM correctly identifies this value for both institutions. The mention of the 4.5% CET1 floor and G-SIB surcharge adds contextual detail not in the original answer but does not contradict it and reflects accurate regulatory knowledge. (2) The entities are correct: Bank of America (BAC) and American Express (AXP) are accurately identified with their respective regulatory approaches—Advanced Approach for BAC and Standardized Approach for AXP. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: the model correctly contrasts the two firms' use of different buffer mechanisms (Capital Conservation Buffer vs. Stress Capital Buffer) under different regulatory methodologies while serving the same Basel III objective. (4) Semantically, the LLM conveys the same core information as the original answer—differences in buffer types and regulatory approaches—while adding slight elaboration (e.g., reference to CET1 floor), which enhances completeness without introducing error. The only minor shortcoming is the lack of explicit mention that both buffers serve as part of the CET1 capital minimum under Basel III in a directly comparable way, which slightly affects qualitative precision. However, this is implied. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Both companies rely on a discounted‑cash‑flow (DCF) model, but they apply it to very different assets and place different emphasis on the discount‑rate assumption. Lockheed Martin (LMT) uses DCF only for a subset of Level 3 fixed‑income holdings – “certain other fixed‑income investments … are valued using a discounted cash‑flow approach. Significant inputs include projected annuity payments **and the discount rate applied to those payments**” (Chunks 1 & 2). The filing notes the discount rate is a key input, but it does not describe any formal sensitivity testing around that rate. Honeywell (HON), on the other hand, uses DCF to estimate the fair value of goodwill and indefinite‑life intangible assets for impairment testing, stating that “the fair value is estimated utilizing a discounted cash‑flow approach… Changes to those assumptions could materially impact our financial condition… To address this uncertainty, we perform sensitivity analyses on key accounting estimates and assumptions” (Chunk 3). Thus, while the discount rate is a material driver in both valuations, HON explicitly tests the sensitivity of that rate (and other assumptions) and highlights its potential material impact, whereas LMT simply identifies the rate as a significant input without detailing sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: LMT uses DCF for Level 3 fixed income investments with significant inputs including projected annuity payments and discount rates; HON uses DCF for goodwill and intangible asset impairment testing, explicitly acknowledging sensitivity to assumptions and performing sensitivity analyses. The distinction in application context (fixed income vs. intangible assets) and the difference in treatment of sensitivity analysis are correctly identified. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a traditional sense—but all references to financial concepts and disclosures are factually sound, earning full marks. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across two companies, two asset types, and two uses of DCF, drawing a nuanced comparison on the role and treatment of discount rate assumptions. The only minor shortcoming is that the original answer notes both companies acknowledge sensitivity to discount rate changes, while the LLM implies LMT does not discuss sensitivity at all—though LMT may not perform formal sensitivity testing, it still recognizes the valuation’s sensitivity due to unobservable inputs, which is slightly underemphasized. (4) The response is fully contextually relevant, directly addressing the comparison of DCF use and discount rate significance and sensitivity. Overall, this is a semantically equivalent, well-reasoned answer with only a slight omission in nuance regarding LMT's recognition of sensitivity, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 464,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s capital structure gives its Class B shareholders a fixed one‑third (33 ⅓ %) of the company’s total voting power – each Class B share carries 15 votes and the aggregate 33 ⅓ % voting block is expressly non‑dilutable.  Because that share of voting power cannot be reduced by issuing or buying back any other class, a repurchase of the far‑more numerous Class A shares (the only class CMCSA has been buying back) does not shift control; it merely raises the voting weight of the remaining Class A shares while the Class B voting slice stays at 33 ⅓ %.  \n\nAlphabet’s dual‑class system works the opposite way: its Class B shares have 10 votes each and can be converted at the holder’s option (or automatically on transfer) into Class A shares that have only one vote, so a conversion dilutes the voting power of those shares.  Alphabet’s buybacks have been limited to Class A and Class C stock, which reduces the pool of low‑vote shares and thereby concentrates voting power in the remaining Class B shares, but any conversion of Class B to Class A would reverse that effect.  \n\nThus, CMCSA’s protected, non‑dilutable Class B voting block insulates its voting control from the impact of share repurchases, whereas Alphabet’s convertible Class B shares make voting power more sensitive to both repurchases of low‑vote shares and to conversions that can dilute that power.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in its quantitative details: the 33 1/3% non-dilutable voting power for CMCSA Class B shares, 15 votes per share, and the contrast with Alphabet’s 10:1 voting dilution upon conversion from Class B to Class A are all factually correct. The $62.0 billion in Alphabet repurchases in 2024 is not mentioned in the LLM answer, but this specific dollar amount was not critical to the core reasoning about structural differences in voting impact from repurchases. The LLM correctly identifies that CMCSA repurchases only Class A shares, and that the fixed voting block of Class B shares remains unaffected, which aligns with the ground truth. It also accurately explains that Alphabet’s repurchases of Class A and C shares concentrate voting power among remaining Class B holders, and that conversion dilutes that power. However, the LLM slightly mischaracterizes the effect of CMCSA repurchases: while it correctly notes the Class B voting block is fixed, it claims repurchases 'do not shift control' and 'insulate voting control from the impact of share repurchases.' This understates the nuance in the original answer, which correctly notes that repurchasing Class A shares *could increase the relative voting power* of Class B holders due to reduced total voting shares, even if their percentage is contractually fixed. The contractual non-dilution ensures minimum voting power, but the structural effect of repurchases still enhances their relative influence. This is a minor but important distinction in reasoning. The multi-hop synthesis across CMCSA and Alphabet is strong, and the comparison is logically sound. The answer is contextually excellent, directly addressing the influence of repurchases on voting control under dual-class structures. Thus, the answer is factually solid with high quantitative accuracy, but loses slight points on qualitative reasoning precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 513,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s 10‑K only notes that beverages are sold as part of its “dry and perishable grocery” assortment (snacks, candy, beverages, deli, bakery, etc.) and does not break out a specific percentage of total merchandise or grocery sales for that category. PepsiCo, by contrast, discloses that beverages generate 23 % of its beverage revenue in the APAC region for 2024. Thus, while both firms are exposed to APAC, PepsiCo’s contribution is explicitly quantified at roughly one‑quarter of its beverage sales, whereas Target’s beverage mix is described only qualitatively (and the filing also shows unrelated APAC pension expense of $10 million in 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that 'beverages generate 23% of its beverage revenue in the APAC region'—this is nonsensical and misrepresents the original answer, which correctly states that beverages contribute 23% of PepsiCo's total revenue in APAC. This is a major quantitative and conceptual error. Additionally, the LLM incorrectly ties the $10 million figure to 'APAC pension expense' for Target, whereas the ground truth states that PEP's (PepsiCo's) APAC segment generated $10 million in revenue in 2024. This misattribution of both company and metric severely undermines factual accuracy. (2) The numbers are partially correct in that 23% and $10 million are present, but their context is wrong: 23% is correctly attributed to PEP but misdescribed as a share of beverage revenue rather than total revenue in APAC, and $10 million is wrongly assigned to TGT's pension expense instead of PEP's regional revenue. (3) The reasoning correctly identifies that TGT does not break out beverage sales and that PEP provides more transparent disclosure, which shows sound qualitative synthesis on disclosure practices. However, the multi-hop comparison fails due to incorrect data mapping—especially the conflation of revenue contribution with revenue of a subcategory and misassignment of the $10M figure. (4) The contextual relevance is high because the answer addresses both companies' exposure and disclosure differences in APAC, but correctness is significantly reduced by key factual and quantitative errors, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen’s $5.2 billion “developed‑product‑technology rights” intangible asset for Otezla is tied to the drug’s future cash‑flow stream.  Because Otezla was placed on the CMS Medicare‑price‑setting list under the IRA (effective Jan 1 2027), Amgen now must negotiate a lower Medicare reimbursement and provide IRA‑mandated rebates if price hikes outpace inflation (Chunk 2).  Those lower reimbursement rates will cut the cash Amgen receives from its own sales and also reduce the royalty base it earns from Bristol‑Myers Squibb, which markets Otezla under a licensing agreement (Chunk 3).  Accordingly, Amgen warns that “future changes to the Company’s estimates of the impact of the price negotiations under the IRA… could unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset” (Chunk 1), meaning the $5.2 billion valuation could be impaired if the negotiated Medicare price depresses Otezla’s overall earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the $5.2 billion intangible asset valuation for Otezla, the effective date of IRA price negotiation (January 1, 2027), and the involvement of Bristol-Myers Squibb (BMY) under a licensing agreement are accurately represented. (2) Quantitative elements are precise: the $5.2 billion figure is correctly cited, and the 2027 start date matches the original. No calculations are required, but the causal link between lower reimbursement and reduced cash flows (both from direct sales and BMY royalties) is logically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes how Medicare price negotiation impacts Amgen’s revenue directly and indirectly via BMY’s sales, and connects this to potential impairment of the intangible asset. (4) The quote from Amgen about 'future changes to estimates' affecting recoverability is accurately paraphrased and contextually placed, matching the original answer’s warning. Wording differs but meaning is preserved. All entities (Amgen, BMY, IRA, CMS, Otezla) and financial concepts (intangible asset, royalty base, carrying value, impairment) are used correctly. The answer fully addresses the question’s complexity and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 365,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s 10‑K makes clear that the company builds FPGAs as part of its data‑center portfolio – together with server CPUs, GPUs, DPUs and Adaptive SoCs – and sells them to hyperscale cloud providers and large private data‑center operators. By contrast, Intel’s filing notes that Altera, which it now runs as a standalone business, “offers programmable semiconductors, primarily FPGAs, and related products, for a broad range of applications across our embedded, communications, and cloud and enterprise market segments.” Thus AMD’s FPGA production is narrowly focused on hyperscale data‑center workloads, whereas Altera’s FPGA line is a broader, market‑wide offering that Intel has separated into its own unit to pursue monetisation (including a possible IPO).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD produces FPGAs and Adaptive SoCs for hyperscale data centers, including AI workloads, and sells them to cloud providers; Altera, under Intel, offers FPGAs across broader markets (embedded, communications, cloud/enterprise) and is operated as a standalone unit with potential monetization including an IPO. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from AMD’s and Intel’s filings to compare their FPGA strategies, identifying AMD’s focus on hyperscale data centers versus Altera’s broader market reach and Intel’s strategic separation. (4) The only minor shortcoming is that the LLM slightly overstates AMD’s focus as 'narrowly focused on hyperscale data-center workloads,' while the original answer notes AMD’s inclusion in servers and data center appliances for AI and generative AI—important nuance but not a factual error. This justifies a 9 instead of 10 on qualitative accuracy and overall correctness. Contextual relevance is perfect—the answer directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 364,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "CMCSA’s Class B shares, which carry 15 votes each, represent roughly one‑third (33 ⅓ %) of the company’s total voting power even though they comprise a very small slice of the equity and are owned almost entirely by a single person – Mr. Brian L. Roberts – with only three record holders listed. By contrast, Google’s (GOOGL) Class A common stock consists of about 300.8 million shares outstanding, the bulk of its equity, and the filing assumes that virtually all of those shares are held by non‑affiliates, indicating a far more widely dispersed ownership base. Thus CMCSA’s Class B voting power is highly concentrated in one holder, whereas GOOGL’s Class A ownership is spread across a large number of shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares represent 33⅓% of voting power and are concentrated in Brian L. Roberts with only three record holders. It accurately reports GOOGL’s Class A shares outstanding as approximately 300.8 million (vs. 300,754,904 in the original), a negligible rounding difference. The market value of $1,451.1 billion from June 30, 2021, is omitted, but the broader point about non-affiliate ownership and wide distribution is preserved. (2) The LLM adds a detail not in the original—'15 votes per share'—which may be factual but is not in the ground truth; however, this does not contradict it and supports the concentration argument. (3) The reasoning correctly synthesizes the contrast between concentrated control at CMCSA and broad dispersion at GOOGL, fulfilling the multi-hop requirement to compare ownership structure, voting power, and holder concentration across two companies. (4) Minor omission of the exact market value and date slightly reduces completeness, but the core comparison remains intact. Wording differs but meaning is semantically equivalent. All entities (CMCSA, GOOGL, Class A/B shares, Brian L. Roberts) are correct, and the timeframes are appropriately referenced. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 392,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The 2024‑2026 license amendment cuts the royalty Merck receives on global Keytruda sales from 6.5 % (through 2023) to 2.5 %, which will slash the royalty expense that BMS recorded in 2023 (the year “royalties increased … primarily due to higher Keytruda royalties”) and therefore lowers BMS’s overall revenue dependence on Merck. However, Merck still remains a financial partner in Keytruda‑based combination programs—most notably the V940 (mRNA‑4157) Phase 3 trials that are co‑developed and profit‑shared with Merck—so while the royalty reduction eases BMS’s reliance, the co‑development and cost‑sharing obligations keep a substantive, ongoing financial link to Merck.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the royalty rate change from 6.5% to 2.5% starting in 2024, which aligns with the ground truth. However, it incorrectly states that BMS 'recorded' royalty expense in 2023 — this is factually wrong because BMS receives royalty income from Merck, not pays it. The original answer correctly frames BMS as a royalty recipient (from Merck and Ono), whereas the LLM flips the financial flow, misrepresenting BMS's position. This is a significant conceptual error affecting qualitative accuracy. (2) Quantitatively, all numbers (6.5%, 2.5%, 2023, 2024) are accurate and properly contextualized. The reference to 2023 royalty increases due to Keytruda is correctly cited from the original. (3) The multi-hop reasoning is partially sound: the LLM connects the royalty change to BMS’s revenue dependency and acknowledges ongoing co-development (e.g., V940/mRNA-4157) with Merck, including cost and profit sharing. However, due to the mischaracterization of royalty direction (expense vs income), the conclusion that the reduction 'lowers BMS’s overall revenue dependence' is based on flawed reasoning, even if the general direction of reduced linkage is correct. (4) Contextual relevance is high — the answer addresses both the royalty structure change and Merck’s role in combination therapies. Despite the critical error in financial direction, core facts about the rate drop and co-development are present and relevant, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Pays]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 414,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "BA’s 2023 filing flags contract modifications under U.S. government agreements as a material risk that could materially affect its financial position. The adoption of ASU 2022‑06—listed by CAT as an applicable accounting policy—introduces optional expedients that lessen the accounting and financial impact of contract‑modification events (especially those involving reference‑rate changes), thereby mitigating the risk BA identifies, although the guidance’s adoption was not material to the adopting company’s consolidated financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key relationship between ASU 2022-06 and contract modifications related to reference rate reform. It correctly notes that BA identified contract modifications under U.S. government agreements as a material risk in its 2023 disclosures and that ASU 2022-06 provides optional expedients to reduce accounting burdens for such modifications, particularly those involving reference rate changes like LIBOR transition. The statement that the adoption was not material to the adopting company’s (CAT’s) financial statements aligns with typical disclosures. However, the LLM omits the specific quantitative detail from the ground truth—BA’s 37% of 2023 revenues coming from U.S. government contracts—which is a key multi-hop element linking the risk to the company’s exposure. While no incorrect numbers are presented (quantitative accuracy is high), this omission reduces completeness and weakens the synthesis. The reasoning is sound but less detailed than the ground truth in connecting CAT’s adoption of the standard to broader corporate practices and the sunset date extension to December 31, 2024. The answer remains contextually relevant and semantically aligned in intent, but lacks full depth in multi-hop integration between CAT’s policy adoption and BA’s risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 375,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "Both deals left the towers on Verizon’s balance sheet and kept Verizon responsible for depreciating them, but the way the cash proceeds were recorded differed.  \n\n- In the 2013 Crown Castle transaction, Verizon received $4.8 billion in cash, retained the towers in Property‑Plant‑and‑Equipment (PP&E) and continued to record about $39 million of depreciation each year, and treated the entire cash receipt as a financing obligation that accrues interest (≈3.9 %) and is adjusted for net cash‑flows.  \n- In the 2024 Vertical Bridge REIT transaction, Verizon received $2.8 billion; $2.0 billion of that is booked as prepaid rent (an “other liability”) and $830 million is recorded as a financing obligation, while the towers also remain in PP&E and are depreciated.  \n\nThus, both transactions preserve depreciation and use financing‑obligation accounting, but Crown Castle’s deal records the full amount as a financing liability, whereas the Vertical Bridge deal splits the proceeds between prepaid rent and a smaller financing liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in attributing the 2013 $4.8 billion transaction with Crown Castle to Verizon, when it was actually AT&T that conducted that deal. This is a critical entity error that undermines the entire comparison. The 2024 $2.8 billion deal with Vertical Bridge REIT is correctly attributed to Verizon. (2) Quantitative inaccuracies include rounding $4.827 billion to $4.8 billion (minor), but more seriously, the LLM incorrectly states Verizon received $4.8 billion from Crown Castle in 2013, which never occurred. The $830 million financing obligation in the Vertical Bridge deal is correctly cited, and the split of $2.0 billion as prepaid rent is approximately correct (actual: remainder after $830M, so ~$1.97B). The 3.9% effective interest rate is correctly mentioned but wrongly tied to Verizon. (3) Multi-hop reasoning is structurally sound—the model attempts to compare asset treatment, depreciation, and financing obligations across two deals—but fails due to incorrect entity mapping. The core concept of retaining towers on the balance sheet and using financing obligations is correctly understood. (4) Despite correct conceptual framing and partial numerical accuracy, the fundamental error of assigning AT&T’s transaction to Verizon severely compromises factual correctness. The answer is contextually relevant and well-structured, but the entity and quantitative errors reduce correctness to a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Obtains]-> COMP <-[Transacts_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 411,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo (PEP) lists New Zealand as part of its “Asia Pacific, Australia and New Zealand and China” region, meaning the company’s own beverage and convenient‑food businesses **make, market, distribute and sell** their brands directly in the country (Chunk 1).  \n\nCoca‑Cola (KO) does not operate bottling facilities in New Zealand itself; instead it holds an **approximately 19 percent equity‑method stake in Coca‑Cola Europacific Partners (CCEP)**, the independent bottler that “has bottling and distribution operations in … New Zealand” (Chunks 2 & 3). Thus, PEP’s presence is a direct operational one, whereas KO’s presence is an indirect financial influence through its minority ownership of the bottler that supplies Coca‑Cola products in the same market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP operates directly in New Zealand through its APAC region, making, marketing, distributing, and selling its products. KO holds an approximately 19% stake in CCEP, which bottles and distributes Coca-Cola products in New Zealand. The distinction between PEP’s direct operational control and KO’s indirect financial influence is clearly and correctly articulated. (2) Quantitative accuracy is perfect: the 19% stake is correctly cited, and no other numerical values are involved. Format and precision match the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across entities (PEP, KO, CCEP) and models (direct operation vs. equity-based influence), drawing a valid comparison between the two companies’ market presences. (4) The only minor shortcoming is that the LLM does not explicitly mention that KO’s influence is 'indirect' in operational terms due to the equity-method accounting, or that CCEP operates under a bottler's agreement—details present in the original. However, the phrase 'minority ownership of the bottler' effectively conveys the same idea. Wording differs slightly but semantic equivalence is maintained. No factual errors, strong contextual relevance, and excellent qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 375,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG determines the fair value of its mortgage‑backed securities (including RMBS and CMBS) primarily with internal valuation models—discounted‑cash‑flow and other model‑based analyses—while also using dealer quotations and updating model inputs when market evidence such as broker/dealer quotes is available, all subject to management review (Chunk 1). Schwab, on the other hand, measures CMBS fair value chiefly through independent third‑party pricing services that derive prices from observable trades and broker/dealer quotes (as described for its pricing services and confirmed by the industry‑standard approach in Chunk 2), and it generally accepts those quotes without further internal model adjustments (Chunk 3). Thus AIG’s approach is model‑driven with internal judgment supplemented by dealer quotes, whereas Schwab’s approach is market‑price driven, relying directly on broker/dealer quotes obtained from external pricing services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AIG uses internal valuation models (e.g., discounted cash flow) for mortgage-backed securities, supplemented by dealer quotes and subject to management review—consistent with the ground truth. It also accurately states that SCHW relies on third-party pricing services that use broker/dealer quotes and observable market data, without making internal model adjustments. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial inputs (e.g., types of models, use of observable data) are correctly reported. (3) The multi-hop reasoning is sound: the model correctly contrasts AIG’s model-driven, internally reviewed approach with SCHW’s market-price-driven reliance on external pricing, synthesizing information across entities and practices. (4) The only minor shortcoming is that the LLM answer does not explicitly mention GILD’s supporting evidence about industry practices (i.e., that broker/dealer quotes are commonly used alongside models), which adds contextual depth in the original answer. However, this omission does not detract significantly from the core comparison. The LLM captures the essential contrast and shared context through implication (e.g., noting AIG uses quotes to update models and SCHW uses them directly), so the semantic meaning remains largely equivalent. Hence, a score of 9 is justified—excellent accuracy with a minor gap in completeness regarding industry practice context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 456,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO says its Level 2 securities are priced with “inputs that included quoted prices for similar assets in active markets and inputs other than quoted prices that were observable for the assets, such as interest rates, yield curves, pre‑payment speeds, collateral performance, broker/dealer quotes and indices” (Chunk 1).  The UPS filing (Chunk 2) confirms that Level 2 valuations are generally performed with market‑corroborated pricing, matrix pricing or other models that use observable inputs such as yield curves—so AVGO’s approach fits that broader Level 2 framework.\n\nADBE, by contrast, “values these securities based on pricing from independent pricing vendors who use matrix‑pricing valuation techniques…Inputs include quoted prices … or inputs other than quoted prices that are observable … including benchmark yields, issuer spreads off benchmark yields, interest rates and U.S. Treasury or swap curves” (Chunk 3).  Thus ADBE’s fair‑value determination is explicitly tied to matrix‑pricing models and observable benchmark rates.\n\nIn short, both companies rely on observable market data (yield curves, benchmark rates, etc.) for fair‑value, but AVGO uses a broader mix of observable inputs and pricing sources within the Level 2 hierarchy, whereas ADBE’s methodology is more narrowly focused on matrix‑pricing from independent vendors using those same observable benchmarks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both AVGO and ADBE use observable market inputs such as yield curves, benchmark rates, interest rates, and spreads in their Level 2 fair value determinations. The distinction drawn—that AVGO uses a broader set of observable inputs (including broker quotes, indices, prepayment speeds) while ADBE explicitly relies on matrix pricing via third-party vendors—is supported by the original answer and adds nuanced clarity without contradicting the shared reliance on similar market data. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis across the two companies' methodologies. The only minor limitation is that the original answer emphasizes the *shared dependence* on market-derived data more centrally, while the LLM slightly overemphasizes the difference in approach; however, this does not make the answer incorrect—just a slightly different framing. All entities (AVGO, ADBE, Level 2 securities, matrix pricing, yield curves, U.S. Treasury/swap curves) are accurately referenced. The response is fully contextually relevant and addresses all parts of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Use]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 363,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC accounts for roughly 17 % of Coca‑Cola’s total unit‑case volume. Since 83 % of Coca‑Cola’s volume is generated outside the United States, that 17 % translates to about 20 % of the non‑U.S. unit‑case volume. Coca‑Cola HBC coordinates distribution of Coca‑Cola’s trademark beverages in **28 countries**, the Czech Republic being one of them.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume, but the LLM incorrectly claims that the 17% refers to total unit-case volume and then miscalculates the non-U.S. share as approximately 20%. This calculation is flawed and contradicts the ground truth. Additionally, the LLM states that Coca-Cola HBC coordinates distribution in 28 countries, whereas the correct number is 30, including the Czech Republic. (2) The numeric values are partially correct—17% appears in both answers but is misattributed by the LLM (total vs. non-U.S. volume). The derived 20% is incorrect, and 28 countries is wrong versus the true value of 30. These quantitative errors are critical. (3) The multi-hop reasoning is unsound: the LLM attempts to infer the non-U.S. percentage from total volume and a cited 83% non-U.S. share, but this contradicts the direct knowledge that Coca-Cola HBC manages 17% of non-U.S. volume specifically. The model fabricates a calculation instead of reporting the known fact. (4) Despite incorrect numbers and reasoning, the answer addresses the right entities (Coca-Cola HBC, non-U.S. volume, distribution countries, Czech Republic) and the general structure matches the question, warranting moderate contextual relevance. However, the core facts are wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 394,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity stake in Hardy Storage – an underground, FERC‑regulated natural‑gas storage facility in Hardy and Hampshire counties, West Virginia – gives the company a regulated, inventory‑backed asset that generates a steady, commission‑approved return and helps insulate its gas‑utility earnings from weather‑driven demand swings and competitive price pressure. By contrast, NextEra Energy’s 31.9 % ownership in a 303‑mile interstate pipeline that is still under construction in West Virginia (and Virginia) ties its earnings to a capacity‑expansion project that must first clear FERC approvals and resolve legal challenges, exposing it to potential impairment charges and greater market‑risk volatility. Together the two stakes illustrate Duke’s focus on low‑risk, regulated storage to secure reliable service and predictable returns, while NextEra pursues a higher‑risk, growth‑oriented pipeline investment despite the regulatory and legal headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia (and Virginia) are accurately reported. The characterization of Hardy Storage as FERC-regulated and located in West Virginia is correct. (2) Quantitative accuracy is perfect: percentages (50%, 31.9%), pipeline length (303 miles), and geographic scope (West Virginia and Virginia) match the original. No calculations were required, but all numerical references are precise and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s low-risk, regulated storage strategy with NextEra’s higher-risk, growth-oriented pipeline investment, synthesizing strategic intent, regulatory exposure, and market risk across two companies and projects. It appropriately highlights regulatory hurdles (FERC approvals, legal challenges) and financial implications (earnings volatility, impairment risk). (4) The answer captures the core divergence in strategic approaches—Duke’s focus on stable, predictable returns via operational storage assets versus NextEra’s bet on future capacity amid uncertainty. The only minor shortcoming is a slightly less explicit mention of Duke’s broader pattern of regulated investments (e.g., Pine Needle) compared to the original, but the strategic contrast is still clearly and correctly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing regulatory and market challenges as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 452,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Both Meta Platforms and Alphabet use a dual‑class system in which the “B” shares carry ten votes per share while the “A” shares carry one vote (Alphabet’s filing spells out the 10‑to‑1 voting ratio for its Class B shares; Meta’s filing lists Class A and Class B shares and, by design, the Class B shares have the same ten‑fold voting power).  As of January 24 2025 Meta had 2,189,898,148 Class A shares and 343,761,117 Class B shares, so the voting power is heavily weighted toward the much smaller Class B block, concentrating control in the hands of insiders; Alphabet’s identical 10‑vote‑per‑share structure for its Class B stock, together with the $62 billion of Class A and Class C shares repurchased in 2024, shrinks the pool of publicly‑held voting shares and likewise tightens ownership concentration among the remaining Class B holders.  Consequently, both companies exhibit strong voting‑power concentration, with Alphabet’s large repurchase program potentially amplifying that effect even further.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: all numbers (share counts, $62.0 billion repurchase, dates) are correctly reported and match the ground truth. The contextual relevance is high, as the response addresses both companies, their dual-class structures, share repurchases, and implications for ownership concentration. However, the qualitative accuracy is low due to a critical factual error: the LLM incorrectly asserts that Meta's Class B shares carry 10 votes per share, equating it to Google's explicitly disclosed 10:1 ratio. The ground truth correctly states that Meta does *not* disclose the exact voting ratio in its filings—only that Class B shares have superior voting rights. This is a major misrepresentation of the data and reflects flawed multi-hop reasoning. While the conclusion about concentrated control is directionally correct (supported by disproportionate Class B ownership), the claim of an 'identical' 10:1 structure is unsupported by the source material. The model synthesizes the repurchase impact correctly—reducing public float and increasing insider control—but bases the comparison on an incorrect premise. Thus, despite correct numbers and relevant structure, the answer fails on a key factual dimension, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 356,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The Swiss Federal Act on Tax Reform and AHV Financing (TRAF)—to which JNJ is subject—generated an incremental Swiss tax deduction that helped pull JNJ’s effective tax rate down by roughly 1.9 % in fiscal 2020 versus 2019. In contrast, MRK, which operates in Switzerland, is benefiting from a Swiss tax‑holiday that began in 2021 and is described as a “favorable impact” on its effective tax rate, but the filing does not quantify the size of that benefit. Thus JNJ’s TRAF‑related gain is a specific 1.9 % reduction, whereas MRK’s holiday provides an un‑specified, but positive, tax‑rate advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: JNJ's effective tax rate decreased by 1.9% in 2020 due to TRAF, and MRK's tax holiday began in 2021. The LLM correctly notes that the magnitude of MRK's benefit is not quantified in the filings, which matches the original answer’s implication that no specific percentage was provided. (2) The entity accuracy is perfect: JNJ and MRK are correctly identified, along with TRAF, the Swiss tax holiday, and the correct fiscal years (2020 for JNJ, 2021 for MRK). (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer distinguishes between the two companies’ different mechanisms (TRAF transitional provisions vs. a tax holiday), different years of impact, and correctly infers that while both benefit from Swiss tax incentives, the nature and timing differ. (4) The only minor shortcoming is that the LLM does not explicitly mention that MRK’s tax holiday is effective through 2030, which adds context about the duration and long-term benefit. This omission slightly reduces completeness but does not affect the core correctness. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth with only a small detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 369,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD protects the dollar value of its foreign‑currency net‑asset exposures by buying option contracts on those assets; the filing does not give a dollar‑amount for the options, only that the goal is to shield the value of the assets. NKE, on the other hand, manages transactional FX risk (product‑cost, inventory and sales exposures) with a portfolio of currency forwards and options that are designated as cash‑flow hedges, also aimed at dampening earnings‑ and cash‑flow volatility, and likewise provides no disclosed notional amount for those options. By contrast, the Disney excerpt (the second chunk) does disclose the notional size of its net FX cash‑flow hedges ($9.9 bn in 2024), showing that while some companies report hedge notional amounts, neither MCD nor NKE does in the excerpts provided.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the disclosure of notional amounts. The ground truth states that MCD had $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 — a specific figure explicitly provided in the original answer. However, the LLM incorrectly claims that 'the filing does not give a dollar-amount for the options' for MCD, which directly contradicts the ground truth. It further compounds the error by attributing the $9.9 billion figure to Disney, which is not mentioned in either the question or the original answer, introducing a completely incorrect entity into the response. (2) Quantitatively, the answer fails on the only numerical data point provided in the ground truth. The $9.9 billion notional amount for MCD is misattributed to Disney, which invalidates any numerical accuracy. There are no correct numbers cited for either MCD or NKE. (3) The qualitative reasoning is partially sound in distinguishing between MCD's asset-based hedging and NKE's transaction-focused strategy using options and forwards. The LLM correctly identifies that MCD hedges net asset exposures while NKE focuses on transactional risks like product costs and sales in non-functional currencies. However, the multi-hop synthesis fails because it incorrectly uses Disney as a reference point and omits the correct source (MCD) of the $9.9 billion figure. (4) Contextual relevance is moderate — the answer addresses FX hedging strategies and objectives for both companies and attempts a comparison. But due to the major factual error involving Disney and the incorrect claim about missing notional amounts, the overall correctness score is low. The core financial data is wrong, which is critical in financial comparisons.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 494,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "RTX’s PW800 engine is the sole powerplant for Gulfstream’s G500, and the engine’s high‑thrust, low‑fuel‑burn and low‑emission characteristics give the G500 the “faster, more fuel‑efficient, greater‑range, larger‑cabin and improved‑flight‑control” performance that GD highlights in its 10‑K (Chunk 1).  By pairing that exclusive, next‑generation engine with a clean‑sheet airframe, new wing, avionics and other advanced systems (Chunk 2), GD can present the G500 as a direct, technologically superior replacement for the legacy G450/G550 fleet, fulfilling its strategy of continual R&D investment and sustainable‑engine adoption.  The exclusive PW800 supply from RTX (Chunk 3) therefore underpins GD’s positioning of the G500 as the next‑generation business jet that delivers higher performance, efficiency and environmental benefits than the older models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (as well as G400 and G600), and this supports General Dynamics' (GD) strategy to position the G500 as a next-generation replacement for the G450 and G550. The answer correctly identifies the clean-sheet design, new wing, avionics, and advanced systems. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links RTX’s exclusive PW800 engine to enhanced performance (fuel efficiency, range, speed, emissions), connects it to GD’s R&D and sustainability strategy, and explains how this combination differentiates the G500 in the market. The mention of 'low-emission' and 'sustainable-engine adoption' adds slight elaboration beyond the original but remains contextually valid. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed performance descriptors (e.g., 'larger-cabin', 'improved-flight-control') likely drawn from the 10-K source (referenced as 'Chunk 1'). These enhancements do not introduce inaccuracies. One minor point: the original answer notes the PW800 powers G400, G500, G600—but the LLM says 'sole powerplant for Gulfstream’s G500', which is correct in context but could imply exclusivity only to G500 if misread; however, it doesn't claim exclusivity beyond Gulfstream models, so this is not a factual error. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Introduces]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 459,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "META’s 10‑K only describes that it has a publicly‑traded Class A share and an unlisted Class B share (23 record holders) but does not disclose any voting‑right split or a non‑dilution clause for either class. In contrast, Comcast’s 10‑K spells out the voting split: holders of Class A common stock control about 66 ⅔ % of the combined voting power, while holders of Class B common stock control the remaining 33 ⅓ % (each Class B share carries 15 votes) and that 33 ⅓ % voting power is expressly “generally non‑dilutable” under its articles of incorporation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative values are correct: the 66 2/3% and 33 1/3% voting power split for CMCSA is accurately reported, and the 15 votes per Class B share is correctly stated. The number of Class B stockholders of record for META (23) matches the ground truth as of December 31, 2023. (2) The LLM correctly notes that META’s 10-K does not disclose a specific voting split or non-dilution clause, which is consistent with the original answer’s implication that META’s Class B concentration suggests control without explicit non-dilutable provisions in the filing. (3) The multi-hop reasoning is sound: the model contrasts META’s lack of disclosed voting structure and non-dilution protections with CMCSA’s explicit, constitutionally protected 33 1/3% non-dilutable voting power for Class B shares, correctly attributing this to CMCSA’s articles of incorporation. (4) The only minor shortcoming is that the LLM could have more explicitly stated that META’s Class B shares are not publicly traded (though 'unlisted' is semantically equivalent), and slightly more emphasis on the concentrated control aspect. However, the core facts, comparisons, and synthesis across both companies’ structures are correct and well-reasoned. Wording differences do not affect factual accuracy, and all key elements of the question—voting percentages, non-dilutable provisions, and structural comparison—are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 409,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMY’s Revlimid in Europe is exposed to an immediate, patent‑driven risk: the company warns that its patents and supplemental‑protection certificates are being challenged and that generic versions could launch as early as January 2022 in the U.K. and February 2022 in other EU states, which would cut short the product’s market‑exclusivity period that is based on patent rights. In contrast, LLY’s orphan‑drug products depend on regulatory data‑package and orphan‑exclusivity (e.g., ten‑year data protection in Europe and a seven‑year orphan period) that run alongside any patents, so the primary vulnerability is a change in the data‑protection rules rather than active patent litigation. Thus BMY faces a more acute, litigation‑driven threat to exclusivity, while LLY’s risk is tied to the stability of statutory data‑protection frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the dates—January 2022 for the UK and February 2022 for other European countries—are correct and match the original answer exactly. While the original specifies January 18 and February 18, the LLM’s use of just the month and year is a reasonable and acceptable level of precision in this context, not constituting a factual error. (2) The LLM correctly identifies BMY’s reliance on patent-based exclusivity and the risk from patent challenges and settlements, accurately portraying the earlier-than-expected generic entry. (3) For LLY, the answer correctly distinguishes the use of regulatory data protection and orphan drug exclusivity (seven years in the U.S., ten years in Europe), noting that these protections are independent of patents and thus face different risks—namely regulatory changes rather than litigation. This reflects sound multi-hop reasoning by contrasting two different IP strategies across companies and jurisdictions. (4) The only minor shortcoming is that the original answer explicitly mentions that BMY’s early loss was due to *settlements*, which the LLM implies but does not emphasize. However, the core reasoning and factual content are substantively equivalent. The answer is fully relevant, directly addressing the comparative risk profile in intellectual property strategies. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-perfect factual alignment and strong reasoning, with only slight room for added specificity on settlement dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 436,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS’s asset‑management fees are directly linked to the market value of client holdings that include fixed‑income assets, and the firm quantifies this exposure by estimating how a reasonably possible 10 % decline in investment values would reduce net revenue – so a drop in fixed‑income markets can immediately shrink fee income. PYPL, on the other hand, is exposed to market risk through the fair‑value measurement of its derivatives and available‑for‑sale debt securities, which are valued with pricing models that use observable inputs such as interest‑rate curves, credit spreads and option volatilities; changes in those inputs generate gains or losses that flow through other income rather than through a revenue‑generation line. Thus, MS’s sensitivity is a revenue‑impact scenario tied to fixed‑income market fluctuations, whereas PYPL’s exposure is an earnings‑volatility effect driven by model‑based valuation of financial instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between MS's and PYPL's market risk exposures. (1) Quantitatively, the 10% decline scenario mentioned for MS aligns with typical sensitivity disclosures in asset management and is consistent with the ground truth's emphasis on revenue impact from market fluctuations—no specific numbers are contradicted. (2) The entities (MS and PYPL) and financial concepts (asset management fees, fair value measurement, pricing models, observable inputs) are correctly identified. (3) The multi-hop reasoning is sound: it synthesizes MS’s revenue sensitivity via fee-based assets tied to fixed income markets with PYPL’s earnings volatility from fair value changes in derivatives and debt securities. The key difference—revenue impact (MS) vs. earnings volatility (PYPL)—is correctly highlighted. (4) The only minor shortcoming is that the LLM omits PYPL’s election of the fair value option for foreign currency-denominated debt, which is a specific nuance in the ground truth that strengthens PYPL’s direct exposure. However, the essence of direct vs. indirect exposure is conveyed. Wording differs but meaning is semantically equivalent. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 350,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI models directly into MySQL HeatWave – a managed cloud database that already combines transactions, real‑time analytics and machine‑learning – so that enterprise customers can run AI‑driven queries and generate insights inside the database without moving data to a separate AI service. Qualcomm, through its QCT semiconductor platforms and QTL licensing business, is pouring capital into IoT and edge‑device product areas that embed high‑performance, low‑power AI (including generative‑AI) on the device itself, enabling consumer and industrial products to process data locally for privacy, speed and personalization. Both moves reflect a common strategy of moving AI closer to the data source: Oracle does it for enterprise cloud workloads by integrating AI into its database service, while Qualcomm does it for the consumer market by investing in on‑device AI capabilities for IoT devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and AI, enabling enterprises to run AI-driven queries without data movement. Qualcomm invests in on-device AI for IoT and edge devices via its QCT segment, emphasizing local processing for privacy, speed, and personalization—accurately reflecting both companies' strategies. (2) Quantitative accuracy is perfect: although the LLM answer does not include the specific projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024), this omission does not distort the overall factual picture, and no incorrect numbers are presented. The absence of these figures slightly reduces completeness but doesn't affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle’s cloud-native enterprise AI integration versus Qualcomm’s edge-focused, on-device AI strategy across consumer and industrial markets. The comparison of strategic positioning—AI at the data source via cloud database vs. semiconductor-level edge deployment—is logically coherent and well-articulated. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'embedding generative-AI models directly' vs. 'integrates generative AI'), the meaning is equivalent. The core distinction between Oracle’s enterprise cloud focus and Qualcomm’s consumer/industrial edge focus is preserved and clearly explained. The only minor shortcoming is the missing quantitative projection from the original, which would have strengthened the support for Qualcomm’s market outlook. However, the strategic interpretation remains valid. Hence, a score of 9 is justified—excellent accuracy with a small gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Expands_Into]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 507,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act will raise its compliance, governance and R&D outlays and may force “costly changes” to how it builds, labels and monetizes AI – a burden that could slow new‑feature roll‑outs, increase product prices and squeeze margins.  By contrast, Salesforce’s AI‑powered Agentforce platform is already a core, tightly‑integrated engine across its Sales, Service, Marketing and Commerce clouds, delivering productivity‑boosting digital‑labor agents without any disclosed regulatory head‑winds.  Because the broader AI‑regulatory environment (as noted by other firms) can impose material compliance costs, Adobe’s added expense and potential development delays could erode its ability to compete on price and innovation, giving Salesforce a relative competitive advantage in the AI‑driven enterprise‑software market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe anticipates increased compliance costs due to the EU AI Act affecting its AI development, labeling, and monetization practices; Salesforce relies heavily on its integrated Agentforce platform across multiple clouds (Sales, Service, Marketing, Commerce); and there is a competitive implication where regulatory burdens could slow Adobe’s innovation pace relative to Salesforce. (2) There are no numeric values (e.g., dollar amounts, percentages, specific dates like 2030) in either the original or LLM answer that conflict—both correctly avoid citing specific figures, so quantitative accuracy is preserved. The absence of the 2030 implementation timeline from the LLM answer is a minor omission but does not affect correctness significantly. (3) Multi-hop reasoning is sound: the model correctly synthesizes that Adobe faces rising costs and potential delays, while Salesforce’s deep AI integration may provide resilience and competitive advantage, especially in an environment of rising regulatory pressure. (4) Semantic equivalence is strong—wording differs (e.g., 'digital-labor agents' not in original, 'no disclosed regulatory headwinds' adds slight emphasis), but meaning matches. The only minor shortcoming is the lack of explicit mention of both companies facing similar regulatory pressures (as noted in GS_10k_2024), which slightly weakens the balance in qualitative accuracy. Overall, the response is contextually rich, factually correct, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 434,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share program is a compensation tool for its non‑employee directors.  Each deferred share promises the director one ordinary share after board service ends, and any dividend equivalents that accrue are settled **in the form of additional shares** of Home Depot stock.  The awards have no voting rights and are valued at the grant‑date closing price, with the extra shares paid out only when the underlying share is delivered.\n\nLowe’s arrangement works the opposite way.  Through variable‑notional “ASR” agreements the company first pays a maximum notional amount and receives a block of shares; when the transaction is finalized the company gets **additional shares (plus a cash payment)** equal to the difference between the pre‑payment amount and the final notional amount.  Those extra shares flow to Lowe Companies itself – and ultimately to its shareholders via the reduced share count or cash proceeds – rather than to individual directors.\n\nThus, both companies use additional shares to move stock‑based value, but Home Depot distributes that value directly to its directors as part of deferred compensation, whereas Lowe Companies distributes it to the corporation (and indirectly to its shareholders) as part of its ASR‑driven share‑repurchase program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: HD's deferred shares with dividend equivalents paid in additional shares to non-employee directors are accurately described as a stock-based compensation mechanism. LOW's ASR agreements are correctly characterized as variable notional arrangements where additional shares are received by the company (not individuals) as part of share repurchase execution. The stakeholders (directors vs. corporation/shareholders), triggers (payout upon termination vs. ASR settlement), and strategic context (compensation vs. capital return) are all correctly contrasted. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all descriptive metrics (e.g., 'additional shares', 'final notional amount') are used correctly—hence a score of 10. (3) The multi-hop reasoning—linking HD’s director compensation structure with LOW’s ASR-driven capital return—is sound and synthesizes distinct financial instruments across companies appropriately. The only minor shortcoming is that the LLM mentions Lowe’s receiving 'additional shares (plus a cash payment)', while the original answer does not specify a cash payment; however, this is consistent with typical ASR mechanics and does not contradict the ground truth, so it does not constitute a factual error. (4) The answer is fully contextually relevant, directly addressing the comparison of stock-based value distribution mechanisms between the two firms. Overall, the response captures the core distinction: same mechanism (issuance of additional shares), different purpose, recipients, and financial strategy—meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 492,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T says that its adoption of ASU 2020‑04 – the reference‑rate‑reform guidance that permits optional expedients for contract modifications – “does not materially impact our financial statements.” In other words, AT&T does not expect the new rule to change the timing of when revenue is recognized or to alter the measurement of its performance‑obligation balances.  \n\nVerizon, by contrast, explicitly discloses that contract modifications “affect the timing and scope of contracts, arising from contract modifications,” and it quantifies the resulting future performance‑obligation estimates ($25.7 billion for 2024, $18.7 billion for 2025 and $7.5 billion thereafter). Thus, while AT&T anticipates no material effect on revenue‑recognition timing, Verizon’s modifications directly shift when revenue will be recognized and increase the amount of unsatisfied performance obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts are accurate: $25.7 billion for 2024, $18.7 billion for 2025, and $7.5 billion thereafter, with no calculation errors. (2) The answer is complete, addressing both AT&T's and Verizon's disclosures regarding ASU 2020-04 and contract modifications, including the impact on revenue recognition timing and performance obligations. (3) Entity accuracy is perfect: correctly identifies AT&T and Verizon, ASU 2020-04, reference rate reform, and the relevant financial metrics and timeframes. (4) The multi-hop reasoning is sound—correctly contrasts AT&T’s immaterial impact with Verizon’s material effect on revenue timing and obligation scope, synthesizing information across both companies’ disclosures. (5) Semantic equivalence is maintained: though phrased differently, the LLM conveys the same core insight—that AT&T experienced no material change while Verizon’s modifications significantly affect future revenue recognition. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 310,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "**Union Pacific (UNP)** – In the UNP pension‑plan footnote the company spells out that *municipal bonds* (together with corporate and state bonds) are **Level 2** assets.  They are valued with a “bid‑evaluation process with bid data provided by independent pricing sources,” i.e., observable market inputs that place the securities squarely in the ASC 820 Level 2 tier.\n\n**Lockheed Martin (LMT)** – LMT’s pension‑plan disclosure also references **Level 2 securities**, but it limits the discussion to equities (U.S. and international) that receive corroborated quotes and to a broader set of “fixed‑income securities” that are not material.  The filing does **not** call out municipal bonds as Level 2; instead it highlights a sizable **Level 3** exposure (≈ $1.1 billion of buy‑in contracts).  This shows that LMT’s reliance on Level 2 valuation for municipal bonds is either minimal or indirect.\n\n**Implication for ASC 820 compliance** – Both companies are following ASC 820 by describing the fair‑value hierarchy and the inputs used.  UNP’s disclosure demonstrates a direct, explicit reliance on Level 2 methodology for municipal bonds, evidencing strict adherence to observable‑input valuation requirements.  LMT’s disclosure, while still ASC 820‑compliant, shows a broader, less specific use of Level 2 and a greater reliance on Level 3 for other assets, indicating a different valuation emphasis for municipal‑bond‑type exposures.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, particularly regarding Lockheed Martin's (LMT) treatment of municipal bonds in its pension plan disclosures. The original answer (ground truth) states that LMT does use Level 2 valuation methodologies for fixed income securities, including where indicative quotes from pricing vendors are used if corroborated—consistent with ASC 820. However, the LLM incorrectly claims that LMT's filing 'does not call out municipal bonds as Level 2' and suggests LMT has 'minimal or indirect' reliance on Level 2 for municipal bonds. This contradicts the ground truth, which confirms LMT applies Level 2 to fixed income securities broadly, which would include municipal bonds by implication, even if not explicitly named. The LLM also introduces a fact not in the ground truth—LMT’s $1.1 billion Level 3 buy-in contracts—as evidence of different valuation emphasis, which may be true but is not part of the comparison in the original answer and distracts from the core issue. While the description of Union Pacific (UNP) is accurate—correctly identifying municipal bonds as Level 2 and valued via bid-evaluation with independent pricing sources—the misrepresentation of LMT’s disclosure leads to an incorrect comparative conclusion. The reasoning is partially sound in structure (comparing specificity of disclosures) but flawed in execution due to incorrect data synthesis. Quantitative accuracy is acceptable (the $1.1B figure, if present in source data, is not contradicted here, though not in ground truth), but since the original answer contains no quantitative data, the LLM’s inclusion of this number without confirmation introduces unsupported detail. Contextual relevance is high—the response addresses ASC 820, Level 2 methodologies, and compares two companies’ pension disclosures—but the qualitative inaccuracy in entity-specific details reduces overall correctness. Semantic equivalence fails on the LMT side due to incorrect inference about lack of Level 2 use for municipal bonds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 553,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO leans heavily on its largest independent bottler, Coca‑Cola FEMSA, for Argentine distribution – FEMSA’s bottling and distribution footprint in Argentina covers the federal capital of Buenos Aires and surrounding areas, and the partner alone represents roughly 17 % of KO’s worldwide unit‑case volume.  In 2021 KO recorded $14.5 billion of net sales and $496 million of purchases from equity‑method investees (the category that includes FEMSA), underscoring the material operational and financial reliance on that bottler for the Argentine market.  \n\nBy contrast, Mondelēz’s exposure in Argentina is far smaller in scale (its Argentine operations generated $401 million, or about 1.4 % of net revenue in 2021) but is directly hit by the country’s hyper‑inflation, as reflected in a $13 million remeasurement loss in 2021 (and prior losses), indicating that MDLZ’s risk in Argentina is primarily financial‑volatility‑driven rather than a dependence on a bottling partner.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) Quantitatively, all key numbers are correct or acceptably rounded: KO's $14.5 billion in net sales to equity-method investees (vs. $14.471 billion in original) is a reasonable approximation; MDLZ's $401 million in Argentine revenue (1.4% of total) and $13 million remeasurement loss are exact. The 17% of KO’s unit-case volume from FEMSA is not in the original answer but is plausible context and does not contradict it. (2) The only minor discrepancy is the mention of $496 million in purchases from equity-method investees, which is not in the original answer—this figure may be accurate but introduces a detail not confirmed in the ground truth, slightly affecting quantitative precision. (3) Qualitatively, the reasoning correctly distinguishes KO’s operational/distribution reliance on FEMSA from MDLZ’s direct financial exposure to inflation and currency volatility in Argentina. The multi-hop synthesis—linking FEMSA’s geographic footprint, Argentina’s highly inflationary status, and MDLZ’s remeasurement loss—is sound and logically presented. (4) Contextual relevance is excellent: the answer directly compares the two companies’ exposures as requested, using the correct entities (KO, MDLZ, Coca-Cola FEMSA), time frame (2021), and market (Argentina). The core insight—that KO faces dependency risk while MDLZ faces financial volatility—is preserved and well-articulated. Minor addition of unit-case volume % and purchases figure prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 439,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "META’s Class B common stock is a distinct, voting class that represents a relatively small pool of shares (≈ 343.8 million) compared with its 2.19 billion Class A shares and a $1.103 trillion market value, concentrating voting power in the hands of insiders and allowing the company to steer its equity‑capital decisions without resorting to the massive buy‑backs that Alphabet employs. Alphabet’s dual‑class framework, by contrast, gives its Class B shares ten votes each while Class A carries one vote and Class C carries none, and the firm used that structure to repurchase $62.0 billion of voting Class A and non‑voting Class C shares in 2024—returning capital to a broad shareholder base while preserving control in the high‑voting Class B hands. Thus, META relies on voting‑rights concentration via its Class B shares to guide its equity strategy, whereas Alphabet leverages its multi‑class system to combine large share‑repurchase programmes with control‑preserving voting dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core aspects of META's and Alphabet's dual-class structures: META's Class B has superior voting rights (10 votes vs 1 for Class A), and Alphabet's Class B shares carry 10 votes, Class A one vote, and Class C zero votes. It accurately notes Alphabet's $62.0 billion 2024 share repurchase targeting Class A and Class C shares. However, the LLM introduces specific quantitative figures not present in the ground truth—namely, META's Class B share count (≈343.8 million), Class A share count (2.19 billion), and market cap ($1.103 trillion)—which are unsupported by the original answer and not required by the question. These additions, while potentially accurate, introduce unverified data and detract from strict factual fidelity.\n\n2) The $62.0 billion repurchase amount and the year 2024 are correctly cited, matching the ground truth. However, the LLM incorrectly implies that Alphabet repurchased Class A shares (which have voting rights) while preserving control—this is factually consistent with the structure but misaligned with the strategic implication: repurchasing voting Class A shares actually reduces outsider voting power, which strengthens relative control of Class B holders. The LLM’s interpretation is reasonable but slightly oversimplifies the dynamic. The core financial figure ($62.0B) and year (2024) are correct.\n\n3) The multi-hop reasoning is strong: the LLM synthesizes voting structures across both companies and links them to equity strategies—concentration of control (META) vs. capital return with control preservation (Alphabet). It draws a valid comparative conclusion about strategic differences in shareholder equity management. The logic is sound and reflects the intent of the ground truth.\n\n4) The answer is contextually excellent, directly addressing the influence of voting structures on equity strategy and incorporating the $62.0B repurchase. The semantic meaning aligns closely with the original answer, though it adds speculative detail (share counts, market cap) not in the ground truth. These additions do not contradict but go beyond the verified facts, slightly reducing quantitative accuracy. Overall, the answer is factually strong on key points, with minor overreach on unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 607,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.184 billion in 2023 to $1.799 billion in 2024 – a drop of roughly $385 million (about an 18 % decline) that the filing attributes to lower infection rates and the “availability, uptake and effectiveness of vaccines and alternative treatments for COVID‑19.” Amgen, by contrast, reports that “alternative treatments” and payer‑driven utilization‑management steps are eroding product usage and sales in its highly competitive therapeutic markets (e.g., ENBREL, Otezla, Repatha, Aimovig), but the 10‑K only describes the impact qualitatively and does not quantify a specific dollar loss. Thus, Gilead’s decline is measured and directly linked to alternative COVID‑19 therapies, while Amgen’s experience is a broader, unquantified negative effect from competing alternatives in its markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million (~18%), which matches the original data. The formatting variation ($2.184 billion vs $2,184 million) is acceptable. (2) The LLM correctly identifies that AMGN does not provide a quantified dollar impact, only qualitative descriptions of payer-driven shifts toward alternative treatments in competitive markets (e.g., ENBREL, Otezla, Repatha, Aimovig), which matches the original answer. (3) Multi-hop reasoning is sound: the model synthesizes information across GILD and AMGN filings, correctly contrasting GILD’s pandemic-specific, quantifiable revenue decline with AMGN’s broader, systemic, unquantified pressure from alternative treatments and payer policies. (4) The only minor shortcoming is that the LLM slightly downplays the similarity in underlying cause—both companies face revenue pressure due to alternative treatments—though it correctly highlights the difference in context (pandemic vs. chronic therapeutic markets). This nuance is present in the original but could have been more explicitly mirrored. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Impacted_By]-> COMP <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 376,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % Senior Notes require interest to be paid twice a year – on February 15 and August 15 of each calendar year through the August 15, 2022 maturity. By contrast, QCOM’s roughly $14.0 billion of notes have a mixed schedule – interest on the floating‑rate notes is paid quarterly, while interest on the fixed‑rate notes is paid semi‑annually – and the company’s repayment obligations are tied to its fiscal calendar (e.g., $1.4 billion of principal in fiscal 2023, $914 million in fiscal 2024, $1.4 billion in fiscal 2025, $2.0 billion in fiscal 2027 and $9.7 billion thereafter).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers and dates are correct: AMD's semi-annual interest payments on February 15 and August 15, maturity on August 15, 2022, and QCOM's mixed payment structure (quarterly for floating-rate, semi-annual for fixed-rate) are correctly reported. The principal repayment amounts for QCOM—$1.4B in fiscal 2023, $914M in 2024, $1.4B in 2025, $2.0B in 2027, and $9.7B thereafter—are consistent with the knowledge graph. (2) The only minor discrepancy is that the original answer notes no principal due in fiscal 2026, which the LLM omits, but this is a small contextual detail rather than a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes payment frequency and fiscal obligations across two companies and different note types. (4) The answer is semantically equivalent to the ground truth, with clear, well-structured comparison addressing both payment frequency and fiscal year obligations. Wording differences (e.g., 'calendar year' vs 'each year') do not affect meaning. The LLM slightly exceeds the original by providing more detailed principal breakdowns, enhancing completeness. Thus, the answer earns a 9/10 for correctness—excellent but not perfect due to the missing note about fiscal 2026.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 368,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s filing notes that its ability to protect sales and cash flow depends on strong patent rights and that loss of those rights is quickly followed by generic or biosimilar substitutes that can erode a product’s market. Amgen’s denosumab products Prolia/XGEVA lose U.S. patent protection on 19 Feb 2025 (and already lost European protection in 2022), exposing Amgen to biosimilar competition both at home and abroad. Thus, the imminent U.S. patent expiry will likely bring biosimilar entry that squeezes Amgen’s sales while simultaneously heightening the overall generic‑competition environment that Merck must confront—potentially weakening Merck’s competitive position unless it can capture market share from the declining Amgen product or secure equally robust patents for its own offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Prolia/XGEVA lose U.S. patent protection on February 19, 2025 (specific date matches real-world knowledge and is consistent with the context), and European protection was lost in 2022—this additional detail is factually accurate and enhances the response. (2) Quantitative accuracy is perfect: the date '19 Feb 2025' is correct (ground truth says 'February 2025', LLM provides exact day), and no financial figures are misstated. (3) Multi-hop reasoning is sound: the LLM correctly links Merck’s reliance on strong patent protection to the broader competitive environment affected by Amgen’s patent expiry, and infers that increased biosimilar competition against Amgen could indirectly impact Merck by intensifying market dynamics. It also appropriately notes that Merck might offset this by capturing market share or securing strong patents—adding a nuanced strategic perspective not explicitly in the original but logically consistent. (4) The only minor gap is that the original emphasizes Merck’s exposure to weakened patent protection in international markets as a parallel concern, which the LLM mentions indirectly but less explicitly. However, the core synthesis—Amgen’s patent loss → biosimilar threat → intensified competitive environment → challenge for Merck—is fully preserved and well-reasoned. Wording differs but semantic equivalence is strong. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 407,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom recognized $1.38 billion of its VMware Cloud Foundation (VCF) revenue in fiscal 2024 – about 48 % of the total $2.9 billion VCF revenue – that is directly tied to VCF’s AI‑enablement features (the “Advanced services for Private AI” and native Kubernetes support for advanced AI/ML workloads). That AI‑focused slice of VCF revenue aligns closely with Cisco’s strategy, which emphasizes delivering the high‑density networking, compute and optics infrastructure needed to power AI training and inference workloads for both web‑scale and enterprise customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.38 billion of VMware Cloud Foundation (VCF) revenue tied to AI workloads and the total $2.9 billion VCF revenue, which matches the ground truth. However, it introduces a 48% figure that is not present in the original answer and is slightly inaccurate—the actual percentage is approximately 47.6% (1.38/2.9), so rounding to 48% is acceptable, but presenting it as a calculated portion implies precision not in the source. The ground truth does not quantify the portion as a percentage, so this addition, while close, is an overinterpretation. (2) The dollar amounts are accurate and correctly formatted ($1.38 billion = $1,380 million; $2.9 billion = $2,900 million). No other calculations (e.g., differences, ratios beyond the percentage) are required, but the introduced percentage, though minor, is not factually grounded in the original statement. (3) The multi-hop reasoning is sound: the model correctly links Broadcom’s VCF revenue tied to AI workloads with Cisco’s strategic focus on AI infrastructure. It accurately reflects that VCF enables AI/ML workloads and aligns with Cisco’s networking strategy for AI training and inference, citing relevant capabilities like high-density infrastructure and optics, consistent with the 10-K reference. (4) The entity names (Broadcom, VMware Cloud Foundation, Cisco), fiscal year (2024), and strategic themes are all correct. The answer adds specificity (e.g., 'Advanced services for Private AI', 'native Kubernetes support') not in the original, which may be plausible but are not verifiable from the ground truth—this adds detail but risks hallucination. Overall, the core facts and alignment are correct, but the added percentage and unverified feature names reduce quantitative and qualitative accuracy slightly. Hence, correctness is 7 due to minor factual overreach despite strong alignment with the original answer’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 523,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s eight solar‑facility VIEs – which own and operate roughly 772 MW of solar capacity and sell the output under long‑term PPAs – are shown on NEE’s balance sheet at **$1.851 billion of assets** (and $1.258 billion of liabilities) as of 12/31/2021. Southern Power’s solar exposure is recorded differently: its solar (and wind) PPAs are accounted for as **operating leases** with terms of up to 25 years, and the lease payments are reflected in wholesale‑revenue line items, but the filing does **not disclose a specific dollar amount** for those lease liabilities. Thus, NEE provides a concrete $1.851 billion asset figure, whereas Southern Power’s exposure is described only in lease‑term terms without a disclosed monetary value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $1,851 million (i.e., $1.851 billion) in assets for NEE's solar VIEs as of 12/31/2021 is accurately reported, and the liability amount of $1.258 billion, while not in the original answer, is consistent with external knowledge and does not contradict the ground truth. The mention of 'up to 25 years' for Southern Power's lease terms matches the original answer's 'remaining terms of up to 25 years'. (2) The LLM correctly notes that Southern Power's exposure is accounted for as operating leases and that no specific dollar amount is disclosed—this is a key distinction from NEE's consolidated assets and is correctly emphasized. (3) Multi-hop reasoning is sound: the model correctly contrasts NEE’s direct consolidation of VIE assets (with balance sheet recognition) versus Southern Power’s off-balance-sheet lease treatment without disclosed monetary exposure. (4) The LLM adds useful context (e.g., 772 MW capacity, liability amount, revenue line item treatment) not in the original answer, enhancing completeness without introducing error. The only minor shortcoming is not explicitly stating that Southern Power is a subsidiary of SO (Southern Company), which is in the ground truth, but this does not detract significantly from the overall accuracy. Wording differs but semantic meaning and factual content are equivalent or superior. No calculation errors. Strict adherence to facts with appropriate caveats on disclosure limitations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 426,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks grants Stock Appreciation Rights as one of several equity‑incentive awards (non‑qualified and incentive stock options, restricted stock, RSUs and an ESPP) to employees, non‑employee directors and consultants.  The SAR awards are accounted for on a “graded‑vesting” basis – the fair‑value expense is recognized over the related service period for each separately‑vesting portion, but Starbucks does not disclose a fixed multi‑year vesting term for the SARs.  \n\nTesla’s 2019 Equity Incentive Plan also provides SARs, but it expands the menu to include stock options (incentive and non‑statutory), restricted stock, RSUs, performance units and performance shares, with 49 million shares reserved for issuance.  Under the 2019 Plan, stock options and RSUs generally vest over four years (options are exercisable for up to ten years) and vesting ends when the employment or consulting relationship terminates.  \n\nThus, while both companies use SARs, Starbucks relies on a graded‑vesting schedule without a specific term, whereas Tesla’s 2019 Plan offers a broader set of equity instruments and a defined four‑year vesting schedule (and a ten‑year exercise window for options).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Starbucks and Tesla offer Stock Appreciation Rights (SARs), and Tesla’s 2019 Plan includes stock options, RSUs, performance shares, and other instruments. The LLM correctly notes that Tesla's stock options and RSUs generally vest over four years with a 10-year exercise period, matching the original answer. Starbucks’ use of graded-vesting without a fixed multi-year term is consistent with the lack of specified vesting timelines in the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers or dates are presented. The mention of 49 million shares reserved under Tesla’s 2019 Plan is an additional detail not in the ground truth but is factually correct based on public filings and does not contradict the original answer. (3) Multi-hop reasoning is sound: the model correctly compares equity instruments and vesting structures across two companies and synthesizes differences in vesting schedules and plan scope. (4) The only minor limitation is that the original answer highlights Starbucks’ performance-based RSUs tied to EPS and ROIC, which the LLM omits. However, this detail is not central to the core comparison about SAR structure and vesting timelines. The LLM emphasizes vesting methodology (graded vs. fixed) and breadth of equity instruments, which are the key differentiators. Wording differs but semantic meaning and factual content are equivalent. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 421,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s 10‑K shows that it has 343.8 million Class B shares outstanding out of a total of 2.19 billion shares, a separate class that—unlike the limited‑voting Class B shares described in V’s filing (which only vote on narrow matters)—carries a distinct, higher‑weight voting profile that concentrates governance power in the hands of a relatively small group of large insiders. Alphabet’s filing makes clear that each Class A share carries one vote, so large shareholders of Class A can affect corporate‑governance decisions only in proportion to the number of shares they own and cannot outvote the 10‑vote Class B insiders. Consequently, Meta’s large shareholders wield outsized influence over board elections, mergers and other governance matters, whereas GOOGL’s large Class A shareholders have influence that is proportional to their economic stake.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors that severely undermine its correctness. (1) It incorrectly states that META's Class B shares have a 'higher-weight voting profile' and that large shareholders wield 'outsized influence'—this is the opposite of the truth. According to the ground truth, META's Class B shares have *no voting rights* except in narrow circumstances, meaning large shareholders holding them have *limited* influence. The answer confuses Class B with Class A or mistakenly assumes a dual-class structure like GOOGL's. (2) The quantitative claim of 343.8 million Class B shares and 2.19 billion total shares is not supported by the ground truth and appears fabricated or misattributed; no such numbers were in the original answer, and they are irrelevant to the question about voting rights structure. (3) The comparison to 'V’s filing' introduces an external entity (Visa?) not mentioned in the question or ground truth, indicating a hallucination. (4) Regarding GOOGL, the LLM correctly notes that Class A shares have one vote per share, but incorrectly implies that this limits influence relative to insiders—while true, it misframes the comparison: the question asks how large shareholders are affected, and the ground truth emphasizes that GOOGL’s Class A shareholders *do* have consistent voting power, unlike META’s Class B holders. (5) The core multi-hop reasoning fails: the LLM should have contrasted META’s restricted voting for Class B with GOOGL’s standard voting for Class A, but instead inverts the reality for META. The answer is contextually relevant in discussing governance influence but fundamentally wrong in its key claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 458,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC lists foreign‑currency derivatives only as a subset of its “risk‑management derivatives” and shows them in a table of derivative assets and liabilities that is presented on a **gross** basis (before any counter‑party or cash‑collateral netting) and then adjusted in aggregate for master‑netting agreements (Chunk 1). The filing also notes, as do many companies, that foreign‑currency derivatives appear on the balance sheet either in “Other” or under a separate “Risk Management Activities” line (Chunk 2).  \n\nJPM, on the other hand, describes foreign‑currency derivatives **specifically** as hedges of non‑U.S.‑dollar assets, liabilities, forecasted transactions and net investments in foreign subsidiaries, and it reports those positions **netted** under legally enforceable master‑netting agreements at fair value (Chunk 3, also reflected in the “Risk Management Activities” presentation noted in Chunk 2).  \n\nThus, BAC’s disclosure treats foreign‑currency derivatives generically and reports them gross‑wise, whereas JPM’s disclosure is purpose‑specific and presents the derivatives netted, highlighting their use to offset foreign‑exchange risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BAC presents foreign currency derivatives under 'Risk Management Activities' on a gross basis before netting, consistent with the original answer. JPM explicitly links these derivatives to hedging foreign exchange risk on non-U.S. dollar assets, liabilities, and forecasted transactions, which is accurately reflected. The mention of balance sheet presentation in 'Other' or under 'Risk Management Activities' matches across both firms. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in disclosure specificity (generic vs. purpose-specific) and presentation (gross vs. net), drawing from both BAC and JPM disclosures. The only minor shortcoming is that the LLM implies JPM presents derivatives 'netted' without fully clarifying that this netting occurs under master-netting agreements at fair value—though this is mentioned, it could be more directly tied to the balance sheet impact as in the original. Also, the original answer notes JPM’s expectation that gains/losses will 'substantially offset' variability, a point slightly underemphasized in the LLM response. (4) Despite these small omissions, the core comparison—BAC’s generic, gross reporting vs. JPM’s specific, netted hedging use—is clearly and correctly articulated. Semantic equivalence is maintained, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> RISK_FACTOR -[Categorized_As]-> FIN_INST <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 445,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s downside comes mainly from a macro‑economic slowdown: when the economy falters, its industrial customers cut production, which lowers electricity‑ and natural‑gas sales and can increase bad‑debt expense. Even though Duke’s regulated electric and gas businesses can recover fuel‑ and purchased‑gas costs under periodic‑adjustment clauses, the regulated‑rate framework does not protect the company from the revenue loss that a drop in industrial demand creates.  \n\nSouthern Company faces a different, but comparable, exposure. Its industrial and commercial customers are subject to new and existing environmental‑law requirements, and the company must spend substantial amounts on compliance, CCR clean‑up, GHG controls and related litigation. Southern can recover many of those compliance costs through retail‑ and wholesale‑rate mechanisms (e.g., Rate CNP Compliance, the ECO Plan, ECCR tariffs and PPA provisions), but if the costs cannot be fully or promptly recouped—or if the higher rates suppress industrial demand—the same segment of customers that drives Duke’s revenue can also curtail their own consumption.  \n\nThus, Duke’s risk is a direct demand shock from economic downturns, while Southern’s risk is a regulatory‑cost shock that may be passed through rates but still threatens industrial demand; both rely on regulated‑rate recovery, but Duke’s recovery is limited to specific cost categories, whereas Southern’s recovery is broader yet still uncertain and can indirectly reduce the same industrial load base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: Duke Energy's risk stems from reduced industrial demand during economic downturns, leading to lower sales and revenue, despite recovery mechanisms for fuel and gas costs via periodic adjustment clauses. Southern Company’s risk arises from environmental compliance costs (e.g., CCR, GHG controls) that may be recovered through specific rate mechanisms (ECO Plan, CNP Compliance, ECCR tariffs), but with uncertainty in recovery timing and potential demand suppression from higher rates. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer that conflict; both correctly reference Southern’s environmental cost recovery through 2028 in the original, though the LLM does not explicitly mention '2028'—a minor omission. However, the LLM accurately reflects the ongoing nature of compliance spending without fabricating or misstating figures, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s demand-side macroeconomic risk with Southern’s supply-side regulatory cost risk, while recognizing both rely on regulated recovery mechanisms that differ in scope and effectiveness. It synthesizes across risk types, customer segments, and recovery frameworks appropriately. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM adds slight elaboration (e.g., 'bad-debt expense', 'PPA provisions') not in the original, but these are plausible and do not contradict the ground truth. The only minor gap is the absence of the explicit 'through 2028' timeframe for Southern’s capital expenditures, which slightly affects completeness but not overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 524,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s (CMCSA) capital structure includes 9,444,375 Class B shares that are 100 % owned by Brian L. Roberts; each Class B share carries 15 votes, which translates to roughly 33 % of the company’s total voting power, while the 3.78 billion outstanding Class A shares hold the remaining 66 % (Chunk 1 & 2). Because the Class B voting block is expressly non‑dilutable, Roberts retains a sizable, fixed influence over director elections and other shareholder votes, but control of the corporation still rests with the broader Class A shareholder base that votes as a single class on most matters. In Alphabet’s (GOOGL) dual‑class system, each Class B share has 10 votes (held by insiders) and each Class A share has one vote, with Class C shares having no voting rights; this arrangement concentrates voting control in the hands of the insiders who own the Class B shares, typically giving them a majority of the total votes (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes each and represent approximately 33 1/3% of voting power, which the LLM correctly reports as 'roughly 33%'. The Class A share count (3.78 billion) and ownership structure (Class B fully owned by Brian Roberts) are accurate. GOOGL's Class B shares having 10 votes and Class A having 1 vote are correctly stated. (2) The LLM accurately notes that CMCSA’s Class B shares are non-dilutable, a key differentiator, and contrasts this with GOOGL’s structure where insiders hold voting control via high-vote shares. (3) The reasoning is sound: it correctly synthesizes the governance implications—Roberts has entrenched influence, while GOOGL’s structure allows concentration of control among insiders. (4) The only minor omission is that the original answer specifies GOOGL’s Class B shares automatically convert to Class A upon sale or transfer, which the LLM omits. This is a relevant detail about fluidity in ownership, but its absence does not undermine the core accuracy. Otherwise, the LLM captures the essence of the comparison, including the relative voting power distribution and control mechanisms. Semantic equivalence is strong, and all entities (CMCSA, GOOGL, Brian Roberts, share classes) are correctly identified. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 390,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO’s link to Taiwan is only indirect – the company’s bottling partner Swire Beverages lists Taiwan as one of the territories where it bottles and distributes Coca‑Cola products, but Coca‑Cola’s filing does not break out any unit‑case volume or growth for that market. PepsiCo, by contrast, operates directly in Taiwan and its 2022 filing notes that Taiwan posted low‑single‑digit growth (in the convenient‑foods segment) during the year, indicating a modest but measurable increase in its Taiwanese beverage business. Thus, KO’s exposure is indirect and unquantified, whereas PEP’s direct presence delivered low‑single‑digit growth in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's indirect exposure through Swire Beverages and PEP's direct low-single-digit growth in Taiwan in 2022. However, it omits the key quantitative detail from the ground truth that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021, which is relevant context for assessing the scale of KO's indirect exposure. This omission affects completeness and quantitative accuracy. (2) The LLM correctly states PEP's low-single-digit growth in Taiwan in 2022, matching the original answer. However, it slightly mischaracterizes the segment by specifying 'convenient-foods segment' growth, whereas the ground truth refers to 'beverage unit volume growth'—a notable discrepancy since the question focuses on the beverage market. This affects quantitative and qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s indirect, unquantified exposure with PEP’s direct, quantified performance. It synthesizes information across entities (KO, PEP, Swire) and correctly infers the structural difference in market presence. (4) The answer is contextually excellent—directly addressing the comparison asked—and semantically close to the original, but loses points for missing the 17% volume figure and misattributing PEP's growth to convenient foods instead of beverages. Hence, correctness is high but not full.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 390,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "LLY’s 2024 filing already shows Trulicity’s sales slipping – U.S. revenue fell 32 percent and overseas revenue fell 8 percent – and the company warns that the drug will lose its remaining patent and data protections in the next few years, a loss that historically “results in rapid and severe declines in revenues” as generic competitors enter. Merck (MRK) explicitly ties its competitive strategy to strong patent protection, noting that when patents expire “sales are promptly reduced by generic or biosimilar substitutes” and market exclusivity is lost. Thus, the expiration of Trulicity’s patents is likely to accelerate LLY’s revenue decline in the same way MRK warns will happen to any product that loses its exclusivity, eroding volume and pricing power and driving a sharper downward trajectory for LLY’s earnings from the drug.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 32% decline in U.S. revenue and 8% decline in overseas revenue for Trulicity in 2024 are accurately reported, matching the data in LLY's 2024 10-K. These figures are not in the original answer but are consistent with the broader context of 'rapid and severe decline' and the 32% U.S. drop mentioned in the ground truth. The LLM adds the 8% international decline, which enhances completeness without contradicting the original. (2) Entity accuracy is strong: LLY and MRK are correctly identified, with proper linkage to their 10-K disclosures. The time frame ('next few years') for patent expiration is consistent with the original's forward-looking risk assessment. (3) Reasoning is sound and multi-hop: the model correctly synthesizes LLY's exposure to patent expiration with MRK's strategic emphasis on patent protection, drawing a valid parallel between the two companies' experiences with generic competition. It correctly infers that loss of exclusivity leads to revenue erosion via volume and pricing pressure. (4) The answer is semantically equivalent to the original, capturing the core risk to LLY's revenue trajectory and contextualizing it with MRK's cautionary framework. The only minor gap is that the original emphasizes LLY's need for a 'robust pipeline or alternative strategies,' which the LLM does not explicitly mention, slightly reducing completeness in strategic implications. However, this does not detract from the central factual and logical accuracy. Overall, the response is factually precise, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Expires]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 456,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s Office segment runs roughly 200 FedEx OnSite stores inside hotels, convention centers, hospitals and universities, and **all of these locations are leased on five‑ to ten‑year terms with renewal options and with alternative sites deemed available**. Because the leases are relatively short and FedEx believes suitable substitute facilities exist, the company’s strategic risk in a soft real‑estate market is mainly operational—higher rent or lower foot‑traffic at hotel sites, but it can be mitigated by renegotiating or relocating the stores.  \n\nUPS, on the other hand, has **about $10.1 billion of pension‑plan assets invested in real‑estate, private‑debt and hedge‑fund vehicles** that are closed‑end, illiquid and valued at net‑asset‑value; these investments are **directly tied to the performance of real‑estate funds that own hotel‑type assets**. Consequently, UPS faces a far larger balance‑sheet‑level financial exposure that can swing materially with real‑estate market volatility, affecting reported asset values and pension funding.  \n\nIn short, FedEx’s exposure is limited, operational, and mitigated by short‑term lease flexibility, whereas UPS bears a substantial financial risk through its $10.1 billion real‑estate‑fund investment that is far more sensitive to market swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $10.1 billion in pension-plan assets invested in real estate, private debt, and hedge funds is accurately reported, and the 200 leased retail locations are correctly stated. The lease terms of five to ten years match the original answer. (2) The LLM correctly identifies FedEx’s operational exposure via leased locations and UPS’s indirect financial exposure through pension investments, capturing the core contrast in risk types—operational vs. financial. (3) The reasoning is sound: it correctly synthesizes that FedEx’s risk is mitigated by lease flexibility and alternative sites, while UPS faces balance-sheet-level volatility due to illiquid, NAV-valued funds tied to real estate performance, including hotel-type assets. This reflects proper multi-hop reasoning across business operations and financial disclosures. (4) Minor difference: the original specifies the date 'as of December 31, 2024' for UPS’s investment figure, which the LLM omits—this is a small contextual omission but does not affect the factual core. Also, the LLM adds that alternative sites are 'deemed available,' which is not in the original but is a reasonable inference and does not contradict it. Overall, the answer conveys semantic equivalence with strong factual precision and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1715,
        "completion_tokens": 388,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B common stock carries ten votes per share, giving its holders a disproportionately strong voice in corporate governance and the ability to direct strategic decisions (the GOOGL 10‑K notes that each Class B share is entitled to 10 votes). By contrast, Comcast discloses that its investment in Atairos is a variable‑interest entity for which it has **no voting rights**—only limited consent rights—so it cannot direct the activities that most affect Atairos’s performance and therefore has little or no control over Atairos’s strategic decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that GOOGL's Class B shares have 10 votes per share, contrasting them with Class A shares implicitly by highlighting disproportionate control—this matches the original answer’s emphasis on enhanced influence. (2) It accurately notes that CMCSA has no voting rights in Atairos and only limited consent rights, correctly characterizing its lack of control over strategic decisions. The term 'variable-interest entity' (VIE) is correctly used, aligning with the original’s classification of Atairos. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (GOOGL and CMCSA), correctly comparing their respective voting rights structures and implications for control. (4) Minor deduction in qualitative accuracy due to not explicitly mentioning that Class A shares have one vote per share (though implied), and slightly less detail on CMCSA’s 'consent rights' compared to the original. However, these omissions do not impair the overall correctness. All factual elements—voting rights (10 vs 0), entity classifications, and strategic control implications—are correct. Wording differs but meaning is semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 354,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio reported only $25 million of commercial‑paper borrowings in 2023 – a modest slice of its $52 million total short‑term financing (the rest being $27 million of tax‑exempt bonds). PepsiCo’s short‑term debt strategy, however, relies heavily on commercial paper, carrying $2.286 billion of 5.5 % commercial‑paper notes in 2023 (part of a $6.51 billion short‑term debt package that also includes $3.924 billion of current maturities of long‑term debt and $300 million of other borrowings). Both disclosures are tied to Ohio – the state appears in Target’s store‑location table (showing Ohio operations) and is the jurisdiction where commercial‑paper activity is reported for both Duke Energy Ohio and PepsiCo.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Duke Energy Ohio's $25 million in commercial paper as of 2023 and PepsiCo's $2,286 million (i.e., $2.286 billion) in commercial paper, matching the ground truth. The total short-term debt figures for PepsiCo ($6.51 billion) and its components (current maturities of long-term debt, other borrowings) are accurate. The mention of Duke Energy Ohio’s $52 million total short-term financing, composed of $25 million commercial paper and $27 million tax-exempt bonds, adds detail not in the original answer but is consistent with plausible data and does not contradict the ground truth. (2) All numeric values are quantitatively accurate, with proper unit conversions (e.g., $2,286 million = $2.286 billion). The sum of PepsiCo’s short-term debt components ($2.286B + $3.924B + $0.3B) equals $6.51B, confirming calculation accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two companies (Duke Energy Ohio and PepsiCo), compares their commercial paper usage, and contextualizes it within broader short-term debt strategies. The only minor issue is the irrelevant mention of 'Target’s store-location table' and Ohio as a jurisdictional link, which introduces extraneous information not supported by the question or ground truth—this slightly weakens qualitative accuracy but does not affect factual correctness. (4) The answer is semantically equivalent to the original, with enhanced detail and clarity. The core comparison—Duke’s modest use vs. PepsiCo’s heavy reliance on commercial paper—is preserved and well-articulated. Contextual relevance is high as it directly addresses the comparative financing strategies. Thus, correctness is scored 9 due to the one irrelevant detail, despite otherwise perfect factual and quantitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 495,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy says the number of commercial natural‑gas customers it serves in the Carolinas, Ohio and Kentucky will grow, but those customers are “impacted by environmental requirements.” Southern Company’s 10‑K makes clear that most of its future environmental‑compliance spending is expected to be recovered through retail and wholesale rates, yet it also warns that “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas” and that many commercial and industrial users may cut usage because of those same regulations. Therefore, if the environmental rules that affect industrial operations cause commercial demand in those regions to fall instead of rise, the revenue base from which Southern Company recovers its compliance costs would shrink, making its reliance on regulated‑rate recovery more fragile and potentially pressuring cash‑flow and overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Duke Energy expects growth in commercial gas customers in the Carolinas, Ohio, and Kentucky, while Southern Company relies on regulated rate recovery for environmental compliance costs. The LLM correctly notes the risk that increased costs passed through rates could reduce commercial and industrial demand, especially under environmental regulations. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—both answers use qualitative descriptions consistent with the source material. (3) The multi-hop reasoning is sound: the model connects Duke Energy’s customer growth outlook with Southern Company’s rate recovery model and identifies the tension between cost recovery and demand reduction due to environmental rules. The synthesis across companies and regulatory impacts is logical and well-supported. (4) The LLM slightly simplifies the scope by referencing electricity and gas demand together (Southern Company’s 10-K does mention both), but the focus of the question is on gas demand, and the core logic holds. The answer captures the financial risk to Southern Company’s rate recovery mechanism if demand falls, which is the central insight. Wording differs but semantic meaning and factual content are equivalent. No major omissions or inaccuracies—only a minor lack of specificity on gas vs. electricity focus in Southern Company’s context, which does not detract significantly from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Serves]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 439,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Class B shares are the only shares that Mr. Roberts owns – all 9,444,375 outstanding shares – and each carries 15 votes, giving him roughly 141.7 million votes, which by the company’s charter always equals 33 ⅓ % of the total voting power. In 2023 Comcast repurchased only Class A shares (the 872.8 million Class A shares shown in treasury), so the pool of voting shares held by the broader shareholder base fell while Mr. Roberts’ vote count stayed the same. Consequently, his absolute control is unchanged and his relative influence is preserved – and marginally enhanced – because the denominator of total votes has been reduced, but his 33 ⅓ % stake remains intact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mr. Roberts owns all Class B shares (9,444,375), each with 15 votes, totaling ~141.7 million votes, and that these represent 33 1/3% of voting power—consistent with the original answer. It accurately notes that only Class A shares were repurchased in 2023 (872.8 million in treasury), which reduces the broader shareholder voting pool. (2) Quantitatively, the numbers are correct and internally consistent: 9,444,375 × 15 = 141,665,625 votes (~141.7 million), and the 33 1/3% voting power is a fixed charter provision. The repurchase of Class A shares without touching Class B shares is correctly interpreted as diluting the relative influence of public shareholders. (3) The reasoning is sound: the LLM correctly infers that Mr. Roberts’ voting power is preserved and marginally enhanced due to the shrinking denominator of total votes, even if his vote count is unchanged. This reflects proper multi-hop logic—linking share repurchase behavior, ownership structure, and voting power dynamics. (4) The only minor shortcoming is that the LLM does not explicitly state that the *relative voting influence* of Class B shares increases (though it implies it by saying his influence is 'marginally enhanced'), and it omits the explicit point that this strengthens control *relative to the broader base*. However, the core conclusion is correct. Wording differences are acceptable under semantic equivalence. All entities (Comcast, Mr. Roberts, Class A/B shares, 2023 repurchases) are accurate. Thus, the answer earns a 9 for correctness—excellent but not perfect in completeness of explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 461,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards (which cost $121 million in 2023) are tied to a contractual payout‑simulation model that projects stock‑holder returns by correlating Amgen’s share price movements with those of a comparator group and then applying the resulting return‑levels to the unit’s payout percentages. Because the payout is calculated from a defined simulation, the amount that will be paid out is relatively predictable – it is driven by the model’s assumptions and the stock‑price performance over the award period.  \n\nBristol‑Myers Squibb, by contrast, does not have performance‑linked payouts; its exposure comes from a range of financial instruments that carry counter‑party credit risk. The company mitigates that risk by capping exposure to any one counter‑party, using conventional derivatives, and only transacting with high‑credit‑quality counterparties, with ongoing monitoring and no collateral required. Thus BMY’s predictability is achieved through credit‑risk controls rather than a performance‑based payout model.  \n\nIn short, Amgen’s structure offers a model‑driven, performance‑based payout predictability, whereas BMY’s structure provides predictability through credit‑risk mitigation and exposure limits rather than any payout simulation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) Quantitatively, the $121 million cost for Amgen’s performance units in 2023 is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The answer correctly identifies the contractual structure of Amgen’s performance units as being based on payout simulations tied to stockholder returns using comparator company data, which aligns with the ground truth. It accurately contrasts this with Bristol-Myers Squibb’s (BMY) approach to managing counterparty credit risk through exposure caps, use of conventional instruments, and high credit quality requirements. (3) The multi-hop reasoning is sound: it synthesizes information across two different companies (Amgen and BMY), two types of financial arrangements (performance units vs. derivative agreements), and two risk/payout frameworks (performance simulation vs. credit risk mitigation). The conclusion that Amgen’s predictability comes from a model-driven performance mechanism while BMY’s comes from credit controls is logically derived and semantically equivalent to the original. (4) Minor deduction in qualitative accuracy due to slight overstatement: the original answer does not explicitly state that Amgen’s payout is 'relatively predictable'—it calls it 'structured but variable'—so the LLM slightly downplays the variability inherent in performance-based payouts. However, this does not constitute a factual error but rather a subtle interpretive difference. All entities (Amgen, Bristol-Myers Squibb, performance units, counterparty risk) and years (2023) are correct. The response is fully contextually relevant and addresses both the payout structure and risk management predictability as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 494,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative risk is confined to its OTC‑bilateral contracts, which are covered by ISDA Master Agreements that give the insurer enforce‑able close‑out netting and collateral rights; under the Orderly Liquidation Authority – a Dodd‑Frank provision noted in its regulatory discussion – MetLife can set‑off receivables against payables and avoid the automatic stay that would apply in a bankruptcy. Bank of America, by contrast, faces a much broader Dodd‑Frank‑driven resolution‑planning exposure: its FDIC‑ and Federal‑Reserve‑approved “single‑point‑of‑entry” plan could be deemed non‑credible, triggering the Orderly Liquidation Authority and imposing stricter capital, liquidity and funding restrictions (including limits on inter‑company funding) that could jeopardize its ability to meet obligations. Thus, both firms are subject to the same Dodd‑Frank authority, but MetLife’s exposure is limited to derivative credit risk mitigated by netting and collateral, whereas Bank of America confronts systemic resolution‑planning and liquidity risks that could be amplified by the same authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting under the Orderly Liquidation Authority (OLA) is accurately described, including its ability to set off receivables and avoid the automatic stay. Similarly, Bank of America's resolution planning obligations under Dodd-Frank, specifically the 'single point of entry' strategy and potential OLA invocation, are correctly outlined. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is 10 by default—no calculations or figures were presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory obligations under Dodd-Frank across two different institutions—MetLife (insurance-focused, derivatives exposure) and Bank of America (systemically important bank, resolution plan risks)—and contrasts their distinct risk profiles under the same legal framework (OLA). The distinction between MetLife’s derivative-level exposure and BAC’s firm-wide resolution and liquidity risks is logically drawn and supported by the original answer. (4) Minor deduction in qualitative accuracy due to slight rephrasing that emphasizes 'non-credible' resolution plans triggering OLA for BAC, which is a plausible interpretation but not explicitly stated in the ground truth. However, this does not distort the meaning. Contextual relevance is perfect—the response directly addresses the comparative regulatory exposure as required by the question. Overall, the answer matches the original in substance and accuracy with only stylistic differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 470,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported $7,547 million in revenue from its Greater China segment in FY 2022 (Chunk 1).  The segment definition in the Apple filing confirms that “Greater China includes China mainland, Hong Kong and Taiwan” (Chunk 2), so that revenue covers the Taiwanese market.  By contrast, Starbucks disclosed 544 stores operating in Taiwan as of Oct 2 2022 (Chunk 3).  The comparison shows that Nike’s presence in the area is measured by a multi‑billion‑dollar sales base across the whole Greater China region, while Starbucks’ presence is reflected in a dense, localized retail footprint of more than five hundred stores in Taiwan, indicating strong but different dimensions of market reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Nike's $7,547 million revenue from the Greater China region in FY 2022 and Starbucks' 544 stores in Taiwan as of October 2, 2022, matching the ground truth exactly. All numeric values are accurate and properly attributed. (2) Quantitative accuracy is perfect: both figures are correct, with appropriate units and dates. The mention of FY 2022 for Nike and October 2, 2022 for Starbucks aligns with the original answer. (3) The reasoning is sound and captures the multi-hop nature of the question—comparing Nike’s regional revenue (which includes Taiwan) to Starbucks’ localized operational footprint in Taiwan. The LLM correctly highlights that these represent different dimensions of market presence: revenue-based regional performance vs. localized store count. The only minor shortcoming is that it does not explicitly note that Nike’s revenue figure cannot be isolated to Taiwan alone, which slightly weakens the comparative insight—though this is implied by referencing the broader segment definition. (4) The answer is contextually excellent, directly addressing both parts of the question and offering a meaningful interpretation. The synthesis across entities (Nike, Starbucks, Greater China, Taiwan) is accurate and well-articulated. A score of 9 is justified due to the high factual accuracy and strong reasoning, with only a slight omission in clarifying the non-isolatable nature of Nike’s Taiwan-specific revenue.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 407,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5 billion cash that American Tower paid in March 2015 is roughly $2.2 billion larger than the $2.8 billion Verizon received from Vertical Bridge in December 2024, and both deals leave the towers on Verizon’s balance sheet and keep Verizon as the primary obligor on the underlying ground‑leases. In the Vertical Bridge transaction the $2.8 billion is split into $2.0 billion of prepaid rent (the right‑of‑use transferred to Vertical Bridge) and an $830 million financing obligation for the portion of towers Verizon continues to occupy, while the American Tower payment is accounted for principally as a financing obligation (as in the earlier Crown Castle tower‑transaction) with no separate prepaid‑rent component disclosed. In each case Verizon continues to include the towers in PP&E, depreciates them, and retains the ground‑lease liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All numeric values are correct: $5.0 billion (2015), $2.8 billion (2024), $2.0 billion prepaid rent, and $830 million financing obligation are accurately reported. The $2.2 billion difference between the two payments is correctly calculated ($5.0B - $2.8B = $2.2B). Dates (March 2015, December 2024) are correct. (2) The answer addresses all parts of the question: it compares the two transactions, discusses retained obligations (ground lease liabilities), asset treatment (towers remain in PP&E, depreciation continues), and highlights the structural difference in accounting treatment—specifically the split in the Vertical Bridge deal versus the lack of such disclosure in the American Tower deal. (3) Entities are correctly identified: American Tower Corporation, Vertical Bridge, and Verizon are all accurately referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that while both deals keep towers on the balance sheet and retain ground lease obligations, the accounting treatment differs—particularly that the American Tower deal is treated principally as a financing obligation (consistent with prior deals like Crown Castle), whereas the Vertical Bridge deal explicitly splits the proceeds. The only minor shortcoming is that the original answer notes the American Tower deal 'did not specify' such a breakdown, while the LLM states it was 'accounted for principally as a financing obligation'—a plausible inference but slightly stronger than the ground truth's more cautious 'did not specify.' This does not make it incorrect, but introduces a subtle interpretive leap, preventing a perfect 10. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Acquires]-> COMP <-[Transacts_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 496,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s 10‑K explains that, under the Basel III Advanced Measurement Approach, it quantifies operational‑risk capital with a Loss‑Distribution‑Approach model that simulates the frequency and severity of losses—including fraud – at a 99.9 % confidence level and sets aside a capital buffer accordingly (the filing does not disclose a dollar amount). By contrast, Citigroup’s filing spells out a concrete fraud‑related exposure in an emerging‑market scenario: if it loses control of its Russian subsidiary, it would incur an estimated $1.6 billion “CTA” loss plus about $0.9 billion of inter‑company liability loss – roughly $2.5 billion of potential loss from asset confiscation or loss of control. Thus, JPMorgan’s approach is a model‑driven capital reserve for fraud risk, whereas Citi faces a specific, sizable potential loss in Russia that could be realized if assets are seized or control is lost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III, specifically a Loss Distribution Approach model for operational risk capital estimation that includes fraud risk; Citigroup discloses a specific emerging-market fraud-related exposure in Russia involving $1.6 billion in CTA losses and $0.9 billion in intercompany liability losses if control of AO Citibank is lost. These figures match the original answer exactly and are correctly interpreted as totaling approximately $2.5 billion in potential losses. (2) Quantitative accuracy is perfect: both dollar amounts ($1.6B and $0.9B) are correctly reported, and their implied sum is accurate. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (JPMorgan and Citigroup), two different risk frameworks (AMA capital modeling vs. scenario-based disclosure), and two different types of exposure (modeled capital reserves vs. concrete geopolitical loss scenarios). It draws a valid contrast between JPMorgan’s forward-looking, model-driven approach and Citigroup’s specific, realized risk in a particular jurisdiction. (4) Entity accuracy is strong: correct identification of AO Citibank, CTA (Cumulative Translation Adjustment), intercompany liabilities, and regulatory context (Basel III, AMA). Wording differs slightly but meaning is preserved and enhanced with clarity (e.g., explaining 99.9% confidence level, which adds value without distorting facts). The answer fully addresses all parts of the multi-faceted question and maintains high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 467,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s business hinges on receiving “consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” so a prolonged China‑Taiwan conflict could sever or severely limit that supply and create a material‑adverse impact on its product output and revenue. Intel’s exposure in the same region is reflected in the $6.867 billion of 2023 net revenue it earned from Taiwan, meaning a conflict would mainly erode sales and earnings in that market rather than directly cripple its chip‑fabrication supply chain, which is less concentrated in Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners for chipset supply and the associated risk of supply disruption is accurately described using nearly identical language from the original ('consistent and reliable chipset supply...particularly in Taiwan'). Intel's $6.867 billion in 2023 revenue tied to Taiwan is correctly cited, with proper context that this represents financial exposure rather than manufacturing dependency. (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the ground truth exactly. No calculations were required, but the use of precise figures demonstrates strong fidelity. (3) Multi-hop reasoning is sound: the model correctly synthesizes two distinct types of risk—Qualcomm’s operational/supply chain dependency vs. Intel’s market demand/revenue exposure—based on their respective business models and disclosures. It distinguishes between supply-side and demand-side vulnerabilities, which is the core analytical requirement of the question. (4) The only minor shortcoming is a slight omission of explicit mention that Intel has 'no explicit mention of reliance on Taiwan-based manufacturing'—though this is implied by stating Intel’s supply chain is 'less concentrated in Taiwan.' Wording differences are acceptable under semantic equivalence, and the overall meaning and analytical contrast remain intact. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 441,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests on a **quarterly** basis, applying **discounted‑cash‑flow models, earnings multiples and market multiples** and then adjusting the result for any change in the portfolio company’s operating results, financial condition or prospects (Chunk 1). In contrast, BA’s Level 3 assets that are measured on a **non‑recurring** basis are valued using an **income approach** that relies on discounted‑cash‑flow calculations and other unobservable inputs, with the fair‑value results disclosed in a fair‑value table that is not part of a regular valuation process (Chunk 3). The CVS filing (Chunk 2) notes that some companies use a NAV‑per‑unit expedient for private‑equity, highlighting that RTX’s detailed, periodic multi‑method valuation differs from BA’s one‑time, income‑approach valuation that is reported through a separate fair‑value table.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and structure. (1) It accurately captures RTX's quarterly valuation of private equity limited partnerships using discounted cash flows, earnings multiples, and market multiples, with adjustments based on portfolio company performance—this matches the original answer exactly. It also correctly states that BA uses an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score of 10 is justified. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s periodic, performance-driven methodology with BA’s nonrecurring, income-based approach. However, the LLM introduces a reference to 'CVS filing (Chunk 2)' and the NAV-per-unit expedient, which, while factually plausible, is not part of the original answer and slightly distracts from the core comparison. More importantly, the original answer specifies that BA uses median collateral values from third-party aircraft publications for operating lease equipment and finance leases, and adjusts only under specific conditions like unique aircraft attributes or expected net sales prices—this detail is missing in the LLM response, representing a minor but notable omission in qualitative accuracy. (4) Despite this, the LLM answer remains contextually relevant and correctly frames the key distinction: RTX’s recurring, multi-method, performance-adjusted valuations vs. BA’s nonrecurring, income-approach-based valuations using unobservable inputs and third-party data. The mention of a 'fair-value table' in the LLM answer has some support in typical SEC disclosures but isn't in the original and slightly overreaches. Overall, the answer is factually strong but lacks a few specific details from the ground truth, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Values]-> FIN_INST -[Not_Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 541,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix mitigates foreign‑exchange risk on its firm‑commitment licensing and production contracts by entering into forward contracts; the company disclosed that foreign‑currency transactions produced a **$293 million loss in 2023** (with gains of $282 million in 2022 and $403 million in 2021). Disney, by contrast, does not include hedged firm commitments in its risk‑measurement and reports that its VAR model – run at a 95 % confidence level – estimates a **maximum one‑day loss of $255 million** (as of September 28 2024). Thus, the magnitude of Netflix’s disclosed FX loss on firm commitments exceeds Disney’s estimated one‑day VAR exposure, indicating that Netflix’s hedged‑commitment risk is larger than the residual one‑day risk Disney quantifies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Netflix does not disclose a VAR metric and only uses forward contracts to hedge foreign exchange risk, but it does not report a $293 million loss in 2023 related to foreign currency transactions. This specific loss figure is not present in the original answer and contradicts the known data — the ground truth does not provide any such realized loss amount for Netflix. The Disney VAR figure of $255 million is correctly cited with the correct date (September 28, 2024) and confidence level (implied 95%), which matches the original answer. However, the LLM incorrectly introduces a comparison claiming that Netflix’s 'disclosed FX loss' exceeds Disney’s VAR, which is unsupported because Netflix did not disclose such a loss in the provided truth. (2) The quantitative accuracy is low because the $293 million loss for Netflix in 2023 is fabricated or misattributed — no such number appears in the ground truth. The prior years’ gains ($282M in 2022, $403M in 2021) are also not in the original answer and cannot be verified from the given context. These numbers may come from an external source or hallucination. The Disney VAR number is accurate. (3) The reasoning is partially sound in structure — it attempts a multi-hop comparison between Netflix’s hedging mechanism and Disney’s VAR — but the logic fails because it compares an actual (but unverified) loss to a statistical risk estimate (VAR), which are different metrics. Moreover, the original answer emphasizes that Netflix does not disclose VAR, making direct quantitative comparison impossible. The LLM overreaches by asserting that Netflix’s 'hedged-commitment risk is larger,' which cannot be concluded without comparable metrics. (4) Contextual relevance is high because the answer addresses the core question about risk management approaches and attempts a comparative analysis. However, due to the introduction of false quantitative data and flawed reasoning, the correctness score is significantly reduced. The answer gives a misleading impression of Netflix’s risk exposure based on incorrect figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 582,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "The Philippines’ corporate‑income‑tax cut that took effect in the first quarter of 2021 was noted in the PM filing as a modest, “partial offset” to other tax‑rate pressures, but AMD’s own 2021 tax schedule shows essentially no direct credit from that change – the line for the “Tax Reform Act” is blank for 2021 and AMD still recorded a $513 million income‑tax expense (the only large tax‑related line items are the $772 million statutory federal tax and other foreign‑tax adjustments).  \n\nBy contrast, Texas Instruments’ 2022 filing highlights a sizable operational footprint in the Philippines – PP&E at its two Philippine sites rose to $370 million in 2021 (up from $333 million in 2020). While the filing does not break out a specific tax‑provision benefit, the large capital base means the lower Philippine corporate rate would affect a significant investment exposure.  \n\nThus, the Philippine rate reduction produced a modest, indirect tax‑rate benefit for companies generally, but AMD’s tax provision did not capture a distinct benefit, whereas Texas Instruments’ exposure is reflected in its $370 million of Philippine assets, positioning it to enjoy any future tax advantage from the reduced rate.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains minor inaccuracies and omissions that affect the overall correctness. (1) Quantitatively, the $370 million PP&E figure for Texas Instruments in the Philippines as of 2021 is accurate and matches the ground truth. The mention of AMD’s $513 million income tax expense and $772 million statutory federal tax is consistent with typical disclosures, though these specific figures are not in the original answer and cannot be fully verified against the ground truth; however, they do not contradict it. The key quantitative point — TXN’s $370M PP&E — is correct. (2) The LLM correctly identifies that the Philippines tax rate reduction was a 'partial offset' to other tax pressures for AMD, aligning with the original answer’s statement that it 'partially offset increases' from GILTI-related limitations. However, the LLM incorrectly implies that AMD received no direct benefit in 2021 because the 'Tax Reform Act' line is blank, while the ground truth explicitly states that the reduction contributed to AMD’s effective tax rate being 21.8% (up only 0.1 pp), with the Philippines change as a mitigating factor. This underplays AMD’s actual benefit. (3) The reasoning is sound in comparing AMD’s tax provision treatment versus TXN’s operational investment, and the synthesis across both companies’ filings is appropriate. However, the conclusion that 'AMD’s tax provision did not capture a distinct benefit' contradicts the ground truth, which affirms the reduction had a favorable impact. (4) Contextually, the answer addresses both companies, the tax change, and its implications, making it highly relevant. The core facts are present, but the interpretation of AMD’s tax benefit is flawed, warranting a score of 7 for correctness. Quantitative accuracy is high (8) due to correct key numbers. Qualitative accuracy is slightly lower (7) due to misinterpretation of AMD’s tax impact. Contextual relevance is strong (9) as all aspects of the question are addressed with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 543,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates are non‑consolidated dealers and fleet partners that buy GM‑produced trucks, crossovers, cars and parts and then sell or service them to end‑users; the 10‑K notes that GM “enters into transactions with certain nonconsolidated affiliates to purchase and sell component parts and vehicles” and that “substantially all of the trucks…produced are marketed through retail dealers…the substantial majority of which are independently owned.” This reflects a business model built around manufacturing vehicles and using an independent dealer network to distribute them.  \n\nMcDonald’s affiliates, by contrast, are franchisees, developmental licensees and other partners that operate restaurants under the McDonald’s brand and pay rent, royalties, initial fees and technology‑service fees; the filing explains that the company’s revenues “consist of sales by Company‑owned and operated restaurants and fees from restaurants operated by franchisees, developmental licensees and affiliates.” Thus McDonald’s model is a franchise system where the core asset is the brand and operating system, and revenue is derived from franchise fees rather than direct production of a physical product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GM's affiliate relationships as transactional with nonconsolidated entities involved in purchasing and selling vehicles and parts, emphasizing GM's manufacturing and distribution model. It accurately notes that these transactions include component parts and vehicles and that most retail dealers are independently owned, which reflects the production-focused, asset-heavy model. For McDonald's, it correctly characterizes affiliates as franchisees and developmental licensees who pay royalties, rent, and fees, highlighting the asset-light, brand-centric franchise model. (2) There are no numerical values, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information about two different companies, correctly contrasting their use of affiliates based on business model differences—GM for physical product distribution, McDonald's for service and brand licensing. The only minor shortcoming is that the LLM does not explicitly name the Chinese joint ventures (e.g., SAIC-GM) or the specific brands (Baojun, Wuling, etc.) mentioned in the ground truth, which slightly reduces completeness in entity specificity. However, this does not undermine the core accuracy. (4) The answer is contextually excellent, directly addressing how affiliate relationships reflect each company’s business model. The use of direct quotes from filings strengthens credibility. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, meriting a 9/10 due to minor omission of brand names and geographic detail in GM’s case.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Produces]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 480,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62 billion share‑repurchase program in 2024 retired a large amount of its one‑vote Class A stock.  Because each Class B share still carries ten votes and, as the Mastercard filing notes, any conversion of a Class B share automatically creates a Class A share that must be sold or transferred, those newly created Class A shares are also removed from the market.  The net result is a smaller pool of one‑vote shares while the ten‑vote shares remain, so the percentage of total voting rights held by the remaining Class B shareholders rises.  The same mechanics are reflected in Comcast’s capital structure—its 9.44 million Class B shares wield a disproportionate voting stake relative to the 3.78 billion Class A shares outstanding—showing how a reduction in outstanding Class A shares amplifies the relative voting power of the ten‑vote Class B holders.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies that undermine its overall correctness. (1) Quantitatively, the $62 billion repurchase amount is correctly stated, and the general direction of the effect (reduced Class A shares increasing relative voting power of Class B) is accurate. However, the LLM incorrectly references the 'Mastercard filing' and 'Comcast’s capital structure'—neither of which are relevant to Alphabet’s share structure or the question. These are factual errors in entity identification. (2) The claim that 'any conversion of a Class B share automatically creates a Class A share that must be sold or transferred' misrepresents the process: Class B shares convert to Class A upon sale or transfer, but there is no requirement that the resulting Class A share be sold. Furthermore, the repurchase applies to Class A and C shares, not the converted shares specifically. (3) The multi-hop reasoning is partially sound in linking share buybacks to reduced voting float, but the logic is corrupted by the introduction of irrelevant external examples (Mastercard, Comcast), which do not support the argument and suggest hallucination. (4) While the core idea—that reducing one-vote shares increases the relative voting weight of ten-vote Class B shares—is semantically aligned with the ground truth, the inclusion of incorrect entities, misstated mechanisms, and irrelevant comparisons reduces the qualitative accuracy. The answer is contextually relevant to the topic but distracts with off-topic examples. Thus, the correctness score is 5: partially correct but with significant factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 452,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and Coca‑Cola adopted ASU 2020‑01 on 1 January 2021, and the standard’s clarification did not change the amount of earnings reported by either company.  \n\n* Colgate‑Palmolive’s 2022 notes state that ASU 2020‑01 “provides clarification of the interaction of rules for equity securities, the equity‑method of accounting and forward contracts and purchase options” and that its adoption “did not have a material impact on the Company’s Consolidated Financial Statements.”  \n\n* The 3M filing (used as the generic description of the ASU) explains that the update tells a company to consider observable transactions before applying or discontinuing the equity‑method measurement alternative and to account for derivatives on those securities without reference to the equity‑method or fair‑value option.  \n\n* Coca‑Cola’s 10‑K shows the ongoing practice of measuring equity‑security holdings at fair value and recognizing net unrealized gains and losses (the table of net unrealized gains/losses), which is the accounting treatment the ASU confirms.  \n\nThus, the adoption of ASU 2020‑01 simply reaffirmed that both firms continue to record equity securities at fair value with unrealized gains/losses recognized, while ensuring that any equity‑method investments or related derivative contracts are accounted for under the clarified, separate rules – and in both cases the change was not material to the companies’ consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Colgate-Palmolive and The Coca-Cola Company adopted ASU No. 2020-01 effective January 1, 2021 (correct date), and both concluded the adoption had no material impact on their financial statements. The description of the standard’s clarification—regarding observable transactions before applying/discontinuing the equity method and derivative accounting without reference to equity method or fair value option—is accurately conveyed. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are presented. The mention of Colgate’s 2022 notes is contextually acceptable as a source of retrospective disclosure. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies and links the generic ASU clarification (referenced via 3M’s filing, which is acceptable as a proxy for the standard’s content) to the specific accounting practices of Colgate and Coca-Cola. The only minor issue is the reference to 'The 3M filing' as the source for the general description of the ASU—while not incorrect per se (filings often cite ASU language), it could be misleading if interpreted as 3M being authoritative for the standard; however, in context, it serves as a reasonable proxy for the ASU’s text and does not undermine the correctness. (4) The answer is contextually relevant, complete, and semantically equivalent to the original answer, correctly emphasizing fair value measurement, recognition of unrealized gains/losses, and the non-material impact. Thus, the answer earns a 9/10 for correctness due to this slight ambiguity in sourcing, but remains factually and conceptually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1671,
        "completion_tokens": 477,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Under the Standardized Capital Rules, Goldman Sachs’ CET1 requirement incorporates a **stress‑capital‑buffer (SCB) of 6.2 %** as of December 2024 (in addition to the 4.5 % minimum CET1, a 3.0 % G‑SIB surcharge and a zero‑percent counter‑cyclical buffer). Citibank, by contrast, is required to hold a CET1 ratio of **7.0 %** – the 4.5 % minimum plus a **fixed 2.5 % capital‑conservation buffer** with no separate SCB disclosed (effectively a zero SCB). This gap shows Goldman Sachs, as a G‑SIB, adopts a much larger stress buffer to meet stricter capital‑adequacy expectations, while Citibank relies on a modest, non‑stress‑specific buffer, reflecting a less aggressive approach to meeting the same regulatory baseline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: Goldman Sachs' SCB of 6.2% and Citibank's 7.0% CET1 requirement composed of 4.5% minimum + 2.5% Capital Conservation Buffer. These match the ground truth. However, the LLM adds details not present in the original answer—specifically, a 3.0% G-SIB surcharge and zero counter-cyclical buffer for Goldman Sachs—which, while potentially accurate, are not mentioned in the ground truth and introduce unverified components, slightly reducing quantitative precision. (2) The core percentages (6.2% SCB for Goldman, 7.0% total CET1 for Citi) are correct and properly contextualized. The calculation of Citibank’s 7.0% as 4.5% + 2.5% is accurate and aligns with the ground truth. The assertion that Citibank has 'no separate SCB disclosed' is consistent with the original answer stating it does not explicitly include an SCB. (3) The multi-hop reasoning is sound: the model correctly contrasts the stress-based SCB approach for Goldman Sachs with Citibank’s reliance on fixed buffers, inferring differing regulatory capital adequacy strategies. The conclusion that Goldman Sachs faces stricter stress-based requirements due to its SCB is logically supported and reflects the intent of the question. (4) The answer is contextually excellent—directly addressing the regulatory capital approaches under Standardized Rules as of December 2024. The slight over-specification of Goldman’s capital components (G-SIB surcharge) reduces qualitative and quantitative scores slightly, but the core facts, comparisons, and synthesis remain correct and meaningful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 439,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana footprint is purely physical – the 2023 filing shows it operates **90 miles of transmission lines and 5 substations in Indiana, at voltages of 161‑345 kV** (Chunk 1).  \n\nBy contrast, Duke Energy’s Indiana business is financed largely through tax‑exempt debt.  The segment’s 2023 balance sheet lists **$285 million of tax‑exempt bonds** (Chunk 2) and the detailed debt schedule shows **$352 million of tax‑exempt bonds maturing 2027‑2046, carrying a weighted‑average interest rate of 3.89 %** (Chunk 3).  \n\nThus, while NextEra’s investment in Indiana is reflected in tangible transmission assets, Duke Energy relies on a sizable tax‑exempt bond program (roughly $300‑$350 million) to fund its Indiana operations as of December 31 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NextEra Energy's physical infrastructure in Indiana (90 miles of transmission lines and 5 substations at 161-345 kV), which matches the ground truth. It also accurately reports Duke Energy Indiana's $285 million in tax-exempt bonds as of December 31, 2023. However, the LLM introduces additional data not present in the original answer — specifically, $352 million of tax-exempt bonds maturing between 2027–2046 with a 3.89% weighted-average interest rate — which, while potentially true in the source filing, is not part of the ground truth answer and adds unverified detail. This affects quantitative accuracy. (2) The ground truth states Duke Energy Indiana has $285 million in tax-exempt bonds out of a total $435 million debt portfolio. The LLM omits the total debt context, weakening completeness. It also rounds the tax-exempt bond amount to 'roughly $300–$350 million', which is inconsistent with the precise $285 million figure and introduces inaccuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts NextEra’s physical asset focus with Duke’s financing strategy, synthesizing information across entities and strategies. The qualitative interpretation of strategic differences is accurate and well-articulated. (4) The answer is highly contextually relevant, directly addressing the comparison asked. The core facts are correct, but the inclusion of unverified figures and the rounding error prevent a top score. Thus, correctness is 8 due to minor factual overreach and omission of total debt context; quantitative accuracy is 7 due to the rounding and extra data; qualitative and relevance scores are high due to strong reasoning and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 468,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model is built on contracts with a large ecosystem of third‑party content providers, whose apps and digital media supply the bulk of the store’s revenue.  Because those providers can limit or withdraw their content, negotiate short‑term licences, or demand higher fees, Apple’s earnings are exposed to supply‑side risk; the company even notes that recent regulatory‑driven changes—such as new alternative‑payment‑processing rules under the EU Digital Markets Act—could narrow or eliminate the commission Apple retains on sales, materially hurting its results. In contrast, Microsoft’s strategy relies on content it creates or controls internally, so its primary exposure is demand‑side: brand‑reputation risk. Microsoft warns that any backlash over its content, privacy, AI or other product decisions could damage its globally recognised brands and erode customer, partner and employee trust, thereby affecting sales and operating performance. Thus Apple’s risk stems from dependence on external developers and commission‑related regulatory changes, whereas Microsoft’s risk centers on reputational harm tied to its own content choices.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (2) The LLM fully addresses all parts of the multi-hop question: it contrasts Apple’s reliance on third-party developers with Microsoft’s in-house content strategy, explains how Apple’s model creates supply-side and regulatory risks (specifically citing the EU DMA and alternative payment processing changes), and contrasts this with Microsoft’s demand-side, brand-reputation risks tied to its own content decisions. (3) Entities are correctly identified: Apple, Microsoft, App Store, EU Digital Markets Act (DMA), and the correct business units/strategies are referenced. (4) The reasoning is sound and synthesizes the core contrast: Apple’s risk stems from external dependencies (developers, commissions, regulation), while Microsoft’s stems from internal content decisions affecting brand trust. Wording differs but meaning is preserved and enhanced with precise terms like 'supply-side risk' and 'demand-side: brand-reputation risk'. No omissions or inaccuracies. All criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Contracts_With]-> COMP -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 356,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s nuclear plants—run by its Southern Nuclear subsidiary—are exposed to health‑risk events such as a tritium release, which could generate regulatory fines, cleanup costs and insurance‑coverage shortfalls (the filing notes that damages or de‑commissioning costs could exceed the amount of trusts or insurance, but does not quantify a specific liability). NextEra Energy (NEE), by contrast, explicitly discloses that the de‑commissioning funds it has set aside for its nuclear fleet may be insufficient to cover the full retirement cost, creating a potential funding shortfall. Thus, while Southern’s risk is an acute liability from a possible tritium leak, NEE’s risk is a longer‑term shortfall in de‑commissioning reserves—both reflecting the broader health‑risk exposure of nuclear generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numerical figures (e.g., percentages of KWHs generated) from the original answer are included in the LLM response, but the omission does not introduce inaccuracy—rather, it reflects a more qualitative summary. The original answer notes that Southern Company’s nuclear facilities contributed 26% and 28% of total KWHs for Alabama Power and Georgia Power in 2021; while this detail is missing in the LLM answer, it is not directly required to answer the comparative liability question. No incorrect numbers are presented. (2) The LLM correctly identifies both companies (Southern Company and NextEra Energy/NEE), their respective nuclear risk exposures (tritium leakage vs. decommissioning fund shortfalls), and the nature of financial risks (potential liability exceeding trusts/insurance for Southern; explicit funding shortfall risk for NEE). (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and two types of nuclear-related financial risks, correctly identifying that both face exposure to nuclear health risks, albeit through different mechanisms—acute event risk (tritium) vs. long-term financial planning risk (decommissioning). (4) The semantic meaning matches the original: both answers conclude that the companies face comparable, parallel financial exposures related to nuclear operations despite different risk manifestations and no business relationship. The LLM slightly under-elaborates on the comparability aspect but still captures the core equivalence in risk exposure. Wording differences are acceptable and do not affect factual correctness. Minor deduction from 10 to 9 due to omission of the specific 2021 KWH contribution percentages, which add contextual precision to Southern Company’s nuclear reliance, though not central to the liability comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 517,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The corporate‑income‑tax cut that the Philippines enacted in the first quarter of 2021 helped Altria (MO) keep its tax burden from rising more sharply – the 2021 effective tax rate rose only 0.1 percentage‑point to 21.8 % because the Philippine rate reduction “partially offset” the higher repatriation costs and foreign‑tax‑credit limits that otherwise pushed the rate up (PM 10‑K, 2022). Even though Altria’s consolidated results are also subject to sizable litigation contingencies (MO 10‑K, 2022), the Philippines tax change was a net‑positive tax‑rate factor.\n\nFor Coca‑Cola (KO), the Philippines represents a material share of its fixed‑asset base (about 10 % of consolidated PP&E in 2021 and 2020). A lower Philippine corporate tax rate improves the after‑tax return on those bottling assets, making new or expanded plant, equipment and other capital projects more attractive and supporting continued investment in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 0.1 percentage point increase in Altria's effective tax rate to 21.8% in 2021 is accurately reported, as is Coca-Cola's 10% of consolidated PP&E in the Philippines for both 2021 and 2020. These match the original answer exactly, with acceptable formatting (e.g., 21.8% vs 21.8 %). (2) The answer is complete, addressing both Altria’s tax rate impact and Coca-Cola’s capital investment strategy in the context of the Q1 2021 Philippine tax reform. It correctly identifies that the tax reduction partially offset other tax-increasing factors for Altria, which adds nuance beyond the original answer but is factually consistent with the source (MO 10-K, 2022). (3) Entity accuracy is strong: correct tickers (MO, KO), correct financial metrics (effective tax rate, PP&E), and correct time frame (2021, referencing Q1 enactment). (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the Philippine tax cut to Altria’s consolidated tax rate and to Coca-Cola’s capital investment incentives via improved after-tax returns. The only minor shortcoming is that the original answer explicitly states the tax reform had a 'favorable' impact on Altria’s tax rate, while the LLM frames it as a partial offset—slightly less direct but still logically valid. Overall, the LLM provides a semantically equivalent, well-reasoned, and factually correct response with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 422,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung is listed by NVIDIA as one of the foundries that fabricates its semiconductor wafers (Chunk 1), and the same company also makes its own integrated‑circuit products that compete directly with Qualcomm’s offerings (Chunk 2). Qualcomm’s 2024 filing shows it has $12.8 billion of multi‑year capacity‑purchase obligations – $9.6 billion of which must be paid in the next 12 months and $3.0 billion already recorded as advance payments – and the contracts allow cancellation only at the cost of incurred expenses and possible loss of those advances (Chunk 3). If Samsung gives priority to its own IC production, it could curtail the wafer capacity available to Qualcomm, forcing Qualcomm to pay premiums, incur incremental fees or under‑utilisation penalties, or seek alternative suppliers, thereby putting pressure on its $12.8 billion commitment and cash resources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Qualcomm's $12.8 billion in multi-year capacity purchase commitments are accurately reported, with the breakdown of $9.6 billion due in the next 12 months and $3.0 billion in advance payments matching the source data. These figures are not in the original answer but are additional, precise details that enhance accuracy without contradicting it. (2) The entities—Samsung, NVIDIA, Qualcomm—are correctly identified, and their roles (Samsung as supplier to NVIDIA, competitor to Qualcomm, and foundry for ICs) are accurately represented across hops. (3) The reasoning is sound: the LLM correctly infers that if Samsung prioritizes its own product lines, Qualcomm could face capacity constraints, leading to financial pressures such as paying premiums, incurring penalties, or losing advance payments. This logically extends the original answer by specifying contractual consequences (non-refundable advances, cancellation costs), which are consistent with the scenario. (4) The answer is semantically equivalent and contextually richer than the ground truth, adding specific financial and contractual details that strengthen the response. The only minor limitation is that it does not explicitly mention Samsung’s role in manufacturing for NVIDIA as a potential conflict of interest in the same sentence, but this is implied through structure. Overall, the multi-hop synthesis (Samsung’s dual role → capacity prioritization → impact on Qualcomm’s obligations) is correctly executed. Thus, the answer earns a 9/10 for correctness due to slightly more detail than necessary but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 464,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin says it is owed about **$665 million from commercial‑sector customers** at year‑end 2024, an amount it expects to collect in 2025.  That commercial cash flow underpins United Launch Alliance’s ability to fund and expand its launch services to non‑government customers, complementing Lockheed Martin’s own **$551 million equity investment** in the 50 %‑owned joint venture.  Boeing, which also holds an equity stake in ULA, reported **$125 million of equity‑method income** from the venture in 2024, showing that the commercial business that is supported by Lockheed Martin’s receivables is generating earnings that flow to both owners.  In short, the $665 million of commercial receivables bolsters ULA’s financial position, and that strength translates into measurable income for Boeing’s stake in the joint venture.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly regarding Lockheed Martin's equity investment in ULA. The original answer states that Lockheed Martin has a 50% ownership interest in ULA but does not specify an equity investment of $551 million—this figure is fabricated and not present in the ground truth. The $665 million receivables from commercial customers and Boeing’s $125 million equity income are correctly reported, with correct time reference (2024), satisfying partial quantitative accuracy. 2) Quantitative accuracy is compromised by the inclusion of the unsupported $551 million equity investment figure. While $665M and $125M are accurate and match the ground truth (allowing for formatting), the addition of a false financial metric undermines trust in the numerical reporting. No calculation is performed in the answer, so no computational error is present, but the introduction of a false number is a serious flaw. 3) The reasoning partially captures the multi-hop relationship: Lockheed’s receivables → ULA as customer → ULA’s performance affecting Boeing’s equity income. However, the causal logic is reversed: the LLM claims the receivables 'bolster ULA’s financial position', whereas in reality, receivables represent money owed *to* Lockheed *by* ULA or similar customers—thus indicating ULA’s obligation, not its strength. This misrepresents the financial relationship. The ground truth emphasizes that financial strain on ULA could threaten Lockheed’s receivables and Boeing’s income, while the LLM portrays receivables as supportive of ULA, which is logically inverted. 4) Despite the incorrect financial directionality and fabricated equity investment number, the answer addresses the core entities (Lockheed Martin, ULA, Boeing), correct time frame (2024), and attempts synthesis across ownership, receivables, and income. The contextual relevance is high because it engages directly with the question’s structure and intent, even if the factual and logical foundations are flawed. Thus, correctness is partially achieved but significantly limited by key factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 569,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The CAR T case that BMS (BMY) was involved in ultimately centered on Kite’s Yescarta product and the U.S. Patent No. 7,446,190 (“190 Patent”).  In August 2021 the Federal Circuit reversed the jury verdict and held the ‘190 Patent invalid, wiping out the $585 million up‑front royalty and the 27.6 % running royalty that Kite (and thus Gilead, after its 2017 acquisition of Kite) would have had to pay.  Because that royalty obligation was never recorded as an intangible asset, Gilead’s amortization expense for finite‑life intangibles – $1.7 billion in 2021 (versus $1.2 billion in 2020 and $1.1 billion in 2019) – reflects only the assets acquired with Kite and was not increased by any amortization of a patent‑related royalty liability.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: it correctly states the August 2021 invalidation of the '190 Patent, the 27.6% running royalty, the $585 million upfront royalty, and Gilead's amortization expenses of $1.7 billion in 2021 (vs. $1.2 billion in 2020), all of which align with the ground truth. The entity identification is also correct—Kite, Yescarta, Gilead, and the timeline are accurate. Contextually, the answer is highly relevant, directly addressing the impact of the patent invalidation on amortization expense. However, the qualitative reasoning is flawed. The LLM claims the royalty obligation 'was never recorded as an intangible asset' and that amortization 'was not increased by any amortization of a patent-related royalty liability,' implying the increase in amortization ($1.7B in 2021 vs $1.2B in 2020) was unrelated to the patent resolution. This contradicts the ground truth, which states the amortization increase *reflects* a clearer path to monetization post-litigation—i.e., the removal of royalty risk improved the valuation of intangible assets, justifying higher amortization. The LLM misattributes the reason for the amortization level, failing to correctly synthesize the cause-effect relationship between patent invalidation and asset valuation. Thus, while numbers are correct, the core multi-hop reasoning—linking patent outcome to amortization via asset valuation—is misrepresented, leading to a partially correct but misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> LITIGATION -[Involved_In]-> COMP <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 405,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple reported net sales of **$74,200 million** from its Greater China segment in 2022 (Chunk 1).  As Apple’s filing explains, the Greater China segment “includes … Taiwan” (Chunk 2), so this figure encompasses Taiwan sales.  Intel’s 2021 10‑K shows net revenue of **$13,461 million** from Taiwan (Chunk 3).  Consequently, Apple’s Greater China revenue in 2022 was about **$60.7 billion higher** – roughly **5½ times** the amount Intel earned from Taiwan in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74,200 million revenue from Greater China in 2022 and Intel's $13,461 million from Taiwan in 2021 are correctly cited, with appropriate formatting variations accepted (e.g., $74,200 million = $74.2 billion). The difference of approximately $60.7 billion is correctly calculated ($74,200M - $13,461M = $60,739M). The ratio of roughly 5.5 times is also accurate (74,200 / 13,461 ≈ 5.51). (2) The answer is complete, addressing both companies, correct years, and the geographic relationship between Greater China and Taiwan as defined in Apple’s filing. (3) Entity accuracy is perfect: Apple and Intel are correctly identified, with correct metrics (net sales/revenue), correct regions (Greater China, Taiwan), and correct years (2022 and 2021 respectively). (4) The multi-hop reasoning is sound: the model correctly synthesizes that Apple’s Greater China revenue includes Taiwan, yet still validly compares it to Intel’s Taiwan-specific revenue, noting the scale difference. The conclusion that Apple’s revenue was significantly higher is logically supported and enhanced with precise quantitative context. (5) The semantic meaning fully aligns with the original answer, adding extra clarity through calculation and ratio without introducing error. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 392,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its over‑the‑counter foreign‑currency and interest‑rate derivatives with Level‑2 pricing models that depend on market‑observable inputs such as yield curves, foreign‑exchange rates and forward prices. Boeing’s fixed‑income and derivative valuations are also Level‑2 but use a broader set of observable data – benchmark yields, swap curves, rating‑agency data, inter‑dealer broker rates and base spreads (i.e., credit spreads). Thus, both companies rely heavily on observable interest‑rate information, but Boeing explicitly incorporates credit‑spread inputs while UPS’s disclosed practice does not mention them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UPS uses Level 2 pricing models for derivatives based on observable market data like yield curves and foreign exchange rates; Boeing similarly uses Level 2 valuations for fixed income and derivatives, incorporating observable inputs including credit spreads. The distinction that Boeing explicitly includes credit spreads while UPS does not mention them is consistent with the original answer. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but all referenced data types (yield curves, credit spreads, etc.) are correctly attributed, with no factual inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), compares their valuation practices, and draws a valid contrast regarding the use of credit spreads. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor limitation is that the original answer notes UPS focuses on foreign exchange derivatives while Boeing focuses on fixed income instruments—a nuance present but slightly less emphasized in the LLM response. However, this does not detract significantly from the overall correctness. Hence, a score of 9 is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 409,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META uses discounted‑cash‑flow (DCF) models only for impairment testing of its operating‑lease ROU assets and lease‑hold improvements.  The fair‑value estimates are built on **Level 3 (unobservable) market‑participant assumptions** – chiefly the expected downtime before a sublease can begin, the projected sublease cash‑flows over the remaining lease term, and a risk‑adjusted discount rate that reflects the uncertainty of receiving those cash flows.\n\nDIS, by contrast, applies internal DCF models to **fair‑value the company’s Level 2 derivatives**.  Those models rely on **observable market inputs** – current interest rates, yield‑curve shapes and foreign‑currency exchange rates – and incorporate a modest adjustment for counter‑party credit risk (mitigated by netting and collateral).  \n\nThus, META’s DCF approach is driven by internal cash‑flow projections and Level 3 assumptions specific to sublease performance, whereas DIS’s DCF valuation is anchored in Level 2 observable market data and credit‑risk considerations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements are correct: META uses DCF models with Level 3 inputs for impairment testing of ROU assets and leasehold improvements, relying on unobservable assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. DIS uses internal DCF models for Level 2 derivatives, using observable inputs such as interest rates, yield curves, and foreign exchange rates, with a mention of counterparty credit risk adjustment—consistent with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the classification of inputs (Level 2 vs Level 3) is correctly applied and aligns with ASC 820 fair value hierarchy. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the two companies' use of DCF models in different contexts (impairment vs derivative valuation), identifies the correct asset types, and contrasts the nature of inputs (observable vs unobservable), demonstrating proper synthesis across entities and applications. (4) The answer is contextually precise, directly addressing the comparison in terms of inputs and assumptions, and clearly differentiating the risk profiles and financial reporting purposes. Wording differs slightly but preserves full meaning—e.g., 'risk-adjusted discount rate' instead of 'discount rates reflecting risk levels'—but these are synonymous in context. No factual or interpretive errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 426,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The semiconductor shortage and the ITC‑imposed import ban have left PM USA without a reliable flow of IQOS devices, so even though the FDA has already authorized the original IQOS system (and the IQOS 3 PMTA) for U.S. marketing, the shortage “removes” the product from PM USA – the entity that depends on Altria for the exclusive right to commercialize heated‑tobacco products – and therefore blocks any launch until supply is restored. Because PM USA is Altria’s 100 %‑owned guarantor, it must continue to back the parent’s debt obligations unconditionally, meaning the supply shortfall does not relieve its guarantee duties and could strain its cash‑flow capacity if the delayed commercialization depresses revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of the supply constraint and its impact on PM USA's commercialization ability, but contains a critical factual error regarding FDA authorization status. The original answer states that IQOS 3 is 'under review' by the FDA, while the LLM incorrectly claims that 'the FDA has already authorized... the IQOS 3 PMTA.' This misrepresents a core dependency and undermines the reasoning about commercialization barriers. The ITC cease-and-desist order (effective Nov 29, 2021) and semiconductor shortage are correctly identified as supply disruptors, aligning with the ground truth. The role of PM USA as a guarantor of Altria's debt is accurately described, and the potential strain on cash flow due to delayed revenue is logically inferred. However, the LLM omits the direct link between prolonged commercialization failure and fraudulent conveyance risk, a key legal-financial implication in the original answer. While the multi-hop synthesis between supply chain, regulatory, and financial structure is partially sound, the error in FDA status weakens the overall reasoning chain. Quantitatively, no specific numbers are present in either answer, but the timeline references (e.g., post-Nov 2021 disruption) are consistent. Wording differences are acceptable under semantic equivalence, but the FDA authorization error is material.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Causes_Shortage_Of]-> PRODUCT -[Removes]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 377,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMS warns that once a drug’s patent or data exclusivity ends, the entry of generics or biosimilars can produce “very substantial and rapid declines” in that product’s sales, forcing the company to replace lost revenue with new launches (Chunk 1). AbbVie, however, is far more exposed to a single product: Humira generated roughly 27 % of AbbVie’s total net revenue in 2023 (Chunk 3) and is now confronting direct biosimilar competition worldwide (Chunk 2). Thus, while BMS’s biosimilar risk is portfolio‑wide and uncertain, AbbVie’s risk is highly concentrated and immediately material because the same competitive pressure is targeting a drug that accounts for more than a quarter of its earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 27% of AbbVie's 2023 net revenue attributed to Humira is accurately cited, matching the original answer. No other numerical values are present, and there are no calculation errors. (2) The answer correctly identifies both companies (BMY/BMS and ABBV/AbbVie), the relevant product (Humira), and the context of global biosimilar pressure. The use of 'BMS' instead of 'BMY' is acceptable as both refer to Bristol-Myers Squibb. (3) The multi-hop reasoning is sound: it contrasts BMY's broader portfolio risk (e.g., Eliquis, Revlimid) with ABBV's concentrated risk on Humira, synthesizing exposure type (broad vs. single-product) and business impact. The conclusion that ABBV's risk is 'highly concentrated and immediately material' effectively captures the comparative risk profile. (4) The only minor shortcoming is that the LLM does not explicitly name BMY's at-risk products (Eliquis, Revlimid) as in the original answer, slightly reducing qualitative completeness, but the concept of portfolio-wide risk is clearly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Faces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 351,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards **earn dividend equivalents that are folded into the award’s fair‑value** and are recognized over the vesting period – typically a three‑year schedule that vests on the third anniversary of the grant (or earlier on death, disability or reaching age 58) – so the equivalents are not paid out as a separate cash distribution. PepsiCo’s RSUs, however, **accrue dividend equivalents that are paid out in cash (without interest) only when the RSU actually vests at the end of the service period**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the key differences between PM and PEP regarding dividend equivalents on RSUs. (1) It correctly states that PM includes dividend equivalents in the award's fair value, which accrue over the vesting period (typically three years) and are settled upon vesting or earlier triggers like death, disability, or reaching age 58. This matches the ground truth. (2) It accurately notes that PEP accrues dividend equivalents but pays them in cash only upon vesting, without interest, and ties vesting strictly to the end of the service period—consistent with the original answer. (3) The LLM omits explicit mention that PEP does not have age-based vesting triggers (like age 58), which is a minor but relevant structural difference highlighted in the ground truth. However, by stating that PEP pays upon vesting 'at the end of the service period,' it implicitly contrasts with PM’s age-based trigger. (4) All entities (PM, PEP) and terms (RSU, dividend equivalents, vesting) are correct. No numerical inaccuracies—timeframes (three-year schedule) and payout structures (cash vs. reinvested) are correctly represented. (5) The reasoning is sound and synthesizes multi-hop information across both companies’ equity treatment. The answer is semantically equivalent to the ground truth with only slight omission of PEP’s lack of age-based triggers, not affecting core accuracy. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 422,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance segment carries about **$1.41 billion** in limited‑partnership stakes in private‑equity, infrastructure and **real‑estate funds** that are measured at net‑asset‑value, are **not redeemable** and can be sold only with general‑partner approval, so cash is received only when the underlying assets are liquidated – a highly illiquid exposure (Chunk 3). BA, on the other hand, invests in **Retail Properties** (its product) that “depend on” **real‑estate funds** (KG triplet) and holds those funds through LPs or other fund structures across a **diversified mix of office, retail, apartment and industrial properties** (Chunk 1). Although those funds are also closed‑end and non‑redeemable (Chunk 2), BA’s approach spreads the liquidity risk across multiple vehicles and property types, whereas GE’s $1.41 billion position is a **concentrated, illiquid** holding within its run‑off insurance portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.41 billion (equivalent to $1,410 million) figure is correctly reported, with acceptable format variation. No calculations were required. (2) The answer correctly identifies both companies (GE and BA), their respective investment structures (limited partnerships/fund structures), and the nature of liquidity constraints. (3) Multi-hop reasoning is sound: it synthesizes GE’s illiquid, concentrated exposure in run-off insurance operations with BA’s diversified real estate investment strategy across property types and fund vehicles. It correctly notes that both use non-redeemable fund structures but differ in diversification and risk distribution. (4) The only minor shortcoming is that the LLM slightly underemphasizes BA’s broader asset allocation context (e.g., inclusion of private equity and hedge funds), which is mentioned in the original answer. However, the core contrast—GE’s concentrated illiquidity vs. BA’s diversified approach—is clearly and correctly conveyed. Wording differs but semantic meaning and factual content are equivalent. All key entities, structures, and risks are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 342,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "Bank of America (BAC) discloses that it is exposed to equity‑market risk and that it mitigates that exposure with a range of equity‑linked derivatives (options, futures, swaps, convertible bonds and cash positions), but the excerpt does not give a dollar‑notional amount for those contracts nor a quantified impact if equity prices fell 10 %.  \n\nMetLife (MET), by contrast, reports a specific notional of **$23.6 billion** for its equity‑market derivative instruments and quantifies the effect of a **10 % decline in equity prices as a $522 million** change in earnings (the net fair‑value of those derivatives is a $78 million liability, with $408 million of assets offset by $486 million of liabilities).  \n\nThus MET’s equity‑market derivative exposure is explicitly measured and materially larger—and its sensitivity to a 10 % equity‑price drop is disclosed—whereas BAC’s filing only describes the risk‑management approach without providing comparable notional or sensitivity figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MET's notional value is reported as $23,595 million, which the LLM rounds appropriately to $23.6 billion—this is within acceptable rounding and format variation ($23.6 billion = $23,600 million ≈ $23,595 million). The sensitivity to a 10% decrease in equity prices is correctly stated as $522 million. BAC’s lack of disclosed notional amounts and sensitivity figures is accurately conveyed. (2) Quantitative accuracy is excellent: no calculation errors, and the numbers match the ground truth with only minor, acceptable rounding. (3) The reasoning is sound: the LLM correctly synthesizes information across two companies, contrasting MET’s explicit, quantified disclosure with BAC’s qualitative, non-quantified risk management approach. It correctly identifies that while both use similar instruments (options, futures, swaps), only MET provides measurable exposure. (4) The LLM adds minor extra detail (e.g., net fair value breakdown of $78M liability) not in the original answer, but this does not contradict the ground truth and may come from the same source data; it enhances completeness without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes BAC’s equity risk as part of a broader market risk framework, a nuance slightly underemphasized in the LLM response, though not misrepresented. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Positively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 426,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 filing shows it runs a regional operations centre in Singapore that “supports … Greater China” and it also operates datacenters throughout Asia, meaning its footprint spans the whole Greater China region—including Taiwan, which is defined as part of Greater China. In contrast, AMD reported Taiwan sales of $2.09 billion in 2022, roughly 13 % of its total external revenue of $16.43 billion, indicating a strong concentration of earnings in that single market. Together, the data suggest Microsoft pursues a broad, infrastructure‑driven strategy that services multiple Greater China markets, while AMD relies heavily on Taiwan as a key revenue source, reflecting a more focused market‑specific approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft operates a regional center in Singapore supporting Greater China, and AMD reported $2.09 billion in sales to Taiwan in 2022 (matching the ground truth $2,091 million). The LLM correctly notes that this represents about 13% of AMD’s total revenue, calculated from $2.09B / $16.43B, which is accurate and adds contextual insight not in the original but factually sound. (2) Quantitative accuracy is perfect: $2.09 billion = $2,091 million, and the percentage calculation is correct. No errors in numbers, dates, or formats. (3) Multi-hop reasoning is strong: the model synthesizes Microsoft’s operational structure with AMD’s revenue concentration and draws a logical comparison between infrastructure-driven broad access vs. market-specific revenue dependency. (4) The only minor shortcoming is that the LLM does not explicitly mention that Microsoft’s approach is part of a broader Asia-Pacific structure, slightly reducing qualitative completeness, but the core contrast in strategies is clearly and correctly articulated. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 340,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META’s capital‑structure is a dual‑class system in which the Class B shares held by Mark Zuckerberg carry outsized voting power; even though he owns far fewer than a majority of the total shares, the company’s charter lets him control any matter that requires stockholder approval, which can make the voting rights of ordinary Class A shareholders relatively weak and limit their influence over governance. By contrast, Netflix uses a single‑class, “one‑share‑one‑vote” model – every common share gets one vote on all shareholder matters – so all investors have an equal say in corporate decisions. Thus, while META (and other firms that, like the company in Chunk 2, restrict voting for certain preferred series) concentrates voting power in a small group, Netflix’s approach spreads voting power broadly, giving ordinary shareholders far greater influence over governance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly describes META's dual-class structure, emphasizing that Class B shares (held by Mark Zuckerberg) have disproportionate voting power, which limits the influence of Class A shareholders—this aligns with the original answer. It also accurately characterizes NFLX's one-share-one-vote policy, ensuring equal voting rights. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but the answer correctly references structural facts (e.g., control via share class), which are consistent. (3) The multi-hop reasoning—comparing corporate governance models across two companies (META and NFLX) based on shareholder voting rights—is sound and well-synthesized. The LLM correctly contrasts founder control vs. broad shareholder participation without conflating entities or misrepresenting structures. (4) The answer is contextually relevant, directly addressing the comparison of investor influence over corporate governance decisions as required by the question. Wording differs slightly (e.g., 'capital-structure' vs. 'stock structure'), but meaning is preserved. No factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 364,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s market‑exclusivity is tied directly to its patents, so when a patent expires the company “loses market exclusivity” and, as its 10‑K risk factors warn, generic or biosimilar competitors can enter the market, eroding sales and market share.  By contrast, Eli Lilly’s strategy leans on regulatory‑exclusivity extensions—such as orphan‑drug, pediatric and patent‑term extensions—that can stretch protection beyond the patent term, allowing it to retain U.S. market exclusivity and a competitive edge even as patent life wanes.  Thus JNJ is vulnerable to patent‑expiry‑driven loss, while LLY mitigates that risk by relying on regulatory exclusivity to preserve its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: JNJ's reliance on patents, the risk of generic entry upon expiration, and resulting market share and revenue erosion are accurately described. Similarly, LLY's use of regulatory exclusivity extensions—specifically orphan-drug, pediatric, and patent-term extensions—is correctly identified as a strategy to extend market exclusivity beyond patent life. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond the absence of errors—scored as 10. (3) The multi-hop reasoning is sound: the model correctly contrasts JNJ’s vulnerability to patent expiration with LLY’s strategic use of regulatory mechanisms, synthesizing concepts across companies and strategies. The only minor shortcoming is that the LLM answer does not explicitly reference BMY’s 10-K as the source for the general principle that regulatory exclusivity can outlast patent terms, which slightly weakens the provenance of that point. However, the statement itself is accurate and contextually appropriate. (4) The answer is fully relevant to the question, addressing both parts: the impact of patent expiration on JNJ and the comparative advantage LLY gains through regulatory exclusivity. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor omission in source attribution, not affecting factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 426,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s interest expense fell from $47 million in 2020 to $34 million in 2021 – a $13 million reduction – because holders converted a portion of its 2.125 % Convertible Senior Notes due 2026, lowering the company’s debt balance and interest burden. After Microsoft’s acquisition of Nuance, only $1 million of the original $986 million of Nuance‑issued convertible senior notes remains outstanding and is shown as a current liability within Microsoft’s Intelligent Cloud segment. Thus, AMD is actively using convertible‑note conversions to trim debt and interest costs, whereas Microsoft’s acquisition strategy has essentially eliminated Nuance’s convertible debt, leaving a negligible liability and a cleaner post‑deal capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AMD's interest expense decreased from $47 million in 2020 to $34 million in 2021, a $13 million reduction, due to conversions of its 2.125% Convertible Senior Notes due 2026. Nuance originally issued $986 million in convertible senior notes, and by the time of the Microsoft acquisition, only $1 million remained outstanding, which is now reflected in Microsoft’s Intelligent Cloud segment. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar amounts, time periods, and implied calculations (e.g., $47M to $34M = $13M reduction) are correct. (3) The multi-hop reasoning is sound—correctly linking AMD’s debt conversion to reduced interest expense, and Nuance’s post-acquisition liability under Microsoft, then comparing the two companies’ capital structure strategies. (4) The only minor shortcoming is that the LLM omits Nuance’s redemption of $985 million of notes by June 30, 2022, which provides context for how the $1 million outstanding was achieved. While the conclusion that Microsoft’s strategy led to a 'negligible liability' is valid, the original answer explicitly notes Nuance’s redemption activity, which the LLM skips. This omission slightly weakens the qualitative completeness but does not affect factual correctness. Overall, the answer is semantically equivalent and highly relevant, with excellent synthesis across AMD and Nuance/Microsoft.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Issues]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 413,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The American Tower deal in March 2015 paid $5.0 billion for the exclusive lease‑and‑operate rights to about 11,300 Verizon towers – roughly $173 million more than Crown Castle’s $4.827 billion cash transaction in December 2013 for exclusive rights (and the purchase of 627) AT&T towers. In both transactions the tower owners (Verizon and AT&T) retained the towers on their balance sheets, continued to depreciate them (Verizon keeps the towers in PP&E; AT&T’s tower net balance was $608 million in 2024 and $647 million in 2023 with $39 million of annual depreciation) and recorded the cash received as a financing obligation rather than a sale‑lease‑back.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion American Tower payment in 2015 for 11,300 Verizon towers and compares it to the $4.827 billion Crown Castle transaction in 2013, noting the $173 million difference — which is accurate ($5.0B - $4.827B = $173M). The number of AT&T towers (9,048) is missing in the LLM answer, though the mention of 627 purchased towers is correct. (2) Dates are correct: March 2015 and December 2013. The dollar amounts are accurate and properly compared. However, the LLM introduces non-ground-truth data — AT&T’s tower net balance in 2024 and 2023 and $39 million annual depreciation — which are not in the original answer and may be factually incorrect or anachronistic (2024 data would not be available in a 2013/2015 context). This affects quantitative accuracy slightly. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both Verizon and AT&T retained ownership, kept towers on their balance sheets under PP&E, and continued depreciation. It also correctly notes the financing obligation treatment and sublease-back structure. However, the original answer specifies Verizon’s lease-back term (minimum 10 years) and AT&T’s estimated 20-year term, which the LLM omits — a minor completeness gap. (4) The LLM answer is contextually relevant and captures the core comparison and accounting treatment. The inclusion of unverified recent financials (2023–2024) for AT&T introduces a factual risk, but the main comparative facts and reasoning are correct. Hence, correctness is high but not perfect due to extraneous and potentially inaccurate data and minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 448,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power monetizes its wind‑project tax credits by pairing each facility with a tax‑equity partner that takes “significantly all” of the federal ITCs and PTCs (the company reported about $0.8 billion of un‑used PTCs that it expects to exhaust by 2024). Those projects are then covered by operating‑lease PPAs that can run as long as 25 years, providing a steady cash‑flow stream that the tax‑equity partner can use to offset the credit purchase price; the partnerships are reflected in Southern’s books using the HLBV consolidation method.  \n\nDuke Energy uses a different structure: its renewable assets are placed in VIEs that are financed through tax‑equity arrangements and backed by corporate guarantees for debt service and O&M reserves. The PPAs for those VIE‑owned facilities are negotiated as part of the VIE structure, and Duke consolidates the VIEs as the primary beneficiary to capture the tax‑credit benefits, even though the assets remain restricted and cannot be pledged.  \n\nThus, while both companies rely on tax‑equity investors to monetize federal credits such as PTCs, Southern Power does so by selling the credits to a partner and locking in long‑term (up to 25‑year) PPAs, whereas Duke Energy embeds the credits in VIEs with guarantee‑backed financing and retains primary beneficiary control over the PPAs.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in structure and reasoning, accurately capturing the core differences between Southern Power and Duke Energy in their use of tax equity partnerships and PPAs to monetize federal tax credits like PTCs. It correctly identifies Southern Power's use of tax equity partners to transfer most tax benefits, the use of long-term (up to 25-year) PPAs, and HLBV consolidation. It also correctly notes Duke Energy's use of VIEs, tax equity financing, corporate guarantees, and consolidation as primary beneficiary. The qualitative comparison—Southern selling tax credits via long-term PPAs vs. Duke embedding them in VIEs with guarantees—is semantically aligned with the ground truth.\n\nHowever, the quantitative accuracy is compromised by the inclusion of a specific number not present in the original answer: 'about $0.8 billion of un-used PTCs that it expects to exhaust by 2024'. This figure does not appear in the ground truth and cannot be verified from the provided knowledge. Its inclusion introduces a factual claim unsupported by the source, lowering confidence in numerical precision. Additionally, the mention of ITCs (Investment Tax Credits) is not in the original answer, which focuses solely on PTCs (Production Tax Credits), potentially conflating incentive mechanisms.\n\nDespite this, the multi-hop reasoning is sound: the model correctly synthesizes information across entities (Southern Power vs. Duke), structures (tax equity partnerships vs. VIEs), and financial mechanisms (PPAs, tax credit monetization, consolidation methods). The contextual relevance is high, as all parts of the question are addressed with appropriate financial and structural detail. Wording differs but meaning is preserved, except for the unsupported numerical and ITC additions, which prevent a top score in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 503,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "CMCSA’s capital structure includes a tiny, separate Class B common‑stock series (9.44 million shares issued versus roughly 3.78 billion Class A shares) that, like the Class B/C series described in the V filing, has no voting power except on a narrow set of matters (e.g., a merger or amendment). Consequently, Class B holders have essentially no say in most major corporate decisions, and control rests with the voting Class A shareholders and management.  \n\nAlphabet’s dual‑class system is the opposite: each Class A share carries one vote, each Class B share carries ten votes, and Class C shares have no votes. The super‑voting Class B stock concentrates decision‑making authority in the hands of insiders, allowing them to steer mergers, strategic moves and governance changes even though a larger pool of economic owners holds Class A and C shares.  \n\nThus, CMCSA’s governance is effectively one‑share‑one‑vote for the dominant Class A holders with a non‑voting minority Class B, while GOOGL’s model concentrates voting power in a super‑voting Class B, giving its insiders far greater influence over major corporate actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA's Class B has no voting rights except in limited circumstances (e.g., merger), and GOOGL's dual-class structure gives Class B 10 votes per share, Class A 1 vote, and Class C none. The governance implications—concentration of power at GOOGL vs. more uniform voting among Class A holders at CMCSA—are correctly interpreted. (2) Quantitative details are accurate: the share counts (9.44 million Class B vs. 3.78 billion Class A) are correctly cited and consistent with known CMCSA capital structure data; no calculations were required, but the relative scale is appropriately emphasized. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in voting rights across two companies and links them to broader corporate governance implications—specifically, how voting concentration affects shareholder influence. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'super-voting' instead of 'concentrating voting power'), the meaning is identical. One minor point preventing a perfect 10 is that the LLM does not explicitly mention CMCSA’s condition about exiting the core payments business as a voting trigger, which was in the original answer—this is a small omission but does not undermine the overall correctness. Otherwise, the answer is complete, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 408,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s capital structure is dual‑class: each Class A share gets one vote, each Class B share gets ten votes, and Class C shares have no voting rights. In 2023 the company repurchased $62.2 billion of its low‑vote Class A and non‑voting Class C shares, which shrinks the pool of one‑vote stock and raises the proportion of voting power held by the high‑vote Class B holders, thereby concentrating control in the hands of insiders. Netflix, by contrast, has a single class of common stock with one vote per share, so voting power is directly proportional to ownership and any buy‑back would dilute all shareholders equally rather than concentrate control.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (1 vote for Class A, 10 votes for Class B, 0 for Class C), the $62.2 billion share repurchase in 2023, and NFLX's one-share-one-vote structure are accurately described. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount is correctly cited, and the explanation of how repurchasing non-voting and low-vote shares affects voting concentration is logically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes how share repurchases in a dual-class structure (GOOGL) concentrate voting power among insiders, contrasting it with NFLX’s more egalitarian structure where buybacks do not disproportionately shift control. (4) The answer is contextually relevant, directly addressing the impact of voting structures on control dynamics and the amplifying effect of repurchases. Minor wording differences (e.g., mentioning Class C has no votes, which is implied in the original) add clarity without altering meaning. No errors in entities, years, or financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 323,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY’s 2022 10‑K explains that when it sold its diabetes business it transferred some royalty rights but kept others on Amylin products, and those retained royalties generated about **$1.9 billion of pretax income in 2021**. Byetta is identified in BMY’s filing (and reiterated in Lilly’s filing) as a **trademark of Amylin Pharmaceuticals**, which is now a Lilly (LLY) affiliate, so the brand is owned by LLY. Nevertheless, BMY’s retained royalty rights on Byetta (via Amylin) continue to provide a **material source of cash‑flow and earnings** for BMY despite the trademark’s current ownership by LLY.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: BMY retained royalty rights on Byetta* after divesting its diabetes business, Byetta* is a trademark of Amylin Pharmaceuticals (now an LLY affiliate), and the pretax income from these royalties was approximately $1.9 billion in 2021, as reported in BMY's 2022 10-K. (2) Quantitative accuracy is perfect: the $1.9 billion figure matches the original answer exactly, and the year (2021) is correctly cited. Format variation (e.g., $1.9 billion vs $1.9B) is acceptable and does not affect correctness. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across entities (BMY, LLY, Amylin), events (divestiture, trademark ownership), and financial implications (retained royalties as a material revenue source). It acknowledges that despite LLY owning the trademark, BMY still benefits financially through retained rights. (4) The answer is contextually relevant, complete, and conveys the financial significance as requested—highlighting that these royalties are a material source of cash flow and earnings, and their decline could impact BMY’s future performance, which aligns with the risk mentioned in the 10-K. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> COMP -[Owns]-> PRODUCT <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 364,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s capital‑buffer framework adds a 2.5 % stress‑capital buffer (SCB) and a 2.5 % capital‑conservation buffer (CCB) on top of the regulatory minimum, so that the inclusive minimum total risk‑based capital ratio is 10.5 % (CET1 7.0 %, Tier 1 8.5 %, Total 10.5 % as disclosed for 2023). JPMorgan Chase, by contrast, applies only the 2.5 % CCB (plus a GSIB surcharge) and therefore must meet a higher inclusive minimum total ratio – 14.0 % under the Basel‑III advanced approach (and 15.5 % under the standardized approach). Thus, even though Schwab carries an extra stress‑buffer, its overall minimum total risk‑based capital requirement is lower than JPMorgan’s, which relies solely on the conservation buffer and a larger baseline regulatory minimum.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative accuracy, particularly in the capital ratio requirements for JPMorgan Chase. According to the ground truth, both Schwab and JPMorgan Chase have a minimum total risk-based capital ratio requirement of 10.5%. However, the LLM incorrectly states that JPMorgan Chase has a minimum total risk-based capital ratio of 14.0% under Basel III advanced and 15.5% under standardized approaches, which contradicts the original answer. This error invalidates the core comparison. While the LLM correctly identifies that Schwab includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer (totaling 5% on top of the 5.5% base minimum, leading to 10.5%), it misrepresents JPMorgan's structure: the ground truth confirms JPMorgan also has a 10.5% requirement with only the 2.5% capital conservation buffer and no additional stress capital buffer—there is no mention of a GSIB surcharge or higher requirement in the original answer. The reasoning is partially sound in distinguishing buffer types, but the synthesis is flawed due to incorrect data. The mention of CET1 and Tier 1 ratios (7.0%, 8.5%) is extraneous and unsupported by the original answer. Thus, while the answer attempts multi-hop reasoning and addresses the question’s intent, the factual inaccuracies—especially in key percentages—severely undermine correctness. Entity names (Schwab, JPMorgan Chase) and buffer terms are accurate, and the structure of the response is relevant, but numerical inaccuracies dominate the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 427,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "LMT’s revolving credit facility is written to reference LIBOR, but it contains fallback language that will automatically switch the interest‑rate calculation to an alternative benchmark (such as SOFR) when LIBOR is no longer published.  Because the change is treated under the accounting relief of ASU 2020‑04, the modification is accounted for with limited‑impact expedients, so LMT does not expect a material effect on its results, balance sheet or cash flow.  \n\nGE’s exposure to LIBOR is concentrated in its LIBOR‑linked floating‑rate debt and preferred‑stock issuances; New York law provides a statutory fallback that will deem those securities to use the “recommended benchmark replacement” – SOFR plus a spread adjustment – once USD LIBOR ceases.  The transition will also be recorded under ASU 2020‑04, which similarly limits the accounting impact of the contract changes, keeping the effect on GE’s financial statements minimal.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: LMT’s credit facility uses LIBOR with fallback to SOFR, and GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus spread adjustment. Both companies apply ASU 2020-04 for accounting relief, minimizing financial statement impact. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the original or LLM answer, so quantitative accuracy is not compromised; all references to standards and benchmarks are correctly named. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across two companies (LMT and GE), different financial instruments (credit facility, debt, preferred stock), and a shared accounting standard (ASU 2020-04), showing how each is affected by the LIBOR transition. (4) The LLM captures all elements of the original answer with slightly more detailed phrasing (e.g., mentioning 'New York law' and 'recommended benchmark replacement'), enhancing clarity without introducing error. Wording differs but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 336,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 balance sheet shows that it issued 9,444,375 Class B common shares – a modest amount relative to the 75 million shares authorized – creating a separate voting class that can be used to concentrate control or to compensate insiders while leaving the much larger Class A pool (≈4.8 billion shares) unchanged. In Alphabet’s dual‑class structure, by contrast, each Class B share carries ten votes and may be converted at any time, but it **automatically converts to a one‑vote Class A share whenever it is sold or transferred**, preventing the high‑voting shares from entering the public market. Thus, Comcast’s Class B shares remain a distinct, non‑convertible class, whereas Alphabet’s Class B shares are designed to become ordinary Class A shares on transfer, preserving insider voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the issuance of 9,444,375 Class B shares by CMCSA in 2023 is accurately stated, and the comparison to Alphabet's dual-class structure is factually sound. The LLM correctly notes that GOOGL's Class B shares carry 10 votes and automatically convert to Class A upon sale or transfer, which matches the original answer. (2) The LLM correctly identifies both companies (CMCSA and GOOGL), the relevant year (2023), and the structural differences in share classes. (3) The reasoning is strong: it correctly synthesizes that CMCSA’s issuance maintains control without significant voting dilution, similar in intent to GOOGL’s structure, but highlights a key difference—CMCSA’s Class B shares are non-convertible upon transfer, unlike GOOGL’s. (4) The only minor omission is that the original answer mentions GOOGL’s $62.2 billion share repurchase in 2023, which the LLM omits. This contextual detail about capital allocation strategy adds depth to the comparison, but its absence does not undermine the core factual accuracy. The LLM still captures the essential structural contrast. Therefore, the answer earns a 9/10 for correctness—excellent but missing one supporting detail from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 365,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension obligations are tied to a very long‑term vest‑related liability.  After its 2019 withdrawal from a union fund the company was assessed a $526 million liability that must be paid pro‑rata over **19 years**; the liability is recorded at a discounted amount and is amortized (with accreted interest of roughly $11‑$12 million a year) as the monthly payments are made, while the regular pension contributions ($4‑$5 million a year) are expensed when incurred.  By contrast, Walmart’s equity‑compensation awards vest over **much shorter periods** – RSUs generally vest 25 % per year over **four years** (previously 50 % at three years and the balance at five years) and performance‑based RSUs vest in **one‑to‑three years** – and the fair‑value of each award is **recognized ratably over the specific vesting period**.  In short, MDLZ’s vesting‑related cost is spread across a 19‑year amortization schedule with interest accrual, whereas WMT’s vesting costs are recognized evenly over 1‑4‑year award windows, reflecting a far shorter duration and a simpler, straight‑line expense pattern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) All key numbers are correct: MDLZ's $526 million withdrawal liability over 19 years, $11 million in interest accruals (LLM says $11–$12 million, which is consistent with the $11 million in 2021 cited in the original), and WMT's 25% annual vesting over four years. The LLM correctly notes the ratable expense recognition for equity awards and the straight-line pattern. It also accurately references Walmart’s prior vesting schedule (50% at three years, balance at five), which adds contextual depth not in the original but is factually correct and enhances completeness. (2) Quantitative accuracy is excellent: all dollar amounts, percentages, and timeframes match or are reasonable approximations (e.g., $4–$5 million annual contributions align with the original’s implication of ongoing costs). The 3.8% dividend discount in the original is not mentioned, but this is a minor omission that does not affect the core comparison. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across MDLZ’s pension withdrawal and WMT’s equity compensation, contrasting long-term, interest-bearing amortization with short-term, straight-line expensing. It correctly identifies the structural differences in cost recognition patterns and duration. (4) The answer is contextually relevant and directly addresses the comparison in terms of duration and cost recognition. The only reason for not scoring a 10 is the omission of the dividend discounting detail in WMT’s fair value calculation, which is part of the cost recognition pattern but not central to the main contrast. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 488,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Bank of America’s Advanced‑Approach buffer is explicitly 2.5 % capital‑conservation buffer + 2.5 % G‑SIB surcharge + 0 % counter‑cyclical buffer, i.e., a total of **5.0 %** of CET1 capital above the 4.5 % risk‑based minimum. Morgan Stanley’s Advanced‑Approach buffer is built the same way – it also adds the 2.5 % capital‑conservation buffer and a zero CCyB, plus its G‑SIB surcharge (the exact percentage is not disclosed in the excerpts). Thus, the structure is identical, and if Morgan Stanley’s G‑SIB surcharge is also 2.5 %, its total buffer would likewise be **5.0 %** above the minimum.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in reasoning that affects completeness. (1) Quantitatively, all provided numbers are accurate: both BAC and MS have a 2.5% Capital Conservation Buffer, 0% Countercyclical Buffer, and a 2.5% G-SIB surcharge, leading to a total 5.0% buffer. The calculation (2.5% + 2.5% + 0% = 5.0%) is correct. (2) The answer correctly identifies the structure for BAC and notes the same components apply to MS. However, it states that MS's G-SIB surcharge 'is not disclosed in the excerpts' and uses a conditional: 'if Morgan Stanley’s G-SIB surcharge is also 2.5%', implying uncertainty. In the ground truth, it is explicitly stated that MS *does* have a 2.5% G-SIB surcharge and thus a confirmed 5.0% total buffer—this is a key multi-hop synthesis point. (3) The reasoning is sound in structure but falls short on definitive synthesis: the model should have affirmed, based on the knowledge graph, that MS's G-SIB surcharge is indeed 2.5%, not treated it as an assumption. (4) Despite this, the conclusion that both have a 5.0% buffer is correct, and the explanation structure is clear and relevant. The answer is semantically close but lacks full confidence and completeness in entity-specific confirmation, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 361,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes would see its fair‑value move by about $1.7 billion for a 50‑basis‑point shift in market rates (roughly $34 million per basis point), even though the interest expense on those notes is unchanged. In contrast, Oracle uses cross‑currency and interest‑rate swaps to convert its fixed‑rate Euro debt to a variable‑rate U.S.‑dollar exposure and to lock floating borrowings into a fixed 3.07% (effective 4.74%) rate, thereby fixing its effective cost of debt rather than exposing it to large fair‑value swings. Cisco’s $0.5 billion swap illustrates the same mechanism—converting a fixed‑rate note to a SOFR‑based floating rate and offsetting fair‑value changes—showing how swaps can neutralize the sensitivity that AVGO experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: AVGO's $56.3 billion fixed-rate notes, $1.7 billion fair value sensitivity to a 50 bps shift, ORCL's 3.07% base rate and 4.74% effective interest rate, and CSCO's $0.5 billion swap are all accurately reported. Format variations (e.g., $56.3 billion vs $56.3 billion) are acceptable. (2) The quantitative accuracy is perfect—no calculation errors, and the implied sensitivity (~$34M per basis point) is a reasonable derivation from $1.7B over 50 bps. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s exposure due to fixed-rate debt with ORCL’s use of swaps to lock in rates, and references CSCO’s swap as an example of converting fixed to floating to manage fair value, aligning with hedging strategies. (4) Minor wording differences exist—ORCL is described as converting fixed-rate Euro debt to variable USD, which adds detail not in the original but does not contradict it. The original states ORCL converted floating to fixed, while the LLM says it locked floating borrowings into fixed, which is consistent. The synthesis across AVGO, ORCL, and CSCO is logically coherent and contextually appropriate. The only reason for not scoring 10 is slight rephrasing of ORCL’s swap purpose, but the financial effect (achieving a fixed effective rate of 4.74%) is correctly captured. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 413,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s filing shows that, as of January 24 2025, it had 2.19 billion Class A shares and 0.34 billion Class B shares outstanding – roughly 13‑14 % of the total share count.  Although the Meta 10‑K excerpt does not spell out the vote‑per‑share multiplier, the company’s charter (and the pattern seen at other dual‑class issuers such as Comcast, where each Class B share carries 15 votes and represents ≈33 % of voting power despite being a minority of shares) makes clear that Meta’s Class B stock is designed to concentrate voting power in a relatively small share class.  \n\nAlphabet, by contrast, does not include its high‑voting Class B shares in its buy‑back program.  Its 2024 repurchase programme targeted only the publicly traded Class A (one vote per share) and non‑voting Class C shares, repurchasing $62 billion of those securities and leaving $44.7 billion of authorized repurchase capacity for further buy‑backs.  Thus, while Meta’s Class B shares concentrate voting control, Alphabet’s strategy uses its multi‑class structure to return capital by buying back lower‑voting (or non‑voting) shares, preserving the control held by the high‑voting Class B holders.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structural differences between META and GOOGL regarding voting power and share repurchases. It accurately states that GOOGL repurchased $62 billion in 2024 across Class A and Class C shares, matching the ground truth. However, it incorrectly claims that Meta had 0.34 billion Class B shares representing '13-14%' of total shares, which contradicts the ground truth that Class B holds 33 1/3% of voting power — a critical factual discrepancy. The LLM also fails to explicitly state the 15 votes per share for Meta’s Class B stock, instead implying it via analogy to Comcast, which is inferential rather than direct. (2) The $62 billion repurchase figure is correct and matches the original answer. The $44.7 billion remaining authorization is additional detail not in the ground truth but does not contradict it. The share counts (2.19B Class A, 0.34B Class B) may be factually accurate based on filings, but the resulting '13-14%' ownership misrepresents the voting power, which is the key point. The ground truth emphasizes that Class B has 33 1/3% of voting power due to super-voting rights (15 votes/share), not economic ownership. (3) The multi-hop reasoning is strong: the model correctly contrasts Meta’s voting concentration with GOOGL’s capital return strategy targeting non- or low-voting shares. It infers correctly that sparing Class B shares in buybacks preserves control, showing sound synthesis of governance and capital allocation dynamics. (4) The correctness score is 8 because the central strategic comparison is accurate and insightful, and the GOOGL repurchase data is correct, but the Meta voting power description contains a significant quantitative inaccuracy. Quantitative accuracy is 7 due to the incorrect implication about economic vs. voting power share. Qualitative accuracy is 9 due to strong reasoning and correct use of structural logic. Contextual relevance is 10 — the answer directly addresses the interplay between voting rights and share structure as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 553,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm sees the surge in AI‑enabled phones as a hardware‑driven growth engine.  Analysts expect **46 % of smartphones sold in 2027 to be generative‑AI capable, up from 19 % in 2024** (Chunk 2).  That outlook reinforces Qualcomm’s strategy of expanding its **on‑device AI, low‑power compute and advanced‑connectivity portfolio** – 5G/5G‑Advanced radios, AI‑accelerated chipsets and the licensing of the underlying IP (Chunk 1).  In other words, the projected smartphone share fuels Qualcomm’s focus on delivering the silicon and network infrastructure that will run generative AI workloads at the edge.\n\nSalesforce, by contrast, is investing the same AI theme on the **software side**.  It is “investing in generative and agentic AI across all products” and has launched **Agentforce**, a layer that lets customers build autonomous AI agents for sales, service, marketing and commerce (Chunk 3).  Salesforce’s emphasis is on embedding AI into its CRM platform to boost productivity, personalization and cloud revenue, rather than on the underlying hardware or connectivity.\n\nThus, while both companies are betting on generative AI, Qualcomm’s projection drives a **hardware‑centric, connectivity‑focused strategy** to power AI‑capable devices, whereas Salesforce’s investment drives a **software‑centric, application‑focused strategy** to embed generative and autonomous AI into its CRM suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024), its strategic focus on on-device AI, low-power compute, and advanced connectivity (5G/5G-Advanced), and Salesforce's investment in generative and agentic AI via the Agentforce platform. The core comparison between Qualcomm’s hardware-centric and Salesforce’s software-centric AI strategies is accurately conveyed. (2) Quantitative accuracy is perfect: the percentages (46%, 19%) and years (2027, 2024) match the ground truth exactly. No calculations were required, but the comparison over time is correctly interpreted. (3) Multi-hop reasoning is sound—information is synthesized across Qualcomm’s market projection and technology focus, and Salesforce’s product-level AI integration, correctly contrasting their strategic domains (edge hardware vs. cloud CRM software). The answer captures the convergence on AI while distinguishing implementation layers. (4) The only minor shortcoming is the omission of the explicit statement that there is no direct business relationship or dependency between the two companies, which is included in the original answer. However, this does not detract significantly from the overall correctness, as the question primarily asks about strategic focus in light of projections. Wording differences (e.g., 'hardware-centric' vs. 'enabling AI at the device level') are semantically equivalent. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Positively_Impacts]-> CONCEPT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 437,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe stresses that the next wave of its Digital Media products must be “intuitive and visually appealing” and must embed AI models that can generate and edit media directly within the workflow – a competitive factor it lists as central to the user‑experience (Chunk 1).  Qualcomm’s roadmap reinforces that vision: it projects that 46 % of smartphones and ≈ 50 % of PCs sold in 2027 will be generative‑AI‑capable, meaning the processors and connectivity it supplies will run large generative‑AI models on‑device, delivering lower latency, greater privacy and richer, context‑aware UI interactions (Chunks 2‑3).  Consequently, Adobe’s AI‑driven UI and media‑creation tools are well‑aligned with Qualcomm’s forecasted surge in on‑device AI processing, because the hardware platform Qualcomm is building will enable Adobe’s tools to execute locally on edge devices, enhancing real‑time responsiveness and personalization of the user interface.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Qualcomm's projection of 46% of smartphones being generative AI-capable in 2027 is accurately cited, and the LLM correctly notes the increase from 19% in 2024 (implied in context though not explicitly repeated). The addition of ≈50% of PCs is a minor expansion beyond the original answer but is plausible and does not contradict known data. (2) Entity accuracy is strong: Adobe and Qualcomm are correctly identified with their respective strategic focuses—Adobe on AI-driven digital media tools and user experience, Qualcomm on edge AI and device-level processing. Years (2024, 2027) and technologies (on-device AI, generative AI) are correctly referenced. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM connects Adobe’s need for intuitive, AI-enhanced UIs with Qualcomm’s hardware roadmap, correctly inferring that on-device processing enables lower latency, greater privacy, and personalized interactions—key enablers for Adobe’s tools. (4) The answer is contextually relevant and fully addresses the question about alignment between Adobe’s UX focus and Qualcomm’s projections. The only minor shortcoming is that the original answer explicitly mentions the 19% baseline in 2024, which the LLM omits, slightly weakening the comparative framing. However, the core logic and factual content remain intact. Wording differences (e.g., 'rich, context-aware UI interactions' vs 'immediacy, privacy, and personalization') are semantically equivalent. Overall, this is a correct, well-reasoned, and complete response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Impacts]-> CONCEPT <-[Enables]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 451,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Both companies tie dividend equivalents to RSU awards, but the timing and form of payment differ. Lockheed Martin credits dividend equivalents as separate phantom‑stock units at the moment a dividend is paid and, for directors, allows those equivalents to be paid together with the RSU award on the first business day of April after the one‑year anniversary of the grant (or upon termination of service). Honeywell’s RSUs – which vest over three‑to‑six years (a schedule similar to the typical three‑year vesting described in the PMI filing) – earn dividend equivalents that are delivered as part of the common‑stock distribution when the RSUs vest, with no distinct separate payment date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lockheed Martin credits dividend equivalents as stock units at dividend payment times (phantom stock units), and for non-employee directors, payment occurs on the first business day of April following the one-year anniversary of the grant or upon termination—this matches the original answer’s description. Honeywell’s RSUs vest over three to six years with dividend equivalents paid in common stock upon vesting, with no separate or delayed payment schedule, which is correctly stated. (2) Quantitative elements—vesting periods (three to six years), timing references (April after one-year anniversary)—are factually accurate and consistent with the ground truth. No calculations are required, and all dates/numbers are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in payment timing and structure between the two companies’ plans, contrasting Lockheed’s delayed, director-specific payout with Honeywell’s integrated, vesting-aligned delivery. (4) The only minor omission is that the LLM does not explicitly mention Lockheed’s DMICP by name or Honeywell’s performance-based vesting focus, which are present in the original answer. However, the core functional differences in dividend equivalent treatment are accurately conveyed. Wording differs slightly (e.g., 'phantom-stock units' vs 'stock units'), but semantic meaning is equivalent. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 432,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says that in 2021 roughly 40 percent of its assembly‑and‑test workload was performed by subcontractors, with the balance supplied by its own fabs and the new facilities it is building. NVIDIA, by contrast, relies on a limited pool of third‑party foundries, contract manufacturers, assembly‑test providers and memory makers for essentially all of its wafer‑fabrication and packaging steps, so its exposure to external capacity is broader and less quantified than TXN’s 40 percent share. Both companies therefore face the same class of supply‑chain vulnerabilities that AMD flags – limited control over capacity allocations, pricing, quality and delivery schedules, and the risk that a supplier could prioritize competitors or suffer disruptions – but TXN mitigates those risks with ongoing internal capacity expansion, whereas NVIDIA’s dependence on a small set of outside manufacturers leaves it more directly subject to the AMD‑style third‑party‑supplier risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly stated, and while no exact percentage is given for NVIDIA, the characterization of its broader and less quantified external dependency is consistent with the original answer's emphasis on NVDA's full reliance on third parties for fabrication, assembly, and testing. The mention of 2021 is an addition not in the original but does not contradict it and may reflect real filing data. (2) All entities—Texas Instruments (TXN), NVIDIA (NVDA), AMD, and implied third-party suppliers—are correctly identified and contextualized. (3) The multi-hop reasoning is sound: the model correctly synthesizes TXN’s partial outsourcing with NVDA’s near-total reliance, compares both to AMD’s cautionary experience, and evaluates shared risks (capacity control, quality, delivery schedules, supplier prioritization). It adds value by noting TXN’s internal capacity expansion as a risk mitigant, which is consistent with TXN’s strategy and implied in the original. (4) The only minor gap is that the original emphasizes NVDA’s exposure being 'amplified by the complexity of its products and global supply chain,' a nuance slightly underdeveloped in the LLM response. However, the core conclusion—that NVDA faces greater exposure—is logically supported and semantically equivalent. Wording differs but meaning is preserved. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 418,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "The Clean Energy Connection program calls for ten new solar facilities at an estimated cost of roughly **$1 billion** to be spent over the next three years.  Like Duke’s solar build‑out, Southern Power finances comparable solar (and wind) projects through power‑purchase agreements, but it records those PPAs as **operating leases with terms that can run as long as 25 years**, with the lease income reflected in its wholesale‑revenue stream.  Thus, both companies rely on PPAs to support renewable‑energy development, though Duke’s $1 billion investment is recovered via base‑rate subscriptions, while Southern Power’s PPAs are treated as long‑term operating‑lease obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities over three years, matching the ground truth. It accurately states that Southern Power uses PPAs treated as operating leases with terms up to 25 years. The only minor discrepancy is the mention of 'Clean Energy Connection' program, which is not in the original answer (though it may be an accurate external detail not in the ground truth). 2) All numeric values—$1 billion, 3-year timeframe, 25-year lease terms—are correct and match the ground truth. No calculations are required, but the financial mechanisms are correctly described. 3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s direct investment recovered via base rates with Southern Power’s use of PPAs as operating leases, showing understanding of both companies’ financial strategies for renewable projects. 4) The answer is semantically equivalent to the original, with slightly different phrasing but full factual alignment. The core comparison between the two companies’ investment models is well articulated. The slight deduction in qualitative accuracy is due to the introduction of a program name not in the original, which, while potentially correct, is unverified in the provided context. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 380,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock grants every share one vote – a uniform voting‑rights structure (Chunk 1). In contrast, Alphabet’s capital structure separates voting power: each Class A share carries one vote, while Class C shares have no voting rights (Chunk 2/3). Because the $62 billion share‑repurchase program in 2024 was executed “in a manner deemed in the best interest of the company and its stockholders, taking into account … the relative trading prices and volumes of the Class A and Class C shares” (Chunk 2/3), the absence of voting rights on Class C stock means Alphabet can use the buy‑back to influence its voting base. Accordingly, the company is likely to allocate a larger share of the $62 billion to Class A (voting) shares to preserve or enhance voting control, while still repurchasing Class C shares for liquidity and price‑optimization reasons. This strategic split reflects the contrast between Netflix’s one‑vote‑per‑share model and Alphabet’s non‑voting Class C capital stock.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Netflix's one vote per share and Alphabet's Class A (1 vote) and Class C (no vote) structures, and accurately references the $62.0 billion 2024 repurchase amount, satisfying quantitative and entity accuracy. However, the core reasoning about the strategic allocation is incorrect. The original answer states that the lack of voting rights in Class C allows Alphabet to retire shares *without diluting control*, implying a preference for repurchasing Class C shares to preserve voting power among existing holders. In contrast, the LLM claims Alphabet would likely repurchase *more Class A shares* to 'preserve or enhance voting control', which is logically flawed—buying back voting shares would reduce the total voting float, but does not 'enhance' control and contradicts typical corporate behavior in dual-class firms, where companies often buy back non-voting shares to avoid transferring economic value to controlling shareholders. The LLM misinterprets the incentive structure. (2) All numbers ($62 billion, 2024) are correct and match the ground truth. (3) The multi-hop reasoning fails: while the model connects Netflix’s structure to Alphabet’s and references the repurchase program, it draws the opposite conclusion regarding strategic allocation. The synthesis is present but flawed in logic. (4) Scores reflect: full credit for numbers (10), partial credit for reasoning due to incorrect strategic implication (5), and high relevance as the response directly addresses the question framework despite factual inaccuracy in conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 436,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "BAC’s 10‑K discloses that, for most of its preferred series, the holders acquire **extra voting power only when dividends fall into arrears** (three or more semi‑annual periods or six quarterly periods). In that event the preferred shareholders vote as a single class and can elect two additional directors, a right that ends once the arrears are cured – a stress‑triggered governance mechanism that gives them a direct say in the board when the company is financially strained.  \n\nBy contrast, V’s 10‑K shows that **Class C common stockholders are a financial instrument with only narrowly defined voting rights** – they may vote only on specific matters such as a merger, an exit from the core payments business, or certain charter amendments, and they do not gain any additional voting authority automatically during dividend or cash‑flow stress.  \n\nThus, BAC’s policy activates broader voting rights for preferred investors under financial distress, whereas V’s structure leaves Class C holders with static, limited voting power regardless of the company’s stress condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors if dividends are in arrears for three semi-annual or six quarterly periods, and these rights terminate after two semi-annual or four quarterly periods of payment — these quantitative thresholds match the original answer exactly. (2) The contrast with V’s Class C common stockholders is accurately portrayed: they have limited voting rights only on specific matters like mergers or exiting the core payments business, and no automatic activation during financial stress. (3) The multi-hop reasoning is sound — the model correctly synthesizes governance mechanisms from two different companies (BAC and V) and contrasts contingent (performance-triggered) voting rights versus structurally limited ones. (4) Minor deduction in qualitative accuracy due to slightly less precise phrasing around 'certain charter amendments' — the original specifies that Class C does not vote on amendments solely affecting preferred stock, which adds nuance not fully captured. However, the core meaning and comparison remain intact. Wording differences are acceptable under semantic equivalence. No calculation errors. All entities (BAC, V, preferred stock, Class C common stock) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> FIN_INST <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 384,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney earns royalties from licensing Star Wars characters on toys, apparel, games and other merchandise – royalties that are calculated as a fixed percentage of the wholesale or retail price of those products (Chunk 3).  Those royalties flow into Disney’s cash pool and are earmarked for its Direct‑to‑Consumer segment, where Disney+ – which prominently features Star Wars programming – is continuously investing in new European‑market content (Chunk 2).  By converting Star Wars licensing cash into Disney+ content spend, Disney can expand and refresh its European catalog, giving it a stronger financial footing to compete with Comcast’s Sky Glass and XClass TV smart‑TV platforms that are targeting the same DTC streaming audience in Europe (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: Disney earns licensing royalties from Star Wars merchandise, these funds support its Direct-to-Consumer segment (including Disney+), and this content investment strengthens its competitive position in European markets against CMCSA's Sky Glass and XClass TV platforms. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links Star Wars licensing revenue → funding for Disney+ content → strategic advantage in Europe → competition with Comcast’s integrated hardware-content platforms. The only minor omission is that the original answer explicitly notes Star Wars programming is a 'core content tile' on Disney+, which the LLM implies but does not state verbatim; however, this does not detract significantly from the overall accuracy. (4) Contextual relevance is perfect—the response directly addresses all parts of the complex, multi-hop question involving revenue mechanism, financial flow, content development, geographic market, and competitive dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT -[Includes]-> PRODUCT <-[Licenses]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 335,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "AXP’s 2024 sensitivity analysis (Chunks 2 & 3) shows that an instantaneous 200‑basis‑point rise in benchmark rates would lower its annual net interest income because the firm’s interest‑rate‑sensitive assets and liabilities are assumed to reprice in line with the rate move, subject only to any applicable caps or floors. In its securitization business, MS routinely enters into interest‑rate caps with the SPEs that hold the transferred mortgage assets (Chunk 1); those caps are expressly used to limit the repricing of the cash‑flows on those assets when rates increase, thereby managing the same repricing‑risk factor that AXP discloses. Thus, the repricing risk that makes AXP’s net interest income vulnerable to a 200‑bp rate hike is the risk that MS seeks to hedge through interest‑rate caps, linking the two firms’ strategies via the common repricing‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: the 200-basis-point rate increase and its negative impact on AXP's net interest income are accurately stated, consistent with the original answer. The reference to repricing risk and the role of caps/floors in AXP’s sensitivity assumptions is factually sound. (2) The LLM correctly identifies that MS uses interest rate caps in securitization transactions with SPEs to manage cash flow repricing on mortgage assets, which matches the ground truth. (3) The multi-hop reasoning is strong: it connects AXP’s exposure to repricing risk in net interest income with MS’s use of interest rate caps to hedge similar repricing dynamics in securitized assets, correctly framing both as responses to the same underlying risk factor. (4) Minor deduction in qualitative accuracy due to slightly narrower framing—while the LLM emphasizes MS’s cash flow protection, the original answer also notes the broader context of structured finance and SPEs, and that both firms use derivatives but in different business contexts. However, the core synthesis is correct and semantically equivalent. Wording differs but meaning is preserved. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Depends_On]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 357,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "Mondelez says that a weaker U.S. dollar “benefits our consolidated earnings and net assets” because the translation of its non‑U.S. subsidiaries into a softer dollar adds a positive adjustment to the whole company’s results. Coca‑Cola, by contrast, notes that a weaker dollar versus the euro and the British pound produced a “favorable impact” only for its Europe, Middle East and Africa segment – a boost that showed up as a modest operating‑income increase (about $7 million) and merely offset part of the broader 5 % revenue hit from a stronger dollar elsewhere. Thus, MDLZ’s currency gain is a company‑wide earnings benefit, while KO’s gain is a limited, segment‑specific uplift that only partially mitigates its overall negative currency effect.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, notably that Coca-Cola's favorable impact was 'about $7 million' and that it offset part of a '5% revenue hit from a stronger dollar elsewhere.' These figures are not in the original answer and cannot be verified from the provided context, making them factually unsupported. The ground truth does not mention any negative overall currency effect for KO or specific dollar amounts, so these additions are incorrect. (2) The qualitative comparison between MDLZ's company-wide benefit and KO's segment-specific benefit is reasonable and aligns with the original answer’s emphasis on both companies being affected by similar currency dynamics (euro and British pound). However, the LLM incorrectly frames KO’s experience as having a net negative currency impact, which contradicts the original answer that only describes a 'favorable impact' without mentioning offsetting negative effects. (3) The multi-hop reasoning is partially sound—correctly identifying both companies and the relevant currencies (euro, British pound)—but fails in synthesis by introducing unverified financial figures and an incorrect net-negative narrative for KO. (4) While the LLM captures the directional impact of currency movements and identifies the correct entities and currencies, the inclusion of fabricated quantitative data and misleading qualitative framing significantly undermines factual accuracy. The contextual relevance is high because the response directly addresses the comparison asked, but correctness is low due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION -[Impacted_By]-> GPE <-[Positively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s capital structure contains only seven Class B shares versus roughly 1,800 Class A shares.  Applying the 15‑vote per Class B share rule (as disclosed by Comcast), the seven Class B shares generate about 105 votes out of a total of ≈1,939 votes – roughly 5 % of the combined voting power.  \n\nVisa, by contrast, has 125 Class B shares and about 1,733 Class A shares.  With the same 15‑vote weighting, the Class B shares supply ≈1,875 votes out of ≈3,608 total votes – about 52 % of the voting power.  \n\nThus, voting power is far more concentrated in Visa’s Class B shares, while Mastercard’s Class B shares hold only a small share of overall voting control.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the total number of Class A shares for Mastercard (MA). The ground truth states 907 Class A shares, but the LLM claims 'roughly 1,800', which is nearly double the correct value. This leads to an incorrect total vote calculation. The LLM calculates Class B voting power at ~5%, but the correct figure is ~10.4% as per the original answer. For Visa (V), the LLM uses 1,733 Class A shares (correct) and 125 Class B shares (correct), but calculates total votes as ≈3,608 and Class B share of voting power as ~52%, whereas the correct total votes are 1,733 + (125 × 15) = 1,733 + 1,875 = 3,608 (correct), and 1,875 / 3,608 ≈ 51.97%, which rounds to ~52% — this part is acceptable. However, the original answer states 68.5%, which contradicts the math unless there is additional context not reflected here. Upon recalculation: 125 × 15 = 1,875 Class B votes; 1,733 Class A votes (1 vote each); total = 3,608; Class B share = 1,875 / 3,608 ≈ 51.97%. Therefore, the original answer’s 68.5% appears to be incorrect, or based on different data. This creates ambiguity, but the LLM’s calculation is mathematically sound given inputs. (2) The LLM incorrectly states Mastercard has 'about 1,800' Class A shares instead of 907, leading to flawed totals: correct total votes = 907 + (7 × 15) = 907 + 105 = 1,012; Class B share = 105 / 1,012 ≈ 10.37% (~10.4%), but LLM says ~5%, which is off by over 100%. This is a major error. (3) The reasoning framework is sound — the LLM correctly applies the 15-vote weighting, computes total votes, and compares concentration. It identifies that V has more concentrated control than MA, which aligns with the conclusion, despite miscalculating MA’s numbers. (4) Contextually, the answer addresses the comparison of voting power concentration using the 15-vote rule and dual-class structures, fulfilling the multi-hop requirement. However, due to the significant error in MA’s share count and resulting voting power percentage, the correctness score is reduced. The LLM also references Comcast as the source of the 15-vote rule, which may be accurate per intermediary evidence but is not part of the core question. Overall, the qualitative reasoning and structure are strong, but quantitative accuracy is compromised by incorrect input data for MA, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 639,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company acknowledge that the biggest financial risk tied to their nuclear plants is the possibility that de‑commissioning costs will outstrip the funds they have set aside. NEE says its de‑commissioning funds and external insurance may be insufficient to cover the full cost of shutting down its reactors, while Southern Company – through its Southern Nuclear subsidiary – warns that de‑commissioning trusts and statutory nuclear‑incident insurance could also be inadequate. Thus, the potential exposure from de‑commissioning overruns is a comparable financial risk for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies both NEE and Southern Company as facing financial risks from decommissioning costs exceeding available reserves, which aligns with the original answer. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and consistent in that regard, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes risk exposure across both companies, noting the potential insufficiency of decommissioning funds and insurance coverage. It accurately references NEE’s and Southern Company’s subsidiaries (Southern Nuclear for Southern Company), though the original answer names Alabama Power and Georgia Power instead. This is a minor discrepancy in specificity but does not affect the overall correctness, as Southern Nuclear operates those plants. (4) The semantic meaning fully matches the original: both highlight material financial exposure due to estimation uncertainties and long-term planning risks. The LLM uses slightly different phrasing (e.g., 'biggest financial risk') but does not overstate or misrepresent. The answer is highly relevant and complete, missing only a minor detail about the specific subsidiaries for Southern Company, which prevents a perfect 10. Thus, correctness is scored at 9, with high marks across all other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 405,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS’s pension‑plan holdings in real‑estate funds were reported at **$9.9 billion** and are measured using a **net‑asset‑value (NAV) practical expedient** – UPS reviews audited and unaudited fund‑manager reports, makes activity adjustments and applies periodic appraisals to estimate fair value (as described in its 10‑K and echoed in the LMT filing’s description of NAV for real‑estate funds).  \n\nGeneral Dynamics, by contrast, classifies its **Level 3 assets** – mainly direct private‑equity investments – as fair‑value measured with **valuation models that rely on unobservable inputs** (i.e., assumptions that cannot be corroborated by market quotes).  \n\nThus, both firms depend on valuation models, but UPS’s $9.9 billion figure comes from a NAV‑based, fund‑report‑driven estimate, whereas GD’s Level 3 assets are valued using more subjective, unobservable‑input models without a comparable disclosed dollar amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $9.9 billion figure for UPS's pension plan investment in real estate funds is correctly stated, and no other numerical values are misrepresented. The absence of a dollar amount for General Dynamics is appropriate, as the original answer does not specify one. (2) The qualitative analysis correctly identifies that UPS uses the net asset value (NAV) as a practical expedient, based on fund manager reports (audited and unaudited), with adjustments for activity between reporting periods and periodic appraisals. It also accurately notes that real estate funds rely on valuation models, consistent with the knowledge base. For General Dynamics, the answer correctly states that Level 3 assets include direct private equity investments valued using unobservable inputs—i.e., internal or fund-level models—per fair value hierarchy disclosures. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (UPS and GD), two types of investments (real estate funds vs. private equity), and two valuation methodologies (NAV-based vs. unobservable inputs), drawing a valid comparison. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'adjustments for investment activity between reporting dates' compared to the original, though the concept is implied in 'activity adjustments'. Otherwise, semantic equivalence is strong, and all key facts are preserved. Contextual relevance is perfect—directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Valued_Using]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 437,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo reports that about 30 percent of its beverage revenue is generated in the Africa‑and‑Middle‑East (AME SA) region. Because Target treats many of its beverage purchases under “pay‑only‑when‑sold’’ vendor agreements (which account for < 5 % of its total sales but are recorded as a virtual simultaneous purchase‑sale), a supply interruption in that region would immediately shrink the amount of beverage inventory Target can stock. With fewer units on hand, the inventory‑turnover metric would rise (or could even fall if stock‑outs depress sales), and Target’s cash outflows for those SKUs would be delayed – yet the corresponding cash inflows would also be postponed because fewer beverages could be sold, tightening the cash‑flow timing for the affected beverage SKUs.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region, which matches the ground truth. However, it introduces a new claim that 'pay-only-when-sold' agreements account for '< 5% of Target's total sales'—this figure is not present in the original answer or question and lacks support from the provided context, making it an unsupported addition. 2) The quantitative accuracy is mostly sound: the 30% figure is correct, and no explicit calculations are performed that contradict the ground truth. The unsupported '< 5%' estimate reduces quantitative precision slightly but does not involve incorrect math. 3) The reasoning contains a critical flaw: the LLM states that 'inventory-turnover metric would rise' due to lower inventory, which contradicts standard financial logic—inventory turnover = COGS / average inventory; if sales (and thus COGS) drop more than inventory, turnover typically falls, especially with stock-outs. The original answer correctly implies turnover decreases due to reduced sales. Additionally, the LLM confuses the impact on cash flows: while it correctly notes delayed outflows (since Target pays after sale), it fails to emphasize that cash inflows are also reduced due to lower sales, which aligns with the original answer’s point about lower cash flow generation. However, the phrase 'tightening the cash-flow timing' is vague and less precise than the original’s clear cause-effect chain. 4) Contextual relevance is high—the response addresses both supply disruption and its implications on inventory turnover and cash flow timing for beverage SKUs at Target, engaging with the multi-hop link between PepsiCo’s regional exposure and Target’s vendor model. However, the flawed reasoning on inventory turnover and introduction of unsupported data reduce qualitative accuracy. Overall, the answer captures key elements but contains significant logical errors in financial interpretation, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 535,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Eli Lilly treats payer‑driven pricing pressure on its high‑cost insulin as a regulatory risk – it warns that public and private payers and pending U.S. legislation could force government‑negotiated pricing and could hurt future revenue, but it does not detail any specific price‑cut or rebate program. Amgen, by contrast, has taken an active, product‑level approach to the same type of pressure on its PCSK9 biologic Repatha: it lowered the net price, expanded discounts and rebates to payers (including Medicare Part D PBMs), introduced new lower‑list‑price NDCs for Medicare patients, and is pursuing payer‑risk‑sharing and patient‑support initiatives to keep the drug accessible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) It correctly identifies that LLY treats payer-driven pricing pressure—particularly on insulin—as a regulatory and legislative risk, highlighting potential government negotiation and reimbursement restrictions without detailing active pricing changes. In contrast, it accurately states that AMGN has taken direct action on Repatha by lowering net and list prices, expanding rebates (especially to Medicare Part D PBMs), introducing lower-priced NDCs, and engaging in risk-sharing and patient-support initiatives. These points align with the original answer’s emphasis on AMGN’s active pricing and partnership strategies versus LLY’s focus on uncertainty. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. The mention of '2019' in the original answer (AMGN discontinuing higher-priced NDCs) is absent in the LLM response, but the core fact—introducing lower-priced NDCs—is included, which is a minor omission. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in strategic responses between two companies (LLY vs. AMGN) across different biologics (insulin vs. Repatha) and different types of payer restrictions. It captures the contrast in approach: passive risk disclosure vs. active pricing and access interventions. (4) The only reason for not scoring a 10 is the omission of the specific 2019 action by AMGN to discontinue higher-priced NDCs, which is a minor but concrete detail in the original. Otherwise, the answer is factually correct, contextually complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 472,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both Bank of America (BAC) and Charles Schwab (SCHW) are operating under a framework in which the counter‑cyclical capital buffer (CCyB) is set at zero. BAC meets its additional buffer requirement by adding the 2.5 % capital‑conservation buffer (CCB) and a 2.5 % G‑SIB surcharge to its 4.5 % CET1 minimum (the CCyB contributes nothing), while SCHW satisfies the same regulatory demand by holding a 2.5 % CCB for its CSB unit and a 2.5 % stress‑capital buffer for its CSC unit, also with a zero CCyB and no G‑SIB surcharge. Thus, both firms rely on the 2.5 % capital‑conservation buffer as the primary extra buffer, but BAC’s approach includes a G‑SIB surcharge whereas SCHW’s approach uses a stress‑capital buffer for one subsidiary.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies that impact the overall correctness. (1) Quantitatively, the LLM incorrectly states that BAC applies a 2.5% capital-conservation buffer (CCB), while the ground truth specifies a Stress Capital Buffer of 2.5% under the Standardized approach. This is a critical error, as the Stress Capital Buffer and Capital Conservation Buffer are distinct regulatory mechanisms. Additionally, the LLM claims SCHW uses a 2.5% stress-capital buffer for its CSC unit, but the original answer states that SCHW's subsidiary CSB maintains a 2.5% Capital Conservation Buffer—there is no mention of a stress-capital buffer for CSC in the ground truth. (2) The LLM incorrectly implies that both firms use a 2.5% CCB, when only SCHW does; BAC uses a Stress Capital Buffer. The G-SIB surcharge of 2.5% for BAC is correctly noted. However, the LLM fabricates a structural use of a stress-capital buffer for SCHW’s CSC unit, which is not supported by the original answer. (3) The qualitative reasoning is partially sound in recognizing that both benefit from the zero CCyB and that BAC has a G-SIB surcharge while SCHW does not, but the synthesis is flawed due to incorrect attribution of buffers. The original answer emphasizes that SCHW structures capital around minimum ratios (7.0%, 8.5%, 10.5%) inclusive of buffers, which the LLM omits entirely—this is a major omission affecting completeness and accuracy. (4) Contextual relevance is high, as the response addresses the regulatory framework and compares both firms’ approaches, but the factual errors in buffer types and entities (CSB vs CSC) and missing structural details about SCHW’s capital ratios reduce correctness. Overall, the answer is partially correct but contains key factual and entity-level errors that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 505,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar build‑out is financed through tax‑equity partnerships that capture its roughly $2 billion of federal investment‑ and production‑tax‑credit carryforwards; the company says those credits should be fully used by 2024.  The solar (and wind) assets are tied to long‑term PPAs that are accounted for as operating leases with terms of up to 25 years.  \n\nDuke Energy, on the other hand, relies on PPAs as the core financing vehicle within VIE structures that also include tax‑equity arrangements with third‑party investors to fund renewable projects.  The filing does not give a specific deadline for using tax credits, implying Duke’s credit utilization is handled on a project‑by‑project basis rather than a firm 2024 horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core strategies of both Southern Company and Duke Energy regarding PPAs and tax equity financing, correctly identifying Southern's use of tax-equity partnerships and long-term PPAs structured as operating leases with up to 25-year terms. It also correctly notes Duke's use of PPAs within VIE structures combined with tax equity. However, there is a significant quantitative error: the LLM states Southern Company has 'roughly $2 billion' in tax credits, while the ground truth specifies '$1.2 billion' as of December 31, 2021. This overstatement by nearly 67% is material. Additionally, the LLM claims Southern 'should be fully used by 2024', which matches the ground truth, but the dollar amount undermines confidence in the source accuracy. 2) The ground truth explicitly states the $1.2 billion figure and 2024 utilization timeline; the LLM's $2 billion is incorrect and not supported. No other numbers (e.g., PPA term of 25 years) are disputed and match exactly. 3) The reasoning is sound in comparing the two companies' strategies: Southern uses tax equity to monetize existing tax credit carryforwards, while Duke integrates PPAs as a core economic driver within VIEs where it is the primary beneficiary. The LLM correctly infers that Duke’s tax credit utilization is project-specific and lacks a firm 2024 deadline, which is a reasonable interpretation given the absence of a stated timeline in the source. It misses the explicit point that Duke controls siting, PPA negotiation, and operations—key reasons it is the primary beneficiary—but still captures the strategic contrast. 4) Despite the major numerical inaccuracy, the answer provides a qualitatively accurate and contextually relevant comparison of financing strategies and tax credit utilization timelines. The core multi-hop synthesis—linking tax credits, PPAs, tax equity, and corporate strategy—is logically structured and mostly factually aligned, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 535,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s charter lets every Class B share (10 votes each) be converted at the holder’s option and, automatically, into a one‑vote Class A share whenever the stock is sold or transferred, effectively eroding high‑vote power as the shares change hands. Comcast, by contrast, locks its 15‑vote Class B shares at a fixed 33 % of total voting power and makes that block non‑dilutable (though it can be converted share‑for‑share into Class A under restrictions), preserving a known, protected voting slice. Because Meta’s dual‑class system gives founder‑controlled Class B shares unchecked voting dominance with no conversion or anti‑dilution safeguard, investors may view Meta’s governance as more entrenched and less balanced than the mitigating mechanisms seen at Google and Comcast, which can dampen sentiment toward Meta’s Class A stock and its overall dual‑class model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert automatically to Class A upon transfer, diluting voting power over time; Comcast's Class B shares are non-dilutable and maintain 33 1/3% voting power; Meta lacks such mitigating mechanisms, leading to concerns about entrenched founder control. (2) Quantitative accuracy is excellent: the 33% voting power at Comcast is correctly stated (equivalent to 33 1/3%), and the description of vote ratios (10 votes for Google Class B, 15 for Comcast) matches known structures, though the exact vote counts are not in the original answer but are plausible and contextually acceptable. No calculations are required, so no errors arise there. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance differences across Google, Comcast, and Meta, drawing a logical comparison that highlights how Meta’s lack of conversion triggers or anti-dilution balancing mechanisms may negatively affect investor sentiment. (4) The only minor shortcoming is that the original answer emphasizes the potential impact on attractiveness of Meta’s Class A stock more explicitly, while the LLM frames it slightly more broadly—still accurate, but with a touch less emphasis on investor behavior. Wording differs but semantic meaning and factual content are equivalent. No incorrect entities or dates are present. Overall, this is a strong, factually correct response with excellent contextual and qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 422,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s new Cordavis unit is teaming directly with drug makers to bring more low‑cost biosimilars to market, which is expected to increase competition and push down overall drug spend. Because UnitedHealth’s pharmacy‑care businesses earn rebates “based on the use of the manufacturers’ products” and accrue them each month under the terms of its contracts, a shift in utilization from brand‑name drugs to cheaper biosimilars would likely reshape those contracts – manufacturers may lower the per‑unit rebate rate but could add volume‑ or market‑share‑based incentives for biosimilar uptake. That change would be reflected in UNH’s $12.5 billion of rebates receivable, with a higher proportion tied to biosimilars, and the timing of revenue recognition would follow the same monthly accrual pattern but the cash receipt would still occur 2‑5 months after billing, potentially smoothing or altering the timing of recognized rebate revenue as biosimilar use grows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CVS launched Cordavis to co-produce biosimilars; UnitedHealth has $12.5 billion in rebates receivable as of December 31, 2024 (implied by context); rebates are based on product utilization and contract terms; accruals occur monthly. The $12.5 billion figure is correctly cited and matches the original answer. (2) Quantitative accuracy is perfect—no calculations were required beyond correct reporting of the $12.5 billion figure, which is accurate in amount and context. Format variation (e.g., $12.5B vs $12.5 billion) is acceptable and handled appropriately. (3) Multi-hop reasoning is sound: the model correctly links CVS’s Cordavis initiative to increased biosimilar availability, then connects that to changes in drug utilization patterns, which in turn affect UNH’s rebate structure and revenue recognition. It correctly infers that rebate contracts may evolve (e.g., lower per-unit rebates but potential volume incentives), and that while monthly accrual timing remains unchanged, cash flow timing (2–5 months post-billing) could influence revenue recognition dynamics. (4) The only minor shortcoming is that the original answer emphasizes the risk of *reduced* total rebates due to lower biosimilar prices displacing high-rebate branded drugs, while the LLM focuses more on structural shifts in rebate design. This is a nuance rather than an error—the LLM does not deny the possibility of lower rebates but frames it as a contractual evolution. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth with excellent reasoning and no factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> COMP -[Works_With]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 467,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest applies to all broker‑dealers, so both Goldman Sachs (GS) and Morgan Stanley (MS) must meet its consumer‑protection standards. GS’s 10‑K notes that its consumer‑oriented activities are now subject to “additional legal requirements…including Regulation Best Interest” and that it is making “significant enhancements to existing controls, systems and procedures,” which will raise its compliance outlays (Chunk 1). MS likewise warns that the rule “may become more costly to provide and distribute our products and services” and could trigger “additional litigation and regulatory investigations” (Chunk 2), and it adds that “certain of our competitors may be subject to different and, in some cases, less‑stringent…regulatory regimes…putting us at a competitive disadvantage” (Chunk 3). Consequently, GS’s expanding retail‑client push is likely to be squeezed by higher compliance costs, while MS’s more cautious or cost‑focused approach to consumer‑protection regulation could help it preserve pricing power and competitive positioning—though both firms will feel pricing pressure from the regulation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Goldman Sachs (GS) and Morgan Stanley (MS) are subject to Regulation Best Interest; GS is investing in 'significant enhancements' to compliance systems, increasing costs; MS acknowledges higher costs and litigation risks, and notes competitive disadvantage due to potentially less-regulated competitors. These points are directly supported by the cited 10-K disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of fabricated or incorrect numbers earns full credit. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while both firms face increased compliance costs, GS is expanding its retail footprint and thus faces higher incremental compliance investments, whereas MS has a more established retail infrastructure and may adapt more efficiently. The LLM also captures the competitive dynamic where differing regulatory burdens across firms could affect pricing power. (4) The only minor shortcoming is that the LLM slightly overemphasizes MS’s 'cautious or cost-focused approach'—the original answer notes MS’s competitive edge comes from established infrastructure, not necessarily a cost-focused regulatory strategy. This nuance is downplayed but not misrepresented. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Applies_To]-> COMP <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 432,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s (CMCSA) dual‑class structure gives the 9.44 million Class B shares – all owned by Brian L. Roberts – a **15‑vote‑per‑share** multiplier.  Because of that multiplier the Class B shares account for **about one‑third of the total voting power (33 ⅓ %)**, while the much larger pool of Class A shares (≈3.78 billion outstanding) holds the remaining **two‑thirds (66 ⅔ %)** of the votes.  \n\nAlphabet (GOOGL) also uses a dual‑class system, but its Class B shares carry **10 votes per share** versus one vote for each Class A share.  The filing does not break out the exact voting‑power percentage, but the 10‑vote multiplier likewise concentrates voting authority in the founders and other insiders who own the Class B stock.  \n\nThus, both companies concentrate control through super‑voting shares, but Comcast’s Class B shares have a higher per‑share voting weight (15 vs 10) and are explicitly defined to represent roughly 33 % of total voting power, whereas Alphabet’s Class B shares provide a 10‑vote multiplier that similarly gives insiders disproportionate control, albeit without a disclosed voting‑power share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes per share and hold 33 1/3% of voting power, while Class A holds 66 2/3%—the LLM correctly reports these percentages (using 'about one-third' and 'two-thirds' with exact fractional notation). GOOGL's Class B shares carry 10 votes per share, which is accurately stated. (2) The LLM correctly notes that GOOGL does not disclose the exact voting power distribution, aligning with the original answer. (3) The reasoning correctly compares the two structures: both use super-voting shares to concentrate control, CMCSA has higher per-share voting power (15 vs 10), and CMCSA’s voting split is explicitly defined while GOOGL’s is not. (4) The LLM omits one qualitative detail present in the ground truth: that GOOGL’s Class B shares can be converted to Class A upon sale or transfer, which introduces a mechanism that could dilute control over time—this is a minor but relevant distinction in assessing concentrated control. However, this omission does not undermine the core correctness. The answer is semantically equivalent in intent and fact, with excellent multi-hop synthesis between CMCSA and GOOGL. Minor deduction only for missing the conversion/dilution point, hence 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 379,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "The 2022 PMI filing notes that Turkey’s total market grew 8.2 % but that growth was “partially offset by a higher estimated prevalence of illicit trade,” which trimmed the company’s cigarette‑volume gains in that country. In contrast, Procter & Gamble’s filing flags Turkey as one of the markets where “significant exchange‑rate fluctuations” have already “significantly impacted our historical net sales, costs and net earnings” and will continue to create translation‑ and transaction‑currency exposure. Together, the two disclosures reveal a dual‑risk picture in the same market: PMI’s legal‑sales volume is being eroded by illicit‑trade activity, while P&G’s profitability is vulnerable to Turkey’s foreign‑exchange volatility—one a market‑share/volume risk, the other a macro‑financial/currency risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the 8.2% market growth in Turkey is correctly cited from PM's filing, and there are no calculations required beyond accurate reporting of this figure. The reference to 'significant exchange-rate fluctuations' impacting P&G’s net sales, costs, and earnings matches the original answer’s description of FX exposure. (2) The entities are correct: PM (PMI) and PG (Procter & Gamble), with proper contextualization of their respective risks in Turkey. The years (implied 2022 from '2022 PMI filing') are consistent with the knowledge graph context. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PM faces illicit trade affecting volume, while PG faces currency volatility affecting financials, and contrasts these as distinct operational risks in the same market. (4) Semantically, the LLM conveys the same core insight as the original answer—that Turkey presents dual, differing risks to two multinationals—though it uses slightly more concise phrasing (e.g., 'market-share/volume risk' vs 'eroding brand loyalty and legitimate sales'). One minor point preventing a perfect 10 is the omission of PM’s indirect benefit from tourism and easing restrictions as a growth driver, which slightly reduces completeness. However, the focus is on the offsetting risk (illicit trade), so this does not undermine correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 422,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a firm‑wide Climate Risk Framework that gives the Climate Risk Management function the mandate to set policies, standards and procedures, build metrics, scenarios and stress‑testing tools, and embed identification, escalation, monitoring and management of transition‑risk drivers across all lines of business with regular reporting to the Board’s Risk Committee. Bank of America, by contrast, is exposed to reputational risk if it fails to meet its climate‑related pledges—most notably its $1.5 trillion sustainable‑finance goal (including $1 trillion earmarked for the low‑carbon transition)—and it relies on dedicated monitoring, reporting to senior management and the ERC, and mitigation processes to curb that reputational fallout. Because transition risk can spill over into reputational risk, JPMorgan’s proactive, integrated framework is aimed at preventing the type of reputational exposure that Bank of America must actively manage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan's Firmwide Climate Risk Framework includes policy-setting, metrics, stress testing, and integration across business lines; Bank of America faces reputational risk tied to its $1.5 trillion sustainable finance goal, including $1 trillion for low-carbon transition. These figures match the original answer exactly, satisfying quantitative accuracy. (2) The LLM correctly identifies both institutions' climate risk approaches—JPMorgan’s proactive, structured risk management vs. BAC’s focus on reputational exposure from unmet public commitments. (3) Multi-hop reasoning is sound: it synthesizes JPMorgan’s internal governance (e.g., Board Risk Committee reporting) with BAC’s external accountability mechanisms, and correctly infers that transition risk can lead to reputational risk, linking the two concepts logically. (4) The only minor shortcoming is slight overreach in stating that JPMorgan’s framework is 'aimed at preventing' the type of reputational exposure BAC faces—while plausible, this comparative effectiveness is not explicitly stated in the ground truth. However, this does not distort the facts and remains a reasonable inference. Wording differs but semantic meaning is equivalent. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 380,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft treats a hardware‑plus‑software bundle as a single performance obligation and records the revenue at the point in time ownership is transferred to the reseller or end‑customer. Cisco’s financing of such hardware is provided through loan receivables that, on average, carry terms of one to three years after the sale, extending beyond the point‑of‑sale revenue recognition. As of July 29 2023, Cisco’s total credit‑loss allowance for its loan‑ and lease‑receivable financing arrangements was **$72 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount ($72 million), date (July 29, 2023), and time range (one to three years) are all accurate and match the original answer exactly. Minor formatting differences (e.g., 'July 29 2023' vs 'July 29, 2023') do not affect correctness. (2) The answer addresses all parts of the multi-hop question: Microsoft's revenue recognition timing (point in time when ownership transfers), the bundling of hardware and software as a single performance obligation, Cisco's average loan receivable terms (1–3 years), and the credit loss allowance amount ($72M as of July 29, 2023). (3) Entities are correctly identified: Microsoft and Cisco are accurately attributed with their respective financial practices and metrics. (4) The reasoning is sound and synthesizes information across two companies and domains—revenue recognition (Microsoft) and financing terms/credit risk (Cisco)—with appropriate logical contrast between point-of-sale revenue recognition and extended financing terms. The semantic meaning is equivalent to the original answer, with slightly enhanced clarity in phrasing (e.g., 'extending beyond the point-of-sale revenue recognition' adds interpretive context without distorting facts). All criteria for correctness, completeness, and accuracy are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 381,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "A delay in the FAA’s approval of Gulfstream’s G700 would keep FedEx from adding the aircraft’s expected fuel‑efficiency to its fleet before ICAO’s January 1 2028 production‑cutoff for non‑compliant types. Because FedEx’s CORSIA‑related expenses are driven by the amount of emissions its fleet generates, having to rely longer on older, less‑efficient jets would raise its carbon‑offset, allowance‑or‑sustainable‑fuel purchases and thus its compliance costs; if the G700 were delivered after the cutoff without meeting the ICAO emissions standards, any use of it would be treated as a non‑compliant aircraft and would incur the same higher cost burden. The Gulfstream filing shows the company is already building inventory for the G700 in anticipation of certification, so a certification lag directly translates into a missed opportunity for FedEx to lower those CORSIA costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2028 ICAO production cutoff date is accurately cited; the link between FAA certification delays and FedEx’s fleet modernization is correctly established; the impact on CORSIA compliance costs via increased emissions from older aircraft is properly explained. (2) Quantitative accuracy is strong: no specific numerical values (e.g., dollar amounts, percentages) are present in either answer, but the 2028 cutoff and implied timeline are consistent. The LLM correctly references the January 1, 2028 date, which is consistent with ICAO standards, though not explicitly detailed in the original answer—this is a minor enhancement, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Gulfstream’s G700 production plans, FAA certification dependency, FedEx’s reliance on fuel-efficient aircraft, and the regulatory framework of CORSIA and ICAO. It appropriately infers that post-cutoff use of non-compliant aircraft would increase costs, which extends but does not misrepresent the original. (4) The only minor gap is that the LLM does not mention the phaseout of free allowances under ETS by 2026—a detail in the original that adds nuance to the cost increase. Additionally, while the LLM suggests the G700 might be treated as non-compliant if delivered after 2028, this is speculative; the original implies the aircraft is designed to meet standards, so delay affects timing of benefits, not compliance status. This slight overstatement prevents a perfect 10. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 460,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "CMCSA’s charter provides that each Class B share carries **15 votes per share**, while the vote count for a Class A share varies with the relative numbers of Class A and Class B shares outstanding – together Class A holders own roughly **66.3 % of the total voting power** and Class B holders about **33.3 %** (Chunk 2; the existence of Class A stock is shown in Chunk 1).  \n\nAlphabet (GOOGL) gives **one vote per Class A share** and **ten votes per Class B share** (Chunk 3).  \n\nThus, on a per‑share basis CMCSA’s Class B stock is more powerful (15 votes vs. GOOGL’s 10 votes), while CMCSA’s overall voting power is split 66.3 %/33.3 % between the two classes versus GOOGL’s fixed 1‑to‑10 vote ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B shares have 15 votes per share (correct), Class A has variable voting power with ~66.7% of total voting power (LLM reports 66.3%, a negligible rounding difference from 66 2/3%), and Class B holds 33.3% (matches 33 1/3% in ground truth). GOOGL’s Class A has 1 vote, Class B has 10 votes—perfectly accurate. (2) The comparison of per-share voting power (15 vs. 10) is correctly highlighted, showing CMCSA’s Class B shares carry more weight per share than GOOGL’s. (3) The reasoning is sound: the LLM correctly synthesizes voting ratios across two companies and draws a valid conclusion about relative voting power. (4) Minor wording difference: LLM says '66.3%' instead of '66 2/3%'—this is a rounding approximation but does not materially affect correctness. The ground truth specifies that CMCSA’s Class A voting power is variable based on outstanding shares, which the LLM mentions, though slightly less precisely phrased. Overall, the answer is factually correct, complete, and contextually appropriate, with only negligible imprecision in percentage formatting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 340,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "CMCSA’s Class B shares carry **15 votes per share** and are expressly stated to represent **33 ⅓ % of the combined voting power** of the company’s common stock, giving their holder a fixed one‑third stake in control. Alphabet (GOOGL) also uses a dual‑class system, but its Class B shares are entitled to **10 votes per share**—ten times the voting right of a Class A share—while the filing does not disclose the exact percentage of total voting power they command. Thus, CMCSA’s Class B holders enjoy a higher per‑share vote count (15 vs 10) and a clearly defined one‑third influence, whereas GOOGL’s Class B holders have a ten‑vote‑per‑share advantage that concentrates control but without a disclosed share of total voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA Class B shares have 15 votes per share and represent 33 1/3% of voting power; GOOGL Class B shares have 10 votes per share. These numbers are factually correct and match the original answer exactly. (2) Quantitative accuracy is perfect—percentages, vote ratios, and comparisons (15 vs. 10 votes) are precise and correctly presented. (3) The reasoning is sound: the LLM correctly identifies that CMCSA’s structure provides a fixed minority control stake with defined voting power, while GOOGL’s does not disclose the total percentage of voting power held by Class B shares. However, the LLM omits a minor but relevant point from the original answer: the conversion feature of GOOGL’s Class B shares into Class A (1 vote) upon sale or transfer, which introduces 'fluidity' in control. This omission slightly weakens the qualitative completeness of the multi-hop comparison. (4) Despite this, the answer remains contextually excellent, directly addressing the comparative voting influence and per-share voting power as asked. Wording differences are acceptable and do not affect meaning. The answer is semantically equivalent with only a slight gap in full depth of structural contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 359,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s S1‑P receptor modulator Zeposia was cleared by the U.S. FDA in **May 2021** for moderately‑to‑severely active ulcerative colitis, whereas Merck’s HIF‑2α inhibitor Welireg received its FDA approval **in August 2021** for adult patients with von Hippel‑Lindau disease – about three months later.  \n\nThe Zeposia approval expanded BMY’s **2021 immunology portfolio**, giving the company a first‑in‑class oral therapy for ulcerative colitis (and later multiple‑sclerosis) alongside its other immunology products. In contrast, Welireg’s approval added a **new oncology asset** to Merck’s 2021 oncology lineup, delivering a novel targeted therapy for VHL and triggering a $50 million milestone payment (with up to $1.05 billion in sales‑based milestones) that bolstered the company’s oncology revenue outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Zeposia FDA approval in May 2021 for UC and Welireg in August 2021 for VHL disease — a three-month difference — matches the original. The $50 million milestone payment is correctly stated. (2) Quantitative elements — dates (May vs. August 2021), the $50M milestone, and even the additional detail of up to $1.05B in sales-based milestones — are factually accurate and consistent with the knowledge graph (the latter being a minor expansion but not contradictory). (3) Multi-hop reasoning is sound: the answer correctly compares timelines across two companies (BMY and MRK), two distinct therapeutic areas (immunology vs. oncology), and links approvals to portfolio impacts. (4) The LLM adds slight elaborative detail (e.g., 'first-in-class oral therapy', 'up to $1.05B in sales-based milestones') not in the original answer, but these are plausible and do not contradict the ground truth; however, the original did not mention the $1.05B, so this is a minor over-extension, preventing a perfect 10. Otherwise, entity names (BMY, MRK, Zeposia, Welireg), indications (UC, VHL), mechanisms (S1P modulator, HIF-2α inhibitor), and impacts on portfolios are all correctly identified and synthesized. Semantic equivalence is maintained with slightly enhanced phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 378,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s equity awards vest on a **company‑specified cliff schedule** – restricted‑stock awards become owned after a fixed service period that can range from **three to ten years** (restricted‑stock units vest after a three‑year cliff). UPS’s multi‑employer pension plans, by contrast, require vesting only as **set by the collective‑bargaining agreements** that govern eligibility and participation; the filings do not give a specific year‑by‑year schedule, and the benefits are paid by a **pooled plan** whose assets are shared among all participating employers. Thus EMR’s vesting is a direct, fully funded compensation timing, while UPS’s vesting is part of a collective benefit scheme that carries shared funding risk (e.g., assets may be used for other employers and the company may face withdrawal liabilities or surcharge contributions if the plan is under‑funded).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: EMR's restricted stock cliff vesting ranges from three to ten years, and UPS’s multiemployer pension vesting is governed by collective bargaining agreements without a fixed numeric schedule. The LLM correctly notes that restricted stock units (a subset) vest after three years, which is consistent with the broader 3–10 year range. No calculations are required, and all financial risk descriptions (e.g., withdrawal liability, surcharge contributions, shared funding) are factually correct. (2) The answer addresses all parts of the multi-hop question: it compares EMR’s equity vesting structure to UPS’s pension vesting, explains differences in funding risk (pooled assets, cross-employer use), and contrasts benefit delivery mechanisms (direct ownership vs. collective plan). (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (EMR and UPS), two types of compensation (equity awards vs. pension plans), and two risk frameworks (individual company funding vs. shared liability). (4) The only minor shortcoming is that the original answer explicitly mentions that EMR recognizes compensation expense ratably over the vesting period—a detail omitted in the LLM response. While not critical to the core comparison, it adds accounting context. Otherwise, the semantic meaning, entity accuracy (EMR, UPS, restricted stock, multiemployer plans), and risk mechanisms are fully preserved. Wording differences (e.g., 'company-specified cliff schedule' vs. 'cliff vesting periods') are stylistic and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 462,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "NFLX’s 10‑K makes clear that the company’s maintenance of members’ personal data (names, age, gender, billing information, etc.) creates a direct exposure to data‑privacy breaches; a breach would require prompt notification of state attorneys‑general, EU data‑protection authorities and the affected individuals, could generate material legal claims and regulatory fines or penalties, and would force costly changes to its business model – especially because Netflix carries no insurance against breach‑related losses. In contrast, Comcast’s filings note that the Communications Act (and related FCC rules) subjects the company to ongoing privacy‑related restrictions on the collection, use, disclosure and retention of personal information, obligating it to build compliance‑focused processes, honor state‑level consumer‑rights requests (access, deletion, portability, opt‑in, etc.) and manage a patchwork of international data‑protection rules; failure to meet those obligations can also trigger regulatory fines and remedial measures, but the risk is an operational compliance burden rather than a breach‑driven penalty. Thus, Netflix’s risk is centered on breach‑related financial penalties and sudden operational adjustments, whereas Comcast’s risk is an ongoing compliance obligation that can impose fines and constrain how personal information is handled on a day‑to‑day basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX faces data breach risks involving personal and billing information, with potential for material fines, legal claims, and operational changes, and explicitly lacks insurance coverage for such events. CMCSA is subject to the Communications Act and must comply with privacy restrictions on data handling, including compliance processes and consumer rights requests, with violations leading to fines and remedial actions. These points match the original answer's core claims. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face regulatory exposure under the Communications Act, but the nature differs—NFLX’s risk is event-driven (breach consequences), while CMCSA’s is ongoing (compliance burden). The distinction between breach-driven penalties vs. operational constraints is logically derived and well-articulated. (4) The LLM adds contextual detail not in the original (e.g., mention of EU authorities, specific consumer rights like portability and deletion), which are reasonable inferences from modern data privacy norms and consistent with CMCSA’s regulatory environment, but not explicitly confirmed in the ground truth. This slightly exceeds the provided knowledge but does not introduce inaccuracies. The absence of insurance for NFLX and CMCSA’s broader compliance framework are correctly emphasized. Overall, the answer is semantically equivalent, comprehensive, and contextually precise—justifying a 9 on correctness (perfect but with minor elaboration beyond ground truth).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Restricts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 492,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "In Sweden, Coca‑Cola Co. (KO) relies on Coca‑Cola Europacific Partners (“CCEP”) to bring its beverages to market – CCEP is a licensed bottler that must purchase all KO concentrates and syrups and then prepares, packages and distributes the trademark drinks under a bottler‑agreement that defines its territory‑specific rights. By contrast, Philip Morris International (PM) entered Sweden by directly launching a new nicotine‑pouch line – Platform 5 – in January 2022, reformulating the Shiro pouches of its newly‑acquired affiliate AG Snus and depending on that affiliate’s existing product platform and limited component supplies rather than on a bottling partnership. Thus, CCEP’s entry is a contract‑based bottling model dependent on KO’s concentrate supply, while PM’s entry is a product‑launch strategy that leverages an internal affiliate’s brand and supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CCEP is KO's licensed bottler in Sweden, PM launched Platform 5 in January 2022 under the Shiro brand via AG Snus acquisition, and the contrast between CCEP’s contract-based distribution model and PM’s direct product launch strategy is clearly articulated. (2) Quantitative accuracy is perfect: the LLM correctly states the January 2022 launch date for Platform 5, and while it omits the specific statistic about KO’s top five bottlers representing 41% of global volume in 2021, this detail is not central to the comparative question about market entry strategies and product dependencies. Its absence does not impair the answer’s correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PM, KO, CCEP, and AG Snus, distinguishing between third-party bottling dependencies and direct market entry through acquisition and internal product development. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original answer. The only minor shortcoming is the slightly less explicit mention of 'product innovation' and 'brand authorization' as strategic differentiators, but these are implied in the description of PM leveraging an internal affiliate’s brand and supply chain versus CCEP’s reliance on KO concentrates. Overall, the answer is factually correct, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 412,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UNH’s 10‑K shows that its stand‑alone Medicare Part D membership fell from 3,315 thousand in 2023 to 3,050 thousand in 2024 – an 8 percent drop. That contraction shrinks the pool of beneficiaries that CVS must cover under its Medicare Advantage contracts, potentially lowering the total premium revenue and the aggregate drug‑cost liability. However, the Inflation Reduction Act (IRA) – as described in Amgen’s filing – imposes new manufacturer‑discount obligations and, beginning 1 January 2025, reduces federal catastrophic re‑insurance, shifting a larger share of drug‑cost risk (including required discounts and higher rebate exposure) onto Part D plans. CVS’s 10‑K notes that such regulatory changes (including the IRA) increase the uncertainty of health‑care cost forecasts and can erode margins because cost overruns cannot be recouped in its fixed‑premium Medicare contracts. Thus, while the 8 % enrollment decline modestly reduces CVS’s exposure by lowering enrollee volume, the IRA‑driven discount and re‑insurance shifts raise per‑member drug‑cost risk, leaving CVS’s overall financial exposure under its Medicare Advantage contracts heightened and more sensitive to accurate cost forecasting and premium pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the 8% decline in UNH's Medicare Part D enrollment from 3,315,000 (3,315 thousand) in 2023 to 3,050,000 (3,050 thousand) in 2024 is accurately reported, and the date of January 1, 2025, for the IRA’s reinsurance changes is correctly cited. (2) The answer correctly identifies the key entities: UNH (UnitedHealth), CVS, the Inflation Reduction Act (IRA), and indirectly references Amgen’s experience through the manufacturer discount context. (3) The reasoning is sound and reflects multi-hop synthesis: it connects UNH’s enrollment drop to reduced beneficiary pool for CVS, links the IRA’s manufacturer discounts and reduced federal reinsurance to increased cost risk for Part D plans, and explains how this affects CVS’s financial exposure under fixed-premium Medicare Advantage contracts. (4) The LLM adds value by explicitly noting that while lower enrollment reduces aggregate liability, higher per-member risk due to IRA shifts increases overall exposure and forecasting challenges—this nuance is consistent with the original answer’s implication of heightened complexity. The only minor shortcoming is that it does not explicitly mention Amgen’s accrual of rebates starting in 2022, which is a detail from the ground truth that adds context to manufacturer discount expectations. However, the core financial mechanism is still accurately conveyed. Thus, the answer is factually correct, well-reasoned, and contextually complete, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 454,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities are regulated by state public‑service commissions that approve cost‑based rates designed to recover all prudently‑incurred expenses – including infrastructure replacement and **environmental‑remediation costs** (Chunk 2).  Because those cost‑recovery mechanisms are built into the rate‑setting process (and, as Chunk 1 notes, limit the utilities’ exposure to market volatility), remediation outlays can be passed through to customers as a recoverable cost.  \n\nDuke Energy, by contrast, records remediation liabilities as **probable and estimable reserves** and generally expenses the costs in its operations unless a regulatory recovery is deemed probable (Chunk 3).  Its exposure is driven by joint‑and‑several or strict‑liability rules, with only limited insurance or contractual indemnity relief, so the company bears direct, uncertain financial risk for cleanup.  \n\nThus, Southern Company can shift remediation costs to ratepayers through a regulated cost‑recovery framework, while Duke Energy faces direct, potentially significant liability exposure under a non‑recoverable, liability‑based regime.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key factual elements are correct: Southern Company uses state-regulated cost recovery mechanisms to pass environmental remediation costs to customers, while Duke Energy records probable and estimable reserves and generally expenses these costs unless recovery is probable. The contrast in regulatory frameworks—cost recovery vs. direct liability exposure—is clearly and correctly articulated. (2) There are no numeric values in the original answer (only a placeholder $X million), so the absence of specific dollar amounts in the LLM response is appropriate and does not affect quantitative accuracy. The LLM correctly refers to 'reserves' in line with typical financial reporting, maintaining semantic and factual equivalence. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across regulatory frameworks (Southern’s rate-based recovery) and liability models (Duke’s expense-based approach under environmental liability rules), drawing a valid comparative conclusion about financial exposure. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'uncertain future costs without assured cost pass-through' compared to the original, though the concept is implied through 'direct, uncertain financial risk.' Wording differs slightly but meaning is preserved. Overall, the response is contextually precise, factually correct, and fully addresses the comparative, multi-entity nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Includes]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 426,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar’s 2024 Form 10‑K reports **40,873,176** securities remaining available under equity‑compensation plans approved by security holders, and Johnson & Johnson reports **111,042,139** such securities. Together they represent **151,915,315** securities.  \n\n3M’s 2024 Form 10‑K shows **39,563 thousand** securities (≈ 39,563,000) remaining under its approved equity‑compensation plans. Thus, the combined Caterpillar‑J&J pool is about **112.35 million securities larger** – roughly **3.8 times** the amount available at 3M.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176 and Johnson & Johnson's 111,042,139 securities are correctly reported. The sum, 151,915,315, is correctly calculated. 3M's available securities are correctly stated as 39,563,000 (noted as '39,563 thousand', which is semantically equivalent). (2) The comparison is quantitatively sound: the difference of approximately 112.35 million (151,915,315 - 39,563,000 = 112,352,315) is accurately approximated, and the ratio (~3.8 times) is correct (151,915,315 / 39,563,000 ≈ 3.84). (3) The multi-hop reasoning is robust—information is correctly synthesized across three companies (Caterpillar, J&J, and 3M) from their respective equity compensation disclosures, with proper aggregation and comparison. (4) The answer addresses all parts of the question: the combined total for Caterpillar and J&J, the individual figures, and the comparison to 3M. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 318,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s Januvia and Janumet retain U.S. market‑exclusivity only until May 2026 (with Janumet XR extending to July 2026) and, under the Inflation‑Reduction‑Act (IRA), a government‑set price for Januvia becomes effective on 1 Jan 2026 and for Janumet/Janumet XR on 1 Jan 2027. These fixed expiry dates and the IRA‑imposed price caps mean Merck’s post‑2025 revenue protection is narrowly time‑bound and will be sharply eroded once exclusivity ends.  \n\nPfizer, by contrast, leans on a broader regulatory‑exclusivity strategy—using patent‑term extensions, orphan‑drug and pediatric exclusivity, and other data‑protection periods that can run concurrently with or beyond patent life—to extend market protection beyond the basic patent term. Thus, while Merck’s protection hinges on a specific May 2026 deadline and statutory pricing limits, Pfizer’s regulatory‑exclusivity toolkit provides a more flexible, potentially longer‑lasting shield for revenue after 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the dates for exclusivity expiration (May 2026 for Januvia and Janumet, July 2026 for Janumet XR) are correct. The IRA pricing constraints are correctly assigned to 2026 for Januvia and 2027 for Janumet/Janumet XR; the LLM specifies January 1 as the effective date, which is more precise than the ground truth’s general year reference and plausible under IRA rules, though the exact month/day is not confirmed in the ground truth—this is a minor overprecision but not factually incorrect. (2) The comparison to Pfizer’s strategy accurately captures the use of regulatory exclusivity mechanisms (pediatric, orphan drug, data protection) that run concurrently with or beyond patents, which is consistent with Pfizer’s broader portfolio protection approach. (3) Multi-hop reasoning is sound: the model correctly synthesizes Merck’s patent expiration timeline, IRA pricing impact, and contrasts it with Pfizer’s regulatory exclusivity toolkit. (4) The conclusion about divergent post-2025 revenue protection strategies—Merck’s time-bound, price-constrained approach vs. Pfizer’s flexible, layered exclusivity—is semantically equivalent to the ground truth. The only minor gap is that the LLM does not explicitly mention 'rebate reductions' as part of Merck’s strategy, which is included in the original answer, but this does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 417,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN holdings are hybrid notes that embed a credit‑protection contract sold to the note issuer; if a reference‑entity credit event occurs the principal on the CLN may not be repaid in full, leaving MS exposed to an un‑hedged credit‑event loss (the filing does not describe any offsetting hedge). In contrast, BAC actively manages its commercial‑credit exposure by entering credit‑derivative contracts – it purchases credit protection (and at times sells protection to reduce cost), carries those positions at fair value and relies on clearing‑house membership and ongoing credit‑rating monitoring to control counter‑party risk. Thus, MS bears a passive, un‑mitigated credit‑event risk on its CLNs, whereas BAC transfers and manages that risk through derivative‑based protection strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley (MS) invests in CLNs that embed credit protection sold to issuers, exposing MS to credit event risk if the reference entity defaults, with potential non-repayment of principal—this matches the original answer's description of MS's direct counterparty risk exposure. The contrast with Bank of America (BAC) is also accurately portrayed: BAC purchases credit protection as part of its commercial credit risk management strategy, uses credit derivatives to hedge risk, and manages counterparty risk through clearing-house membership and credit-rating monitoring. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all qualitative financial concepts (e.g., fair value accounting, hedging behavior) are correctly referenced. (3) The multi-hop reasoning is sound—correctly synthesizing that both firms use credit derivatives but in opposite directions: MS as a protection seller (risk taker), BAC primarily as a protection buyer (risk mitigator). The LLM adds a slight nuance—mentioning that BAC 'at times sells protection to reduce cost'—which is plausible and consistent with typical hedging strategies, though not explicitly stated in the ground truth; this does not detract from accuracy. (4) The only minor gap is the characterization of MS's risk as 'passive' and 'un-mitigated'—while the ground truth does not explicitly confirm the absence of hedges, the filings do not describe offsetting positions, so this is a reasonable inference. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Offers]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 481,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "Both companies disclose an indemnification policy, but the way the risk is allocated is different.  \n\n*In the 3M (MMM) spin‑off, the separation‑and‑distribution agreement moves the identified liabilities to the new Solventum entity and obligates Solventum to indemnify and defend MMM for those matters. Because the liability is transferred, MMM can keep the exposure off its balance sheet and only disclose the potential loss, rather than accrue a liability for it (as described in the ASC 450 contingency discussion).  \n\n*In RTX’s case, Note 16 states that a portion of its third‑party financial, market‑value and product‑performance guarantees are “subject to indemnification for our benefit.” RTX retains the guarantee but obtains indemnification from the counter‑party; therefore RTX must still evaluate the guarantee for probable and estimable losses and, if required, record a contingent liability under ASC 450.  \n\nThus, 3M’s structure shifts the liability to Solventum and limits the parent’s loss‑recognition, whereas RTX’s structure keeps the liability on RTX’s books and only mitigates loss exposure through indemnification, which may still require accrual of probable losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: 3M transferred liabilities to Solventum, which assumed indemnification and defense obligations, allowing 3M to avoid accruing the liability if not probable and estimable, consistent with ASC 450. RTX retains its financial guarantees but benefits from third-party indemnification, requiring it to assess and potentially accrue contingent liabilities under the same accounting standard. The distinction in liability transfer versus retention with indemnification is correctly identified. (2) There are no numeric values in the question or answer that require verification; thus, quantitative accuracy is not applicable but assumed perfect due to absence of errors. (3) The multi-hop reasoning is sound—correctly comparing two different corporate structures (spin-off vs. third-party guarantees) and their accounting implications under ASC 450 and ASC 610-30. The synthesis across entities (3M/Solventum and RTX) and accounting frameworks is logically coherent. (4) The LLM omits explicit mention of ASC 610-30 (related to de-recognition in spin-offs), which is included in the original answer and adds depth to 3M’s accounting treatment. This is a minor omission affecting completeness but does not undermine the core correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as all parts of the question are addressed: indemnification structure, transfer of liability, and recognition of potential losses.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 425,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 filing shows that sales to Taiwan were $1.84 billion – about 8 % of its $22.68 billion total external‑customer revenue. In NVIDIA’s 2023 filing the company warns that its foundry partners are based in Taiwan and that “geopolitical tensions… involving Taiwan and China… could have a material adverse impact” on a “significant portion” of its revenue, a supply‑chain vulnerability also highlighted in Qualcomm’s filing about Taiwanese foundries. Thus, AMD’s exposure to Taiwan is quantified as a modest sales share, whereas NVIDIA faces a broader operational risk that could affect a larger share of its earnings if Taiwan‑China tensions disrupt its Taiwanese foundry partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's $1.84 billion in sales to Taiwan in 2023 (equivalent to $1,841 million in the ground truth), and accurately calculates this as approximately 8% of AMD’s total external revenue ($22.68 billion), which aligns with the knowledge graph data. The figure for NVIDIA does not include specific revenue numbers but correctly captures the qualitative risk from its filing—geopolitical tensions involving China and Taiwan could have a 'material adverse impact' on a 'significant portion' of its revenue due to reliance on Taiwanese foundries. (2) All numeric values are accurate and properly contextualized. The conversion from $1,841 million to $1.84 billion is correct, and the percentage calculation (1,841 / 22,680 ≈ 8.1%) is valid. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s revenue exposure (market-side) with NVIDIA’s supply chain dependency (production-side) in Taiwan, drawing a clear contrast between sales significance and operational vulnerability. It appropriately references both companies’ filings and correctly identifies the nature of the risk—NVIDIA’s reliance on foundry partners like TSMC in Taiwan. Mentioning Qualcomm adds slight extra context but does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly more contextual framing (e.g., percentage of total revenue) that enhances clarity without introducing error. The only minor limitation is that the original answer emphasizes NVIDIA’s 'core supply chain vulnerability' more directly, while the LLM uses 'broader operational risk'—a slightly softer phrasing—but the meaning remains aligned. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 487,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s generation fleet is largely covered by long‑term power‑sales agreements, and the repowered wind portion carries a weighted‑average remaining term of roughly 15 years; this horizon, tied to forecasted electricity output and earnings, locks in price and volume for a substantial share of its 28,759 MW of capacity and even feeds into its depreciation and asset‑retirement expense modeling, giving the company a highly predictable, multi‑year revenue stream. In contrast, Southern Power’s operating revenues are derived from power‑sales agreements that are disclosed but without any disclosed contract lengths or terms, leaving the duration and certainty of its cash flows opaque and making it more reliant on active marketing, hedging and market‑based pricing. Consequently, NEER’s known 15‑year contract structure provides a clear long‑term revenue‑visibility advantage over Southern Power’s less‑transparent PPA framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER's repowered wind facilities is correctly stated. The mention of 28,759 MW of capacity, while not in the original answer, does not contradict it and may reflect additional context from NEER's overall fleet; however, this specific number is not verified in the ground truth and could be extraneous, though not incorrect. No calculation errors are present. (2) The core comparison between NEER and Southern Power is complete: NEER’s long-term contracts enhance revenue predictability, while Southern Power does not disclose contract terms, leading to less transparency. The LLM correctly identifies that this affects revenue visibility and financial planning. (3) Multi-hop reasoning is sound—synthesizing NEER's disclosed contract duration with Southern Power's lack of disclosure to infer a structural advantage in revenue predictability. (4) The LLM adds value by noting how the contracts influence depreciation and asset-retirement modeling, which is a reasonable extension of the implications of long-term contracts and enhances the explanation without distorting facts. The only minor gap is that the original emphasizes investor confidence more explicitly, which the LLM implies but does not directly state. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only slight deduction for the unverified capacity figure and slightly less emphasis on investor confidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 434,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "Both companies are governed by the FAR, but they face very different accounting and risk implications. RTX’s FAR‑guided contracts are fixed‑price, so the company records revenue as performance‑based or progress payments are earned—often recognizing revenue ahead of billings and reporting the excess as contract‑asset balances, and it uses a percentage‑of‑completion method for long‑term aftermarket work. Honeywell, by contrast, is exposed under the same FAR regime to the government’s right to terminate contracts for convenience (or for performance failures) and to audits that can force price adjustments, refunds or loss of future awards—so its primary concern is termination risk rather than the timing of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings under FAR for fixed-price contracts using performance-based or progress payments, resulting in contract assets; it also uses the percentage-of-completion method for long-term aftermarket work (consistent with known accounting practices). Honeywell’s exposure to termination for convenience and audit-related risks under the same FAR framework is correctly identified. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer that conflict—both avoid specific figures beyond general references to payment structures, so quantitative accuracy is intact. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies operate under FAR, but face different risk and accounting implications—RTX on revenue timing and asset recognition, Honeywell on termination and audit risk. (4) The LLM adds slightly more detail (e.g., mention of percentage-of-completion method and audits/refunds) not in the original, but this enhances rather than distorts the answer. The only minor gap is that the original emphasizes the 80–90% cost coverage by payments (a detail omitted in the LLM response), which slightly affects completeness but not overall correctness. Semantic equivalence is preserved, and the response fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 402,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock is permanently non‑voting – each share “has no voting rights, except as required by applicable law” – so holders have no say in board or corporate decisions and control remains with the Class A and especially the 10‑vote‑per‑share Class B shareholders.  The non‑voting shares still participate in the company’s equity program, as Alphabet repurchased roughly $59‑$62 billion of Class A and Class C shares in each of the 2022‑2024 years and has $44.7 billion of additional repurchase authority remaining.  \n\nComcast, on the other hand, voluntarily gave up its board seats and “substantially all voting rights” in its Hulu investment, handing full operational control to Disney; that relinquishment generated a direct financial payoff – Disney paid $8.6 billion (the $9.2 billion minimum equity value less $557 million of prior capital calls), produced a tax gain in 2023 and reduced Comcast’s recorded Hulu investment to $883 million (2024), while also supporting a $5.2 billion term loan collateralized by the put/call proceeds.  \n\nThus, Alphabet’s non‑voting shares affect governance but do not create an immediate cash event, whereas Comcast’s surrender of voting rights was a strategic transaction that transferred control to another party and yielded a sizable cash infusion and balance‑sheet impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies that Alphabet's Class C shares have no voting rights except as required by law, and that control is retained via Class A and Class B shares (with emphasis on the 10-vote Class B, which is contextually accurate though not in the original answer). The $44.7 billion remaining repurchase authority matches the ground truth. (2) For Comcast, it accurately states the relinquishment of 'substantially all voting rights' in Hulu, transfer of control to Disney, the $9.2 billion minimum equity value, the $8.6 billion net payment (after $557 million in prior capital calls), and the $883 million recorded investment value as of December 31, 2024. The mention of a tax gain and a $5.2 billion term loan is additional context not in the ground truth but does not contradict it and may reflect broader public knowledge; however, since these details are not in the original answer, they are not penalized as long as core facts remain correct. (3) The multi-hop reasoning is sound: the model contrasts Alphabet’s structural use of non-voting shares for capital optimization without immediate financial event versus Comcast’s strategic surrender of voting rights for a direct financial payout and balance sheet impact. (4) The core facts, numbers, dates, and entities are all correct: Alphabet, Comcast, Hulu, Disney, 2019 relinquishment, 2023 put exercise, $8.6B, $557M, $883M, $44.7B. The only minor deviation is the claim of $59–62 billion in annual repurchases for 2022–2024, which is not in the original answer and could be misleading (the original only states remaining authority, not actual repurchase amounts), but this does not materially distort the main point. Overall, the answer conveys semantic equivalence with strong reasoning and high factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 495,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "LLY’s 10‑K makes clear that the rapid uptake of its incretin medicines has been hampered by intermittent delays and tight supplies, a problem rooted in quality‑assurance and Good Manufacturing Practice issues that can trigger production interruptions, recalls or import bans at its third‑party manufacturers. TMO, meanwhile, carries $26.92 billion of remaining performance obligations—about half of which will be recognized beyond the next year—and those obligations are largely tied to three‑to‑five‑year contract‑manufacturing agreements that depend on the same external suppliers. Because LLY’s quality‑assurance challenges can negatively affect those third‑party manufacturers—and, as the AMD filing notes, such suppliers are subject to capacity constraints, yield variability, limited contractual guarantees, and other supply‑chain risks—both companies share a vulnerability that supply‑chain or quality lapses could delay deliveries, impair revenue recognition and jeopardize their ability to meet long‑term contractual commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: LLY's supply constraints due to third-party manufacturing and quality issues, TMO's $26.92 billion in remaining performance obligations, and the 3-5 year duration of contract manufacturing agreements are all accurately represented. The reference to AMD’s 10-K highlighting supplier risks (capacity constraints, yield variability) is correctly included. (2) Quantitatively, the $26.92 billion figure is exact and properly contextualized; the statement that 'about half' of TMO's obligations extend beyond the next year is a reasonable inference not contradicted by the ground truth, though not explicitly in the original. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly links shared reliance on third-party manufacturers, identifies how quality issues at these suppliers create cascading risks for both LLY (supply shortages) and TMO (contract fulfillment), and ties this to financial and operational consequences (revenue recognition, customer relationships). (4) The only minor gap is that the LLM answer does not explicitly state that LLY's supply tightness is expected to last 'in the next several years'—a small omission affecting completeness but not core accuracy. Wording differs slightly (e.g., 'Good Manufacturing Practice issues' vs 'quality assurance risks'), but semantic meaning is equivalent. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong synthesis across entities and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> PRODUCT -[Negatively_Impacts]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 438,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The 2024 filing shows that NextEra Energy Resources has recorded a **$0.8 billion** OTTI loss on XPLR in 2024 and a **$1.2 billion** OTTI loss in 2023, for a **total cumulative impairment of about $2.0 billion** on the XPLR investment.  Prior to the 2024 write‑down, the equity‑method investment carried a value of **approximately $2.6 billion** (as disclosed in the 2024 note), so the cumulative impairments represent roughly 77 % of that pre‑impairment amount and leave a post‑2024 carrying value of about $1.8 billion.  XPLR is one of the principal entities within NEE’s total equity‑method investments of $6.1 billion reported at year‑end 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.2 billion impairment in 2023 and $0.8 billion in 2024 sum to the correct cumulative $2.0 billion total, which aligns with the original answer. The pre-2024 carrying value of $2.6 billion and post-impairment value of $1.8 billion are correctly stated. The additional observation that impairments represent ~77% of the pre-impairment value is a correct derived calculation (2.0 / 2.6 ≈ 76.9%) and adds insight without contradicting the ground truth. (2) The answer is complete, addressing both parts of the question: the total cumulative impairment charge as of December 31, 2024, and the comparison to the carrying value before the 2024 impairment. (3) Entities are correctly identified: NextEra Energy Resources, XPLR, and the use of OTTI (other-than-temporary impairment) is contextually appropriate. (4) The multi-hop reasoning is sound—LLM correctly synthesized data across two reporting periods (2023 and 2024) and linked the impairments to changes in carrying value, demonstrating accurate financial logic. (5) Semantic equivalence is achieved: while the LLM adds minor contextual detail (e.g., XPLR’s role in NEE’s portfolio), it does not introduce inaccuracies and conveys the same core facts as the original answer. All variations in wording are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 395,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE has adopted ASU 2022‑04 (effective 1 Jan 2023) and therefore must provide the foot‑note disclosures the standard calls for, but the filing states that the adoption “did not have a material impact on the Company’s consolidated financial statements.” GE does not break out a specific “confirmed‑invoice” balance or show the obligation as a distinct line‑item on the balance sheet; the disclosure is limited to the required narrative footnote.\n\nBy contrast, 3M (MMM) also follows the same ASU 2022‑04 policy and its Note 16 “Supplier Finance Program Obligations” quantifies the obligation: the outstanding balances of confirmed invoices were about **$0.3 billion** at both 12/31/2024 and 12/31/2023. Those amounts are explicitly **included within accounts payable** on the consolidated balance sheet, and the note also details the volume of invoices confirmed and paid during the year.\n\nThus, while GE’s adoption adds the required disclosure but leaves the obligation off the balance sheet and without a disclosed amount, MMM’s disclosures under the same standard are far more transparent—showing the exact confirmed‑invoice balances and presenting them directly in accounts payable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, with prospective roll-forward disclosures starting January 1, 2024; MMM reported $0.3 billion in confirmed invoice balances as of December 31, 2024 and 2023; these amounts are included in accounts payable. The numbers and dates match exactly, with acceptable formatting (e.g., $0.3 billion). (2) Quantitative accuracy is perfect: the $0.3 billion figure is correctly cited for both years and companies, and no incorrect calculations are made. (3) The qualitative reasoning is sound: the LLM correctly contrasts GE’s narrative-only footnote disclosure (no separate balance sheet line item or quantified balance) with MMM’s more transparent, quantified disclosures in Note 16, including the inclusion in accounts payable. It accurately captures the multi-hop comparison between two companies’ implementation of the same standard. (4) The only minor shortcoming is that the LLM does not explicitly mention that GE’s retrospective disclosures began in 2024 for prior periods, which is a nuance in timing under the standard. However, this does not detract significantly from the overall correctness. The answer is contextually excellent, directly addressing transparency differences in supplier finance disclosures under ASU 2022-04.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Agrees]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 381,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its stake in Cronos using the equity‑method (with a one‑quarter lag), so it must recognize Cronos’s share of earnings (or losses) and adjust the investment’s carrying amount. Because Cronos’s U.S. cannabis business is subject to FDA regulations, any FDA enforcement action—such as fines, product seizures, or operational shutdowns—could depress Cronos’s profitability or trigger an impairment, which would directly reduce Altria’s reported earnings and could also expose Altria to civil, criminal or tax liability and reputational harm. Walmart’s pharmacy business, by contrast, is itself a regulated entity that must hold DEA and FDA licenses and meet strict security and dispensing standards; non‑compliance would result in direct penalties, recalls or increased compliance costs that affect Walmart’s profitability, rather than an indirect equity‑method impact. Thus, Altria’s risk is indirect and tied to an investee’s regulatory performance, while Walmart’s exposure is direct and stems from its own FDA‑subject pharmacy operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Altria uses equity-method accounting for Cronos with a one-quarter lag (consistent with Altria's actual reporting practices), and Cronos's exposure to FDA regulations affects its profitability, which in turn impacts Altria's financials through equity-method losses or impairments. Walmart’s pharmacy operations are directly regulated by the FDA and DEA, and noncompliance risks include penalties, recalls, and operational disruptions—this direct vs. indirect exposure distinction is correctly emphasized. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how equity-method accounting links Altria to Cronos’s regulatory risks, and contrasts this with Walmart’s direct operational exposure. The only minor shortcoming is that the original answer notes both companies face a 'mirroring' regulatory risk profile despite different structures, a nuance slightly underemphasized in the LLM response, though not contradicted. (4) The answer is fully contextually relevant, directly addressing both parts of the comparative question and maintaining precise focus on FDA regulatory exposure through different financial and operational mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 388,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY’s 2022 filing notes that Cardinal Health carries roughly 15‑20 % of LLY’s U.S. sales, making Cardinal a principal distributor of LLY’s products. The same Cardinal is a 50 % owner of Red Oak Sourcing, the generic‑sourcing VIE that CVS consolidates; CVS, as the primary beneficiary, records Red Oak in its Retail/LTC segment and receives the quarterly Cardinal payments (about $183 million per year) that are recognized in cost of products sold and described as immaterial. Thus, while Cardinal’s dual role ties a sizable slice of LLY’s distribution to the joint‑venture partner, CVS’s consolidated exposure to Red Oak is limited to the modest, immaterial payments and the VIE consolidation itself, not materially amplified by LLY’s reliance on Cardinal.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content: it accurately states that Cardinal Health distributes 15-20% of LLY’s U.S. sales (matching the ground truth), correctly identifies Cardinal as a 50% owner of Red Oak Sourcing, notes CVS consolidates Red Oak as primary beneficiary, and reports the $183 million annual payments from Cardinal to CVS (consistent with the 2021 data in the original answer). The mention of immateriality aligns with the original answer’s implication that the payments are not major relative to CVS’s scale. However, the LLM answer downplays the risk linkage emphasized in the ground truth—specifically, that disruption in Cardinal’s distribution of LLY products could impair Cardinal’s financial health and thus its ability to make payments to Red Oak, affecting CVS’s consolidated financial position. This causal chain is underemphasized and instead the LLM concludes that CVS’s exposure is 'not materially amplified,' which shifts the emphasis from risk interdependence to current immateriality, missing a key analytical point.\n\n2) Quantitatively, all numbers are accurate: 15–20% distribution share, $183 million annual payments, 50% ownership, and correct attribution to 2022/2021 filings. No calculation errors.\n\n3) The multi-hop reasoning is partially sound: the model correctly links LLY → Cardinal (distribution), Cardinal → Red Oak (JV ownership), Red Oak → CVS (consolidation), and payment flow from Cardinal to CVS. However, it fails to fully synthesize the second-order risk: that LLY’s reliance on Cardinal creates a vulnerability that could propagate through Cardinal’s financial condition into Red Oak and thus CVS. This is a critical element of the original answer’s logic and represents a gap in reasoning.\n\n4) Contextual relevance is high—the answer addresses the structure of the relationships and financial flows directly tied to the question. The inclusion of immateriality is relevant but used to minimize risk rather than contextualize it, slightly distorting the conclusion. Overall, the answer is factually strong but weaker in capturing the full implications of the interconnected dependencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Consolidates]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 577,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a dedicated short‑term facility that lets it issue unsecured promissory notes (commercial‑paper notes) – $401 million of which were outstanding as of May 31 2024 – and the net proceeds are used for general corporate purposes.  In contrast, Cisco raised $13.5 billion of senior fixed‑rate notes in February 2024; those senior notes are senior debt that rank **pari passu** with the company’s commercial‑paper obligations (i.e., they have the same priority as its short‑term paper) and $0.5 billion of the issue is hedged with an interest‑rate swap.  Consequently, Oracle relies on a relatively modest, stand‑alone commercial‑paper program for short‑term financing, whereas Cisco’s debt structure combines a much larger senior‑note issuance with its commercial‑paper program on an equal‑ranking basis, creating a more layered financing profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Oracle's $6.0 billion commercial paper program with $401 million outstanding as of May 31, 2024, and Cisco's $13.5 billion senior fixed-rate notes issued in February 2024 are accurately reported. The pari passu ranking of Cisco’s senior notes with its commercial paper obligations is correctly stated. (2) Quantitative accuracy is perfect: dollar amounts ($6.0B, $401M, $13.5B), dates (May 31, 2024; February 2024), and the $0.5 billion hedged portion via interest rate swaps are all factually correct and match the ground truth (note: ground truth says 'hedged via interest rate swaps' generally; LLM specifies $0.5B hedged, which may be a slight over-precision but does not contradict). (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s reliance on a modest, standalone short-term commercial paper program with Cisco’s more complex, layered debt structure that includes large long-term senior notes ranked equally with commercial paper. (4) The only minor shortcoming is that the LLM does not explicitly mention that Oracle’s notes mature through August 2024, which is a small omission affecting completeness but not the core comparison. Also, the ground truth notes that Cisco’s notes are redeemable with a makewhole premium, which the LLM omits. These omissions prevent a perfect 10 but do not undermine the overall correctness. Semantic equivalence is maintained, and the conclusion about Cisco having a more layered financing profile is valid and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Related_To]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 434,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment simply states that wind is one of the resources it “relies on” for generation, but the filing does not attach a specific capacity or long‑term contract to that reliance. In contrast, Southern Company’s filing shows a concrete strategic bet on wind through the Skookumchuck project—a 136‑MW wind facility that is locked in a 20‑year power‑purchase agreement—signalling a sizable, dedicated, long‑term wind investment. Thus, Duke’s wind exposure is described in broad, portfolio terms, whereas Southern’s is quantified and committed to a specific 136‑MW, 20‑year wind asset.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy's Commercial Renewables segment includes wind but does not disclose specific capacity, while Southern Company's Skookumchuck project has a 136 MW nameplate capacity and a 20-year PPA. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—136 MW and 20-year PPA are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s broad portfolio approach with Southern’s specific, quantified commitment, synthesizing information about strategy, capacity, and contractual terms across both companies. (4) The answer addresses all parts of the question: it compares Duke’s general reliance on wind with Southern’s targeted project, highlights the strategic implications of the PPA and capacity, and maintains contextual relevance throughout. Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 296,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "MS’s Advanced‑Approach buffer is defined as the sum of a 2.5 % capital‑conservation buffer, the G‑SIB capital surcharge and the counter‑cyclical capital buffer (CCyB), and the Federal Reserve has set the CCyB at zero. Charles Schwab (CSB/CSC) must also hold a 2.5 % capital‑conservation buffer and a CCyB of zero (plus a 2.5 % stress‑capital buffer for its CSC unit), but it does not carry a G‑SIB surcharge. Thus, with the CCyB set at zero, both firms’ buffers contain the same 2.5 % CCB component; the difference is that MS adds a G‑SIB surcharge while Schwab’s requirement includes a separate stress‑buffer for CSC and no G‑SIB surcharge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all percentages are correct: both MS and SCHW have a 2.5% Capital Conservation Buffer, the CCyB is correctly stated as zero, and the G-SIB surcharge applies only to MS. The mention of a '2.5% stress-capital buffer for its CSC unit' is an additional detail not present in the original answer; while this may reflect a real regulatory requirement for Schwab’s bank holding company (CSC), it was not part of the provided ground truth and introduces a nuance that could slightly misalign with the scope of the original comparison. However, this does not contradict the original answer. (2) The reasoning is sound: the LLM correctly identifies that both firms share the same CCB and CCyB treatment, and that the key difference lies in the G-SIB surcharge, which only applies to MS as a systemically important institution. (3) Entity accuracy is strong: MS and SCHW (referred to as CSB/CSC) are correctly identified, and the regulatory components (CCB, CCyB, G-SIB) are properly named. (4) The answer addresses all parts of the multi-hop question: compares buffer structures, incorporates the role of CCyB (currently zero), and differentiates based on G-SIB status. The only minor deviation is the introduction of the 'stress-capital buffer' for Schwab, which, while potentially accurate, is not in the original truth and slightly extends beyond the provided context. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with a small deduction for the extra, unverified detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 447,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivative contracts with internal discounted‑cash‑flow (DCF) models that rely on observable market inputs such as interest‑rate curves, yield curves and foreign‑exchange rates – a Level 2 fair‑value approach that is also used in its non‑recurring fair‑value measurements for impairment (the filing notes impairment charges in fiscal 2024 but does not disclose the amount). Meta, by contrast, applies DCF models as a Level 3 income‑approach to estimate the fair value of operating‑lease ROU assets and lease‑hold improvements, using market‑participant assumptions about expected downtime, projected sub‑lease income and risk‑adjusted discount rates; this methodology produced a $383 million impairment loss for 2024. Thus, Disney’s DCF use is for routine derivative valuation with observable inputs, whereas Meta’s DCF use is for impairment testing of lease assets with more subjective Level 3 inputs, resulting in a quantified $383 million charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $383 million impairment charge in 2024 is correctly attributed to Meta, not Disney, which matches the original answer. The LLM correctly notes that Disney had an impairment charge in fiscal 2024 but clarifies that the amount is not disclosed—this is consistent with the knowledge graph, which assigns the $383M charge to Meta, not Disney. (2) The entity accuracy is strong: both Disney and Meta are correctly identified, along with the correct financial instruments (Level 2 derivatives for Disney, operating lease assets for Meta), and the correct years (fiscal 2024). (3) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly contrasts Disney’s use of DCF models with observable (Level 2) inputs for derivatives versus Meta’s use of unobservable (Level 3) inputs for impairment testing of lease assets. (4) The only minor discrepancy is that the LLM slightly overemphasizes Disney’s use of DCF models for non-recurring impairment measurements without specifying that the $383M charge is not Disney’s—however, it correctly states that Disney’s filing does not disclose the amount, which prevents a factual error. This nuance keeps the answer from being perfect but does not undermine correctness. Overall, the answer is factually accurate, contextually relevant, and semantically equivalent to the ground truth with excellent qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 412,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market (from 114.8 bn units in 2020 to 124.2 bn units in 2021) lifted PMI’s shipments in the country from 47.5 bn to 55.7 bn units and pushed its Turkey market‑share from 41.3 % to 44.8 % – a 3.5‑point gain that helped raise PMI’s overall Middle‑East‑Africa regional share by 1.1 points to 23.1 % (Chunk 2). Although the volume boost was partially offset by a higher estimated prevalence of illicit trade in Turkey, the net effect was a stronger PMI position in that market (Chunk 1).  \n\nIn contrast, Altria (MO) cites illicit trade as a broad risk factor that can damage brand perception, deprive lawful wholesalers, reduce tax revenues and trigger regulatory actions that may hurt its consolidated tobacco businesses (Chunk 3). Thus, while PMI’s market‑share in Turkey improved despite the illicit‑trade headwind, MO’s exposure to illicit trade is a systemic negative that can adversely affect its overall tobacco operations rather than being offset by any specific volume increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PM's shipments increased from 47.5B to 55.7B units, market share rose from 41.3% to 44.8%, and Turkey's total market grew 8.2% from 114.8B to 124.2B units—these numbers match the knowledge graph. The calculation of the 3.5-percentage-point gain is accurate. (2) Quantitative accuracy is perfect: all figures are correctly reported, and the implied math (e.g., 55.7 / 124.2 ≈ 44.8%) checks out. Format variations (e.g., 'bn' for billion) are acceptable and clear. (3) Reasoning is sound: the LLM correctly synthesizes that PMI benefited from volume growth in Turkey despite rising illicit trade, while MO frames illicit trade as a systemic risk without an offsetting volume gain. The multi-hop logic—linking Turkey market dynamics to PMI’s share gain and contrasting with MO’s broader risk exposure—is well executed. (4) The only minor shortcoming is that the LLM introduces a detail not in the original answer—PMI’s Middle East-Africa regional share increasing by 1.1 points to 23.1%—which, while potentially true, is not part of the ground truth and slightly exceeds the provided context. However, this does not contradict the original answer and adds contextual depth without harming accuracy. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 388,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act rewrites Medicare Part D so that the government’s share of the drug‑benefit bill is reduced and more of the claim risk is pushed onto the health‑plan sponsors.  CVS notes that “the IRA contains changes to the Part D program… that could shift more of the claim liability to plans and away from the government,” meaning its Medicare Part D business could be required to absorb higher drug‑cost liabilities and therefore faces greater financial exposure if costs exceed its expectations.  \n\nAt the same time, the same redesign makes manufacturers responsible for a larger share of the benefit cost and gives CMS authority to set prices and impose mandatory discounts.  AbbVie explains that under the IRA “the U.S. Department of Health and Human Services can effectively set prices for certain single‑source drugs … reimbursed under Medicare Part D,” and that Imbruvica was selected for government‑set pricing beginning in 2026.  The new Part D design also replaces the 70 % coverage‑gap discount with a 10 % (or 20 % for high‑spending beneficiaries) manufacturer discount, creating a statutory ceiling on the drug’s net price.  Consequently, AbbVie must lower Imbruvica’s price and accept reduced reimbursement, reshaping its pricing strategy for the product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CVS faces increased financial exposure due to shifted claim liability under the Inflation Reduction Act (IRA), and AbbVie is subject to government-set pricing for Imbruvica starting in 2026. (2) Quantitative elements are accurate: the replacement of the 70% coverage-gap discount with a 10% (or 20% for high-spending beneficiaries) manufacturer discount is correctly stated and aligns with the IRA provisions. The statutory ceiling on net price is properly described. (3) Multi-hop reasoning is sound: the answer synthesizes information across two companies (CVS and AbbVie), connects the same regulatory change (IRA's Part D redesign) to different financial impacts (liability for insurers vs. pricing pressure for manufacturers), and correctly identifies the causal mechanisms. (4) Entity accuracy is perfect: both companies, the drug (Imbruvica), the year (2026), and the regulatory body (CMS/HHS) are correctly named. The explanation of pricing strategy changes and financial exposure is thorough and contextually appropriate. Minor wording differences (e.g., 'rewrites' vs. 'redesign') do not affect factual equivalence. No errors in logic, numbers, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 361,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing’s fair‑value table discloses that the impaired customer‑financing assets are valued by taking a median collateral value from a consistent group of third‑party aircraft‑value publications, with adjustments for the specific condition or features of each aircraft.  Those publications are based on the firms’ knowledge of market trades and other market factors, so the valuation is a Level 3 measurement that relies on unobservable inputs derived from external market data and is reviewed each quarter.  \n\nRTX’s fair‑value table shows that its private‑equity limited‑partnership holdings are valued quarterly using discounted‑cash‑flow models, earnings multiples and market multiples, with adjustments for changes in the portfolio companies’ results and prospects.  This also is a Level 3 measurement that depends on unobservable inputs such as assumptions about future cash flows, discount rates and comparable market multiples.  \n\nThus, both companies rely on unobservable inputs, but Boeing leans on external third‑party aircraft publications, whereas RTX relies on internal modeling and market‑based multiples to arrive at its quarterly valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Boeing uses a median from third-party aircraft value publications, adjusts for aircraft-specific attributes, and reviews quarterly—this matches the ground truth. RTX uses discounted cash flows, earnings multiples, and market multiples with adjustments for portfolio company performance, also correctly stated. Both are identified as Level 3 fair value measurements relying on unobservable inputs. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; all descriptive metrics are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes Boeing’s external-data-driven approach with RTX’s internal modeling approach and draws a valid comparison regarding reliance on third-party data vs. forward-looking financial modeling. (4) The only minor shortcoming is a slight simplification in phrasing: the LLM says Boeing’s inputs are 'derived from external market data' while the original emphasizes that the third-party publications themselves are based on market trades—this nuance is preserved in spirit but slightly less detailed. Also, the original explicitly states that RTX’s adjustments reflect changes in 'operating results or financial condition,' while the LLM uses 'results and prospects,' which is semantically close but slightly less precise. These are minor and do not affect overall correctness. The answer is contextually fully relevant, directly addressing the comparison in methodology and reliance on unobservable inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Not_Subject_To]-> FIN_INST <-[Values]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 459,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s proxy filing shows that, as of 24 Jan 2025, it had 2.19 billion Class A shares (the only shares that trade publicly) and 0.34 billion Class B shares.  Because each Class B share carries ten votes per share (the same 1‑vote/10‑vote split that Meta’s charter mirrors in Alphabet’s structure), the 343 million Class B shares command roughly 3.4 billion votes versus about 2.2 billion votes from all Class A shares – giving the minority Class B holders a majority of voting power and concentrating control in the hands of insiders.  Alphabet’s 10‑K confirms the identical voting split (Class A = 1 vote, Class B = 10 votes, Class C = 0) and notes that in 2024 it repurchased $62 billion of Class A and Class C stock, shrinking the pool of one‑vote shares while leaving the Class B block unchanged; this further raises the proportion of total votes held by Class B shareholders and intensifies the concentration of corporate control at both companies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares have 10 votes per share, when in fact, according to the ground truth, Meta's Class A shares have full voting rights and Class B shares have *no* voting rights except in limited circumstances. This is a critical error that completely inverts the voting structure at Meta. (2) The LLM claims that the 343 million Class B shares command 3.4 billion votes, which is false under the actual Meta structure—since Class B shares have no voting power, they hold zero votes. (3) The LLM incorrectly asserts that Meta mirrors Alphabet’s (GOOGL) 10-vote/1-vote split, but in reality, Meta’s structure is fundamentally different: Class A has voting rights, Class B does not—this is the opposite of the control concentration described. (4) The share counts are approximately correct (2.19B and 0.34B vs. 2,189,898,148 and 343,761,117), and the $62 billion repurchase by GOOGL in 2024 is accurately cited. (5) The reasoning about GOOGL’s repurchase activity reducing the pool of one-vote shares (Class A and C) and thereby increasing the relative voting power of Class B is correct and well-reasoned. However, the multi-hop synthesis fails because it applies GOOGL’s dual-class structure to Meta incorrectly. The answer is contextually relevant and addresses the question’s focus on control concentration and repurchases, but the core factual misunderstanding of Meta’s voting structure renders the conclusion invalid. Thus, while some numbers and the GOOGL analysis are correct, the central claim about Meta is false, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 454,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PEP said its convenient‑foods unit volume in the APAC region rose 19% in 2022, the increase being driven by double‑digit growth in China and Thailand while Taiwan posted only low‑single‑digit growth. By contrast, PG notes that it operates in the Greater China market— a region that explicitly includes Taiwan (as confirmed in the Apple filing)— and that it is “well positioned” there, “often holding a leadership or significant market‑share position,” rather than citing a specific growth rate. Thus, PEP’s performance is measured by a concrete 19% volume gain (with modest growth in Taiwan), whereas PG’s standing in the same broader geography that includes Taiwan is described qualitatively as market‑share leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports PEP's 19% convenient foods unit volume growth in APAC in 2022 and specifies that Taiwan contributed low-single-digit growth, which aligns with the ground truth. It accurately contrasts this with PG's qualitative description of its market position in Greater China, where Taiwan is included, noting PG's leadership or significant market share without citing a specific growth rate. All key facts are present and correctly represented. (2) Quantitatively, the 19% growth figure and the characterization of Taiwan's growth as low-single-digit are accurate. The year 2022 is correctly cited. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s performance data and PG’s market positioning, while referencing Apple’s segment reporting to confirm that Taiwan is included in Greater China. This supports the valid comparison between PEP’s growth metric and PG’s qualitative market strength in overlapping geographies. (4) The only minor shortcoming is that the LLM attributes the confirmation of Taiwan’s inclusion in Greater China to 'Apple’s filing,' whereas the ground truth references 'Apple's segment reporting'—a slight imprecision in source attribution, but the factual point about Taiwan being part of Greater China is correct and contextually supported. This does not undermine the overall accuracy. Thus, the answer is factually correct, complete, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 418,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "Under the Basel III Capital Rules the Prompt‑Corrective‑Action (PCA) framework was revised so that an insured depository institution must now hold a CET1 ratio of at least 6.5 % (with total risk‑based capital ≥ 10 % and a leverage ratio ≥ 5 %) to be classified as well‑capitalized. Capital One (COF), a Category III bank that currently meets the baseline 4.5 % CET1 minimum, therefore must lift its CET1 to 6.5 % to achieve well‑capitalized status (otherwise it remains only adequately capitalized). Bank of America (BAC) is also subject to the same PCA thresholds, but its CET1 regulatory minimum already includes a 4.5 % floor plus a 2.5 % G‑SIB surcharge and a 2.5 % capital‑conservation buffer (≈ 9.5 % effective CET1 in 2023, ≈ 10.4 % in 2022), so it comfortably exceeds the new 6.5 % benchmark and remains classified as well‑capitalized.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA thresholds under Basel III, stating that a CET1 ratio of 6.5% or more (along with total risk-based capital ≥10% and leverage ratio ≥5%) is required for well-capitalized status, which aligns with the ground truth. It accurately notes that COF, as a Category III institution, has a 4.5% CET1 minimum but must meet the 6.5% threshold to be well-capitalized. However, the LLM introduces a leverage ratio requirement (≥5%) not mentioned in the original answer, which may be accurate in general but is not part of the provided ground truth and adds unverified detail. The treatment of BAC contains a significant quantitative inaccuracy: while it correctly states BAC is subject to the same PCA thresholds, it claims BAC’s CET1 minimum includes a 4.5% floor plus a 2.5% G-SIB surcharge and 2.5% capital conservation buffer, totaling ≈9.5% in 2023. This level of specificity (including years and exact surcharges) is not supported by the original answer, which only states BAC must maintain 6.5% CET1 to be well-capitalized—same as COF. The original does not mention G-SIB surcharges or buffer calculations, nor does it provide BAC’s actual CET1 ratios in 2022 or 2023. These additions, while plausible, go beyond the ground truth and introduce unverified data. The reasoning is logically sound and contextually relevant, correctly distinguishing between regulatory minimums and PCA well-capitalized thresholds. However, the unsupported numerical claims about BAC’s effective CET1 ratios and surcharges reduce quantitative accuracy. The answer is semantically aligned in intent and covers all question parts, but the extra, unverified calculations and figures prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Updates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 468,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s audit sensitivity work centers on the viewing‑hour assumptions that drive the amortization schedule for its content – the auditor runs “what‑if” tests to see how different historical‑or‑forecast‑viewing patterns would change the timing and amount of amortization expense. By contrast, T’s audit sensitivity analyses focus on two very different levers: the discount‑rate assumptions used to measure defined‑benefit pension and post‑retirement obligations (which can materially alter the recorded liability) and the key forward‑looking inputs in its goodwill‑impairment models (terminal growth rates, long‑term EBITDA margins, weighted‑average cost of capital), which can materially shift the fair‑value of goodwill. Both sets of analyses are judged complex and material, but Netflix’s sensitivity affects expense timing, whereas T’s sensitivity affects liability and asset valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analysis focuses on viewing-hour assumptions affecting content amortization timing, while T's analyses cover pension discount rates and goodwill impairment inputs (terminal growth, EBITDA margins, WACC). These match the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct representation of financial concepts—this is fully satisfied. (3) Multi-hop reasoning is sound: the model correctly synthesizes audit-level sensitivity analyses across two different companies (NFLX and T), distinguishing between consumption-based amortization (NFLX) and long-term liability/asset valuation assumptions (T). (4) The only minor shortcoming is a slight reduction in detail compared to the original—e.g., the original specifies that T’s pension discount rates are tied to 'corporate bond credit quality and timing of benefit payments,' which the LLM omits—but this does not affect the overall correctness. The LLM captures the essential contrast in focus: expense timing vs. asset/liability valuation. Wording differs but semantic meaning is equivalent. Thus, correctness is excellent, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 373,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe lists Taiwan as one of its many local field‑office locations, giving it a dedicated on‑the‑ground presence in the country. Apple does not highlight a separate Taiwan office; instead it groups Taiwan within its “Greater China” segment (which also covers mainland China and Hong Kong), and that segment generated $74.2 billion in net sales in 2022. Thus Adobe’s Taiwan footprint is a single localized office, while Apple’s strategy is a broader regional approach that captures Taiwan as part of a much larger, high‑revenue Greater China market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022—this number is accurately cited and matches the original answer. (2) Quantitative accuracy is perfect: the $74.2 billion figure is correctly stated with proper context and year. (3) The multi-hop reasoning is sound—correctly contrasting Adobe’s localized presence with Apple’s consolidated regional strategy, synthesizing information about operational models and market segmentation across two companies. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor limitation is that it does not explicitly mention Hong Kong as part of Apple’s Greater China segment, though it is implied by referencing the segment name. This small omission prevents a perfect 10 on qualitative accuracy, but does not detract significantly from the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 303,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin notes that its credit facility and a number of derivative contracts still reference LIBOR, but the facility contains fallback language that will trigger alternative‑rate calculations and the company is using the ISDA 2020 IBOR Fallbacks Protocol; under ASU 2020‑04 it therefore expects only a limited, non‑material impact on its operating results, financial position or cash flows. 3M, on the other hand, does not call out any specific LIBOR‑linked financing; instead it has adopted ASU 2020‑04 and will apply the temporary expedients and hedge‑accounting exceptions the standard provides to any contracts that are modified, and its review concluded that the reference‑rate reform will not have a material effect on its consolidated results. Thus, Lockheed Martin’s exposure is concrete but mitigated by built‑in fall‑backs, while 3M’s position is one of procedural preparedness with no material LIBOR exposure identified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lockheed Martin has LIBOR-based credit facilities and derivatives with fallback provisions via the ISDA 2020 IBOR Fallbacks Protocol, and expects minimal impact; 3M adopted ASU 2020-04, applied its expedients, and concluded no material impact. These match the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates like 'December 31, 2022') in the ground truth that are contradicted or omitted in a way that affects accuracy—though the LLM omits the specific 'by December 31, 2022' deadline mentioned in the original, this detail is contextual and does not alter the core correctness of the financial impact assessment. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their exposure (or lack thereof) to LIBOR, their use of ASU 2020-04, and the resulting low expected impact. It appropriately contrasts Lockheed’s concrete exposure with mitigation mechanisms versus 3M’s procedural readiness and lack of identified exposure. (4) Semantic equivalence is maintained: while the LLM uses slightly different phrasing (e.g., 'procedural preparedness' vs 'similar low expectation of disruption'), the meaning is consistent. The only minor shortcoming is the omission of the explicit mention of SOFR as the alternative rate, but since neither company's materiality hinges on naming SOFR, this does not detract significantly from the qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 449,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s proxy statement (Chunk 2) says that holders of Class A common stock control about **66.3 %** of the combined voting power, while the **33.3 %** held by Class B common stock is “generally non‑dilutable” under its charter.  Each Class B share carries **15 votes per share** (Chunk 2), and because only **9.44 million** Class B shares are outstanding (Chunk 3) versus roughly **3.78 billion** Class A shares, those 15‑vote shares give a tiny equity holder (Mr. Brian L. Roberts) roughly a‑third of all votes despite representing less than 0.3 % of the equity.  This dual‑class structure—where a small block of high‑voting shares wields disproportionate control—is the same mechanism used by Meta (Chunk 1), linking Meta’s Class B shares to Class A shares and, through the KG triplet, to Comcast’s voting framework.  Consequently, the 15‑vote per‑share design concentrates overall shareholder control in the hands of the Class B owner.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the percentages are correctly reported as approximately 66.3% and 33.3%, which are acceptable approximations of 66⅔% and 33⅓% respectively—minor rounding is permissible. The 15 votes per share for Class B is exact. The share counts (9.44 million Class B vs ~3.78 billion Class A) are consistent with the data and support the conclusion that Class B holds disproportionate voting power despite minimal equity ownership. (2) The calculation of less than 0.3% equity ownership by Class B holders is accurate: (9.44M / (9.44M + 3,780M)) ≈ 0.25%, so the statement is correct. (3) The reasoning is sound and demonstrates strong multi-hop synthesis: it connects the high-vote Class B shares to concentrated control, references the non-dilutable nature of the voting rights, and even draws a valid parallel to Meta’s dual-class structure via the KG triplet, showing deeper contextual understanding. (4) All entities (CMCSA/Comcast, Class A/B stock, Brian L. Roberts) are correctly identified. The only minor deviation is the use of approximate percentages instead of exact fractions, but this does not affect factual correctness. Thus, the answer fully addresses both parts of the question: voting power distribution and the impact on shareholder control. Scores reflect near-perfect performance with negligible tolerance for rounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 396,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CMCSA’s sensitivity analyses are used to measure **interest‑rate market risk** – the company applies market‑valuation and sensitivity testing to its mix of fixed‑ and variable‑rate debt and related interest‑rate swaps to see how adverse rate moves would change its interest expense. NFLX’s sensitivity analyses, by contrast, are applied to the **content‑amortization estimates** – the auditor tests how changes in the historical and forecasted viewing‑hour assumptions would affect the timing and amount of amortization expense for its content assets. Both sets of analyses are reviewed by the same audit firm (the auditor that has served NFLX since 2012 and also audits CMCSA), but they reflect distinct risk exposures: macro‑economic interest‑rate risk for CMCSA versus estimation/operational risk in content valuation for NFLX.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA uses sensitivity analyses for interest-rate risk related to debt and interest rate swaps; NFLX uses them for content amortization driven by viewing pattern estimates. The auditor is the same and has served NFLX since 2012, also auditing CMCSA. (2) Quantitative accuracy is perfect: while the LLM does not explicitly mention the $56 million reduction in interest expense for CMCSA in 2023, this is a minor omission that does not affect the overall correctness, as the focus of the question is on the *use* of sensitivity analyses and risk exposures, not the specific dollar impact. No incorrect numbers or dates are presented. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms use sensitivity analyses differently due to distinct risk profiles (interest rate vs. estimation risk), despite sharing an auditor, and infers the implication of consistent audit standards. (4) The answer is contextually excellent—directly addressing the comparative use of sensitivity analyses, the nature of financial risks, and the role of the common auditor. The only reason for not scoring a 10 is the omission of the $56M figure, which is part of the original answer but not critical to the central comparison. Semantic equivalence is otherwise strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 385,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer lists Enbrel as a core inflammation‑immunology product (Chunk 1) and the U.S. formulation patent that underpins that product does not expire until October 19 2037 (Chunk 2). That long‑term patent protection effectively postpones the regulatory exclusivity hurdle that AbbVie’s biologics must meet under the 12‑year BPCIA framework (and any extensions described in Chunk 3). Consequently, Enbrel’s 2037 expiry gives Pfizer a substantially longer barrier to biosimilar entry, strengthening its competitive position relative to AbbVie, which relies on a shorter, more uncertain regulatory‑exclusivity period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies the 2037 expiration date of Pfizer's Enbrel U.S. formulation patent, which matches the ground truth. However, it mischaracterizes the relationship between patent protection and regulatory exclusivity. The claim that the 2037 patent 'postpones the regulatory exclusivity hurdle that AbbVie’s biologics must meet under the 12-year BPCIA framework' is factually incorrect: patent life and BPCIA exclusivity are distinct mechanisms and one does not 'postpone' the other. 2) Quantitatively, the date (2037) is accurate, and no other numbers are misstated. The LLM does not introduce false figures, so quantitative accuracy is high. 3) The reasoning is flawed in its multi-hop synthesis: while both companies use intellectual property and exclusivity strategies, the LLM incorrectly frames Pfizer’s patent as extending beyond or replacing regulatory exclusivity, whereas the ground truth clarifies that AbbVie uses a *combination* of patent and regulatory exclusivity (including pediatric extensions), not a 'shorter, more uncertain' period. In fact, BPCIA exclusivity is statutory and not inherently uncertain. Additionally, the LLM omits that Enbrel is marketed outside the U.S. and Canada by Pfizer, a key contextual detail. 4) The answer is contextually relevant and addresses the competitive positioning question, but the flawed comparison undermines the qualitative accuracy. The conclusion that Pfizer has a 'substantially longer barrier' oversimplifies and misrepresents the strategic differences described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 426,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The G‑SIB surcharge is a regulatory capital add‑on that Morgan Stanley (MS) discloses as affecting JPMorgan Chase’s capital requirements.  If the Federal Reserve were to adopt the proposal with **0.1‑percentage‑point** increments rather than the current **0.5‑percentage‑point** steps, the extra capital buffer that JPM must hold would be markedly smaller.  Consequently, in a resolution in which the Parent Company files for Chapter 11, the **minimum level of unsecured external long‑term debt (“eligible LTD”) and other loss‑absorbing capacity** that must be maintained to recapitalise the subsidiaries would be lower, reducing the amount of additional capital JPM would need to raise while still leaving eligible LTD holders to absorb losses after priority and secured claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies that undermine its correctness. (1) ENTITY INACCURACY: It incorrectly states that Morgan Stanley (MS) discloses the G-SIB surcharge as affecting JPMorgan Chase, which is false — the G-SIB surcharge is a Federal Reserve regulation applied directly to systemically important banks like JPMorgan Chase, not disclosed by another bank. This misrepresents the regulatory framework. (2) QUANTITATIVE and REASONING ERROR: While the shift from 0.5- to 0.1-percentage-point increments is correctly identified, the LLM incorrectly implies that this change would 'markedly' reduce JPMorgan's capital requirements. The ground truth states the impact could be either a marginal increase or decrease depending on JPM's G-SIB score — the direction is uncertain. The LLM assumes a definitive reduction, which is unsupported. (3) REASONING: The explanation of the single point of entry (SPOE) resolution strategy is partially correct — losses are absorbed first by equity, then unsecured creditors including eligible long-term debt (LTD). However, the LLM incorrectly links a reduction in G-SIB surcharge directly to a lower required level of eligible LTD, without acknowledging that the LTD requirement is calibrated to total loss-absorbing capacity (TLAC) standards, which may not change proportionally with small surcharge adjustments. (4) CONTEXTUAL RELEVANCE: The answer addresses the resolution scenario and capital requirements, so it remains relevant. Some correct terminology is used (e.g., 'eligible LTD', 'resolution', 'Chapter 11'), though Chapter 11 is not typically used for bank holding companies in SPOE — Title II of Dodd-Frank is more accurate. Overall, while the answer shows understanding of the general regulatory landscape, it fails on key factual and logical points, especially entity accuracy and directional impact of the policy change, warranting a low-to-mid correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 521,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "LMT values Level 3 fixed‑income investments with a discounted‑cash‑flow model in which the “significant inputs include projected annuity payments and the discount rate applied to those payments.” The filing notes that the valuation is driven by those inputs but does not describe a formal sensitivity analysis. HON, on the other hand, uses a discounted‑cash‑flow approach to test goodwill and indefinite‑life intangible assets, incorporating strategic and annual operating plans, terminal‑value assumptions and a range of cash‑flow and growth assumptions, and it explicitly performs sensitivity analyses on the projected cash flows and the discount rate, warning that changes could materially affect fair value. Thus, both companies rely on projected cash flows and discount rates, but HON emphasizes and quantifies the sensitivity of those assumptions, whereas LMT’s discussion simply identifies the key inputs without detailing sensitivity testing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: LMT uses a discounted cash flow (DCF) model for Level 3 fixed income investments based on projected annuity payments and discount rates, while HON applies DCF to goodwill and indefinite-lived intangible assets using strategic plans, terminal value, and growth assumptions. The LLM correctly notes that HON performs explicit sensitivity analyses on key assumptions (e.g., growth rates, discount rates), whereas LMT identifies key inputs but does not describe formal sensitivity testing—this nuance is supported by the original answer and adds precision. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all referenced inputs are qualitative and correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two asset types (Level 3 fixed income vs. goodwill/intangibles), and two applications of DCF, drawing a valid comparison regarding sensitivity analysis emphasis. (4) The LLM enhances the original answer by highlighting a key distinction—HON’s explicit sensitivity analysis versus LMT’s lack thereof—which is implied in the ground truth but not explicitly stated. This shows strong qualitative reasoning. The only reason for not scoring a 10 is that the original answer emphasizes both companies’ sensitivity to economic and performance shifts, a broader contextual point slightly underemphasized in the LLM response, though not omitted. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 460,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its defined‑benefit pension and post‑retirement obligations using discount rates that are built from corporate‑bond yields, so the auditor must evaluate the credit quality of the bonds and the match between the bonds’ cash‑flow timing and the expected benefit payments. Netflix, by contrast, amortizes its content on the basis of historical and forecasted viewing‑hour patterns, and the auditor tests management’s assumptions about those patterns by comparing them to current viewing trends, checking the completeness of the underlying data and running sensitivity analyses. In both cases the companies disclose significant, judgment‑heavy assumptions that are subject to the auditor’s review of the design and operating effectiveness of controls over those assumptions, but AT&T’s assumptions are market‑rate‑driven while Netflix’s are usage‑forecast driven.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, no specific dollar amounts or numerical values are incorrect—the ground truth mentions $67,854 million in goodwill and postretirement liabilities, but the LLM answer does not include this figure. However, since the LLM response focuses on the methodology rather than the magnitude of liabilities and the question does not explicitly ask for financial figures, this omission does not constitute a critical error. All other financial concepts (discount rates, amortization methods) are correctly represented. (2) The LLM accurately identifies both companies—AT&T and Netflix—and correctly associates AT&T with discount rates based on corporate bond yields and Netflix with forecasted viewing patterns for content amortization. These are key entities and assumptions in the question. (3) The reasoning is sound and reflects multi-hop synthesis: it connects auditor evaluation practices across two different firms, industries, and types of assumptions (market-rate-driven vs. usage-forecast-driven), highlighting both differences and parallels in audit scrutiny. It correctly notes that auditors perform sensitivity analyses, test data completeness, and assess controls—aligning with the ground truth’s mention of auditor use of sensitivity analysis and historical comparisons. (4) Semantically, the LLM answer matches the original: both emphasize that significant, judgment-heavy assumptions are used by each company and subject to auditor review. The LLM adds slightly more detail on audit procedures (e.g., testing completeness of data), which enhances rather than distorts the meaning. The only minor shortcoming is the absence of the specific liability amount ($67,854 million), which was present in the ground truth and could have strengthened completeness. However, since the question asks for a comparison of assumption use and auditor evaluation—not quantitative impact—the omission does not undermine correctness. Overall, the response is factually accurate, contextually appropriate, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 579,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "MO has already adopted ASU No. 2023‑07 for its 2024 annual filing, adding expanded footnote disclosures in Note 17 and stating that the new interim‑segment‑disclosure requirements will begin in its first‑quarter 2025 interim statements. In contrast, PMI (PM) made its segment‑reporting change earlier – in January 2024 it folded the former Swedish Match segment into its four existing geographic segments and re‑classed prior‑year amounts, a structural revision driven by the new segment‑reporting guidance. For context, 3M also adopted the same ASU for the year ended Dec 31 2024 and applied it retrospectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates and adoption timelines are correct: MO adopted for 2024 with interim disclosures starting Q1 2025; PM adopted retrospectively for the year ended December 31, 2024, with changes effective January 2024. These match the original answer exactly. (2) The qualitative details about segment reporting changes are correct: PM integrated the Swedish Match segment into its four geographic segments, and MO enhanced disclosures in Note 17. The mention of retrospective application by PM aligns with the original. (3) The multi-hop reasoning is sound—correctly contrasting MO’s phased implementation (current year adoption, future interim reporting) with PM’s earlier structural integration and restatement of prior periods. (4) The only minor issue is the introduction of '3M' at the end, which is irrelevant and incorrect in this context (the question is about MO and PM only), suggesting a hallucination or data contamination. This does not affect the correctness regarding MO and PM but slightly reduces qualitative accuracy. Otherwise, the answer is semantically equivalent, factually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 344,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "BMY’s small‑molecule cancer drug Pomalyst – which enjoys a five‑year U.S. regulatory exclusivity (Chunk 1) – was named by HHS in January 2025 for IRA price‑negotiation beginning in 2027 (Chunk 2).  BMY warns that this “negotiation” could accelerate revenue erosion before the end of its exclusivity and therefore may materially depress its future Medicare Part D sales, although the company does not quantify the hit.  \n\nPfizer, which also relies heavily on Medicare Part D, has already quantified its IRA exposure – it projects a roughly $1 billion year‑over‑year revenue reduction in 2025 from the Part D redesign and anticipates further cuts as other single‑source drugs (e.g., Eliquis, Ibrance, Xtandi) are added to the maximum‑fair‑price program (Chunk 3).  \n\nThus, while both firms face IRA‑driven price‑setting after the nine‑year threshold that follows their exclusivity periods, BMY’s impact is presently uncertain and tied to the upcoming Pomalyst negotiation, whereas Pfizer’s exposure is concrete, already reflected in a $1 billion revenue drag and expected to grow with additional drug selections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pomalyst was selected by HHS for IRA price negotiation starting in 2027 (Chunk 2), BMY faces potential revenue erosion before exclusivity ends, and PFE expects ~$1B revenue reduction in 2025 due to Part D redesign and IRA pressures on Ibrance, Xtandi, and others. The $1 billion figure and 2025 timeline match the original answer exactly. (2) Quantitative accuracy is perfect: the $1 billion impact for PFE in 2025 is correctly cited, and the 2027 start for IRA pricing is consistent. No calculations were required, but temporal and financial data are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes BMY’s unquantified but material risk around Pomalyst with PFE’s broader, quantified exposure across multiple drugs and mechanisms (Part D redesign, inflation rebates, price negotiations). It distinguishes BMY’s single-drug uncertainty from PFE’s already realized and growing impact. (4) Minor deduction in qualitative accuracy because the LLM omits mention of PFE’s exposure to inflation rebates and slightly downplays the parallel 2027 pricing pressure on Ibrance and Xtandi by grouping them under 'added to the maximum-fair-price program' without explicitly naming IRA negotiation. However, the core comparison—BMY’s narrow, uncertain risk vs. PFE’s broad, quantified exposure—is accurately conveyed. Wording differences do not affect semantic equivalence. Contextual relevance is full, addressing all aspects of the question: IRA impact, revenue outlook, Medicare Part D reliance, and exclusivity timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 447,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine business generated $401 million of net revenue in 2021 – roughly 1.4 % of its consolidated net revenues – so its exposure to Argentina is modest but quantifiable. In contrast, Coca‑Cola’s exposure to Argentina is indirect, coming through Arca Continental, which is listed among KO’s five largest independent bottlers, operates in northern Argentina (as well as other regions), and together with the other four top bottlers accounts for 41 % of KO’s worldwide unit‑case volume, making the reliance strategic but not expressed as a specific dollar amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MDLZ's $401 million in net revenues from Argentina in 2021 is accurately reported. The LLM adds contextual analysis by estimating this as ~1.4% of consolidated revenue, which is a reasonable inference (assuming MDLZ's total revenue was ~$28.6 billion in 2021) and does not contradict the ground truth. The statement that Arca Continental is one of KO’s five largest independent bottlers and accounts for 41% of KO’s worldwide unit-case volume matches known disclosures from KO’s 10-K filings. (2) The ground truth mentions a $13 million remeasurement loss due to Argentina's inflationary status, which the LLM omits. This is a minor but notable omission affecting completeness, particularly regarding MDLZ’s financial risk exposure. (3) Entity accuracy is strong: MDLZ, KO, Arca Continental, geographic scope (northern Argentina), and the nature of the bottler relationship are all correctly identified. (4) Multi-hop reasoning is sound: the LLM correctly contrasts MDLZ’s direct operational exposure with KO’s indirect exposure via a key bottler, and explains the strategic significance through contractual reliance. (5) Semantic equivalence is high—while the LLM does not explicitly mention the remeasurement loss or use the phrase 'highly inflationary economy,' it captures the core comparative exposure accurately. The omission of the remeasurement loss prevents a perfect score, but all other elements are factually correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 427,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s filing stresses that the FDA’s fast‑track pathway is a key tool for accelerating review and getting a product to market more quickly, which can materially reduce development time and cost. Lilly’s acquisition of Prevail therefore gains strategic value because PR006 already carries FDA fast‑track designation, increasing the odds that the gene therapy will obtain its first regulatory approval in the U.S., Japan, the U.K., Germany, France, Italy or Spain before the Dec 31 2024 deadline that triggers the $4.00‑per‑share (≈$160 million) CVR payment; the fast‑track status thus helps protect the full CVR value, since any approval after that date would shave about 8.3 cents per month from the payment until the CVR expires in Dec 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: the $4.00-per-share CVR (≈$160 million total), the December 31, 2024 deadline for full payment, and the mention of a declining payout post-2024 (8.3 cents per month reduction) until 2028. While the ground truth does not explicitly detail the monthly reduction, this incremental decay is logically consistent with a time-limited CVR and adds precision rather than contradicting the original. (2) The entities are correctly identified: BMY (Bristol Myers Squibb) as an example of Fast Track engagement, LLY (Lilly) as acquirer, Prevail, PR006, and its Fast Track Designation for frontotemporal dementia with GRN mutations. (3) The multi-hop reasoning is sound: the answer connects BMY’s regulatory strategy to the value of expedited pathways, applies it to PR006’s Fast Track status, and links that to the CVR’s time-sensitive financial incentive—correctly inferring that faster approval increases the likelihood of a full $4.00/share payout. (4) The only minor gap is that the original answer specifies the indication (frontotemporal dementia with GRN mutations), which the LLM omits, slightly reducing completeness. However, the core strategic logic, numbers, and synthesis are correct. Wording differs but meaning is semantically equivalent. The answer is highly contextually relevant and enhances understanding with the decay rate detail, which, while not in the original, is plausibly derived.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 416,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s equity table shows that its Class A common‑stock count rose from 1,594 shares in 2023 to 1,733 shares in 2024 – an increase of 139 shares (about an 8.7 % rise).  At the same time V’s Class B‑1/B‑2 shares fell from 245 to 125, indicating that part of the Class A growth likely came from converting or otherwise retiring Class B shares, with a small net addition of new Class A stock.  \n\nMastercard (MA) discloses that every Class B share can be converted one‑for‑one into a Class A share, but the holders must immediately sell or otherwise transfer any Class A shares they receive, and only 7 Class B shares were issued and outstanding in 2024.  Consequently, the conversion mechanism can add at most seven Class A shares and, because of the forced sale, does not increase the number of Class A shares held by shareholders (Class A outstanding actually fell slightly to 907 from 927).  \n\nThus, V’s shareholder structure is actively expanding its Class A base (both through conversion of a larger Class B pool and new issuance), whereas MA’s structure remains essentially static, with a negligible and transitory impact from a tiny, convertible Class B pool.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies V's increase in Class A shares from 1,594 to 1,733 (a difference of 139 shares) and notes the 8.7% rise, which is accurate. However, it introduces information not present in the ground truth: specifically, that V’s Class B-1/B-2 shares decreased from 245 to 125. This data is absent from the original answer and cannot be verified from the provided context, making it a significant factual overreach. Additionally, the claim that 'Class A outstanding actually fell slightly to 907 from 927' for MA is not supported by the original answer, which does not mention total Class A shares outstanding for MA—only that 7 Class B shares remained in 2024. These unsupported numbers reduce quantitative accuracy.\n\n2) Calculations: The 139-share increase and ~8.7% growth for V are mathematically correct (139 / 1,594 ≈ 0.087). However, the MA Class A share count decline (927 to 907) and its attribution to the conversion mechanism are not in the ground truth and appear fabricated, making those calculations invalid.\n\n3) Reasoning: The multi-hop synthesis between V's share growth and MA's conversion mechanism is conceptually sound. The LLM correctly interprets MA's one-for-one conversion rule and the requirement to divest post-conversion, aligning with the original answer’s emphasis on structural constraints limiting long-term Class B retention. It also draws a reasonable contrast between V’s expanding Class A base and MA’s static structure, which matches the qualitative insight in the ground truth.\n\n4) Despite introducing unsupported numerical details, the LLM captures the core comparative dynamic: V is growing its Class A shares (possibly via conversion and issuance), while MA’s structure limits lasting changes due to minimal remaining Class B shares and forced divestiture. This semantic equivalence in reasoning justifies a moderate correctness score. The answer is more detailed than the original but includes speculative data, hurting quantitative accuracy. Contextual relevance is high as it directly addresses the shareholder structure evolution comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 564,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe warns that Saudi Arabia’s new data‑localisation rules are a risk to its international business, and Mastercard likewise notes that Saudi Arabia has adopted such requirements. Because NVIDIA’s H100 and L40S accelerators are subject to U.S. export‑control licensing for shipments to Saudi Arabia (Country Group D5), the need to keep any data processed by those chips inside Saudi borders creates an additional compliance hurdle. The combined effect is that NVIDIA would have to obtain the required U.S. licences and put in place local‑data‑storage arrangements, which could delay, restrict or increase the cost of deploying the H100 and L40S chips in Saudi Arabia.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core risks NVIDIA faces in deploying H100 and L40S chips in Saudi Arabia due to the intersection of data localization requirements and U.S. export controls. (1) The key entities—Adobe, Mastercard, NVIDIA, H100, L40S, Saudi Arabia—are correctly identified, and the central issue of data localization as a regulatory hurdle is accurately presented. (2) There are no numeric values requiring verification (e.g., dollar amounts, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is mostly sound: it connects Adobe’s and Mastercard’s observations about Saudi data rules with NVIDIA’s export control constraints. However, there is a minor factual inaccuracy: the LLM states that H100 and L40S are subject to export controls under 'Country Group D5', while the ground truth specifies 'Country Group D4'. This is a significant but not critical error, as both refer to U.S. export control regimes for sensitive destinations, and the broader implication—that licenses are required—remains valid. (4) The answer correctly infers that the combination of local data storage mandates and export licensing could delay, restrict, or increase deployment costs, aligning semantically with the original answer’s conclusion about limited market access and reduced revenue opportunities. The mention of Mastercard, while not in the original answer, adds contextual support and does not detract from accuracy. Overall, the answer is factually strong with only a moderate error in regulatory classification, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Implements]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 438,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing points out that it is **subject to the temporary extension** of the LIBOR‑relief guidance (ASU 2022‑06, which defers to ASU 2020‑04) and that the optional expedients are available through Dec 31 2024, but the company has seen **no material effect** from the reform and is merely monitoring its contracts for any future application. GE’s filing, on the other hand, says it **evaluated the LIBOR discontinuation under the original ASU 2020‑04 guidance** (the underlying relief) and determined the impact on its financial statements is **immaterial**, without referencing the later extension. Thus, FedEx is taking a cautious, monitoring stance under the extended relief, while GE has already applied the original relief and concluded there is no material impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FedEx acknowledges the extension via ASU 2022-06 through December 31, 2024, reports 'no material effect,' and continues monitoring; GE states the impact under ASU 2020-04 is 'immaterial' without referencing the extension. These match the original answer exactly. (2) Quantitative accuracy is perfect: the date (Dec 31, 2024) and references to ASU 2020-04 and ASU 2022-06 are correctly cited. No numerical calculations are required, but all dates and standard identifiers are accurate. (3) The multi-hop reasoning is sound—comparing two companies' differing applications of the same accounting framework—and correctly infers that FedEx maintains a cautious, forward-looking stance under the extension, while GE has already assessed and concluded immateriality under the original guidance. (4) The only minor shortcoming is a slight nuance: the original answer emphasizes that both companies applied the same framework (ASU 2020-04, extended by ASU 2022-06), whereas the LLM implies GE may not have considered the extension at all. However, this does not contradict the data—GE may still be within the framework without explicitly mentioning the extension. Thus, the LLM interpretation is reasonable and factually supported. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 402,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s 10‑K makes clear that a substantial portion of its devices are assembled and its components are sourced from outsourcing partners “located primarily … in Taiwan.”  It warns that geopolitical tensions in Taiwan could bring tariffs, export controls or sudden disruptions that would force Apple to change suppliers, raise component costs and delay product deliveries. NVIDIA’s filing similarly states that its critical chip‑fabrication and assembly partners are in Taiwan, and that any escalation of China‑Taiwan tensions could sever or severely limit that foundry supply, leading to inventory shortfalls, higher production costs and a material adverse impact on revenue. Because both companies depend on Taiwan‑based manufacturing and foundry capacity, heightened political risk in the region threatens the continuity and economics of their supply‑chain operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies both Apple and NVIDIA, their reliance on Taiwan-based manufacturing and foundry partners, and the potential impacts of geopolitical tensions—such as supply disruptions, increased costs, and delays. These points align precisely with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data supports a perfect score. (3) The multi-hop reasoning is sound: the model synthesizes information from both Apple’s and NVIDIA’s 10-K filings, correctly linking their shared dependency on Taiwanese manufacturing infrastructure and the associated geopolitical risks. (4) The answer is highly contextually relevant, directly addressing how supply chain operations for both companies could be affected by tensions involving Taiwan. Wording differs slightly but conveys the same meaning with equivalent or enhanced detail (e.g., mentioning tariffs, export controls, inventory shortfalls, and revenue impact), all of which are consistent with typical 10-K risk disclosures. No factual errors, omissions, or misrepresentations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 370,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s filing says that of the $24,156 million of developed‑technology intangibles acquired in the VMware deal, **a “significant portion” is tied to VMware Cloud Foundation**, but it does not disclose a precise percentage (Chunk 2; Chunk 3).  \n\nOracle’s 2024 balance sheet shows net developed‑technology of $1,276 million against total intangible assets of $6,890 million, which works out to **about 18.5 %** of its intangibles (Chunk 1).  \n\nSo, while Broadcom’s VCF‑related share is described only qualitatively, Oracle’s developed‑technology represents roughly one‑fifth of its total intangible asset base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Broadcom's $24,156 million developed technology intangible, Oracle's $1,276 million developed technology, and $6,890 million total intangible assets are accurately reported. The calculated percentage for Oracle (18.5%) is correct (1,276 / 6,890 ≈ 0.185 or 18.5%), with only a negligible rounding difference from the ground truth's 18.4%—this is within acceptable precision. (2) The answer correctly notes that Broadcom does not disclose the exact percentage tied to VMware Cloud Foundation, accurately reflecting the 'significant portion' qualitative description. (3) Multi-hop reasoning is sound: the model synthesizes data from Broadcom’s acquisition and Oracle’s balance sheet, compares the strategic emphasis on developed technology between the two firms, and draws a valid qualitative contrast. (4) The only minor shortcoming is that the LLM does not explicitly state that Oracle's developed technology represents a 'much smaller share' of its intangible base compared to Broadcom's implied emphasis on VCF, which slightly weakens the comparative insight. However, stating that Oracle’s is 'roughly one-fifth' and contrasting it with Broadcom’s non-quantified 'significant portion' preserves semantic equivalence. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 389,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and together account for roughly one‑third (33 ⅓ %) of the company’s total voting power, yet they are held by only three record holders – essentially Brian L. Roberts – giving a highly concentrated control structure. By contrast, Alphabet (GOOGL) reports a non‑affiliate market value of about **$1.45 trillion** and has 300.8 million Class A, 44.6 million Class B and 315.6 million Class C shares outstanding, a far broader ownership base; its Class B shares, while a small share‑count, enjoy superior voting rights (the dual‑class mechanism that concentrates voting power with insiders) and thus provide class‑based control within a much larger pool of non‑affiliated shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 33⅓% voting power and 15 votes per share for CMCSA's Class B stock, as well as the fact that only three record holders exist, which aligns with the ground truth. It also correctly references GOOGL's non-affiliate market value, approximating $1.45 trillion (ground truth: $1,451.1 billion), which is acceptable in format and rounding. However, the LLM introduces significant inaccuracies by stating that GOOGL has 44.6 million Class B and 315.6 million Class C shares outstanding—this data is not present in the original answer and contradicts the ground truth, which only mentions 300,754,904 Class A shares outstanding as of June 30, 2021. There is no mention of Class B or Class C share counts in the original, so including them constitutes a factual overreach or hallucination. (2) The quantitative accuracy is reduced due to the inclusion of unsupported share counts for GOOGL’s Class B and Class C stock. While the $1.45 trillion figure is close to $1,451.1 billion, the additional numerical claims about share classes are incorrect and not in the source. (3) The reasoning is generally sound in comparing CMCSA’s concentrated control via Class B shares to GOOGL’s dual-class structure with broader non-affiliate ownership. The LLM correctly infers that GOOGL uses a dual-class mechanism to concentrate voting power with insiders despite a large non-affiliate base, which is consistent with the original answer’s intent. However, the synthesis is weakened by fabricating share count details not present in the ground truth. (4) The contextual relevance is high because the answer directly addresses the comparison of voting power distribution and control mechanisms between CMCSA and GOOGL, focusing on class-based control and ownership dispersion. The qualitative accuracy is strong in logic and structure, but penalized slightly for unsupported details. Overall, the core facts about CMCSA and the approximate non-affiliate market value at GOOGL are correct, but the added share count figures reduce quantitative accuracy, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 569,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "CMCSA’s 2024 filing shows it issued roughly 4.65 billion Class A common shares and only 9.44 million Class B shares (about 0.2 % of its total equity), so its capital is overwhelmingly concentrated in Class A stock. Meta’s 10‑K, however, reports 2.19 billion Class A shares and 343.8 million Class B shares outstanding (≈14‑15 % of total equity), indicating a much more balanced distribution across the two classes. Both companies, like Alphabet which also discloses distinct Class A and Class B securities in its 10‑K, use multi‑class structures, but the relative share counts reveal CMCSA’s equity is highly concentrated in one class whereas Meta’s equity is comparatively diversified.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the approximate share counts for both CMCSA and META with acceptable rounding (e.g., 4.65 billion vs 4,651,093,045; 343.8 million vs 343,761,117). The percentage estimate of Class B shares at ~14-15% of META’s total equity is accurate (actual: 343.76M / (2,189.898M + 343.761M) ≈ 13.6%), so minor rounding is acceptable. However, the LLM incorrectly states that CMCSA’s Class B shares are 0.2% of total equity—actual total shares are ~4.66B, so 9.44M Class B shares represent ~0.202%, which is correct. (2) All numeric values are accurately rounded and contextually appropriate; no calculation errors beyond acceptable approximation. (3) The multi-hop reasoning is mostly sound: it compares equity structures across CMCSA and META, identifies concentration vs diversification, and references Alphabet as a comparator. However, it omits the critical qualitative disclosure from the ground truth about voting rights (10 votes for Class B vs 1 for Class A) and automatic conversion upon transfer—key elements explaining *why* META’s structure concentrates voting power. This weakens the qualitative analysis. (4) Despite missing the voting rights detail, the LLM captures the core contrast in equity concentration and correctly interprets the implications of share distribution. Wording differs but meaning is largely equivalent. Contextual relevance is high as it directly addresses the question’s focus on equity structure concentration. Score deductions: -1 for missing voting rights explanation, -1 for slight overstatement of META’s class balance (calling it 'diversified' may overinterpret; still dual-class with concentrated control).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 460,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is vulnerable because a large share of its revenue comes from Medicare and Medicare‑Advantage payments, so any reduction in Medicare reimbursement rates or rule changes – such as those the IRA will bring to the Medicare program – could cut the fees it receives for its primary‑care services. AbbVie’s exposure is of a different type: the IRA gives HHS authority to set statutory ceiling prices for certain single‑source drugs under Medicare Part B and Part D (price‑setting begins in 2026‑2028), so the company could see its drug prices and reimbursements forced down and could face penalties for non‑compliance. Thus, both are tied to the IRA’s impact on Medicare, but CVS faces service‑payment‑rate risk, while AbbVie faces direct government‑price‑cap risk on its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CVS's Oak Street Health relies heavily on Medicare/Medicare Advantage revenue, making it sensitive to reimbursement rate changes; AbbVie faces government-imposed price caps under the IRA for certain drugs in Medicare Part B and Part D, starting in 2026–2028. (2) Quantitative accuracy is perfect: the LLM correctly identifies the 2026–2028 timeline for IRA price-setting implementation, aligning with the ground truth (2026 for Part B, 2028 for Part D). No numerical errors or miscalculations. (3) Multi-hop reasoning is sound—correctly linking both companies to Medicare via different mechanisms (service payments vs. drug pricing), and tying both to the IRA’s impact on Medicare. The only minor omission is that the LLM does not explicitly name Imbruvica as the drug selected for price-setting, which is included in the original answer and adds specificity to AbbVie’s exposure. However, this does not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing the comparative exposure question and synthesizing across entities and regulatory mechanisms. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to this slight lack of specificity, but all critical elements are present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 384,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 2022 Form 10‑K lists operating systems as part of its “product revenue,” showing that the OS is a core, revenue‑generating product that Microsoft continues to design, develop and certify. AMD’s 2022 Form 10‑K (both excerpts) makes clear that its x86‑based microprocessors and its graphics products rely on Microsoft designing and developing its operating systems – and on Microsoft‑certified drivers – to run on or support those products; a loss of that support would materially hurt AMD’s ability to sell them. Thus, because Microsoft treats the OS as a major product line, AMD’s dependence on Microsoft’s OS support is amplified – AMD’s product success is directly tied to Microsoft’s ongoing OS development and certification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that Microsoft includes operating systems in its product revenue (as confirmed in Microsoft's 2022 10-K), and correctly states that AMD depends on Microsoft's OS development and certification for its x86 microprocessors and graphics products (supported by AMD's 2022 10-K). The reasoning correctly synthesizes information across both companies' filings, establishing the dependency link: Microsoft's continued investment in OS development affects AMD's ability to sell its products. The answer adds value by referencing Microsoft-certified drivers, which strengthens the argument, though this detail is not in the original answer. There are no numerical inaccuracies—dates (2022), entities (Microsoft, AMD), and financial categorizations (product revenue) are correct. The only minor shortcoming is a slight lack of elaboration on downstream effects (e.g., ISV optimization, customer purchasing behavior) mentioned in the original answer, but the core causal mechanism and material impact are preserved. Thus, the answer is semantically equivalent and multi-hop reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> PRODUCT -[Develops]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 331,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference solution is essentially a high‑performance network fabric.  In its 2024 filing Cisco says it powers AI workloads with high‑density routers and switches, high‑performance optics, automated observability and a unified management platform that “delivers multicloud architectures” and provides policy‑ and operational‑consistency whether the workload runs on‑premise or in the cloud.  The focus is on connectivity, bandwidth and management of the data‑center fabric that underpins AI workloads.\n\nBroadcom, through VMware Cloud Foundation (VCF), supplies the software‑defined stack that runs those AI workloads.  VCF “delivers integrated, enterprise‑class compute, networking, storage, management and security across any environment,” and it includes **native Kubernetes** to support both VMs and containerized AI/ML jobs on a single platform.  VCF also offers license‑portability, letting customers move the VCF environment between on‑premise data centers and public‑cloud endpoints—i.e., a built‑in multicloud capability.\n\n**Comparison:** Cisco provides the underlying high‑density, multicloud‑ready network infrastructure that enables AI training and inference, while Broadcom’s VCF adds the integrated compute, storage, security and native Kubernetes layer that actually runs enterprise‑scale AI/ML workloads and extends them across multicloud environments.  In other words, Cisco supplies the connectivity and fabric, and Broadcom supplies the Kubernetes‑enabled platform that leverages that fabric for AI workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cisco provides high-density routers, switches, and high-performance optics to support AI workloads with automated observability and unified management, enabling multicloud architectures and operational consistency. Broadcom’s VMware Cloud Foundation (VCF) offers native Kubernetes support, runs both VMs and containerized workloads, and enables license portability across on-premises and cloud environments. These points match the original answer exactly in substance. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—thus, quantitative accuracy is not applicable but assumed perfect as no incorrect numbers were introduced. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that Cisco focuses on the network fabric (connectivity layer) while Broadcom/VCF provides the software-defined platform (compute, storage, Kubernetes) that runs on top of such infrastructure, and both support multicloud operations in complementary ways. The strategic role of VCF in AI workloads is accurately reflected, though the LLM omits the specific valuation method (multi-period excess earnings) mentioned in the ground truth, which is a minor omission affecting completeness but not core understanding. (4) The answer is contextually excellent—directly addressing the comparison in terms of multicloud architectures and Kubernetes integration, with clear differentiation of roles. Wording differs but semantic equivalence is preserved. One point deducted from correctness and qualitative accuracy for missing the valuation detail, though it is not central to the functional comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1630,
        "completion_tokens": 478,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal values the bulk of its derivative contracts with pricing models that are classified as Level 2 – they incorporate observable market data such as currency rates, yield curves, option volatilities and equity prices, and the company states it has no assets or liabilities that require recurring fair‑value measurement using significant unobservable inputs. In contrast, Morgan Stanley’s disclosures show that it applies Level 3 valuation techniques to non‑traded investments and certain securities, and by definition (see the Level 3 description) those techniques rely on significant assumptions that are not observable in the market (e.g., discounted‑cash‑flow analyses, comparable‑transaction multiples, or other unobservable inputs). Thus, PayPal’s derivative pricing is largely based on observable inputs with minimal reliance on unobservable assumptions, whereas Morgan Stanley’s Level 3 valuations depend heavily on such unobservable inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses Level 2 inputs for its derivatives, relying on observable market data such as currency rates, yield curves, option volatilities, and equity prices, and explicitly notes the absence of Level 3 assets or liabilities—aligning with the original answer's claim that PayPal had no Level 3 assets or liabilities as of December 31, 2024. (2) The LLM accurately contrasts this with Morgan Stanley’s use of Level 3 valuations for non-exchange-traded investments and certain securities, emphasizing reliance on unobservable inputs like discounted cash flow analyses and comparable transaction multiples. While the exact phrase 'December 31, 2024' is omitted, the temporal context is implied through consistent reporting periods in the filings and does not affect factual correctness. (3) The multi-hop reasoning—comparing two firms’ fair value measurement approaches across different levels of the fair value hierarchy—is sound and synthesizes the correct inferences from each company’s disclosures. (4) All entities (PayPal, Morgan Stanley), valuation levels (Level 2, Level 3), and financial concepts (observable vs. unobservable inputs) are correctly identified and contrasted. Wording differs slightly but conveys identical meaning. No calculation errors or factual inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 388,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "META’s 343,761,117 outstanding Class B shares represent a relatively small pool of voting power and, as described in the voting‑rights section, can only vote on a narrow set of actions (e.g., a merger, an exit of the core payments business or certain charter amendments). Because those shares carry limited rights, even if all Class B holders acted together they could influence only those specific corporate events and would still be a modest fraction of META’s total equity.\n\nIn contrast, CMCSA’s 3,778,302,017 outstanding Class A shares are the company’s primary voting class and can vote on all shareholder matters. That voting bloc is roughly eleven times larger than META’s limited‑voting Class B pool and is not constrained to special‑case votes.\n\nTherefore, the ability of shareholders to drive governance changes is far greater at Comcast (CMCSA) – where a large, fully‑voting Class A base exists – than at Meta (META), where the 343 million Class B shares have limited voting rights and represent a much smaller share of overall voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights applicable only in specific corporate actions (e.g., merger, exit from core payments business), and CMCSA has 3,778,302,017 Class A shares with full voting rights. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—both the share counts are correct, and the statement that CMCSA’s voting bloc is 'roughly eleven times larger' is accurate (3.778B / 343.76M ≈ 11.0). (3) The reasoning correctly synthesizes the implications of ownership structure on shareholder-driven governance: limited voting rights at META constrain influence, while CMCSA’s broad voting base enables greater shareholder power. The multi-hop logic—comparing voting rights, share counts, and governance implications across two companies—is sound. (4) The only minor shortcoming is that the LLM does not explicitly mention that META’s Class A shareholders (not Class B) control most governance decisions, which slightly weakens the contrast in governance structure. However, this is implied by stating Class B has limited rights and cannot influence broader decisions. Wording differs but semantic meaning is equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 373,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO’s non‑U.S. unit‑case volume is 71 % attributable to sparkling soft drinks – the same mix that applies across the non‑U.S. markets where its bottling partner Coca‑Cola Europacific Partners (CCEP) operates, including Portugal. In contrast, Philip Morris International (PM) has a tangible operational footprint in that key CCEP market: one of its largest manufacturing facilities is located in Portugal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 71% figure for KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories is correctly stated. (2) The answer correctly identifies that this includes Portugal and notes PM's manufacturing presence there. (3) The multi-hop reasoning is sound: it connects KO's reliance on CCEP for distribution in key markets like Portugal with PM's direct operational footprint in the same country. (4) The only minor omission is that the ground truth specifies PM's Portugal facility produces 'over 30 billion units (cigarettes and heated tobacco units combined)', which adds quantitative context about the scale of PM's operations that the LLM answer leaves out. While this detail is not critical to the core comparison, its absence prevents a perfect score. Otherwise, all entities (KO, CCEP, PM), relationships, and strategic implications are accurately represented. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 304,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s loan‑receivable portfolio – which explicitly includes financing for the sale of its hardware, software and **technical‑support services** (as described in its 10‑K financing‑receivables section) – carried a credit‑loss allowance of **$103 million in 2022** that was cut to **$53 million in 2023**. The $50 million reduction indicates that Cisco now expects far fewer defaults on these loans, freeing up capital and improving cash flow that can be redeployed to extend or enhance financing for technical‑support services. Because technical support (the product Adobe also offers) depends on loan receivables, the lower allowance should strengthen Cisco’s ability to fund those support arrangements, albeit with a smaller cushion should future losses arise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Cisco's credit loss allowance decreased from $103 million in 2022 to $53 million in 2023, a $50 million reduction. It accurately notes that technical support services are included in the loan receivables portfolio, as stated in the original answer. The quantitative values (dollar amounts and years) are correct and match the ground truth. (2) The $50 million reduction is correctly calculated ($103M - $53M = $50M), though the percentage decrease (48.5%) is not mentioned, which is a minor omission. However, the absolute dollar change is accurate and sufficient for correctness. (3) The reasoning is sound: the reduced allowance implies lower expected defaults, improved credit quality, and potentially more capacity to extend financing. The LLM correctly links this to Cisco’s ability to finance technical support services, which are explicitly part of the loan receivables. The mention of 'freeing up capital and improving cash flow' aligns with the implication of reduced risk and increased financial flexibility. The only minor flaw is the irrelevant mention of 'Adobe', which is not related to Cisco and appears to be a factual error or confusion, but it does not impact the core reasoning about Cisco. (4) The answer is contextually relevant, complete in addressing the question, and semantically equivalent to the ground truth in meaning, despite slightly different phrasing. The core insight — that lower credit loss allowance enhances Cisco’s ability to finance technical support services — is preserved and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Provides]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 439,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares – created under the company’s certificate of designations (Chunk 1) – are granted voting rights only in narrowly defined situations, namely a consolidation, merger or similar transaction that would give the preferred holders securities or cash different from what the class A common shareholders receive (Chunk 2). In contrast, every share of Netflix common stock carries one vote on **all** shareholder matters (Chunk 3). Consequently, AT&T’s Series B investors have a very limited, conditional voice in corporate governance, whereas Netflix’s common shareholders enjoy broad, universal voting power over the company’s decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that AT&T’s Series B Preferred Stockholders have voting rights only in specific merger-related scenarios—specifically, when a transaction would result in different treatment compared to Class A common shareholders—while Netflix common stockholders have one vote per share on all matters. This aligns with the original answer’s emphasis on limited vs. universal voting rights. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not applicable beyond correct reference to share voting rights, which are accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (AT&T and Netflix) and contrasts their voting frameworks. It identifies the conditional, narrow scope of AT&T preferred stock voting rights versus the universal voting power of Netflix common stockholders. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that AT&T Series B holders vote 'as a single class' with votes proportional to shares held, a small but relevant structural detail present in the ground truth. However, this omission does not distort the overall meaning. Wording differs but maintains semantic equivalence. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 439,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal warns that the speed of “rapid, significant and disruptive technological changes” – from real‑time payments and tokenisation to virtual‑currency, blockchain and BNPL solutions – is a material risk to its business; if it cannot adopt or integrate these new services quickly, or if third‑party platforms (including competitors) restrict its access, PayPal’s product relevance and revenue could be harmed. Visa, on the other hand, explicitly recognises the same alternative‑payment providers (BNPL and crypto platforms) as both partners that can route transactions over its network and competitors that vie for the same spend, and it leans on its global brand, broad credential set and “network‑of‑networks” strategy to capture value from them while defending its position. Thus PayPal faces a direct disruption risk that could erode its earnings, whereas Visa’s dual‑partner‑and‑competitor stance gives it a more insulated, strategically balanced exposure to those emerging payment methods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency as a material risk, citing its inability to adopt or integrate new technologies quickly as a threat to product relevance and revenue—consistent with the original answer. (2) It accurately characterizes Visa’s dual role as both partner and competitor to alternative payment providers, leveraging its global network, brand, and 'network-of-networks' strategy to maintain strategic balance—this aligns precisely with the original answer’s emphasis on Visa’s adaptive positioning. (3) The multi-hop reasoning is sound: the model synthesizes comparative strategic postures across two companies (PayPal and Visa) in response to the same emerging technologies, correctly contrasting direct disruption risk (PayPal) with strategic insulation (Visa). (4) There are no numerical values in the question or answers, so quantitative accuracy is not applicable, but all qualitative elements—entities, risks, strategies—are correctly identified and contextualized. Wording differs slightly but preserves full meaning, demonstrating strong semantic equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Partners_With]-> COMP <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 359,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 proxy statement makes clear that “the holders of each share of common stock shall be entitled to one vote per share.” Alphabet’s 2023 filing likewise states that “each share of Class A common stock is entitled to one vote per share” (while its Class B and Class C shares have different voting rights). Thus, the voting power per share of Netflix’s common stock is identical to the voting rights of Alphabet’s Class A common stock – each provides one vote for each share owned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Netflix's common stock provides one vote per share, citing its 2023 filing, and correctly notes that Alphabet's Class A Common Stock also provides one vote per share, as per its 2023 filing. (2) There are no numerical values requiring calculation, but the key quantitative fact—'one vote per share'—is correctly reported for both companies, with no discrepancies in numbers or dates. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies' filings and compares their voting rights structures, noting that while Alphabet has multiple share classes (Class B with 10 votes, implied by contrast), the Class A shares and Netflix shares are equivalent in voting power. (4) The answer is fully relevant, directly addressing the comparison question and providing precise, contextualized information. Minor wording differences (e.g., 'proxy statement' vs '10-K') do not affect accuracy, as both are valid SEC filings containing the required disclosures. All entities—Netflix, Alphabet, Class A common stock, voting rights—are correctly identified and analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 342,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both PM and MDLZ state that their VAR calculations are performed under **normal market conditions**, using a **95 % confidence interval**, a **one‑day holding period** and a **parametric delta‑gamma approximation** (PM Chunk 1; MDLZ Chunk 3). PM’s model derives the inter‑relationships only from interest‑rate and forward‑currency movements, while MDLZ’s model also incorporates commodity‑price movements and explicitly values currency and commodity options, giving MDLZ a broader risk‑exposure scope. Neither filing discloses the resulting VAR dollar amounts, whereas DIS’s variance‑covariance VAR (Chunk 2) reports a concrete one‑day loss estimate of **$255 million** (down from $284 million), illustrating that the parametric delta‑gamma approach used by PM and MDLZ is methodologically similar but, in the excerpts, lacks a disclosed VAR figure and differs in the breadth of exposures considered.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions with a 95% confidence level and one-day holding period, which aligns with the ground truth. It also correctly notes that PM focuses on interest rate and forward currency movements, while MDLZ includes commodity prices and explicitly values options differently—this reflects accurate entity and methodological understanding. However, a critical factual error occurs in the claim that 'neither filing discloses the resulting VAR dollar amounts,' which directly contradicts the ground truth stating that 'MDLZ provides specific disclosure of their VAR amounts at year-end.' This is a significant omission and misstatement, undermining the correctness. (2) Quantitatively, the LLM incorrectly introduces DIS (The Walt Disney Company) and its VAR figure of $255 million, which is irrelevant to the question comparing PM and MDLZ. This number is accurate for DIS per its filing, but its inclusion distorts the comparison and introduces an extraneous entity not mentioned in the original question or ground truth. No other numbers are misstated, but the absence of MDLZ’s disclosed VAR (which should have been acknowledged) reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes methodology across PM and MDLZ, identifying differences in risk exposure breadth (commodities, options treatment). However, it fails the final synthesis by incorrectly concluding no VAR figures are disclosed, when MDLZ does disclose. This breaks the chain of accurate inference. (4) Contextual relevance is high—the response stays focused on VAR methodology, assumptions, and risk exposure. The structure effectively compares the two firms. However, the introduction of DIS and the incorrect denial of MDLZ's VAR disclosure reduce factual correctness. The qualitative reasoning is mostly logical but flawed at a key point, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 544,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One’s market‑risk exposure is triggered by a size test: because its aggregate trading assets and liabilities are at least 10 % of total assets **or** $1 billion, the firm must apply the **Market Risk Rule**, which forces an adjustment to its risk‑based capital ratios on top of the baseline Basel III capital rules. JPMorgan Chase, while also subject to Basel III, does not face a comparable trading‑asset threshold; instead its regulatory capital is derived from a **Basel III “Regulatory VaR”** framework that uses a ten‑business‑day holding period and a 99 % confidence‑level (with a separate one‑day, 95 % “Risk‑Management VaR”). Thus, Capital One’s exposure is linked to a quantitative asset‑size trigger, whereas JPMorgan’s capital requirement is driven by a VaR‑based methodology applied to the positions covered by Basel III.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitative accuracy: All numbers and thresholds are correct — the $1 billion or 10% of total assets trigger for Capital One is accurately stated, as is JPMorgan's use of a 99% confidence level and ten-business-day holding period for Regulatory VaR. No calculations were required, and all metrics match the original. (2) Completeness: The LLM addresses both firms' regulatory frameworks, the triggering mechanism for the Market Risk Rule, and the methodological differences in VaR usage. However, it omits mention of Capital One’s evaluation under the proposed Expanded Risk-Based Approaches phasing in by 2028, which is part of the multi-hop synthesis in the ground truth. This is a minor but notable omission affecting completeness. (3) Entity accuracy: Both companies (Capital One/COF, JPMorgan Chase/JPM) and regulatory frameworks (Market Risk Rule, Basel III, Regulatory VaR) are correctly identified. (4) Reasoning: The logic is sound — the LLM correctly contrasts Capital One’s threshold-based applicability of the Market Risk Rule with JPMorgan’s reliance on internal VaR modeling under Basel III. It synthesizes the key regulatory distinction well, though it doesn’t fully reflect the evolving nature of COF’s framework under future Basel III expansions. (5) Semantic equivalence: The meaning conveyed is substantially equivalent to the original, with only slight trimming of forward-looking context on COF. Wording variations are acceptable and do not distort facts. Overall, this is a strong, factually correct response with only minor qualitative gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 447,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco quantifies the service‑delivery risk tied to its technical‑support financing by maintaining a $53 million allowance for credit losses on loan receivables (which include hardware, software and technical‑support arrangements) as of July 29 2023. In contrast, Salesforce (CRM) does not disclose a comparable credit‑loss reserve; instead its 10‑K highlights a strategic reliance on third‑party providers to deliver professional and technical support and flags the associated delivery risk qualitatively. Thus, Cisco’s exposure is reflected in a specific $53 million allowance, whereas Salesforce’s exposure is described only in narrative terms without a disclosed allowance amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $53 million credit loss allowance and the date (July 29, 2023) are correctly reported, matching the original answer exactly. The format ($53 million vs $53 million) is acceptable. (2) The LLM correctly identifies that Cisco includes technical support in its financing arrangements and maintains a specific allowance, while Salesforce does not disclose a numerical reserve but instead discusses reliance on third parties. (3) The multi-hop reasoning is sound: it contrasts Cisco’s direct financial risk (quantified via allowance) with Salesforce’s operational risk (qualitative disclosure of third-party dependency), synthesizing information across both companies’ 10-Ks. (4) The only minor shortcoming is that the LLM slightly generalizes by saying Salesforce 'does not disclose a comparable credit-loss reserve'—while true, the original answer adds nuance by explaining that Salesforce’s risk affects customer satisfaction and revenue recognition, which the LLM omits. However, this does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Relates_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 340,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s 10‑K warns that its dual‑class system gives the small block of Class B shares (held by Mark Zuckerberg) decisive voting power and embeds anti‑takeover provisions, so the widely held Class A shares can become less attractive and their price may be depressed – a clear governance risk that erodes investor confidence in Meta’s Class A common stock. Comcast, on the other hand, reports a modest Class B class (9.44 million shares issued out of a 3.97‑billion‑share Class A base) that carries no one‑for‑one conversion right or any governance‑linked restrictions; therefore its Class A shareholders do not face the same governance‑risk premium that Meta’s investors confront (unlike Mastercard, which does impose a conversion‑restriction on its Class B).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the number of CMCSA Class B shares (9.44 million) is correctly reported, matching the ground truth 9,444,375 (rounded appropriately). META's governance structure is described without specific numerical errors. (2) The LLM correctly identifies that CMCSA’s Class B shares lack conversion mechanisms tied to governance restrictions, contrasting with META’s dual-class structure where Class B holders (especially Zuckerberg) have disproportionate control. The mention of META’s 'controlled company' status and its potential negative impact on Class A investor confidence is accurately reflected, though the exact 35% voting power threshold for change-in-control approval is omitted. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance risks across two companies, contrasting META’s explicit investor confidence risks with CMCSA’s lack of similar governance-linked features. (4) The erroneous mention of 'Mastercard' is a clear factual error—this company was not part of the original comparison and introduces a false entity, slightly undermining qualitative accuracy. However, this does not affect the core comparison between META and CMCSA. Overall, the answer is factually strong, contextually relevant, and semantically equivalent to the ground truth with only minor omissions and one extraneous reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 397,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities with a discounted‑cash‑flow model that depends on significant unobservable assumptions – a constant pre‑payment rate and loss‑severity estimates – for a portfolio worth roughly $1.3 billion (about $100 million of the $1.45 billion total fixed‑maturity securities shown in its 2024 balance sheet). Morgan Stanley also uses discounted‑cash‑flow techniques (e.g., in goodwill‑impairment testing), but it applies them within a fair‑value hierarchy that emphasizes observable inputs; Level 3 (unobservable) assets represent only about 0.9 % of its total assets, so its reliance on unobservable inputs is far more limited than AIG’s RMBS valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key numbers are correct: MS's Level 3 assets at 0.9% of total assets as of December 31, 2024, match the original answer. The AIG RMBS valuation using unobservable inputs (CPR and loss severity) is correctly described, though the specific ranges (4.10%–9.26% CPR, 40.81%–76.72% loss severity) are omitted. The $1.3 billion RMBS portfolio value and $1.45 billion total fixed-maturity securities are not in the ground truth and appear to be inferred or added details; while plausible, they are not verifiable from the provided original answer and introduce unconfirmed specifics. (2) The comparison between AIG and MS is sound: AIG relies heavily on unobservable inputs for RMBS, while MS uses DCF models but with a smaller proportion of Level 3 assets, indicating more limited reliance on unobservables. This synthesis across both firms is correct and logically presented. (3) Entity accuracy is strong: AIG, MS, RMBS, DCF models, Level 3 assets, and goodwill impairment testing are all correctly identified and contextualized. (4) The reasoning is multi-hop and valid—comparing valuation techniques and reliance on unobservable inputs across two firms using fair value hierarchy concepts. The only minor shortcomings are the omission of specific input ranges for AIG and the inclusion of unverified dollar amounts, which slightly affect quantitative precision but do not undermine the core correctness. Semantic equivalence is maintained, and the answer fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_Using]-> ACCOUNTING_POLICY <-[Estimates]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 437,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables that finance its hardware fell from **$103 million at July 30 2022 to $53 million at July 29 2023** – a **$50 million reduction**, indicating that Cisco now expects far fewer credit losses on the hardware‑related financing it provides. In contrast, Microsoft treats hardware that is “highly dependent on, and interrelated with, the underlying operating system” as a **single performance obligation** and records the entire amount of revenue **at the point of transfer** to the reseller or end‑customer, rather than maintaining a credit‑loss allowance for those sales. The comparison shows that Cisco’s financial exposure is chiefly **credit‑risk on financed hardware**, which has improved, whereas Microsoft’s exposure is **revenue‑recognition risk** for bundled hardware‑software offerings, reflecting a different type of financial risk tied to integrated products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers and dates are correct: Cisco's allowance decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, a $50 million reduction—this is correctly reported, including the exact dollar figures and fiscal dates (July 30, 2022, and July 29, 2023), which align with Cisco’s fiscal year-end. (2) The qualitative analysis correctly identifies that Cisco manages credit risk via allowances on financing for hardware, while Microsoft, due to the interdependence of hardware and software (e.g., with the operating system), treats such sales as a single performance obligation under revenue recognition rules and recognizes revenue at the point of transfer. This reflects accurate synthesis across both companies’ financial reporting practices. (3) The multi-hop reasoning is sound: it connects Cisco’s credit loss allowance trend to its financing model and contrasts it with Microsoft’s revenue recognition policy for integrated offerings, correctly inferring different types of financial exposure—credit risk vs. revenue recognition risk. (4) The only minor shortcoming is that the LLM does not explicitly mention that Cisco’s financing is tied to both its own and third-party hardware, as noted in the ground truth, which slightly reduces completeness. However, this does not undermine the core accuracy. Wording differs but meaning is semantically equivalent. All key facts, calculations, and comparative insights are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 422,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a **realized $75 million loss** in 2024 from the “Embedded derivatives” line of its investment‑income table (Chunk 3).  \n\nMorgan Stanley, by contrast, only discloses a **potential credit‑risk exposure** tied to its holdings of CDOs (and CLNs) that are hybrid instruments with embedded derivatives. The 10‑K notes (Chunks 1 & 2) explain that the firm has invested in these securities and that, if a credit event occurs on the underlying reference entity, the principal may not be repaid in full—but the filing does not quantify that exposure.  \n\nThus, AIG’s loss is a known $75 million hit to earnings, whereas Morgan Stanley’s exposure is a contingent, un‑quantified credit risk arising from the same type of embedded‑derivative instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states AIG's $75 million loss in 2024 from embedded derivatives, matching the original answer. It accurately notes that MS does not quantify its exposure, which is consistent with the source. No calculations are required, and all numbers/dates are correct. (2) The answer is complete: it addresses both AIG’s realized loss and MS’s unquantified but comparable credit risk exposure through CDOs/CLNs containing embedded derivatives. (3) Entity accuracy is strong—AIG, MS, CDOs, CLNs, embedded derivatives, and 2024 are all correctly identified and contextualized. (4) The reasoning is sound and reflects multi-hop synthesis: it contrasts a realized loss (AIG) with a contingent risk (MS) while correctly identifying the structural similarity in exposure via hybrid instruments. The only minor shortcoming is a slight underemphasis on the parallel nature of the risk mechanism (i.e., both face principal loss due to credit events), though this is implied. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 322,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s policy states that it “hedges its forecasted foreign‑currency transactions for periods generally not to exceed **four years**” and it uses foreign‑exchange forward and option contracts for those cash‑flow hedges. Google, by contrast, notes that its foreign‑currency forward and option contracts (including collars) used as cash‑flow hedges “have **maturities of 24 months or less**.” Thus, while both companies rely on option contracts to manage FX exposure, Disney’s hedges can extend up to about four years, whereas Google’s hedges are limited to a maximum of roughly two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the durations—'four years' for Disney and '24 months or less' for Google—are accurately reported, with no discrepancies in time periods or numerical values. The mention of option contracts aligns with both companies' hedging instruments. (2) While the LLM answer does not include the specific dollar amounts ($9.9 billion for Disney and $731 million for Google), these figures were not required to answer the comparative question about hedge durations. The core of the question focuses on the time horizon of hedges, which is fully addressed. (3) The multi-hop reasoning is sound: the model correctly identifies that both companies use option contracts but differ in maturity periods, synthesizing information across two distinct entities and their hedging policies. (4) The semantic meaning is equivalent to the original answer, with clear, accurate comparison and proper context. The omission of the dollar figures does not detract from the correctness, as they serve as supplementary detail rather than core to the duration comparison. All entities, metrics, and timeframes are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Hedges]-> FIN_INST -[Impacts]-> FIN_INST <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 337,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "QCOM says that the 15 % global‑minimum‑tax (Pillar Two) that will begin to apply in FY 2025 “is not expected to materially impact our consolidated financial statements,” reflecting a geographic mix that does not include material operations in low‑tax jurisdictions. In contrast, Intel notes that a larger share of its earnings now comes from non‑U.S. jurisdictions and that it is “continuing to evaluate the impacts” of Pillar Two in those countries, indicating a greater exposure to additional tax costs. Thus, QCOM’s FY 2025 tax liability is expected to be essentially unchanged, whereas INTC faces a more substantive risk from the Pillar Two rules because of its broader non‑U.S. footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: QCOM expects minimal impact from the 15% Global Minimum Tax starting in FY 2025 due to lack of material operations in low-tax jurisdictions; INTC has significant non-U.S. earnings and is still evaluating Pillar Two impacts. (2) Quantitative accuracy is perfect: the 15% minimum rate, FY 2025 start date, and correct company tickers (QCOM, INTC) are all accurately cited. No calculations were required, but comparative exposure is correctly framed. (3) Multi-hop reasoning is sound—LLM correctly synthesizes geographic tax exposure differences between the two firms and links them to differential Pillar Two risk. (4) The only minor shortcoming is that the LLM omits mention of the EU’s 2024 adoption plans, which adds context to INTC’s uncertainty. However, this does not undermine the core conclusion. Wording differs but semantic meaning matches the original answer. Contextual relevance is excellent, directly addressing the comparative impact question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 302,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes and lets the holder convert it at any time into a Class A share with only one vote, creating a 10‑to‑1 voting‑power ratio that lets the founders hold a super‑majority and dominate board and shareholder votes. Comcast’s Class B shares carry fifteen votes per share but are contractually limited to an aggregate one‑third (33 ⅓ %) of the company’s total voting power and cannot be diluted by issuing other classes, so the controlling shareholders are confined to a protected minority block. Thus, the higher, convertible voting‑power ratio in Alphabet yields far stronger founder control than Comcast’s fixed, non‑dilutable one‑third block—a contrast echoed in Meta’s filing, which notes that even a minority‑sized voting class can confer “controlled‑company” status, but the magnitude of control is far greater under Alphabet’s structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast in governance structures between Alphabet and Comcast and correctly identifies the implications for founder control, showing strong contextual relevance and reasonable qualitative reasoning. However, it contains a critical quantitative error: it states that Comcast’s Class B shares carry 'fifteen votes per share', which is incorrect and not supported by the ground truth. The original answer specifies that Comcast’s Class B shares have a non-dilutable 33⅓% of total voting power, not a per-share vote count like Alphabet’s 10:1 ratio. This misrepresentation undermines the quantitative accuracy. While the LLM correctly notes the non-dilutable nature and fixed voting block (33⅓%), inventing a '15 votes per share' figure introduces a factual error that affects the validity of the comparison. Additionally, the LLM incorrectly implies that Comcast uses a per-share voting ratio (like 15:1), whereas the ground truth emphasizes a cap on aggregate voting power, which is structurally different. The reasoning about Alphabet’s 10:1 ratio and conversion mechanism is accurate and well-explained. The synthesis of how these structures affect founder control is partially correct—Alphabet does allow stronger concentrated control, while Comcast’s is fixed but not necessarily weaker in insulation—but the flawed numeric basis for Comcast weakens the conclusion. The mention of Meta’s filing adds context but is extraneous and not required by the question. Overall, the answer gets the general direction of the comparison right but fails on a key factual detail, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 446,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The Distribution Agreement makes PMI the indemnifier for Altria (and its U.S. subsidiary PM USA) for any tobacco‑product claims that arise from products manufactured by PMI or contract‑manufactured for PMI, while PM USA indemnifies PMI for claims based on products it makes.  Because of that arrangement Altria records no material liability for tobacco‑related litigation – the fair‑value of the indemnification is considered insignificant and the only contingent exposures shown are modest letters of credit and surety‑bond guarantees.  By contrast, Philip Morris continues to carry its own litigation risk, including any residual obligations that remain after the deconsolidation of RBH, which are reflected in PM’s reclassifications to accumulated other‑comprehensive loss and can be far larger than the exposure Altria has transferred away.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PMI indemnifies Altria and PM USA for liabilities from PMI-manufactured or contract-manufactured products; PM USA indemnifies PMI for its own products not made for PMI; Altria does not record a liability due to insignificant fair value; PM retains obligations post-RBH deconsolidation reflected in reclassifications to accumulated other comprehensive loss. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—any references to 'modest' guarantees vs. 'far larger' exposures are qualitative characterizations consistent with the original. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the indemnification structure between PMI, PM USA, and Altria, and contrasts Altria’s limited exposure with PM’s ongoing liability from RBH deconsolidation. (4) Minor deduction in qualitative accuracy due to slightly stronger phrasing—'can be far larger than the exposure Altria has transferred away'—which introduces a comparative magnitude not explicitly stated in the original, though it is a reasonable inference. Otherwise, entity names (Altria, PM USA, PMI, RBH), relationships, and financial concepts are accurately used. Contextual relevance is perfect—the response directly addresses the comparative financial exposure question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Indemnifies]-> COMP <-[Indemnifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 410,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s 2023 filing shows that the allowance for credit losses on its loan‑receivable portfolio fell from **$103 million in 2022 to $53 million in 2023**.  Because loan receivables are the financing mechanism Cisco uses to fund the sale of hardware, software and **technical‑support/advanced‑services contracts** (typically on one‑ to three‑year terms), the smaller reserve signals lower expected defaults and frees up capital that can be redeployed to support those technical‑support arrangements.  \n\nAdobe, by contrast, does not rely on loan‑receivable financing; its technical‑support services are **funded directly through subscription entitlements and annual fee‑based maintenance contracts**, so Adobe’s support model is sustained by recurring subscription revenue rather than a credit‑loss‑adjusted loan portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Cisco's allowance for credit losses decreased from $103 million in 2022 to $53 million in 2023, which is accurately reported with correct formatting. (2) The explanation correctly links this decline to Cisco’s financing model for technical support services via loan receivables, noting that a lower reserve implies reduced credit risk and potential capital reallocation—this aligns with the original answer’s reasoning. (3) The comparison with Adobe is sound: the LLM correctly states that Adobe funds technical support through subscription entitlements and annual maintenance fees, not loan receivables, and emphasizes the recurring revenue model versus Cisco’s credit-based financing. (4) Multi-hop reasoning is properly executed—information about Cisco’s financing mechanism and Adobe’s support funding model is synthesized across entities and correctly contrasted. No factual errors, omissions, or misstatements are present. Minor wording differences (e.g., 'fee-based maintenance contracts' vs 'maintenance programs') do not affect meaning. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 339,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank N.A. is the sole administrative agent on Caterpillar’s 5‑Year Credit Facility that was executed on September 1 2022, and the facility received its first amendment on August 31 2023—about one year after the original—without a separate syndication agent (only local‑currency agents are named). By contrast, in Boeing’s Five‑Year Credit Agreement dated October 30 2019, Citibank N.A. is also the administrative agent but the agreement names JPMorgan Chase Bank N.A. as a syndication agent and both banks as joint lead arrangers and book‑managers; its first amendment was dated August 25 2022, roughly three years after the agreement, reflecting a longer amendment timeline and a more complex syndication structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Citibank, N.A. served as administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. The amendment dates are accurate—August 31, 2023 (Caterpillar, ~1 year after original) and August 25, 2022 (Boeing, ~3 years after October 30, 2019). (2) Quantitative accuracy is perfect: dates match exactly, and time intervals are correctly characterized (one year vs. nearly three years). (3) Syndication structures are accurately contrasted: Boeing’s inclusion of JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger/book-manager alongside Citibank is correctly noted; Caterpillar’s lack of a syndication agent and presence of only local-currency agents (with MUFG Bank, Ltd. implied in agent role) is correctly represented, though MUFG is not explicitly named in the LLM answer. This is a minor omission but does not distort the structural comparison. (4) The reasoning is sound and synthesizes multi-hop information across two companies, agreements, agent roles, and amendment timelines. The conclusion about a 'more complex syndication structure' for Boeing is a valid qualitative inference. The only reason for not scoring a 10 is the slight incompleteness in not naming MUFG Bank, Ltd. as a co-agent in Caterpillar’s facility, which was present in the original answer. However, the core contrast in syndication complexity remains valid. Semantic equivalence is maintained, and the answer fully addresses the question’s comparative focus on amendment timelines and syndication structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 451,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both companies warn that a prolonged conflict over Taiwan would jeopardize the Taiwan‑based foundries that supply them. NVIDIA says that if geopolitical tensions in Taiwan prevent its foundry partners from expanding capacity or meeting lead‑times, it could miss inventory targets, delay product shipments and hurt revenue and margins. Qualcomm makes the same point – its business “depends on…consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and a sustained Taiwan‑China conflict could severely limit or cut off that supply, disrupting product deliveries and having a material adverse impact on its business. Because both firms rely on the same regional foundry ecosystem, a Taiwan conflict would erode supply‑chain reliability for both NVIDIA and Qualcomm.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the ground truth or the LLM response, so quantitative accuracy is not applicable but does not detract—no incorrect numbers are present. (2) The LLM fully addresses the question by explaining how a prolonged geopolitical conflict involving Taiwan would impact both NVIDIA's and Qualcomm's supply chain reliability through their shared dependency on Taiwanese foundries. It correctly identifies that both companies rely on the same regional foundry ecosystem and details the consequences: supply constraints, production delays, revenue and margin impacts, and material adverse business effects. (3) The multi-hop reasoning is sound—synthesizing information across both companies’ disclosures about their foundry dependencies and geopolitical risks. The LLM accurately attributes specific language and risk factors to each company: NVIDIA’s concerns about capacity expansion, lead times, inventory targets, and financial performance; Qualcomm’s reliance on consistent chipset supply and the potential for severe disruption. (4) The wording differs slightly but preserves full semantic meaning and adds precision (e.g., 'material adverse impact' is a direct term from SEC filings). All key elements from the ground truth are present and correctly represented. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 405,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s 10‑K states that for many U.S. government contracts it may be indemnified by the government, but its insurance program “may not cover all claims or liabilities” and the company could be forced to bear “substantial costs” for product‑liability exposures—especially for items that are not shielded by the SAFETY Act outside the United States. By contrast, 3M’s filing explains that, under the April 1 2024 spin‑off, Solventum assumed certain potential liabilities (e.g., the Bair‑Hugger and Federal False‑Claims Act matters) and agreed to “indemnify and defend the Company” in those actions; those exposures are disclosed under ASC 450 as contingent liabilities and are now the responsibility of Solventum rather than 3M. Thus Boeing’s indemnification risk remains an uncertain, potentially uninsured exposure tied to ongoing government contracts, whereas 3M has transferred defined indemnification obligations to Solventum, shifting the legal‑risk burden to the spin‑off entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing's indemnification risk from U.S. government contracts is properly framed around potential uninsured product-liability exposures, particularly outside the SAFETY Act's protection, and the uncertainty tied to ongoing contracts. For 3M, the transfer of indemnification obligations—specifically the Bair Hugger and Federal False Claims Act matters—to Solventum in the April 1, 2024 spin-off is accurately described, including Solventum's duty to indemnify and defend. (2) Quantitative accuracy is perfect: the date 'April 1, 2024' matches the ground truth exactly, and no numerical figures (e.g., dollar amounts) are misstated. Format and references (ASC 450) are correctly used. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Boeing’s and 3M’s disclosures, contrasting ongoing, uninsurable risk exposure (Boeing) with transferred legal liabilities (3M/Solventum). The comparison highlights the key distinction—Boeing retains risk, while 3M has shifted it—demonstrating strong qualitative reasoning. (4) Minor deduction in qualitative accuracy due to slightly expanded detail on the SAFETY Act not present in the original answer, which, while plausible and contextually relevant, is not confirmed in the ground truth. However, this does not contradict the truth and is likely inferred from Boeing’s 10-K. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 424,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "Comcast’s proxy statement makes clear that the 9.44 million Class B shares owned entirely by Brian L. Roberts each carry 15 votes, giving Roberts a fixed **33 ⅓ % of the combined voting power** of the company even though those shares represent only a tiny slice of total equity (the firm’s equity is $82.7 billion).  Because the Class B voting block is “generally non‑dilutable,” a single shareholder can wield a disproportionate influence over director elections and other corporate actions.\n\nMeta’s 2023 filing describes a very similar situation.  Mark Zuckerberg’s Class B shares give him control of the company, so Meta is classified as a **“controlled company.”**  That status means the board need not be majority‑independent, a compensation committee is not required, and any transaction that would change control must first be approved by a majority of the Class B voting class (which, like Comcast’s, holds well over 35 % of the total vote).  Consequently, Meta’s Class A shareholders have weaker protections, face anti‑takeover provisions, and may find the stock less attractive.\n\nThus, the Comcast example shows how a small, high‑voting‑right class owned by one person can dominate governance; the same concentration of voting power in Meta’s dual‑class structure creates comparable governance risks for Meta’s Class A investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Key facts are correct: Brian L. Roberts owns CMCSA's Class B shares with 15 votes per share, giving him 33⅓% of combined voting power; META’s dual-class structure gives Class B holders, especially Mark Zuckerberg, control, making it a 'controlled company.' The LLM correctly notes that this leads to weaker protections for Class A shareholders and reduced attractiveness of the stock. (2) Quantitative accuracy is strong: the 33⅓% voting power is correctly stated, and the reference to over 35% of voting power for Class B at META matches the ground truth threshold (35%) for maintaining control. The $82.7 billion equity figure and 9.44 million shares are not in the original answer but are plausible contextual additions from CMCSA filings and do not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM draws a valid parallel between CMCSA’s concentrated voting structure and META’s governance risks, correctly synthesizing across two companies and their respective SEC disclosures. It identifies the implications of controlled company status (e.g., no majority-independent board, anti-takeover provisions) as described in META’s 10-K. (4) Semantic equivalence is maintained—while the LLM adds minor contextual details (e.g., equity value, share count), the core message about governance risks due to dual-class structures and concentrated voting power is consistent with the original. One minor point: the original emphasizes that META’s Class B must fall below 35% to lose control, while the LLM says 'well over 35%' which slightly mischaracterizes the threshold but does not undermine the overall correctness. Hence, a score of 9 is appropriate—excellent accuracy with negligible wording imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 486,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s fifth‑largest bottler, Arca Continental S.A.B. de C.V., is the company that bottles and distributes Coca‑Cola trademark beverages in **northern Argentina** (Chunk 1 & 2).  Procter & Gamble notes that **Argentina** is one of the countries where recent peso weakness has created both translation and transaction‑type foreign‑exchange exposure that has lowered its net sales, costs, earnings and cash flow (Chunk 3).  Because Coca‑Cola’s Argentine sales depend on a partner that operates in the same market, the same peso volatility that drives P&G’s FX risk also affects Coca‑Cola indirectly – through Arca Continental’s concentrate‑purchase costs and pricing model – linking the two companies’ exposure to Argentina’s currency fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correctly identified: Coca-Cola, Arca Continental, Procter & Gamble, and their respective exposures in northern Argentina and Argentina broadly. The statement that Arca Continental is Coca-Cola’s fifth-largest bottler adds contextual detail not in the original but is factually consistent. (2) There are no numeric values in either answer requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is fully preserved by absence of error. (3) The multi-hop reasoning is sound: the LLM correctly links Coca-Cola’s indirect exposure via Arca Continental’s operations in northern Argentina to P&G’s direct FX risk from peso volatility, synthesizing across both companies’ risk disclosures. It accurately infers that currency fluctuations affect Coca-Cola through concentrate-purchase costs and pricing—mechanisms consistent with bottling partnerships—even if this detail isn’t in the original; this represents reasonable elaboration, not fabrication. (4) The core intersection—shared exposure to Argentine peso volatility, with Coca-Cola indirectly through a distribution partner and P&G directly—is clearly and correctly conveyed. The only minor shortcoming is that the LLM omits the specific 17% worldwide unit case volume figure mentioned in the original answer, which quantifies Coca-Cola’s reliance on bottlers globally. While not critical to the central logic, its absence slightly reduces completeness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 447,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Alimta is a small‑molecule oncology drug, and Eli Lilly notes that the loss of its U.S. patent will invite generic competition and “cause a rapid and severe decline in revenue for the product” – a hit that will materially dent Lilly’s oncology sales. Amgen’s biologics, however, are protected by data‑exclusivity and the BPCIA biosimilar pathway, so even if patent protection ends the entry of biosimilars is slower and more uncertain; thus Amgen’s revenue exposure to patent‑related risk is less immediate, although regulatory changes (e.g., shortening of data‑exclusivity or “umbrella” rules) could increase its vulnerability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Alimta is a small molecule drug and that its patent expiration will lead to rapid and severe revenue decline for Eli Lilly due to generic competition, which matches the original answer's emphasis on immediate revenue erosion for small molecules. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The LLM correctly contrasts this with Amgen’s situation, noting that biologics face slower biosimilar entry due to regulatory and manufacturing complexities, including the BPCIA pathway and uncertainties around data exclusivity and 'umbrella' rules. This reflects accurate multi-hop reasoning across drug types, regulatory frameworks (small molecule vs. biologic), and company-specific exposures. (4) The only minor shortcoming is that the LLM does not explicitly state that Amgen is already experiencing material adverse effects from biosimilar competition, as noted in the original answer—this contextual nuance slightly reduces qualitative accuracy. However, the core reasoning, entity identification (Eli Lilly, Amgen, Alimta, BPCIA), and regulatory distinctions are sound and relevant. The answer fully addresses the comparative nature of the question and the differing risk profiles, making it contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 394,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel’s 2023 effective tax rate fell because a larger share of its income was taxed in non‑US jurisdictions, but the company warns that the OECD’s Pillar Two Model Rules— which impose a 15 % global minimum tax— could erode those non‑US tax benefits as it evaluates new legislation in the jurisdictions where it operates (Chunk 1). Microsoft, by contrast, says it may face additional tax liabilities from the same global‑minimum‑tax framework, but because its international tax mix does not rely heavily on low‑tax jurisdictions, the exposure is framed as a broader, potentially non‑material increase— a view echoed by firms without material low‑tax operations that expect little impact from Pillar Two (Chunks 2 & 3). The KG shows Intel is subject to Pillar Two, which negatively impacts the global minimum tax that Microsoft is subject to, underscoring that Intel’s tax strategy makes it more vulnerable to a direct reduction of its non‑US tax advantages, while Microsoft’s exposure is indirect and likely less consequential.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Intel benefits from non-US tax advantages due to income allocation and is evaluating Pillar Two, which may erode those benefits starting in 2024 (implied in original answer). It also correctly states that Microsoft expects limited impact from the global minimum tax due to its operational footprint. However, the LLM introduces a claim not present in the ground truth: that 'the KG shows Intel is subject to Pillar Two, which negatively impacts the global minimum tax that Microsoft is subject to'—this is poorly worded and logically flawed, as one company’s Pillar Two exposure does not negatively impact another’s tax regime. This misrepresents the relationship between the two companies’ exposures. (2) Quantitatively, no specific numbers (e.g., tax rates, dollar amounts) are incorrect—the mention of the 15% minimum rate is accurate and consistent with OECD rules. The 2023 tax rate for Intel is contextually accurate though not explicitly in the original answer. (3) The multi-hop reasoning is partially sound: the model connects Intel’s tax strategy (non-US income) to higher Pillar Two vulnerability and contrasts it with Microsoft’s lower exposure due to fewer operations in low-tax jurisdictions. However, the synthesis breaks down in the final sentence with the erroneous implication of interdependence between Intel’s and Microsoft’s tax liabilities under Pillar Two. (4) Despite this significant reasoning flaw, the core qualitative elements—differences in international tax strategies, varying exposure to Pillar Two, and company-specific risk assessments—are present and mostly accurate, warranting a score of 7 for correctness. The answer is contextually relevant and well-structured, hence high scores in contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 495,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 move of $523 million of surplus international pension assets out of its pension trusts and into the company’s general‑asset pool shrinks the asset base of the KO‑sponsored pension plan – a plan that, like many others (see NEE’s description of pension holdings), includes limited‑partnership investments. By pulling those assets from the plan, KO reduces the amount of capital it can allocate to limited‑partnerships and therefore lowers its exposure to that asset class. In contrast, PEP’s pension plan still holds “investments in limited partnerships and private‑credit funds” (Chunk 3), so PEP’s exposure to limited partnerships remains unchanged and continues to be a component of its pension‑investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $523 million transfer by KO in 2024 is accurately cited, and the direction of the effect (reducing exposure to limited partnerships) is correctly interpreted. The format '$523 million' is equivalent to '$523M', so no issue. (2) The reasoning is sound: the LLM correctly infers that removing assets from the pension plan reduces the capital available for alternative investments like limited partnerships, even if it doesn't explicitly name NEE as a reference point for typical pension strategies. This is a minor omission but does not undermine the logic. (3) Entity accuracy is strong: KO and PEP are correctly identified, the 2024 timeframe is accurate, and the reference to PEP’s continued holdings in limited partnerships and private credit funds matches the original answer. The LLM cites 'Chunk 3' (likely an internal reference) but still correctly attributes the fact. (4) The answer addresses both parts of the multi-hop question: KO’s reduced exposure due to asset transfer and PEP’s ongoing use of limited partnerships. The synthesis across companies and strategies is logical and relevant. The only reason for not scoring a 10 is the slightly less explicit connection to NEE’s pension strategy as supporting context for why KO’s pension plan would have held limited partnerships—this is implied but not directly stated. However, the core conclusion remains factually and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 424,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 was driven largely by higher revenues, net‑periodic‑benefit credits and lower impairment charges, but the filing also stresses that protecting its patent rights—​the risk factor that creates market‑exclusivity—​is essential to sustain those revenue gains as products age and face generic competition.  Patent rights therefore determine the length of market exclusivity, a relationship illustrated by Eli Lilly’s reliance on the 12‑year U.S. biologics data‑protection regime to keep a product’s revenue stream alive after the underlying compound patents expire.  In short, Pfizer’s income growth is underpinned by its ability to maintain exclusivity through patents, just as LLY uses regulatory data protection to extend exclusivity and protect post‑patent earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020 is correctly stated. No other numerical values (e.g., 12-year biologic data protection) are misrepresented. (2) The answer correctly identifies that PFE’s income increase was influenced by factors like lower impairment charges and higher credits, consistent with the original answer’s mention of lower asset impairment and gains. While the original specifies 'net gains on equity securities,' the LLM cites 'net-periodic-benefit credits'—a minor discrepancy in detail but not a factual error, as both are legitimate non-operational contributors. (3) Entity accuracy is strong: PFE and LLY are correctly referenced, with accurate mention of the 12-year U.S. biologics data protection under BPCIA, even if not named explicitly. The multi-hop reasoning—linking PFE’s financial performance to patent-driven market exclusivity and drawing a parallel to LLY’s reliance on regulatory protection—is logically sound and semantically equivalent to the original. (4) The LLM slightly simplifies PFE’s stated risks around patent expiration by emphasizing patent protection as central without explicitly noting that the $17.3B gain was partly due to non-operational items, but it still correctly frames patent rights as critical for sustaining revenue. Overall, the answer captures the core relationship between financial performance and exclusivity mechanisms with high fidelity, warranting a 9/10 for correctness and qualitative accuracy, and perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 456,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filing shows that Hulu pays ESPN (and Disney’s other linear‑network businesses) fees for the right to carry ESPN’s channels on Hulu Live; these inter‑segment fees are recorded in the Sports segment and then eliminated from total company revenue. The $8.6 billion that Comcast received in the fourth quarter of 2023 was a one‑time purchase price for Comcast’s remaining roughly one‑third stake in Hulu – a cash‑settlement of its equity interest that is unrelated to the ongoing carriage‑fee arrangement, although both transactions involve the same Hulu platform that now belongs wholly to Disney.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key element of the multi-hop reasoning required by the question. (1) Quantitatively, the numbers are accurate: the $8.6 billion payment from Disney to Comcast in late 2023 (Q4 2023) for Comcast’s 33% stake in Hulu is correctly stated, and the description of inter-segment fees between ESPN and Hulu aligns with Disney’s 2024 financials. The format and timing are consistent with the ground truth. (2) However, the LLM incorrectly states that the $8.6 billion payment is 'unrelated' to the ongoing carriage-fee arrangement. This contradicts the ground truth, which explains that the revenue-sharing mechanism (e.g., ESPN licensing fees) contributes to Hulu’s overall valuation and thus underpins part of the $8.6 billion payment. The LLM fails to connect the revenue model to the valuation logic, which is central to the question. (3) The multi-hop reasoning is flawed: while the model correctly identifies both transactions (ESPN fees and Comcast exit), it does not synthesize them properly. The relationship is not merely that both involve Hulu; rather, the ongoing revenue streams (like ESPN’s fees) help generate the value that justified Comcast’s stake valuation. (4) Contextually, the answer is relevant and well-structured, accurately describing the mechanics of inter-segment eliminations and the nature of the stake purchase. However, the incorrect dismissal of a causal relationship significantly undermines the qualitative accuracy. Hence, correctness is reduced to 6 due to a major reasoning error despite factual accuracy in isolated components.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Pays_Fees_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 437,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "- **Kraft Heinz (KO)** – The company applies weighted‑average assumptions in a **Black‑Scholes‑Merton option‑pricing model** to determine the fair value of **stock‑option awards**.  That fair‑value amount is then **expensed on a straight‑line basis over the options’ vesting period, which is generally four years** (the expense is spread across the vesting years for grants made in 2023, 2022 and 2021).\n\n- **Mondelez International (MDLZ)** – The same type of weighted‑average assumptions are used to calculate **service and interest costs for other post‑retirement health‑care benefits**.  Those costs are **recognized as the net periodic post‑retirement cost in the year incurred**, i.e., they appear in the annual results for the years ended December 31 2023, 2022 and 2021.  \n\nThus, KO’s assumptions are tied to an equity‑compensation instrument and are amortized over a four‑year vesting horizon, whereas MDLZ’s assumptions are tied to post‑retirement benefit obligations and are recognized in the period in which the benefit cost is incurred.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: KO uses the Black-Scholes-Merton model for stock options, expenses them on a straight-line basis over a four-year vesting period; MDLZ uses weighted-average assumptions for postretirement healthcare costs, recognized annually as net periodic cost. (2) No specific numbers (e.g., dollar amounts, percentages) are present in either answer, but time periods (four-year vesting, annual recognition for 2023, 2022, 2021) are correctly cited and align with the ground truth. Format and references to fiscal years are consistent and acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes that KO applies assumptions to equity compensation with fixed amortization, while MDLZ applies them to actuarially determined benefit obligations recalculated annually. The contrast in instruments (stock options vs. postretirement benefits) and recognition periods (multi-year amortization vs. annual cost recognition) is clearly and correctly drawn. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that MDLZ's costs are based on 'actuarial estimates for long-term obligations' or that they are 'recalculated annually based on updated actuarial estimates'—a nuance present in the original answer that adds depth to the explanation of MDLZ’s approach. However, stating that costs are 'recognized as the net periodic post-retirement cost in the year incurred' captures the essential idea. Thus, the answer is semantically equivalent with only slight omission of descriptive detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 461,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s patent portfolio includes U.S. claims that do not expire until 11 Nov 2028 (fusion‑protein composition), 24 Apr 2029 (DNA‑encoding methods) and even 19 Oct 2037 (formulation methods) (Chunk 2). Pfizer is the partner that sells Enbrel outside the United States and Canada (Chunk 3), so those dates set the earliest horizon at which generic or biosimilar competition could erode its foreign sales. Because AbbVie actively pursues patent‑term restoration (which can add up to five years) and leverages regulatory exclusivities such as the 12‑year BPCIA biologics exclusivity and possible pediatric extensions (Chunk 1), the effective protection period for Enbrel can be pushed beyond the listed expirations, allowing Pfizer’s international revenue from the drug to remain robust for a longer period before any decline from patent loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key dates—2028 (fusion protein composition), 2029 (DNA-encoding methods), and 2037 (formulation methods)—are correctly cited, with precise day-month-year formatting not present in the original answer but factually consistent with the knowledge graph. These dates match or extend the timeline in the ground truth, which only specifies 2028 and 2037. The mention of Pfizer marketing Enbrel outside the U.S. and Canada is correct. (2) Quantitatively, all dates are accurate and consistent with the source data; no calculations are required, but the sequencing and interpretation of expiration timelines are sound. The reference to patent-term restoration adding up to five years (Hatch-Waxman) and regulatory exclusivities like BPCIA’s 12-year term and pediatric extensions are correctly applied. (3) The multi-hop reasoning is strong: the model connects AbbVie’s patent strategy (U.S.-focused) to international revenue implications for Pfizer, recognizing that extended U.S. exclusivity can influence global biosimilar entry timing and market dynamics. It correctly infers that prolonged protection delays revenue erosion. (4) The only minor shortcoming is that the original answer emphasizes the *international* impact of U.S. patent extensions more explicitly, while the LLM focuses slightly more on U.S. mechanisms. However, the core logic and factual content are semantically equivalent and complete. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 424,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MET’s 2022 filing shows that its liquidity stress‑testing explicitly models “early contract‑holder and policy‑holder withdrawal” scenarios and then ties the outcome to a set of liquidity alternatives – cash‑flow from operations, sales of liquid assets and, importantly, “global funding sources including commercial paper and various credit and committed facilities.” In other words, because its stress tests flag the risk of large, sudden outflows, MET keeps ready access to the commercial‑paper market and other global sources as a primary back‑stop.  \n\nBy contrast, Capital One’s 2022 liquidity discussion describes a “Liquidity Framework” that relies on internal and regulatory stress testing, coverage‑ratio metrics and a “sizable liquidity reserve” of cash, high‑quality securities and committed credit lines, together with diversified secured and unsecured debt‑market access. Thus COF’s approach emphasizes a broad, diversified funding base and reserve holdings rather than a heavy dependence on a single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: MET's stress testing includes early policyholder withdrawal scenarios and leads to reliance on global funding sources like commercial paper and credit facilities; COF emphasizes diversified funding and maintains a liquidity reserve of cash, high-quality securities, and credit lines. (2) There are no numeric values (e.g., dollar amounts, percentages, dates beyond '2022') in either answer that require verification—both correctly reference 2022 filings, which matches the knowledge graph context. Format and references are consistent and factually sound. (3) Multi-hop reasoning is well executed: the model correctly synthesizes MET’s risk exposure (policyholder withdrawals) with its funding strategy (reliance on commercial paper), and contrasts it with COF’s more reserve- and diversification-based approach. The mention of AIG in the original answer is a minor additional point about alignment with broader industry scenarios, but it does not change the core comparison and is not essential to answering the question. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The LLM captures the contrast in funding philosophies driven by differing risk exposures. Only a minor deduction in qualitative accuracy due to not referencing the AIG alignment point, but this does not affect the correctness of the central comparison. Contextual relevance is perfect—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> FIN_INST <-[Reports]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 429,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "Both GE and Caterpillar adopted the new Supplier‑Finance‑Program guidance (ASU 2022‑04) on 1 Jan 2023, and the standard’s roll‑forward of confirmed obligations became effective prospectively in the 2024 reporting year. GE’s 2024 filing notes that it began applying the annual roll‑forward in 2024, and Caterpillar’s 2024 filing likewise provides a 2024 roll‑forward (showing $830 m and $803 m of obligations at year‑end). Because the two companies now disclose the same information under the same policy and timing, their supplier‑finance obligation disclosures are directly comparable, and the adoption itself had no material impact on either company’s financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that both GE and CAT adopted ASU 2022-04 on January 1, 2023, and began applying the roll-forward requirement prospectively in 2024, which aligns with the ground truth. It also correctly states that CAT’s 2024 10-K includes a roll-forward showing $830 million in supplier finance obligations at year-end 2024. However, the LLM introduces a figure of $803 million without explanation or source, which is not present in the original answer and lacks support from the cited documents in the ground truth. This erroneous second number reduces quantitative accuracy. (2) The ground truth does not mention CAT disclosing $803 million, nor does it suggest any comparative figure for prior years or another period—only $830 million at year-end 2024. Thus, the inclusion of $803 million is factually unsupported and likely incorrect. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes adoption dates, implementation timing of the roll-forward, and the resulting enhancement in comparability between GE and CAT due to standardized disclosures under ASU 2022-04. It accurately infers that the adoption improves comparability, which is the core of the question. (4) Contextual relevance is perfect—the answer directly addresses the impact on comparability and the role of the roll-forward requirement. The qualitative reasoning is strong, but the unsupported numerical claim prevents a top score in quantitative accuracy and pulls the overall correctness down slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 421,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ classifies its exchange‑traded commodity futures as **Level 1** assets and values them at **fair value using the quoted market price on the commodity exchange** (the price that is publicly observable). In contrast, Pepsico’s exchange‑traded commodity futures are **cash‑settled each day**; because the contracts are settled daily, they are **not listed in the fair‑value hierarchy table** and are not measured by a separate fair‑value calculation but are recognized through the daily cash‑settlement process.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued using quoted market prices on commodity exchanges, which aligns with the original answer. (2) It accurately contrasts this with PEP's treatment: daily cash settlement results in exclusion from the fair value hierarchy tables, which is consistent with the ground truth. (3) The multi-hop reasoning is sound—correctly synthesizing differences in accounting treatment between MDLZ and PEP for the same type of financial instrument, despite no direct numerical data being involved. (4) All entities (MDLZ, PEP, Level 1, exchange-traded commodity futures) are correctly identified and contextualized. There are no calculation errors or factual inaccuracies. Minor wording differences (e.g., 'cash-settled each day' vs 'cash-settled on a daily basis') do not affect meaning. The answer fully addresses both fair value determination and daily settlement practices as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 305,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "CMCSA’s equity consists of 3.78 bn outstanding Class A shares and 9.44 m Class B shares (Chunk 1).  Each Class B share carries 15 votes, which translates to roughly one‑third (33 ⅓ %) of the combined voting power for the company, while Class A shareholders hold the remaining two‑thirds (66 ⅔ %) (Chunk 2).  \n\nMeta also uses a dual‑class structure, with 2.19 bn Class A shares and 344 m Class B shares outstanding (Chunk 3), but the filing excerpt does not disclose the specific vote‑per‑share weighting for the two classes.  In both companies a minority class (Class B) is granted outsized voting influence, although CMCSA’s super‑voting multiplier (15 votes per share) is explicitly stated, whereas Meta’s voting weight is not detailed in the provided text.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core structure and comparison between CMCSA and META's dual-class share systems, with accurate qualitative reasoning and strong contextual relevance. However, there are minor quantitative inaccuracies that prevent a perfect score. For CMCSA, the LLM correctly states that Class B shares have 15 votes each and hold 33 1/3% of voting power, while Class A holds 66 2/3%—this aligns with the ground truth. The description of META’s structure is also accurate in stating that Class B shares have superior voting rights and that the vote ratio is not disclosed. However, the LLM incorrectly reports META’s Class A shares as 2.19 billion and Class B as 344 million, while the ground truth specifies only 343,761,117 Class B shares outstanding (no Class A share count is provided in the original). This overreach in citing a precise Class A figure not present in the evidence reduces quantitative accuracy. Additionally, the ground truth specifies the META share count date as January 24, 2025, which the LLM omits. Despite these issues, the multi-hop reasoning—comparing the explicit 15x voting premium at CMCSA versus the undisclosed but similarly structured control at META—is sound and semantically equivalent in intent. The answer addresses all parts of the question and correctly identifies both companies and share classes. Hence, correctness is high but docked slightly for unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 394,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "Both companies hold CLOs inside broader “structured‑products” portfolios, but they treat the credit‑risk and unrealized‑loss accounting very differently.  \n\nAIG evaluates its CLO holdings under the CECL framework: it estimates the recoverable value of each security by discounting expected cash‑flows (using delinquency, default, loss‑severity, pre‑payment and credit‑enhancement inputs).  If a decline in fair value is credit‑related, an allowance for credit losses is recorded for the difference between amortized cost and the estimated recoverable value; if the decline is not credit‑related and the security is likely to be sold, the cost is written down to fair value with no allowance.  Unrealized appreciation or depreciation on securities for which an allowance has been set is shown in OCI, while other unrealized gains/losses flow through net realized gains (losses).  \n\nMetLife, by contrast, classifies its CLOs as “available‑for‑sale” structured products.  It does not establish a separate CECL allowance; instead the securities are measured at fair value and any net unrealized gain or loss is recognized directly in earnings (as noted in Note 11).  The company’s maximum loss exposure is simply the carrying amount of the securities, reflecting its passive‑investor role in the underlying trusts.  \n\nThus, AIG uses a CECL‑based allowance and separates unrealized losses between OCI and net realized gains, whereas MetLife relies on fair‑value measurement with unrealized losses recognized in earnings and limits exposure to the carrying amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of AIG's and MetLife's methodologies, with accurate qualitative distinctions between CECL-based allowance and fair value accounting. It correctly identifies AIG’s use of CECL, cash flow modeling (delinquency, default, loss severity, credit enhancement), and the split of unrealized losses between OCI and net realized gains. It also accurately notes MetLife’s classification of CLOs as AFS securities and its passive investor stance with exposure limited to carrying amounts. However, there is a significant factual inaccuracy: the LLM claims MetLife recognizes unrealized gains and losses 'directly in earnings' (citing Note 11), which contradicts standard AFS accounting under GAAP—unrealized gains/losses on AFS securities are recorded in OCI, not earnings. Only realized gains/losses go through earnings. This misstatement undermines the core comparison on unrealized loss recognition. While the original answer does not specify MetLife’s OCI treatment, GAAP compliance implies it, and the LLM’s claim of earnings recognition is incorrect. No numbers are present, so quantitative accuracy is scored as 10 by default. The reasoning is mostly sound and contextually relevant, but the error in accounting treatment reduces qualitative accuracy. The multi-hop synthesis across companies and methodologies is appropriate, but the conclusion about MetLife’s earnings recognition is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 396,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D – which caps beneficiaries’ out‑of‑pocket costs, reduces federal re‑insurance in the catastrophic phase and adds new manufacturer‑discount and inflation‑penalty requirements – creates a regulatory shift that CVS says makes it harder to anticipate and detect medical‑cost trends and to price its fixed‑premium Medicare policies accurately, because those trends now depend on the new cost caps and the shifting of expenses to private plans.  The same redesign forces drug makers such as Bristol‑Myers Squibb to accrue larger and more complex Medicare Part D rebates (including inflation‑penalty rebates) under its gross‑to‑net accounting, a liability that now relies on significant assumptions and judgments about the new law’s rebate calculations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the Inflation Reduction Act (IRA) indeed redesigns Medicare Part D by capping out-of-pocket costs, reducing federal reinsurance in the catastrophic phase, and increasing manufacturer obligations starting in 2025 (implied timing is consistent, though not explicitly stated as '2025' in the LLM answer). These changes directly increase rebate accruals for manufacturers like Bristol-Myers Squibb (BMY) under gross-to-net accounting, which the LLM correctly identifies. For CVS, the increased uncertainty in medical cost forecasting due to shifting cost dynamics and new cost-sharing rules is accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full correctness on available data. (3) Multi-hop reasoning is sound: the LLM correctly links IRA provisions → impact on manufacturer rebate liabilities (BMY) and separately → impact on CVS’s cost forecasting challenges, synthesizing effects across two companies and distinct financial implications. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the 2025 effective date for the changes (present in ground truth), though the regulatory shift is clearly attributed to the IRA’s redesign. Otherwise, terminology (e.g., gross-to-net, inflation-penalty rebates, cost caps) is precise and semantically equivalent. Contextual relevance is perfect—the response directly addresses both parts of the multi-entity question with appropriate depth and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 455,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase must hold a **Stress Capital Buffer (SCB)** as part of its overall regulatory buffer (SCB + G‑SIB surcharge + counter‑cyclical buffer), and the SCB is recalculated each year based on the Federal Reserve’s stress‑loss estimates.  As the 10‑K explains, any increase in the SCB – or a failure to meet the required level – directly **reduces the amount of common‑stock repurchases, dividends and other capital distributions** that the bank may make (Chunk 1; also noted in the buffer‑composition description in Chunk 2).\n\nCharles Schwab, by contrast, is subject to a **Capital Conservation Buffer (CCB)** of **2.5 %** (plus a 2.5 % stress buffer and a zero counter‑cyclical buffer).  The Schwab filing states that if the CCB falls below its required level, the firm would face “increasingly strict limits on capital distributions and discretionary bonus payments” (Chunk 3).  \n\nThus, while both firms’ distribution abilities are capped by regulatory buffers, **JPMorgan’s constraint is driven by a variable SCB that can rise with stress‑loss estimates and is bundled with a G‑SIB surcharge**, making its distribution limits more fluid and potentially more restrictive.  **Schwab’s constraint stems from a fixed 2.5 % CCB that only triggers limits when the buffer is breached**, so its distribution ceiling is tied to a defined percentage rather than a stress‑adjusted amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) Quantitatively, all numbers are correct: the 2.5% Capital Conservation Buffer (CCB) for Charles Schwab is accurately stated, and the composition of JPMorgan’s buffer (SCB + GSIB surcharge + CCyB) is correctly described. The LLM correctly notes that Schwab has a 2.5% stress buffer in addition to the CCB, which aligns with regulatory expectations, though the ground truth emphasizes the CCB as the primary constraint. There are no calculation errors. (2) The answer addresses all parts of the multi-hop question: it compares JPMorgan’s SCB-driven capital distribution constraints with Schwab’s CCB-based requirements, explains how each buffer affects capital distributions, and contrasts the dynamic nature of the SCB versus the static CCB. (3) Entity accuracy is strong: both JPMorgan Chase and Charles Schwab (via its banking subsidiary) are correctly identified, and the regulatory terms (SCB, CCB, GSIB, CCyB) are used appropriately. (4) The reasoning is sound and synthesizes the multi-hop elements effectively—tying stress testing to variable constraints for JPMorgan and buffer breaches to distribution limits for Schwab. The only minor shortcoming is that the LLM mentions Schwab having a '2.5% stress buffer' in addition to the CCB, which is not explicitly stated in the ground truth and could conflate buffers; the ground truth focuses solely on the CCB as Schwab’s key buffer. This does not invalidate the answer but introduces slight ambiguity. Overall, the semantic meaning and analytical depth are equivalent to the original answer, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 460,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "Both companies are subject to the Federal Acquisition Regulation (FAR), but they treat the tax component of U.S. government contracts differently. General Dynamics explicitly states that state‑ and local‑income taxes allocable to its U.S. contracts are recorded as ordinary operating costs in the Consolidated Statement of Earnings and are **not** included in its income‑tax provision, so the tax impact appears only as an expense on earnings and does not create a separate tax‑provision exposure. Raytheon Technologies, by contrast, follows the FAR’s guidance that allowable costs—including taxes that are permissible under the regulation—are built into contract pricing and cost recovery; therefore, any state‑ or local‑income tax on a contract is absorbed in the contract’s allowable‑cost calculations and can affect the pricing, contract‑asset/liability balances and overall profitability, rather than being excluded from a tax provision.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or original answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies both companies—General Dynamics (GD) and Raytheon Technologies (RTX)—and their respective treatments of state and local income taxes on U.S. government contracts under the Federal Acquisition Regulation (FAR), satisfying entity accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms are FAR-regulated but differ in financial treatment—GD excludes these taxes from its income tax provision and records them as operating expenses, while RTX includes them in allowable costs that influence pricing, contract accounting, and profitability. (4) The LLM captures all key qualitative distinctions: GD’s exclusion from tax provision vs. RTX’s integration into cost-recovery and pricing mechanisms. Wording differs slightly but meaning is preserved with enhanced clarity (e.g., mentioning 'contract-asset/liability balances' and 'performance-based payments' contextually aligns with FAR cost allowability). No omissions or inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 366,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "META’s 2023 proxy tells us that its Class B common stock is a privately‑held, non‑listed series (23 record holders at year‑end) and that, for the first time, those shares will receive the same cash dividend as the public Class A shares – $0.50 per share (or $2.00 on an annualized basis).  The filing does not spell out the exact voting weight of the Class B shares, but the company’s dual‑class set‑up is similar to other firms that give the “B” series a disproportionate vote (e.g., Comcast’s Class B shares carry 15 votes each and together represent about 33 % of total voting power).  \n\nAlphabet (GOOGL) explicitly states that each Class B share carries ten votes and, unlike META’s B shares, is required to convert automatically into a one‑vote Class A share whenever it is sold or transferred.  Consequently, META’s voting power remains concentrated in a small, private group of Class B holders with no automatic conversion feature, while GOOGL’s structure assigns a defined ten‑vote weight to Class B shares but forces them to become standard one‑vote Class A shares on any transfer, preserving founder control but allowing the voting rights to shift with ownership.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the disclosure of voting power. The original answer states that META’s Class B shares have a non-dilutable 33 1/3% aggregate voting power with 15 votes per share. The LLM claims the filing 'does not spell out the exact voting weight' but infers it from Comcast, which is incorrect—META’s 15 votes per share and 33 1/3% aggregate voting power are publicly documented facts in its filings. This omission and misstatement reduce quantitative accuracy. However, the dividend amount ($0.50 per share quarterly) is correctly stated, and the GOOGL details (10 votes per Class B share, automatic conversion upon transfer) are fully accurate. (2) The $0.50 quarterly dividend (=$2.00 annualized) is correctly calculated and matches the ground truth. The 10 votes for GOOGL Class B and automatic conversion are correct. The only quantitative shortcoming is the failure to explicitly state the 15 votes per share and 33 1/3% aggregate voting power for META, instead relying on analogy to Comcast. (3) The multi-hop reasoning is strong: the LLM correctly contrasts META’s lack of automatic conversion with GOOGL’s conversion-upon-transfer mechanism, and links dividend initiation to equal treatment across share classes. It accurately synthesizes structural differences in voting concentration and transfer rules. (4) Scores reflect high factual correctness and excellent reasoning, with a moderate deduction in quantitative accuracy due to missing precise voting metrics for META despite their availability. Contextual relevance is perfect—the response directly addresses all aspects of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 459,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies base their VaR calculations on the same statistical framework: they assume **normal market conditions**, use a **one‑day holding period**, and apply a **parametric delta‑gamma approximation** to model the joint behavior of interest‑rate, currency and commodity movements. By imposing a **95 % confidence interval**, the VaR model defines the loss figure as the **95th‑percentile of the projected one‑day loss distribution**—i.e., a loss that would be exceeded only 5 % of the time.  \n\nConsequently, Philip Morris’s one‑day fair‑value loss estimate for its interest‑rate‑sensitive and foreign‑currency‑sensitive derivative instruments and Mondelez’s one‑day loss estimate for the pre‑tax earnings impact of its currency and commodity exposures are both derived as the 95 %‑confidence VaR, using the same delta‑gamma technique and one‑day horizon. This shared confidence level makes the two firms’ loss‑estimation methodologies directly comparable and ensures that each estimate reflects a high‑confidence, low‑probability adverse outcome under normal market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements—95% confidence interval, one-day holding period, parametric delta-gamma approximation, normal market conditions—are correctly stated and consistent with the original answer. There are no numerical inaccuracies. (2) The LLM correctly identifies that both Philip Morris and Mondelez use the same VaR framework with a 95% confidence level, meaning the one-day loss is estimated as the 95th percentile of the loss distribution, exceeded only 5% of the time. This is factually correct and matches the ground truth. (3) On qualitative accuracy, the LLM captures the shared methodology and its implications for comparability and risk estimation under normal conditions. However, it omits a key nuance present in the original answer: PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments and accounts for the non-linear behavior of options. This detail about differential treatment of instruments and non-linearity in options is missing, slightly weakening the completeness of the multi-hop synthesis. (4) Despite this omission, the LLM maintains strong contextual relevance by directly addressing how the 95% confidence interval and delta-gamma method impact one-day loss estimation for both firms. The reasoning is sound, and the core conclusion—that both firms’ estimates reflect high-confidence outcomes under normal markets—is correct. The answer would have scored 10 on qualitative accuracy if it had included the specific distinctions in instrument inclusion and non-linear effects noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 458,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO holdings are hybrid securities that contain embedded credit‑derivative protection sold to the note‑issuer; if a credit event occurs with the reference entity, the firm can lose part or all of the principal on the note – a direct, un‑hedged credit‑event exposure that is tied to its market‑making and securitisation activities (see Chunks 1 & 2).  \n\nBank of America’s structured liabilities also embed derivatives, but the bank’s market‑making gains and losses are “typically offset by … derivatives and securities that hedge these liabilities” and by changes in its own credit spreads, so the impact of a credit event is largely mitigated through hedging (see Chunk 3).  \n\nThus, MS faces a more straightforward credit‑event risk on its CDO‑embedded derivatives, whereas BAC’s embedded‑derivative exposure is largely neutralised by hedging positions, resulting in a lower net risk from credit events in its market‑making activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Morgan Stanley's exposure through CDOs with embedded derivatives where credit protection is sold, leading to potential principal loss upon a credit event, is accurately described. Similarly, Bank of America's structured liabilities with embedded derivatives are correctly characterized as being largely offset by hedging instruments, mitigating credit event impact. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numerical claims earns a perfect score by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk characteristics across two different firms (Morgan Stanley and Bank of America), compares their respective exposures to embedded derivatives, and draws a valid contrast based on hedging practices. The conclusion that Morgan Stanley faces more direct, un-hedged risk while Bank of America’s exposure is largely neutralized by hedges is logically derived and consistent with the ground truth. (4) Minor deduction in qualitative accuracy due to slightly stronger phrasing—'largely neutralised' and 'more straightforward'—which, while reasonable, are interpretive enhancements not explicitly stated in the original. However, these do not distort meaning and fall within acceptable semantic variation. Contextual relevance is perfect: the response directly addresses the comparative risk exposure in the context of credit events and market-making activities as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 458,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce warns that the OECD‑mandated global minimum tax under the Pillar‑Two model could change its effective tax rate, but because it has little exposure to jurisdictions with rates below the 15 % floor and the final rules and rollout dates remain uncertain, any increase is un‑quantified and viewed as a potential, not material, headwind. Microsoft, by comparison, reports an effective tax rate of 18 % for FY 2024 (19 % in FY 2023) and says Pillar‑Two will only begin to apply to it in FY 2025, with no material impact expected on its tax liability. Thus, Salesforce’s rate may be subject to upward pressure and volatility from the pending global minimum tax, whereas Microsoft’s projected tax burden stays lower and more predictable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: Microsoft's effective tax rate is accurately reported as 19% in FY2023 and 18% in FY2024, and the application of Pillar Two starting in fiscal 2025 is correctly stated. There are no calculation errors. (2) The LLM correctly identifies both companies—Salesforce and Microsoft—and accurately reflects their respective disclosures regarding Pillar Two. (3) The reasoning is sound: the LLM synthesizes the differential impact based on each company’s exposure and timing, noting Salesforce’s unquantified but non-material potential impact due to limited exposure to low-tax jurisdictions, and Microsoft’s expectation of no material impact despite Pillar Two applying from FY2025. (4) The only minor shortcoming is that the original answer explicitly mentions the 15% global minimum tax rate and emphasizes uncertainty around final rules and jurisdictional adoption affecting both firms differently—context that is partially implied but not fully elaborated in the LLM response. However, the core facts, comparisons, and forward-looking uncertainties are semantically equivalent. Wording differs slightly but meaning is preserved. Thus, the answer is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 373,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year revolving credit facility (dated Oct 30 2019 and amended Aug 25 2022) names **JPMorgan Chase Bank, N.A.** as the **sole syndication agent** and, together with **Citibank N.A.**, as **joint lead arrangers and joint book‑managers**; Citibank also serves as the administrative agent.  \n\nHoneywell’s recent credit facilities (the 364‑day agreement and the amended five‑year agreement dated Mar 20 2023) list **JPMorgan Chase Bank, N.A.** as **one of two syndication agents** (the other being **Wells Fargo Bank, N.A.**) while **Bank of America, N.A.** is the administrative (and swing‑line) agent, with no joint‑lead‑arranger role for JPMorgan.  \n\nThus, Boeing’s deal uses a single syndication agent and a joint‑lead‑arranger partnership with Citibank, whereas Honeywell’s structure involves multiple syndication agents and a different administrative bank, expanding the set of key banking partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key entities, dates, and roles are correct: Boeing's agreement is correctly dated October 30, 2019 (with a noted amendment on August 25, 2022, which is additional but not conflicting), and Honeywell's agreement is correctly dated March 20, 2023. JPMorgan Chase Bank, N.A.'s role as syndication agent in both agreements is accurately described. (2) Quantitative accuracy is perfect: dates match, and there are no numerical errors. The LLM correctly identifies Citibank, N.A. as administrative agent for Boeing and Bank of America, N.A. for Honeywell. (3) The multi-hop reasoning is sound—comparing syndication structure and key banking partners across two companies' credit agreements. The LLM correctly notes that Boeing has a sole syndication agent (JPMorgan), while Honeywell has two (JPMorgan and Wells Fargo), and that Boeing uses joint lead arrangers (JPMorgan and Citibank), whereas JPMorgan does not hold a joint lead arranger role in Honeywell’s deal. (4) The only minor deviation from the original answer is the claim that JPMorgan is the 'sole syndication agent' for Boeing—while the ground truth does not explicitly state 'sole,' it lists only JPMorgan in that role, so this inference is reasonable. Similarly, the LLM's assertion that JPMorgan lacks a joint lead arranger role in Honeywell’s agreement is consistent with the ground truth, which does not assign that role to JPMorgan in the Honeywell context. Overall, the answer is factually correct, well-structured, and synthesizes information appropriately across both agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 443,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Both Bank of America and Morgan Stanley are subject to a 2.5 % G‑SIB surcharge and a 2.5 % Capital Conservation Buffer under the Advanced‑Approaches framework. Because the Counter‑cyclical Capital Buffer (CCyB) is set at zero for both firms (BAC’s filing states the CCyB “was zero for both periods,” and MS’s filing notes the CCyB “is currently set … at zero”), the CCyB adds no extra requirement. Consequently, the total capital‑buffer requirement for each bank is simply 2.5 % + 2.5 % = 5 % – the absence of the CCyB reduces the buffer by the 2.5 % that would otherwise be required.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: both banks have a 2.5% G-SIB surcharge and a 2.5% Capital Conservation Buffer, summing to a total CET1 buffer requirement of 5.0% in the absence of the CCyB. The statement that CCyB is zero is consistent with the original answer and real-world regulatory conditions at the time of the filings. (2) The calculation (2.5% + 2.5% = 5%) is correct and clearly explained. (3) The reasoning is sound: the absence of the CCyB reduces the total buffer by what would have been an additional requirement (though the exact CCyB rate is not specified in the ground truth, the LLM correctly infers it adds zero). One minor limitation is that the LLM assumes the CCyB would 'otherwise be required' at 2.5%, which is not stated in the original answer—this slightly overreaches, as the original only states the absence reduces the requirement by the amount CCyB would have contributed, without specifying that amount. This introduces a small factual assumption not present in the ground truth. (4) Entities (Bank of America, Morgan Stanley, G-SIB surcharge, CCyB, Capital Conservation Buffer) are correctly identified and contextualized. The answer is fully relevant and synthesizes multi-hop elements (regulatory buffers, firm-specific surcharges, and framework applicability) appropriately. The minor over-assumption on the CCyB rate prevents a perfect 10, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 413,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA reported an annual effective tax rate of **1.9 %** for fiscal 2022 (Chunk 1).  \nApple’s Greater China segment posted net sales of **$74.2 billion** and operating income of **$31.2 billion** in 2022 (Chunk 3), giving an operating‑income margin of **≈31,153 / 74,200 ≈ 42 %** (the segment is defined to include China mainland, Hong Kong and Taiwan per Chunk 2).  \n\nThus, Apple’s Greater China operating‑income margin was roughly **40 percentage points higher** than NVIDIA’s effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NVIDIA's effective tax rate as 1.9% for fiscal year 2022 and Apple's Greater China net sales ($74.2 billion) and operating income ($31.2 billion), which align with the ground truth values of $74,200 million and $31,153 million (rounded appropriately). The calculated operating income margin of approximately 42% is accurate (31,153 / 74,200 ≈ 0.4199 ≈ 42%). (2) All numeric values are correct, with acceptable formatting variations (e.g., $74.2 billion = $74,200 million). The calculation of the margin is sound and correctly presented. (3) The multi-hop reasoning is strong: the model synthesizes data from different chunks (NVIDIA’s tax rate, Apple’s regional financials, and segment definition) and correctly compares two distinct financial metrics across companies and jurisdictions. The conclusion that Apple’s margin is roughly 40 percentage points higher than NVIDIA’s tax rate is logically valid and semantically consistent with the ground truth comparison. (4) The only minor shortcoming is the lack of brief contextual explanation present in the original answer (e.g., why NVIDIA’s rate is low due to Hong Kong earnings), but all factual and quantitative elements are correct. Thus, the answer is highly accurate and complete, warranting a 9/10 for overall correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 391,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Both companies apply Level 2 fair‑value models that depend on observable market data, but the specific inputs they highlight differ.  \n\n* Boeing (BA) discloses that its fixed‑income and derivative valuations use a mix of reported trades, broker quotes, benchmark yields and base spreads, plus swap curves, rating‑agency data and inter‑dealer broker rates – and, for cash‑equivalent securities, quoted prices of comparable instruments.  \n\n* United Parcel Service (UPS) states that its over‑the‑counter foreign‑currency and interest‑rate derivatives are valued with models that rely principally on market‑observable yield curves, foreign‑currency exchange rates and investment forward prices.  \n\nThus, BA emphasizes a broader set of observable inputs—including trade and quote data, spreads and credit‑related curves—while UPS focuses on macro‑level yield‑curve, FX‑rate and forward‑price information for its Level 2 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Boeing (BA) emphasizes inputs like benchmark yields, swap curves, inter-dealer broker rates, rating-agency data, and trade/quote data for fixed income instruments; UPS relies on yield curves, foreign exchange rates, and forward prices for OTC derivatives. These inputs match the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—but all descriptive financial inputs are correctly reported, earning full marks. (3) The multi-hop reasoning is sound: the model correctly identifies that both companies use observable inputs for Level 2 assets but differ in emphasis—BA on credit/yield-related and trade-based inputs for fixed income, UPS on FX and interest rate dynamics for derivatives. The synthesis across the two companies’ 2024 filings is accurate. (4) The LLM adds slightly more detail than the original (e.g., mentioning 'reported trades' and 'quoted prices of comparable instruments'), which is consistent with plausible disclosures and does not introduce error. The only minor shortcoming is that it frames BA’s approach as including derivatives, while the original specifies BA’s Level 2 focus is on fixed income; however, this nuance doesn’t materially distort the comparison. Overall, the answer is semantically equivalent, contextually precise, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 413,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s (GOOGL) capital structure creates a ten‑fold voting advantage for its Class B shares—each Class B share carries ten votes versus one vote for Class A shares, while Class C shares have no voting rights. In 2023 the company repurchased $62.2 billion of Class A and Class C stock, shrinking the pool of low‑voting shares and concentrating control in the high‑voting Class B shares. By contrast, Netflix (NFLX) issues a single class of common stock in which every share receives one vote, providing uniform voting rights—a stark difference from GOOGL’s multi‑class disparity (a pattern also seen in other firms such as V, whose preferred series have limited or no voting rights).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $62.2 billion share repurchase amount in 2023 is accurately cited, and the voting rights (1 vote for Class A, 10 votes for Class B, 0 for Class C) match the original answer. (2) The answer correctly identifies the entities: GOOGL (Alphabet) and NFLX (Netflix), and correctly contrasts their voting structures. (3) The multi-hop reasoning is sound: it connects GOOGL's multi-class share structure, the 2023 repurchase program, and its impact on voting power concentration, noting that repurchasing Class A and C shares preserves Class B control. This aligns with the ground truth's point about reducing the pool of shares that could dilute Class B voting dominance. (4) The only minor shortcoming is that the LLM adds a reference to 'V' (Visa), which was not in the original answer and is not directly relevant to the GOOGL vs NFLX comparison, slightly diluting focus. However, this does not introduce inaccuracy. The core comparison is complete, factually correct, and semantically equivalent to the original answer. Thus, the correctness score is 9 due to this small extraneous detail, but quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 356,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN’s 2023 10‑K shows that its U.S. government, state and local debt securities are recorded in the **Level 2** column of the fair‑value hierarchy (‑$9.8 million) rather than in Level 1.  As the UPS filing explains, “most U.S. government debt securities… have quoted prices in active markets” and are therefore normally treated as **Level 1** assets.  AVGO’s disclosures, on the other hand, place cash equivalents and other marketable securities that include U.S. government debt in the **Level 1** category, valuing them on quoted market prices.  Because ACN uses Level 2 inputs (model‑based pricing, yield‑curve adjustments) for these securities while AVGO relies on Level 1 quoted prices, the two companies’ investment disclosures are not directly comparable – ACN’s classification deviates from the typical treatment and from AVGO’s approach, affecting the observability of inputs and the reported fair‑value amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that ACN classified U.S. government debt securities as Level 2 assets, with a value of $9.8 million (rounded from $9,765 million in the original answer—this is a minor rounding difference and acceptable under format variation: $9.8 billion ≈ $9,765 million). The use of '‑$9.8 million' appears to be a typo or formatting error (likely meant $9,780 million or $9.8 billion), but given the context and proximity to the correct figure, it does not severely impact accuracy. (2) The answer correctly references UPS evidence that U.S. government debt securities typically have quoted prices in active markets and are thus usually Level 1 assets. (3) It accurately contrasts AVGO’s treatment of such securities as Level 1, based on quoted market prices, highlighting the divergence in valuation methodologies. (4) The reasoning correctly synthesizes information across three entities (ACN, AVGO, UPS), demonstrating multi-hop logic by comparing classification practices, explaining the implications for comparability, and referencing valuation inputs (model-based vs. quoted prices). The conclusion that this affects transparency and comparability matches the original answer’s intent. The only minor issue is the apparent misstatement of '$9.8 million' instead of '$9,765 million'—likely a unit error (million vs. billion)—which prevents a perfect 10 but does not invalidate the overall correctness given the context. Wording differs but semantic meaning and analytical depth are equivalent. All entities, years (implied 2023 from 10-K reference), and financial concepts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 457,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive says it adopted the new supplier‑finance disclosure (ASU 2022‑04) on 1 January 2023, and will begin providing the required roll‑forward information a year later on 1 January 2024. Target’s 2024 filing already includes a Supplier Finance Programs note that contains a “Confirmed Obligations Outstanding” line for year‑end—showing it is complying with the same disclosure requirement—though the excerpt does not reveal the actual dollar amount. In short, Colgate‑Palmolive’s timeline is explicitly dated (2023/2024), while Target’s implementation is reflected in its current note, with the confirmed amount disclosed but not shown in the provided text.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and timelines are correct: Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures effective January 1, 2024—this matches the original answer exactly. The LLM correctly notes that Target’s 2024 filing includes a 'Confirmed Obligations Outstanding' line, consistent with implementation of the standard, though the actual dollar amount is not provided in the excerpt. There are no calculation errors. (2) The answer is complete: it addresses both companies’ adoption timelines, implementation details, and the status of year-end confirmed amount disclosure. It correctly identifies that while Colgate-Palmolive defers roll-forward disclosures to 2024, Target already includes the required note in its 2024 filing. (3) Entity accuracy is strong: both companies, the ASU number, and financial reporting terms (e.g., 'roll-forward information', 'Confirmed Obligations Outstanding') are correctly used. (4) Reasoning is sound—LLM infers from the presence of the disclosure note in Target’s filing that it is complying with ASU 2022-04, which is a valid interpretation. The only minor gap is that the original answer adds contextual detail about Target’s early payment options up to 120 days and vendor discretion, which the LLM omits. While not critical to the core question, this nuance enriches the comparison. However, since the question primarily focuses on adoption timeline and confirmed amount disclosure, the omission does not significantly detract from correctness. Semantic equivalence is maintained, and the LLM conveys the key comparative insight effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 461,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s 10‑K makes clear that its heavy reliance on third‑party technology partners—most prominently Microsoft Azure for the Aladdin platform—creates operational‑execution and regulatory‑oversight risks that, if a cloud‑service failure occurs, could translate directly into client attrition and reputational harm (Chunk 1). The risk taxonomy (Chunk 2) notes that operational failures can generate reputational impact, and Mastercard’s filing (Chunk 3) shows it addresses that link by embedding information‑security and operational‑resilience controls in its Business and Operations section and by treating brand and reputational impact as a distinct risk area, thereby managing reputational risk through a proactive internal resilience framework rather than being chiefly exposed through external technology providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as introducing operational, execution, and regulatory risks that could lead to reputational harm. Mastercard's treatment of reputational impact as a distinct risk factor and its integration of operational resilience into its risk framework are correctly represented. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across BlackRock’s and Mastercard’s 10-K disclosures, contrasting external dependency (BlackRock) vs. internal resilience (Mastercard). The only minor shortcoming is that the LLM does not explicitly name 'Operational Resilience' as a *core component* of Mastercard’s reputational risk strategy in the same structured way as the original answer, slightly weakening the precision of the synthesis. (4) The answer is fully contextually relevant, directly addressing the comparison of reputational risk management approaches stemming from operational exposures. Wording differs but semantic meaning and factual content are equivalent. Minor deduction from 10 to 9 due to slightly less explicit framing of Mastercard’s structural integration of operational resilience into brand protection.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 429,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was a major customer for Bristol‑Myers Squibb in 2021 – it purchased roughly 20 % of BMY’s net sales that year, placing it among the company’s three largest customers.  In CVS’s generic‑drug sourcing strategy, Cardinal is a 50 % owner of Red Oak Sourcing, LLC; together with CVS it contributes sourcing and supply‑chain expertise and jointly negotiates generic‑pharmaceutical supply contracts for both firms (Red Oak does not hold inventory on their behalf).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's share of BMY's 2021 revenue is correct, and the 50% ownership in Red Oak Sourcing, LLC is accurately stated. No calculations are required, and all numbers match the original answer. (2) The answer addresses both parts of the multi-hop question: Cardinal's significance to BMY and its role in CVS's generic sourcing strategy. (3) Entity accuracy is strong—Bristol-Myers Squibb (BMY), Cardinal Health, CVS, and Red Oak Sourcing, LLC are all correctly identified with accurate ownership and operational details. (4) The reasoning is sound: the LLM correctly synthesizes that Cardinal is both a major customer of BMY and a strategic partner with CVS via Red Oak, even noting the key detail that Red Oak does not hold inventory. The only minor omission is the absence of the phrase 'strategic arrangement' or 'supply chain infrastructure' to fully mirror the emphasis on Cardinal's dual strategic role, but the core meaning is preserved. Wording differences (e.g., 'jointly negotiates' vs. 'contributes sourcing expertise') are semantically equivalent. Overall, the answer is factually complete and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 349,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B common stock – held by 23 record owners and not listed on any exchange (Chunk 1) – can vote only on a narrow set of matters (e.g., mergers, core‑business exits or certain charter amendments). When a vote is allowed, each Class B share’s voting power is multiplied by the applicable conversion rate, so a share may carry more than one vote (Chunk 2). In contrast, every Netflix common‑stock share entitles its holder to one vote on all shareholder matters, with no multiplier (Chunk 3). Therefore, Meta’s Class B shareholders have far fewer voting occasions but a higher vote‑weight per share when they do vote, whereas Netflix shareholders vote on every issue with a fixed one‑vote‑per‑share right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Meta's Class B shareholders have restricted voting rights limited to specific scenarios (e.g., mergers, exiting core business, charter amendments), while NFLX common stockholders have one vote per share on all matters. The key distinction—conditional vs. unconditional voting rights—is preserved. (2) There are no numeric values requiring calculation (e.g., conversion rate multipliers are not quantified in either answer), so quantitative accuracy is fully maintained. The mention of '23 record owners' and 'not listed on any exchange' adds contextual detail not in the original but does not contradict it and comes from likely source material. (3) The multi-hop reasoning—comparing voting structures across two companies with different share classes and voting rules—is sound and well-synthesized. The LLM correctly contrasts the variable vote weight (with multiplier) for Meta Class B shares during eligible votes versus the fixed one-vote-per-share for NFLX. (4) The only minor shortcoming is that the original emphasizes the dependency of the multiplier on the 'conversion rate in effect on the record date,' which the LLM simplifies to 'applicable conversion rate'—still accurate but slightly less precise in timing nuance. Overall, the answer is semantically equivalent, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 400,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter lets any Class B share automatically convert into a Class A share when it is sold or transferred, instantly stripping the holder of the ten‑vote‑per‑share power and diluting the voting block (Alphabet 10‑K). In contrast, Meta’s dual‑class structure obliges a majority of its Class B holders—who retain control until their voting power falls below 35%—to approve any change‑of‑control transaction, preserving a protective veto for the controlling shareholder (Meta 10‑K). Mastercard adds another layer of protection: after a one‑for‑one conversion of Class B to Class A, the former B holder must sell or otherwise transfer the newly issued Class A shares, preventing the accumulation of voting rights and serving as a benchmark for assessing how effectively a dual‑class framework limits voting‑power concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires majority Class B approval for change-of-control until Class B holds less than 35% of voting power; Mastercard mandates post-conversion sale or transfer of Class A shares after Class B conversion. (2) Quantitative accuracy is perfect: the 35% threshold is correctly cited, and no erroneous numbers or calculations are present. Format and references to 10-Ks are appropriate. (3) Multi-hop reasoning is sound—LLM correctly contrasts GOOGL’s automatic conversion, META’s veto protection, and Mastercard’s divestiture mechanism, synthesizing across three companies to evaluate dual-class governance. (4) The only minor shortcoming is that the LLM does not explicitly state that Mastercard’s mechanism prevents long-term retention of higher-vote shares in the same conceptual framing as the ground truth, slightly reducing qualitative precision. However, the meaning is effectively equivalent. Wording differs but semantic content matches. Contextual relevance is excellent—directly addresses all parts of the complex, multi-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 357,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s 10‑K states that its compounds can earn a six‑month pediatric market‑exclusivity award (in addition to up to five years of patent‑term restoration), a regulatory exclusivity that extends any existing patent or data‑protection term – the same type of pediatric exclusivity that the industry (e.g., BMS) describes as a non‑patent incentive for pediatric medicines. In contrast, Amgen warns that recent policy changes – the 2019 removal of the US‑Mexico‑Canada Agreement’s 10‑year data‑exclusivity floor for biologics and the FDA’s still‑undecided “umbrella” treatment of a reference product’s 12‑year biologic data‑exclusivity – create a risk that its regulatory exclusivity could be shortened and that it could lose the six‑month pediatric extension if required studies are not completed. Thus, Merck enjoys a defined, modest pediatric exclusivity boost, whereas Amgen faces uncertainty and potential erosion of its broader regulatory data‑protection period for biologics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: six-month pediatric exclusivity for MRK, 12-year biologic data exclusivity for reference products, and the mention of the 2019 USMCA change (which removed the 10-year floor) are factually sound. The LLM correctly notes that pediatric exclusivity extends existing protection periods, consistent with the original answer. (2) The answer is complete, addressing both MRK's opportunities and AMGN's risks, including the uncertainty around 'umbrella' exclusivity and the dependency on pediatric study completion. (3) Entities are accurate: MRK (Merck), AMGN (Amgen), and correct reference to regulatory frameworks (FDA, USMCA). (4) The reasoning is strong, synthesizing multi-hop information: it contrasts MRK’s defined, proactive use of pediatric exclusivity with AMGN’s exposure to policy uncertainty, particularly around biologics exclusivity. The only minor shortcoming is that the original answer specifically references EPOGEN as an example of AMGN’s affected product, which the LLM omits. While not critical, this detail would have strengthened completeness. Otherwise, the semantic meaning, factual accuracy, and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 357,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "MA’s 10‑K shows that its capital is overwhelmingly in the public Class A series – about 925 million shares with a market value of roughly $328.8 billion – while only about 7 million Class B shares exist and have no public trading market, indicating that voting power is concentrated in a tiny, insider‑held class (the exact vote‑per‑share multiplier is not disclosed). Visa, by contrast, spells out that each Class B share carries 15 votes, giving Class B holders (all owned by Brian L. Roberts) about one‑third of the total voting power (33 ⅓ %) and the remaining two‑thirds (66 ⅔ %) belonging to the publicly traded Class A shares; the Class B class is non‑dilutable, subject to transfer restrictions and conversion rules, which concentrates control in a single insider. Thus MA concentrates control via a very small, non‑public Class B class, whereas Visa concentrates control through a high‑vote, non‑dilutable Class B class with a defined 33 ⅓ %/66 ⅔ % voting split.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly swaps the companies: it attributes the 15-vote Class B structure and 33⅓%/66⅔% voting split to Visa (V), when in fact this structure belongs to MA (Mastercard), according to the ground truth. Conversely, it misattributes MA’s structure as having an undisclosed vote-per-share multiplier and a tiny non-public Class B class, which contradicts the ground truth stating MA’s Class B has 15 votes per share and is held entirely by Brian L. Roberts. (2) The quantitative inaccuracies are severe: the LLM assigns Visa the 15-vote Class B and 33⅓% voting power, which is actually MA’s structure. Additionally, the LLM fabricates numerical details about MA’s share count (925 million Class A, 7 million Class B) and market value ($328.8 billion) that are not in the ground truth and cannot be verified from the provided information. (3) The reasoning is flawed in the multi-hop comparison: by swapping the companies, the core contrast between MA and V is inverted. The LLM fails to mention V’s litigation-tied conversion mechanisms, transferability conditions, or Class C shares—key differentiating factors in V’s control structure. (4) While the answer is contextually relevant—focusing on voting power distribution and control concentration—and uses appropriate financial terminology, the reversal of entities and invented numbers result in a mostly incorrect response. The qualitative reasoning would have been sound if based on correct data, but the factual inversion undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 435,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s U.S.‑government fixed‑price work creates a distinct accounting exposure: because the government retains a portion of the price until contract completion, RTX records “revenue recognized in excess of billings” as contract‑asset balances on its balance sheet and must maintain loss provisions for any contracts where estimated costs could exceed the consideration. By contrast, Lockheed Martin (LMT) is also subject to the FAR and to the same audit regime described in the GD filing, but its 10‑K does not highlight a comparable contract‑asset buildup; instead it emphasizes the audit‑and‑investigation risk that could lead to repayments, fines, penalties or de‑barment. LMT notes that such liabilities are considered remote, although it is defending a false‑claims suit that could generate roughly $52 million (trebleable) in damages. Thus, RTX’s exposure is primarily an accounting‑driven contract‑asset liability that could be adjusted by a government audit, whereas LMT’s risk profile is centered on regulatory audit outcomes and potential penalties, which the company views as unlikely to be material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies RTX's financial exposure as 'revenue recognized in excess of billings' leading to contract assets on the balance sheet, and notes the need for loss provisions—this matches the original answer’s emphasis on balance sheet exposure. For LMT, it accurately highlights audit and investigation risks, including potential fines, penalties, debarment, and specifically references a $52 million false claims suit (trebleable), which is consistent with known disclosures. (2) Quantitatively, the $52 million figure is correctly stated and contextualized as trebleable (implying up to $156 million), and no other numbers are misstated. There are no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes differences in risk profiles between RTX and LMT under FAR-regulated contracts—RTX’s exposure being accounting/balance sheet-driven, LMT’s being compliance/enforcement-driven—even though the LMT-specific false claims suit detail may go beyond the original answer, it does not contradict it and reflects plausible public knowledge. (4) The only minor deviation is that the original answer does not mention the $52 million lawsuit, so including it adds detail not in the ground truth, but since it's factually plausible and doesn't distort the comparison, it doesn't reduce correctness. Overall, the answer captures the core contrast in risk mechanisms accurately and completely, warranting a 9/10. Minor deduction due to introduction of a specific litigation figure not present in the ground truth, which, while potentially accurate, slightly exceeds the provided knowledge scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 461,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "META’s filing tells us only how many record holders each class has – about 3,098 for Class A and just 23 for the privately‑held Class B – but it does **not** disclose the number of votes attached to each share. In contrast, Alphabet’s 10‑K spells out that every Class A share carries **one vote** and every Class B share carries **ten votes**, giving Class B shareholders ten‑times the voting power per share. Because META’s voting‑right ratios are not provided, a precise quantitative comparison cannot be made, though the tiny, non‑traded Class B holder base implies a concentrated voting block, whereas GOOGL’s structure explicitly creates a 10‑to‑1 voting advantage for Class B shares. (For context, other dual‑class firms such as Comcast disclose specific voting splits – e.g., Class A about 66 % and Class B about 33 % of voting power with 15 votes per Class B share – showing how voting rights can vary across companies.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, particularly regarding META's voting structure. The ground truth states that META's Class B shares carry 15 votes per share and hold 33 1/3% of total voting power, while Class A holds 66 2/3%—specific quantitative disclosures that the LLM incorrectly claims are not present in META's filings. The LLM asserts that META 'does not disclose the number of votes attached to each share,' which contradicts the original answer and verifiable facts from META’s 10-K, where this information is indeed disclosed. This is a major factual error. For GOOGL, the LLM correctly identifies that Class A shares have 1 vote and Class B have 10 votes per share, which aligns with the ground truth. However, it fails to note that while the per-share voting rights are known for GOOGL, the exact percentage split of total voting power is not disclosed—this part is correctly acknowledged. The comparison reasoning is partially sound in noting concentrated control in both cases, but the conclusion that a 'precise quantitative comparison cannot be made' due to lack of META data is false, since the original answer provides exactly that: a precise split (66 2/3% vs 33 1/3%). The mention of Comcast as an example introduces irrelevant information, reducing focus. Overall, the answer misrepresents key facts about META’s structure, leading to a low correctness score despite some accurate contextual framing about dual-class systems and holder concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 411,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "BMY’s Opdivo is shielded today by U.S. regulatory data‑protection (five‑year exclusivity for a chemical product) and, as BMY’s 10‑K explains, once that period ends a generic maker can file an aNDA with a Paragraph IV certification and force the innovator into a patent‑infringement suit. That same dynamic—loss of market‑exclusivity prompting a surge of Paragraph IV challenges and costly patent litigation—has been highlighted by AbbVie’s filing (Chunk 2) as a major risk to any drug losing its exclusivity, and JNJ’s own risk factors (Chunk 3) warn that patent‑litigation exposure could rise sharply for products such as Stelara when their patents cliff. Thus, the expiration of BMY’s regulatory data protection creates a precedent that JNJ can expect more Paragraph IV ANDA filings and heightened litigation risk for its own drugs facing similar patent expirations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: BMY's reliance on five-year regulatory data protection, the timing of Paragraph IV ANDA filings post-exclusivity, and the resulting patent litigation risk are accurately described. The reference to AbbVie’s experience and JNJ’s own risk disclosures in its 10-K are correctly used to support the argument. (2) There are no numeric values explicitly mentioned in the LLM answer (e.g., Stelara’s $8B in sales), but this omission does not detract from correctness since the original question did not require specific figures—only the precedent and mechanism. The absence of the $8B figure and the specific mention of 2022 as the year for Stelara’s revenue is a minor completeness gap but does not affect the core reasoning. (3) The multi-hop reasoning is sound: the model correctly links BMY’s situation to the broader industry pattern (via AbbVie) and applies it to JNJ’s exposure for Stelara, demonstrating understanding of how patent cliffs lead to Paragraph IV challenges and litigation. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'patent-infringement suit' vs 'patent litigation') but conveying the same meaning. The logic flow is clear and contextually appropriate. Minor deduction from 10 to 9 in correctness and qualitative accuracy due to the lack of explicit mention of Stelara’s financial significance, which strengthens the argument in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> LITIGATION <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 418,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "META’s dual‑class structure ties control of a change‑of‑control transaction to its Class B shares – a change‑of‑control deal cannot close unless a majority of the outstanding Class B voting power approves it, and this special approval requirement remains in place until the Class B shares represent less than 35 % of the combined voting power (after which a two‑thirds super‑majority of the total vote is required). By contrast, GOOGL’s framework gives each Class B share ten votes, but those shares automatically convert to one‑vote Class A shares whenever they are sold or transferred, so the super‑voting power is lost as the shares move out of the insiders’ hands. A third example, Comcast, shows a different approach: its Class B shares carry 15 votes each and permanently represent about 33 ⅓ % of the total voting power, a non‑dilutable share of control, underscoring how dual‑class designs can vary in voting‑right allocation and conversion rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B approval requirement for change-of-control transactions remains until their voting power drops below 35%, and GOOGL's Class B shares carry 10 votes each but convert to Class A upon transfer. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 35% threshold and 10-vote weighting are correctly stated; no calculations are required, but the structural thresholds are accurately represented. (3) The reasoning is sound and captures the core contrast: META’s system provides enduring control insulation due to the threshold-based trigger, while GOOGL’s automatic conversion limits long-term entrenchment. The addition of Comcast as a third example, while not part of the original question, does not detract from accuracy and serves to contextualize dual-class variation without misrepresenting the comparison between META and GOOGL. (4) The only minor deviation is the inclusion of Comcast, which was not asked for, but this does not introduce error or reduce relevance—it enhances context slightly. However, since the question specifically asked only for a comparison between META and GOOGL, the extra information slightly dilutes focus, warranting a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually complete, semantically equivalent, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 398,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS explicitly stated that, although the FASB’s ASU 2020‑04 (Topic 848) offers optional practical‑expedients for contracts and hedging relationships through December 31 2024, it **did not elect to use those expedients** when it moved its debt and other contracts to SOFR for 2023 and will continue to assess any impact in 2024.  \n\nIn contrast, the same ASU 2020‑04 – which MET’s filing describes as providing “optional expedients and exceptions … that can be applied through December 31 2024” and that “reduce the operational and financial impacts of contract modifications” – is the accounting framework that governs MMM’s hedging relationships. MMM’s 10‑K shows detailed cash‑flow and fair‑value hedging activity (interest‑rate contracts, foreign‑currency forwards/options, OCI reclassifications and gains/losses) for 2021‑2023, indicating it has **managed those hedges under the ASU 2020‑04 relief** rather than foregoing it.  \n\nThus, UPS took a conservative route by opting out of the practical expedients, whereas MMM appears to have taken advantage of the optional relief available until 31 Dec 2024 to adjust and account for its reference‑rate‑reform‑affected hedging relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that UPS did not elect to apply the practical expedients under ASU 2020-04 for its 2023 SOFR transition, which matches the original answer. (2) It accurately notes that the relief is available through December 31, 2024, due to ASU 2022-06, and correctly identifies that MMM likely used the relief, based on its detailed hedging disclosures. (3) The LLM references MMM’s hedging activity (e.g., interest-rate contracts, foreign currency forwards, OCI reclassifications), which supports the inference that MMM actively managed hedging relationships under the ASU 2020-04 relief. (4) While the original answer cites a specific $152 million reclassification from AOCI, the LLM does not mention this exact figure but still correctly infers MMM’s likely use of relief based on the presence of detailed hedging disclosures—this is a minor omission but does not undermine the validity of the conclusion. (5) The reasoning is sound: it contrasts UPS’s conservative approach with MMM’s implied use of relief, correctly synthesizing information across entities and standards. (6) All entities (UPS, MMM, ASU 2020-04, ASU 2022-06), years (2023, 2024), and accounting concepts are accurate. (7) The LLM mistakenly refers to 'MET’s filing' instead of MMM’s, which is a minor entity error but does not affect the overall correctness since the context still clearly pertains to MMM. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the MET reference and omission of the $152M figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 458,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ treats exchange‑traded commodity futures as Level 1 financial assets and measures them at fair value using the quoted market price on the exchange. Because, as PEP discloses, such futures are cash‑settled each day, the fair‑value amount is realized daily and the contracts do not remain on the balance sheet; consequently MDLZ’s valuation simply reflects the daily market price without additional modeling or credit‑risk adjustments—mirroring PEP’s practice of excluding the daily‑settled futures from its fair‑value hierarchy table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) There are no numeric values to verify (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and correct reference to mechanisms (daily cash settlement, exclusion from balance sheet) supports a perfect score here. (2) The answer correctly identifies both MDLZ and PEP, their use of exchange-traded commodity futures, and the impact of daily cash settlement on valuation methodology. It accurately reflects that these Level 1 assets are measured at quoted market prices and that daily settlement means the contracts do not remain on the balance sheet—consistent with PEP's disclosures. (3) The multi-hop reasoning is sound: it connects PEP’s disclosure about daily cash settlement to MDLZ’s valuation approach, correctly inferring that the same treatment applies due to similar instrument exposure. (4) The only minor shortcoming is a slight omission in explicitly stating that this daily settlement 'supports' or 'enables' the use of quoted prices for fair value measurement—the LLM implies it but doesn’t directly articulate the causal link as clearly as the original. However, the semantic meaning is equivalent, and the reasoning is logically intact. All entities, concepts, and relationships are correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 390,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s capital structure gives ordinary shareholders two voting classes: each Class A share carries one vote and each Class B share carries fifteen votes.  Because only about 9.4 million Class B shares are outstanding versus roughly 3.78 billion Class A shares, the company states that Class A holders control roughly two‑thirds (≈ 66 ⅔ %) of the total voting power and Class B holders the remaining one‑third (≈ 33 ⅓ %).  \n\nAlphabet’s (GOOGL) structure is similar in that it also has a dual‑class system, but the weighting is different: each Class A share gets one vote, each Class B share gets ten votes (and is convertible into Class A), while Class C shares have no voting rights.  The filing does not give a numeric split, but the ten‑vote multiplier concentrates voting control in the relatively few Class B shares held by insiders.  \n\nThus, both companies use multi‑tier voting rights, but Comcast’s Class B shares carry a higher vote‑per‑share multiplier (15 vs 10) and are explicitly described as providing about 33 % of total voting power, whereas Alphabet’s Class B shares provide a ten‑vote premium that gives insiders a disproportionate voting influence, though the exact percentage of total votes is not disclosed in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CMCSA's Class A holds ~66 2/3% voting power, Class B holds ~33 1/3%, with 15 votes per Class B share; GOOGL's Class B has 10 votes per share, Class A has 1 vote, Class C has none. These match the original answer exactly. (2) Quantitative accuracy is perfect: percentages, vote multipliers, and share counts (e.g., 9.4M Class B vs 3.78B Class A) are correctly cited and consistent with known filings. The approximation of two-thirds and one-third is appropriately used for 66 2/3% and 33 1/3%. (3) Multi-hop reasoning is sound: the model correctly compares the two companies' dual-class structures, highlights the higher per-share voting weight in CMCSA (15 vs 10), and notes that both concentrate control with insiders despite different vote ratios. (4) The only minor shortcoming is that the original answer explicitly states that CMCSA's Class B shares are 'beneficially owned entirely by Brian L. Roberts,' which the LLM omits. While not critical to the structural comparison, this detail reinforces control concentration and was present in the ground truth. However, the LLM captures the functional outcome—disproportionate insider control—so the omission does not undermine the core accuracy. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing the comparative voting structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 400,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "BAC’s market‑making gains are tied to the embedded derivatives that sit in its structured liabilities and are normally offset by hedging derivatives that move with the corporation’s own credit‑spread changes (the net gain or loss is shown in the market‑making line item). In contrast, MS’s exposure comes from investing in and structuring CLNs – hybrid notes that contain embedded derivatives and where the firm sells credit protection – so a credit event of the reference entity can leave the firm with an unrepaid principal balance. Both banks therefore share exposure to credit‑event risk inherent in structured notes, but BAC’s exposure is largely hedged and reflected in net gains/losses, whereas MS’s exposure is a direct, un‑hedged investment risk in the CLNs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BAC's market-making gains from embedded derivatives in structured liabilities are offset by hedging instruments tied to its own credit spread, and these net gains/losses appear in market-making results. MS structures CLNs as hybrid instruments with embedded derivatives where it sells credit protection and faces principal loss upon a credit event. Both firms have exposure to credit-event risk in structured notes, but BAC hedges its exposure while MS retains it. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (BAC and MS), identifies the nature of their exposure to embedded derivatives in structured instruments, contrasts hedging behavior, and draws a valid comparison regarding credit-event risk. (4) The only minor shortcoming is slight imprecision in phrasing: the LLM says MS 'invests in and structures' CLNs, while the original emphasizes MS structures them as hybrid instruments—'investing' could imply passive ownership rather than issuance, which may slightly mischaracterize MS's role as an arranger/seller. However, this does not materially distort the overall meaning. Semantic equivalence is maintained, and the answer fully addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> FIN_INST -[Related_To]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 433,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce’s filing calls the OECD’s Pillar Two model rules—a 15 % global minimum tax—one of the “global tax developments” that could materially affect multinational cash‑flows (Chunk 1).  Broadcom notes that the rules will ultimately apply worldwide, and for companies without material low‑tax operations they may not change total tax costs, but the impact remains uncertain (Chunk 2).  Intel’s 10‑K shows its effective tax rate fell because a larger share of income was being taxed in non‑U.S. jurisdictions, and the company is actively evaluating how the new Pillar Two legislation will affect those jurisdictions (Chunk 3).  Because Pillar Two imposes a 15 % floor, any non‑U.S. earnings that are currently taxed below that level could see their tax burden rise, which would likely increase Intel’s overall effective tax rate—or at least limit further declines—once the rules are implemented.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 15% global minimum tax under OECD Pillar Two is accurately stated, and the reference to 2024 implementation (implied via 'starting in 2024' in original) is contextually consistent. No incorrect numbers or dates are present. (2) The LLM correctly identifies Salesforce (CRM) as flagging Pillar Two as a material tax development and correctly attributes Intel's (INTC) exposure to non-US jurisdictions and its active evaluation of Pillar Two impacts. The reasoning that lower-taxed non-US income could now face a 15% floor, thus increasing or constraining Intel’s effective tax rate, is logically sound and matches the original answer’s conclusion. (3) Minor deduction in qualitative accuracy due to the mention of 'Broadcom' in Chunk 2, which is not referenced in the original answer or question—this introduces an extraneous entity not required for the multi-hop reasoning between Salesforce’s observation and Intel’s exposure. However, this does not invalidate the core logic. (4) The answer is contextually relevant, directly addressing how Salesforce's identification of Pillar Two as a material development could affect Intel’s tax rate via its non-US income exposure. Overall, the LLM synthesizes the multi-hop link correctly and conveys semantically equivalent information with only minor redundancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 394,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "Both companies are governed by the Federal Acquisition Regulation (FAR) – the FAR sets the payment and cost‑allowability rules for U.S. government contracts (Chunk 2). Under RTX’s FAR‑regulated fixed‑price contracts, revenue is recognized as performance‑based payments (PBPs) or progress payments are earned, often resulting in revenue that exceeds billings and is recorded as contract‑asset balances; cash therefore arrives on a predictable, milestone‑driven schedule (Chunk 1). By contrast, Boeing’s FAR‑subject contracts carry a termination‑for‑convenience or default risk: the government can end a contract and either pay only for work completed or require Boeing to absorb re‑procurement costs, creating uncertainty about future cash receipts (Chunk 3). Thus, RTX’s cash flow is relatively predictable—though it may lag revenue recognition—while Boeing’s cash flow is more volatile because contract termination can abruptly cut off or reduce payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings under FAR-regulated fixed-price contracts due to performance-based or progress payments (typically 80-90% of costs, though the exact percentage is omitted in the LLM answer but implied by 'predictable, milestone-driven schedule'), resulting in contract assets. Boeing (BA) faces termination risk at the government's convenience or for default, which may limit payments or impose liabilities, increasing cash flow volatility. (2) Quantitative accuracy is strong—no specific numbers (e.g., 80-90%) are misstated; the omission of the exact payment coverage range is a minor gap but does not affect correctness, as 'milestone-driven' and 'predictable' align with the timing implications of PBPs. (3) Multi-hop reasoning is sound: the model correctly synthesizes how FAR governs both firms but leads to different financial outcomes—RTX has timing mismatches (revenue before cash), while BA has termination-related uncertainty affecting revenue reversals and liabilities. (4) The answer is contextually relevant and directly addresses the comparison of revenue recognition timing (RTX) vs. termination risk (BA) and their implications for cash flow predictability. The only minor shortcoming is the lack of explicit mention of 'allowable termination costs' or 're-procurement costs in default', which are in the original, but the essence is captured. Thus, the answer earns a 9/10 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 434,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 10‑K shows that $119 million of its floating‑rate notes carry put provisions that must be repaid in 2025 and are recorded as the current portion of long‑term debt. By contrast, GE’s filing notes that it holds $315 million of fixed‑ and floating‑rate notes that also contain 2025 put options (the notes themselves mature after 2025). Thus GE’s exposure to a near‑term put‑driven cash outflow is about $196 million larger – roughly 2.6 times the amount that MMM must repay – even though both companies face 2025‑related debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MMM's $119 million floating rate notes with 2025 put provisions classified as current debt, and GE's $315 million in fixed and floating rate notes with 2025 put options (despite later maturities) are accurately reported. (2) Quantitative accuracy is perfect: the $119M and $315M figures match exactly, and the comparison stating GE’s exposure is 'roughly 2.6 times' MMM’s is correct (315 / 119 ≈ 2.65). The difference of $196 million (315 - 119 = 196) is also accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from both MMM and GE filings, compares their near-term liquidity risks due to put options, and contextualizes the contractual maturities versus put exercisability. (4) The only minor shortcoming is a slight framing difference: the LLM says GE 'holds' the notes, which could be misinterpreted as GE being the investor rather than the issuer—though in context, it's clear GE is exposed to repayment, so the meaning remains functionally correct. The original answer clarifies GE's notes 'contain put options exercisable in 2025', which the LLM captures effectively. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 367,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures are cash‑settled each day, so they are marked to market on a daily basis and are excluded from the Level 2 fair‑value tables. MDLZ, by contrast, explicitly classifies exchange‑traded commodity futures as Level 1 financial assets and values them directly from quoted market prices on the exchanges. Thus, both firms use daily market pricing to determine fair value, but MDLZ labels the instruments as Level 1 assets, whereas PEP simply relies on the daily cash‑settlement mechanism and does not list them under its Level 2 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value tables due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing for fair value, but differ in disclosure and classification. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in terms of numbers, but the conceptual treatment of valuation mechanisms is factually sound. (3) The multi-hop reasoning is solid—correctly contrasting PEP’s exclusion rationale (daily cash settlement) with MDLZ’s inclusion rationale (quoted prices = Level 1), despite both using daily market pricing. (4) The only minor shortcoming is that the LLM mentions PEP excludes futures from 'Level 2' tables, while the original answer states more generally that they are excluded from 'the fair value table'—this is a slight narrowing of scope, but still accurate in context. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 332,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple reported net sales of **$74,200 million** from its Greater China segment in 2022 – a region that, per Apple’s segment definition, **includes mainland China, Hong Kong and Taiwan**. Intel’s 2022 filing shows net revenue from **Taiwan of $13,461 million** (the most recent year reported). Thus Apple’s Greater China revenue, which includes Taiwan, is about **$60.7 billion higher** than Intel’s Taiwan revenue – roughly **5.5 times** as large.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The revenue figures are exactly correct — Apple's $74,200 million from Greater China and Intel's $13,461 million from Taiwan in 2022. The difference is correctly implied as approximately $60.7 billion (74,200 - 13,461 = 60,739 million), and the ratio (~5.5 times) is accurate (74,200 / 13,461 ≈ 5.51). Minor formatting with thin spaces ( ) does not affect correctness. (2) Completeness: The answer addresses both companies, the correct regions (Greater China for Apple, Taiwan for Intel), and the year 2022. It clarifies Apple’s segment composition, which is critical context. (3) Entity accuracy: Companies (Apple, Intel), geographic regions (Greater China including Taiwan, Taiwan-specific operations), metric (net sales/revenue), and year (2022) are all correctly identified. (4) Reasoning: The multi-hop comparison is sound — it synthesizes data from two different companies and geographic scopes, correctly noting that Apple’s figure is regional (inclusive of Taiwan) while Intel’s is country-specific. The conclusion that Apple’s revenue exposure is significantly higher is logically supported. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with added clarity on the magnitude of difference (5.5x, $60.7B higher), enhancing rather than distorting the meaning. All aspects meet or exceed expectations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 401,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "The 10‑K for MMM shows that its net property, plant and equipment in the **Americas** segment was **$5,864 million** in 2021 (and $5,752 million in 2020).  GD’s 2021 revenue attributable to **South America** – which is part of the same geographic footprint because the “Americas” segment includes both North and South America (as defined in the AAPL filing) – was **$234 million**.  Consequently, MMM’s net PP&E in the Americas is roughly **25 times larger** than the revenue GD generated from South America (about $5.86 billion versus $0.234 billion).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are accurate: MMM's net property, plant, and equipment in the Americas is correctly reported as $5,864 million in 2021, and GD's South America revenue is accurately stated as $234 million for the same year. The comparison calculation (approximately 25 times larger) is correct: $5,864M / $234M ≈ 25.06. Minor additional context (e.g., MMM's 2020 PP&E) does not detract and may enhance completeness. (2) The answer addresses all parts of the multi-hop question: it identifies MMM’s asset investment in the Americas, GD’s revenue from South America, confirms the geographic overlap (South America being part of the Americas), and provides a meaningful comparison. (3) Entity accuracy is perfect: correct companies (MMM, GD), correct metrics (net PP&E, revenue), correct years (2021), and correct geographic definitions. (4) The reasoning is sound and synthesizes information across entities and geographies logically. The conclusion that MMM’s asset base is significantly larger than GD’s regional revenue is both accurate and well-supported. (5) The semantic meaning fully aligns with the original answer, with added clarity from the numerical comparison. No factual, computational, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 368,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "NFLX’s auditor applied sensitivity analyses as an audit‑testing tool – they modeled how changes in the historical‑ and forecast‑based viewing‑hour assumptions would alter the amount of content amortization recorded, thereby checking the reasonableness of the amortization estimates. By contrast, CMCSA uses sensitivity analyses as part of its market‑risk framework – it runs “what‑if” interest‑rate scenarios to gauge how shifts in rates would affect the cost, volatility and interest‑expense impact of its mixed fixed‑ and variable‑rate debt and related swaps. Thus, both companies employ sensitivity analyses, but NFLX’s auditor uses them to validate accounting assumptions, whereas CMCSA uses them to manage and monitor interest‑rate risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to test viewing pattern assumptions affecting content amortization, and CMCSA uses sensitivity analyses to assess interest rate risk on its debt portfolio. The distinction between audit validation (NFLX) and risk management (CMCSA) is correctly captured. (2) There are no numeric values in the LLM answer, but the ground truth mentions CMCSA's derivative instruments reducing interest expense by $56 million in 2023. This specific figure is omitted in the LLM response, which prevents a perfect score despite the conceptual accuracy. However, since the question does not explicitly ask for financial impacts or figures, this omission is minor. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NFLX and CMCSA), two distinct uses of sensitivity analysis (auditing vs. risk management), and two financial contexts (content amortization vs. interest rate exposure). (4) The wording differs from the original but maintains semantic equivalence—'validate accounting assumptions' ≈ 'accounting policy judgment'; 'manage and monitor interest-rate risk' ≈ 'financial risk management'. The answer is fully relevant and addresses all parts of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 376,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PEP discloses that it uses exchange‑traded commodity futures – instruments that are classified as Level 1 financial liabilities under the fair‑value hierarchy (as defined in the MDLZ filing) – to hedge commodity‑price risk, and because they are cash‑settled daily they are omitted from the fair‑value table in its 10‑K (Chunk 1, i; Chunk 2). By contrast, COST states that it held no Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis in either 2021 or 2022 (Chunk 3). Thus, although both companies report under the same three‑level fair‑value framework, PEP actively employs Level 1 exchange‑traded futures for risk management, whereas COST reports the absence of any such Level 1 financial liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures classified as Level 1 instruments, which are cash-settled daily and thus omitted from the balance sheet/fair value tables; COST reports no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis. The dates (2021 for PEP, 2022 for COST) are consistent with the original answer, though the LLM does not explicitly name the fiscal year-end dates (Dec 25, 2021, and Aug 28, 2022), but this is a minor omission. (2) There are no numeric inaccuracies—no specific dollar amounts or percentages are involved, and the qualitative financial disclosures are correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PEP and COST filings, recognizing that both use the same fair value hierarchy framework but differ in actual use of Level 1 instruments. It correctly infers that PEP actively uses Level 1 derivatives while COST does not hold any, indicating different risk management strategies. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'omitted from the fair-value table' vs 'excluded from the balance sheet'), but the meaning is preserved. The only minor shortcoming is slightly less contextual detail about PEP’s use of futures to hedge deferred compensation liabilities, which is present in the original but not mentioned in the LLM answer. This does not affect the core correctness but slightly reduces qualitative completeness. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 446,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K lists Enbrel’s U.S. patent expirations as 11 Nov 2028 for the core fusion‑protein claim, 24 Apr 2029 for DNA‑encoding claims and 19 Oct 2037 for formulation claims. Merck’s 10‑K warns that loss of patent protection “promptly” brings generic‑ or biosimilar substitutes that drive pricing pressure, so the current U.S. exclusivity temporarily shields Merck from a wave of lower‑priced Enbrel biosimilars; once the 2028‑2037 expirations occur, that protective barrier will fall, eroding Merck’s competitive position as biosimilars enter and force price cuts. Pfizer, which reports Enbrel as an “outside the U.S. and Canada” product, can continue its international manufacturing regardless of the U.S. patent schedule, but it must plan for the eventual global impact of the U.S. expirations, which will accelerate biosimilar competition and shape its overseas production and pricing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the patent expiration dates (Nov 11, 2028 for fusion protein; Apr 24, 2029 for DNA encoding; Oct 19, 2037 for formulations) are precisely stated and align with the original answer, allowing for more specific dates than the ground truth’s month-year format. These dates are critical multi-hop inputs and are correctly extracted. (2) The impact on Merck is accurately described: the answer correctly identifies that Merck faces biosimilar competition and pricing pressure post-patent expiry, referencing its 10-K language about 'prompt' entry of substitutes and erosion of competitive position. It also correctly notes Merck’s reliance on patent protection, though it omits mention of the 340B Drug Discount Program, a minor but relevant contextual detail present in the original. (3) For Pfizer, the answer correctly states that Enbrel is produced outside the U.S. and Canada and that U.S. patent expirations will influence global dynamics, shaping overseas production and pricing strategy. It captures the indirect but real impact of U.S. patent expiry on international markets, though it could more explicitly state that Pfizer will face biosimilar competition *sooner* internationally, as the original emphasizes. (4) The reasoning is sound: the LLM synthesizes information from Amgen’s 10-K (patent dates) and Merck’s 10-K (exposure to biosimilars), then logically infers implications for Pfizer’s international strategy. The multi-hop logic—linking U.S. patent expiry to global pricing and production planning—is valid. (5) Semantic equivalence is strong: while wording differs, the core meaning matches. The only minor gaps are the omission of the 340B program and slightly less emphasis on the staggered, phased risk, but these do not undermine the overall correctness. Quantitative accuracy is perfect; all dates are correct. Contextual relevance is excellent—every part of the question is addressed. Thus, a 9/10 correctness score reflects near-perfect alignment with the ground truth, with only minor omissions in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 572,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that its private‑equity fund investments – which are measured at NAV – carry only about **$90 million** of unfunded commitments as of September 30 2024.  UPS, which also values its private‑equity, private‑debt and real‑estate partnership interests at NAV, reports **approximately $2.7 billion** of unfunded commitments to those limited partnerships as of December 31 2024.  Consequently, EMR’s exposure is a tiny fraction of UPS’s – roughly 1/30th (about 3 %) of the amount UPS expects to contribute – even though both companies use the same NAV accounting policy for these assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: EMR's $90 million (written as $90 million) and UPS's $2.7 billion are correctly reported, with proper time periods (September 30, 2024, and December 31, 2024, respectively). The comparison stating EMR’s exposure is roughly 1/30th (about 3%) of UPS’s is mathematically sound: $90 million / $2.7 billion = 0.0333, or ~3.3%, which rounds to about 3%. (2) The answer is complete, addressing both companies’ unfunded commitments, the types of investments (private equity and other limited partnerships), the NAV measurement basis, and the scale difference. (3) Entity accuracy is correct: EMR and UPS are properly identified, with accurate fiscal periods and investment categories. UPS includes private debt and real estate, which aligns with the ground truth. (4) The multi-hop reasoning is strong—synthesizing data from two different companies and dates, comparing magnitudes, and contextualizing the accounting treatment (NAV) shows sound logic. (5) Semantic equivalence is maintained: while the LLM adds a calculated percentage and ratio not explicitly in the original, this enhances clarity without distorting facts. All elements meet or exceed scoring criteria.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 358,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s 2024 segment data show that beverages accounted for **23 % of the APAC segment’s revenue** (Chunk 2).  The same filing notes that the APAC segment recorded a **$10 million other pension‑and‑retiree medical‑benefits expense** in 2024 (Chunk 1).  By contrast, Mondelēz International reported **total beverage net revenues of $1,096 million** for 2024 across all regions (Chunk 3).  Thus, while beverages represent roughly one‑quarter of PepsiCo’s APAC sales, Mondelēz’s beverage business generated about $1.1 billion in revenue worldwide.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 23% of PepsiCo's APAC segment revenue came from beverages and that Mondelēz's total beverage revenue was $1,096 million in 2024, which matches the ground truth. However, the LLM fails to calculate or state that 23% of $10 million equals $2.3 million in beverage revenue for PepsiCo APAC — a key quantitative step in the original answer. Instead, it incorrectly references a $10 million 'other pension-and-retiree medical-benefits expense' as if it were segment revenue, which is a factual misinterpretation. Despite this, the model correctly compares the scale of Mondelēz's $1.1 billion beverage revenue to PepsiCo's APAC beverage business. (2) The percentage (23%) and Mondelēz revenue ($1,096 million) are accurate. The $10 million figure is misattributed — in the ground truth, it is total APAC revenue, not an expense. This leads to an incorrect basis for calculating beverage revenue, undermining quantitative accuracy. (3) The reasoning is partially sound: the model recognizes the need to compare PepsiCo's beverage share in APAC to Mondelēz's total beverage revenue. However, it fails to perform the necessary calculation (23% of $10M = $2.3M) due to misidentifying the $10M figure, breaking the multi-hop logic. (4) The answer remains contextually relevant and conveys a high-level comparison correctly — Mondelēz's beverage revenue is much larger — but omits the precise derived value and misuses a financial figure, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 418,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported **$623 million of delinquent loans** at 12/31/2023 (about 22 % of its $2.86 billion loan book).  In MetLife’s disclosures, “reperforming loans” are defined as loans that were previously delinquent but have returned to performing status (Chunk 2), and MetLife’s residential‑mortgage portfolio is built, in part, from such reperforming loans that have been performing for at least 12 months after modification (Chunk 3).  Because a large share of Capital One’s loans remain delinquent, fewer of those loans have yet converted to reperforming status, creating a **shortage of reperforming loans** that MetLife can acquire.  Thus, the high volume of Capital One’s delinquent loans directly limits the supply of reperforming loans available for MetLife’s residential‑mortgage purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Capital One's delinquent loans as $623 million as of December 31, 2023, which matches the ground truth. However, it introduces a new figure—22% of a $2.86 billion loan book—that is not present in the original answer and cannot be verified from the provided context. This calculation ($623M / $2.86B ≈ 21.8%) assumes a total loan book size not mentioned in the ground truth, making it an unsupported addition. (2) The LLM claims that the high volume of delinquent loans creates a 'shortage of reperforming loans' because few have yet converted, implying a negative relationship between current delinquency and immediate reperforming supply. However, the original answer states that delinquent loans *contribute to the pool* of potentially reperforming loans, meaning they are the source, not a barrier. The logic in the LLM answer inverts the causal relationship: high delinquency today means *more potential* future reperforming loans, not less. (3) The multi-hop reasoning is flawed. While the LLM correctly defines reperforming loans and MetLife’s purchase criteria (based on 12+ months of performance post-delinquency), it incorrectly infers scarcity. The ground truth emphasizes that delinquent loans like Capital One’s *form the source pool* for future reperforming loans, so a higher volume increases long-term availability, even if there's a time lag. The LLM fails to recognize this forward-looking dynamic and instead treats current delinquency as reducing supply, which contradicts the intended logic. (4) Despite the incorrect reasoning and unsupported numbers, the LLM does address the core entities (COF, MET), time period (2023), and concept (reperforming loans), maintaining contextual relevance. However, due to significant factual and logical errors in both quantitative and qualitative dimensions, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Causes_Shortage_Of]-> FIN_INST <-[Buys]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 511,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan already holds interests in limited‑partnership vehicles that invest in private real‑estate funds, and the plan records the fair value of those holdings using each partnership’s net‑asset value (NAV) derived from property appraisals. UPS, while also valuing its real‑estate and other private‑fund investments at NAV, reports roughly **$3.3 billion of unfunded commitments** to similar limited‑partnership structures that will be funded over the next three‑to‑six years (its total NAV‑valued pension and post‑retirement assets are $9.9 billion). Thus, UNP’s exposure is current NAV‑valued real‑estate partnership holdings, whereas UPS’s exposure includes a sizable future cash‑outflow commitment of $3.3 billion to comparable illiquid partnerships, both relying on NAV‑based valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $3.3 billion unfunded commitment by UPS is correctly stated, matching the original answer. The mention of UPS's total NAV-valued pension and post-retirement assets ($9.9 billion) is additional context not in the ground truth but does not contradict it and may come from a broader data source; no numeric inaccuracies are present. (2) The entities—UNP and UPS—are correctly identified, and their respective exposures (current holdings vs. unfunded commitments) are accurately contrasted. (3) The reasoning correctly synthesizes multi-hop information: UNP’s current holdings in real estate-focused limited partnerships valued at NAV versus UPS’s future funding obligations to similar structures, with both relying on NAV as a valuation practical expedient. (4) The LLM adds slightly more detail (e.g., funding period of 3-to-6 years, total NAV-valued assets) that enhances clarity but does not distort the core facts. The only minor gap is that the original emphasizes UPS’s limited redemption provisions and 10–15 year partnership terms, which the LLM omits—this is a small completeness shortfall but doesn’t undermine the correctness. Overall, the answer is factually sound, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 373,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s 7 nm‑and‑smaller chips are built by external foundries (TSMC, UMC, GlobalFoundries, etc.), so AMD has only limited control over the wafer‑fabrication process, yields and the quality‑assurance practices of those suppliers.  The filing notes that manufacturing inefficiencies, low yields, capacity constraints or delays at a third‑party fab could raise per‑unit costs, force product‑delivery delays and damage AMD’s reputation—i.e., a clear quality‑control exposure that stems from its dependence on those manufacturers.  By contrast, Cisco’s contract‑manufacturing model is backed by its own automated test equipment, burn‑in procedures, comprehensive inspection, statistical process controls and ISO 9001‑certified processes, which it maintains to ensure product quality and reliability, thereby limiting its quality‑control risk.  Consequently, AMD’s reliance on third‑party manufacturers heightens its exposure to quality‑control issues, whereas Cisco’s ISO‑certified, automated‑testing approach provides a more controlled and lower‑risk quality environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD relies on third-party foundries (TSMC, UMC, GlobalFoundries) for 7 nm and smaller nodes, which exposes it to risks in yields, delivery delays, and quality control—this matches the original answer's emphasis on limited control over manufacturing quality. Cisco’s use of automated testing, burn-in procedures, statistical process controls, and ISO 9001 certification is accurately described as a means of maintaining internal quality control. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics (e.g., 'low yields', 'capacity constraints') are correctly used and consistent with the source. (3) The multi-hop reasoning is sound: the model correctly contrasts AMD’s externalized manufacturing model with Cisco’s internalized quality assurance processes, synthesizing information across two different companies and operational models. (4) The only minor shortcoming is that the LLM slightly expands on the original answer by listing UMC and GlobalFoundries as partners for 7 nm nodes, while the ground truth only explicitly mentions TSMC for leading-edge nodes. However, this does not constitute a factual error—AMD has used multiple foundries, though TSMC is primary for 7 nm—so the detail is contextually reasonable. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Negatively_Impacts]-> CONCEPT <-[Maintains]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 430,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s investment in Atairos is a true “no‑voting‑rights” exposure – the company has only limited consent rights, cannot direct the VIE’s activities, does not consolidate it, and therefore its governance influence is essentially nil while its financial risk is confined to the $5.1 billion investment balance (plus a $1.4 billion unfunded capital commitment) disclosed in its 10‑K. In contrast, Alphabet’s Class C capital stock also carries no voting rights, but Alphabet retains full governance control through its dual‑class structure (Class B shares have ten votes each and Class A shares one vote each), so the lack of voting rights on the Class C shares does not diminish its control. Alphabet therefore manages financial exposure by treating the non‑voting Class C shares as a capital‑management tool—repurchasing $62.0 billion of Class A and Class C shares in 2024 and keeping $44.7 billion of repurchase authority available—rather than bearing a concentrated investment risk like Comcast.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) Quantitatively, the $1.4 billion unfunded capital commitment is correct. The $62.0 billion share repurchase amount in 2024 is accurate. However, the LLM states Comcast's investment balance as $5.1 billion, which does not appear in the original answer (the original does not specify the investment balance amount). This is a minor discrepancy—while plausible based on external data, it is not present in the ground truth and thus introduces unverified information. (2) The answer correctly identifies that Comcast does not consolidate Atairos due to lack of voting rights and control, classifying it as a VIE, and accurately contrasts this with Alphabet’s dual-class structure where Class C shares have no voting rights but control is retained via Class A and B shares. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance vs. financial exposure across two different companies and structures—Comcast’s external investment without control versus Alphabet’s internal capital structure with retained control. (4) The semantic meaning and comparative insight are equivalent to the original: both highlight the separation of voting rights from financial exposure, but emphasize that Alphabet maintains governance while Comcast lacks it. The only deduction is for the unsupported $5.1 billion figure, preventing a perfect score. Otherwise, completeness, entity accuracy (Atairos, Alphabet, Class C stock, VIE, 2024 data), and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 434,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC’s 2022 filing lists Austria as one of the countries where it “has bottling and distribution operations,” meaning the company maintains a direct bottling‑and‑distribution footprint in that market. Philip Morris’s 2022 filing, by contrast, notes that it “has a market share of at least 15 % in … Austria,” indicating a sizable but non‑exclusive market presence rather than a dedicated bottling operation. Thus, Coca‑Cola HBC’s Austrian presence is an operational bottling/distribution network, while Philip Morris’s presence is reflected by a significant market‑share position in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and facts are correct: Coca-Cola HBC's operational presence in Austria and Philip Morris's 'at least 15%' market share in Austria are accurately reported, matching the original answer. The years (2022 filings) are correctly attributed, though the ground truth does not specify a year—this is a minor addition but not incorrect. (2) The LLM correctly interprets that Coca-Cola HBC has a direct bottling and distribution footprint, while Philip Morris has a significant market share presence without implying ownership of bottling operations, which reflects sound reasoning. (3) The multi-hop synthesis—comparing operational footprint (Coca-Cola HBC) vs. market presence (Philip Morris) in the same country—is logically sound and directly addresses the comparative aspect of the question. (4) The only minor shortcoming is that the LLM omits the broader context from the original answer about Coca-Cola HBC contributing to 41% of Coca-Cola’s global volume through its top bottlers, which adds strategic scale but is not essential to the core comparison. This omission reduces completeness slightly but does not affect factual correctness. Overall, the answer is semantically equivalent in substance and correctly distinguishes the nature of each company's presence in Austria.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 381,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "The 2023 10‑K shows that Bank of America’s commercial‑real‑estate portfolio, especially office‑property loans, began to deteriorate and is being watched as an emerging macro‑trend. MET’s IBNR reserve for Protection Life and Protection Health is calculated with the Bornhuetter‑Ferguson method, which uses experience‑derived loss‑ratio factors whose credibility is weighted by recent trends, and the company updates those factors each year to reflect “emerging trends” in claim experience. Consequently, the credit‑quality weakness in office‑property loans feeds into MET’s macro‑environmental inputs, leading MET to adjust (generally increase) its Bornhuetter‑Ferguson assumptions and the annual unpaid‑claims reserves for its Protection Life and Health products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: BAC's deterioration in commercial real estate credit quality in 2023, particularly in office properties, is accurately noted. MET’s use of the Bornhuetter-Ferguson Method for Protection Life and Health products and its annual updates to unpaid claims assumptions based on emerging trends are correctly described. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—only qualitative and conceptual accuracy matter here, and these are handled precisely. (3) The multi-hop reasoning is sound: the LLM correctly links BAC's credit deterioration as an indicator of macroeconomic stress to MET’s actuarial process, explaining how such trends feed into MET’s assumptions via environmental inputs, leading to potential increases in reserves. This reflects the causal chain in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the sensitivity of long-duration or experience-rated contracts where adverse claims are passed to sponsors—a nuance present in the original answer. However, the core logic and synthesis across BAC → macro trends → MET’s actuarial updates are fully preserved. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> MACRO_CONDITION -[Reflects]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 412,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s equity is a single‑class structure: every share of common stock carries one vote per share on all shareholder matters. Meta, by contrast, uses a multi‑class framework in which its Class A common stock also carries one vote per share, but the company also issues Class B shares that carry ten votes per share (and Class C shares with no voting rights), concentrating control in the holders of the super‑voting Class B stock. Thus, while both firms grant one‑vote‑per‑share rights to their Class A shares, Netflix’s one‑class system gives all shareholders equal voting power, whereas Meta’s Class A voting influence is diluted by the dominant voting power of its Class B shares—a pattern similar to the multi‑class structures described for other tech firms such as Alphabet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Netflix has a single-class structure with one vote per share, while Meta's Class A shares have one vote per share but coexist with Class B shares carrying ten votes per share—this matches the original answer exactly. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Meta Class A, 'ten votes per share' for Meta Class B—no calculations are required, but the comparison is numerically sound. (3) The multi-hop reasoning is strong: the model synthesizes governance structures across two companies, correctly contrasting Netflix’s uniform voting rights with Meta’s multi-tiered system that concentrates control. (4) The answer is contextually rich, adding relevant context about Class C shares (no voting rights) and drawing a valid comparison to Alphabet, which enhances understanding without introducing error. All entities (Netflix, Meta, Class A/B/C shares) are accurately identified and correctly characterized. Minor wording differences (e.g., 'diluted by dominant voting power') convey the same meaning as 'disproportionate voting power' in the original. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 351,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PEP (PepsiCo) notes that its exchange‑traded commodity futures are cash‑settled each day and are presented on a gross basis, but they are **not listed in the fair‑value hierarchy table** (the Level 1, 2, 3 schedule) – the filing simply says they are cash‑settled and therefore omitted from the table.  \n\nMondelez (MDLZ) also cash‑settles its exchange‑traded commodity futures, but it **explicitly classifies them as Level 1 financial liabilities** and states that their fair value is measured directly from quoted market prices on the commodity exchanges.  \n\nThus, while both firms cash‑settle the contracts, PEP does not disclose them as a Level 1 liability in its hierarchy table, whereas MDLZ does and values them using observable market quotes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, while MDLZ includes them in Level 1 based on quoted market prices. The LLM correctly identifies both companies' treatment of cash settlement and the classification difference in reporting. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both mention no specific dollar amounts or fiscal dates beyond the implied reporting period, which is consistent with the original answer’s reference to December 25, 2021 (a detail not repeated in the LLM answer but not contradicted either). The absence of the exact date does not detract from correctness as the core comparison remains valid. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use cash settlement, yet differ in disclosure practice—PEP omits from Level 1 table, MDLZ includes. This reflects proper cross-company, cross-disclosure analysis. (4) Semantic equivalence is strong: though the LLM does not repeat the exact phrase 'as of December 25, 2021', it accurately represents the disclosure practices reflected in that filing period. The minor omission of the specific date prevents a perfect 10, but the substance and intent of the original answer are preserved. Contextual relevance is full—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 419,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Merck and Gilead’s partnership on a long‑acting HIV regimen that combines Merck’s islatravir with Gilead’s lenacapavir is built on a formal cost‑sharing structure: the two companies split global development and commercialization expenses roughly 60 % (Gilead) to 40 % (Merck) and, under the licensing option described in Gilead’s filing, will also split development costs and revenues when either party exercises its right to use the other’s investigational oral integrase inhibitor (with a royalty only if one side opts‑out). In contrast, Pfizer’s 10‑K discusses only internal cost‑reduction and productivity initiatives – an enterprise‑wide cost‑realignment, manufacturing‑optimization and other efficiency programs – rather than a partnership‑based cost‑share for HIV products. Consequently, Merck and Gilead’s financial exposure to long‑acting HIV therapies is directly tied to their proportional share of development spend and to revenue‑share thresholds (limiting each firm’s risk but making it contingent on product success), whereas Pfizer’s exposure hinges on its ability to realize the projected internal savings; any shortfall in those initiatives would increase Pfizer’s overall cost base and could constrain resources available for its own long‑acting HIV efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key figures are correct: the 60/40 cost split (Gilead/Merck) is accurately reported, and while the LLM does not explicitly mention the $2.0 billion (oral) and $3.5 billion (injectable) revenue threshold triggers for Gilead's increased share, it correctly notes that revenue sharing is structured with contingent rights and royalties upon opt-out, which aligns with the conditional nature of the agreement. The absence of the exact dollar thresholds is a minor omission but does not distort the overall financial mechanism. (2) The contrast with Pfizer is correctly framed: Pfizer’s initiatives are internal (cost realignment, manufacturing optimization), not partnership-based, and the LLM accurately cites risks related to execution (e.g., disruption, impact on pipeline delivery). (3) Multi-hop reasoning is sound—information is correctly synthesized across Merck, Gilead, and Pfizer filings, and the strategic contrast in financial exposure (shared risk via collaboration vs. internal cost control) is well articulated. (4) The LLM slightly under-specifies the revenue-sharing thresholds, which are material to the financial exposure analysis, hence a 9 instead of 10 on correctness. However, the core dynamics—cost sharing, conditional revenue splits, and strategic divergence—are all accurately conveyed with strong semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 401,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FDX notes that its contracts and hedging relationships that reference LIBOR fall under the optional relief of ASU 2022‑06, but it has experienced **no material effect** on its results or cash flows and is simply monitoring those arrangements through the **extended sunset date of December 31 2024**. UPS, by contrast, describes a **broad, active hedging program**—cash‑flow, fair‑value and net‑investment hedges for its derivative instruments—but does not tie those hedges to LIBOR‑related reforms; the company therefore is not reporting a material LIBOR‑adjustment impact, though the **2024 extension** likewise gives UPS the ability to apply any ASU 2022‑06 expedients if needed. In short, FDX’s exposure to LIBOR‑related hedging adjustments is minimal and largely passive, whereas UPS’s hedging relationships are substantive but not directly affected by the LIBOR reform, and both benefit from the ASU 2022‑06 sunset being pushed to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FDX has experienced no material effect from ASU 2022-06 as of May 31, 2024, and continues to monitor LIBOR-related contracts; the sunset date for ASU 2022-06 is correctly stated as December 31, 2024. UPS maintains an active hedging program including cash flow and fair value hedges, and while it does not report material LIBOR-related impacts, it benefits from the extended relief. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' matches the ground truth, and there are no numerical calculations required beyond correct date reporting. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across FDX and UPS, contrasting FDX’s passive, minimal exposure with UPS’s active but currently unaffected hedging framework, and correctly infers that both benefit from the extended sunset provision. (4) The only minor deviation is that the original answer explicitly states UPS 'may benefit' from the extended relief to manage LIBOR-related contracts, while the LLM says UPS can apply expedients 'if needed'—a slightly more cautious phrasing but semantically consistent. The LLM also adds 'net-investment hedges' not mentioned in the original, which is plausible but not confirmed in the ground truth; this does not detract significantly from accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 405,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class system gives its controlling shareholder (Mark Zuckerberg) decisive voting power even though he owns far less than a majority of the total shares, and until Class B stock falls below about 35 % of the combined voting power many corporate actions require a separate Class B vote.  This limits the rights of other shareholders, can make Meta’s Class A shares less attractive and depress the stock price, and therefore weakens investor protections.  \n\nAlphabet’s (Google’s) structure also creates a voting‑power differential—each Class B share carries ten votes versus one for Class A—but the Class B shares may be converted at any time and automatically convert to Class A on any sale or transfer, so the extra voting power is lost when the shares change hands.  Because the voting premium is not permanent, Alphabet’s arrangement does not curtail investor protections to the same extent as Meta’s dual‑class setup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Meta's dual-class structure allows Mark Zuckerberg to maintain control with less than a majority of shares, and Class B shares retain voting power until they fall below 35% of combined voting power—this threshold is correctly stated. Alphabet's Class B shares have 10 votes vs. 1 for Class A, and automatically convert to Class A upon sale or transfer—this is accurately described. (2) Quantitative accuracy is perfect: the 35% threshold and 10:1 vote ratio are correct, with no calculation errors. (3) Multi-hop reasoning is sound: the answer correctly contrasts Meta’s enduring control mechanism with Alphabet’s temporary insider control due to conversion on transfer, and draws a valid conclusion about relatively weaker investor protections at Meta. (4) The only minor shortcoming is a slight omission in not explicitly stating that GOOGL’s conversion mechanism may lead to more eventual governance balance over time, which is in the original answer. However, the implication is clearly conveyed through the explanation of automatic conversion. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—every part of the question is addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 370,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO uses option contracts as cash‑flow hedges for its forecasted foreign‑currency and commodity transactions, designating the contracts so that gains and losses are recorded in other comprehensive income and only re‑recognized in earnings when the underlying transaction occurs—an approach that generally offsets the exposure and, per the filing, does not produce a material earnings impact (a practice mirrored by a peer’s $99 million deferred gain on $9.9 billion of net foreign‑exchange hedges). In contrast, MDLZ reports the net gains and losses on its forecasted transactions directly in the income statement, showing $106 million in cost of sales, $17 million in interest expense, a $8 million reduction in SG&A and a total impact of $1.949 billion in 2024, indicating a material effect on earnings. Thus KO’s strategy emphasizes risk mitigation and deferral of impact, whereas MDLZ’s disclosures reflect realized financial results that immediately affect earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states MDLZ's $106 million gain in cost of sales and $17 million in interest and other expense, it fabricates a '$8 million reduction in SG&A' and a 'total impact of $1.949 billion in 2024'—neither of which appear in the original answer or are supported by the ground truth. The $1.949 billion figure is entirely unsupported and represents a major factual error. Additionally, the reference to a 'peer’s $99 million deferred gain on $9.9 billion of net foreign-exchange hedges' is not mentioned in the original answer and introduces unverified data. (2) The original answer does not provide any total impact number or SG&A adjustment for MDLZ, nor does it mention KO having 'no material earnings impact'—this characterization, while plausible, is not directly supported by the provided ground truth. (3) Qualitatively, the LLM correctly identifies KO’s use of option contracts as cash flow hedges with gains/losses deferred in AOCI (referred to as 'other comprehensive income'), and contrasts this with MDLZ’s recognition of gains in specific income statement line items. This reflects sound multi-hop reasoning in comparing hedging strategies and financial statement treatment. (4) Contextually, the response is well-structured and directly addresses the comparative question about financial impact and hedging strategy. However, the inclusion of fabricated numerical data severely undermines factual reliability, warranting a moderate correctness score despite accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 435,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "TMO lists its domestic and non‑U.S. fixed‑income pension holdings ($739 m and $299 m) in the “not subject to leveling” column, meaning those funds are valued outside the fair‑value hierarchy and are not measured with Level 1, 2 or 3 inputs. BMY, on the other hand, classifies its fixed‑income funds as Level 2 and values them at the funds’ NAV using significant‑other‑observable inputs (quoted prices for similar instruments or market‑derived data). Thus BMY’s pension‑asset valuation for fixed‑income relies on observable market data, whereas TMO’s approach reflects little or no reliance on such data, using a practical‑expedient or other method that bypasses the hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the dollar amounts ($739M and $299M) for TMO's domestic and non-U.S. fixed-income pension holdings are correctly reported, and while these figures were not in the original answer, they are consistent with external data and do not contradict the ground truth; their inclusion adds detail without introducing error. (2) The entity accuracy is correct—TMO and BMY are properly identified, and their respective classifications ('not subject to leveling' vs. Level 2) are accurately attributed. (3) The reasoning is sound: the LLM correctly interprets 'not subject to leveling' as exclusion from the fair value hierarchy and contrasts it with BMY’s use of Level 2, which relies on observable inputs like NAV and quoted prices for similar instruments. This reflects proper multi-hop synthesis across the two companies’ valuation approaches. (4) Semantically, the conclusion—that BMY relies on observable market data while TMO does not—is identical in meaning to the original answer. The LLM adds specificity by mentioning NAV and 'practical expedient,' which are reasonable inferences consistent with accounting standards (e.g., ASC 820), making the explanation slightly more detailed than the ground truth without overreaching. The only reason for not scoring a 10 is that the original answer does not include the specific dollar amounts, and while they are likely correct, their presence introduces unverified granular data not confirmed in the knowledge graph; however, this does not detract from correctness. Overall, the response is factually accurate, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 466,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Both Lockheed Martin (LMT) and Boeing (BA) are subject to the Federal Acquisition Regulation (FAR) for their U.S. Government cost‑plus‑fixed‑fee contracts – the GD filing notes that FAR governs the allowability of costs and subjects contracts to audit. LMT’s 10‑K explains that FAR clauses give the government ownership of work‑in‑process and the right to terminate for convenience, so LMT recognizes revenue continuously over time as performance obligations are satisfied. BA’s 10‑K, however, says that under FAR‑governed contracts it is entitled to payment for work completed (or upon a termination‑for‑convenience event), meaning BA generally records revenue at the point work is finished or accepted, creating a later‑recognition timing compared with LMT’s continuous‑over‑time approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to a significant factual error in reasoning: the LLM incorrectly asserts that Boeing (BA) recognizes revenue at a point in time (upon completion or acceptance), while the ground truth states that both LMT and BA recognize revenue progressively over time under FAR-regulated cost-plus-fixed-fee contracts due to termination for convenience clauses. The LLM creates a false contrast between LMT’s continuous recognition and BA’s point-in-time recognition, which contradicts the original answer that both companies have a 'comparable revenue recognition pattern.' While the LLM correctly identifies relevant FAR provisions (e.g., termination for convenience, payment for costs plus profit), it misinterprets BA’s revenue recognition policy, likely misreading or misrepresenting the BA 10-K. This undermines the multi-hop synthesis required to compare the two companies’ practices accurately. Contextual relevance is high as the response addresses the core topic and cites appropriate contractual mechanisms, but the erroneous conclusion about timing differences invalidates the main claim. Thus, the correctness score is low (4) due to a major factual and reasoning flaw despite correct use of context and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 387,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s debt is set out in a series of supplemental indentures – Nos. 6 through 9 – dated September 26 2019, November 21 2019 and May 14 2020, each naming U.S. Bank National Association as the trustee (and, in several of the agreements, also as transfer agent and registrar). In contrast, Abbott Laboratories issues its notes through a separate issuing entity, Abbott Ireland Financing DAC; the original indenture (with U.S. Bank National Association as trustee) was dated September 27 2018, a first supplemental indenture was executed on the same day, a second supplemental indenture on November 19 2019, and additional notes (e.g., 1.150 % due 2028 and 1.400 % due 2030) were filed in 2020, giving a note‑issuance timeline that runs from 2018 through 2020. Thus, both companies rely on U.S. Bank National Association as trustee, but AbbVie’s agreements are direct and confined to a 2019‑2020 window, whereas Abbott’s structure uses Abbott Ireland Financing DAC as the issuer and spans a longer, staggered issuance period beginning in 2018.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core structure of AbbVie's debt agreements with U.S. Bank National Association as trustee under Supplemental Indentures 6 through 9, with accurate dates for Nos. 6 (September 26, 2019), 7 (November 21, 2019), and 8 and 9 (May 14, 2020). It also correctly notes U.S. Bank’s roles as trustee, transfer agent, and registrar. For Abbott Ireland Financing DAC, the LLM correctly identifies the September 27, 2018 Indenture and November 19, 2019 Second Supplemental Indenture with U.S. Bank as trustee. However, it introduces inaccuracies in the specific notes issued: it cites a '1.150% due 2028' and '1.400% due 2030' issued in 2020, which are not present in the ground truth. The ground truth specifies the 1.500% Note due 2026 and the 0.100% Note due 2024. These are significant factual errors in note terms and maturities. (2) Quantitative accuracy is partially compromised: while the dates of the indentures are correct, the interest rates and maturity years of the notes are incorrect. The LLM fabricates note details not supported by the original data. (3) The multi-hop reasoning is sound in comparing the two corporate structures—AbbVie’s direct supplemental indentures vs. Abbott’s use of a DAC issuer—and correctly identifies U.S. Bank’s recurring trustee role. It also captures the broader timeline difference (2019–2020 for AbbVie vs. 2018–2020 for Abbott). However, it omits the key detail that AbbVie uses Elavon Financial Services DAC as a paying agent via Agency Agreements, a distinguishing feature highlighted in the ground truth. This omission reduces completeness. (4) Despite these issues, the LLM answer is contextually relevant, well-structured, and conveys a largely accurate comparison. The core entities, dates, and structural differences are correct, warranting a score of 7 for correctness. Quantitative accuracy is docked due to incorrect note terms; qualitative accuracy remains high due to strong reasoning; contextual relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 542,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s 10‑K makes clear that the company’s entire fab supply chain rests on third‑party foundries being able to **deliver the most advanced geometry nodes (7 nm and below)** – any failure to develop or scale those small‑node processes would directly curtail NVIDIA’s product supply and margins. AMD, by contrast, also leans on TSMC (and other foundries) for its 7 nm‑and‑smaller designs **but its competitive edge hinges on those foundries’ ability to ship **larger‑diameter wafers** (i.e., increased wafer sizes) that can sustain high‑volume, cost‑effective IC production. Thus, while both firms share exposure to TSMC’s capacity and technology, NVIDIA’s risk is chiefly the **availability of the smallest‑node wafers**, whereas AMD’s risk is the **combined need for advanced nodes and larger‑wafer output** to keep its chips competitive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key entities—NVDA, AMD, TSMC, 7nm and smaller process nodes—are correctly identified, and there are no incorrect numbers, dates, or financial figures (quantitative accuracy is perfect as no specific numerical values were required). (2) The answer correctly captures the core distinction: NVDA’s primary dependency is on the availability of advanced process nodes (7nm and below), while AMD additionally emphasizes the importance of larger wafer sizes for cost-effective, high-volume production. This reflects accurate synthesis from both companies’ 10-K disclosures. (3) The multi-hop reasoning is sound—comparing NVDA’s node-centric risk to AMD’s dual reliance on node advancement and wafer size scaling—demonstrating proper cross-company analysis of supply chain dependencies on TSMC. (4) The only minor shortcoming is that the original answer more explicitly mentions shared risks (e.g., yield issues, supply shortages, increased costs, launch delays), which the LLM answer implies but does not fully enumerate. However, the semantic meaning and strategic insight are equivalent. Wording differences are acceptable and do not affect factual correctness. Contextual relevance is excellent as it directly addresses the comparative supply chain exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 374,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Philip Morris’s filing makes clear that Thailand’s customs‑valuation and tax rules for imported cigarettes are still being contested after a 2010 WTO panel decision and that the Thai government has not yet brought its practices into full compliance. Because Colgate‑Palmolive operates a major oral‑, personal‑ and home‑care manufacturing site in Thailand, any future change or stricter enforcement of those customs and tax rules would likely raise the duties and taxes on the raw materials and components the plant imports, driving up its cost of sales and forcing the company to devote additional resources to compliance. Accordingly, the unresolved WTO‑related customs‑valuation dispute creates heightened regulatory‑risk exposure for Colgate‑Palmolive in Thailand, as the firm could be subject to audits, penalties or sudden rule changes that affect its operations and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the WTO panel decision (2010 is correctly implied, though not explicitly stated in the original answer, it is consistent with known facts), Thailand's non-compliance, and the ongoing dispute due to the inoperability of the Appellate Body are contextually accurate. The LLM correctly identifies Colgate-Palmolive's manufacturing presence in Thailand. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or figures. (3) The multi-hop reasoning is sound: the model connects Philip Morris’s regulatory challenge to broader customs enforcement risks in Thailand and logically infers that Colgate-Palmolive, as a manufacturer importing raw materials, could face higher duties, compliance costs, audits, or penalties. This synthesis across companies and regulatory implications is appropriate and well-reasoned. (4) The LLM slightly enhances the original answer by specifying 'oral-, personal-, and home-care manufacturing site,' which is plausible and adds detail without contradicting the ground truth. The only minor gap is that it does not explicitly reference the 'regulatory inertia' or 'non-aligned customs enforcement' framing from the original, but the meaning is semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Faces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 415,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UnitedHealthcare’s stand‑alone Medicare Part D enrollment fell by 265 thousand members (from 3,315 K in 2023 to 3,050 K in 2024, an 8 % drop) — a change that coincides with the IRA‑driven redesign of Medicare Part D that took effect on 1 Jan 2024. The IRA redesign caps beneficiaries’ out‑of‑pocket costs, reduces catastrophic re‑insurance and imposes new manufacturer‑discount and rebate obligations, shifting cost pressure onto Part D plans and drug makers. Those same provisions are why Pfizer now expects a roughly $1 billion revenue loss in 2025, as it will have to provide the statutory 10 %/20 % discounts and inflation‑linked rebates on its Part D drugs. Thus, UNH’s enrollment decline and Pfizer’s projected loss are both direct outcomes of the IRA’s overhaul of Medicare Part D.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $265,000 decline in UNH's Medicare Part D enrollment, though it interprets this as 265 thousand members (265K), which is consistent with typical SEC filing reporting (e.g., 'in thousands'). The original answer states '$265,000 decline' which likely refers to a $265 million financial decline, not enrollment—this is a critical ambiguity. However, the LLM interprets it as a membership decline of 265,000 (from 3,315K to 3,050K), which aligns with real-world UnitedHealth 2023–2024 Part D enrollment data. This suggests the LLM correctly understood the intended meaning despite the original answer's likely typo (should be '265 thousand members', not '$265,000'). The 8% drop is accurate based on those numbers. The IRA's redesign effective January 1, 2024, is correctly cited (though major cost provisions like the $2,000 cap take effect in 2025). (2) The LLM accurately notes Pfizer's $1 billion revenue loss projection in 2025 due to IRA mandates—specifically the 10%/20% manufacturer discounts and inflation rebates—matching the ground truth. (3) The multi-hop reasoning is sound: it connects UNH’s enrollment drop (plan-level impact) with IRA policy changes and links the same policy to financial pressure on manufacturers like Pfizer. It correctly synthesizes how cost-shifting under the IRA affects both insurers and drug makers. (4) The only minor issue is the interpretation of '$265,000'—while the original answer likely meant a financial figure, the LLM treated it as enrollment, which is more contextually plausible and consistent with public data. This does not undermine the overall correctness. The answer is semantically equivalent, well-reasoned, and contextually precise. Hence, high scores across all categories with a 9 in correctness due to the slight ambiguity in number interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 504,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin’s 2024 balance sheet shows a **$4,863 million** investment in private‑equity funds that are measured at net asset value using the **NAV practical expedient** (Chunk 1 + Chunk 2). FedEx also applies the **NAV practical expedient**, but it does so to equity securities that do not have readily determinable fair values (Chunk 3). FedEx’s filing does not disclose a comparable dollar amount for those securities; it only notes that the unrealized gains‑and‑losses from the NAV‑valued equity holdings were immaterial (e.g., a $14 million gain in 2024). Thus, Lockheed Martin’s exposure is quantified at $4.86 billion, whereas FedEx’s use of the same accounting policy is described qualitatively with no specific amount disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, the $4,863 million figure for Lockheed Martin is accurately reported, and the reference to a $14 million gain for FedEx in 2024 is consistent with the data (though not in the original answer, it does not contradict it). The conversion to $4.86 billion is acceptable and accurate. (2) The LLM correctly identifies that both companies apply the NAV practical expedient: Lockheed Martin for private equity funds and FedEx for equity securities without readily determinable fair values. (3) The multi-hop reasoning is sound—comparing how each company applies the same accounting policy and noting differences in disclosure depth. (4) However, the LLM omits key qualitative details present in the original answer: specifically, that FedEx adjusts cost only for observable price changes and impairments, and that its cumulative and annual impairments are immaterial under the measurement alternative. It also misses that Lockheed Martin’s NAV-based investments are part of a broader portfolio including real estate and hedge funds. These omissions reduce completeness but do not introduce factual errors. The LLM instead focuses on the lack of disclosed dollar amount at FedEx and emphasizes immateriality of gains, which is contextually valid. Overall, the answer is factually accurate and relevant, with strong quantitative and qualitative performance, but slightly less comprehensive than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 422,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Both companies give their insiders a high‑vote “Class B” that can be turned into the lower‑vote “Class A,” but the effect on voting power is opposite.  \n\n*Comcast (CMCSA)* – Each Class B share carries 15 votes and, taken together, the Class B stock holds a fixed 33 ⅓ % of the company’s total voting power (the remainder belongs to Class A). The articles protect that 33 ⅓ % from dilution by new issuances, yet the Class B shares are **convertible, share‑for‑share, into Class A** (subject to restrictions). Because a Class A share’s vote count varies with the relative number of A and B shares outstanding, converting a B share into an A share reduces the holder’s votes per share and therefore dilutes the voting power of the converted shares.  \n\n*Alphabet (GOOGL)* – Class B shares have 10 votes each, Class A has one vote, and Class C has none. Class B may be converted to Class A at the holder’s option (and automatically on any sale or transfer). In 2024 Alphabet repurchased **$62.0 billion** of its Class A and Class C shares, retiring a large pool of low‑vote (A) and non‑voting (C) stock. By removing those shares, the proportion of total votes held by the remaining Class B shares **increases**, effectively concentrating voting power rather than diluting it.  \n\nThus, while Comcast’s conversion of Class B to Class A can **dilute** the voting influence of its high‑vote shares, Alphabet’s massive repurchase of low‑vote/Class C shares in 2024 works in the opposite direction, **enhancing** the relative voting power of its Class B holders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between CMCSA and GOOGL's voting structures and repurchase impact, showing strong contextual understanding and relevant synthesis. However, there are significant factual inaccuracies that reduce correctness. (1) The claim that CMCSA Class B shares carry '15 votes each' is incorrect — the ground truth states that Class B holds 33⅓% of total voting power collectively, not per share, and does not specify vote counts per share. This misrepresents the mechanism as per-share voting power rather than a fixed aggregate percentage. (2) The explanation of CMCSA's conversion causing dilution of the converted shares is misleading: the original answer emphasizes that the 33⅓% voting power is *non-dilutable*, meaning it is contractually protected regardless of conversions or new issuances; thus, conversion does not dilute the remaining Class B voting power. The LLM incorrectly suggests that conversion dilutes voting power, contradicting the non-dilutable provision. (3) The GOOGL portion is mostly accurate: Class B has 10 votes, Class A has 1, Class C has 0, and the $62.0 billion 2024 repurchase of Class A and C shares is correctly stated. The reasoning that this increases the relative voting power of Class B is sound and aligns with the original answer. (4) The multi-hop reasoning is strong in comparing mechanisms and repurchase effects, but flawed in the CMCSA analysis due to misinterpretation of the non-dilutable clause. (5) Wording and structure are clear and relevant, but quantitative inaccuracy on vote count and qualitative error on dilution mechanism limit overall correctness. The $62.0 billion figure is correctly cited, satisfying quantitative accuracy for that part.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 468,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s link to Cardinal Health is indirect – CVS and Cardinal each own 50 % of Red Oak Sourcing, LLC, a generic‑drug sourcing joint venture that negotiates contracts with Cardinal but does not hold inventory, and the filing does not disclose any specific revenue share that Red Oak contributes to CVS. By contrast, Eli Lilly (LLY) states that Cardinal Health is one of its three top U.S. wholesalers and accounts for roughly 15 %‑20 % of LLY’s consolidated revenue, a direct and material exposure that is explicitly quantified.  Hence, CVS’s exposure through Red Oak is indirect and unquantified, whereas LLY’s reliance on Cardinal Health is direct and represents a sizable 15‑20 % of its total revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS and Cardinal Health each own 50% of Red Oak Sourcing, LLC, a joint venture for negotiating generic drug contracts without holding inventory. LLY (Eli Lilly) relies on Cardinal Health as one of three top U.S. distributors, accounting for 15–20% of its consolidated revenue. These percentages match the original answer exactly. (2) Quantitative accuracy is perfect: the 15–20% revenue exposure for LLY is correctly cited, and the absence of specific revenue figures for CVS’s Red Oak stake is accurately noted as unquantified. No calculations were required, but the comparison in exposure type (indirect vs. direct) is sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies (CVS and LLY), their relationships with Cardinal Health, and the nature of those relationships (joint venture vs. distribution channel). It correctly infers that CVS’s exposure is indirect and not revenue-based, while LLY’s is direct and material. (4) The only minor shortcoming is that the LLM does not explicitly name McKesson and AmerisourceBergen as the other two distributors for LLY, which the original answer includes for completeness. However, this omission does not detract from the core comparison about Cardinal Health’s role. The answer remains semantically equivalent in meaning and highly relevant to the question. Thus, a score of 9 is justified—excellent accuracy with only a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 423,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s 2024 balance sheet lists Class B common stock (733 shares) (Chunk 1). The voting‑rights policy disclosed by Honeywell states that common shareholders receive one vote per share (Chunk 3), and the KG links UPS’s Class B shares to that same voting‑rights policy, so both UPS’s Class B shares and Honeywell’s common shares have one vote per share – a difference of 0 votes per share (the 10‑vote per‑share structure for Alphabet’s Class B shares in Chunk 2 shows that voting rights can differ across companies).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It falsely claims that UPS's Class B common stock has 1 vote per share by incorrectly linking it to Honeywell's voting policy via the knowledge graph, when in fact UPS's Class B shares have 10 votes per share as per standard public disclosures. (2) The quantitative error is severe: the correct difference is 9 votes per share (10 - 1), but the LLM reports 0, due to wrong input data. (3) The multi-hop reasoning fails: instead of retrieving UPS's actual Class B voting rights and comparing them to Honeywell's 1 vote per share, it erroneously assumes both have the same voting rights based on a flawed KG link. (4) The mention of Alphabet’s Class B shares is irrelevant and further distracts from the correct comparison. While the answer attempts to address the question structure and cites chunks, the factual basis is wrong, leading to a very low correctness score. Contextual relevance is slightly above zero because the entities (UPS, Honeywell, voting rights) are correctly identified, but the synthesis is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 303,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % 2024 notes were fully repaid by the end of 2024 (the table shows a $‑‑‑ notional amount for 2024 after a $1.4 billion balance in 2023).  Because the notes matured, the $1.4 billion of interest‑rate swap contracts that had been used to hedge those notes also matured and were terminated in 2024.  \n\nIn contrast, AbbVie’s 2024 filing shows that it still held interest‑rate swap contracts designated as cash‑flow hedges – the OCI table reports a $0 pre‑tax gain/loss for 2024, indicating the swaps remained in place rather than being unwound.  Thus, Amgen’s swaps ended with the note’s maturity, whereas AbbVie’s swaps continued to be used as cash‑flow hedges throughout 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with a major factual error regarding ABBV's interest rate swap contracts in 2024. (1) On the AMGN side, the answer is factually correct: the 3.625% 2024 Notes matured in 2024, leading to the termination of $1.4 billion in associated interest rate swaps. This aligns with the ground truth and is supported by the drop in notional amount from $1.4 billion in 2023 to zero in 2024. (2) However, the LLM incorrectly states that AbbVie 'still held interest-rate swap contracts designated as cash-flow hedges' in 2024, citing a $0 gain/loss in OCI as evidence. This contradicts the ground truth, which explicitly states that ABBV had $0 in active interest rate swaps designated as cash flow hedges in 2024 (compared to $6 million in 2022). A $0 gain/loss in OCI does not imply the presence of active swaps—it can result from inactive or expired hedges. Therefore, the conclusion that ABBV’s swaps 'continued to be used' is factually wrong. (3) The multi-hop reasoning is partially sound—comparing maturity-triggered termination at AMGN with ABBV’s hedging activity—but fails in synthesis because it misinterprets the absence of OCI activity as presence of contracts. (4) Quantitative accuracy is partially correct: $1.4 billion for AMGN is accurate, but the interpretation of ABBV’s $0 as ongoing activity is misleading. The answer is contextually relevant and well-structured, hence high relevance score, but the core factual error on ABBV’s 2024 hedge position significantly undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 426,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One adopted ASU 2022‑02 on January 1 2023, which eliminated the prior TDR accounting guidance and required the bank to accumulate and report financial‑difficulty modifications (FDMs) on a rolling twelve‑month basis; although the underlying modification types—principal forgiveness, interest‑rate reductions, other‑than‑insignificant payment delays, term extensions or any combination—did not change, the new FDM disclosures are not directly comparable to Capital One’s earlier TDR figures because the accounting and disclosure rules differ. By contrast, JPMorgan’s pre‑ASU disclosures treated similar concessions as TDRs (e.g., $362 million in 2022 and $866 million in 2021) without the rolling‑basis reporting and with only aggregate amounts and a note that no additional lending commitments were made. After the ASU change, JPM now reports FDMs with explicit financial effects—$136 million in 2023 FDMs, a 20‑year extension of the weighted‑average loan life and a reduction in the weighted‑average contractual interest rate from 7.21 % to 4.44 %—showing how the new guidance replaces the older TDR framework that both firms previously followed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-02 adoption date (January 1, 2023), elimination of TDR framework, introduction of FDMs, and the continuity of modification types (interest rate reductions, term extensions, principal forgiveness, etc.) are accurately described for both Capital One and JPMorgan. (2) Quantitative accuracy is excellent: the $136 million in FDMs for JPMorgan in 2023, the 20-year extension of loan life, and the reduction in weighted-average interest rate from 7.21% to 4.44% are all correctly reported. The prior TDR amounts for JPMorgan ($362M in 2022, $866M in 2021) are additional details not in the original answer but are factually consistent with pre-ASU reporting and do not contradict the ground truth. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how both firms transitioned from TDRs to FDMs, compares pre- and post-adoption reporting, and explains the change in disclosure practices (e.g., rolling twelve-month basis, non-comparability of TDRs to FDMs). (4) The only minor shortcoming is that the original answer emphasizes that the shift reflects a 'more standardized reporting approach'—a contextual nuance slightly underdeveloped in the LLM response—but this does not detract from factual correctness. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. All entities (Capital One, JPMorgan, ASU 2022-02, FDMs, TDRs) and years are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 415,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s 10‑K explains that its interest‑rate‑swap contracts are cash‑flow hedges whose “dollar‑weighted two‑year average maturity … generally matches the duration of the activities that are at risk” (Chunk 1). In contrast, UPS’s 10‑K states that its swaps are “intended to provide an economic hedge of portions of our outstanding debt,” are not designated as hedges for accounting purposes, and are periodically terminated or de‑designated without reference to a matching maturity schedule (Chunks 2 & 3). Thus, GD aligns swap maturities with the underlying exposure to achieve precise hedge‑accounting and duration matching, while UPS uses swaps mainly as a flexible, economic offset to debt exposure, reflecting a priority on overall debt‑risk mitigation rather than exact maturity alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GD uses interest rate swaps as cash-flow hedges with a dollar-weighted two-year average maturity that matches the duration of the underlying risk, which is explicitly stated in the original answer. UPS uses swaps as economic hedges without formal hedge accounting or maturity alignment, instead terminating or de-designating them to manage market valuation effects—this is accurately reflected. (2) There are no numerical inaccuracies; the only quantitative detail is the 'two-year average maturity' for GD, which is correctly reported and matches the ground truth. Format and meaning are preserved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both GD’s and UPS’s 10-Ks, contrasting their hedging strategies in terms of maturity alignment and accounting treatment, and infers their differing risk management priorities—duration matching vs. dynamic offsetting. (4) The LLM slightly simplifies the UPS rationale by not explicitly mentioning 'offsetting positions to terminate existing swaps and eliminate market valuation effects' but captures the essence in stating swaps are 'periodically terminated or de-designated' and used for 'flexible, economic offset.' This minor omission does not detract from the overall correctness. Semantic equivalence is maintained. Contextual relevance is perfect—directly addresses all parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Enables]-> ACCOUNTING_POLICY <-[Aims]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 419,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑back removed $62.2 billion of outstanding Class A (1‑vote) and Class C (no‑vote) shares. Because each Class B share carries ten votes and can be converted to Class A at any time, the reduction in the pool of voting Class A shares raises the proportion of total votes that the undiluted Class B shares hold – their relative voting power increases as fewer 1‑vote shares remain.  \n\nBy contrast, Comcast’s dual‑class structure gives each Class B share fifteen votes, but the articles of incorporation lock those shares at exactly one‑third (33 ⅓ %) of the combined voting power, a percentage that is “generally non‑dilutable” regardless of any repurchases of Class A or Class C stock.  \n\nThus, Alphabet’s buy‑backs can boost the effective voting weight of its Class B shares, whereas Comcast’s Class B voting power is fixed at 33 ⅓ % and does not change with share‑repurchase activity. (The KG links Class A and Class B securities across firms such as Alphabet and Meta, illustrating how changes in Class A affect the relative influence of the higher‑voting Class B shares.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Alphabet's $62.2 billion 2023 share repurchase targeted Class A and Class C shares; Class B shares have 10 votes and are undiluted; Comcast's Class B shares have 15 votes and a fixed 33 1/3% non-dilutable voting power. (2) Quantitative accuracy is perfect: the dollar amount ($62.2 billion) and voting power percentages (33 1/3%) match the original. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how repurchasing low/no-vote shares increases the relative voting power of high-vote Class B shares at Alphabet, while contrasting this with Comcast’s constitutionally capped voting structure that prevents such dilution effects. (4) The explanation is clear, logically structured, and adds contextual insight (e.g., convertibility of Class B to A, non-dilutable nature of Comcast’s structure) without introducing errors. Minor wording differences (e.g., 'non-dilutable' vs 'generally non-dilutable') do not affect factual correctness and reflect acceptable variation in expression. All parts of the question are addressed thoroughly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 331,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Rule 10b5‑1(c) trading plan at Disney authorizes the sale of **up to 372,412 shares** of Disney common stock and is set to **terminate on December 17, 2024** (with an early‑termination provision). Peggy Alford’s Rule 10b5‑1(c) plan at Meta, by contrast, authorizes the sale of **an aggregate of up to $1.2 million worth of Meta Class A shares** and will **terminate on November 15, 2025** (also subject to early termination). Both plans are governed by the same Rule 10b5‑1(c) affirmative‑defense framework, but Iger’s plan is share‑count‑based and ends about a year earlier, while Alford’s is dollar‑value‑based and runs for a longer period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412), dollar amount ($1.2 million), and termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are all accurately reported. Format variations (e.g., 'up to $1.2 million worth' vs 'up to $1.2M') are semantically equivalent and acceptable. (2) Completeness: The answer addresses all parts of the question—structure, number of shares, termination dates, and regulatory framework (Rule 10b5-1(c)). It also correctly contrasts the share-count-based vs. value-based nature of the plans. (3) Entity accuracy: Companies (DIS/Disney, META/Meta), individuals (Robert Iger, Peggy Alford), and regulatory rule (10b5-1(c)) are correctly identified. (4) Reasoning: The multi-hop comparison across two executives, companies, and plan structures is sound. The synthesis of differences in duration, structure (fixed shares vs. fixed value), and timing is logically presented. (5) Semantic equivalence: While wording differs slightly (e.g., 'aggregate of up to $1.2 million worth'), the meaning is identical to the original. The addition of 'early-termination provision' is a minor elaboration but does not contradict the ground truth. All key facts are preserved and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 368,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "CL’s equity awards (non‑qualified stock options) vest ratably over a three‑year period, so the related compensation cost is spread on a straight‑line basis throughout those three years. In contrast, PMI’s RSU awards vest in a single tranche on the third anniversary of the grant (a three‑year cliff), but the fair‑value cost is amortized over the restriction period with a weighted‑average recognition horizon of about 17 months, meaning PMI records most of the expense earlier than CL’s evenly‑spread three‑year expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, all numbers are correct: the three-year vesting for CL, the three-year cliff vesting for PM (referred to as PMI, which is a common shorthand for Philip Morris International), and the 17-month weighted-average recognition period for PM's unrecognized compensation cost are all accurately reflected. The $160 million figure is omitted, but the 17-month period is correctly stated, and this is a minor detail in context. (2) The answer correctly identifies CL's ratable vesting and straight-line expense recognition over three years, and PM's cliff vesting with accelerated expense amortization. (3) The multi-hop reasoning is sound: it contrasts the structural differences in equity awards and correctly infers the implications for compensation expense timing—CL spreads it evenly, while PM accelerates it, leading to earlier recognition. (4) The only minor shortcoming is that the LLM does not mention the specific triggering events (death, disability, age 58) that allow earlier expense recognition for PM, which is part of the original answer’s qualitative nuance. However, the key implication—that PM recognizes expense earlier due to amortization over a shorter weighted-average period—is clearly and correctly conveyed. The use of 'PMI' instead of 'PM' is acceptable as it refers to the same entity in context. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Vest]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 418,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory moves that strip away the ways the companies can set their products apart—plain‑packaging or standardized‑size rules in the EU and elsewhere, bans on menthol and other characterising flavours, and the large graphic warnings that leave little room for branding—force Philip Morris to reformulate and curtail its visual identity, which it says can drive down‑trading and blunt its ability to raise prices, especially in the EU and in markets such as Japan where government approvals already limit pricing flexibility.  Altria‑owned MO faces the same squeeze in the United States: State Settlement Agreements and a wave of state‑level flavour bans (e.g., California, New York, Illinois) prohibit outdoor and transit brand advertising, brand‑name sponsorships and the use of characterising flavours, eroding the distinctiveness of its brands and constraining the premium pricing it can command.  In both firms, the loss of product‑differentiation tools directly weakens brand equity and reduces pricing power in their key international and U.S. markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) All factual elements are correct: both PM and MO face regulatory restrictions on flavor and packaging that impair brand equity and pricing power. The LLM correctly identifies EU plain packaging and flavor bans affecting PM, including menthol and characterizing flavors, and notes advertising restrictions from State Settlement Agreements impacting MO. It also references specific markets (EU, Japan, California, New York, Illinois), which aligns with the original answer’s emphasis on key U.S. and international markets. (2) Quantitative accuracy is perfect—there are no numerical claims in the LLM answer that contradict the ground truth, and it avoids making unsupported figures (e.g., it omits the 8% EU illicit trade statistic but does not misstate it). (3) Multi-hop reasoning is sound: the model synthesizes regulatory impacts across geographies (EU, U.S. states), product features (flavors, packaging), and business outcomes (brand equity, pricing power) for both companies. The logic linking loss of differentiation to weakened pricing is coherent and supported. (4) The only reason for not scoring a 10 is a slight incompleteness: the original answer includes specific details such as menthol bans in Turkey and Brazil, proposed nicotine caps in Massachusetts, and FCTC guidelines, which the LLM omits. However, these are contextual enhancements rather than central facts, and the LLM captures the essential synthesis. Wording differs but semantic equivalence is strong. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 460,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is reflected in the accounting for its structured‑security portfolio: the company does not set an allowance for credit losses at acquisition, but later adjusts the allowance for credit losses and makes prospective yield‑adjustments whenever actual cash‑flows differ from the expected cash‑flows that already incorporate expected credit losses and pre‑payment assumptions (Chunk 1). MetLife’s filing confirms that those structured securities include residential‑mortgage‑backed securities (Chunk 2). By contrast, Bank of America’s RMBS holdings are Level‑3 instruments that are valued at fair value, and the firm discloses that changes in market yields, default rates, loss severities and especially pre‑payment speeds would materially swing the fair‑value of those positions (Chunk 3). Thus AIG measures exposure through allowance‑and‑yield adjustments to amortized cost, whereas BAC measures exposure through fair‑value valuation risk driven by market‑driven yield, default‑rate and pre‑payment changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's accounting treatment: no initial allowance for credit losses, with subsequent adjustments to both the allowance for credit losses and prospective yield adjustments based on revised expected cash flows that include credit losses and prepayment assumptions. It also correctly notes that these structured securities include RMBS, citing MetLife as confirmation (though MetLife is not part of the original question, this is a minor contextual addition, not a factual error). (2) For BAC, the LLM accurately states that RMBS holdings are Level-3 fair value instruments and that their valuation is sensitive to changes in market yields, default rates, loss severities, and prepayment speeds—aligning with the original answer’s emphasis on valuation risk from default and prepayment volatility. (3) The multi-hop reasoning is sound: it synthesizes AIG’s amortized cost approach with yield and credit loss adjustments and contrasts it with BAC’s fair value sensitivity to market dynamics. (4) The only minor shortcoming is the reference to 'MetLife’s filing' as a source for AIG’s RMBS inclusion, which is extraneous and potentially misleading (though the fact itself—that AIG’s structured securities include RMBS—is correct). This does not undermine the factual accuracy but slightly affects reasoning clarity. All financial concepts and entities (AIG, BAC, RMBS, yield adjustments, credit losses, prepayment speeds, default rates, fair value) are correctly identified and contrasted. No numerical inaccuracies exist—this is a qualitative comparison, and all descriptive metrics are consistent with the ground truth. Wording differs but semantic equivalence is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 484,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its cyber‑security developed technology—including its cloud‑security solutions—by applying a **multiperiod excess‑earnings (discounted‑cash‑flow) method**.  The approach estimates the present value of the cash flows the technology is expected to generate, subtracts the contribution of other assets and bases the asset’s useful life on the technology cycle and forecast cash flows (Chunk 1 & 2).  \n\nCisco does not value the technology; instead it **recognizes revenue from its Cloud Security product category** under ASC 606 by treating the offering as a single distinct performance obligation and recording revenue **ratably over the contract term** for SaaS and term‑license components (hardware and perpetual software are recognized upfront) (Chunk 3).  \n\nThus, Broadcom’s method is an asset‑valuation exercise that discounts future cash flows, whereas Cisco’s method is a revenue‑recognition practice that spreads sales revenue over time as the performance obligation is satisfied.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Broadcom uses the multiperiod excess earnings method under the income approach to value its developed cybersecurity technology, including cloud security, based on projected cash flows less contributions from other assets, with useful life determined by technology cycle and forecasts. Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single performance obligation for SaaS arrangements, consistent with ASC 606. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the original or LLM answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—correctly contrasting Broadcom’s asset valuation methodology with Cisco’s revenue recognition policy, synthesizing information across two different companies and financial concepts (valuation vs. revenue recognition). (4) The LLM adds slight clarification (e.g., mentioning hardware/perpetual software recognized upfront) that is consistent with Cisco’s revenue policy and enhances completeness without introducing error. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 359,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s 2025 proxy reports 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, and the filing links the two classes, indicating that the Class B shares carry a higher voting weight per share than the one‑vote Class A. Alphabet’s 10‑K makes this disparity explicit: each Class A share gets one vote, while each Class B share gets ten votes, concentrating control in the relatively few Class B shares held by insiders. As shown by the voting‑rights provisions for another dual‑class issuer (Chunk 2), high‑vote shares—whether Meta’s or Alphabet’s—can dominate key corporate‑governance decisions such as mergers, board elections and charter amendments even though they represent a modest portion of total shares outstanding.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly reports the exact numbers of shares outstanding for both META Class A (2,189,898,148) and Class B (343,761,117), matching the ground truth, earning full marks for quantitative accuracy. It also accurately states that GOOGL’s Class B shares have 10 votes per share versus 1 for Class A, which aligns with the original answer. However, the LLM mischaracterizes META’s voting structure: it claims Class B shares 'carry a higher voting weight per share' than Class A, which contradicts the ground truth stating that Class B shares only have voting rights in 'specified circumstances' and are not generally higher-vote shares. In reality, META’s Class B shares do not have enhanced per-share voting power under normal conditions—this is a key distinction from GOOGL, where Class B consistently has 10 votes. This error affects the qualitative accuracy, as it misrepresents the core mechanism of META’s dual-class structure and weakens the comparative reasoning. Despite this, the answer correctly identifies the broader governance implication—that high-vote shares can dominate decisions despite being a minority of total shares—and addresses the multi-hop aspect by comparing both companies’ structures in relation to corporate governance. The contextual relevance is high because it directly engages with the question’s focus on voting disparity, share counts, and governance influence. The answer would have been stronger with precise clarification of when and how META’s Class B shares exercise voting power, as specified in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 427,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling and distribution platform in Argentina is one of KO’s equity‑method investees, so every case of concentrate and syrup that FEMSA purchases in that territory is recorded in KO’s “net sales to equity‑method investees.”  Those sales rose to **$14.5 billion in 2021** (up from $13.0 billion in 2020) as the Argentine market recovered from COVID‑19 and, under KO’s **incidence‑based concentrate‑pricing model**, the price of the concentrates was tied to the bottler’s own pricing, channel mix and package‑mix, helping lift the overall equity‑method sales figure.  \n\nAt the same time, the Argentine market was a key driver of **Colgate‑Palmolive’s organic sales growth in Latin America**, which rose **8 % in 2021** (net sales up 7 %).  The region‑level organic growth was “led by Brazil, Mexico, **Argentina** and Colombia,” indicating that the same consumer demand that fuels FEMSA’s bottling volumes also supported CL’s stronger organic performance in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the multi-hop relationship between Coca-Cola FEMSA's operations in Argentina, KO's net sales to equity method investees, and CL's organic sales growth in Latin America. It accurately references KO's incidence-based concentrate pricing model and explains how bottler pricing and mix affect KO's revenue. It also correctly notes that Argentina was a key growth driver for CL in Latin America. However, there are key quantitative inaccuracies: the LLM states KO's net sales to equity method investees were $14.5 billion in 2021, while the ground truth is $14,471 million ($14.471 billion), which is close but presented with false precision. More significantly, the LLM claims CL's organic sales growth in Latin America was 8% in 2021, while the ground truth is 7.0% net sales increase (with organic growth implied but not explicitly stated as 8%). The 8% figure is incorrect and not supported by the original answer. 2) The dollar amount is approximately correct but rounded and presented as $14.5 billion instead of $14,471 million; this is acceptable within format variation, but the CL growth rate is factually wrong. The original answer specifies a 7.0% net sales increase, not 8%. There is no indication in the ground truth that organic growth was 8% or that net sales were up 7% (the LLM conflates these). 3) The reasoning is sound: the LLM correctly synthesizes that strong demand in Argentina benefits both FEMSA (boosting KO's concentrate sales) and CL's consumer products, and it links the pricing model to revenue impact. It captures the parallel growth effect across companies. 4) The contextual relevance is high—answer addresses all parts of the question, uses correct entities (KO, CL, Coca-Cola FEMSA, Argentina), and explains the contractual pricing model. The qualitative reasoning is strong, but the incorrect CL growth figure reduces quantitative accuracy. Correctness score is 7 due to core facts being right but significant error in a key percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 538,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Both Abbott and Merck rely on a net‑asset‑value (NAV) practical expedient to value their private‑equity‑type holdings, but the disclosures differ in detail and in the redemption constraints they describe. Abbott states that its private‑equity, private‑credit, private‑real‑estate and private‑energy funds are measured at NAV on a quarterly‑lag basis and that redemption rights vary – roughly half of the funds permit only weekly or monthly withdrawals with a 2‑ to 30‑day notice, the remainder allow daily redemptions, and some funds are illiquid and will return capital only through liquidation. Merck’s 10‑K likewise records alternative‑investment positions at NAV (the NAV column in its fair‑value table shows amounts for developed‑ and emerging‑market equities and real‑estate), but it does not specify redemption terms; under the typical partnership structures described in the UPS filing, such private‑equity interests are generally locked‑up until the end of a 10‑ to 15‑year partnership term. Thus, while both companies use NAV as the valuation method, Abbott provides explicit, more frequent redemption‑frequency disclosures, whereas Merck’s NAV‑based measurement is presented in aggregate and reflects the usual long‑term lock‑up of private‑equity funds.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states Abbott has $555 million in unfunded commitments and Merck has $382 million in NAV-based assets, but the LLM answer omits these specific figures entirely. Instead, it introduces unsupported details such as 'quarterly-lag basis' and redemption frequencies (weekly, monthly, daily) that are not present in the original answer and contradict the ground truth, which clearly states Abbott's funds 'cannot be redeemed' and will distribute only through liquidation from 2024 to 2033. Similarly, Merck's disclosures are misrepresented — while the LLM claims Merck reports NAV-based assets without specifying redemption terms, it fails to report the $382 million figure and incorrectly implies Merck's funds are private equity, whereas the original specifies 'private real estate and equity funds'. (2) The quantitative accuracy is low because key dollar amounts and timeframes are either missing or fabricated. The original answer's precise numbers ($555M, $382M) are critical for comparison, and their absence undermines the response. Additionally, the LLM invents redemption terms (daily, weekly) that are not in the source. (3) The multi-hop reasoning is partially sound — the model correctly identifies that both companies use NAV as a practical expedient and references UPS's 10-K to contextualize typical private equity lock-up periods. It also attempts to compare disclosure granularity. However, it fails to synthesize the core comparative insight from the ground truth: that Abbott faces longer liquidation timelines and greater unfunded commitments than Merck. Instead, it draws an incorrect contrast based on redemption frequency. (4) Contextual relevance is high because the answer addresses the valuation method (NAV), redemption restrictions, and cross-company comparison, aligning with the question’s intent. However, due to major factual errors and omission of key quantitative data, the correctness score is limited to 5 — partially correct but with significant inaccuracies affecting the validity of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 575,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s Separate Account assets are held in its wholly‑owned BlackRock Life Limited subsidiary and are expressly **legally segregated** – they are not subject to the claims of BlackRock’s general creditors and are recorded on BlackRock’s consolidated balance sheet together with an equal‑and‑offsetting Separate Account liability. AIG’s Separate Account liabilities are defined as the **contract‑holder account balances** that sit in those assets and, by policy, must be **equal and offsetting to total Separate Account assets**. Because the underlying assets are protected from other creditor claims, AIG can report liabilities that directly mirror the segregated asset pool, ensuring the liabilities are fully backed and insulated from claims arising from any other business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BlackRock’s Separate Account Assets are legally segregated and not subject to general creditor claims, recorded with equal and offsetting liabilities on its balance sheet; AIG reports liabilities equal to contract holder account balances in these assets, which must mirror the asset values. The answer correctly identifies the structural and accounting relationship between BlackRock’s asset reporting and AIG’s liability reporting. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages—however, the absence of any numerical inaccuracies supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly links BlackRock’s asset segregation and offsetting liability treatment to AIG’s obligation to report matching liabilities based on contract holder balances. The only minor shortcoming is that the LLM introduces a detail not in the original—namely, that the assets are held in 'BlackRock Life Limited'—which, while potentially true, is not present in the ground truth and adds unverified specificity. This does not impair correctness but slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how BlackRock’s management of Separate Account Assets impacts AIG’s liability reporting. Overall, the semantic meaning matches the original answer, with only minor addition of a subsidiary name not in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 438,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales as part of its net‑revenue because AbbVie is the “principal” seller to the end‑customer; the 50 % pre‑tax profit that belongs to Janssen is then booked as a cost of product sold (the cost‑sharing agreement also has Janssen bearing roughly 60 % of development costs while the profit‑and‑loss split is 50/50). In contrast, Johnson & Johnson – through its Janssen Biotech affiliate – holds the exclusive license to commercialize Imbruvica outside the United States and therefore drives the drug’s global rollout, recognizing the full non‑U.S. revenue on its books and sharing the resulting pre‑tax profit equally with AbbVie rather than treating those sales as a cost component. This shows AbbVie’s U.S. revenue‑recognition reflects a gross‑sale model with a cost offset for Janssen’s share, whereas J&J’s strategy is an exclusive, worldwide commercialization of the product outside the U.S. with profit sharing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AbbVie recognizes 100% of U.S. Imbruvica sales as net revenue, Janssen's 50% pre-tax profit share is treated as cost of goods sold, Janssen bears ~60% of development costs while AbbVie bears 40%, and both share pre-tax profits and losses equally. Outside the U.S., Janssen (under Johnson & Johnson) has exclusive commercialization rights and recognizes full non-U.S. revenue, sharing profits equally with AbbVie. (2) Quantitative accuracy is perfect: percentages (50% profit split, ~60% Janssen development cost share) match the original answer exactly. No calculation errors. (3) Multi-hop reasoning is sound—correctly synthesizes revenue recognition practices, cost-sharing, and commercialization roles across two companies and two geographies. (4) The only minor shortcoming is slight omission of the term 'co-exclusive commercialization model' and less emphasis on how Janssen leverages its international infrastructure for global expansion, which is mentioned in the original. However, the core meaning and factual content are semantically equivalent. Wording differs slightly but meaning is preserved. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 361,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict over Taiwan would strike at the core of both companies’ supply chains. For NVIDIA, the 10‑K warns that its foundry partners – most of which are located in Taiwan – could lose lead‑time and capacity, leaving the company unable to secure enough chips, to fill orders on time or to meet demand, which would erode revenue, market share and gross‑margin performance. At the same time, Apple’s 10‑K notes that a large share of its device assembly is outsourced to contract manufacturers in Taiwan; a sustained geopolitical disruption would interrupt those factories, raise component‑costs, force supplier re‑sourcing and delay product shipments, creating material adverse effects on Apple’s manufacturing operations and earnings. Thus, the Taiwan‑based dependency chain (NVDA → foundry partners → Taiwan ← Apple) makes both firms vulnerable to the same geopolitical shock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: NVIDIA's dependency on Taiwanese foundry partners for advanced chip manufacturing and Apple's reliance on contract manufacturers in Taiwan for device assembly are accurately represented. The consequences—production delays, increased costs, supply chain reconfiguration, revenue impact—are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing any. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across both companies' 10-K disclosures, identifying the shared geographic risk in Taiwan despite different roles in the supply chain (NVIDIA as fabless relying on foundries, Apple relying on assembly). The conceptual 'dependency chain' visualization is insightful and semantically valid. (4) Minor deduction in qualitative accuracy due to slightly stronger phrasing—'erode revenue, market share and gross-margin performance'—which extends beyond the original answer’s 'reduce revenue' and 'damage customer relationships'; while reasonable, this adds nuance not explicitly in the ground truth. Otherwise, the answer is contextually excellent, directly addressing both parts of the question with precise, relevant, and logically structured information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 400,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income holdings are valued with pricing models that draw only on **verifiable observable market data** – such as interest‑rate and yield‑curve levels, quoted credit spreads and broker or dealer bids on comparable securities – and the filing does not note any extra risk‑adjustment step. Honeywell, by contrast, also uses pricing models (along with broker bids and comparable quotes) for corporate bonds and government securities, but its disclosure states that those models **include adjustments for risks that may not be observable**, specifically credit‑ and liquidity‑risk adjustments. Thus, both firms rely on observable inputs, but HON adds explicit non‑observable risk adjustments that LMT’s description does not mention.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that LMT uses pricing models based solely on verifiable observable market data—such as interest rates, yield curves, credit spreads, and broker bids—without mentioning additional risk adjustments. It correctly contrasts this with HON, which uses similar observable inputs but explicitly includes non-observable adjustments for credit and liquidity risks. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial concepts (e.g., Level 2 inputs, risk adjustments) are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), their respective use of pricing models, and the distinction in risk adjustment practices. (4) The answer is contextually precise, directly addressing the comparison in terms of observable inputs and risk adjustments. Wording differs slightly but preserves and conveys the exact same meaning as the ground truth, with enhanced clarity. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 356,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola said that in 2024 a stronger U.S. dollar created an **unfavourable foreign‑exchange drag on its Europe, Middle East and Africa (EMEA) segment**.  The stronger dollar was one of the drivers of an 11 % hit to consolidated operating income and a 5 % decline in consolidated net‑operating revenue, both of which were felt in the EMEA region.  However, the impact was **partially offset** because the dollar was weaker versus the euro and the British pound, giving a modest favourable offset to the segment’s results.  \n\nMondelez describes the same macro‑condition in broader terms: a **stronger U.S. dollar “adversely affects our consolidated earnings and net assets,”** and while the company uses derivatives to hedge a large portion of its currency exposure, it acknowledges that it **cannot fully eliminate the volatility**.  \n\nThus, Coca‑Cola’s EMEA segment experienced a net negative but partially mitigated effect from the stronger dollar, whereas Mondelez flags the stronger dollar as an overall adverse exposure that remains a residual risk despite hedging.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that Coca-Cola experienced an 11% unfavorable impact on consolidated operating income due to foreign exchange rates in 2024, which matches the original answer. It also mentions a 5% decline in consolidated net operating revenue, which is not explicitly stated in the ground truth but does not contradict it and may reflect additional context from the filing; this minor addition does not detract from accuracy. (2) The entity identification is correct: Coca-Cola (KO) and Mondelez (MDLZ) are accurately referenced with correct tickers, and the time period (2024) is correct. (3) The reasoning is sound: the LLM correctly synthesizes that the stronger U.S. dollar negatively affected KO’s EMEA segment, with partial offset from the euro and British pound, and compares this to MDLZ’s broader macro-level risk disclosure about currency translation effects. (4) The comparison between KO’s quantified impact and MDLZ’s emphasis on residual risk despite hedging is semantically equivalent to the original answer. The only minor gap is that the LLM slightly expands on KO’s revenue impact (5%) not explicitly in the ground truth, but this does not introduce error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Impacted_By]-> MACRO_CONDITION <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 374,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO’s FY 2024 balance sheet shows $365 million of long‑lived assets in Taiwan – a concrete, $‑valued stake in the island. In QCOM’s 10‑K, however, the company warns that its ability to obtain consistent chipset supply from its foundry partners—most of which operate in Taiwan—could be sharply curtailed by the current China‑Taiwan geopolitical tensions, a risk that could have a material adverse impact on its business. Thus, while AVGO’s exposure is measured by a $365 million asset investment, QCOM’s exposure is operational, hinging on the reliability of Taiwanese supply chains that could be disrupted regardless of any asset size.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AVGO's $365 million in long-lived assets in Taiwan for fiscal 2024 and accurately reflects QCOM's risk disclosure regarding its reliance on Taiwanese foundry partners. All factual elements—company exposures, nature of risk (asset-based vs. supply chain), and geopolitical context—are correctly conveyed. (2) Quantitatively, the $365 million figure is accurately reported with acceptable formatting (e.g., $365 million vs $365M). No calculations were required, and all numbers match the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from AVGO’s balance sheet (asset exposure) and QCOM’s 10-K risk factors (operational dependency), drawing a valid contrast between physical asset presence and supply chain vulnerability. The logic aligns with the original answer’s core insight. (4) The only minor shortcoming is a slight lack of emphasis on the phrase 'materially impacting QCOM’s business'—while the LLM mentions 'material adverse impact,' it could have more explicitly mirrored the severity language from the original. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong cross-document synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 363,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s 10‑K makes clear that “substantially all” of its product manufacturing is outsourced to partners in Asia — including Taiwan, which is part of its “Greater China” segment (Chunk 2).  Because Apple relies on single or limited sources in Taiwan, any political event, trade dispute, war or other disruption in that region can directly raise component costs, delay assembly and hurt margins (Chunk 1).  Microsoft, by contrast, serves Greater China from a regional operations centre in Singapore (Chunk 3), giving it geographic separation and the ability to shift among multiple contract manufacturers; this buffers Microsoft from a direct Taiwan‑specific shock, although it still faces broader regional geopolitical risks.  Consequently, Apple’s heavy reliance on Taiwan makes its supply chain more exposed to Taiwan‑related geopolitical risk than Microsoft’s Greater China business, which is managed from Singapore and enjoys greater sourcing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Apple relies on outsourced manufacturing in Asia, including Taiwan, which is part of its Greater China segment, increasing its exposure to geopolitical risks such as trade disputes, political instability, or war. It also accurately notes Microsoft's use of a regional operations center in Singapore to support Greater China, which reduces its direct dependence on localized manufacturing in high-risk areas. (2) There are no numerical values, dates, or financial figures in either the question or answers that require verification; thus, quantitative accuracy is not applicable in a traditional sense, but all referenced facts (e.g., 'substantially all' manufacturing outsourced) are consistent with Apple's 10-K disclosures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s supply chain structure and Microsoft’s operational model, drawing a valid comparative conclusion about differential exposure to geopolitical risk. The only minor shortcoming is a slight oversimplification in stating Microsoft can 'shift among multiple contract manufacturers'—while plausible, this detail isn't explicitly confirmed in the ground truth, making the reasoning slightly less substantiated than it could be. (4) The answer is contextually precise, directly addressing the comparative geopolitical risk exposure between Apple and Microsoft based on their operational footprints. Overall, the response conveys the same core message as the original answer with strong factual grounding and logical flow, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 456,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut – which affected Union Pacific’s operations in the state (e.g., its North Platte yard) – was part of a package of state‑level rate reductions that lowered UNP’s deferred tax expense by **$114 million** for the year. By contrast, Boeing’s 10‑K only warns that **delays in U.S. government appropriations** could hurt its defense‑related business and cash flow, but it does not assign a specific dollar amount to that risk. Thus, UNP’s tax‑rate change produced a quantifiable $114 million reduction in deferred tax expense, whereas Boeing’s exposure to appropriations delays remains a qualitative, un‑measured risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 corporate tax rate cut, matching the ground truth in both amount and context. It accurately contrasts this with Boeing's qualitative disclosure about federal appropriations delays without assigning a dollar amount, which aligns with the original answer. (2) All numeric values are correct: the $114 million figure is accurately reported, and no incorrect calculations are made. The LLM correctly refrains from quantifying Boeing’s risk, as the original answer does not provide a number. (3) The multi-hop reasoning is sound: the model synthesizes information from two separate 10-K filings (Union Pacific and Boeing), correctly attributing state-level tax benefits to UNP and federal funding risks to Boeing. It draws a logical comparison between a quantifiable financial impact (UNP) and a qualitative risk disclosure (Boeing). (4) The only minor shortcoming is that the LLM does not explicitly mention that the disclosures were made in the 2024 10-K filings (for the 2023 fiscal year), though this is implied. Otherwise, the answer is factually complete, contextually accurate, and semantically equivalent to the ground truth. Hence, high scores across all categories with a 9 on correctness due to slight omission of filing year detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Introduces]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 382,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Amgen’s U.S. patents on Enbrel do not run out until 11 / 22 / 2028 (fusion‑protein composition), 4 / 24 / 2029 (DNA‑encoding and manufacturing methods) and 10 / 19 / 2037 (formulation claims), giving that competitor a decade‑plus window of exclusivity. Merck’s 10‑K notes that loss of patent protection “promptly” invites generic or biosimilar substitutes and can materially hurt sales, cash flow and valuation, so the company “actively protects its patent rights.” Because Enbrel will remain protected for many years, Merck is likely to double‑down on extending and defending its own patents—through continuation‑in‑part filings, regulatory extensions, or next‑generation product development—to preserve exclusivity and blunt the competitive surge that will arise as Enbrel’s patents eventually expire.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all Enbrel-related patent expiration dates: 11/22/2028 (fusion protein composition), 4/24/2029 (DNA encoding and manufacturing methods), and 10/19/2037 (formulation claims), matching the ground truth exactly. It also accurately reflects MRK's strategic stance from its 10-K, noting that loss of patent protection leads to generic/biosimilar competition and harms sales, cash flow, and valuation, and that MRK actively protects its patent rights.\n\n2) Quantitative accuracy is perfect: all dates are correct and properly attributed. No calculations were required, but the timeline interpretation (a decade-plus window of exclusivity) is reasonable given the 2028–2037 span.\n\n3) The reasoning is sound and multi-hop: it connects Enbrel’s patent timeline (Amgen’s product) to Merck’s strategic incentives in the competitive biopharmaceutical landscape. It correctly infers that because Enbrel remains protected for years, Merck has both time and motivation to strengthen its own patent portfolio via continuation-in-part filings, regulatory extensions, or next-gen products—aligning with the ground truth’s emphasis on robust patent defense as a strategic imperative.\n\n4) The only minor shortcoming is that the LLM answer slightly overemphasizes Merck 'doubling down' as a forward-looking inference, while the original answer more neutrally frames it as 'reinforcing emphasis' based on stated 10-K risk factors. The LLM adds a small degree of strategic speculation (e.g., 'blunt the competitive surge') not explicitly in the ground truth, though it is logically consistent. This does not constitute an error but a slight difference in tone and certainty.\n\nOverall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across entities (AMGN, MRK), patents, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 502,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "- AMD reported $2,091 million of sales to external customers in Taiwan for 2022 (its revenue from operations in that market).  \n- Apple’s 2022 net‑sales for the Greater China segment – which the filing defines as “China mainland, Hong Kong and Taiwan” – were $74,200 million.  \n\nBecause Apple’s $74.2 billion figure includes Taiwan (along with mainland China and Hong Kong), Apple’s revenue tied to the region is roughly thirty‑five times larger than AMD’s Taiwan‑only revenue. This disparity indicates that Apple has a far stronger market presence in Greater China (including Taiwan) than AMD does in Taiwan alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports AMD's 2022 revenue from Taiwan as $2,091 million and Apple's 2022 Greater China net sales as $74,200 million, both of which match the ground truth. The comparison stating Apple's revenue is 'roughly thirty-five times larger' is accurate (74,200 / 2,091 ≈ 35.5), so the calculation and rounding are reasonable. 2) All numeric values are correct and properly formatted; minor variation in presentation (e.g., $74.2 billion vs $74,200 million) is acceptable and does not affect accuracy. 3) The reasoning correctly acknowledges that Apple's figure includes Taiwan as part of a broader region (Greater China), and thus a direct one-to-one comparison is limited. It appropriately infers relative market presence despite this aggregation. However, it slightly overreaches by implying a direct comparison between AMD's Taiwan-only revenue and Apple's entire Greater China revenue as a measure of 'market presence in Greater China', without fully emphasizing that AMD's exposure is limited to Taiwan while Apple's is regional. The original answer more carefully notes that we cannot isolate Taiwan's contribution within Apple's data. 4) Despite this nuance, the LLM answer captures the core insight: Apple's scale in the region vastly exceeds AMD's Taiwan-specific revenue, suggesting a much larger regional footprint. The response is contextually relevant, factually sound, and synthesizes multi-hop information (two companies, two geographic scopes, one year) correctly. The only minor shortcoming is the lack of explicit caution about comparing a country-level figure (AMD in Taiwan) to a multi-country segment (Apple’s Greater China), which slightly affects qualitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 475,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can retire large amounts of its non‑voting Class C capital stock – it repurchased $62.2 billion of Class A and Class C shares in 2023 and has authority to buy back another $70 billion (with $36.3 billion still available) – without any impact on voting control because Class C shares “has no voting rights” (KG: GOOGL → Class C Capital Stock → Voting Rights → NFLX). This lets Alphabet allocate cash to buybacks flexibly while preserving the voting power held by its Class A and B shares. Netflix’s common stock, by contrast, gives every share “one vote per share” (uniform voting rights), so any repurchase reduces the total voting pool and can affect shareholder influence, making its buy‑back strategy less free of governance considerations than Alphabet’s non‑voting‑share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies that Alphabet repurchased $62.2 billion in Class A and C shares in 2023 and had $36.3 billion remaining under the authorization — matching the original answer. However, it incorrectly states the total authorization as $70 billion (implying $62.2B used + $36.3B remaining = $98.5B total, which contradicts the $70B figure), introducing a minor quantitative inconsistency. The correct total authorization should be approximately $98.5 billion, though this total isn't explicitly stated in the ground truth. (2) The entity identification is accurate: Alphabet, Netflix, Class C shares, voting rights structure, and correct years are used. (3) The reasoning is sound: the model correctly synthesizes the multi-hop concept that repurchasing non-voting shares allows capital return without diluting control, whereas uniform voting rights at Netflix mean buybacks affect the voting pool. (4) Semantic equivalence is strong — the LLM explains the governance implications clearly and accurately, with only the minor error in inferring the total authorization amount preventing a perfect score. Contextual relevance is excellent, directly addressing the comparative capital allocation flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Lacks]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 362,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s 2024 RMBS portfolio shows $12.6 billion of pass‑through mortgage‑backed securities, of which $1.699 billion (5 % of the total) are non‑agency “NQM and Alt‑A” loans.  Those pass‑through securities carry a net unrealized loss of $1.294 billion for the year.  By contrast, AIG does not disclose a specific dollar amount for its mortgage‑related holdings, but its 10‑K warns that a sizable portion of its investment portfolio – including mortgage loans and other real‑estate‑linked securities – is illiquid and difficult to value, creating liquidity risk if those assets cannot be sold or accurately priced.  In short, MET’s exposure is quantified and already reflected in a $1.294 billion unrealized loss on $1.699 billion of non‑agency pass‑through assets, whereas AIG’s risk is more qualitative, centering on the uncertainty and potential cash‑flow impact of valuing and liquidating illiquid mortgage‑related investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: MET's $12.6 billion in pass-through MBS (matches $12,567 million, rounded appropriately), $1.699 billion in non-agency NQM and Alt-A loans, and $1.294 billion in unrealized losses—all align with the original answer and are correctly attributed to 2024. The percentage (5%) is a reasonable approximation (1.699 / 12.567 ≈ 13.5%, but this appears to be an error; however, the LLM likely miscalculated or misstated the percentage—this is the only quantitative issue). (2) Entity accuracy is strong: MET and AIG are correctly identified, with correct metrics and years. The mention of AIG’s lack of specific dollar disclosure but presence of qualitative risk in its 10-K is accurate and contextually appropriate. (3) Multi-hop reasoning is sound: the model correctly contrasts MET’s quantified, marked-to-market exposure with AIG’s more qualitative liquidity and valuation risks, synthesizing information across both companies’ disclosures. (4) Semantic equivalence is maintained—though wording differs, the core meaning, risk comparison, and factual basis are preserved. The only minor flaw is the incorrect percentage (5% instead of ~13.5%), which does not affect the overall correctness of the exposure comparison but slightly undermines quantitative precision. This justifies a 9 on correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy except for the percentage error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Secured By]-> FIN_INST <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 417,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia‑Pacific segment generated **$5.291 billion in total net operating revenue** (the “Asia Pacific” column in its 10‑K table). Because Coca‑Cola’s business is essentially all‑beverage, that figure represents the company’s **beverage‑only contribution in the region** (i.e., ≈ 100 % of APAC revenue).\n\nPepsiCo’s 10‑K shows that, for the same year, **only 20 % of its Asia‑Pacific sales came from the beverage segment** (the remaining 80 % were from convenient‑food products). The filing provides the percentage but not the dollar amount.\n\n**Comparison:** Coca‑Cola’s APAC beverage revenue was $5.3 billion and comprised the entire APAC revenue, whereas PepsiCo’s beverage business contributed just 20 % of its APAC revenue. Thus, Coca‑Cola’s beverage contribution in Asia‑Pacific was both a larger absolute amount and a much higher share of regional sales than PepsiCo’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported revenue figure for Coca-Cola's Asia Pacific segment. The ground truth states that Coca-Cola generated $4,682 million (i.e., $4.682 billion) in third-party beverage revenue from APAC in 2021, but the LLM claims $5.291 billion in total net operating revenue. This overstates the actual figure by more than $600 million. While the LLM correctly notes that Coca-Cola's business is primarily beverage-focused (so regional revenue ≈ beverage revenue), the dollar amount is incorrect. (2) The LLM correctly reports that PepsiCo derived 20% of its APAC revenue from beverages, which matches the ground truth. However, it does not mention that the exact dollar amount for PepsiCo’s APAC beverage revenue is not disclosed—this omission reduces completeness. (3) The multi-hop reasoning is partially sound: the model correctly contrasts the structure of the two companies’ reporting and infers that Coca-Cola’s APAC revenue is effectively all beverage-related, while PepsiCo only allocates 20% to beverages. However, the use of an incorrect base figure for KO undermines the comparison. (4) The contextual relevance is high—the answer addresses the core question about revenue contribution comparison and correctly identifies the key difference in business mix. The qualitative reasoning about segment composition and reporting differences is accurate and insightful, despite the numerical inaccuracy. Thus, the correctness score is reduced primarily due to the incorrect dollar figure, which affects quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 441,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Under the Gilead‑Merck long‑acting HIV collaboration the companies split development and commercialization costs 60 %/40 % (Gilead/Merck) and share product revenue 50/50 until the oral combo exceeds $2 billion or the injectable combo exceeds $3.5 billion in net sales; once those thresholds are passed Gilead’s share rises to 65 % and Merck’s falls to 35 % of the incremental revenue. By contrast, Merck’s Keytruda patent‑license agreement obligates it to pay royalties of 6.5 % of global sales through 2023 and 2.5 % from 2024‑2026, with the royalty split 75 % to BMS and 25 % to Ono. Consequently, the Gilead deal can deliver a larger upside for Merck—potentially up to half of sales (or 35 % of sales above the thresholds) but only if the HIV products achieve blockbuster levels—whereas the Keytruda royalty imposes a modest, predictable margin drag on a high‑volume product; Merck’s overall profitability is further buffered by the 20 %‑24 % royalty it receives from BMS on the Reblozyl collaboration (which generated $212 million of alliance revenue in 2023), partially offsetting the Keytruda royalty cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the 50/50 revenue split between Gilead and Merck for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales, after which Gilead’s share increases to 65% (Merck’s to 35%). It correctly states Merck’s royalty obligations to BMS and Ono: 6.5% through 2023 and 2.5% from 2024–2026, with BMS receiving 75% of those payments. It also correctly includes the $212 million in 2023 alliance revenue from Reblozyl and the 20–24% royalty Merck receives from BMS. (2) All numbers, percentages, and dollar amounts match the ground truth exactly. Format variations (e.g., $2 billion vs $2.0 billion) are acceptable and semantically equivalent. Calculations are not required beyond reporting, and all reported figures are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three distinct partnerships (Gilead-Merck, Merck-BMS/Ono for Keytruda, and Merck-BMS for Reblozyl), correctly contrasting revenue-sharing versus royalty-payment dynamics. The conclusion about Merck’s profitability—highlighting upside potential from Gilead collaboration, margin drag from Keytruda royalties, and partial offset via Reblozyl royalties—is logically derived and aligns with the ground truth implications. (4) The only minor deviation is that the LLM adds a detail not in the original answer—specific cost-sharing (60%/40%)—which, while plausible, is not present in the ground truth. However, since the question focuses on revenue-sharing and royalty obligations, and this addition does not contradict or distort the core answer, it does not significantly impact correctness. All other elements are semantically equivalent and fully accurate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Pays]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 520,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "Bank of America’s 10‑K shows that the corporation “administers, structures or invests in … CDOs” that are VIE‑backed securities whose cash‑flows are split into tranches and whose risk is transferred by embedded credit‑default‑swap‑like derivatives. The filing does not quantify any loss from those CDOs – it only discloses a “maximum loss exposure” that would arise only if the underlying assets became worthless, and no 2024 loss is reported. By contrast, AIG’s 2024 results include a realized $75 million loss on “Embedded derivatives” (which include credit contracts), a loss that was triggered when a credit event affected the reference entities underlying those derivatives. Thus, while both institutions’ exposures hinge on credit events, BAC’s CDO investment represents a potential, un‑realized risk measured only by a maximum‑loss estimate, whereas AIG’s exposure materialized as a $75 million loss in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: AIG's $75 million loss in 2024 is accurately reported, and the absence of a realized loss for BAC is correctly noted. There are no calculation errors. (2) The LLM correctly identifies that BAC invests in CDOs with embedded credit default swap-like derivatives and tranche structures, and that AIG reported a realized $75 million loss from embedded derivatives in 2024—both consistent with the original answer. (3) The reasoning is sound: it distinguishes between BAC’s potential (unrealized) exposure, measured as maximum loss, and AIG’s actual realized loss, which was triggered by a credit event. This reflects correct multi-hop synthesis across institutions and instrument types. (4) The answer adds precision not in the original—citing VIE-backed structures and clarifying that BAC’s 10-K reports only maximum loss exposure, not a realized loss—enhancing factual depth. The only minor shortcoming is that it doesn’t explicitly mention the cascading risk through tranches affecting senior investors like BAC, which is a nuance present in the original. However, the core financial mechanism and comparative risk exposure via credit events are correctly conveyed. Wording differs but semantic meaning is equivalent or superior in clarity. No factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 384,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is listed as a financial‑institution party to 3M’s May 2023 Five‑Year Credit Agreement (the filing simply incorporates the agreement and the KG links the agreement to Citibank, but does not give it the title of “administrative agent”). In the Caterpillar credit facilities dated September 2022, Citibank, N.A. is expressly named “Agent” (the 3‑year and 5‑year facilities both state “Citibank, N.A., as Agent”), which makes it responsible for the day‑to‑day administration of the loans, coordination with the local‑currency agents and overall lender communication— a role that mirrors its administrative‑agent function in other agreements such as Boeing’s Five‑Year Credit Agreement (where it is also identified as the administrative agent). Thus, Citibank’s involvement with 3M is limited to being a participant/lender, whereas with Caterpillar it carries full administrative‑agent responsibilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding Citibank, N.A.'s role in 3M’s May 2023 Five-Year Credit Agreement. The ground truth states that Citibank, N.A. serves as both an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with clear administrative responsibilities. However, the LLM incorrectly claims that Citibank is only a 'financial-institution party' and 'participant/lender' without the title of administrative agent, directly contradicting the verified knowledge graph data. This undermines the core of the multi-hop comparison. In contrast, the LLM correctly identifies Citibank, N.A.'s role as 'Agent' in Caterpillar’s September 2022 credit facilities and accurately describes its administrative responsibilities, including coordination with local currency agents. The dates (May 2023, September 2022) and entity names (Citibank, N.A., 3M, Caterpillar) are correct, satisfying quantitative and entity accuracy. However, the reasoning fails on the critical multi-hop element: the comparison of administrative responsibilities across the two agreements is flawed because it misrepresents Citibank’s role at 3M. The conclusion that Citibank has 'full administrative-agent responsibilities' at Caterpillar but only a limited role at 3M is therefore incorrect, as Citibank does hold shared administrative responsibilities at 3M. While the LLM attempts relevant contextual analysis (e.g., referencing Boeing as a comparator), the foundational error in one half of the comparison severely limits the answer’s correctness. Semantic equivalence is not achieved due to this key factual discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 449,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO relies on option contracts as a focused cash‑flow hedge to offset its foreign‑currency liabilities, treating the contracts as designated hedging instruments whose gains and losses are deferred in AOCI and recognized when the underlying liability changes—a practice that mirrors Disney’s use of option and forward contracts to protect foreign‑currency assets and liabilities and to record deferred gains in AOCI. PepsiCo, by contrast, manages foreign‑exchange risk through a broader program that includes a mix of derivatives (including options and forwards), forward contracts, and operational initiatives such as productivity improvements and global‑purchasing programs to hedge assets, liabilities and net investments, and it discloses its foreign‑currency liabilities as part of that overall risk‑management framework rather than isolating option contracts as the primary tool. Thus, KO’s approach is instrument‑specific and accounting‑driven, while PepsiCo’s strategy is more comprehensive, integrating hedging with broader operational controls to mitigate the impact on its foreign‑currency liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies and irrelevant information that undermine its overall correctness. (1) Quantitatively, the answer does not include any incorrect numbers per se—there are no specific figures mentioned that contradict the ground truth (e.g., PEP’s 1.5 percentage point revenue impact or 44% international revenue are not misstated), so quantitative accuracy is acceptable. However, it fails to mention the key quantitative disclosures from the original answer: PEP’s 1.5 percentage point negative impact on net revenue in 2024 and that 44% of PEP’s revenue comes from international operations. These omissions reduce completeness and factual richness. (2) The most serious error is the introduction of Disney as a comparison point—this is entirely irrelevant and factually inappropriate, as the question only asks for a comparison between KO and PEP. This suggests a failure in entity accuracy and reasoning. (3) While the LLM correctly identifies that KO uses option contracts as cash flow hedges with AOCI deferral, and that PEP uses a mix of derivatives including options and forwards, it mischaracterizes the distinction: the original answer emphasizes that both companies use similar instruments, with KO highlighting AOCI treatment and PEP focusing on offsetting exposure from large international operations. The LLM instead frames KO’s strategy as 'instrument-specific and accounting-driven' and PEP’s as 'comprehensive' with operational initiatives, which overstates differences not present in the ground truth. The original answer does not support the claim that PEP uses productivity improvements or global purchasing as part of its FX risk management—this appears to be an inference or fabrication. (4) The reasoning is partially sound in recognizing both firms use options and forwards, but the synthesis is flawed due to the inclusion of irrelevant entities (Disney) and unsupported differentiating claims. Contextual relevance is moderate because the core topic (FX hedging with options and impact on liabilities) is addressed, but the answer drifts off-topic. Overall, the answer is partially correct but contains critical factual and reasoning flaws, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 602,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "Both companies rely on a discounted‑cash‑flow (DCF) accounting policy, but they apply it differently. GE uses DCF to test goodwill for impairment and explicitly runs sensitivity analyses on the key inputs—its cash‑flow forecasts and the discount rate—stating that changes to those assumptions could materially affect fair‑value results. Lockheed Martin (LMT) also uses a DCF model to value Level 3 fixed‑income investments, with “projected annuity payments and the discount rate” as the significant inputs, but the filing does not describe formal sensitivity testing, so while the valuation is inherently sensitive to those assumptions, GE’s approach is more explicitly calibrated and disclosed for discount‑rate and cash‑flow sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GE uses DCF for goodwill impairment testing with sensitivity analyses on cash flow forecasts and discount rates; LMT uses DCF for valuing Level 3 fixed income investments based on projected annuity payments and discount rates. The answer correctly notes that while both rely on forward-looking cash flows and discount rates, only GE explicitly discloses sensitivity testing. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all descriptive financial concepts (e.g., Level 3 investments, sensitivity to assumptions) are used correctly—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GE and LMT), two distinct applications of DCF (goodwill impairment vs. asset valuation), and compares them in terms of sensitivity analysis and disclosure practices. The only minor shortcoming is that the LLM slightly underemphasizes the difference in purpose—GE’s use being internally driven by strategic planning, LMT’s externally focused on pension fund assets—though this is implied in the context. (4) The answer is fully relevant to the question, directly addressing the comparison of DCF usage, sensitivity to assumptions, and differences in application and disclosure. Wording differs slightly from the original but maintains semantic equivalence. A score of 9 is justified due to near-perfect factual and conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 435,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Alphabet’s capital structure gives each Class A share one vote and each Class B share ten votes, while its Class C shares have no voting rights; the 2023 repurchase program of $62.2 billion was directed only at Class A and Class C shares, leaving the super‑voting Class B pool untouched. Comcast’s dual‑class system, by contrast, allocates roughly 66.3 % of the combined voting power to holders of its Class A common stock (the $0.01‑par “Class A Common Stock” listed on the Nasdaq) and 33.3 % to its Class B shares, each of which carries 15 votes per share, and its 2023 common‑stock repurchases occur within this framework. Thus, while Alphabet’s repurchases concentrate voting power in its high‑vote Class B stock, Comcast already splits voting power between a majority‑voting Class A and a fixed‑percentage, higher‑vote Class B, reflecting a different balance of voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class A holds ~66.7% (stated as 66.3%, a negligible rounding difference) of voting power, Class B holds ~33.3% with 15 votes per share; GOOGL's Class A has 1 vote, Class B has 10 votes, Class C has none; GOOGL repurchased $62.2 billion of Class A and C shares in 2023. These numbers match the ground truth exactly or are acceptably close (66.3% vs 66 2/3% = 66.66...%). (2) The answer correctly identifies that GOOGL’s repurchases of non–Class B shares preserve and potentially concentrate voting power among Class B holders, while CMCSA’s structure already has a fixed split, with Brian L. Roberts’ Class B shares holding a defined minority voting stake. (3) Multi-hop reasoning is sound: the model synthesizes voting rights, share classes, and repurchase impacts across two companies and connects them to the broader theme of voting power distribution. (4) Minor wording deviation: LLM says CMCSA repurchases 'occur within this framework' but does not explicitly state that CMCSA does not disclose repurchase volumes (a small omission), though it doesn’t falsely claim disclosure either. This does not undermine correctness. Overall, the answer is factually precise, contextually relevant, and logically structured, warranting a 9/10 due to near-perfect alignment with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 390,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "The 8.2 % rise in Turkey’s total cigarette market – driven largely by a surge in inbound tourism (the same macro‑trend that lifted volumes in Mexico, as noted in the Americas commentary) – fed directly into Philip Morris’s higher cigarette volume and pricing in Turkey, helping lift its net‑revenue by 10.4 % (18.3 % on an adjusted basis) and its operating income by 23.8 % for the year. In contrast, Colgate‑Palmolive’s presence in Turkey is limited to a manufacturing/warehousing facility for its oral, personal‑care and home‑care businesses, so its performance there reflects an operational footprint rather than a direct benefit from the tobacco‑market expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—10.4% net revenue growth and 23.8% operating income growth for PM—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, significantly undermining quantitative accuracy. The 8.2% cigarette market growth is correctly cited, but the downstream financial impacts on PM are not supported by the original. (2) The original answer notes PM benefited from favorable volume/mix and pricing in Turkey, contributing to Middle East & Africa performance, but does not quantify PM’s overall net revenue or operating income growth. Thus, the LLM’s precise percentages (10.4%, 18.3% adjusted, 23.8%) are incorrect or unsubstantiated. (3) Qualitatively, the LLM correctly identifies the driver (inbound tourism) and correctly contrasts PM’s market-driven benefit with CL’s operational footprint in manufacturing and warehousing for oral/personal/home care. This reflects sound multi-hop reasoning by linking tourism → cigarette demand → PM sales benefit vs. CL’s infrastructure presence. (4) Contextually, the answer is highly relevant and well-structured, addressing both companies’ exposure in Turkey. However, the inclusion of unverified quantitative claims severely reduces factual correctness. While the conceptual contrast is accurate and semantically aligned with the original, the made-up metrics result in a partial score. Minor note: reference to 'Mexico' and 'Americas commentary' introduces external information not in the original context, potentially confusing the logic chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[positively_impacted_by]-> MACRO_CONDITION -[Positively_Impacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 448,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies rely on the same Taiwanese foundry ecosystem, so a flare‑up in Taiwan‑China tensions threatens that supply base. NVIDIA warns that if its Taiwanese contract manufacturers cannot expand capacity or meet lead‑times because of a geopolitical shock, it could face inventory shortfalls, delayed shipments and margin pressure; Qualcomm makes the same point – its key chipset‑fabrication and assembly plants are in Taiwan, and any war‑or‑terror‑related disruption would curtail chipset deliveries, stall QCT product launches and licensing revenue, and materially hurt its overall business. Thus, the shared dependence on Taiwan’s manufacturing infrastructure makes both NVIDIA’s foundry‑supply timing and Qualcomm’s regional operations vulnerable to the same geopolitical risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual content is correct: both NVIDIA and Qualcomm rely on Taiwanese foundries, and geopolitical tensions could disrupt supply, leading to delayed shipments, inventory issues, and revenue impacts. The LLM correctly identifies that both companies face material risks due to shared infrastructure. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies depend on the same regional manufacturing base and that a disruption would have cascading effects on supply timing (NVIDIA) and operations/product launches (Qualcomm). (4) The wording differs slightly—LLM adds 'margin pressure' and 'war-or-terror-related disruption'—but these are reasonable inferences consistent with 10-K risk disclosures and do not contradict the ground truth. The only minor gap is that the LLM does not explicitly mention 'customer relationships' as a risk for NVIDIA, which is included in the original answer, but it does reference delayed shipments and inventory shortfalls, which imply relationship risks. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 382,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "ASU 2020‑04 gave FedEx an optional expedient for contracts that reference LIBOR, but FedEx says that, as of May 31 2024, “there has been no material effect to our financial condition, results of operations, or cash flows from reference‑rate reform” and it is merely monitoring its contracts for any future application. In contrast, 3M’s (MMM) hedging relationships that are subject to the same reference‑rate‑reform guidance are reflected directly in its income: cash‑flow hedges produced $560 million of income in 2023 (versus $147 million in 2022 and $165 million in 2021), fair‑value hedges showed a $15 million gain in 2023 after losses in prior years, and interest‑rate hedge reclassifications from OCI added $9 million each year. Thus, FedEx’s exposure to LIBOR‑related modifications is essentially immaterial, whereas MMM records measurable gains, losses and OCI reclassifications from hedging relationships affected by the reform.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that FDX has not experienced a material effect from ASU 2020-04 or reference rate reform as of May 31, 2024, and is monitoring affected contracts—this aligns with the ground truth. It also correctly contrasts FDX’s immaterial exposure with MMM’s active financial treatment of hedging relationships under the same reform, showing sound multi-hop reasoning across entities and accounting treatments. However, there are significant quantitative inaccuracies: the LLM claims MMM's cash flow hedges produced $560 million in income in 2023, which is not supported by the original answer (which only mentions $9 million in losses related to interest rate contracts). The $560M figure appears to be a misinterpretation or hallucination, as does the $15 million gain in fair-value hedges and the claim about OCI reclassifications adding $9 million each year—while the original answer only states that MMM reported $9 million in losses in 2023. These errors undermine the quantitative accuracy despite correct qualitative directionality. The entity names (FDX, MMM), years (2023), and context (ASU 2020-04, LIBOR reform) are accurate, and the comparison logic is valid—FDX has no material impact while MMM does. The answer is highly relevant and synthesizes across companies and standards appropriately, but the fabricated financial figures reduce overall correctness. Semantic equivalence fails on the MMM financial impact due to these exaggerations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 405,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s charter creates two voting classes in which the 9.44 million Class B shares owned 100 % by Brian L. Roberts carry 15 votes each.  Because the total voting power is split 66 ⅔ % to the public‑held Class A shares and 33 ⅓ % to the insider‑held Class B shares, Roberts controls a fixed, non‑dilutable one‑third of all votes – enough to block or heavily influence director elections and major actions, but not to dominate the vote outright.  \n\nAlphabet’s structure is similar in that it uses high‑vote shares, but its Class B shares (held mainly by founders) have 10 votes per share versus one vote for Class A and no votes for Class C.  The concentration of Class B voting power normally gives insiders a controlling majority of the total votes even though they own a relatively small percentage of the economic equity.  \n\nThus, while both companies give insiders disproportionate voting rights, Comcast’s insider block is limited to a one‑third voting stake (33 ⅓ %) that must coexist with a two‑thirds public block, whereas Alphabet’s dual‑class system typically grants insiders a decisive majority, concentrating governance control far more heavily in the hands of the founders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B shares carry 15 votes per share and represent 33⅓% of total voting power, entirely owned by Brian L. Roberts; GOOGL’s Class B shares have 10 votes per share, Class A have 1, and Class C have none. The LLM correctly notes the non-dilutable nature of CMCSA’s Class B shares and contrasts it with GOOGL’s structure where insiders typically hold a controlling majority. (2) Quantitative accuracy is perfect: 33⅓% and 66⅔% splits are correctly stated, vote ratios (15:1 vs 10:1) are accurate, and the 9.44 million Class B shares detail—though not in the original answer—is consistent with public filings and adds precision without contradicting the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes ownership concentration, voting power distribution, and governance implications across two companies, highlighting that CMCSA’s structure gives Roberts a strong blocking minority but not majority control, whereas GOOGL’s founders typically hold a decisive majority. (4) The only minor shortcoming is that the original answer emphasizes the 'structurally rigid' and 'non-dilutable' aspect of CMCSA more explicitly, which the LLM mentions but could have stressed more in comparative terms. However, the semantic meaning and factual content are equivalent. Wording differences do not affect correctness. All entities (CMCSA, GOOGL, Brian L. Roberts, Class A/B/C shares) are accurately identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 426,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Both Amgen and Eli Lilly elected under the 2017 Tax Act to satisfy the one‑time “toll” repatriation tax over an eight‑year period (2018‑2025). As of December 31 2023, Amgen’s filing lists the **remaining scheduled installments** of that tax (shown in a table of millions of dollars), whereas Eli Lilly’s filing lists the **future cash payments** it still expects to make for the same provision (also shown in a table of millions). Thus, each company has ongoing obligations under the same eight‑year payment schedule, with Amgen’s figures representing the balance of remaining installments and Lilly’s figures representing the cash outflows required to meet the same tax liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Amgen and Eli Lilly elected to pay the one-time 'toll tax' under the 2017 Tax Act over an eight-year period from 2018 to 2025, which matches the original answer. (2) There are no explicit dollar amounts in either the original or LLM answer, so no numerical discrepancies exist; both refer to payments being reported in tables in millions, which is consistent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies are under the same regulatory framework and payment schedule, and it accurately contrasts how each company presents the obligation—Amgen as 'remaining scheduled installments' and Eli Lilly as 'future cash payments'—which reflects equivalent concepts in financial reporting. (4) The LLM slightly reframes the information with more focus on disclosure terminology (e.g., 'scheduled installments' vs 'cash outflows'), but this enhances rather than distorts the meaning. No factual errors; minor deduction in qualitative accuracy only because it doesn't explicitly mention that the differing amounts stem from differences in foreign earnings and individual tax calculations, a nuance present in the original. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 372,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s earnings are tied to the exclusivity enjoyed by its biologic portfolio, so a loss of that exclusivity could invite biosimilar rivals; however, as the filing notes, the timing of biosimilar entry is uncertain because U.S. rules (the BPCIA and a 12‑year data‑protection period) and the long development and manufacturing timelines often delay competition. In contrast, Bristol‑Myers Squibb carries a broader set of biologics (Opdivo, Yervoy, Orencia, Reblozyl and Empliciti) and therefore faces biosimilar exposure in both the United States—where patents can be challenged as early as four years even though a 12‑year data block exists—and the European Union—where the “8+2+1” regime and the fact that patents are not listed with regulators allow generics/biosimilars to launch after roughly a decade. Thus BMY’s exposure is larger and more immediate, especially in the EU, whereas Amgen’s risk is more uncertain and generally mitigated by the longer U.S. data‑exclusivity framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, regulatory timelines, and comparative exposure between Amgen and Bristol Myers Squibb (BMY). Quantitatively, the 12-year U.S. data protection period and the EU '8+2+1' regime are accurately cited, and the explanation of how these frameworks affect biosimilar entry timing is sound. The LLM correctly identifies BMY's biologics (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti) as per the original answer. However, it incorrectly lists Amgen’s biologics as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' in the ground truth, which are not Amgen products—this error is not repeated in the LLM answer, but the LLM fails to name any specific Amgen biologics at all, which is a notable omission given the question’s focus on product portfolios. This affects completeness and entity accuracy. The reasoning about U.S. BPCIA, IPR challenges, and earlier patent challenges (e.g., 4 years) is plausible but slightly overreaches—the original mentions litigation and IPR weakening patents, but not a specific '4-year' challenge window, which is not standard and lacks precise support. Still, the core multi-hop synthesis—comparing U.S. vs. EU regulatory pathways and their impact on biosimilar entry for two companies—is logically structured and contextually appropriate. The conclusion that BMY faces broader and more immediate exposure, especially in the EU, is consistent with the ground truth. Wording differs but semantic meaning is preserved on key points. Minor entity omission and one potentially unsupported claim prevent a top score, but overall accuracy and relevance are high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Negatively_Impacts]-> ACCOUNTING_POLICY <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 454,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s Medicaid exposure is tied to the broader cost‑containment environment in which government programs (including Medicaid) limit the amount they will reimburse for procedures and devices.  This creates pricing‑pressure that can compress margins across Medtronic’s wide‑ranging medical‑device and therapy portfolio, but the risk is diffuse and tied to overall reimbursement‑rate declines.  \n\nAbbVie’s pricing pressure comes from the Inflation‑Reduction Act, which gives HHS the authority to set statutory ceiling prices and mandatory discounts for single‑source drugs and biologics reimbursed under Medicare Part B/D (and, indirectly, for Medicaid rebates).  Those IRA‑driven caps can sharply cut prices for specific high‑revenue pharmaceuticals, creating a more direct and potentially larger revenue‑erosion risk for AbbVie’s product line.  \n\nThus, while both firms face pricing pressures, Medtronic’s Medicaid‑related risk is a broader, reimbursement‑rate squeeze on its device portfolio, whereas AbbVie’s IRA‑related pressure is a targeted, statutory price‑cap that threatens revenue on its key drug products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions in specificity. (1) All factual elements are correct: Medtronic's exposure to Medicaid reimbursement limitations affecting device pricing and AbbVie's direct exposure to IRA-driven government price setting are accurately described. The distinction between diffuse reimbursement pressure (Medtronic) vs. targeted statutory price caps (AbbVie) is well articulated. (2) There are no numeric values, dates, or percentages in the LLM answer that contradict the ground truth; the ground truth mentions specific drugs (Imbruvica, Vraylar, Linzess) and years (2023, 2025, 2026, 2027), but the LLM answer does not include them. However, since the LLM does not make any incorrect claims about timing or drug names—and the absence of these specifics does not distort the meaning—the quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face healthcare cost-containment pressures but through different mechanisms (reimbursement rates for devices vs. direct price setting for drugs), which aligns with the knowledge graph. (4) The answer is contextually excellent, directly addressing the comparison in exposure, product portfolios, and revenue risks. The only reason for not scoring a 10 is the lack of mention of specific drugs and IRA selection years, which are part of the original answer and add precision. However, the semantic meaning and analytical depth are equivalent. Thus, the answer is factually correct, well-reasoned, and relevant, warranting a 9 for overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 459,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS’s 401(k)‑type plan holds limited‑partner interests in private‑equity, private‑debt and real‑estate funds that are valued using NAV as a practical expedient, and it reports roughly **$2.7 billion of unfunded commitments** to those partnerships that will be funded over the next three‑to‑six years. General Dynamics also values certain plan assets – including its Level 1 commingled equity and fixed‑income funds – at NAV, but it explicitly states that **unfunded commitments related to those NAV‑valued investments were not material** at December 31, 2024. Thus, UPS’s NAV‑based approach translates into a sizable, quantified future cash outflow of $2.7 billion, whereas GD’s NAV usage is primarily a valuation method with no comparable unfunded‑commitment exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: UPS's $2.7 billion in unfunded commitments as of December 31, 2024, and the 3-to-6-year funding horizon are accurately reported. The statement that General Dynamics had no material unfunded commitments related to NAV-valued assets is consistent with the ground truth, which implies the absence of significant future cash outflows. (2) The entities—UPS, General Dynamics (GD), private equity funds, Level 1 plan assets—are correctly identified, and the time frame (December 31, 2024) matches. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use NAV as a practical expedient for alternative investments but differ in liquidity and commitment structure. It accurately contrasts UPS’s significant unfunded commitments (indicating illiquidity and long-term capital calls) with GD’s NAV usage being primarily for valuation without material future funding obligations. (4) The only minor shortcoming is that the LLM does not explicitly mention the difference in redemption terms (e.g., GD’s monthly/quarterly vs. UPS’s 10–15 year restrictions), which is present in the original answer and adds nuance to the liquidity comparison. However, this omission does not undermine the core factual accuracy or the logical conclusion about differential cash flow exposure. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but missing one contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 427,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 balance sheet shows that the company issued 9,444,375 shares of a newly‑created Class B common stock (out of 75 million authorized) in addition to its 3.78 billion Class A shares.  As described in the voting‑rights discussion for a comparable dual‑class issuer (the “V” filing), a Class B common share normally carries no voting power on most matters and votes only on a narrow set of defined actions; therefore the new Class B shares dilute equity but do not shift voting control away from the voting Class A shareholders.  \n\nMeta’s filing, by contrast, discloses a classic dual‑class structure: 2.19 billion Class A shares (one vote each) and 343.8 million Class B shares that carry multiple votes per share, concentrating voting power in the Class B tier.  Thus, while CMCSA’s Class B issuance adds a largely non‑voting class that leaves voting authority with Class A holders, Meta’s dual‑class framework explicitly gives its Class B stock greater voting rights than its Class A stock.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but makes a critical error in the qualitative comparison between CMCSA and META's dual-class structures, leading to a significant factual inaccuracy. (1) Quantitatively, the issuance of 9,444,375 Class B shares by CMCSA is correctly stated, as is the reference to Class A shares (though 3.78 billion is not in the ground truth and cannot be verified from the provided data). The META share counts (2.19 billion Class A, 343.8 million Class B) are not present in the original answer and appear to be fabricated or misattributed, as the ground truth does not include these numbers. (2) The core error lies in the characterization of META’s dual-class structure: the LLM claims META’s Class B shares have 'multiple votes per share' and 'greater voting rights than Class A', which directly contradicts the ground truth stating that META’s Class B stockholders 'generally do not' have voting rights except in defined events like a merger—just like CMCSA’s Class B. Thus, the comparison is inverted: both companies grant voting power primarily to Class A, not Class B. (3) The multi-hop reasoning fails because the model incorrectly synthesizes META’s structure, drawing a contrast that does not exist. Instead of identifying the similarity in governance design (both use non-voting Class B shares to preserve control among Class A holders), it falsely presents them as opposites. (4) Despite this, the answer is contextually relevant, addresses both companies, and correctly interprets CMCSA’s structure. The numerical value for CMCSA’s issuance is accurate, warranting moderate scores for quantitative accuracy and relevance, but the fundamental misrepresentation of META’s voting structure severely undermines correctness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 489,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA gives the U.S. government the authority to set Medicare Part B and Part D prices for selected drugs, with the first ten drugs subject to mandatory price‑setting beginning in 2026 and an additional 15 drugs added in 2027 (and more in later years). Because Amgen’s sales “depend on coverage and reimbursement from Medicare” (Chunk 1), the same price‑setting rules that are already forcing AbbVie’s Imbruvica to be priced by the government in 2026 and Vraylar in 2027 (Chunks 2‑3) could cause Amgen’s federally reimbursed products to experience revenue erosion well before their patent expirations—potentially shifting the erosion timeline into the mid‑2020s rather than later in the product life‑cycle. In short, the IRA’s Medicare pricing provisions are likely to accelerate Amgen’s revenue decline in a manner analogous to AbbVie’s experience, compressing the high‑margin period for any Amgen drug that is selected for government‑set pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2026, 2027) and program details (10 drugs in 2026, 15 in 2027) are correct and consistent with the IRA's rollout schedule. The reference to AbbVie’s Imbruvica and Vraylar being subject to pricing in 2026 and 2027 matches the original answer. (2) The answer correctly identifies that Amgen, like AbbVie, depends on Medicare reimbursement, and thus faces accelerated revenue erosion due to government price-setting. (3) The multi-hop reasoning is sound: it connects the IRA’s pricing mechanism → its application to AbbVie’s drugs → the implication for Amgen’s similarly situated products. (4) The only minor shortcoming is that the original answer specifies the 9- or 13-year post-approval timeline for small molecules vs biologics under the IRA, which the LLM omits. This is a relevant detail about the structural trigger for price-setting, but its absence does not invalidate the core conclusion. The LLM instead emphasizes the mid-2020s erosion timeline, which is contextually reasonable. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 338,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reported that 37,028 (thousand) securities – about 37.0 million shares – remain available for future issuance under equity‑compensation plans that have been approved by security holders. Procter & Gamble’s 10‑K table lists the total securities remaining available only as a footnote (2) and does not disclose a numeric value in the excerpt, so a direct numeric comparison cannot be made. For context, Energizer (EMR) disclosed 3,837 (thousand) securities remaining under comparable plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37.0 million), which matches the ground truth. However, it incorrectly states that Procter & Gamble did not disclose a numeric value, claiming it is only in a footnote without a number. This is false — the ground truth confirms P&G disclosed 133,185,995 total remaining available securities across approved plans, which the LLM fails to report. (2) The quantitative accuracy is partially correct for Colgate but entirely incorrect for P&G; the model omits the actual number and thus cannot support the comparison. The mention of Energizer (EMR) is irrelevant and not requested in the question, adding misleading context. (3) The multi-hop reasoning fails because the LLM does not synthesize the required comparison between Colgate and P&G — instead, it asserts that a comparison cannot be made due to lack of data, which contradicts the ground truth. (4) The contextual relevance is moderate because it addresses the right topic and company (Colgate), but introduces an unrelated company (Energizer) and misrepresents P&G’s disclosure, undermining the core purpose of the question. The conclusion about PG having a larger pool is entirely missing due to this error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 357,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMY (through its Bristol‑Myers Squibb unit) works with Ono to co‑develop and co‑commercialize Opdivo, Yervoy and other biologics in Taiwan, with BMS supplying the product and sharing profits – 50 %/50 % on combination therapies and an 80 %/20 % split when only one party’s compound is involved.  Because Taiwan’s drug‑registration rules require local clinical‑trial data for biologics, this partnership must generate additional bridging studies that can lengthen development and launch timelines.  By contrast, Merck has removed its biosimilars from its core business by spinning them off into the independent Organon company, thereby distancing the parent from the direct regulatory burden – including Taiwan’s local‑data requirement – that would otherwise apply to its biosimilar products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY (via BMS) collaborates with Ono in Taiwan on Opdivo and Yervoy, with BMS handling supply and profit-sharing; Merck spun off its biosimilars into Organon. The 50/50 and 80/20 profit splits are specific details not in the original answer but are factually correct and add precision without contradicting the ground truth. (2) Quantitative accuracy is perfect: percentages are correctly stated and contextually appropriate. (3) Multi-hop reasoning is sound—LLM correctly links Taiwan’s local clinical trial requirement to increased regulatory burden, contrasts BMY’s collaborative market-entry strategy with MRK’s strategic divestiture, and infers that spinning off biosimilars reduces direct exposure to such regulatory demands. (4) The answer is semantically equivalent to the original, with slightly more detail on profit splits and clearer articulation of regulatory implications. The only minor gap is that the original emphasizes MRK’s retreat due to global competition and complexity, which the LLM implies but doesn’t explicitly state. However, this does not detract from factual correctness. Overall, the response is complete, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 357,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment – which by definition (Chunk 2) comprises mainland China, Hong Kong and **Taiwan** – generated **$74.2 billion** in net sales (Chunk 1). Adobe’s filing, however, only lists a **local field office in Taiwan** as part of its worldwide operations (Chunk 3) and provides no separate revenue figure for that market. Thus, Apple’s Taiwan‑related contribution is embedded in a multi‑billion‑dollar sales total, whereas Adobe’s presence in Taiwan is limited to an operational office with no disclosed revenue amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $74.2 billion (i.e., $74,200 million) net sales figure for Apple's Greater China segment in 2022 is accurately reported, with acceptable format variation (billion vs. million). (2) The answer correctly identifies that ADBE has a local field office in Taiwan but does not disclose revenue for that region, which aligns with the original answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes AAPL’s revenue data (which includes Taiwan within Greater China) with ADBE’s operational footprint data, drawing a valid comparison between revenue exposure and operational presence. (4) The entities (AAPL, ADBE, Taiwan, Greater China, 2022) and metrics (net sales, operational presence) are accurately identified and contextualized. The answer is semantically equivalent to the ground truth, with clear, precise, and relevant information addressing both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 284,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "CMCSA’s capital structure gives public‑market Class A shareholders about two‑thirds (≈66 ⅔ %) of the total voting power, while the single holder of all Class B shares – Brian L. Roberts – controls the remaining one‑third (≈33 ⅓ %) because each Class B share carries 15 votes (see Chunk 2).  The Class A shares are listed on Nasdaq (Chunk 1), so a broad base of investors can vote, but the concentrated Class B block still provides a decisive voice in director elections and other governance matters.  \n\nMeta’s structure is the opposite: its Class A stock trades on the Nasdaq Global Select Market (Chunk 3) and is held by thousands of investors (3,098 record holders), whereas its non‑listed Class B stock is owned by only 23 record holders, indicating a very tight ownership concentration that, under Meta’s charter, carries a disproportionate voting weight (the filing does not state the exact percentage but the small number of holders implies dominant control).  Consequently, Meta’s corporate‑governance decisions are effectively driven by the small Class B group, limiting the influence of the much larger Class A shareholder base, whereas Comcast’s decisions must balance the interests of a broad Class A electorate with the single, powerful Class B holder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CMCSA's Class A has 66 2/3% voting power, Class B has 33 1/3%, each Class B share carries 15 votes, and META has 23 Class B stockholders of record as of December 31, 2023 (implied from context). The LLM correctly notes that META does not disclose the exact voting power percentage, which matches the original answer. (2) The LLM accurately identifies entities: CMCSA (Comcast) and META (Meta Platforms), their respective stock classes, listing status (Nasdaq), and control structures. (3) Multi-hop reasoning is sound: it contrasts CMCSA’s structured dual-class balance with META’s more concentrated and opaque control, correctly inferring governance implications—Class B dominance at META limits Class A influence, while CMCSA must balance broader Class A input with Roberts’ Class B block. (4) The only minor shortcoming is that the LLM implies Brian L. Roberts is the single holder of *all* Class B shares at CMCSA, while the original answer says Class B is 'led by' him—this slightly overstates certainty but is consistent with common interpretations in filings. Otherwise, the answer is factually complete, semantically equivalent, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 361,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "Eli Lilly (LLY) is the party that can **directly obtain pediatric exclusivity** – in the United States the FDA may grant an extra six months that is added to the drug’s data‑protection period and to any non‑expired patents (or orphan‑drug exclusivity) (Chunk 1; the same six‑month incentive is described as a regulatory‑data‑protection (RDP) benefit in the BMY filing, Chunk 2). In the European Union the pediatric provision likewise tacks on six months to the term of a Supplementary Protection Certificate (SPC), extending the product’s market exclusivity (Chunk 3).  \n\nMerck (MRK), by contrast, does **not receive pediatric exclusivity itself**; instead the pediatric provision **positively impacts MRK’s broader market exclusivity** – the six‑month pediatric extension is added to the patent‑term‑restored or SPC‑based market exclusivity that MRK enjoys in both the U.S. and the EU (the KG link Pediatric Exclusivity → Market Exclusivity ← MRK).  \n\nThus LLY benefits by a direct six‑month boost to its data‑protection/patent term, whereas MRK benefits indirectly through a six‑month extension of its overall market‑exclusivity (including SPCs) that the pediatric rule augments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the six-month pediatric exclusivity extension in both the U.S. and EU, which is quantitatively accurate and matches the ground truth. However, the qualitative reasoning is flawed in a key aspect: it incorrectly suggests that Merck (MRK) does not 'receive pediatric exclusivity itself' and instead benefits only indirectly, while the ground truth states that MRK *does* receive the six-month extension—specifically, in the U.S., it is added to Orange Book-listed patents and regulatory data exclusivity, and in the EU, to the SPC term. This mischaracterization of MRK’s direct benefit undermines the multi-hop synthesis. The answer also inaccurately implies a structural difference in how LLY and MRK benefit (direct vs. indirect), whereas the real distinction lies in the regulatory frameworks (U.S. vs. EU) and how each company leverages them, not in the mechanism of benefit (direct/indirect). LLY’s benefit is correctly described for the U.S., but the EU application is not clearly differentiated for LLY. The answer mentions EU SPC extension but incorrectly ties it to LLY without specifying that the EU pediatric extension applies uniformly to SPCs, not uniquely to LLY. Thus, while the numbers and general concepts are correct, the reasoning and entity-specific synthesis are partially incorrect, leading to a misleading comparison between LLY and MRK.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 384,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities fell from $22 million in 2023 to $20 million in 2024 – a modest $2 million reduction. By contrast, LMT’s foreign‑currency hedge portfolio (largely option contracts that affect foreign‑currency liabilities) grew to a notional $7.5 billion at year‑end 2024, up from $6.5 billion in 2023 – an increase of about $1 billion, which is orders of magnitude larger than EMR’s liability change (and roughly comparable to the $9.9 billion of foreign‑exchange cash‑flow hedges reported by DIS). This disparity indicates that LMT (and peers like DIS) run extensive hedging programs to manage sizable foreign‑exchange exposures, whereas EMR’s exposure is relatively small and declining, suggesting a less intensive risk‑management approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the scale of EMR's foreign currency liabilities: it reports $22 million and $20 million for 2023 and 2024, respectively, whereas the ground truth states $22 billion and $20 billion. This is a 1,000-fold error, making the $2 million reduction (vs. correct $2 billion) grossly inaccurate. Additionally, the LLM incorrectly claims LMT's hedge portfolio 'grew to $7.5 billion...up from $6.5 billion in 2023', introducing data not present in the original answer, which only states LMT had $7.5 billion in outstanding hedges at end-2024 with no prior year value. The comparison to DIS's $9.9 billion hedges is extraneous and unsupported by the ground truth. (2) Quantitative accuracy is severely compromised: the misrepresentation of billions as millions invalidates all numerical comparisons. The calculation of a $2 million reduction is wrong due to unit error. The $1 billion increase in LMT hedges is fabricated. (3) Multi-hop reasoning is partially sound in structure—comparing liability changes to hedge positions to infer risk management strategies—but is based on incorrect data. The conclusion that EMR has a 'less intensive risk-management approach' diverges from the original interpretation, which suggested EMR may be reducing liabilities as a strategy rather than lacking hedging. The original emphasized LMT's use of options to manage earnings volatility, which the LLM omits. (4) Scores reflect major factual inaccuracies (correctness: 3), extremely poor quantitative accuracy (2), partial qualitative accuracy due to flawed but structured reasoning (4), and moderate relevance as the general topic and direction of comparison are appropriate (6).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 469,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that AENB paid to its parent, American Express, in 2023 could be made only because AENB determined that the payout would not push its leverage‑ratio below the minimum levels imposed by federal banking regulators (Chunk 2).  Those same leverage‑ratio and supplementary‑leverage requirements apply to Wells Fargo, which must satisfy Basel III‑style leverage caps and related capital‑plan rules before it can distribute any dividends (Chunk 3).  Consequently, the dividend is directly linked to AENB’s need to stay in compliance with the leverage‑ratio standards that govern both AENB and WFC under the broader regulatory framework outlined in the proposed rulemaking for internal long‑term debt (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.6 billion dividend amount and the year 2023 are accurately reported, with no calculation errors. (2) The entities—AENB (American Express National Bank), AXP (American Express), and WFC (Wells Fargo)—are correctly identified, and the regulatory frameworks (federal banking regulations, Basel III, leverage and supplementary leverage ratios) are accurately referenced. (3) The multi-hop reasoning is sound: the answer correctly links AENB’s dividend payment to its compliance with leverage ratio requirements, explains that such payments are constrained by capital adequacy rules, and draws a valid parallel to WFC’s similar regulatory constraints under the same type of framework. (4) The semantic meaning fully matches the original answer, though the LLM references 'Chunk 1', 'Chunk 2', etc., which suggests it is citing source material—this does not detract from factual correctness but slightly reduces precision in standalone clarity. The only minor shortcoming is a slightly less explicit elaboration on the 'internal long-term debt' rulemaking mentioned in Chunk 1, which is referenced but not clearly tied back to the leverage framework. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across regulatory and institutional entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 392,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax mix – about $62.9 bn earned in the United States and $44.9 bn earned abroad – means that a sizable share of its earnings is generated in foreign jurisdictions where the statutory rate can be below the OECD Pillar Two floor of 15 %. Because the foreign portion is largely produced through its Irish regional centre, which already taxes earnings at rates at or above the floor, Microsoft says the Pillar Two Model Rules (the regulatory requirement that implements the Global Minimum Tax) are unlikely to have a material impact on its consolidated statements when they become effective in FY 2025. Qualcomm is subject to the same Pillar Two rules from FY 2025 and, like Microsoft, states that it does not expect a material impact; its exposure appears comparable or even lower because it does not highlight a large low‑tax foreign‑income component, mirroring the experience of other firms (e.g., the company in Chunk 2) that have no material operations in jurisdictions below the 15 % minimum.  Consequently, while Microsoft’s U.S./foreign income split creates a modest theoretical exposure to the global minimum tax, both companies anticipate the effect will be immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: Microsoft's $62.9B U.S. and $44.9B foreign pre-tax income in fiscal 2024 are accurately reported, and the fiscal 2025 implementation timeline for both Microsoft and Qualcomm under Pillar Two is correctly stated. No calculations were required, but the relative scale of foreign earnings is appropriately contextualized. (2) The answer addresses all parts of the multi-hop question: it analyzes Microsoft’s geographic income distribution and its implications for Pillar Two exposure, references Microsoft’s own assessment of immaterial impact, and compares this to Qualcomm’s expected impact under the same framework with the same FY2025 timeline. (3) Entities are correct—Microsoft, Qualcomm, OECD Pillar Two Model Rules, Global Minimum Tax, fiscal years—all are accurately identified and discussed. (4) The reasoning is sound and adds value beyond the ground truth by specifying Microsoft’s Irish regional center as a source of foreign earnings and noting that it already operates at or above the 15% minimum tax rate, which strengthens the explanation for why the impact is immaterial. This detail is plausible and consistent with public knowledge, though not present in the original answer; however, it does not contradict it. The comparison to Qualcomm is logically drawn, noting both companies expect no material impact, though the LLM slightly extends the reasoning by suggesting Qualcomm’s exposure may be 'comparable or even lower'—a reasonable inference but not explicitly confirmed in the ground truth. This minor extrapolation prevents a perfect 10, but the core facts, synthesis, and conclusions are correct and well-supported. Semantic equivalence is maintained, with enhanced contextual explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 492,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "WMT discloses that it has $37.2 billion of unrecorded purchase obligations – including $15.9 billion due within the next year – that are legally binding firm commitments for inventory, utilities, capital‑expenditure, software, licences and service contracts. The VAR methodology described in the DIS filing (and used by MDLZ) explicitly **excludes** forecasted transactions, firm commitments and accounts receivable/payable, and instead measures only the one‑day, 95 %‑confidence market‑risk loss on debt, derivatives and equity instruments. Because those large, cash‑intensive purchase obligations are outside the scope of the VAR model, WMT’s liquidity and operational risk from the $37.2 billion exposure is not captured in the VAR figures that peers such as MDLZ report.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $37.2 billion unrecorded purchase obligations are correctly stated, and the breakdown of $15.9 billion due within the next year, while not in the original answer, is plausible and does not contradict it—this additional detail may come from a more granular part of WMT’s filing and enhances completeness without introducing error. The use of 'billion' and formatting ($37.2 billion) is consistent and acceptable. (2) The entity references are correct: WMT as the company with unrecorded obligations, MDLZ as the peer using VAR, and DIS’s 10-K as the source of VAR methodology. The fiscal year end (January 31, 2025) is missing in the LLM answer, but this is a minor omission that doesn’t affect core accuracy. (3) The multi-hop reasoning is sound: the model correctly links WMT’s off-balance sheet obligations to the limitations of VAR models as described in DIS’s filing and applied by MDLZ. It accurately notes that VAR excludes firm commitments, forecasted transactions, and payables/receivables, focusing only on market-sensitive instruments. (4) The conclusion—that WMT’s liquidity and operational risks from these obligations are not captured by standard VAR models—is logically derived and semantically equivalent to the original answer. The only minor gap is the lack of specific mention of MDLZ’s 'parametric delta-gamma approximation technique,' but the core point about scope exclusion is preserved. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Does_Not_Relate_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 434,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UNH uses interest‑rate swaps as a broad risk‑management tool – it matches a portion of its $27 billion of floating‑rate liabilities (and $33 billion of floating‑rate assets) with swap contracts so that changes in market rates do not materially affect its overall interest expense. By contrast, Amgen’s swaps are tied to a single debt issue: it had $1.4 billion of swap notional that matured at the same time it repaid the full $1.4 billion principal of its 3.625 % 2024 Notes, converting the fixed‑rate coupons on those notes to floating‑rate (SOFR‑based) coupons and thereby hedging the specific exposure created by that repayment. Thus UNH’s swaps are a general matching strategy for floating‑rate exposure, while Amgen’s swaps are a targeted hedge that directly offset the $1.4 billion 3.625 % 2024 Note repayment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UNH has $27 billion in floating-rate liabilities (and $33 billion in floating-rate assets), and uses interest rate swaps broadly across its balance sheet; AMGN had $1.4 billion in interest rate swaps tied to the 3.625% 2024 Notes, which matured and were repaid in 2024. The LLM correctly identifies SOFR-based floating-rate conversion and the timing alignment of swap maturity with note repayment. (2) Quantitative accuracy is perfect: $27 billion (UNH liabilities), $1.4 billion (AMGN swaps and note repayment), 3.625%, and 2024 maturity are all correctly stated. Format variations (e.g., $1.4 billion vs $1.4 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes that UNH’s use of swaps is part of a broad asset-liability matching strategy, while AMGN’s use is a targeted hedge directly linked to a specific debt instrument. This contrast is the core of the comparison and is accurately conveyed. (4) The answer is fully relevant, directly addressing the comparative use of interest rate swaps in relation to the $1.4 billion repayment of the 3.625% 2024 Notes by AMGN and UNH’s broader exposure management. No irrelevant or extraneous information is included. All scoring categories warrant the highest marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 378,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes – a $1 billion, fixed‑rate, unsecured bond that matures in 2032 – contain an “event of default” clause that would accelerate the notes, making the entire principal and any accrued interest immediately payable and thereby cutting short the 2032 maturity. Oracle’s $6 billion revolving credit facility, by contrast, does not have a single fixed‑rate bond but a flexible borrowing line that is scheduled to be due on March 8 2027; if an event of default occurs, the lenders may terminate the facility early, causing all amounts that have been drawn to become due immediately (or before the 2027 maturity). Thus, both companies face default‑triggered acceleration, but AMD’s acceleration applies to a specific senior‑note principal with a set 2032 maturity, whereas Oracle’s acceleration applies to any outstanding revolving‑credit borrowings and can end the facility ahead of its 2027 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AMD's $1.0 billion 3.924% Senior Notes Due 2032 can be accelerated upon Event of Default, requiring immediate repayment of principal and accrued interest. Oracle's $6.0 billion Revolving Credit Agreement can also be accelerated, making all drawn amounts due immediately upon default, with the facility scheduled to mature on March 8, 2027. These numbers, dates, and dollar amounts match the original answer exactly. (2) Quantitative accuracy is perfect: $1B for AMD, $6B for Oracle, correct interest rate (3.924%), and correct maturity dates (2032 and March 8, 2027) are all correctly reported. (3) The reasoning is sound and captures the multi-hop comparison: it correctly contrasts AMD’s fixed, unsecured note with Oracle’s flexible revolving facility, highlighting differences in repayment structure and maturity conditions. It accurately notes that Oracle’s facility allows for borrowing and reborrowing until maturity, unlike AMD’s one-time bond. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Oracle’s interest rates are tied to credit ratings—a detail present in the original answer—but this does not undermine the core comparison on acceleration and maturity. The answer remains semantically equivalent in substance and fully addresses the question’s focus on default-triggered obligations and structural differences. Thus, the answer is excellent, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues_Financial_Instrument]-> FIN_INST -[Accelerated_Maturity]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 441,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance business holds about **$31 billion** in assets that are placed in reinsurance‑security trusts. These assets are held by an independent trustee for the ceding insurers and must be managed under the **strict investment guidelines** set out in each re‑insurance contract – limits on asset‑class concentration, single‑issuer exposure, asset‑liability duration, credit‑quality, yield, liquidity and diversification, plus requirements tied to risk‑based capital, regulatory constraints and surplus‑volatility tolerance. Accordingly, the portfolio is exposed to **credit risk, interest‑rate risk and even equity risk** despite being largely investment‑grade debt.\n\nBy contrast, General Dynamics reports **$191 million** of marketable securities held in trust as of 12/31/2021. Its **investment policy** restricts purchases to **investment‑grade fixed‑income securities with a maximum maturity of five years**, a much narrower, short‑term, high‑quality mandate that limits exposure primarily to modest credit and interest‑rate risk. Thus, GE’s trust assets are orders of magnitude larger and governed by a more complex, risk‑intensive investment framework, whereas GD’s trust holdings are relatively small and subject to a conservative, low‑risk policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: GE's $31.0 billion in trust assets under reinsurance agreements and General Dynamics' $191 million in marketable securities as of December 31, 2021, are correctly reported (allowing for formatting: $31 billion = $31.0 billion). (2) The investment policies are accurately described: GE’s strict guidelines include asset-class concentration limits, issuer exposure, duration, credit quality, diversification, risk-based capital, and regulatory constraints; GD’s policy restricts investments to investment-grade fixed-income securities with a maximum five-year maturity. (3) Risk exposures are correctly contrasted: GE faces credit, interest rate, and equity risk due to a broader and more complex portfolio, while GD has a conservative, short-duration, low-risk profile. (4) The multi-hop reasoning—comparing scale, investment policy, and risk exposure across two companies from different sectors (insurance vs. defense/aerospace) using data from the same time period—is sound and well-synthesized. The only minor shortcoming is that the LLM mentions 'equity risk' for GE without explicit grounding in the original answer, which notes 'potential inclusion of non-traditional asset classes' but emphasizes investment-grade debt and diversification. This is a slight overstatement but does not materially misrepresent the risk profile. Otherwise, the answer is semantically equivalent, contextually precise, and quantitatively flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 429,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level 2 valuations of the publicly‑traded fixed‑income securities held in its pension plans (as described in the investment‑strategy section) are built on verifiable observable inputs – current interest‑rate levels, yield‑curve points at standard quoting intervals, credit‑spread levels and broker/dealer bid quotes or comparable‑security prices. PayPal’s Level 2 derivative valuations, by contrast, use observable market data such as currency‑exchange rates, interest‑rate yield curves, option‑price volatility and equity market prices. Both firms therefore rely on Level 2 observable data (with interest‑rate curves common to both), but Lockheed’s inputs are bond‑focused while PayPal’s are broader to reflect the multi‑asset nature of its derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, credit spreads, and broker/dealer quotes for its Level 2 fixed income securities; PayPal uses currency rates, yield curves, volatility, and equity prices for its Level 2 derivatives. These match the original answer exactly in substance. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect—no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly identifies that both firms use Level 2 methodologies based on observable inputs, draws the appropriate comparison (shared reliance on yield curves), and distinguishes the asset classes (fixed income vs. derivatives). The added detail about pension plans and broker quotes is contextually supported and enhances accuracy without introducing error. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved and even enriched with precise terms like 'bond-focused' and 'multi-asset nature.' The only minor deduction is for slight expansion beyond the original scope (mentioning pension plans and broker quotes), which, while plausible, are not explicitly confirmed in the ground truth. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 387,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are quite sensitive to market rates – a 50‑basis‑point rise or fall would move the fair value of its $56.3 billion of notes by roughly $1.7 billion (about $3.4 billion for a full 100‑bp move), and the change is not offset by any hedge. Cisco, by contrast, has entered into a $0.5 billion interest‑rate swap that is a fair‑value hedge of a portion of its $13.5 billion fixed‑rate senior‑note portfolio; the swap converts that fixed‑rate exposure to floating and its gain‑or‑loss essentially cancels the fair‑value impact of interest‑rate movements on the hedged slice. Thus AVGO faces a larger, un‑hedged sensitivity, whereas CSCO’s swap limits and largely neutralizes the rate‑change effect on the portion of debt it hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: AVGO's $56.3 billion in fixed-rate notes and $1.7 billion fair value change for a 50 bps shift are accurately reported. The $0.5 billion notional amount of CSCO's interest rate swap is also correct. The LLM correctly infers the linear relationship (approximating $3.4 billion for 100 bps) which is reasonable and consistent with the sensitivity given. (2) The entity identification is accurate—AVGO and CSCO are correctly referenced with appropriate financial instruments (senior notes, interest rate swaps). (3) The reasoning correctly contrasts AVGO’s lack of offsetting hedge for existing debt with CSCO’s use of a fair-value hedge via a swap that converts fixed to floating rates on a portion of its debt, accurately reflecting differing hedging strategies. (4) The LLM adds contextual detail not in the original (e.g., CSCO’s total fixed-rate debt of $13.5B), which is plausible and enhances clarity without contradicting the ground truth. One minor omission: the original specifies the hedged note is due in fiscal 2025 and that AVGO uses treasury rate locks for *future* issuances—this nuance about timing and hedge purpose is missing in the LLM answer, slightly weakening the qualitative completeness. However, the core multi-hop comparison—AVGO’s un-hedged sensitivity vs. CSCO’s hedged partial exposure—is sound and well-reasoned. Semantic equivalence is maintained, and the answer fully addresses the comparative sensitivity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 428,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMY’s Eliquis alliance with Pfizer is structured as a co‑exclusive licence that obliges both companies to sit on joint executive and operating committees and to share research, development, distribution, sales and marketing responsibilities.  BMY paid an upfront licence fee to Pfizer and may incur additional milestone payments, but those amounts are not disclosed and are recorded as deferred income and amortised over the co‑promotion period. In contrast, Pfizer’s multi‑year collaboration with Beam includes a disclosed $300 million upfront payment (recorded as acquired‑in‑process R&D) and, if Pfizer licences all three targets, up‑to‑$1.05 billion of development, regulatory and commercial milestones – a total potential deal value of $1.35 billion. Thus BMY’s financial commitment is qualitatively described and amortised, whereas Pfizer’s commitment to Beam is quantified, with a large upfront cash outlay and substantially higher potential milestone exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the structure of both collaborations and provides accurate quantitative details for the Pfizer-Beam deal: a $300 million upfront payment and up to $1.05 billion in potential milestones, totaling $1.35 billion. This matches the ground truth exactly in both amount and structure. However, the LLM incorrectly states that BMY paid an upfront license fee to Pfizer in the Eliquis alliance. The ground truth indicates that Pfizer made the upfront payment to BMY (not the other way around), and that this payment is being amortized over BMY’s co-promotion obligation period. This reversal of the payment direction is a significant factual error, especially in a financial comparison. While the qualitative description of shared responsibilities under Eliquis is accurate, the misattribution of the upfront payment undermines the financial comparison. The reasoning and contextual relevance are strong—the model correctly contrasts disclosed vs. undisclosed amounts and amortization treatment—but the core financial fact is inverted. Semantic equivalence fails on this key point. Other elements, such as the mention of joint committees and amortization, add context not in the original but do not contradict it. The multi-hop synthesis across two distinct collaborations is well-executed, but the error in payment direction reduces correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Introduces]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 379,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments says that when it is “reasonably certain” it will exercise a lease‑extension or termination option, the expected payments are folded into the present‑value of the lease liability (and the corresponding right‑of‑use asset) at lease commencement.  The liability is recorded on the balance sheet as a long‑term lease liability and the expense is recognized on a straight‑line basis over the lease term.  \n\nCisco’s disclosures note that its customer‑financing arrangements – which, like the Boeing note, can also contain extension or termination options – are accounted for as financing receivables (sales‑type leases) and the related revenue is deferred and then recognized ratably over the period the services are performed; when Cisco provides a guarantee on those arrangements it records a liability for the fair‑value of the guarantee and defers the associated revenue until the guarantee is removed.  \n\nThus, TXN’s practice brings the extension/termination option directly into a long‑term lease liability and expense, whereas Cisco treats the same type of provision within a financing‑receivable framework, deferring revenue (and, if guaranteed, recording a separate liability) rather than increasing lease liabilities up‑front.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments includes lease extension/termination options in lease liabilities when 'reasonably certain' they will be exercised, using present value and impacting long-term liabilities—this matches the original answer. Cisco treats similar provisions in customer financing arrangements as sales-type leases (financing receivables), defers revenue, and recognizes it over time, especially when guarantees are involved, which affects revenue timing and credit exposure. The LLM correctly identifies that TXN's treatment impacts lease liabilities and expenses, while CSCO's affects revenue recognition and may involve a separate guarantee liability. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all qualitative financial treatments are correctly described—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes across two different companies (TXN and CSCO), two different accounting standards (lease accounting vs. revenue recognition in financing arrangements), and contrasts their implications on liabilities vs. revenue. The only minor shortcoming is that the LLM does not explicitly mention Cisco's use of collateral in customer financing (noted in the ground truth), which slightly reduces completeness. However, this does not affect the core financial impact described. (4) The answer is contextually excellent—directly addresses the comparison, uses correct terminology (e.g., 'financing receivables', 'sales-type leases', 'deferred revenue'), and draws a clear distinction in financial statement impacts. Overall, the answer is semantically equivalent to the ground truth with only a minor omission, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Contains]-> FIN_INST <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 511,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic – disclosed in its DMED segment as a 73 % interest in the domestic National Geographic network – gives Disney direct control over the channel’s documentary library, which is presented as a dedicated “National Geographic” tile on Disney+ alongside Disney, Pixar, Marvel and Star Wars. Because this content is owned rather than licensed, Disney+ can differentiate its catalog with exclusive, low‑cost programming, reducing the incremental expense of adding titles and therefore lowering the cost of acquiring new subscribers compared with YouTube, which must license comparable documentary titles from third‑party providers and incurs higher per‑subscriber licensing costs. The KG reflects Disney (ORG) has a stake in National Geographic (COMP), National Geographic content is included in Disney+ (PRODUCT), and Disney+ competes with Google (ORG).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic is accurately stated, and the integration of National Geographic as a top-level tile on Disney+ is correctly described. The answer correctly identifies that this ownership allows Disney to use the content without licensing fees, reducing costs. The comparison to YouTube's reliance on third-party licensing is valid and contextually appropriate. (2) Quantitative accuracy is perfect: the 73% stake is correctly cited, and no other numerical values require verification. Format and precision match the original. (3) Multi-hop reasoning is sound: the model connects Disney's ownership of National Geographic → exclusive content on Disney+ → reduced content acquisition costs → competitive advantage in subscriber acquisition cost relative to YouTube. This synthesis across ownership, content strategy, and cost structure is logically coherent and supported by the knowledge graph. (4) The only minor shortcoming is that the LLM slightly overemphasizes the DMED segment disclosure, which was not part of the original answer’s focus, and does not explicitly mention YouTube's 'ongoing licensing expenditures' as a structural contrast. However, the core implication about higher per-subscriber costs for YouTube is effectively conveyed. Wording differs but semantic meaning and factual content are equivalent. No factual errors, minor stylistic over-specification does not detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Includes]-> PRODUCT <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 423,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologic products are subject to a statutory 12‑year regulatory exclusivity (with a possible six‑month pediatric add‑on) that bars the FDA from approving a biosimilar until that period ends, thereby extending market protection beyond the life of any underlying patents (Chunk 1 & 2). By contrast, Merck’s Januvia family saw its key U.S. patent expire in January 2023, but favorable court rulings and settlement agreements have pushed the loss of market exclusivity back to May 2026 for Januvia and July 2026 for Janumet XR, effectively extending protection beyond the patent term through legal mechanisms rather than a fixed regulatory exclusivity term (Chunk 3). Thus, BMY relies on a defined regulatory‑exclusivity timeline to shield its biologics, whereas MRK’s experience shows that market exclusivity can also be prolonged by litigation outcomes, with both approaches serving to keep generic or biosimilar competition at bay beyond patent expiration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BMY's 12-year biologic exclusivity (with mention of possible pediatric extension, which is accurate though not in the original answer), MRK's Januvia patent expiration in January 2023, and market exclusivity extended to May 2026 for Januvia and July 2026 for Janumet XR. The dates match exactly with the ground truth. (2) Quantitative accuracy is perfect: all dates (January 2023, May 2026, July 2026) are correct, and the 12-year exclusivity period is accurately stated. The LLM correctly notes that MRK’s extension came via legal mechanisms, not regulatory exclusivity. (3) Multi-hop reasoning is sound: the model correctly contrasts BMY’s reliance on statutory regulatory exclusivity for biologics with MRK’s use of litigation and secondary patents for small molecules, synthesizing across different regulatory frameworks. (4) The only minor shortcoming is that the LLM omits explicit mention of Janumet (non-XR) having exclusivity until July 2026 as well—though it does mention Janumet XR. This is a small omission but does not undermine the overall correctness. The answer also correctly identifies the strategic difference in how market protection is extended beyond patents. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 411,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 2024 filing shows that it has issued 40,000 shares of its 4.75 % non‑cumulative Series F preferred stock (Chunk 1) and that, under the redemption terms, it may redeem the entire issue within 90 days of a “rating‑agency event” at $25,500 per share (plus accrued dividends) before March 15 2025 (Chunk 2). A “rating‑agency event” is defined as any change by a rating agency that lowers the equity credit of the security, i.e., a downgrade. AIG’s 10‑K likewise flags rating‑agency downgrades as a risk that could limit its ability to write new business and impair customer retention (Chunk 3). Thus, a downgrade that would trigger MetLife’s redemption obligation also constitutes the same rating‑downgrade risk factor that AIG identifies as threatening its business and liquidity, linking MetLife’s potential cash outflow from the Series F redemption directly to AIG’s exposure to rating‑downgrade‑driven financial risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and terms are correct: 40,000 shares of Series F preferred stock, 'rating-agency event' defined as a change lowering equity credit, redemption at $25,500 per share plus accrued dividends within 90 days before March 15, 2025—these details are factually consistent with typical SEC filing disclosures and enhance precision beyond the original answer without contradicting it. (2) The definition of a 'rating-agency event' as effectively a downgrade due to reduced equity credit is correctly interpreted. (3) The multi-hop reasoning linking MetLife’s contingent redemption obligation to AIG’s exposure to rating downgrades is sound: both are tied to rating agency actions impacting financial strength perception, though the mechanisms differ (MetLife faces a potential cash outflow; AIG faces business constraints). The LLM correctly synthesizes this parallel risk exposure across companies. (4) The answer adds specific contractual details (redemption price, deadline) not in the original answer, which improves precision but does not distort the core logic. One minor point preventing a perfect 10 is that the LLM implies a direct linkage—'directly to AIG’s exposure'—which slightly overstates the connection; the risks are parallel, not causally linked. However, this is a nuance in emphasis rather than a factual error. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 421,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s balance sheet shows $121 million of U.S. Government securities classified entirely in Level 2 as of 12/31/21, which under its accounting policy (Chunk 2) means they are valued with matrix pricing (or yield‑curve/ index methods) when quoted broker prices are not available. UPS, by contrast, places most U.S. government debt securities in Level 1 and values them at quoted market prices; its matrix‑pricing approach is reserved for other Level 2 assets such as corporate and municipal bonds (Chunk 3). Thus LMT relies on matrix pricing for its Level 2 government‑security holdings, whereas UPS generally does not use matrix pricing for its U.S. government securities, applying it only to non‑government Level 2 instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states LMT's $121 million in U.S. Government Securities as of December 31, 2021, classified in Level 2, which aligns with the ground truth. This part is factually accurate. However, the LLM incorrectly claims that UPS generally does not use matrix pricing for U.S. government securities and instead places them in Level 1. The ground truth states that UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt, though the specific amount is not disclosed. Thus, the core comparison is flawed—LLM asserts a divergence in methodology, while the ground truth indicates alignment in using matrix pricing when direct quotes are unavailable. (2) Quantitative accuracy is perfect: the $121 million figure and date (12/31/21) are correct, and no other numbers are misstated. (3) Multi-hop reasoning fails: the model incorrectly infers that because UPS uses quoted prices for some government securities (Level 1), it does not use matrix pricing for others in Level 2, but the ground truth confirms UPS *does* apply matrix pricing to U.S. government debt within Level 2 when appropriate. The synthesis across LMT and UPS is therefore invalid. (4) Contextual relevance is high—the answer addresses the question’s focus on valuation methodologies and Level 2 classifications—but the qualitative inaccuracy in representing UPS’s methodology severely undermines the conclusion. Hence, correctness and qualitative accuracy are low despite strong quantitative performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 422,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PM values its derivative contracts with “standard valuation models that use, as their basis, readily observable market inputs” – spot foreign‑exchange rates, interest‑rate differentials and contract maturities – a Level 1, highly observable approach (Chunk 1). MDLZ, on the other hand, values its real‑estate fund holdings using net‑asset‑value calculations of participation units (supported by actual purchase‑sale prices) together with periodic appraisals and discounted‑cash‑flow projections that rely on both observable market data and unobservable assumptions (Level 2/Level 3 inputs) (Chunks 2 & 3). Thus PM’s model is based almost entirely on observable market prices, whereas MDLZ’s real‑estate valuations incorporate a mix of observable and judgment‑based inputs, making them less directly observable.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately identifies that PM uses standard valuation models based on observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturities, which corresponds to Level 1 or 2 fair value measurements. This matches the original answer. (2) For MDLZ, the LLM correctly states that real estate fund investments are valued using net asset value calculations, appraisals, and discounted cash flow projections, incorporating both observable and unobservable inputs. However, the original answer specifies that MDLZ relies primarily on unobservable inputs (e.g., projected operating performance, local market conditions), leading to Level 3 classification. The LLM answer softens this by stating 'Level 2/Level 3 inputs', which is less precise—while not entirely incorrect, it underemphasizes the dominance of unobservable inputs noted in the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s highly observable, market-driven approach with MDLZ’s more judgment-based method, capturing the core of the question. (4) There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (PM, MDLZ, derivatives, real estate funds) are correctly identified. The answer is contextually relevant and directly addresses the comparison of observability in valuation models. The slight deduction in qualitative and overall correctness is due to the imprecise characterization of MDLZ’s valuation level—original answer clearly states Level 3, while LLM suggests a mix of Level 2/3, which slightly misrepresents the degree of observability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 470,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures are subject to a set of liquidity‑linked covenants that limit how and when the company can retire the securities.  MetLife may elect to defer interest on the debentures, but any elective deferral triggers the dividend‑stopper provisions and the company can only repay, redeem or purchase the notes after it first receives cash proceeds from the sale of designated replacement securities – a restriction that ties repayment directly to available liquidity and regulatory capital tests. In contrast, the AIGLH junior‑subordinated debentures that AIG inherited are simply outstanding debt (‑ $54 m due 2030, $142 m due 2046 and $31 m due 2045) that are guaranteed by the AIG parent; the filing mentions no deferral right or liquidity‑related covenants, so AIG’s obligation is a fixed‑rate, guaranteed liability without the repayment‑deferral mechanisms that constrain MetLife.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: MetLife's deferral provisions, dividend stopper triggers, and replacement capital covenants are accurately described. AIGLH's debentures are correctly detailed with $54M due 2030 (8.5%), $142M due 2046 (8.125%), and $31M due 2045 (7.57%), all guaranteed by AIG Parent. The LLM correctly notes that AIG does not guarantee AIGLH borrowings post-distribution, though this nuance is slightly less emphasized than in the original. (2) Quantitative accuracy is perfect: all dollar amounts, interest rates, and maturities match exactly. Format variations (e.g., $54 million vs $54M) are acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the model synthesizes information across MetLife’s deferral and repayment constraints versus AIG’s fixed, guaranteed obligations without deferral rights. The contrast in liquidity constraints and deferral provisions is clearly and logically drawn. (4) Semantic equivalence is strong—wording differs but meaning is preserved. One minor point: the original emphasizes AIG’s lack of guarantee on AIGLH borrowings post-distribution as a key differentiator in liquidity risk, which the LLM mentions indirectly but could have highlighted more explicitly. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Repay]-> FIN_INST -[Issues]-> COMP <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 389,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA lists Samsung as a direct rival in the SoC and GPU space (NVDA 10‑K, p.15), which signals Samsung’s strong design‑and‑fabrication capabilities in the same product categories where Intel hopes to win foundry business. Intel’s IFS Foundry Services must now contend with Samsung’s established foundry operation (Intel 10‑K, p.54‑55), a challenge made steeper by Intel’s own history of delayed node introductions—its 10 nm rollout and the later postponement of the Intel 4 (formerly 7 nm) process—leaving it behind Samsung on performance, density, yields and time‑to‑market. As a result, NVIDIA’s competition with Samsung highlights the heightened strategic pressure on Intel: to scale IFS it must close the technology‑gap and improve capacity, pricing and reliability enough to attract customers who might otherwise gravitate to Samsung’s superior manufacturing platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets (supported by NVDA 10-K, p.15), Samsung is a competitor to Intel's IFS (Intel 10-K, pp.54–55), and Intel has faced manufacturing delays with its 10nm and Intel 4 (formerly 7nm) processes. These delays have put Intel behind in process performance, time-to-market, yields, and density—key factors for foundry competitiveness. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised; references to process nodes (10nm, Intel 4) are factually correct and contextually appropriate. (3) The multi-hop reasoning is sound: the answer correctly links NVIDIA’s competition with Samsung to Samsung’s strong foundry position, which in turn raises the bar for Intel’s IFS. It recognizes that Samsung’s dual role—as both a product competitor and a foundry player—creates strategic pressure on Intel. The only minor shortcoming is that the answer does not explicitly state that NVIDIA’s pressure on Samsung *indirectly* affects Intel’s IFS scaling, which is a subtle but important causal link emphasized in the original. However, the implication is present through the framing of heightened strategic pressure. (4) The answer is contextually excellent, directly addressing the interplay between competitive dynamics and Intel’s foundry ambitions, with proper sourcing cues from 10-K filings. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for not fully articulating the indirect causal chain, but overall reasoning is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Competes_With]-> PRODUCT <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 462,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 buy‑back of $62 billion was limited to its 1‑vote Class A shares and its non‑voting Class C shares, leaving the 10‑vote Class B shares (which carry the bulk of voting power) untouched; this lets the company return cash without diluting the high‑voting stake held by founders and insiders. Comcast, whose 15‑vote Class B shares—owned entirely by Brian Roberts and representing a non‑dilutable 33.3 % of voting power—remain unchanged, has been repurchasing only Class A shares (as shown by the 872.8 million Class A shares held in treasury), which shrinks the publicly‑held voting pool and thereby concentrates control even further with the single Class B owner. Thus, both firms target lower‑voting or non‑voting stock for repurchases to preserve the influence of their high‑voting share classes, with Comcast’s concentrated Class B ownership making this effect especially pronounced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024; these classes have 1 vote and no votes respectively, while Class B (10 votes) was not repurchased. The answer correctly notes that Class B shares convert to Class A upon sale, preserving founder control. For Comcast, it accurately states that Class B shares carry 15 votes and are fully owned by Brian L. Roberts, representing 33.3% of voting power. The detail about 872.8 million Class A shares in treasury is consistent with known data and supports the reasoning. (2) Quantitatively, all numbers match or are valid rephrasings: $62 billion (vs $62.0 billion), 33.3% (vs 33⅓%), 15 votes, 10 votes—no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that repurchasing low/no-vote shares (Class A/C at Alphabet, Class A at Comcast) preserves and enhances the relative voting power of the high-vote Class B shares. It synthesizes governance impact across both firms and correctly emphasizes the amplification effect in Comcast due to concentrated ownership. (4) Minor deduction in qualitative accuracy because the ground truth mentions automatic conversion of Alphabet’s Class B to Class A upon sale, which the LLM omits—though the effect (preserved control) is still correctly conveyed. Otherwise, the answer is semantically equivalent, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 410,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s 2024 filing calls out NSCLC – non‑small‑cell lung cancer – as a distinct therapeutic focus, underscoring a pipeline aimed specifically at that lung‑cancer indication (Chunk 1). In contrast, Bristol Myers Squibb’s December 2024 FDA approval of Opdivo Qvantig adds a **subcutaneous** formulation of nivolumab (with hyaluronidase) that is cleared for “most previously approved adult solid‑tumor Opdivo indications” as monotherapy, maintenance or in combination (Chunks 2 & 3). Thus, while Amgen concentrates on a single cancer type, BMY is expanding its market by introducing a new injection route that broadens the product’s reach across a wide array of adult solid‑tumor cancers beyond NSCLC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amgen's 2024 focus on NSCLC is accurately reported, and BMS's December 2024 FDA approval of Opdivo Qvantig with subcutaneous administration is correctly dated and described. The administration method (subcutaneous) and its applicability to 'most previously approved adult solid tumor indications' are faithfully represented, including use as monotherapy, maintenance, or in combination. (2) Quantitative elements—specifically the December 2024 approval date—are correct, and no numerical calculations were required. (3) Multi-hop reasoning is sound: the model successfully synthesizes information across Amgen’s strategic focus and BMS’s regulatory and delivery innovation, contrasting a disease-specific approach (Amgen) with a delivery-driven market expansion (BMS). (4) The answer captures the core divergence in strategy between the two companies, though it omits minor contextual details present in the original answer—such as the explicit mention of improved patient adherence and market access due to convenience—making it slightly less comprehensive. However, the omission does not detract from factual correctness or the main comparative insight. Wording differs but semantic equivalence is maintained. No entity errors: company names (Amgen, Bristol Myers Squibb), drug names (Opdivo Qvantig), and indications (adult solid tumors, NSCLC) are all accurate. Overall, this is a strong, factually correct response with only minor room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Impacts]-> PRODUCT <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 427,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "CMCSA’s charter guarantees that the 9,444,375 Class B shares – each carrying 15 votes – always control exactly 33 ⅓ % of the company’s total voting power and that this share cannot be diluted by any future issuance of other stock.  The Class B shares are convertible, share‑for‑share, into Class A shares, but the conversion only adds to the pool of Class A stock; it does not change the fixed 33 ⅓ % voting block held by Class B.  Consequently, the remaining 66 ⅔ % of voting rights belongs to Class A shareholders, and because Alphabet’s (GOOGL’s) holdings are in Class A stock – which under Alphabet’s own rules carries one vote per share – GOOGL can exercise at most that two‑thirds share of the vote.  The protected Class B voting power therefore caps GOOGL’s influence regardless of how many Class A shares it owns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core concept that CMCSA's Class B shares are protected to maintain exactly 33 1/3% of voting power, which limits GOOGL's influence despite its Class A stake. The reasoning about non-dilution and conversion mechanics is sound and aligns with the ground truth. However, the LLM introduces specific quantitative details not present in the original answer or typically public knowledge: '9,444,375 Class B shares' and 'each carrying 15 votes' are precise figures that cannot be verified from the provided ground truth and may be inaccurate or outdated. The ground truth does not specify share count or vote ratio per share—only the structural protection of 33 1/3% voting power. This introduces a risk of factual overreach, lowering quantitative accuracy. The claim that GOOGL can 'exercise at most that two-thirds share of the vote' is misleading; it implies GOOGL holds all remaining Class A shares, while the original answer only states GOOGL holds a stake (not majority). The structural cap on influence is correctly understood, but the extent of GOOGL's voting power is overstated. Despite these issues, the multi-hop reasoning—linking CMCSA’s capital structure to GOOGL’s limited governance impact—is logically sound and contextually relevant. The answer addresses all key aspects of the question with strong qualitative accuracy, even if numerically over-specified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 387,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market (Chunk 2) expands the sales base for PEP, but the gain is partially eroded by a higher estimated prevalence of illicit trade.  Because the illicit‑trade environment is a key socioeconomic concern, PEP’s merger‑related integration charges continue to include sizable liabilities to fund socioeconomic programmes in South Africa (Chunk 1).  The same illicit‑trade prevalence is a risk factor that negatively impacts MO, raising its exposure to regulatory, tax‑revenue and brand‑reputation risks in its international operations (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 13.2% increase in South Africa's tobacco market volume is correctly cited, with no numerical errors. (2) The answer correctly identifies the dual impact on PEP and MO: PEP’s merger-related socioeconomic obligations are tied to integration charges that include funding for socioeconomic programs due to illicit trade concerns—this is consistent with the original answer. For MO, the increased illicit trade prevalence raises risks around regulation, tax revenue, and brand reputation, which maps to the original answer’s mention of lost sales, brand dilution, and regulatory actions. (3) The multi-hop reasoning is sound—linking market growth to illicit trade, then separately to PEP’s financial obligations and MO’s risk exposure is logically and factually valid. (4) Minor wording differences exist (e.g., 'brand-reputation risks' vs 'brand dilution'), but these are semantically equivalent. The only slight gap is that the LLM does not explicitly mention 'legal or regulatory actions against distribution channels' as in the original, but it does reference regulatory risks broadly. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 352,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack – a competitor to Alphabet’s workspace‑communication offerings – was sued in a series of securities class actions tied to its 2019 S‑1 filing; after motions to dismiss, appeals and a brief Supreme Court grant, the Ninth Circuit finally dismissed the complaint with prejudice on Feb. 10 2025, leaving any monetary award unspecified. In contrast, Meta’s privacy‑related litigation has already produced concrete liabilities—a $725 million settlement of a consumer‑privacy class action and a $5 billion FTC penalty paid in 2020—while other government and shareholder suits remain pending, so Meta faces a far larger and ongoing financial exposure.  Procedurally, Slack’s case ended in dismissal, whereas Meta’s cases have resulted in settlements, some dismissals and multiple appeals that are still unresolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's securities litigation was dismissed with prejudice by the Ninth Circuit on February 10, 2025, after a partial denial of a motion to dismiss in 2020 and subsequent appeals, including a brief Supreme Court involvement (implied in the LLM answer but not in the original; this is an acceptable addition if factually correct, though not required). Meta's $725 million privacy settlement (approved in 2023) and $5.0 billion FTC penalty (paid in 2020) are accurately cited. The procedural outcomes—dismissal for Slack versus settlements and ongoing litigation for Meta—are correctly contrasted. (2) Quantitative accuracy is perfect: $725 million, $5 billion, and the 2025 dismissal date match the original. The LLM specifies the exact date (Feb 10, 2025), which is more precise than the original but not contradictory. (3) Multi-hop reasoning is sound: the model correctly synthesizes across Slack’s IPO litigation timeline and Meta’s privacy liabilities, comparing both procedural outcomes and financial exposure. (4) The only minor shortcoming is the mention of a 'Supreme Court grant,' which is not in the original answer and, while potentially accurate (e.g., certiorari granted but later dismissed), introduces a detail not confirmed in the ground truth. This does not undermine correctness but slightly reduces qualitative accuracy. Otherwise, the answer is contextually complete, directly addressing procedural outcomes and financial liabilities as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 429,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PM’s RSU awards vest in a single “cliff” on the third anniversary of the grant, yet the company expects to expense the $160 million of un‑recognized RSU compensation over a weighted‑average period of only about 17 months. Walmart, on the other hand, changed its RSU vesting from a 25 %‑per‑year, four‑year schedule to roughly 8 % each quarter over three years, so the fair‑value cost of those units is now recognized ratably over a three‑year period (instead of four). Consequently, PM’s RSU expense is recognized much more quickly (≈1½ years) than Walmart’s, whose new schedule spreads expense over a longer three‑year horizon, though that horizon is shorter than Walmart’s prior four‑year schedule.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual and reasoning errors that significantly undermine its correctness. (1) Quantitatively, while the $160 million unrecognized cost for PM and the 17-month weighted-average recognition period are correctly stated, the LLM incorrectly interprets the implication: it claims PM recognizes expenses over ~17 months as 'much more quickly' than WMT’s three-year schedule. However, the ground truth clarifies that PM’s vesting is cliff-based (three years or upon specific events), meaning cost recognition is back-loaded, not accelerated. The 17-month weighted average may reflect expected turnover or early vesting events but does not imply faster overall recognition than WMT’s new schedule. (2) For WMT, the shift from 25% annual over four years to 8% quarterly over three years is accurately described numerically (8% x 12 quarters = 96%, close enough to 100%), so quantitative accuracy is acceptable. However, the LLM incorrectly concludes that WMT now spreads costs over a 'longer three-year horizon' compared to PM—this is false: WMT’s new schedule is shorter than the prior four-year one and leads to earlier and more even recognition than PM’s cliff vesting. (3) The core multi-hop reasoning is flawed: the question asks how differing vesting timelines affect cost recognition periods. The ground truth correctly states that WMT’s change accelerates and smooths recognition relative to its prior model and results in earlier cost recognition than PM’s back-loaded structure. The LLM reverses this logic, claiming PM recognizes costs faster, which is incorrect. (4) Entity accuracy is good—PM and WMT are correctly identified, fiscal 2023 change at WMT implied correctly, and RSU terminology used appropriately. (5) Contextual relevance is high—the answer addresses both companies, vesting schedules, and cost recognition. But due to the fundamental misinterpretation of the direction of the comparison (accelerated vs. back-loaded), the qualitative and overall correctness scores are low. The answer gets facts partially right but synthesizes them into an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Vest]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 567,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing warns that, because of ongoing federal‑tax audits, it could see a **$620 million** reduction in unrecognised tax benefits over the next 12 months – a concrete, potentially material exposure – but it also notes that the OECD’s 15 % global minimum‑tax (Pillar 2) is not expected to raise its tax cost because it has no material operations in jurisdictions with rates below the Pillar 2 floor. Lockheed Martin, which is subject to the same OECD Pillar 2 framework that will take effect in stages (some aspects on 1 Jan 2024 and others on 1 Jan 2025, with varied timing across countries), says it does **not** expect Pillar 2 to have a material impact on its effective tax rate, consolidated results, or cash flows. Thus Boeing’s risk is a specific, dollar‑amount exposure, whereas Lockheed Martin’s assessment is a qualitative judgment that the staggered implementation of Pillar 2 will be immaterial to its taxes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's $620 million risk in unrecognized tax benefits due to federal tax audits is accurately stated; the 15% OECD global minimum tax (Pillar 2) is correctly noted; Lockheed Martin's assessment of no material impact on effective tax rate, consolidated results, or cash flows is correctly reported. (2) Quantitative accuracy is perfect: the $620 million figure, 15% rate, and implementation dates (1 Jan 2024 and 1 Jan 2025) are all factually correct and match the original answer. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly contrasts Boeing’s specific dollar-amount exposure with Lockheed Martin’s qualitative, forward-looking assessment, highlighting the differing nature of their risks under Pillar 2. It synthesizes information across both companies and the OECD framework. (4) The only minor shortcoming is that the LLM omits the reference to General Electric’s evidence about varied national adoption timelines and modifications to domestic incentives, which adds contextual nuance in the original answer. However, this does not undermine the core comparison between Boeing and Lockheed Martin. The answer remains semantically equivalent in substance and fully addresses the question’s main thrust. Hence, a score of 9 is warranted—excellent accuracy with only a minor omission in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 406,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "ASU No. 2023‑07 adds a requirement that a company disclose disaggregated expense information for each reportable segment. PepsiCo’s 2024 filing says it will recast its segment presentation to reflect a new structure—PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods, International Beverages Franchise and the EMEA bottling segment—and that this recasting will begin in the first quarter of 2025. Because the new structure will be reported under the ASU, PepsiCo will have to provide the incremental, segment‑level expense footnotes that the standard now mandates for those newly defined segments starting in Q1 2025.  \n\nAltria (MO) has already adopted ASU 2023‑07, expanded its footnote disclosures (Note 17), and states it will include the interim‑period segment‑information requirements in its condensed interim statements beginning in the first quarter of 2025. Thus Altria’s adoption timeline and disclosure obligations line up with PepsiCo’s – both companies will be meeting the same ASU‑driven segment‑reporting requirements at the same time, with PepsiCo applying them to its newly reorganized segments and Altria applying them to its existing segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will recast its segment reporting starting Q1 2025 under ASU No. 2023-07, which mandates disaggregated expense disclosures by reportable segment. Altria adopted the standard in 2024 and will implement interim requirements in Q1 2025. These dates and timelines match the original answer. (2) Quantitative accuracy is perfect: no numerical errors; all dates (Q1 2025 for both companies’ enhanced reporting) are correct. (3) The multi-hop reasoning is sound—correctly linking ASU adoption, segment reorganization, retrospective application, and cross-company timeline alignment. The only minor discrepancy is that the LLM lists 'International Beverages Franchise' and 'EMEA bottling segment' as part of the new structure, which are not explicitly mentioned in the ground truth, though they may be implied within the broader reorganization. This does not contradict the truth but adds detail not confirmed. (4) The answer fully addresses both parts of the question—PepsiCo’s reporting changes and Altria’s adoption timeline—and correctly concludes that both companies align with the ASU’s effective dates. Wording differs slightly but meaning is semantically equivalent. Thus, high scores across all dimensions with a 9 on correctness due to slight over-specification of segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 384,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 (sotatercept) has a clearly‑stated U.S. patent expiration of 2027 for the product itself (Chunk 1), and, as a biologic, it will also receive 12 years of data exclusivity on approval plus method‑of‑use patents that run until 2037 (Chunk 2). In contrast, Pfizer’s biologics portfolio is protected by a “basic product” patent term that can be lengthened through pediatric exclusivity, supplementary protection certificates and later‑expiring patents (Chunk 3), giving Pfizer a more flexible, potentially longer exclusivity horizon that depends on the success of those extensions. Thus, Merck’s timeline is fixed (2027 / 2037 with a 12‑year exclusivity window), whereas Pfizer relies on a layered extension strategy that can push protection beyond the basic expiry date.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding Merck's exclusivity timeline. Quantitatively, the key dates (2027 base expiration and 2037 potential extension) are correctly stated, matching the original answer. The mention of 12 years of data exclusivity for biologics is factually accurate under U.S. law (BPCIA), though the original answer does not specify this duration—this addition is contextually valid but introduces a detail not confirmed in the ground truth for sotatercept specifically. The LLM correctly identifies that Merck’s protection could extend to 2037 via later-expiring patents or PTEs, which matches the original. On Pfizer’s side, the LLM accurately describes their use of pediatric exclusivity, SPCs, and layered patents as part of a flexible extension strategy, consistent with the original answer’s emphasis on variability due to external factors. The comparison between Merck’s more fixed timeline and Pfizer’s adaptive, multi-layered approach is logically sound and represents valid multi-hop reasoning across both companies’ strategies. However, the LLM implies that the 2037 date for Merck is tied to method-of-use patents rather than explicitly citing patent term extensions (PTEs), which are highlighted in the original answer. This shifts the rationale slightly without contradicting it, but introduces ambiguity about the mechanism of extension. Overall, core facts and numbers are correct, reasoning is strong, and the answer addresses all parts of the question, warranting a high score with minor deduction for imprecision in attributing the 2037 date.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 450,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Cost overruns on fixed‑price contracts erode Lockheed Martin’s profit‑booking rates and force “reach‑forward” loss provisions – the company now carries roughly $270 million‑$280 million of cumulative losses on a classified development contract and a ground‑radar program – which directly depress segment operating profit, margins and cash flow. The same overruns, magnified by today’s high‑inflation environment that pushes material, component and labor costs higher and by the technical complexity of large, multi‑party projects, create operational‑execution risk for GE: schedule delays, penalties or liquidated‑damage claims and other unanticipated expenses that strain cash flows and can materially hurt profitability and overall financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $270 million and $280 million cumulative reach-forward losses for Lockheed Martin are correctly reported, with appropriate context on the contracts (classified development and ground-radar program), matching the original answer's figures as of December 31, 2023. Format variation (e.g., $270 million vs $270M) is acceptable and semantically equivalent. (2) The explanation of inflationary pressures—material, labor, component costs—and technical complexity impacting fixed-price contracts aligns with RTX’s 10-K insights cited in the ground truth, even though RTX is not explicitly named; however, this is a minor omission since the focus is on Lockheed Martin and GE. (3) For GE, the LLM correctly identifies operational execution risks: schedule delays, penalties, liquidated damages, and financial strain in complex multi-party projects, which corresponds to the original answer’s emphasis on Power and Renewable Energy segment challenges and consortium liabilities. (4) The reasoning is sound and synthesizes multi-hop elements: linking cost overruns to financial impacts (profit margins, cash flow) for Lockheed Martin and operational risks for GE under inflation and complexity. The only minor gap is the lack of explicit mention of 'joint liability in consortiums' and the specific GE segments, but the core operational and financial risks are accurately conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 433,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ hedges the price risk of raw‑material inputs by entering into exchange‑traded commodity futures (and listed options).  These contracts are classified as Level 1 financial liabilities, so their fair value is taken directly from quoted market prices on the commodity exchanges and is recorded on the balance sheet (asset‑ or liability‑side) with unrealized gains or losses recognized in earnings or OCI.  By contrast, COST reports that it held **no** Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis, meaning it has no commodity‑future exposure and its derivative‑related liabilities are limited to Level 2 instruments such as senior notes, which are valued using observable inputs rather than exchange‑quoted prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MDLZ uses exchange-traded commodity futures for raw materials (e.g., cocoa, sugar, wheat), which are classified as Level 1 financial liabilities measured at fair value using quoted market prices. COST disclosed no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022 (date implied in context), indicating no exposure to exchange-traded derivatives like commodity futures. (2) There are no numeric inaccuracies—while no specific dollar amounts are mentioned, the qualitative classification of fair value levels is factually correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), compares their derivative instruments, and links the use of commodity futures to fair value hierarchy levels (Level 1 vs Level 2). It correctly infers that absence of Level 1 liabilities implies no direct commodity futures exposure for COST. (4) The only minor shortcoming is that the LLM mentions COST’s derivative-related liabilities being limited to Level 2 instruments such as senior notes—this detail, while plausible, is not explicitly confirmed in the original answer and slightly extends beyond the provided ground truth. However, this does not introduce factual error but adds interpretive context. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 428,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s Class A shares are fully convertible into Class B shares, and the company had **4.6 billion Class A shares authorized as of December 31, 2024** (Chunk 2 & 3).  \n\nLockheed Martin reported that the separate trust set aside for its non‑qualified defined‑benefit pension plans held **$658 million in assets as of December 31, 2024** (Chunk 1).  \n\nThus, the number of convertible UPS Class A shares (billions of shares) is a vastly larger quantity than the modest $658 million of assets held in Lockheed Martin’s non‑qualified pension trust.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: 4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets as of December 31, 2024—both match the original answer exactly, with acceptable formatting (e.g., '4.6 billion' and '$658 million'). (2) The answer addresses both parts of the multi-part question: the number of convertible UPS shares and the comparison to Lockheed Martin’s pension assets. (3) Entity accuracy is strong: UPS and Lockheed Martin are correctly identified, along with the relevant financial instruments (Class A/B shares, nonqualified pension trust). (4) The reasoning is sound: the model correctly synthesizes information across entities and time (same date), and the qualitative comparison (billions vs. millions) is logically valid and contextually appropriate. The only minor limitation is the use of 'authorized' shares instead of 'outstanding' or 'convertible'—though in context and based on the source chunks referenced, it appears the 4.6 billion refers to the pool of convertible shares, which matches the ground truth. This nuance does not materially misrepresent the facts. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Held_By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 361,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s outstanding fixed‑rate senior notes are quite sensitive to market rates – a 50‑basis‑point rise or fall would move the aggregate fair value of the $56.3 billion of notes by roughly $1.7 billion (about $1.4 billion a year earlier) even though the interest expense would not change, and AVGO only uses treasury‑rate‑lock contracts for future issuances rather than a swap on the existing notes. By contrast, Cisco (CSCO) has entered into a $0.5 billion‑notional interest‑rate swap that is designated as a fair‑value hedge; the swap converts the fixed‑rate portion of its senior notes to floating (SOFR‑based) and the gain or loss on the swap is recorded in interest expense, substantially offsetting the fair‑value impact of any rate move on the hedged debt. Thus AVGO’s exposure remains large and un‑hedged on the existing notes, while CSCO’s swap neutralizes the interest‑rate sensitivity for the portion of debt it hedges.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key numbers are correct: AVGO's $56.3 billion in fixed-rate senior notes, $1.7 billion decline in fair value from a 50 bps rate increase (as of November 3, 2024, implied by context), and CSCO's $0.5 billion notional interest rate swap. The mention of $1.4 billion a year earlier is additional context not contradicted by the original answer. (2) Quantitative accuracy is perfect: dollar amounts, basis points, and financial impacts match or are consistent with the ground truth. Format variations (e.g., $56.3 billion vs $56.3 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly contrasts AVGO’s lack of hedging on existing debt (only using treasury-rate locks for future issuances) with CSCO’s active use of a fair-value hedge via an interest rate swap tied to SOFR, which offsets fair value changes. (4) Entity accuracy is strong: both companies (AVGO, CSCO), financial instruments (fixed-rate senior notes, interest rate swaps), and mechanisms (SOFR, fair-value hedging) are correctly identified and contextualized. The conclusion that AVGO has large unhedged exposure while CSCO mitigates risk on a portion of its debt is logically derived and fully aligned with the original answer. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 380,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "Both companies disclose a VAR model that is run under normal‑market‑conditions, a 95 % confidence level and a one‑day holding period, but they use the parametric delta‑gamma approximation in different ways.  \n\n- **PM** applies the technique mainly to capture the observed inter‑relationships between interest‑rate movements and forward‑currency rates and to calculate the risk of the underlying derivative positions; it does not reference commodity exposures or option‑specific adjustments.  \n- **MDLZ** uses the same delta‑gamma approximation to generate the expected‑return distribution for three separate asset classes—fixed‑income (interest rates), currency‑exchange and commodities—and explicitly values currency and commodity options (which do not move one‑for‑one with their underlyings), thereby extending the method beyond the interest‑rate/currency focus of PM.  \n\nThus, while both rely on a parametric delta‑gamma VAR under normal market conditions, PM’s application is narrower (interest‑rate‑currency inter‑relationships), whereas MDLZ’s is broader, covering interest rates, currencies, commodities and option‑adjusted valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both PM and MDLZ use the parametric delta-gamma approximation within VAR models under normal market conditions with a 95% confidence level and one-day horizon—though these specifics were not in the original answer, they are consistent with standard VAR disclosures and do not contradict the ground truth. (2) Quantitatively, no specific numbers (e.g., dollar amounts, exact percentages) are mentioned in either answer, so no discrepancies exist; the timeframes (prior quarter for year-end, four prior quarters for average VAR) are accurately reflected in spirit, though the LLM does not explicitly mention 'high and low VAR amounts' for MDLZ, which is a minor omission. (3) The multi-hop reasoning is sound: the LLM correctly contrasts PM’s focus on interest rates and forward currency rates without commodity exposure, versus MDLZ’s inclusion of commodities and explicit treatment of non-linear option behavior. The mention of 'option-adjusted valuations' and 'non-one-for-one movement' effectively captures MDLZ’s explicit accounting for option non-linearity, as stated in the ground truth. (4) The only minor gap is that the LLM does not explicitly state that MDLZ uses the four prior quarters for average, high, and low VAR amounts—though it does reference 'average VAR amounts'—but this does not undermine the core accuracy. Overall, the answer is semantically equivalent, with excellent qualitative reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Relates_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 424,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 10‑K makes clear that the company is deliberately using its global scale and local presence to “increase the adoption of our products and services in markets around the globe” and to ensure that “patients around the world deserve access” to its life‑saving therapies – a positive driver of patient‑access risk. By contrast, Amgen’s filing describes how payers—especially the PBM Express Scripts—are leveraging rebate‑management organizations to demand deeper discounts, impose step‑therapy and prior‑authorization requirements, and otherwise restrict out‑of‑pocket costs, which has “limited … patient affordability and use” of its drug Repatha and could materially hurt Amgen’s sales. Thus, Medtronic is proactively expanding global patient access, while Amgen is battling payer‑driven discount pressure that curtails affordability and limits access to its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Medtronic's emphasis on global patient access via its local presence and product pipeline (from its 2024 10-K) is accurately represented, as is Amgen's challenge with payer pressure—specifically Express Scripts—limiting access to Repatha through rebate-driven formulary restrictions. (2) There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is 10; all references to market structure (e.g., 'top six PBMs') are consistent in meaning even if not explicitly quantified in the LLM response. (3) Multi-hop reasoning is sound: the model correctly synthesizes Medtronic’s proactive access strategy with Amgen’s reactive struggle against PBM-driven affordability barriers, linking Express Scripts’ use of rebate management organizations to real-world outcomes like step therapy, prior authorization, and patient abandonment. (4) The LLM omits the specific statistic about the top six PBMs controlling 94% of U.S. pharmacy prescriptions and does not mention Medicare patient prescription abandonment due to high co-pays—minor but relevant contextual details present in the original. However, these omissions do not undermine the central argument or factual correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is perfect—the response directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Positively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> COMP <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 412,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is directed exclusively at its low‑voting Class A shares (one vote per share) and its non‑voting Class C shares – it repurchased $50.3 billion in 2021, $59.3 billion in 2022 and $62.2 billion in 2023, and in April 2023 authorized an additional $70 billion of such repurchases, leaving $36.3 billion still available.  By shrinking the outstanding pool of Class A stock, which is the class into which every 10‑vote Class B share can be converted at any time, Alphabet limits the number of shares that could be created through conversion and thereby preserves the voting power of the high‑vote Class B holders.  The fact that Class A Common Stock is also publicly traded by Comcast (CMCSA) underscores that Class A shares are market‑traded, but Alphabet’s focus on repurchasing its own Class A and Class C shares signals a strategic effort to manage its internal voting control rather than affect the broader market for Class A securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $62.2 billion repurchase amount in 2023 and $36.3 billion remaining authorization are correct. However, the LLM adds repurchase figures for 2021 ($50.3B) and 2022 ($59.3B) and mentions a $70B authorization in April 2023, which are not present in the original answer. While these details may be factually correct, they go beyond the provided ground truth and introduce unverified data, slightly reducing quantitative accuracy. (2) The core financial figures from the original—$62.2B repurchased in 2023 and $36.3B remaining—are accurately reported. (3) Qualitatively, the reasoning is sound: the LLM correctly explains that repurchasing Class A and C shares (rather than Class B) preserves the relative voting power of Class B shares, since Class B can be converted to Class A at any time. It also correctly notes that Class B shares carry 10 votes and are convertible, and that avoiding repurchases of Class B helps maintain concentrated voting control. (4) The mention of Comcast (CMCSA) trading Class A common stock is accurately included and correctly interpreted as evidence that Class A shares are a market-standard voting class, reinforcing Alphabet’s strategic governance motive. The synthesis across Alphabet’s share structure, repurchase behavior, conversion rights, and external market context (Comcast) demonstrates strong multi-hop reasoning. The only minor issue is the inclusion of extra repurchase data not in the ground truth, which does not contradict but exceeds it—hence a score of 9 rather than 10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 444,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group, which sits among the six largest integrated health plans and PBMs, routinely uses step‑therapy, prior‑authorization and heavy rebate demands to reshape formularies – actions that have already narrowed patient access to Amgen’s high‑cost biologic Repatha (Chunk 2). Eli Lilly’s biologic revenue growth is explicitly tied to patient access (Chunk 3), and in a market already pressured by insurers and payers that can force price cuts and erode market share (as Gilead notes in its discussion of pricing pressure from payers and competition – Chunk 1), UnitedHealth’s formulary restrictions would likely reduce utilization of Lilly’s biologics, compel deeper discounts and therefore hamper the company’s ability to maintain its revenue‑growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UnitedHealth Group is correctly identified as one of the top six integrated health plans and PBMs with significant formulary control; the reference to Repatha's access challenges due to prior authorization and step-therapy is consistent with the original; Eli Lilly's dependence on patient access for biologic revenue growth is accurately cited. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) Multi-hop reasoning is sound: the model correctly links UnitedHealth’s restrictive practices (using Repatha as a case study) to broader payer pressure in the biologics market, and logically infers that similar restrictions could hinder Eli Lilly’s revenue growth by reducing utilization and forcing discounts. The mention of Gilead’s experience adds contextual support about payer pressure, though it is not in the original answer—it does not detract from accuracy but slightly extends beyond the provided evidence. (4) Semantic equivalence is strong: the core conclusion—that formulary restrictions by dominant payers like UnitedHealth may constrain Eli Lilly’s revenue growth due to reduced access—is fully aligned with the ground truth. The only minor limitation is the introduction of Gilead as an additional example, which, while contextually relevant, is not part of the original knowledge graph answer and slightly dilutes focus. However, this does not introduce inaccuracy. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 458,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3 billion commercial‑paper program is a standby facility that lets the company issue unsecured short‑term promissory notes, but Oracle reported that no commercial‑paper notes were outstanding as of May 31 2022, so the program was not being used at that time. In contrast, Cisco carries $9 billion of senior fixed‑rate notes (carrying $8.9 billion, fair‑valued at $9.7 billion) that are treated as being at par with any commercial‑paper it might issue under its short‑term debt program, and Cisco hedges $1.5 billion of that debt with interest‑rate swaps and retains the right to redeem the notes at any time. Thus, both companies have exposure to short‑term financing mechanisms, but Oracle’s exposure is dormant, whereas Cisco’s senior‑note exposure is active and managed through hedging and redemption provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: Oracle's $3.0 billion commercial paper program with zero outstanding as of May 31, 2022, and Cisco's $9.0 billion in senior fixed-rate notes outstanding as of July 30, 2022, are accurately reported. The LLM adds additional detail—fair value of $9.7 billion and carrying amount of $8.9 billion—which is consistent with typical 10-K disclosures and does not contradict the ground truth. The $1.5 billion hedged via interest rate swaps is correctly stated. (2) The date for Cisco’s disclosure (July 30, 2022) is slightly different from Oracle’s (May 31, 2022), but the LLM correctly reflects this distinction without conflating timelines. (3) The reasoning is sound: the comparison between Oracle’s dormant commercial paper program and Cisco’s active, hedged long-term debt structure is logically synthesized and captures the multi-hop nature of the question. (4) The LLM correctly identifies that Cisco’s senior notes rank at par with potential commercial paper, indicating shared exposure to short-term mechanisms, and notes Oracle’s non-utilization of its facility. The only minor deviation is the addition of redemption rights and fair value details not present in the ground truth, but these are plausible and do not introduce inaccuracies. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 399,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The extension of ASU 2022‑06 through December 31 2024 lets both companies keep any LIBOR‑referenced hedges in place under the optional relief. FedEx notes that, because of the ASU, its existing LIBOR‑linked contracts and hedging relationships can continue to be accounted for using the expedients, which has so far had no material effect on its results and lets it monitor the contracts without having to unwind or re‑designate them. Caterpillar’s interest‑rate risk program—fixed‑to‑floating swaps and forward‑rate agreements that it designates as fair‑value or cash‑flow hedges—also falls under the same relief, so the company can maintain those derivatives and their hedge accounting through 2024 without the operational or financial disruption that a forced LIBOR transition would otherwise create.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 is extended until December 31, 2024, which matches the original answer. FedEx continues to use the expedients without material impact, and Caterpillar benefits from continued hedge accounting for its interest rate derivatives. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' is correctly cited, and no erroneous figures are introduced. Format is consistent and precise. (3) Multi-hop reasoning is sound—LLM correctly synthesizes how the ASU extension impacts both companies' LIBOR-related risk management and derivative accounting. It accurately distinguishes FedEx's monitoring approach from Caterpillar's active hedging program, reflecting entity-specific strategies. (4) The answer is contextually relevant and fully addresses the question. The only minor shortcoming is that the LLM does not explicitly state that both companies are using the relief to support a smooth transition away from LIBOR, a point emphasized in the original answer. However, this is implied in the explanation about avoiding disruption. Wording differs slightly but semantic meaning and factual content are equivalent. No factual errors or omissions affect the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 360,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s October 2019 five‑year credit agreement names **Citibank, N.A.** only as the **administrative agent**, while **JPMorgan Chase Bank, N.A.** serves as the **syndication agent** and together with Citibank acts as joint lead arranger and book‑manager; the only amendment to that facility was **Amendment No. 1 dated August 25 2022** (no 2023 amendment is disclosed).  \n\nCaterpillar’s September 2022 multi‑facility (3‑year and 5‑year) credit agreements also name **Citibank, N.A.** as the **sole agent** (with Citibank Europe and MUFG as local‑currency agents) and do not list a separate syndication agent; the agreements were newly executed in 2022 and each was **amended once in August 2023 (Amendment No. 1 to the 3‑year and 5‑year facilities)**, showing amendment activity in 2023 that Boeing did not have.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement was dated October 30, 2019, and amended on August 25, 2022 (Amendment No. 1), with Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, joint lead arranger, and joint book manager—this matches the original answer. Caterpillar’s 3-Year and 5-Year Facilities were executed on September 1, 2022, with Citibank, N.A. as agent, and amended in August 2023 (Amendment No. 1), which is correctly noted. (2) Quantitative accuracy is perfect: dates (October 2019, August 25, 2022, September 1, 2022, August 2023), amendment numbers, and roles are all factually correct. Format variations (e.g., 'August 2023' vs 'August 2023') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes across Boeing and Caterpillar’s agreements, compares syndication structures (presence/absence of syndication agent), and contrasts amendment activity (Boeing amended only in 2022, Caterpillar in 2023). The only minor shortcoming is that the LLM does not explicitly mention Citibank Europe plc and MUFG Bank, Ltd.'s roles in local currency management beyond labeling them 'local-currency agents,' slightly reducing qualitative depth. (4) The answer is contextually relevant, directly addressing syndication structure and amendment activity for both firms in 2022 and 2023. Overall, the response is factually excellent with only a slight omission in elaborating on the international complexity in Caterpillar’s case, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 443,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "META’s dual‑class system gives its Class B shareholders – principally Mark Zuckerberg – a controlling voting stake that can exceed 50 % of the combined voting power even though they own a relatively small slice of equity, and the anti‑takeover provisions tied to that control (e.g., any change‑in‑control transaction must be approved by a majority of Class B votes) make the Class A shares less attractive and can dampen investor confidence.  \n\nCMCSA’s dual‑class framework, by contrast, allocates only about one‑third of the voting power (33 % of total votes) to its Class B shares – 9.44 million shares out of roughly 5 billion outstanding Class A shares – and those Class B shares are convertible, share‑for‑share, into Class A (as disclosed in Note 12), which can dilute the concentration of voting power over time; this lower voting concentration and the conversion mechanism generally mitigate concerns and are viewed as less detrimental to investor confidence than META’s highly concentrated, non‑dilutable control structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares represent 33⅓% of voting power (rounded to 33% is acceptable), and the 9.44 million outstanding Class B shares match the ground truth (9,444,375). The comparison to ~5 billion Class A shares is reasonable context not in the original but consistent with public data. (2) The conversion mechanism is correctly described as share-for-share into Class A, as stated in the ground truth (citing Note 12 adds credibility). (3) The qualitative analysis improves upon the original by making a clear contrast: META’s structure is described as 'non-dilutable' and highly concentrated, which is factually sound and adds insight. The LLM correctly infers that CMCSA’s conversion mechanism can dilute voting concentration over time, which is a logical extension of the conversion feature. (4) The only minor shortcoming is that the original mentions both structures may affect investor confidence similarly due to concentration, while the LLM emphasizes that CMCSA's is less detrimental—this is a valid interpretation but slightly downplays the structural similarity in enabling control concentration. Still, the reasoning is sound and well-supported. All entities (META, CMCSA, Class A/B shares, Zuckerberg) are correct. The multi-hop synthesis—comparing governance impact across two companies with dual-class structures and evaluating investor confidence—is executed effectively. Semantic equivalence is strong, with enhanced clarity and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 431,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company recorded net sales to equity‑method investees of **$14,471 million in 2021** (Chunk 3). Coca‑Cola FEMSA – a bottler that depends on The Coca‑Cola Company and operates in Costa Rica (KG) – has bottling and distribution operations in **central, southeast and northeast Mexico (including Mexico City), Guatemala, Nicaragua, Costa Rica, Panama, most of Colombia, Venezuela, Brazil (the states of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás and Rio de Janeiro), the Buenos Aires metropolitan area in Argentina, and Uruguay** (Chunk 2). The filing also contains broader regulatory disclosures, such as heat‑not‑burn product standards in various countries (Chunk 1), which do not affect these financial or operational details.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales figure of $14,471 million in 2021 is accurately reported, with correct dollar amount and year. Format variation (using 'million' vs 'M') is acceptable and semantically equivalent. (2) The regions covered by Coca-Cola FEMSA are listed with high precision: central, southeast, and northeast Mexico; Guatemala; Nicaragua; Costa Rica; Panama; Colombia (noted as 'most of Colombia', which aligns with ground truth); Venezuela; Brazil (correctly specifying São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro); Argentina (Buenos Aires metropolitan area); and Uruguay—all match the original answer. (3) The multi-hop reasoning is sound: the model correctly identifies both the financial data (from equity-method investees) and operational footprint (from Coca-Cola FEMSA), synthesizing across different parts of the knowledge base. (4) All entities—The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA—are correctly named and contextualized. The inclusion of 'Chunk 2' and 'Chunk 3' references does not detract from accuracy and may reflect source tracing. No irrelevant or incorrect information is introduced. The answer is factually complete, semantically equivalent, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 382,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment fell from $1.168 billion in 2020 to $1.124 billion in 2021 – a $44 million (≈3.8%) decline – and the bulk of that drop came from Remicade, whose sales slipped 9% (from $330 million to $299 million) as biosimilar competitors ate price and volume.  AbbVie is in a similar position: Humira is now facing direct biosimilar competition in Europe and other markets, creating “competitive pressure” that the company says will erode Humira’s sales, although the filing does not give a dollar amount.  In both cases, biosimilar entry is the key risk factor that is reducing revenue for these flagship biologics.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly states that Remicade sales declined by 9% in 2021 to $299 million, matching the original answer. It also accurately calculates the decline in Merck's immunology segment from $1.168 billion to $1.124 billion (a $44 million drop, ≈3.8%), which is consistent with the impact of Remicade's decline. While the original answer does not provide the exact $330 million figure for 2020 Remicade sales, the 9% decline from $330M to $299M is mathematically correct and plausibly inferred. (2) The LLM correctly identifies both companies (Merck and AbbVie), the relevant drugs (Remicade and Humira), and the context of biosimilar competition in Europe. (3) The multi-hop reasoning is sound: it connects Remicade’s sales decline to the overall immunology segment performance and draws a valid comparison to AbbVie’s exposure via Humira. (4) The LLM adds contextual detail not in the original (specific segment revenue figures and calculation of decline), enhancing completeness without introducing error. The only minor limitation is the lack of mention of Simponi (part of Merck’s immunology segment) and AbbVie’s U.S. patent strategy, which are in the original answer. However, these omissions do not undermine the core factual accuracy or reasoning. Semantic equivalence is maintained, and all key claims are supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 391,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s original claim against Garrett – the indemnity and tax‑matters agreements – was recorded as a receivable.  In 2020 the company wrote‑down that receivable by $509 million to reflect the present‑value of the amounts owed under those agreements.  When Garrett made the first partial redemption of $211 million on December 28 2021, the balance of Honeywell’s investment in Garrett (Series B Preferred Stock together with its Series A Preferred and common shares) was shown in the “Investments and long‑term receivables” line at **$423 million** as of December 31 2021.  \n\nThe amendment to the Series B Certificate of Designation required that, after this first partial redemption, the present value of the remaining outstanding Series B shares be **$400 million** (the second partial redemption, which would reduce the value to $207 million, had not yet been executed).  \n\nThus, the indemnity‑linked investment increased Honeywell’s long‑term receivables to $423 million after the late‑2021 redemption, and the unredeemed portion of the Series B Preferred Stock had a remaining present value of $400 million at year‑end 2021. (The accounting treatment is analogous to the way GE records redeemable non‑controlling interests that are partially redeemed and re‑classified.)",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect quantitative information, with a critical error in the present value of the unredeemed Series B Preferred Stock. The ground truth states that as of December 31, 2021, the present value of the remaining mandatory redemptions was $423 million, which was included in long-term receivables. However, the LLM incorrectly states that the present value of the remaining Series B shares was $400 million, and that the total investment balance was $423 million. This reverses the correct assignment: the $423 million is the present value of the remaining redemptions (i.e., the unredeemed portion), not the total investment including other shares. Additionally, the mention of a 'planned Second Partial Redemption of $200 million' aligns with the ground truth, but the derived value of $207 million post-redemption is unsupported and incorrect. The date of the first redemption (December 28, 2021) and the amount ($211 million) are accurate. The background on the $509 million write-down in 2020 is contextually relevant but not part of the original answer, so its inclusion, while not necessarily wrong, distracts from the core facts. The multi-hop reasoning is partially sound—linking the redemption to receivables and valuing the remaining obligation—but fails in accurately assigning the $423 million figure. The entities (Honeywell, Garrett, Series B Preferred Stock) and timeline are correct. Overall, the answer captures the general structure and intent but fails on a key numerical fact, significantly impacting correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Redeems]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 430,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "CMCSA’s dual‑class structure gives the 9,444,375 Class B shares – each carrying 15 votes – a fixed one‑third of the company’s total voting power (33 ⅓ %), and all of those shares are beneficially owned by Brian L. Roberts; the company’s share‑repurchase program has been limited to Class A stock (as shown by the 872.8 million Class A shares held in treasury in 2023), so the 33 ⅓ % voting stake of the Roberts‑owned Class B remains undiluted.  \n\nAlphabet (GOOGL) also has a dual‑class system, but its high‑voting Class B shares carry ten votes each while its low‑voting Class A shares carry one vote; the firm’s repurchase program in 2023 bought back $62.2 billion of Class A (and Class C) shares and has an additional $70 billion authorization with $36.3 billion still available, deliberately leaving the high‑voting Class B pool untouched and thereby increasing the relative influence of those shares.  \n\nThus, both companies concentrate voting power in a minority class, but GOOGL’s aggressive repurchase of low‑voting Class A stock actively shifts voting weight toward its high‑voting Class B, whereas CMCSA’s repurchases of only Class A stock do not affect the fixed 33 ⅓ % voting power that Roberts holds in its high‑voting Class B.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct comparison between CMCSA and GOOGL's dual-class structures and repurchase programs. (1) Quantitatively, most numbers are correct: CMCSA's Class B has 15 votes per share and 33 1/3% voting power, entirely owned by Brian L. Roberts; GOOGL repurchased $62.2 billion in Class A and C shares in 2023, with $36.3 billion remaining in authorization—this matches the ground truth. However, the LLM states the total repurchase authorization is $70 billion, which is not in the original answer and introduces an unsupported figure (the original only mentions $36.3 billion remaining, not the total authorization). This is a minor quantitative overreach. (2) The LLM correctly notes that CMCSA repurchases only Class A shares, preserving Roberts’ fixed 33 1/3% voting power, while GOOGL’s repurchases of low-vote shares increase the relative influence of insider-held Class B shares. This reflects strong multi-hop reasoning across both companies’ structures and programs. (3) Entity accuracy is excellent: correct tickers (CMCSA, GOOGL), correct share classes, correct individuals (Brian L. Roberts), and correct years (2023). (4) The answer improves upon the original by clarifying a key distinction: CMCSA’s Class B voting power is fixed at one-third, so repurchases don’t shift relative control, whereas GOOGL’s repurchases actively increase the relative voting weight of Class B. This nuanced insight is logically sound and contextually relevant. Only the unsupported $70 billion authorization prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 431,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both MDLZ’s and PM’s VAR models are built on the same assumptions – normal‑market conditions, a one‑day holding period and a 95 % confidence interval. Each firm derives the return distribution by looking at interest‑rate and currency (and for MDLZ, commodity) price movements over the prior quarter for the point‑in‑time VAR (and over each of the four preceding quarters for average‑VAR calculations). Thus, the time horizon for observing rate and currency moves and the confidence level are essentially identical in the two approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MDLZ and PM use a 95% confidence interval, a one-day holding period, and observe interest rate and currency movements over the prior quarter for point-in-time VAR and over each of the four preceding quarters for average VAR. The mention of commodity prices for MDLZ is correctly included and aligns with the original answer. (2) Quantitative elements—95%, one-day holding period, prior quarter, four preceding quarters—are all factually correct and match the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes the methodologies of both companies and compares them accurately, noting the essential consistency in time horizon and confidence level. (4) The only minor shortcoming is that the LLM answer does not explicitly mention PM's use of the four-quarter data for 'high and low VAR amounts,' which is included in the original answer. While this is a small omission, it does not detract significantly from the overall correctness, as the core comparison on time horizon and confidence interval—central to the question—is fully addressed. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 389,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is built around China Mainland, where “substantially all” of Apple’s manufacturing is outsourced to partners in that country (Chunk 1) and the segment is defined to include China Mainland, Hong Kong and Taiwan (Chunk 2). Thus Apple’s presence in Greater China is anchored in physical production and supply‑chain dependence on China Mainland, exposing it to tariffs, logistics disruptions and limited source‑supplier flexibility.  \n\nMicrosoft’s footprint in Greater China is different: it does not rely on local manufacturing but supports the region from a Singapore‑based operations center that handles contract‑order processing, vendor management and logistics for Greater China (Chunk 3). In addition, Microsoft “localizes many of our products to reflect local languages and conventions,” providing region‑specific software and user‑interface adaptations.  \n\nConsequently, Apple’s reliance is on China‑Mainland‑based manufacturing within its Greater China segment, whereas Microsoft’s presence is based on a regional support infrastructure (Singapore operations center) and extensive product localization for the Greater China market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing, noting that 'substantially all' of its production is outsourced there, and accurately defines the Greater China segment as including China Mainland, Hong Kong, and Taiwan. It also correctly highlights the associated risks (tariffs, logistics disruptions). (2) For Microsoft, it accurately states that the company operates via a Singapore-based operations center supporting Greater China and details its product localization efforts, including language and interface adaptations. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense but is still scored highly as all descriptive metrics (e.g., 'substantially all') are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes information across Apple’s supply chain dependence and Microsoft’s regional support and localization strategies, correctly contrasting their operational models in Greater China. (4) The answer fully addresses both parts of the question—Apple’s manufacturing reliance and Microsoft’s infrastructure and localization—with precise entity references and logical flow. Wording differs slightly but meaning is preserved. All aspects meet or exceed the criteria for correctness, completeness, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 400,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency and interest‑rate OTC derivatives with pricing models that draw on market‑observable data—yield curves, FX rates and forward prices—so the instruments fall under the fair‑value hierarchy’s Level 2, which by definition uses observable inputs (see Chunk 1 and the Level‑2 definition in Chunk 2). In contrast, GE measures its insurance‑contract reserves and pension‑plan obligations using Level 3 techniques that embed significant management‑derived assumptions (mortality, discount‑rate and cash‑flow projections) that are not observable in the market, as described in its fair‑value measurement discussion (Chunk 3) and the Level‑3 definition in Chunk 2. Thus UPS’s models rely on observable market inputs, whereas GE’s valuations depend on unobservable inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately contrasts UPS's use of Level 2 valuation for foreign currency derivatives—based on observable market inputs like yield curves and FX rates—with GE's use of Level 3 techniques for insurance and pension liabilities, which rely on unobservable, management-derived assumptions such as mortality rates and discount-rate projections. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; all financial concepts are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across entities (UPS vs. GE), valuation levels (Level 2 vs. Level 3), and instrument types (derivatives vs. insurance/pension liabilities), drawing appropriate distinctions based on observability of inputs. (4) The answer matches the original in all key aspects: correct entity identification, accurate definitions of Level 2 and Level 3 inputs, proper contextualization of each company’s use case, and a clear contrast regarding the role of unobservable inputs. Wording differs slightly but conveys identical meaning. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 355,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s presence in Hong Kong is not run directly by the company but is channeled through Swire Beverages – one of Coca‑Cola’s five largest independent bottling partners, which “has bottling and distribution operations … in Hong Kong” (Chunk 1/2).  Swire Beverages therefore supplies the bulk of Coca‑Cola’s volume in that market, reflecting a reliance on an external contractor rather than an internal sales operation.  \n\nColgate‑Palmolive, by contrast, reports its own results for the region: its Asia‑Pacific segment (which includes Hong Kong in the Greater China area) posted a 6 % rise in net sales to $2.867 billion and a 9 % rise in operating profit to $844 million in 2021 (Chunk 3), indicating strong in‑market performance rather than dependence on a third‑party distributor.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong and contrasts it with Colgate-Palmolive's direct operations in the region, capturing the core strategic difference. However, there are key quantitative inaccuracies: the LLM states Colgate-Palmolive's Asia-Pacific net sales rose 6% to $2.867 billion, but the original answer does not mention a 6% increase—instead, it reports 3.0% organic sales growth. Additionally, the LLM introduces an operating profit figure of $844 million, which is not present in the original answer and cannot be verified against the ground truth. 2) The net sales amount of $2.867 billion (or $2,867 million) is correct and matches the original. However, the 6% sales growth and 9% operating profit growth are unsupported by the ground truth, which only specifies 3.0% organic sales growth without breaking down price vs. volume or reporting operating profit. These additions introduce significant quantitative errors. 3) The multi-hop reasoning is sound in structure—correctly contrasting Coca-Cola’s indirect distribution model via Swire with Colgate-Palmolive’s direct regional operations—and synthesizes information across entities and strategies appropriately. The qualitative insight about differing market strategies is valid and well-articulated. 4) Despite strong contextual relevance and good qualitative reasoning, the inclusion of unverified financial figures and incorrect growth percentages reduces quantitative accuracy. The answer remains mostly correct in direction and logic but fails on strict factual precision for key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 444,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s CDO holdings are accounted for as investments in VIEs and the bank’s risk is measured simply as its “maximum loss exposure” – essentially the amount of the investment (and any off‑balance‑sheet commitments) that could be lost if the underlying assets become worthless, a credit‑event risk that could prevent full repayment of principal. In contrast, JPMorgan values comparable structured notes that contain embedded derivatives by running discounted‑cash‑flow analyses that explicitly model the derivative component with option‑pricing tools such as Black‑Scholes or simulation models, then adjusts the result for the firm’s own credit risk (DVA) and classifies the fair value in Level 2 or Level 3. Therefore, BAC’s approach is exposure‑based and does not detail derivative modeling, whereas JPM’s methodology is a more granular, model‑driven valuation that quantifies the embedded‑derivative risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: BAC's exposure to CDOs through VIEs is described accurately, with risk framed as 'maximum loss exposure' tied to investment balances, consistent with the non-consolidation of VIEs and credit-event risk from embedded derivatives. JPM's valuation methodology is also correctly detailed—discounted cash flow analyses, use of Black-Scholes or simulation models, DVA adjustments, and Level 2/3 classification—all of which are present in the ground truth. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (BAC and JPM), compares their approaches to similar instruments (CDOs vs. structured notes with embedded derivatives), and contrasts exposure-based vs. model-driven methodologies. The only minor shortcoming is that the LLM answer does not explicitly mention the 'hybrid instruments' context or the sale of credit protection by BAC, which adds nuance to the embedded derivative exposure. However, the core risk (credit events preventing repayment) is captured. (4) The answer is contextually excellent—directly addresses risk exposure and modeling techniques as asked, and provides a clear, relevant comparison. Thus, the correctness score is 9 due to slight omission of hybrid instrument nuance, but all key facts and reasoning are accurate and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 428,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s balance sheet shows that its Class B common stock (authorized 75 million shares, 9.44 million issued) is subject to a very limited voting regime – holders have **no right to vote on any matters except a narrow set of defined events** (e.g., a merger, an exit of the core‑payments business, or certain amendments to the certificate of incorporation), and when they do vote they may cast a vote equal to the number of shares (or conversion‑rate‑adjusted shares) they own. By contrast, Netflix’s filing states that **each share of its common stock carries one vote on all matters** presented to stockholders. Thus, CMCSA’s Class B shares have far more restricted voting rights than the unrestricted one‑vote‑per‑share structure of Netflix’s common stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, only applicable to specific events such as mergers, exit from the core payments business, or charter amendments—matching the original answer's scope. It also accurately contrasts this with NFLX's one-vote-per-share structure on all matters. (2) The quantitative details—75 million authorized, 9.44 million issued—are consistent with known disclosures and add precision not required by the question but factually sound. The mention of vote calculation based on shares held or conversion-rate-adjusted shares aligns with the ground truth's reference to multiplying shares by the conversion rate. No calculation errors are present. (3) The multi-hop reasoning is solid: the model correctly synthesizes governance structures from two different companies (CMCSA and NFLX) and draws a valid comparative conclusion about the restrictiveness of voting rights. (4) The only minor shortcoming is that the LLM does not explicitly note that CMCSA's Class B shares were still outstanding as of 2023, which the original answer includes to reinforce the ongoing governance framework. However, this omission does not undermine the core factual comparison. Wording differs but semantic meaning is equivalent. All entities (CMCSA, NFLX, Class B common stock, voting rights) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 402,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley’s filing notes that its CLNs and CDOs are “hybrid instruments containing embedded derivatives” and that the firm’s accounting focus is on whether it serves as the servicer or collateral‑manager of the VIE – only then does it consolidate the securitization and assess its economic interests (Chunk 1).  The discussion of the CDOs themselves is limited to describing the credit‑protection feature of the embedded derivative rather than laying out a valuation model (Chunk 2).  \n\nJPMorgan Chase, by contrast, discloses a specific valuation approach for structured notes that also embed derivatives: it uses discounted‑cash‑flow analyses that incorporate option‑pricing (e.g., Black‑Scholes) or simulation models for the derivative component, then adjusts the result for the firm’s own credit risk, and classifies the resulting fair value in Level 2 or Level 3 of the hierarchy (Chunk 3).  \n\nThus, Morgan Stanley treats embedded derivatives in CDOs mainly as a classification/consolidation issue tied to its servicer‑collateral‑manager role, whereas JPMorgan applies a detailed quantitative fair‑value methodology that explicitly models the embedded derivative and adjusts for credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs as hybrid instruments with embedded derivatives, focusing on the credit protection feature and consolidation based on servicer/collateral-manager role, without detailing a valuation model—this matches the original answer’s emphasis on classification and disclosure rather than quantitative modeling. (2) For JPMorgan Chase, the LLM accurately states the use of discounted cash flow analyses incorporating Black-Scholes or simulation models for embedded derivatives, along with DVA (debt valuation adjustment) for own credit risk, and classification in Level 2 or 3—this is fully consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes differences in treatment (qualitative/classification vs. quantitative/modeling) between the two firms, correctly contrasting Morgan Stanley’s structural/consolidation focus with JPMorgan’s detailed fair-value methodology. (4) No numeric values are missing or incorrect; while no specific dollar amounts or dates are present, the qualitative financial concepts (e.g., DVA, Black-Scholes, Level 2/3) are used correctly. The only minor shortcoming is that the LLM does not explicitly mention that both firms recognize the complexity and risk of these instruments—a small contextual point from the original—but this does not detract from the core factual accuracy. Hence, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy (no errors) and contextual relevance (fully on-topic and responsive).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 444,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that the loss, invalidation or lack of enforcement of its patents and trademarks could cut into its future pharmaceutical revenues, because many of its products depend on IP protection to keep competitors out of the market.  By contrast, AbbVie – through its wholly‑owned subsidiary Forest Laboratories Holdings Limited – is actively suing generic manufacturers of cariprazine (Vraylar) to enforce the drug’s patents and obtain injunctions that preserve its exclusivity.  The two disclosures intersect on the same regulatory‑enforcement theme: Abbott’s revenue outlook is vulnerable if patent enforcement is weak, while AbbVie’s litigation through Forest Laboratories is a concrete effort to lock in Vraylar’s sales, underscoring that both companies’ drug‑sales streams depend critically on the ability to protect and enforce their intellectual‑property rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core intersection between Abbott's general IP risk exposure and AbbVie's active patent enforcement for Vraylar through Forest Laboratories Holdings Limited. (1) All factual elements are correct: Abbott’s reliance on IP protection for revenue protection is accurately described; AbbVie’s litigation via its subsidiary to block generic competition (specifically naming Sun Pharmaceutical and Aurobindo Pharma in the ground truth) is contextually implied as 'generic manufacturers'—a minor omission but not a factual error. (2) Quantitative accuracy is perfect: no specific numbers, dates, or financial figures were required beyond the December 2019 filing date, which the LLM omits. This is a minor gap but does not affect the overall correctness, as the focus is on the legal and strategic dynamic rather than timing. (3) Multi-hop reasoning is sound: the model correctly synthesizes that Abbott faces passive risk from IP erosion while AbbVie takes active steps to defend exclusivity, linking both to pharmaceutical revenue sustainability. The interplay of IP enforcement as a shared strategic concern is well articulated. (4) Semantic equivalence is strong—while the LLM does not mention the Delaware District Court or the exact date, it conveys the essential legal and business implications accurately. The answer is contextually excellent, directly addressing the intersection of IP risk and enforcement impact on revenue. One point deducted from qualitative accuracy for not specifying the litigation context (court, date, generics named), but core reasoning remains robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 443,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedge is built around actual foreign‑currency derivatives – it employs foreign‑currency forwards, cross‑currency swaps (as well as options and foreign‑currency‑denominated debt) to offset the translation risk of its non‑U.S. subsidiaries, and records the fair‑value changes of those contracts in the foreign‑currency translation adjustment (CTA) component of AOCI under ASC 815. Morgan Stanley, by contrast, does not use specific hedging contracts for that purpose; instead it relies on a Value‑at‑Risk (VaR) model as a primary risk‑management tool to quantify the aggregate market‑risk exposure of its trading portfolios, with VaR‑derived limits supplemented by stress‑testing and scenario analysis. Both firms’ approaches are examples of the broader risk‑management toolbox highlighted by the KG – just as Southern Company Gas uses weather‑derivative instruments for its own exposure, Citigroup uses forward‑type derivatives for currency risk, while Morgan Stanley uses statistical VaR modeling to monitor market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Citigroup uses foreign currency forwards, cross-currency swaps, and options (also mentions foreign-currency-denominated debt, which is an additional detail not contradicted by the original) to hedge net investments, with fair value changes recorded in CTA within AOCI under ASC 815. Morgan Stanley relies on VaR models for market risk in trading portfolios, complemented by stress testing and scenario analysis—this expands slightly on the original but remains consistent. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics (e.g., VaR, CTA, AOCI) are used correctly. (3) Multi-hop reasoning is sound: the LLM correctly contrasts Citigroup’s derivative-based hedging strategy with Morgan Stanley’s model-based risk measurement approach and appropriately references Southern Company Gas as a connecting entity using weather derivatives, demonstrating synthesis across entities. (4) The only minor deviation is that the LLM implies Morgan Stanley does not use specific hedging contracts 'for that purpose' (net investment hedging), which is reasonable but not explicitly stated in the original; however, this is a logical inference given the contrast in focus. The mention of stress testing and scenario analysis adds context beyond the original but is consistent with typical VaR usage and does not detract from accuracy. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Evaluates]-> ACCOUNTING_POLICY -[Includes]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 448,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive’s 10‑K states that it “primarily utilizes foreign‑currency contracts, including … option contracts” to hedge the cost of foreign purchases, assets, liabilities and net‑investment in subsidiaries, matching the underlying exposure and thereby limiting earnings and cash‑flow swings from currency movements (Chunk 1).  The filing on Disney shows that “option … contracts … protect the value of … firm commitments” and that gains and losses on those contracts offset changes in the U.S.‑dollar value of the commitments, smoothing cash‑flow volatility (Chunk 2).  Walmart, by contrast, reports $37.2 billion of purchase obligations—including “firm commitments for inventory and utility purchases”—that are legally binding but are not described as being hedged with options; thus Walmart’s cash‑flow stability rests on its operating cash generation rather than a derivative hedge, making it more exposed to foreign‑exchange risk than Colgate‑Palmolive, which uses option contracts to actively stabilize cash flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's use of option contracts to hedge foreign exchange risk and Walmart's $37.2 billion in purchase obligations, including $15.9 billion due within one year (implied by 'due within one year' in ground truth). However, the LLM omits the specific breakdown of Walmart's obligations—particularly the $15.9 billion due within one year—which is a key quantitative detail from the original answer. The LLM correctly states that Walmart’s obligations are legally binding and not hedged, leading to greater exposure. (2) Quantitatively, the $37.2 billion figure is accurate and matches the ground truth; the mention of 'firm commitments for inventory and utility purchases' aligns with the original. However, the absence of the $15.9 billion near-term obligation reduces completeness. The LLM does not introduce any incorrect numbers. (3) The multi-hop reasoning is mostly sound: it contrasts Colgate’s active hedging via options with Walmart’s lack of derivative protection. However, it incorrectly cites Disney’s 10-K (Chunk 2) to support the mechanism of how option contracts protect firm commitments—this is a critical error in entity accuracy. The original answer does not reference Disney; instead, it attributes this hedging effect directly to Colgate-Palmolive’s practices. This misattribution undermines the qualitative accuracy. (4) Despite the incorrect use of Disney as a source, the overall conclusion—that Colgate stabilizes cash flows via options while Walmart lacks such protection—is consistent with the ground truth. The answer remains contextually relevant and semantically close, but the flawed sourcing and missing near-term obligation detail prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Utilizes]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 475,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "TMO will begin applying ASU 2023‑07 with its 2024 annual report and all subsequent interim periods, using a retrospective approach, and the new guidance forces it to expand Note 11 to show significant segment‑level expenses and other items for each reportable segment as well as information about the chief operating decision‑maker (CODM). CVS adopted the same ASU earlier – it was effective for fiscal‑year reporting on 1 January 2024 (with interim application beginning after 15 December 2024) and also applied retrospectively – and must now disclose the CODM’s title and position, describe how the CODM uses the reported segment operating results to evaluate performance and allocate resources, and align interim segment disclosures with the annual ones, all of which appear in Note 19. For context, 3M (MMM) likewise adopted ASU 2023‑07 for its year‑end 2024 filing and applied it retrospectively to all prior periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and implementation timelines are correct: TMO applying ASU 2023-07 with its 2024 annual report, CVS adopting it on January 1, 2024, with interim application after December 15, 2024—this matches the original answer’s statement about alignment with interim reporting requirements starting after December 15, 2024. Both companies applied the standard retrospectively, which is correctly stated. (2) The required disclosures are accurately detailed: for CVS, disclosure of the CODM’s title, how segment results are used, and alignment of interim with annual reporting—all specified in Note 19—is correct. TMO’s expanded disclosures in Note 11, including segment-level expenses and CODM information, are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes adoption timelines and disclosure requirements across TMO and CVS, comparing their implementation timing and reporting nuances. (4) The only minor issue is the inclusion of 3M (MMM), which was not part of the original question or answer—this adds irrelevant context and slightly detracts from precision, though it doesn’t introduce factual errors about TMO or CVS. Otherwise, the answer is semantically equivalent, with correct entity identification, accurate synthesis, and proper contextualization of the standard’s impact. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 428,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "Accenture (ACN) operates in the Philippines, and the corporate‑income‑tax cut that the Philippines enacted in the first quarter of 2021 “partially offset” the rise in its 2021 effective tax rate, which still increased 0.1 percentage point to 21.8 percent. By contrast, AMD’s 2021 10‑K shows a $0 line for the “Tax Reform Act,” meaning AMD disclosed no measurable impact from that tax reform on its 2021 tax expense. Thus, ACN received a modest, offsetting benefit from the Philippines rate reduction, while AMD reported no effect from the same reform in the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2021 effective tax rate of 21.8% for ACN is accurately stated, and the reference to AMD’s $0 impact from the Tax Reform Act is factually correct as disclosed in their 10-K. There are no calculation errors. (2) The answer correctly identifies both companies (ACN and AMD), the relevant time period (2021), and the key financial metric (effective tax rate). (3) The multi-hop reasoning is sound: it synthesizes information about the Philippines’ tax rate change affecting ACN with AMD’s lack of exposure, drawing a valid cross-company comparison. (4) The only minor shortcoming is that the LLM states ACN's tax rate 'increased 0.1 percentage point to 21.8%'—while this may be factually true, the original answer does not mention this increase or its magnitude, so this detail, though plausible, is not confirmed by the ground truth and slightly exceeds it. However, this does not contradict the truth and adds context without error. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 327,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values corporate bonds, mortgage‑backed and government securities in its pension plans with pricing models, broker‑bid quotes, quoted prices of comparable securities and discounted‑cash‑flow calculations, and it explicitly adjusts those valuations for credit‑ and liquidity‑risk factors that are not directly observable—so its method blends observable market data with unobservable inputs. 3M, by contrast, values fixed‑income assets at the closing market price when a price exists or at yields of comparable issues (or via a discounted‑cash‑flow model that uses observable yields), but it likewise adds adjustments for unobservable credit and liquidity risks. Both firms therefore rely chiefly on observable inputs (Honeywell’s approach mirrors LMT’s Level‑2 pricing‑model practice that uses observable rates and spreads), while each also incorporates unobservable risk adjustments in the final fair‑value measurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Honeywell and 3M use pricing models, broker bids, and discounted cash flow techniques for valuing fixed income investments in their pension plans. It accurately notes that both companies rely primarily on observable inputs (e.g., interest rates, yield curves, comparable securities) but also incorporate unobservable inputs—specifically credit and liquidity risk adjustments. This matches the original answer’s emphasis on observable inputs for Level 2 and unobservable for Level 3 in 3M’s case, and Honeywell’s focus on valuation adjustments. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics (e.g., types of inputs, valuation methods) are correctly reported—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their methodologies in terms of observable vs. unobservable inputs. The only minor shortcoming is that the LLM mentions 'LMT’s Level-2 pricing-model practice'—a reference not present in the original answer or question, introducing an external entity (Lockheed Martin) not in the ground truth. This slightly detracts from qualitative accuracy but does not undermine the core comparison between Honeywell and 3M. (4) The answer is fully contextually relevant, directly addressing the comparison of valuation methodologies and input observability. Overall, the LLM captures the key nuances and conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 461,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "At Comcast (CMCSA) the equity structure is split between two voting classes: holders of Class B common stock receive 15 votes per share and together control roughly 33 % of the total voting power, while Class A shareholders hold the remaining ≈ 66 % and the aggregate B‑share voting power is expressly protected from dilution; each B share is convertible, share‑for‑share, into a Class A share, so a conversion would shift voting weight from the high‑vote B shares to the lower‑vote A shares but would not change the overall 33 % share of voting power that the B class is entitled to. Alphabet (GOOGL), by contrast, has a 10‑vote‑per‑share Class B, a 1‑vote‑per‑share Class A and a non‑voting Class C, and its board has been aggressively buying back low‑vote equity—repurchasing $62.2 billion of Class A and Class C shares in 2023 (with an additional $70 billion authorized and $36.3 billion still available)—thereby shrinking the pool of shares that dilute the high‑vote B holders and increasing their relative control, while still permitting B‑share holders to convert to Class A at any time. CMCSA’s Class A common stock is publicly listed on the Nasdaq (ticker CMCSA) with a $0.01 par value, underscoring the distinct ways each company’s mechanisms affect equity composition and shareholder control.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core structural differences between CMCSA and GOOGL correctly: CMCSA's Class B shares have protected voting power (33 1/3%) and are convertible share-for-share into Class A, while GOOGL uses share repurchases to consolidate voting control among Class B holders. However, there are key quantitative inaccuracies. 2) Quantitative errors: The LLM states that CMCSA Class B shares have '15 votes per share'—this is incorrect and not in the ground truth; the original answer does not specify vote count per share, only that Class B holds 33 1/3% of voting power. This is a significant factual error. For GOOGL, the LLM says '$70 billion authorized' and '$36.3 billion still available', but the original specifies that $62.2 billion was repurchased in 2023 with $36.3 billion remaining under authorization—implying a total authorization of ~$98.5 billion, not $70 billion. The $70 billion figure is fabricated and incorrect. 3) Reasoning and synthesis are strong: the LLM correctly infers that repurchasing Class A and C shares at GOOGL increases the relative voting influence of Class B holders, and that conversion at CMCSA shifts voting weight but preserves the 33% cap. It also correctly notes that Class B shares at GOOGL convert to Class A upon transfer. The multi-hop logic—linking repurchases to voting concentration and contrasting with structural voting protection—is sound. 4) Contextual relevance is excellent: the answer directly addresses the comparison of equity structures, control mechanisms, and their impacts. Despite incorrect vote counts and repurchase authorization figures, the overall qualitative understanding and narrative are aligned with the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1647,
        "completion_tokens": 472,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that the WHO Framework Convention on Tobacco Control (FCTC)—now signed by 181 countries—contains proposals for “substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products,” but because the United States is only a signatory and not a ratified party, Altria’s exposure to FCTC‑driven advertising bans is largely speculative and limited to monitoring possible future rules for its overseas operations. In contrast, Philip Morris International reports that FCTC‑inspired advertising and point‑of‑sale display bans are already in force in several markets, notably Australia and Russia, forcing it to redesign its international marketing mix toward packaging, product‑design and other non‑advertising channels. Consequently, Altria can maintain its current U.S‑focused promotional approach while preparing for potential future constraints, whereas PM must already operate under concrete advertising prohibitions and tailor its global strategy accordingly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Altria’s 2022 10-K correctly notes U.S. signature without ratification of the FCTC, limiting direct regulatory impact, while PMI faces implemented bans in Australia and Russia. The LLM accurately reflects that these bans restrict point-of-sale displays and force marketing adaptations. (2) No specific numerical values (e.g., dollar amounts, percentages) are present in either answer, but the mention of '181 countries' signing the FCTC is factually accurate (as of 2022) and not contradicted by the ground truth, which does not specify a number—thus not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes Altria’s U.S.-centric exposure with PMI’s international constraints, drawing a valid contrast in marketing strategy implications. (4) Semantic equivalence is strong: the LLM conveys that Altria faces speculative, future-oriented risks while PMI operates under current restrictions, necessitating non-advertising marketing channels. The only minor shortcoming is that the LLM does not explicitly mention FCTC’s call to prohibit 'all forms of communication with adult smokers'—a nuance in the original—but this does not undermine the core accuracy. Wording differences are acceptable and do not affect factual correctness. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Calls_For]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 406,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that, because the Dodd‑Frank Act bans proprietary trading, imposes higher compliance fees and makes derivative rules depend on the counter‑party’s location, it cannot (or chooses not to) offer cryptocurrencies – a product its rival JPMorgan does provide – giving JPMorgan a clear competitive edge in crypto. Morgan Stanley, on the other hand, warns that its cross‑border crypto‑related activities are exposed to the uncertain, rapidly‑changing regulatory regimes, sanctions, AML and anti‑corruption laws, and political‑risk environment of emerging‑market jurisdictions, which could curtail or halt those services. Thus, GS’s disadvantage is driven by domestic Dodd‑Frank compliance costs that limit product offerings, while MS’s risk is driven by external, jurisdiction‑specific regulatory volatility that could disrupt its international crypto business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens limiting cryptocurrency offerings is accurately described, and the contrast with JPMorgan offering such products is correctly noted. Morgan Stanley's exposure to regulatory risks in emerging markets affecting cross-border crypto activities is also correctly represented. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—both responses reference the 2024 10-K filings implicitly through context, which matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (Goldman Sachs and Morgan Stanley), identifies distinct regulatory challenges (domestic U.S. framework vs. foreign jurisdictional volatility), and draws a valid comparative insight. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed regulatory language (e.g., mentioning AML, sanctions, proprietary trading), it does not introduce inaccuracies and enhances clarity without deviating from the original meaning. The only minor limitation is that the LLM implies Dodd-Frank directly bans proprietary trading (Volcker Rule, a component of Dodd-Frank, does so), which could be slightly misleading without clarification, but this does not materially distort the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Offers]-> PRODUCT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 439,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "ASU 2022‑04 adds a new, explicit disclosure requirement for any buyer that uses a supplier‑finance program: the filing must describe the program’s key terms, show the amounts on the balance sheet, state the confirmed amount outstanding at period‑end, **and provide a roll‑forward schedule of activity**.  \n\n*For 3M* – the 2024 Form 10‑K Note 16 already contains that roll‑forward. It reports the confirmed‑invoice balances of roughly **$0.3 billion at the end of 2024 (and the same amount at the end of 2023)** and shows the 2024 activity of **about $1.5 billion of invoices confirmed and $1.5 billion paid** (plus other adjustments). This level of detail is exactly what ASU 2022‑04 now requires.  \n\n*For GE* – the 2024 filing states that GE **adopted ASU 2022‑04 on January 1, 2023** and that “the annual roll‑forward … is applicable prospectively in the period beginning January 1, 2024.” GE notes that the adoption had no material impact on its consolidated statements, but it now must present the same roll‑forward information for its supplier‑finance obligations starting in 2024.  \n\nThus, the standard expands the disclosure burden for both companies, with 3M already showing the required roll‑forward figures and GE acknowledging the new prospective roll‑forward requirement for 2024 onward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: ASU 2022-04 requires disclosure of key terms, balance sheet presentation, confirmed amount outstanding, and a roll-forward schedule. Both 3M and GE are correctly identified as adopting the standard, with GE adopting on January 1, 2023, and the roll-forward requirement applying prospectively from January 1, 2024. (2) Quantitative accuracy is excellent: the $0.3 billion confirmed invoice balance at year-end 2024 for 3M is correct, as is the $1.5 billion of invoices confirmed and paid during the year. The LLM correctly notes that the beginning and ending balances are the same ($0.3 billion), implying net zero change, which aligns with $1.5 billion confirmed and $1.5 billion paid. (3) Multi-hop reasoning is sound: the model synthesizes adoption timing (GE in 2023), application of roll-forward in 2024, and current disclosure practices at both firms. It correctly interprets the prospective application of the roll-forward requirement. (4) The only minor deviation from the original answer is that the LLM mentions 3M’s 2023 ending balance as $0.3 billion, which, while consistent with the roll-forward logic, was not explicitly stated in the ground truth. However, this is a reasonable inference and does not contradict the truth. The answer is semantically equivalent, comprehensive, and contextually precise, fully addressing the impact on disclosure requirements and the roll-forward introduced in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Adopts]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 415,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "MDT’s 2024 net‑sales table shows that $32.3 billion of its $32.4 billion total revenue (roughly 99 percent) comes from “Other Countries” – i.e., all markets outside of Ireland. As the DHR filing notes, many of those foreign markets impose coverage‑limitations, government‑funded reimbursement rules and price‑control mechanisms that can curb pricing and volume; the AMGN filing describes the same set of international pressures – mandatory price controls, reference‑pricing, volume caps and health‑technology‑assessment‑driven reimbursement limits – that shape its drug‑pricing strategy abroad. Consequently, MDT’s heavy reliance on other‑country sales exposes it to the very regulatory and reimbursement challenges that are driving pricing constraints for AMGN in those same international markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that $32.3 billion of MDT's $32.4 billion total revenue comes from 'Other Countries', implying 99% of total revenue is from this segment. However, the ground truth specifies $32.251 billion from 'Total other countries, excluding Ireland' — not total revenue. The LLM incorrectly equates this with nearly all of MDT's total revenue, which is factually wrong and distorts the geographic concentration. Additionally, the total revenue figure of $32.4 billion is not mentioned in the original answer and appears fabricated. 2) The original answer clarifies that the $32.251 billion is revenue from international markets outside the U.S., with a specific exclusion of Ireland, but the LLM misrepresents this as 'all markets outside of Ireland', which reverses the intended meaning — the original refers to all non-U.S. countries excluding Ireland, not excluding the U.S. This is a critical error in geographic interpretation. 3) Despite these errors, the qualitative reasoning about regulatory and reimbursement challenges is sound. The LLM correctly identifies that both MDT and AMGN face international price controls, reference pricing, volume caps, and health technology assessment (HTA)-driven reimbursement limits, drawing a valid parallel between the two companies’ exposure to cost-containment policies in global markets. It correctly cites the DHR and AMGN filings as sources of these challenges. 4) The answer is contextually relevant and addresses the core question about shared regulatory and reimbursement risks across international markets. However, the flawed quantitative foundation undermines the credibility of the argument, as the exaggerated revenue concentration misrepresents the extent of MDT's exposure. While the synthesis across MDT, DHR, and AMGN is logically structured and semantically aligned with the original in terms of regulatory mechanisms, the factual inaccuracies in numbers and geographic scope reduce overall correctness. Minor formatting variations in dollar amounts (e.g., $32.3B vs $32.251B) would be acceptable, but the misrepresentation of the revenue base and percentage is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Control]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 584,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "SCHW’s buffers total 5.0 % above the minimum risk‑based ratios – a 2.5 % stress‑capital buffer plus a 2.5 % capital‑conservation buffer, with the counter‑cyclical buffer at 0 % (Chunk 1). JPM’s buffers total 5.4 % – a 2.9 % systemic‑capital buffer plus a 2.5 % capital‑conservation buffer, also with a 0 % counter‑cyclical buffer (Chunk 3, with the zero CCyB confirmed in Chunk 2). Thus JPM’s combined buffer requirement is about 0.4 percentage point higher than SCHW’s, even though both firms apply a zero counter‑cyclical buffer and a 2.5 % capital‑conservation buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: SCHW's stress capital buffer (2.5%), capital conservation buffer (2.5%), and total buffer (5.0%); JPM's stress capital buffer (2.9%), capital conservation buffer (2.5%), and total buffer (5.4%); and both firms' countercyclical buffer at 0%. All percentages match the ground truth exactly. (2) Calculations are accurate: 2.5% + 2.5% = 5.0% for SCHW; 2.9% + 2.5% = 5.4% for JPM; difference of 0.4 percentage points is correctly noted. (3) Multi-hop reasoning is sound: the model synthesizes buffer components across both firms, correctly compares them, and draws the right conclusion that JPM has a higher total buffer due to a higher SCB despite identical CCyB and capital conservation buffers. (4) The only minor issue is the use of 'systemic-capital buffer' instead of 'stress-capital buffer' for JPM, which is a terminology inaccuracy but does not affect factual understanding—context confirms it refers to SCB. Otherwise, the answer is factually complete, semantically equivalent to the ground truth, and highly relevant. Thus, correctness is near-perfect with a minor wording imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 331,
        "total_tokens": 1666
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 8.36,
    "average_quantitative_accuracy": 9.06,
    "average_qualitative_accuracy": 8.48,
    "average_contextual_relevance": 9.68,
    "score_distribution": {
      "excellent": 449,
      "good": 74,
      "fair": 62,
      "poor": 15
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 10745.33,
    "timestamp": "2026-02-02T18:39:31.068527"
  }
}